<SEC-DOCUMENT>0001171843-17-001428.txt : 20170310
<SEC-HEADER>0001171843-17-001428.hdr.sgml : 20170310
<ACCEPTANCE-DATETIME>20170310170737
ACCESSION NUMBER:		0001171843-17-001428
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		90
CONFORMED PERIOD OF REPORT:	20161231
FILED AS OF DATE:		20170310
DATE AS OF CHANGE:		20170310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOINT Corp
		CENTRAL INDEX KEY:			0001612630
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				900544160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36724
		FILM NUMBER:		17682993

	BUSINESS ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 240
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
		BUSINESS PHONE:		480 245 5960

	MAIL ADDRESS:	
		STREET 1:		16767 N PERIMETER DRIVE
		STREET 2:		SUITE 240
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85260
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>f10k_031017p.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML><HEAD>
     <TITLE></TITLE>
</HEAD><BODY STYLE="font: 10pt Times New Roman, Times, Serif">





<p style="margin: 0"></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<!-- Field: Rule-Page --><div align="CENTER" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt"><b>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</b></font></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt">Washington, D.C. 20549</font></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><font style="font-size: 12pt">&nbsp;</font></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><font style="font-size: 12pt"><b>FORM 10-K</b></font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&#9746; <b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)&nbsp;OF
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>For the fiscal year ended December 31, 2016</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>OR</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&#9744; &nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>For the transition period from _______ to ________</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Commission File Number: 001-36724</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 18pt; text-align: center; margin: 0pt 0"><b><u>The Joint Corp.</u></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>(Exact name of registrant as specified in its charter)</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><b>Delaware</b></font></td>
    <td style="width: 50%; text-align: center"><font style="font-size: 10pt"><b>90-0544160</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-size: 10pt"><i>(State or Other Jurisdiction of</i></font></td>
    <td style="text-align: center"><font style="font-size: 10pt"><i>(I.R.S. Employer</i></font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><font style="font-size: 10pt"><i>Incorporation)</i></font></td>
    <td style="text-align: center"><font style="font-size: 10pt"><i>Identification No.)</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">
        <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>16767 N. Perimeter Drive, Suite 240, Scottsdale</b></p>
        <p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Arizona</b></p></td>
    <td style="width: 50%; font-size: 10pt; text-align: center"><font style="font-size: 10pt"><b>85260</b></font></td></tr>
<tr>
    <td style="font-size: 10pt; text-align: center"><font style="font-size: 10pt"><i>(Address of Principal Executive Offices)</i></font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-size: 10pt">(Zip Code)&nbsp;</font></td></tr>
</table>
<p style="font-size: 10pt; text-indent: 27pt; margin: 0pt 0"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>(480) 245-5960</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>(Registrant&#8217;s Telephone Number, Including Area Code)</i></p>

<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><i>&nbsp;</i><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 27pt; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 50%; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><u>Title Of Each Class</u></font></td>
    <td style="width: 50%; text-decoration: underline; text-align: center"><font style="font-size: 10pt"><u>Name Of Each Exchange On Which Registered</u></font></td></tr>
<tr>
    <td style="text-align: center"><font style="font-size: 10pt">Common Stock, $0.001 Par Value Per Share</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">The NASDAQ Capital Market LLC</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">Securities Registered Pursuant to Section 12(g) of the Act:</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>None</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if the registrant is
a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if the registrant is
not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant:
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9745; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9744;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes&nbsp;&nbsp; &#9745; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp; &#9744;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark if disclosure of delinquent
filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant&#8217;s
knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment
of this Form 10-K.&nbsp;&nbsp;&nbsp; &#9744;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule&nbsp;12b-2
of the Exchange Act. (Check one):</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td nowrap style="width: 25%"><font style="font-size: 10pt">Large accelerated filer&nbsp;&nbsp; &#9744;</font></td>
    <td nowrap style="width: 25%"><font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; Accelerated filer&nbsp;&nbsp; &#9744;</font></td>
    <td nowrap style="width: 25%"><font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; Non-accelerated filer&nbsp;&nbsp; &#9744;&nbsp;&nbsp;</font></td>
    <td nowrap style="width: 25%"><font style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; Smaller reporting company &#9745;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act).&nbsp;&nbsp;Yes&nbsp;&nbsp; &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;
&#9745;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The aggregate market value of the voting and
non-voting common equity held by non-affiliates of the registrant was approximately $21.2 million as of June 30, 2016 based on
the closing sales price of the common stock on the NASDAQ Capital Market.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;There were&nbsp;13,054,531 shares of
the registrant&#8217;s common stock issued and outstanding as of March 1, 2017.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>Documents Incorporated by Reference</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Portions of the registrant's Proxy Statement
relating to its 2017 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission (&#8220;SEC&#8221;)
pursuant to Regulation&nbsp;14A within 120 days after the registrant&#8217;s fiscal year ended December 31, 2016, are incorporated
by reference in Part&nbsp;III of this Form&nbsp;10-K.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;<b>TABLE OF CONTENTS</b></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 86%">&nbsp;</td>
    <td style="text-align: center; width: 7%"><b>Page</b></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><b><u>Numbers</u></b></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">PART I</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_001">Item&nbsp;1.</a></td>
    <td><a href="#a_001">Business</a></td>
    <td style="text-align: center"><a href="#a_001">1</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_002">Item&nbsp;1A.</a></td>
    <td><a href="#a_002">Risk Factors&nbsp;</a></td>
    <td style="text-align: center"><a href="#a_002">12</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_003">Item&nbsp;1B.</a></td>
    <td><a href="#a_003">Unresolved Staff Comments</a></td>
    <td style="text-align: center"><a href="#a_003">29</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_004">Item&nbsp;2.</a></td>
    <td><a href="#a_004">Properties</a></td>
    <td style="text-align: center"><a href="#a_004">29</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_005">Item&nbsp;3.</a></td>
    <td><a href="#a_005">Legal Proceedings</a></td>
    <td style="text-align: center"><a href="#a_005">29</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_006">Item&nbsp;4.</a></td>
    <td><a href="#a_006">Mine Safety Disclosures</a></td>
    <td style="text-align: center"><a href="#a_006">29</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">PART II</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_007">Item&nbsp;5.</a></td>
    <td><a href="#a_007">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></td>
    <td style="text-align: center"><a href="#a_007">30</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_008">Item&nbsp;6.</a></td>
    <td><a href="#a_008">Selected Financial Data</a></td>
    <td style="text-align: center"><a href="#a_008">31</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_009">Item&nbsp;7.</a></td>
    <td><a href="#a_009">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></td>
    <td style="text-align: center"><a href="#a_009">32</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap><a href="#a_010">Item 7A.</a></td>
    <td><a href="#a_010">Quantitative and Qualitative Disclosures About Market Risk</a></td>
    <td style="text-align: center"><a href="#a_010">40</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_011">Item&nbsp;8.</a></td>
    <td><a href="#a_011">Financial Statements and Supplementary Data</a></td>
    <td style="text-align: center"><a href="#a_011">40</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_012">Item&nbsp;9.</a></td>
    <td><a href="#a_012">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></td>
    <td style="text-align: center"><a href="#a_012">68</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_013">Item&nbsp;9A.</a></td>
    <td><a href="#a_013">Controls and Procedures</a></td>
    <td style="text-align: center"><a href="#a_013">68</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_014">Item&nbsp;9B.</a></td>
    <td><a href="#a_014">Other Information</a></td>
    <td style="text-align: center"><a href="#a_014">69</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">PART&nbsp;III</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_015">Item&nbsp;10.</a></td>
    <td><a href="#a_015">Directors, Executive Officers and Corporate Governance</a></td>
    <td style="text-align: center"><a href="#a_015">69</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_016">Item&nbsp;11.</a></td>
    <td><a href="#a_016">Executive Compensation</a></td>
    <td style="text-align: center"><a href="#a_016">70</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_017">Item&nbsp;12.</a></td>
    <td><a href="#a_017">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></td>
    <td style="text-align: center"><a href="#a_017">70</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_018">Item&nbsp;13.</a></td>
    <td><a href="#a_018">Certain Relationships and Related Transactions, and Director Independence</a></td>
    <td style="text-align: center"><a href="#a_018">70</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_019">Item&nbsp;14.</a></td>
    <td><a href="#a_019">Principal Accountant Fees and Services</a></td>
    <td style="text-align: center"><a href="#a_019">70</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold; text-align: center">PART IV</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td><a href="#a_020">Item&nbsp;15.</a></td>
    <td><a href="#a_020">Exhibits, Financial Statement Schedules</a></td>
    <td style="text-align: center"><a href="#a_020">70</a></td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2"><a href="#a_021">SIGNATURES</a></td>
    <td style="text-align: center"><a href="#a_021">71</a></td></tr>
</table>


<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: center; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;<b>Forward-Looking Statements and Terminology</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>The information in this Annual Report on
Form 10-K, or this Form 10-K, including this discussion under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains forward-looking statements and information
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, or the Exchange Act, which are subject to the &#8220;safe harbor&#8221; created by those sections. All statements,
other than statements of historical facts, included or incorporated in this Form 10-K could be deemed forward-looking statements,
particularly statements about our plans, strategies and prospects under the headings &#8220;Business&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations.&#8221; In some cases, you can identify forward-looking
statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221;
&#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221;
&#8220;continue,&#8221; &#8220;intend&#8221; or the negative of these terms or other comparable terminology. All forward-looking
statements in this Form 10-K are made based on our current expectations, forecasts, estimates and assumptions, and involve risks,
uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking
statements. In evaluating these statements, you should specifically consider various factors, uncertainties and risks that could
affect our future results or operations as described from time to time in our SEC reports., including those risks outlined under
&#8220;Risk Factors&#8221; in Item 1A of this Form 10-K. These factors, uncertainties and risks may cause our actual results to
differ materially from any forward-looking statement set forth in this Form 10-K. You should carefully consider the trends, risks
and uncertainties described below and other information in this Form 10-K and subsequent reports filed with or furnished to the
SEC before making any investment decision with respect to our securities. All forward-looking statements attributable to us or
persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.&nbsp;&nbsp;Some of the important
factors that could cause our actual results to differ materially from those projected in any forward-looking statements include,
but are not limited to, the following:</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to successfully implement our growth strategy if we or our franchisees are unable to locate and secure appropriate sites for clinic locations, obtain favorable lease terms, and attract patients to our clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we have limited experience operating company-owned or managed clinics, and we may not be able to duplicate the success of some of our franchisees, and in the case of certain company-owned or managed clinics that we have or may close, we were not able to duplicate the success of our most successful franchisees;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to acquire operating clinics from existing franchisees or develop company-owned or managed clinics on attractive terms;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>any acquisitions that we make could disrupt our business and harm our financial condition;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to continue to sell franchises to qualified franchisees;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may not be able to identify, recruit and train enough qualified chiropractors to staff our clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>new clinics may not be profitable, and we may not be able to maintain or improve revenues and franchise fees from existing franchised clinics;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>the chiropractic industry is highly competitive, with many well-established competitors, which could prevent us from increasing our market share or result in reduction in our market share;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>recent administrative actions and rulings regarding the corporate practice of medicine and joint employer responsibility may jeopardize our business model;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we may face negative publicity or damage to our reputation, which could arise from concerns expressed by opponents of chiropractic and by chiropractors operating under traditional service models;</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>legislation, regulations, as well as new medical procedures and techniques could reduce or eliminate our competitive advantages; and</i></font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt"><i>we face increased costs as a result of being a public company.</i></font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Additionally, there may be other risks that
are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking
statements in this report should be considered in light of various important factors, including the risks and uncertainties listed
above, as well as others.</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As used in this Form 10-K:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">&#8220;we,&#8221;&nbsp;&nbsp;&#8220;us,&#8221; and &#8220;our&#8221; refer to The Joint Corp.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">a &#8220;clinic&#8221; refers to a chiropractic clinic operating under our &#8220;Joint&#8221; brand, which may be (i) owned by a franchisee, (ii) owned by a professional corporation or limited liability company and managed by a franchisee; (iii) owned directly by us; or (iv) owned by a professional corporation or limited liability company and managed by us.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">when we identify an &#8220;operator&#8221; of a clinic, a party that is &#8220;operating&#8221; a clinic, or a party by whom a clinic is &#8220;operated,&#8221; we are referring to the party that operates all aspects of the clinic in certain jurisdictions, and to the party that manages all aspects of the clinic other than the practice of chiropractic in certain other jurisdictions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 71px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">when we describe our acquisition or our opening of a clinic, we are referring to our acquisition or opening of the entity that operates all aspects of the clinic in certain jurisdictions, and to our acquisition or opening of the entity that manages aspects of the clinic other than the practice of chiropractic in certain other jurisdictions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>PART&nbsp;I</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><a name="a_001"></a>ITEM 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
BUSINESS</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><img src="business.jpg"></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Overview</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our principal business is to develop, own,
operate, support and manage chiropractic clinics through direct ownership, management arrangements, franchising and the sale of
regional developer rights throughout the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We are a rapidly growing franchisor and operator
of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic
care in the markets we serve and to become the most recognized brand in our industry through the rapid and focused expansion of
chiropractic clinics in key markets throughout North America and abroad. We strive to accomplish our mission by making quality
care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic
clinics operated by franchisees and by us that employ licensed chiropractors. We have priced our services below most competitors&#8217;
pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment required for an insurance-covered
service).</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Since acquiring the predecessor to our company
in March, 2010, we have grown our enterprise from eight to 370 clinics in operation as of December 31, 2016, with an additional
115 franchise licenses sold but not yet developed across our network. In the year ended December 31, 2016, our system registered
4.1 million patient visits and generated system-wide sales of $98.6 million. As of December 31, 2016, 309 of our clinics were operated
by franchisees and 61 clinics were operated as company-owned or managed clinics. Our future growth strategy will focus on rapidly
growing our franchise base through the sale of additional franchises and through a robust regional developer network, and opportunistically
adding and operating clinics owned or managed by us. We collect a royalty of 7.0% of revenues from franchised clinics. We remit
a 3.0% royalty to our regional developers on the gross sales of franchises opened within certain regional developer protected territories.
We also collect a national marketing fee of 2.0% of gross sales of all franchised clinics. We receive a franchise sales fee of
$39,900 for each franchise we sell directly and a franchise fee ranging from $19,950 to $25,400 for each franchise sold through
our network of regional developers.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 14, 2014, we completed our initial
public offering, or the IPO, of 3,000,000 shares of common stock at an initial price to the public of $6.50 per share, and we received
net proceeds of approximately $17.1 million. Our underwriters exercised their option to purchase 450,000 additional shares of common
stock to cover over-allotments on November 18, 2014, pursuant to which we received net proceeds of approximately $2.7 million.
Also, in conjunction with the IPO, we issued warrants to the underwriters for the purchase of 90,000 shares of common stock, which
can be exercised between November 10, 2015 and November 10, 2018 at an exercise price of $8.125 per share.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 25, 2015, we closed on our follow-on
public offering of 2,272,727 shares of our common stock, offered and sold by the Company, at a price to the public of $5.50 per
share. We granted the underwriters a 45-day option to purchase up to 340,909 additional shares of common stock to cover over-allotments,
if any. On December 30, 2015, our underwriters exercised their over-allotment option to purchase an additional 340,909 shares of
common stock at a price of $5.50 per share. After giving effect to the over-allotment exercise, the total number of shares offered
and sold in our follow-on public offering increased to 2,613,636 shares. With the over-allotment option exercise, we received aggregate
net proceeds of approximately $13.0 million.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended December 31, 2016 and 2015,
we had net losses after taxes of $15,173,872 and $8,797,321, respectively.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We deliver convenient, appointment-free chiropractic
adjustments in an inviting, open bay environment at prices that are approximately 68% lower than the average industry cost for
comparable procedures offered by traditional chiropractors, according to 2016 industry data from Chiropractic Economics. In support
of our mission to offer affordable and convenient care and value for our patients, our clinics offer a variety of customizable
membership and wellness treatment plans which offer additional value pricing even as compared with our single-visit pricing schedules.
These flexible plans are designed to attract patients and encourage repeat visits and routine usage as part of an overall health
and wellness program.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, we had 370 franchised
or company-owned or managed clinics in operation in 30 states. The map below shows the states in which we or our franchisees operate
clinics and the number of clinics open in each state as of December 31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="clinics.jpg"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our retail locations have been selected to be
visible, accessible and convenient. We offer a welcoming, consumer-friendly experience that attempts to redefine the chiropractic
doctor/patient relationship. Our clinics are open longer hours than many of our competitors and our patients do not need appointments.
We accept cash or major credit cards in return for our services. We do not accept insurance and do not provide Medicare covered
services. We believe that our approach, especially our commitment to affordable pricing and our ready service delivery model, will
attract existing consumers of chiropractic services and will also appeal to the growing market of consumers who seek alternative
or non-invasive wellness care, but have not yet tried chiropractic.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our patients arrive at our clinics without appointments
at times convenient to their schedules. Once a patient has joined our system and is returning for treatment, they simply swipe
their membership card at a card reader at the reception desk to announce their arrival. Typically, within three to five minutes
(the average throughout our system), the patient is escorted to our open adjustment area, where they are required to remove only
their outerwear to receive their adjustment. The adjustment process, administered by a licensed chiropractor, takes approximately
15&nbsp;&#8211;20 minutes on average for a new patient and 5&nbsp;&#8211;&nbsp;7 minutes on average for a returning patient. Each
patient&#8217;s records are digitally updated for ready retrieval in our proprietary data storage system by our chiropractors in
compliance with all applicable medical records security and privacy regulations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our consumer-focused service model targets the
non-acute treatment market, which we believe to be the largest segment of the $15 billion chiropractic services market. As our
model does not focus on the treatment of severe, acute injury, we do not provide expensive and invasive diagnostic tools such as
MRIs and X-rays. Instead we refer those with acute symptoms to alternate healthcare providers, including traditional chiropractors.&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Our Industry</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Chiropractic care is widely accepted among individuals
with a variety of medical conditions, particularly back pain. A 2016 Gallup report commissioned by Palmer College of Chiropractic
shows that 35.5 million U.S. adults (11% of the total U.S. population) now seek chiropractic care each year, an increase of 1.9
million as compared to the 33.6 million U.S. adults reported in the inaugural 2015 Gallup-Palmer report. These numbers represent
a marked increase over the 2012 National Health Interview Survey that measured chiropractic use at 20.6 million U.S. adults, or
8% of the population. According to the American Chiropractic Association, 80% of Americans experience back pain at least once in
their lifetime. According to the 2016 Gallup report commissioned by the Palmer College of Chiropractic, over half of adults in
the United States (55%) say they are likely to see a chiropractor if they had significant neck or back pain. Chiropractic care
is increasingly recognized as an effective treatment for pain and potentially for a variety of other conditions. The American College
of Physicians (ACP) now recommends for patients with chronic low back pain, non-drug therapy such as spinal manipulation as a first
line of treatment. The ACP states that treatments such as spinal manipulation are shown to improve symptoms with little risk of
harm. The National Center for Complementary &amp; Alternative Medicine of the National Institutes of Health has stated that spinal
manipulation appears to benefit some people with low-back pain and also may be helpful for headaches, neck pain, upper- and lower-extremity
joint conditions and whiplash-associated disorders. The Mayo Clinic has recognized chiropractic as safe when performed by trained
and licensed chiropractors, and the Cleveland Clinic has stated that chiropractors are established members of the mainstream medical
team.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The Bureau of Labor Statistics
estimates that $90 billion is spent on back pain each year in the U.S. The chiropractic industry in the United States is large,
growing and highly fragmented. According to a report issued by IBIS World Chiropractors Market Research in August 2016,
expenditures for chiropractic services in the U.S. are $15.0 billion annually. The United States Bureau of Labor Statistics
expects employment in chiropractic to grow faster than the average for all occupations. Some of the factors that the Bureau
of Labor Statistics identified as driving this growth are healthcare cost pressures, an aging population requiring more
health care and technological advances, all of which are expected to increasingly shift services from inpatient facilities
and hospitals to outpatient settings. We believe that the demand for our chiropractic services will continue to grow as a
result of several additional drivers, such as the increased awareness of the benefits of regular maintenance therapy coupled
with an increasing awareness of the convenience of our service and of our pricing at a significant discount to the cost
of traditional chiropractic adjustments and, in most cases, at or below the level of insurance co-payment amounts.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Today, most chiropractic services are provided
by sole practitioners, generally in medical office settings. The chiropractic industry differs from the broader healthcare services
industry in that it is more heavily consumer-driven, market-responsive and price sensitive, in large measure a result of many treatment
options falling outside the bounds of traditional insurance reimbursable services and fee schedules. According to First Research,
the top 50 companies delivering chiropractic services in the United States generated less than 10% of all industry revenue. We
believe these characteristics are evidence of an underserved market with potential consumer demand that is favorable for an efficient,
low-cost, consumer-oriented provider.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Most chiropractic practices are set up to accept
and to process insurance-based reimbursement. While chiropractors typically accept cash payment in addition to insurance, Medicare
and Medicaid, they continue to incur overhead expenses associated with maintaining the capability to process third-party reimbursement.
We believe that most chiropractors who use this third-party reimbursement model would find it economically difficult to discount
the prices they charge for their services to levels comparable with our pricing.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Accordingly, we believe these and certain other
trends favor our business model. Among these are:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">People have increasingly active lifestyles and are living longer, requiring more medical, maintenance and preventative support; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">People are increasingly open to alternative, non-pharmacological types of care; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Utilization of more conveniently situated, local-sited urgent-care or &#8220;mini-care&#8221; alternatives to primary care is increasing; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Popularity of health clubs, massage and other non-drug, non-invasive wellness maintenance providers is growing. </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b>Our Competitive Strengths</b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe the following competitive strengths
have contributed to our initial success and will position us for future growth:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Retail, consumer-driven approach</i>.&nbsp;&nbsp;To
support our consumer-focused model, we use strong, recognizable retail approaches to stimulate brand-awareness and attract patients
to our clinics. We intend to continue to drive awareness of our brand by locating clinics mainly at retail centers and convenience
points, displaying prominent signage and employing consistent, proven and targeted marketing tools. Most of our clinics offer patient
care six or seven days per week at convenient locations. We offer our patients the flexibility to visit our clinics without an
appointment and receive prompt attention. Additionally, we offer extended hours of operation, including weekends, which is not
typical among our competitors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We attracted an average per clinic of 880 new
patients during the year ended December 31, 2016, as compared to the 2016 chiropractic industry average of 364 new patients per
year for traditional insurance-based non-multidisciplinary or integrated practices, according to a 2016 Chiropractic Economics
survey.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Quality Service</i>.&nbsp;&nbsp;Across our
system we have a community of over 800 fully licensed chiropractic doctors, performing more than 4 million adjustments annually.
Our doctors provide patient care focused on pain relief and ongoing wellness to promote healthy, active lifestyles. We provide
our doctors one-on-one training, as well as ongoing coaching and mentoring through our partnerships with two of the profession&#8217;s
preeminent instructors in chiropractic technique and adjusting. Our doctors continually refine their skills, as our clinics see
an average of 228 patients per week, as compared to the 2016 chiropractic industry average of 132 patients per week for non-multidisciplinary
or integrated practices, according to a 2016 Chiropractic Economics survey. Our service offerings encourage consumer trial, repeat
visits and sustainable patient relationships.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">By limiting the administrative burdens of insurance
processing, our model helps chiropractors focus on patient service. We believe the time our chiropractors save by not having to
perform administrative duties related to insurance reimbursement allows more time to see more patients, establish and reinforce
chiropractor/patient relationships, and educate patients on the benefits of chiropractic maintenance therapy.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our approach has made us an attractive alternative
for chiropractic doctors who want to spend more time treating patients than they typically do in traditional practices, which are
burdened with greater overhead, personnel and administrative expense. We believe that our model helps us to recruit chiropractors
who want to focus their practice principally on patient care.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Pricing Structure.</i>&nbsp;&nbsp;We believe
that our strongest competitive advantages are our price and convenience. We offer a much less expensive alternative to traditional
chiropractic services by focusing on non-acute care and by not participating in insurance or Medicare reimbursement. We can do
this because our clinics do not have the expenses of performing certain diagnostic procedures and processing reimbursement claims.
Our model allows us to pass these savings on to our patients. According to Chiropractic Economics in 2016, the average fee for
a chiropractic treatment involving spinal manipulation in a cash-based practice in the United States is approximately $74. By comparison,
our average fee as of December 31, 2016, was approximately $24, approximately 68% lower than the industry average price.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe our pricing and service offering structure
helps us to generate higher usage. The following table sets forth our average price per adjustment as of December 31, 2016, for
patients who pay by single adjustment plans, multiple adjustment packages, and multiple adjustment membership plans. Our price
per adjustment as of December 31, 2016 averaged approximately $24 across all three groups.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: justify">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">The Joint Service Offering</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: justify">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Single Visit</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Package(s)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Membership(s)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; font-size: 10pt">Price per adjustment</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 11%; font-size: 10pt; text-align: right">39</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-size: 10pt">$20&nbsp;&#8211;&nbsp;$33</font></td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-size: 10pt">$15&nbsp;&#8211;&nbsp;$20</font></td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Proven track record of opening clinics and
growing revenue at the clinic level</i>.&nbsp;&nbsp;We have grown our clinic revenue base consistently since we acquired our predecessor
in March 2010. From January 2012 through December 31, 2016, we have increased monthly sales at our clinics from $0.4 million to
$9.3 million. During this period, we increased the number of clinics in operation from 33 to 370.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We continue to be encouraged by the ability
of individual clinics to generate growth. While there is significant variation in results among our system, and the results of
our top-performing clinics are not representative of our system overall, we believe it is worth noting that in January 2012, the
highest-performing clinic in our system was a franchise clinic which had monthly sales of approximately $45,000, and in December
2016, the highest performing clinic in our system was a franchise clinic which had monthly sales of approximately $88,000.</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="monthly_sales.jpg"></p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><i>Strong and proven management team.</i>&nbsp;&nbsp;Our
strategic vision is directed by our President and Chief Executive Officer Peter D. Holt, who has more than 30 years of experience
in domestic and international franchising, franchise development and operations. His appointment confirms our commitment to the
continued strengthening of operations, the continued cultivation and management of our franchise community, as well as a strong
commitment to future clinic development both domestically and internationally. Mr. Holt was most recently president and chief executive
officer of Tasti-D-Lite &amp; Planet Smoothie. He has also served as chief operating officer of 24seven Vending (U.S), where he
directed its franchise system in the U.S., and as executive vice president of development for Mail Boxes Etc. and vice president
of international for I Can&#8217;t Believe It&#8217;s Yogurt and Java Coast Fine Coffees. Mr. Holt directs a team of dedicated
leaders who are focused on executing our business plan and implementing our growth strategy. We believe that our management team&#8217;s
experience and demonstrated success in building and operating a robust franchise system, will be a key driver of our growth and
will position us well for achieving our long-term strategy.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our Growth Strategy</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our goal is not only to capture a significant
share of the existing market but also to expand the market for chiropractic care. We are accomplishing this through the rapid geographic
expansion of our affordable franchising program and the opportunistic addition of company-owned or managed clinics. We do not expect
to acquire or to open any company-owned or managed clinics in 2017; however, at the appropriate time, we intend to resume the addition
of company-owned or managed clinics. Accordingly, our long-term growth tactics include:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: middle">
    <td style="width: 3%">&nbsp;</td>
    <td style="text-align: left; width: 2%; vertical-align: top">&#8226;</td>
    <td style="text-align: justify; width: 95%">the continued growth of system sales and royalty income;&nbsp;</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">the opening of clinics already in development;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">the sale of additional franchises;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">the sale of additional regional developer protected territories;&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">increasing the capability and capacity of our existing regional developer network;</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">improving operational margins and leveraging infrastructure;</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">the opportunistic acquisition of existing franchises; and</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&#8226;</td>
    <td style="text-align: justify">the continued development of company-owned clinics in clustered geographies.</td></tr>
</table>


<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;Our analysis of data from over 450,000
patient records from 362 clinics across 30 states suggests that the United States market alone can support at least 1,700 of our
clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="potential.jpg"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Continued growth of system sales. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">System wide comparable same-store sales growth,
or &#8220;Comp Sales,&#8221; for 2016 was 27.5% for the full year of 2016. Comp Sales refers to the amount of sales a clinic generates
in the most recent accounting period, relative to the amount of sales it generated in a similar period in the past. Comp Sales
include the sales from both company-owned or managed clinics and franchised clinics that in each case have been open at least 13
full months and exclude any clinics that have closed. We believe that the experience we have gained in developing and refining
management systems, operating standards, training materials and marketing and customer acquisition activities has contributed to
our system&#8217;s revenue growth. In addition, we believe that increasing awareness of our brand has contributed to revenue growth,
particularly in markets where the number and density of our clinics has made cooperative and mass media advertising attractive.
We believe that our ability to leverage aggregated and general media digital advertising and search tools will continue to grow
as the number and density of our clinics increases.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We acquired our first company-owned or managed
clinic on December 31, 2014. In the first full calendar quarter after that acquisition, total revenue from company-owned or managed
clinics was $0.4 million, growing to approximately $2.4 million in the quarter ended December 31, 2016. Total revenue from our
61 company-owned or managed clinics was approximately $8.6 million for the year ended December 31, 2016 as compared to $3.7 million
for the year ended December 31, 2015. Through December 31, 2016, revenue from company-owned or managed clinics consisted of revenue
earned from 32 franchised clinics that we acquired, as well as 29 clinics that we developed.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Opening clinics in development. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to our 370 operating clinics, as
of December 31, 2016, we have granted franchises either directly or through our regional developers for an additional 115 clinics
that we believe will be developed in the future. We will continue to support our franchisees and regional developers to open these
clinics and to achieve sustainable performance as rapidly as possible.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, we
terminated 17 franchise licenses for undeveloped clinics that were in default.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Selling additional franchises. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We will continue to sell franchises. We believe
that to secure leadership in our industry and to maximize our opportunities in our markets, it is important to gain brand equity
and consumer awareness as rapidly as possible, consistent with a disciplined approach to opening clinics. We believe that continued
sales of franchises in selected markets is the most effective way to drive brand awareness in the short term. Our longer-term strategy
includes the resumption of opening or acquiring company-owned or managed clinics, and we believe that a growth strategy that includes
both franchised and company-owned or managed clinics has advantages over either approach by itself.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Continue to improve margins and leverage infrastructure. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe our corporate infrastructure can scale
to support a clinic base greater than our existing footprint. As we continue to grow, we expect to drive greater efficiencies across
our operations, development and marketing programs and further leverage our technology and existing support infrastructure. We
believe we will be able to control corporate costs over time to enhance margins as general and administrative expenses grow at
a slower rate than our clinic base and sales. At the clinic level, we expect to drive margins and labor efficiencies through continued
sales growth and consistently applied operating standards as our clinic base matures and the average number of patient visits increases.
In addition, we will consider introducing selected and complementary branded products such as nutraceuticals or dietary supplements
and related additional services.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Acquiring existing franchises. </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">While we do not expect to acquire any operating
franchised clinics in 2017, we do not rule out the opportunistic acquisition of existing franchised clinics that meet our criteria
for demographics, site attractiveness, proximity to other clinics and additional suitability factors. Following the completion
of the IPO through December 31, 2016, we acquired a net of 32 existing franchises and now operate them as company-owned or managed
clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Development of company-owned or managed clinics. </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In June, 2016, we ceased additional
expansion of our company-owned or managed clinic portfolio to allow our portfolio of clinics to mature and to focus resources
on the growth of our franchise system. In January, 2017, we sold the assets of six of our 11 clinics in the Chicago area for
a nominal amount to a limited liability company that includes existing franchisees as members, and recorded a related impairment
charge in 2016. The limited liability company  will operate the clinics pursuant to a franchise agreement. We closed
the remaining five Chicago-area clinics, as well as three company-managed clinics in upstate New York.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We do not rule out the opportunistic development
of company-owned or managed clinics that meet our criteria for demographics, site attractiveness, proximity to other clinics and
additional suitability factors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">When we resume the acquisition and development
of company-owned or managed clinics we intend to target geographic clusters where we are able to increase efficiencies through
a consolidated real estate penetration strategy, leverage cooperative advertisement and marketing and attain general corporate
and administrative operating efficiencies. We also believe that the development timeline and point of break-even for company-owned
or managed clinics can be shortened and that our revenue from company-owned or managed clinics will ultimately exceed revenue that
would be generated through royalty income from a franchise-only system.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Regulatory Environment</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>HIPAA </i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In an effort to further combat healthcare fraud
and protect patient confidentiality, Congress included several anti-fraud measures in the Health Insurance Portability and Accountability
Act of 1996 (HIPAA). HIPAA created a source of funding for fraud control to coordinate federal, state and local healthcare law
enforcement programs, conduct investigations, provide guidance to the healthcare industry concerning fraudulent healthcare practices,
and establish a national data bank to receive and report final adverse actions. HIPAA also criminalized certain forms of healthcare
fraud against all public and private payors. Additionally, HIPAA mandates the adoption of standards regarding the exchange of healthcare
information in an effort to ensure the privacy and security of electronic patient information. Sanctions for failing to comply
with HIPAA include criminal penalties and civil sanctions. In February 2009, the American Recovery and Reinvestment Act of 2009
(ARRA) was enacted. Title XIII of ARRA, the Health Information Technology for Economic and Clinical Health Act (HITECH), includes
substantial Medicare and Medicaid incentives for providers to adopt electronic health records (&#8220;EHR&#8221;) and grants for
the development of health information exchange (&#8220;HIE&#8221;) systems. Recognizing that HIE and EHR systems will not be implemented
unless the public can be assured that the privacy and security of patient information in such systems is protected, HITECH also
significantly expands the scope of the privacy and security requirements under HIPAA. Most notable are the new mandatory breach
notification requirements and a heightened enforcement scheme that includes increased penalties, and which now apply to business
associates as well as to covered entities. In addition to HIPAA, a number of states have adopted laws and/or regulations applicable
in the use and disclosure of individually identifiable health information that can be more stringent than comparable provisions
under HIPAA and HITECH.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that our operations substantially
comply with applicable standards for privacy and security of protected healthcare information. We cannot predict what negative
effect, if any, HIPAA/HITECH or any applicable state law or regulation will have on our business.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>State regulations on corporate practice of chiropractic. </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In states that regulate the &#8220;corporate
practice of chiropractic,&#8221; our chiropractic services are provided by legal entities organized under state laws as professional
corporations, or PCs. Each of the PCs is wholly owned by one or more licensed chiropractors, and employs or contracts with chiropractors
in one or more offices. We do not own any capital stock of (or have any other ownership interest in) any such PC. We and our franchisees
that are not owned by chiropractors enter into management services agreements with PCs to provide the PCs on an exclusive basis
with all non-clinical administrative services needed by the chiropractic practice. In November, 2015, the California Board of Chiropractic
Examiners commenced an administrative proceeding to which we were not a party, in which it claimed that the doctor who owns the
PC that we manage in southern California violated California&#8217;s prohibition on the corporate practice of chiropractic, among
other claims, because our management of the clinics operated by his PC involved the exercise of control over certain clinical aspects
of his practice. The California Board of Chiropractic Examiners has subsequently dismissed claims against the doctor who owns the
PC in congruence with findings of the overseeing administrative judge. In June 2015, the New York Attorney General announced that
it had entered into an Assurance of Discontinuance with a provider of business services to independently owned dental practices
in New York, pursuant to which the provider paid a substantial fine and agreed to change its business and branding practices. While
the effect of the proceeding before the California Board of Chiropractic Examiners and the New York Assurance of Discontinuance
is that our business practices in California and New York may be under stricter scrutiny than elsewhere, we believe we are in substantial
compliance with all applicable laws relating to the corporate practice of chiropractic.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Regulation relating to franchising </i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to the rules and regulations of
the Federal Trade Commission and various state laws regulating the offer and sale of franchises. The Federal Trade Commission and
various state laws require that we furnish a Franchise Disclosure Document or FDD containing certain information to prospective
franchisees, and a number of states require registration of the FDD at least annually with state authorities. Included in the information
required to be disclosed in our FDD is our business experience, material litigation, all fees due to us from franchisees, a franchisee&#8217;s
estimated initial investment, restrictions on sources of products and services we impose on franchisees, development and operating
obligations of franchisees, whether we provide financing to franchisees, our training and support obligations and other terms and
conditions of our franchise agreement. We are operating under exemptions from registration in several states based on our qualifications
for exemption as set forth in those states&#8217; laws. Substantive state laws regulating the franchisor-franchisee relationship
presently exist in many states. We believe that our FDD and franchising procedures comply in all material respects with both the
Federal Trade Commission guidelines and all applicable state laws regulating franchising in those states in which we have offered
franchises. We have not elected to sell franchises in certain states where the time and cost associated with registering our FDD
in that state is not, in our judgment, justified by current demand for franchises in that state. As of December 31, 2016, we were
registered to sell franchises in 30 states.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Other federal, state and local regulation </i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to varied federal regulations
affecting the operation of our business. We are subject to the U.S. Fair Labor Standards Act, the U.S. Immigration Reform and Control
Act of 1986, the Occupational Safety and Health Act and various other federal and state laws governing such matters as minimum
wage requirements, overtime, fringe benefits, workplace safety and other working conditions and citizenship requirements. A significant
number of our clinic service personnel are paid at rates related to the applicable minimum wage, and increases in the minimum wage
could increase our labor costs. We are continuing to assess the impact of recently-adopted federal health care legislation on our
health care benefit costs. Many of our smaller franchisees will qualify for exemption from the mandatory requirement to provide
health insurance benefits because of their small number of employees. The imposition of any requirement that we or our franchisees
provide health insurance benefits to our or their employees that are more extensive than the health insurance benefits that we
currently provide to our employees or that franchisees may or may not provide, or the imposition of additional employer paid employment
taxes on income earned by our employees, could have an adverse effect on our results of operations and financial position. Our
distributors and suppliers also may be affected by higher minimum wage and benefit standards, which could result in higher costs
for goods and services supplied to us.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In August, 2015, the National Labor Relations
Board (or &#8220;NLRB&#8221;) adopted a more expansive definition of what it means to be a &#8220;joint employer,&#8221; making
it easier for employees of franchisees to organize and bargain collectively. This NLRB action, as well as a July 2014 NLRB action
holding that McDonald&#8217;s Corporation could be held jointly liable for labor and wage violations by its franchisees, may also
make it easier for a franchisor to be held responsible as employer for a franchisee&#8217;s misconduct.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are required to comply with the accessibility
standards mandated by the U.S. Americans with Disabilities Act of 1990 and related federal and state statutes, which generally
prohibit discrimination in accommodation or employment based on disability. We may, in the future, have to modify our clinics to
provide service to or make reasonable accommodations for disabled persons. While these expenses could be material, our current
expectation is that any such actions will not require us to expend substantial funds.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are subject to extensive and varied state
and local government regulation affecting the operation of our business, as are our franchisees, including regulations relating
to public and occupational health and safety, sanitation, fire prevention and franchise operation. Each franchised clinic is subject
to licensing and regulation by a number of governmental authorities, which include zoning, health, safety, sanitation, environmental,
building and fire agencies in the jurisdiction in which the clinic is located. We require our franchisees to operate in accordance
with standards and procedures designed to comply with applicable codes and regulations. However, our or our franchisees&#8217;
inability to obtain or retain health or other licenses would adversely affect operations at the impacted clinic or clinics. Although
we have not experienced and do not anticipate any significant difficulties, delays or failures in obtaining required licenses,
permits or approvals, any such problem could delay or prevent the opening of, or adversely impact the viability of, a particular
clinic. In addition, in order to develop and construct our clinics, we need to comply with applicable zoning and land use regulations.
Federal and state regulations have not had a material effect on our operations to date, but more stringent and varied requirements
of local governmental bodies with respect to zoning and land use could delay or even prevent construction and increase development
costs of new clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Competition</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The chiropractic industry is highly fragmented.
According to First Research&#8217;s August 2015 report, the top 50 providers of chiropractic services in the United States generate
less than 10% of industry revenue. Our competitors include approximately 39,000 independent chiropractic offices currently open
throughout the United States as well as certain multi-unit operators. We may also face competition from traditional medical practices,
outpatient clinics, physical therapists, med-spas, massage therapists and sellers of devices intended for home use to address back
and joint discomfort. Our three largest multi-unit competitors are HealthSource Chiropractic, AlignLife Chiropractic &amp; Natural
Health Centers and ChiroOne Wellness Centers, all of which are insurance-based models.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We have identified two competitors who are
attempting to duplicate our cash-only, low cost, appointment-free model. Based on publicly available information, these competitors
operate ten clinics and two clinics, respectively, as franchises. We anticipate that other direct competitors will join
our industry as our visibility, reputation and perceived advantages become more widely known. We believe our first mover advantage,
proprietary operations systems, and strong unit level economics will continue to accelerate our growth even with the spawning of
additional competition.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Employees</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of March 1, 2017, we had 94 employees on
a full-time basis. None of our employees are members of unions or participate in other collective bargaining arrangements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Facilities</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We lease the property for our corporate headquarters
and all of the properties on which we own or manage clinics. As of March 1, 2017, we leased 47 facilities in which we operate or
intend to operate clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our corporate headquarters are located at 16767
North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260. The term of our lease for this location expires on July 31, 2019.
The primary functions performed at our corporate headquarters are financial, accounting, treasury, marketing, operations, human
resources, information systems support and legal.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are also obligated under non-cancellable leases
for the clinics which we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial
term of five years, include one to two options to renew for terms of five years, and require us to pay a proportionate share of
real estate taxes, insurance, common area maintenance charges and other operating costs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As of March 1, 2017, our franchisees operated
322 clinics in 29 states. All of our franchise locations are leased.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Intellectual Property</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Trademarks, trade names and service marks</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&#8220;The Joint Chiropractic&#8221; is our
trademark, registered in December 2016, under registration number 5095943. We have also registered &#8220;Relief. On so many levels&#8221;
in December 2015, under registration number 4871809, and &#8220;The Joint&#8221; in April 2015, under registration number 4723892.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Additional trademarks previously registered
include &#8220;The Joint&#8230; the Chiropractic Place&#8221; registered in February 2011, under registration number 3922558.
We also registered the words, letters, and stylized form of service mark, &#8220;The Joint&#8230; the Chiropractic Place&#8221;
in April 2013 under registration number 4323810.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_002"></a>ITEM 1A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RISK
FACTORS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Risks Related to Our Business</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our expansion into new markets may be more costly and difficult
than we currently anticipate which would result in slower growth than we expect.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As experienced with our entry into the Chicago
market, clinics we open in new markets may take longer to reach expected sales and profit levels on a consistent basis and may
have higher construction, occupancy, marketing or operating costs than clinics we open in existing markets, thereby affecting our
overall profitability. New markets may have competitive conditions, consumer tastes and discretionary spending patterns that are
more difficult to predict or satisfy than our existing markets. We may need to make greater investments than we originally planned
in advertising and promotional activity in new markets to build brand awareness. We may find it more difficult in new markets to
hire, motivate and keep qualified employees who share our vision and culture. We may also incur higher costs from entering new
markets, particularly with company-owned clinics if, for example, we hire and assign regional managers to manage comparatively
fewer clinics than in more developed markets. For these reasons, both our new franchised clinics and our new company-owned or managed
clinics may be less successful than our existing franchised clinics or may achieve target rates of patient visits at a slower rate.
If we do not successfully execute our plans to enter new markets, our business, financial condition and results of operations could
be materially adversely affected.</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0"><b>New clinics, once opened, may not be profitable, and the increases
in average clinic sales and comparable clinic sales that we have experienced in the past may not be indicative of future results.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our clinics continue to
demonstrate increases in comparable clinic sales even as they mature. The annual Comp Sales for clinics that have been open
for greater than 48 months was 16.1%. However, we cannot assure you that this will continue for our existing clinics or that
clinics we open in the future will see similar results. In new markets, the length of time before average sales for new
clinics stabilize is less predictable and can be longer than we expect because our limited knowledge of these markets and
consumers&#8217; limited awareness of our brand. New clinics may not be profitable and their sales performance may not follow
historical patterns. In addition, our average clinic sales and comparable clinic sales for existing clinics may not
increase at the rates achieved over the past several years. Our ability to operate new clinics, especially company-owned or
managed clinics, profitably and increase average clinic sales and comparable clinic sales will depend on many factors, some
of which are beyond our control, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">consumer awareness and understanding of our brand; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">general economic conditions, which can affect clinic traffic, local rent and labor costs and prices we pay for the supplies we use; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">changes in consumer preferences and discretionary spending; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">competition, either from our competitors in the chiropractic industry or our own clinics; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the identification and availability of attractive sites for new facilities and the anticipated commercial, residential and infrastructure development near our new facilities; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">changes in government regulation; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">other unanticipated increases in costs, any of which could give rise to delays or cost overruns. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If our new clinics do not perform as planned,
our business and future prospects could be harmed. In addition, if we are unable to achieve our expected average clinics sales,
our business, financial condition and results of operations could be adversely affected.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our failure to manage our growth effectively could harm our business
and operating results.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our growth plan includes a significant number
of new clinics, focused currently on franchised clinics, but in the long term, also including company-owned or managed clinics.
Our existing clinic management systems, administrative staff, financial and management controls and information systems may be
inadequate to support our planned expansion. Those demands on our infrastructure and resources may also adversely affect our ability
to manage our existing clinics. Managing our growth effectively will require us to continue to enhance these systems, procedures
and controls and to hire, train and retain managers and team members. We may not respond quickly enough to the changing demands
that our expansion will impose on our management, clinic teams and existing infrastructure which could harm our business, financial
condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our long-term strategy involves opening new, primarily company-owned
or managed clinics, and is subject to many unpredictable factors.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">One component of our long-term growth strategy
will be to open new company-owned or managed clinics and to operate those clinics on a profitable basis. After the sale or closing
of 14 company-owned or managed clinics in Chicago and Upstate New York, we currently own or manage 47 company-owned or managed
clinics. We have suspended the development of new company-owned or managed clinics, and when we resume this activity, we may not
be able to open new company-owned or managed clinics as quickly as planned. In the past, we have experienced delays in opening
some franchised clinics, for various reasons, including the landlord&#8217;s failure to turn over the premises to our franchisee
on a timely basis. Such delays could happen again in future clinic openings. Delays or failures in opening new clinics could materially
and adversely affect our growth strategy and our business, financial condition and results of operations. As we operate more clinics,
our rate of expansion relative to the size of our clinic base will eventually decline.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, one of our biggest challenges is
locating and securing an adequate supply of suitable new clinic sites in our target markets. Competition for those sites is intense,
and other medical and retail concepts that compete for those sites may have unit economic models that permit them to bid more aggressively
for those sites than we can. There is no guarantee that a sufficient number of suitable sites will be available in desirable areas
or on terms that are acceptable to us in order to achieve our growth plan. Our ability to open new clinics also depends on other
factors, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">negotiating leases with acceptable terms; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">identifying, hiring and training qualified employees in each local market; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">timely delivery of leased premises to us from our landlords and punctual commencement and completion of construction; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">managing construction and development costs of new clinics, particularly in competitive markets; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">obtaining construction materials and labor at acceptable costs, particularly in urban markets; </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">unforeseen engineering or environmental problems with leased premises; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">generating sufficient funds from operations or obtaining acceptable financing to support our future development; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">securing required governmental approvals, permits and licenses (including construction permits and operating licenses) in a timely manner and responding effectively to any changes in local, state or federal laws and regulations that adversely affect our costs or ability to open new clinics; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#8226;</font></td>
    <td><font style="font-size: 10pt">avoiding the impact of inclement weather, natural disasters and other calamities. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Opening new clinics in existing markets may negatively affect
revenue at our existing clinics.</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The target area of our clinics varies by location
and depends on a number of factors, including population density, other available retail services, area demographics and geography.
As a result, the opening of a new clinic in or near markets in which we already have clinics could adversely affect the revenues
of those existing clinics. Existing clinics could also make it more difficult to build our patient base for a new clinic in the
same market. Our business strategy does not entail opening new clinics that we believe will materially affect revenue at our existing
clinics, but we may selectively open new clinics in and around areas of existing clinics that are operating at or near capacity
to effectively serve our patients. Revenue cannibalization between our clinics may become significant in the future as we continue
to expand our operations and could affect our revenue growth, which could, in turn, adversely affect our business, financial condition
and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Any acquisitions that we make could disrupt our business and
harm our financial condition.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">From time to time, we may evaluate potential
strategic acquisitions of existing franchised clinics to facilitate our growth. We may not be successful in identifying acquisition
candidates. In addition, we may not be able to continue the operational success of any franchised clinics we acquire or successfully
integrate any businesses that we acquire. We may have potential write-offs of acquired assets and an impairment of any goodwill
recorded as a result of acquisitions. Furthermore, the integration of any acquisition may divert management&#8217;s time and resources
from our core business and disrupt our operations or may result in conflicts with our business. Any acquisition may not be successful,
may reduce our cash reserves and may negatively affect our earnings and financial performance. We cannot ensure that any acquisitions
we make will not have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Damage to our reputation or our brand in existing or new markets
could negatively impact our business, financial condition and results of operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe we have built our reputation on high
quality patient care, and we must protect and grow the value of our brand to continue to be successful in the future. Our brand
may be diminished if we do not continue to make investments in areas such as marketing and advertising, as well as the day-to-day
investments required for facility operations, equipment upgrades and staff training. Any incident, real or perceived, regardless
of merit or outcome, that erodes our brand, such as, failure to comply with federal, state or local regulations including allegations
or perceptions of non-compliance or failure to comply with ethical and operating standards, could significantly reduce the value
of our brand, expose us to adverse publicity and damage our overall business and reputation. Further, our brand value could suffer
and our business could be adversely affected if patients perceive a reduction in the quality of service or staff.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We may be unable to maintain or improve our operating margins,
which could adversely affect our financial condition and ability to grow.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If we are unable to successfully manage our growth,
we may not be able to capture the efficiencies and opportunities that we expect from our expansion strategy. If we are not able
to capture expected efficiencies of scale, maintain patient volumes, improve our systems and equipment, continue our cost discipline
and retain appropriate chiropractors and overall labor levels, our operating margins may stagnate or decline, which could have
a material adverse effect on our business, financial condition and results of operations and adversely affect the price of our
common stock.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We have experienced net losses and may not achieve or sustain
profitability in the future.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We have experienced periods of net losses, including
consolidated net losses of approximately $15.2 and $8.8 million for the years ended December 31, 2016 and 2015, respectively. Our
revenue may not grow and we may not achieve or maintain profitability in the future. Even if we do achieve profitability, we may
not sustain or increase profitability on a quarterly or annual basis in the future. Our ability to achieve profitability will be
affected by the other risks and uncertainties described in this section and in Management&#8217;s Discussion and Analysis. If we
are not able to achieve, sustain or increase profitability, our business will be materially adversely affected and the price of
our common stock may decline.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our marketing programs may not be successful.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We incur costs and expend other resources in
our marketing efforts to attract and retain patients. Our marketing activities are principally focused on increasing brand awareness
and driving patient volumes. As we open new facilities, we undertake aggressive marketing campaigns to increase community awareness
about our growing presence. We plan to utilize targeted marketing efforts within local neighborhoods through channels such as radio,
digital media, community sponsorships and events, and a robust online/social media presence. These initiatives may not be successful,
resulting in expenses incurred without the benefit of higher revenue. Our ability to market our services may be restricted or limited
by federal or state law.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We will be subject to all of the risks associated with leasing
space subject to long-term non-cancelable leases for clinics that we intend to operate.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We do not own and we do not intend to own any
of the real property where our company-owned or managed clinics will operate. We expect the spaces for the company-owned or managed
clinics we intend to open in the future will be leased. We anticipate that our leases generally will have an initial term of five
or ten years and generally can be extended only in five-year increments (at increased rates). We expect that all of our leases
will require a fixed annual rent, although some may require the payment of additional rent if clinic sales exceed a negotiated
amount. We expect that our leases will typically be net leases, which require us to pay all of the cost of insurance, taxes, maintenance
and utilities, and that these leases will not be cancellable by us. If a future company-owned clinic is not profitable, resulting
in its closure, we may nonetheless be committed to perform our obligations under the applicable lease including, among other things,
paying the base rent for the balance of the lease term. In addition, we may fail to negotiate renewals as each of our leases expires,
either on commercially acceptable terms or at all, which could cause us to pay increased occupancy costs or to close stores in
desirable locations. These potential increases in occupancy costs and the cost of closing company-owned or managed clinics could
materially adversely affect our business, financial condition or results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our intended reliance on sources of revenue other than from franchise
and regional developer licenses exposes us to risks including the loss of revenue and reduction of working capital.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">From the commencement of our operations until
we began to acquire or open company-owned or managed clinics, we have relied exclusively on the sale of franchises and regional
developer licenses as sources of revenue until the franchises we have sold begin to generate royalty revenues. While we have determined
to re-emphasize our franchising strategy in the near term, we may place less reliance in the future on these sources of revenue
when we resume acquiring, developing and operating company-owned or managed clinics. We do not recognize revenues from company-owned
or managed clinics until the opening of those clinics, and we will be required to use our working capital to operate our business
and to develop company-owned or managed clinics. If the opening of our company-owned or managed clinics is delayed or if the cost
of developing company-owned or managed clinics exceeds our expectations, we may experience insufficient working capital to fully
implement our development plans, and our business, financial condition and results of operations could be adversely affected.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our potential need to raise additional capital to accomplish
our objectives of expanding into new markets and selectively developing company-owned or managed clinics exposes us to risks including
limiting our ability to develop or acquire clinics and limiting our financial flexibility.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We intend, at the appropriate time, to resume
the selective development and acquisition of company-owned or managed clinics and related businesses. If we do not have sufficient
cash resources, our ability to develop and acquire clinics and related businesses could be limited unless we are able to obtain
additional capital through future debt or equity financings. Using cash to finance development and acquisition of clinics and related
businesses could limit our financial flexibility by reducing cash available for operating purposes. Using debt financing could
result in lenders imposing financial covenants that limit our operations and financial flexibility. Using equity financing may
result in dilution of ownership interests of our existing stockholders. We may also use common stock as consideration for the future
acquisition of clinics and related businesses. If our common stock does not maintain a sufficient market value or if prospective
acquisition candidates are unwilling to accept our common stock as part of the consideration for the sale of their clinics or businesses,
we may be required to use more of our cash resources or greater debt financing to complete these acquisitions.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes in economic conditions and adverse weather and other
unforeseen conditions could materially affect our ability to maintain or increase sales at our clinics or open new clinics.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our services emphasize maintenance therapy, which
is generally not a medical necessity, and should be viewed as a discretionary medical expenditure. The United States in general
or the specific markets in which we operate may suffer from depressed economic activity, recessionary economic cycles, higher fuel
or energy costs, low consumer confidence, high levels of unemployment, reduced home values, increases in home foreclosures, investment
losses, personal bankruptcies, reduced access to credit or other economic factors that may affect consumer discretionary spending.
Traffic in our clinics could decline if consumers choose to reduce the amount they spend on non-critical medical procedures. Negative
economic conditions might cause consumers to make long-term changes to their discretionary spending behavior, including reducing
medical discretionary spending on a permanent basis. In addition, given our geographic concentrations in the West, Southwest and
mid-Atlantic regions of the United States, economic conditions in those particular areas of the country could have a disproportionate
impact on our overall results of operations, and regional occurrences such as local strikes, terrorist attacks, increases in energy
prices, adverse weather conditions, tornadoes, earthquakes, hurricanes, floods, droughts, fires or other natural or man-made disasters
could materially adversely affect our business, financial condition and results of operations. Adverse weather conditions may also
impact customer traffic at our clinics. All of our clinics depend on visibility and walk-in traffic, and the effects of adverse
weather may decrease visits to malls in which our clinics are located and negatively impact our revenues. If clinic sales decrease,
our profitability could decline as we spread fixed costs across a lower level of sales. Reductions in staff levels, asset impairment
charges and potential clinic closures could result from prolonged negative clinic sales, which could materially adversely affect
our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our dependence on the success of our franchisees exposes us to
risks including the loss of royalty revenue and harm to our brand.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A substantial portion of our revenues comes from
royalties generated by our franchised clinics. We anticipate that franchise royalties will represent a substantial part of our
revenues in the future. As of December 31, 2016, we had 123 franchisees operating 309 clinics. Accordingly, we are reliant on the
performance of our franchisees in successfully opening and operating their clinics and paying royalties to us on a timely basis.
Our franchise system subjects us to a number of risks as described in the next four risk factors, any one of which could impact
our ability to collect royalty payments from our franchisees, may harm the goodwill associated with our brand and may materially
adversely affect our business and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees are independent operators over whom we have limited
control.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Franchisees are independent operators, and their
employees are not our employees. Accordingly, their actions are outside of our control. Although we have developed criteria to
evaluate and screen prospective franchisees, we cannot be certain that our franchisees will have the business acumen or financial
resources necessary to operate successful franchises in their approved locations, and state franchise laws may limit our ability
to terminate or modify these franchise agreements. Moreover, despite our training, support and monitoring, franchisees may not
successfully operate stores in a manner consistent with our standards and requirements, or may not hire and adequately train qualified
managers and other store personnel. The failure of our franchisees to operate their franchises successfully and the actions taken
by their employees could have a material adverse effect on our reputation, our brand and our ability to attract prospective franchisees,
and on our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A July, 2014 decision by the United States National
Labor Relations Board held that McDonald&#8217;s Corporation could be held jointly liable for labor and wage violations by its
franchisees. If this decision is upheld, it could result in us having responsibility for damages, reinstatement, back pay and penalties
in connection with labor law violations by our franchisees over whom we have no control, and could have a material and adverse
effect on our financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the risk that our franchise agreements may
be terminated or not renewed.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Each franchise agreement is subject to termination
by us as the franchisor in the event of a default, generally after expiration of applicable cure periods, although under certain
circumstances a franchise agreement may be terminated by us upon notice without an opportunity to cure. The default provisions
under the franchise agreements are drafted broadly and include, among other things, any failure to meet operating standards and
actions that may threaten our intellectual property. In addition, each franchise agreement has an expiration date. Upon the expiration
of the franchise agreement, we or the franchisee may, or may not, elect to renew the franchise agreement. If the franchise agreement
is renewed, the franchisee will receive a new franchise agreement for an additional term. Such option, however, is contingent on
the franchisee&#8217;s execution of the then-current form of franchise agreement (which may include increased royalty payments,
advertising fees and other costs) and the payment of a renewal fee. If a franchisee is unable or unwilling to satisfy any of the
foregoing conditions, we may elect not to renew the expiring franchise agreement, in which event the franchise agreement will terminate
upon expiration of its term. The termination or non-renewal of a franchise agreement could result in the reduction of royalty payments
we receive.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees may not meet timetables for opening their clinics,
which could reduce the royalties we receive.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our franchise agreements specify a timetable
for opening the clinic. Failure by our franchisees to open their clinics within the specified time limit would result in the reduction
of royalty payments we receive and could result in the termination of the franchise agreement. As of December 31, 2016, we have
115 active licenses which we believe to be developable.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our franchisees may elect bankruptcy protection and deprive us
of income.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The bankruptcy of a franchisee could negatively
impact our ability to collect payments due under such franchisee&#8217;s franchise agreement. In a franchisee bankruptcy, the bankruptcy
trustee may reject the franchisee&#8217;s franchise agreement pursuant to Section 365 under the United States Bankruptcy Code,
in which case we would no longer receive royalty payments from the franchisee.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our regional developers are independent operators over whom we
have limited control.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our regional developers are independent operators.
Accordingly, their actions are outside of our control. We depend upon our regional developers to sell a minimum number of franchises
within their territory and to assist the purchasers of those franchises to develop and operate their clinics. The failure by regional
developers to sell the specified minimum number of franchises within the time limits set forth in their regional developer license
agreements would reduce the franchise fees we receive, delay the payment of royalties to us and result in a potential event of
default under the regional developer license agreement. Of our total of eight regional developers as of December 31, 2016, six
have not met their minimum franchise opening requirements within the time periods specified in their regional developer agreements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;	</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our ability to operate effectively could be impaired if we fail
to attract and retain our executive officers.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our success depends, in part, upon the continuing
contributions of our executive officers and key employees at the management level. Although we have employment agreements with
certain of our key executive officers, there is no guarantee that they will not leave. The loss of the services of any of our executive
officers or the failure to attract other executive officers could have a material adverse effect on our business or our business
prospects. If we lose the services of any of our key employees at the operating or regional level, we may not be able to replace
them with similarly qualified personnel, which could harm our business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>A lack of qualified employees will significantly hinder our growth
plans and adversely affect our results of operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As we grow, our ability to increase productivity
and profitability will be limited by our ability to employ, train and retain skilled personnel. There can be no assurance that
we will be able to maintain an adequate skilled labor force necessary to operate efficiently, that our labor expenses will not
increase as a result of a shortage in the supply of skilled personnel or that we will not have to curtail our planned internal
growth as a result of labor shortages.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We may not be able to successfully recruit and retain qualified
chiropractors.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our success depends upon our continuing ability
to recruit and retain qualified chiropractors. In the event we are unable to attract a sufficient number of qualified chiropractors,
our growth rate may suffer.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our clinics and chiropractors compete for patients in a highly
competitive environment that may make it more difficult to increase patient volumes and revenues.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The business of providing chiropractic services
is highly competitive in each of the markets in which our clinics operate. The primary bases of such competition are quality of
care and reputation, price of services, marketing and advertising strategy and implementation, convenience, traffic flow and visibility
of office locations and hours of operation. Our clinics compete with all other chiropractors in their local market. Many of those
chiropractors have established practices and reputations in their markets. Some of these competitors and potential competitors
may have financial resources, affiliation models, reputations or management expertise that provide them with competitive advantages
over us, which may make it difficult to compete against them. Our three largest multi-unit competitors are HealthSource Chiropractic,
which currently operates 360 units; AlignLife Chiropractic &amp; Natural Health Centers, which currently operates 25 units; and
ChiroOne Wellness Centers, which currently operates 41 units. Each of these competitors is currently operating under an insurance
based model. In addition, a number of other chiropractic franchises and chiropractic practices that are attempting to duplicate
or follow our business model are currently operating in our markets and in other parts of the country and may enter our existing
markets in the future.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our success is dependent on the chiropractors who control the
professional corporations, or PC owners, with whom we enter into management services agreements, and we may have difficulty locating
qualified chiropractors to replace PC owners.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In states that regulate the corporate practice
of chiropractic, our chiropractic services are provided by legal entities organized under state laws as professional corporations,
or PCs. Each PC employs or contracts with chiropractors in one or more offices. Each of the PCs is wholly owned by one or more
licensed chiropractors, or medical professionals as state law may require, and we do not own any capital stock of any PC. We and
our franchisees that are not owned by chiropractors enter into management services agreements with PCs to provide on an exclusive
basis all non-clinical services of the chiropractic practice. The PC owner is critical to the success of a clinic because he or
she has control of all clinical aspects of the practice of chiropractic and the provision of chiropractic services. Upon the departure
of a PC owner, we may not be able to locate one or more suitably qualified licensed chiropractors to hold the ownership interest
in the PC and maintain the success of the departing PC owner.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our management services agreements with our affiliated PCs could
be challenged by a state or chiropractor under laws regulating the practice of chiropractic, and some state chiropractic boards
have made inquiries concerning our business model.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The laws of every state in which we operate contain
restrictions on the practice of chiropractic and control over the provision of chiropractic services. The laws of many states where
we operate permit a chiropractor to conduct a chiropractic practice only as an individual, a member of a partnership or an employee
of a PC, limited liability company or limited liability partnership. These laws typically prohibit chiropractors from splitting
fees with non-chiropractors and prohibit non-chiropractic entities, such as chiropractic management services organizations, from
engaging in the practice of chiropractic and from employing chiropractors. The specific restrictions against the corporate practice
of chiropractic, as well as the interpretation of those restrictions by state regulatory authorities, vary from state to state.
However, the restrictions are generally designed to prohibit a non-chiropractic entity from controlling or directing clinical care
decision-making, engaging chiropractors to practice chiropractic or sharing professional fees. The form of management agreement
that we utilize, and that we recommend to our franchisees that are management service organizations, explicitly prohibits the management
service organization from controlling or directing clinical care decisions. However, there can be no assurance that all of our
franchisees that are management service organizations will strictly follow the provisions in our recommended form of management
agreement. The laws of many states also prohibit chiropractic practitioners from paying any portion of fees received for chiropractic
services in consideration for the referral of a patient. Any challenge to our contractual relationships with our affiliated PCs
by chiropractors or regulatory authorities could result in a finding that could have a material adverse effect on our operations,
such as voiding one or more management services agreements. Moreover, the laws and regulatory environment may change to restrict
or limit the enforceability of our management services agreements. We could be prevented from affiliating with chiropractor-owned
PCs or providing comprehensive business services to them in one or more states.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In February, 2015, the Arkansas Board of Chiropractic
Examiners questioned whether our business model might violate Arkansas law in its response to an inquiry we made on behalf of one
of our franchisees. While the Arkansas Board did not thereafter pursue the matter of a possible violation, it might choose to do
so at any time in the future. The Kansas Healing Arts Board, in response to a third party complaint about one of our franchisees,
sent a letter to the franchisee in February 2015 questioning whether the franchise business model might violate Kansas law regarding
the unauthorized practice of chiropractic care. We and the franchisee have had several communications with the Kansas Board with
respect to modifying the management agreement to address its concerns, but we have no assurance that changes to the agreement will
satisfy these concerns. The Oregon Chiropractic Board of Examiners has made several inquiries since our franchisees began operating
in Oregon. While we have satisfied these past inquiries by providing a brief response or documentation, recently the Oregon Board
has asked to meet with the franchisee&#8217;s PC chiropractor owner to address questions which may relate to our business model.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In November, 2015, the California Board of Chiropractic
Examiners commenced an administrative proceeding to which we are not a party, in which it claimed that the doctor who owns the
PC that we manage in southern California violated California&#8217;s prohibition on the corporate practice of chiropractic, among
other claims, because our management of the clinics operated by his PC involved the exercise of control over certain clinical aspects
of his practice. The claims have subsequently been dismissed; however, we cannot assure you that similar claims will not be made
in the future, either against us or our affiliated PCs.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The New York Attorney General&#8217;s recent
investigation into the practices of a provider of business support services to independently owned dental practices may mean that
our business model will be subject to greater scrutiny in New York. The New York Attorney General concluded that the provider,
Aspen Dental Management, improperly made business decisions impacting clinical matters, illegally engaged in fee-splitting with
dental practices and required the dental practices to use the &#8220;Aspen Dental&#8221; trade name in a manner that had the potential
to mislead consumers into believing that the &#8220;Aspen Dental&#8221;&nbsp;&#8212;- branded offices were under common ownership
with the provider. In June 2015, the New York Attorney General agreed to an Assurance of Discontinuance, pursuant to which Aspen
Dental paid a substantial fine and agreed to change its business and branding practices, including changes to its website and marketing
materials in order to make clear that the Aspen-branded dental offices were independently owned and operated. The New York Attorney
General could similarly choose to challenge our contractual relationships with our affiliated PCs in New York and, in particular,
might question whether use of The Joint trademark by our affiliated PCs misleads consumers, causing them to incorrectly conclude
that we are the provider of chiropractic treatment.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Recent decisions by the United States National Labor Relations
Board expanding the meaning of &#8220;joint employer&#8221; mean that we could have liability for employment law violations by
our franchisees.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">A July, 2014 decision by the United States National
Labor Relations Board, or the NLRB, held that McDonald&#8217;s Corporation could be held liable as a &#8220;joint employer&#8221;
for labor and wage violations by its franchisees. Subsequently, the NLRB issued a number of complaints against McDonald&#8217;s
Corporation in connection with these violations. Additionally, an August 2015 decision by the NLRB held that Browning-Ferris Industries
is a &#8220;joint employer&#8221; obligated to negotiate with the Teamsters union over workers supplied by a contract staffing
firm within one of its recycling plants. In January 2016, Browning-Ferris Industries filed an appeal in a U.S. appellate court
of an unfair labor practices charge arising out of this NLRB decision.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">If this expanded definition of &#8220;joint employer&#8221;
is upheld in the Browning-Ferris appeal or in an expected appeal of the McDonald&#8217;s decision, it could result in us having
responsibility for damages, reinstatement, back pay and penalties in connection with labor law violations by our franchisees over
whom we have no control and could have a material and adverse effect on our financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We and our affiliated chiropractor-owned PCs are subject to complex
laws, rules and regulations, compliance with which may be costly and burdensome.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We, our franchisees and the chiropractor-owned
PCs to which we and our franchisees provide management services, are subject to extensive federal, state and local laws, rules
and regulations, including:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">state regulations on the practice of chiropractic; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the Health Insurance Portability and Accountability Act of 1996, as amended, and its implementing regulations, or HIPAA, and other federal and state laws governing the collection, dissemination, use, security and confidentiality of patient-identifiable health and financial information; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">federal and state laws and regulations which contain anti-kickback and fee-splitting provisions and restrictions on referrals; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">the federal Fair Debt Collection Practices Act and similar state laws that restrict the methods that we and third party collection companies may use to contact and seek payment from patients regarding past due accounts; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">state and federal labor laws, including wage and hour laws. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Many of the above laws, rules and regulations
applicable to us, our franchisees and our affiliated PCs are ambiguous, have not been definitively interpreted by courts or regulatory
authorities and vary from jurisdiction to jurisdiction. Accordingly, we may not be able to predict how these laws and regulations
will be interpreted or applied by courts and regulatory authorities, and some of our activities could be challenged. In addition,
we must consistently monitor changes in the laws and regulatory schemes that govern our operations. Although we have tried to structure
our business and contractual relationships in compliance with these laws, rules and regulations in all material respects, if any
aspect of our operations were found to violate applicable laws, rules or regulations, we could be subject to significant fines
or other penalties, required to cease operations in a particular jurisdiction, prevented from commencing operations in a particular
state or otherwise be required to revise the structure of our business or legal arrangements. Our efforts to comply with these
laws, rules and regulations may impose significant costs and burdens, and failure to comply with these laws, rules and regulations
may result in fines or other charges being imposed on us.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We conduct business in a heavily regulated industry and, if we
fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes
to our operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The healthcare industry is heavily regulated
and closely scrutinized by federal, state and local governments. Comprehensive statutes and regulations govern the manner in which
we provide and bill for services, our contractual relationships with our physicians, vendors and customers, our marketing activities
and other aspects of our operations. Failure to comply with these laws can result in civil and criminal penalties such as fines,
damages, overpayment recoupment, loss of enrollment status or exclusion from government healthcare programs. The risk of our being
found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by
regulatory authorities or the courts, and their provisions are sometimes open to multiple interpretations. Any action against us
for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal
expenses and divert our managements&#8217; attention from the operation of our business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our chiropractors are also subject to ethical
guidelines and operating standards of professional and trade associations and private accreditation agencies. Compliance with these
guidelines and standards is often required by our contracts with our customers or to maintain our reputation. The laws, regulations
and standards governing the provision of healthcare services may change significantly in the future. New or changed healthcare
laws, regulations or standards may materially and adversely affect our business. In addition, a review of our business by judicial,
law enforcement, regulatory or accreditation authorities could result in a determination that could adversely affect our operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our facilities are subject to extensive federal and state laws
and regulations relating to the privacy and security of individually identifiable information.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HIPAA required the United States Department of
Health and Human Service, or HHS, to adopt standards to protect the privacy and security of individually identifiable health-related
information, or PHI. HHS released final regulations containing privacy standards in December 2000 and published revisions to the
final regulations in August 2002. The privacy regulations extensively regulate the use and disclosure of PHI. The regulations also
provide patients with significant rights related to understanding and controlling how their health information is used or disclosed.
The security regulations require healthcare providers to implement administrative, physical and technical practices to protect
the security of individually identifiable health information that is maintained or transmitted electronically. The Health Information
Technology for Economic and Clinical Health Act, or HITECH, which was signed into law in February of 2009, enhanced the privacy,
security and enforcement provisions of HIPAA by, among other things, extending HIPAA&#8217;s privacy and security standards to
&#8220;business associates,&#8221; which, like us, are independent contractors or agents of covered entities (such as the chiropractic
PCs and other healthcare providers) that create, receive, maintain, or transmit PHI in connection with providing a service for
or on behalf of a covered entity. HITECH also established security breach notification requirements, created a mechanism for enforcement
of HIPAA by state attorneys general, and increased penalties for HIPAA violations. Violations of HIPAA or HITECH could result in
civil or criminal penalties. In addition to HIPAA, there are numerous federal and state laws and regulations addressing patient
and consumer privacy concerns, including unauthorized access or theft of personal information. State statutes and regulations vary
from state to state. Lawsuits, including class actions and action by state attorneys general, directed at companies that have experienced
a privacy or security breach also can occur. We have established policies and procedures in an effort to ensure compliance with
these privacy related requirements. However, if there is a breach, we may be subject to various penalties and damages and may be
required to incur costs to mitigate the impact of the breach on affected individuals.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the data privacy, security and breach notification
requirements of HIPAA and other data privacy and security laws, and the failure to comply with these rules, or allegations that
we have failed to do so, can result in civil or criminal sanctions.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HIPAA required the United States Department of
Health and Human Service, or HHS, to adopt standards to protect the privacy and security of certain health-related information.
The HIPAA privacy regulations contain detailed requirements concerning the use and disclosure of individually identifiable health
information and the grant of certain rights to patients with respect to such information by &#8220;covered entities.&#8221; As
a provider of healthcare who conducts certain electronic transactions, each of our facilities is considered a covered entity under
HIPAA. We have taken actions to comply with the HIPAA privacy regulations and believe that we are in substantial compliance with
those regulations. These actions include the creation and implementation of policies and procedures, staff training, execution
of HIPAA-compliant contractual arrangements with certain service providers and various other measures. Ongoing implementation and
oversight of these measures involves significant time, effort and expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to the privacy requirements, HIPAA
covered entities must implement certain administrative, physical and technical security standards to protect the integrity, confidentiality
and availability of certain electronic health-related information received, maintained or transmitted by covered entities or their
business associates. We have taken actions in an effort to be in compliance with these security regulations and believe that we
are in substantial compliance, however, a security incident that bypasses our information security systems causing an information
security breach, loss of protected health information or other data subject to privacy laws or a material disruption of our operational
systems could result in a material adverse impact on our business, along with fines. Ongoing implementation and oversight of these
security measures involves significant time, effort and expense.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The Health Information Technology for Economic
and Clinical Health Act, or HITECH, as implemented in part by an omnibus final rule published in the Federal Register on January
25, 2013, further requires that patients be notified of any unauthorized acquisition, access, use, or disclosure of their unsecured
protected health information, or PHI, that compromises the privacy or security of such information. HHS has established the presumption
that all unauthorized uses or disclosures of unsecured protected health information constitute breaches unless the covered entity
or business associate establishes that there is a low probability the information has been compromised. HITECH and implementing
regulations specify that such notifications must be made without unreasonable delay and in no case later than 60 calendar days
after discovery of the breach. If a breach affects 500 patients or more, it must be reported immediately to HHS, which will post
the name of the breaching entity on its public website. Breaches affecting 500 patients or more in the same state or jurisdiction
must also be reported to the local media. If a breach involves fewer than 500 people, the covered entity must record it in a log
and notify HHS of such breaches at least annually. These breach notification requirements apply not only to unauthorized disclosures
of unsecured PHI to outside third parties, but also to unauthorized internal access to or use of such PHI.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">HITECH significantly expanded the scope of the
privacy and security requirements under HIPAA and increased penalties for violations. The amount of penalty that may be assessed
depends, in part, upon the culpability of the applicable covered entity or business associate in committing the violation. Some
penalties for certain violations that were not due to &#8220;willful neglect&#8221; may be waived by the Secretary of HHS in whole
or in part, to the extent that the payment of the penalty would be excessive relative to the violation. HITECH also authorized
state attorneys general to file suit on behalf of residents of their states. Applicable courts may award damages, costs and attorneys&#8217;
fees related to violations of HIPAA in such cases. HITECH also mandates that the Secretary of HHS conduct periodic compliance audits
of a cross-section of HIPAA covered entities and business associates. Every covered entity and business associate is subject to
being audited, regardless of the entity&#8217;s compliance record.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">States may impose more protective privacy restrictions
in laws related to health information and may afford individuals a private right of action with respect to the violation of such
laws. Both state and federal laws are subject to modification or enhancement of privacy protection at any time. We are subject
to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These statutes
vary and could impose additional requirements on us and more severe penalties for disclosures of health information. If we fail
to comply with HIPAA or similar state laws, including laws addressing data confidentiality, security or breach notification, we
could incur substantial monetary penalties and our reputation could be damaged.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, states may also impose restrictions
related to the confidentiality of personal information that is not considered &#8220;protected health information&#8221; under
HIPAA. Such information may include certain identifying information and financial information of our patients. Theses state laws
may impose additional notification requirements in the event of a breach of such personal information. Failure to comply with such
data confidentiality, security and breach notification laws may result in substantial monetary penalties.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our business model depends on proprietary and third party management
information systems that we use to, among other things, track financial and operating performance of our clinics, and any failure
to successfully design and maintain these systems or implement new systems could materially harm our operations.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We depend on integrated management information
systems, some of which are provided by third parties, and standardized procedures for operational and financial information, as
well as for patient records and our billing operations. We may experience unanticipated delays, complications, data breaches or
expenses in implementing, integrating, and operating our systems. Our management information systems regularly require modifications,
improvements or replacements that may require both substantial expenditures as well as interruptions in operations. Our ability
to implement these systems is subject to the availability of skilled information technology specialists to assist us in creating,
implementing and supporting these systems. Our failure to successfully design, implement and maintain all of our systems could
have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>If we fail to properly maintain the integrity of our data or
to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially
adversely affected.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We increasingly use electronic means to interact
with our customers and collect, maintain and store individually identifiable information, including, but not limited to, personal
financial information and health-related information. Despite the security measures we have in place to ensure compliance with
applicable laws and rules, our facilities and systems, and those of our third-party service providers, may be vulnerable to security
breaches, acts of cyber terrorism, vandalism or theft, computer viruses, misplaced or lost data, programming and/or human errors
or other similar events. Additionally, the collection, maintenance, use, disclosure and disposal of individually identifiable data
by our businesses are regulated at the federal and state levels as well as by certain financial industry groups, such as the Payment
Card Industry organization. Federal, state and financial industry groups may also consider from time to time new privacy and security
requirements that may apply to our businesses. Compliance with evolving privacy and security laws, requirements, and regulations
may result in cost increases due to necessary systems changes, new limitations or constraints on our business models and the development
of new administrative processes. They also may impose further restrictions on our collection, disclosure and use of individually
identifiable information that is housed in one or more of our databases. Noncompliance with privacy laws, financial industry group
requirements or a security breach involving the misappropriation, loss or other unauthorized disclosure of personal, sensitive
and/or confidential information, whether by us or by one of our vendors, could have material adverse effects on our business, operations,
reputation and financial condition, including decreased revenue; material fines and penalties; increased financial processing fees;
compensatory, statutory, punitive or other damages; adverse actions against our licenses to do business; and injunctive relief
whether by court or consent order.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We, along with our affiliated PCs and their chiropractors, may
be subject to malpractice and other similar claims and may be unable to obtain or maintain adequate insurance against these claims.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The provision of chiropractic services by chiropractors
entails an inherent risk of potential malpractice and other similar claims. While we do not have responsibility for compliance
by affiliated PCs and their chiropractors with regulatory and other requirements directly applicable to chiropractors, claims,
suits or complaints relating to services provided at the offices of our franchisees or affiliated PCs may be asserted against us.
As we develop company-owned or managed clinics, our exposure to malpractice claims will increase. We have experienced six malpractice
claims since our founding in April, 2010, which we have defended or are vigorously defending and do not expect its outcome to have
a material adverse effect on our business, financial condition or results of operations. The assertion or outcome of these claims
could result in higher administrative and legal expenses, including settlement costs or litigation damages. Our current minimum
professional liability insurance coverage required for our franchisees, affiliated PCs and company-owned clinics is $1.0 million
per occurrence and $3.0 million in annual aggregate, with a self-insured retention of $0 per claim and $0 annual aggregate. In
addition, we have a corporate business owners policy with coverage of $2.0 million per occurrence and $4.0 million in annual aggregate.
If we are unable to obtain adequate insurance or if there is an increase in the future cost of insurance to us and the chiropractors
who provide chiropractic services or an increase in the amount we have to self-insure, there may be a material adverse effect on
our business and financial results.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We could be party to litigation that could adversely affect us
by distracting management, increasing our expenses or subjecting us to material monetary damages and other remedies.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition to potential malpractice claims,
we are also subject to a variety of other claims arising in the ordinary course of our business, including personal injury claims,
contract claims and claims alleging violations of federal and state law regarding workplace and employment matters, equal opportunity,
harassment, discrimination and similar matters, and we could become subject to class action or other lawsuits related to these
or different matters in the future. Regardless of whether any claims against us are valid, or whether we are ultimately held liable,
claims may be expensive to defend and may divert time and money away from our operations and hurt our performance. A judgment in
excess of our insurance coverage for any claims could materially and adversely affect our financial condition and results of operations.
Any adverse publicity resulting from these allegations may also materially and adversely affect our reputation or prospects, which
in turn could materially adversely affect our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are subject to the risk that our current insurance may not
provide adequate levels of coverage against claims.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our current insurance policies may not be adequate
to protect us from liabilities that we incur in our business. Additionally, in the future, our insurance premiums may increase,
and we may not be able to obtain similar levels of insurance on reasonable terms, or at all. Any substantial inadequacy of, or
inability to obtain insurance coverage could materially adversely affect our business, financial condition and results of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Furthermore, there are types of losses we may
incur that cannot be insured against or that we believe are not economically reasonable to insure. Such losses could have a material
adverse effect on our business and results of operations. Failure to obtain and maintain adequate directors&#8217; and officers&#8217;
insurance would likely adversely affect our ability to attract and retain qualified officers and directors.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Events or rumors relating to our brand names or our ability to
defend successfully against intellectual property infringement claims by third parties could significantly impact our business.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Recognition of our brand names, including &#8220;THE
JOINT CHIROPRACTIC&#8221;, and the association of those brands with quality, convenient and inexpensive chiropractic maintenance
care are an integral part of our business. The occurrence of any events or rumors that cause patients to no longer associate the
brands with quality, convenient and inexpensive chiropractic maintenance care may materially adversely affect the value of the
brand names and demand for chiropractic services at our franchisees or their affiliated PCs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our ability to compete effectively depends in
part upon our intellectual property rights, including but not limited to our trademarks. Our use of contractual provisions, confidentiality
procedures and agreements, and trademark, copyright, unfair competition, trade secret and other laws to protect our intellectual
property rights may not be adequate. Litigation may be necessary to enforce our intellectual property rights, or to defend against
claims by third parties that the conduct of our businesses or our use of intellectual property infringes upon such third party&#8217;s
intellectual property rights. Any intellectual property litigation or claims brought against us, whether or not meritorious, could
result in substantial costs and diversion of our resources, and there can be no assurances that favorable final outcomes will be
obtained in all cases. Our business, financial condition or results of operations could be adversely affected as a result.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We present Adjusted EBITDA as a supplemental measure to help
us describe our operating performance. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should
not be construed as an alternative to net income (loss) or as a better indicator of operating performance.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Adjusted EBITDA consists of net income (loss),
before interest, income taxes, depreciation and amortization, acquisition related and stock compensation expense, bargain purchase
gain, and loss on disposition or impairment. We present Adjusted EBITDA as a supplemental measure to help us describe our operating
performance. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative
to net income (loss) (as determined in accordance with generally accepted accounting principles in the United States, or GAAP)
or as a better indicator of operating performance. You should not consider Adjusted EBITDA as a substitute for operating profit,
as an indicator of our operating performance or as an alternative to cash flows from operating activities as a measure of liquidity.
We may calculate Adjusted EBITDA differently from other companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In addition, in the future we may incur expenses
similar to those excluded when calculating Adjusted EBITDA. Our presentation of these measures should not be construed as an inference
that our future results will be unaffected by unusual or non-recurring items. Our computation of Adjusted EBITDA may not be comparable
to other similarly titled measures computed by other companies, because all companies do not calculate Adjusted EBITDA in the same
fashion.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management does not consider Adjusted EBITDA
in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted
EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements.
Some of these limitations are: (i) Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital
expenditures or contractual commitments; (ii) Adjusted EBITDA does not reflect changes in, or cash requirements for, our working
capital needs; (iii) Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest
or principal payments, on our debts, and although depreciation and amortization are non-cash charges, the assets being depreciated
and amortized will often have to be replaced in the future; (iv) Adjusted EBITDA does not reflect any cash requirements for such
replacements; (v) Adjusted EBITDA does not reflect the bargain purchase gain, which represents the excess of the fair value of
net assets acquired over the purchase consideration; and (vi) Adjusted EBITDA does not reflect the loss on disposition or impairment,
which represents the impairment of assets from Company managed clinics held for sale as of the reporting date. We do not consider
these to be indicative of our ongoing operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes to financial accounting standards will require our operating
leases to be recognized on the balance sheet.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As we increase the number of our company-owned
or managed clinics we will have considerable obligations relating to our operating leases. Changes to financial accounting standards
will require such leases to be recognized on our balance sheet. All of our existing clinics are subject to leases. The lease terms
of our clinics vary, but typically have initial terms of between five and ten years with five year renewal options. The accounting
treatment of these leases is described in Note 1 to our consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In February, 2016, the Financial Accounting Standards
Board, or FASB, released the new Accounting Standards Update related to leases. The changes require that substantially all operating
leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard,
which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense
in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments
over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after December
15, 2018. While we have not quantified the impact this standard will have on our financial statements, when our current operating
leases are instead recognized on the balance sheet, it will result in a significant increase in the liabilities reflected on our
balance sheet and in the interest expense and depreciation and amortization expense reflected in our statement of operations, while
reducing the amount of rent expense. This could potentially decrease our reported net income.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We are an &#8220;emerging growth company&#8221; as defined in
the Securities Act and the reduced disclosure requirements applicable to emerging growth companies may make our common stock less
attractive to investors.</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are an &#8220;emerging growth company&#8221;
as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221;
including, among other things, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, as amended, reduced financial disclosure requirements, which include being permitted to provide only two years of
audited financial statements, with correspondingly reduced &#8220;Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations&#8221; disclosure, reduced disclosure obligations regarding executive compensation and exemptions from
the requirements of holding a non-binding stockholder advisory vote on executive compensation and stockholder approval of any golden
parachute payments not previously approved. As a result, our stockholders may not have access to certain information that they
may deem important. In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of
the extended transition period provided in Section 7(a)(2) of the Securities Act for complying with new or revised accounting standards.
We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will
be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We could be an emerging growth company until
as late as December 31, 2019 (the last day of the fiscal year following the fifth anniversary of the date of our initial public
offering, which occurred on November 14, 2014), although circumstances could cause us to lose that status earlier, including (i)
if our total annual gross revenue exceeds $1.0 billion, if we issue more than $1.0 billion in non-convertible debt securities during
any three-year period, or (ii) if the market value of our common stock held by non-affiliates exceeds $700.0 million as of any
June 30 before that time. Investors may find our common stock less attractive because we may rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and
our stock price may be more volatile.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Pursuant to the JOBS Act, our independent registered public accounting
firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404
for so long as we are an &#8220;emerging growth company.&#8221;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Section 404 of the Sarbanes-Oxley Act of 2002,
as amended, or the Sarbanes-Oxley Act, requires annual management assessments of the effectiveness of our internal control over
financial reporting, starting with the second annual report that we file with the SEC as a public company, including disclosure
of any material weaknesses identified by our management in our internal control over financial reporting. The Sarbanes-Oxley Act
generally requires in the same report a report by our independent registered public accounting firm on the effectiveness of our
internal control over financial reporting. However, under the JOBS Act, our independent registered public accounting firm will
not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 until we
are no longer an &#8220;emerging growth company.&#8221; We could be an &#8220;emerging growth company&#8221; as late as December
31, 2019 (the last day of the fiscal year following the fifth anniversary of the date of our initial public offering, which occurred
on November 14, 2014).</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We may identify material weaknesses that we may
not be able to remediate in time to meet the applicable deadline imposed upon us for compliance with the requirements of Section
404 of the Sarbanes-Oxley Act. In addition, if we fail to achieve and maintain the adequacy of our internal controls, as such standards
are modified, supplemented or amended from time to time, we may not be able to conclude that we have effective internal controls
over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act. If we are not able to implement the requirements
of Section 404 of the Sarbanes-Oxley Act in a timely manner or with adequate compliance, our independent registered public accounting
firm may issue an adverse opinion due to ineffective internal controls over financial reporting and we may be subject to sanctions
or investigation by regulatory authorities, such as the SEC. As a result, there could be a negative reaction in the financial markets
due to a loss of confidence in the reliability of our financial statements. In addition, we may be required to incur costs in improving
our internal control system and the hiring of additional personnel. Any such action could have a material adverse effect on our
business, prospects, results of operations and financial condition.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management, with the participation of our
Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period ended December 31, 2016. Based
on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure
controls and procedures were effective.</p>

<p style="font-size: 10pt; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>The requirements of being a public company, including compliance
with the reporting requirements of the Exchange Act and the requirements of the Sarbanes-Oxley Act, may strain our resources, increase
our costs and distract management, and we may be unable to comply with these requirements in a timely or cost-effective manner.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our initial public offering had a significant,
transformative effect on us. Prior to our initial public offering, our business operated as a privately owned company, and we now
incur significant additional legal, accounting, reporting and other expenses as a result of having publicly-traded common stock.
As a public company with listed equity securities, we need to comply with certain laws, regulations and requirements, including
corporate governance provisions of the Sarbanes-Oxley Act, related regulations of the SEC, and the requirements of The NASDAQ Capital
Market with which we had not been required to comply as a private company. Complying with these statutes, regulations and requirements
occupies a significant amount of time of our Board of Directors and management and has significantly increased our costs and expenses.
We will continue to:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">institute more comprehensive corporate governance and compliance functions; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">design, establish, evaluate and maintain a system of internal control over financial reporting in compliance with the requirements of Section 404(a) of the Sarbanes-Oxley Act and the related rules and regulations of the SEC and the Public Company Accounting Oversight Board; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">comply with rules promulgated by The NASDAQ Capital Market; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">prepare and distribute periodic public reports in compliance with our obligations under the federal securities laws; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">establish new internal policies, such as those relating to disclosure controls and procedures and insider trading; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">to a greater degree than previously, involve and retain outside counsel and accountants in the above activities. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Risks Related to Our Public Offerings and Listing of Our Common
Stock on the NASDAQ Capital Market</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Our stock price could be volatile and could decline.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The price at which our common stock will trade
could be extremely volatile and may fluctuate substantially due to the following factors, some of which are beyond our control:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">variations in our operating results;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">variations between our actual operating results and the expectations of securities analysts, investors and the financial community;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">announcements of developments affecting our business or expansion plans by us or others; and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&#8226;</font></td>
    <td style="width: 96%; text-align: justify"><font style="font-size: 10pt">conditions and trends in the chiropractic industry.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As a result of these and other factors, investors
in our common stock may not be able to resell their shares at or above their purchase price.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the past, securities class action litigation
often has been instituted against companies following periods of volatility in the market price of their securities. This type
of litigation, if directed at us, could result in substantial costs and a diversion of management&#8217;s attention and resources.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Provisions of Delaware law could discourage a takeover that stockholders
may consider favorable.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As a Delaware corporation, we have elected
to be subject to the Delaware anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law. Under
Delaware law, a corporation may not engage in a business combination with any holder of 15% or more of its capital stock unless
the holder has held the stock for three years or, among other things, the Board of Directors has approved the transaction. Our
Board of Directors could rely on this provision to prevent or delay an acquisition of us. For a description of our capital stock,
see &#8220;Description of Capital Stock.&#8221;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Future sales of our common stock may depress our stock price
and our share price may decline due to the large number of shares eligible for future sale or exchange.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Sales of substantial amounts of our common
stock in the public market by our officers, directors or significant shareholders may adversely affect the market price of our
common stock. Shares issued upon the exercise of outstanding options and shares issuable upon the exercise of the warrants we issued
to the underwriters in our initial public offering also may be sold in the public market. Such sales could create the perception
to the public of difficulties or problems with our business. As a result, these sales might make it more difficult for us to sell
securities in the future at a time and price that we deem necessary or appropriate.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The market price of our common stock could decline
as a result of sales of a large number of shares of common stock in the market or the perception that such sales could occur. These
sales, or the possibility that these sales may occur, might also make it more difficult for us to sell equity securities in the
future at a time and at a price that we deem appropriate. As of December 31, 2016, we have 13,020,889 outstanding shares of common
stock. The trading volume of shares of our common stock has averaged 29,167 shares per day during the year ended December 31, 2016.
Accordingly, sales of even small amounts of shares of our common stock by existing stockholders may drive down the trading price
of our common stock.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>If securities analysts do not publish research or reports about
our business or if they downgrade our company or our sector, the price of our common stock could decline.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">The trading market for our common stock depends
in part on the research and reports that industry or financial analysts publish about us or our business. We do not influence or
control the reporting of these analysts. If one or more of the analysts who do cover us downgrade or provide a negative outlook
on our company or our industry, or the stock of any of our competitors, the price of our common stock could decline. If one or
more of these analysts ceases coverage of our company, we could lose visibility in the market, which in turn could cause the price
of our common stock to decline.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Financial forecasting by us and financial analysts that may publish
estimates of our financial results will be difficult because of our limited operating history, and our actual results may differ
from forecasts.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As a result of our limited operating history,
it is difficult to accurately forecast our revenues, operating expenses and results, and operating data. The inability by us or
the financial community to accurately forecast our operating results could cause our net losses in a given quarter to be greater
than expected, which could cause a decline in the trading price of our common stock. We have a limited amount of meaningful historical
financial data upon which to base planned operating expenses. We base our current and forecasted expense&nbsp;and cash expenditure
levels on our operating plans and estimates of future revenues, which are dependent on the growth of the number of patients and
the demand for our services. As a result, we may be unable to make accurate financial forecasts or to adjust our spending in a
timely manner to compensate for any unexpected shortfalls in revenues. We believe that these difficulties in forecasting are even
greater for financial analysts that may publish their own estimates of our financial results.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>We do not intend to pay dividends. You will not receive funds
without selling shares, and you may lose the entire amount of your investment.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have never declared or paid any cash dividends
on our capital stock and do not intend to pay dividends in the foreseeable future. We intend to invest our future earnings, if
any, to fund our growth. We cannot assure you that you will receive a positive return on your investment when you subsequently
sell your shares or that you will not lose the entire amount of your investment.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Claims for indemnification by our directors and officers may
reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to
us.</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our amended and restated certificate of incorporation
and bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware
law. In addition, we have entered and expect to continue to enter into agreements to indemnify our directors, executive officers
and other employees as determined by our Board of Directors. Under the terms of such indemnification agreements, we are required
to indemnify each of our directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis
of the indemnitee&#8217;s involvement was by reason of the fact that the indemnitee is or was a director or officer of the Company
or any of its subsidiaries or was serving at the Company&#8217;s request in an official capacity for another entity. We must indemnify
our officers and directors against all reasonable fees, expenses, charges and other costs of any type or nature whatsoever, including
any and all expenses and obligations paid or incurred in connection with investigating, defending, being a witness in, participating
in (including on appeal), or preparing to defend, be a witness or participate in any completed, actual, pending or threatened action,
suit, claim or proceeding, whether civil, criminal, administrative or investigative, or establishing or enforcing a right to indemnification
under the indemnification agreement. The indemnification agreements also require us, if so requested, to advance within 30 days
of such request all reasonable fees, expenses, charges and other costs that such director or officer incurred, provided that such
person will return any such advance if it is ultimately determined that such person is not entitled to indemnification by us. Any
claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims
and may reduce the amount of money available to us.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_003"></a>ITEM 1B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UNRESOLVED STAFF COMMENTS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Not applicable.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_004"></a><b>ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
PROPERTIES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We lease the property for our corporate headquarters
and all of the properties on which we own or manage clinics. As of March 1, 2017, we leased 47 facilities in which we operate or
intend to operate clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our corporate headquarters are located at 16767
North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260. The term of our lease for this location expires on July 31, 2019.
The primary functions performed at our corporate headquarters are financial, accounting, treasury, marketing, operations, human
resources, information systems support and legal.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We are also obligated under non-cancellable leases
for the clinics which we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial
term of five years, include one to two options to renew for terms of five years, and require us to pay a proportionate share of
real estate taxes, insurance, common area maintenance charges and other operating costs.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">As of March 1, 2017, our franchisees operated
322 clinics in 29 states. All of our franchise locations are leased.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_005"></a>ITEM 3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
LEGAL PROCEEDINGS &nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, we are party
to litigation from time to time. We maintain insurance to cover certain actions and believe that resolution of such litigation
will not have a material adverse effect on the Company.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As previously disclosed, on July 7, 2015 six
franchisees who owned a total of 13 franchise licenses ("Claimants") filed a Demand for Arbitration against the Company
alleging breach of contract, breach of implied covenant of good faith and fair dealing, wrongful termination, fraud, promissory
fraud, negligent misrepresentation, and claims under or arising out of violations of Section 31300, 31301, 31201 and 31202 of the
California Franchise Investment Law. The Company vigorously denied liability for all of Claimants' claims and asserted counterclaims
against each Claimant for breach of contract, breach of guaranty, among other claims, and sought a declaratory judgment that termination
was proper because Claimants failed to adhere to the development schedules in their respective franchise agreements. The Company,
through its counterclaim, sought damages for each unopened license, in accordance with the terms of the parties&#8217; franchise
agreements. The parties entered into a settlement agreement dated December 12, 2016, which included, among other things, a
mutual general release of claims. The arbitration was subsequently dismissed with prejudice, based on the parties' stipulation.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_006"></a>ITEM 4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MINE SAFETY DISCLOSURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Not applicable.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><b>PART II</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_007"></a>ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MARKET&nbsp;FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Beginning November 11, 2014, our common stock
is traded on the NASDAQ Capital Market under the symbol &#8220;JYNT.&#8221; The following table sets forth the high and low sales
prices for our common stock for the calendar quarters or other periods indicated as reported by the NASDAQ Capital Market.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;<b>Company Stock Performance</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; border-bottom: Black 1.1pt solid">Fiscal Year 2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">High</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Low</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left">First Quarter</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">10.50</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">6.16</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Second Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">12.99</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7.29</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Third Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">10.78</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">5.99</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Fourth Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7.90</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">4.95</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; border-bottom: Black 1.1pt solid">Fiscal Year 2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">High</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Low</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left">First Quarter</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">5.89</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">2.65</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Second Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">3.90</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.03</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Third Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">3.20</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.85</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Fourth Quarter</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.80</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.96</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Holders</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, there were approximately&nbsp;15
holders of record of our common stock and&nbsp;13,020,889 shares of our common stock outstanding.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Dividends</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Since our initial public offering, we have
not declared nor paid dividends on our common stock and we do not expect to pay cash dividends on our common stock in the foreseeable
future.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_008"></a>ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp; SELECTED FINANCIAL DATA</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center">(in thousands, except per share data)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Consolidated Statement of Operations Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Total revenues</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">20,524</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">13,835</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,940</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,820</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Selling, general and administrative expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">29,086</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">20,332</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Loss from operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,023</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(9,316</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Net loss</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,174</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(8,797</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(0.88</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; text-indent: -20pt; padding-left: 30pt">Weighted average shares outstanding
    used in computing basic and diluted income (loss) per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">10,042,001</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Non-GAAP Financial Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Net income (loss)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,174</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(8,797</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Interest expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Depreciation and amortization expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,269</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Income tax expense (benefit)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">164</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(236</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">EBITDA</td><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(12,429</td><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7,749</td><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Stock compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">825</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Acquisition related expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">75</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">393</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Loss on disposition or impairment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,520</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<TR STYLE="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Bargain purchase gain</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(261</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Adjusted EBITDA</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,711</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(6,792</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; text-align: left">Consolidated Balance Sheet Data:</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center">(in thousands)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">3,010</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">16,793</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,725</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,139</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,585</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,141</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Goodwill and intangible assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,089</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,009</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,646</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,280</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">17,055</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">33,362</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,309</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,949</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,820</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,734</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">10,129</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,683</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,925</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">20,679</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 1px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">(1)</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA consists of net income (loss), before interest, income taxes, depreciation and amortization, acquisition related and stock compensation expense, bargain purchase gain, and loss on disposition or impairment. We have provided Adjusted EBITDA because it is a measure of financial performance commonly used for comparing companies in our industry. Adjusted EBITDA provides an alternative measure of cash flow from operations. You should not consider Adjusted EBITDA as a substitute for operating profit as an indicator of our operating performance or as an alternative to cash flows from operating activities as a measure of liquidity. We may calculate Adjusted EBITDA differently from other companies. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">We believe that the use of Adjusted EBITDA provides
an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures
with other outpatient medical clinics, which may present similar non-GAAP financial measures to investors. In addition, you should
be aware when evaluating Adjusted EBITDA that in the future we may incur expenses similar to those excluded when calculating these
measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected
by unusual or non-recurring items. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures
computed by other companies, because all companies do not calculate Adjusted EBITDA in the same fashion.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Our management does not consider Adjusted EBITDA
in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of Adjusted
EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements.
Some of these limitations are:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">a.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">b.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">c.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px; text-align: justify">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">d.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 21px">&nbsp;</td>
    <td style="width: 20px; text-align: justify"><font style="font-size: 10pt">e.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the bargain purchase gain, which represents the excess of the fair value of net assets acquired over the purchase consideration. We do not consider this to be indicative of our ongoing operations. </font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">f.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Adjusted EBITDA does not reflect the loss on disposition or impairment, which represents the impairment of assets from Company managed clinics held for sale as of the reporting date. We do not consider this to be indicative of our ongoing operations. </font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">Because of these limitations, Adjusted EBITDA
should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate
for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only supplementally. You should review
the reconciliation of net income (loss) to Adjusted EBITDA above and not rely on any single financial measure to evaluate our business.
The table above reconciles net loss to adjusted EBITDA for the years ended December 31, 2016 and 2015.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_009"></a>ITEM 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following discussion and analysis of the
results of operations and financial condition of The Joint Corp. for the years ended December 31, 2016 and 2015 should be read
in conjunction with the consolidated financial statements and the notes thereto, and other financial information contained elsewhere
in this Form 10-K.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Overview</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our principal business is to develop, own,
operate, support and manage chiropractic clinics through franchising and the sale of regional developer rights, and through direct
ownership and management arrangements throughout the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;We seek to be the leading provider
of chiropractic care in the markets we serve and to become the most recognized brand in our industry through the rapid and focused
expansion of chiropractic clinics in key markets throughout North America and abroad.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Key Performance Measures.</i>&nbsp;&nbsp;We
receive both weekly and monthly performance reports from our clinics which include key performance indicators including gross clinic
sales, total royalty income, and patient office visits. We believe these indicators provide us with useful data with which to measure
our performance and to measure our franchisees&#8217; and clinics&#8217; performance.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Key Clinic Development Trends</i>. &nbsp;&nbsp;As
of December 31, 2016, we and our franchisees operated 370 clinics. Of the 61 company-owned or managed clinics, 29 were constructed
and developed by us, and 32 were acquired from franchisees.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our current growth strategy is to grow through
the sale and development of additional franchises, and to foster the growth of acquired and developed clinics that are owned and
managed by us.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We recognize the critical importance of preserving
cash and strengthening clinics we have already developed. Therefore, we do not plan to add additional company-owned or managed
clinics during the 2017 fiscal year. The scaling back of launching company-owned or managed clinics allows us to continue to focus
on growing gross sales, streamlining operations across all 61 company-owned or managed clinics and expanding franchise development.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We believe that The Joint has a remarkably
sound concept, benefiting from the fundamental changes taking place in the manner in which Americans access chiropractic care and
their growing interest in seeking effective, affordable natural solutions for general wellness. These trends join with the strong
preference we have seen among chiropractic doctors to reject the insurance-based model, to produce a dynamic combination that benefits
the consumer and the service provider alike. We believe that these forces create an important opportunity to accelerate the growth
of our network through new franchise development.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Recent Developments</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, we
opened eight company-owned or managed clinics and terminated the regional developer rights in one territory. In addition, we acquired
six developed franchises and one undeveloped franchise in California and New Mexico. We are operating the six developed franchises
as company-owned or managed clinics and have terminated the undeveloped clinic license.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January, 2017, we entered into a Credit
and Security Agreement (the &#8220;Credit Agreement&#8221;), and signed a revolving credit note payable to the lender. Under the
Credit Agreement, we are able to borrow up to an aggregate of $5,000,000 under revolving loans. Interest on the unpaid outstanding
principal amount of any revolving loans is at a rate equal to 10% per annum, provided, however, that the minimum amount of interest
paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is $200,000. Interest is due and payable
on the last day of each fiscal quarter in an amount determined by us, but not less than $25,000. The lender&#8217;s lending commitments
under the Credit Agreement terminate in December 2019, unless sooner terminated in accordance with the provisions of the Credit
Agreement. We intend to use the credit facility for general working capital needs. We have drawn $1,000,000 of the $5,000,000 available
under the Credit Agreement.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January, 2017, we sold the assets
of six of our 11 clinics in the Chicago area for a nominal amount to a limited liability company that includes existing
franchisees. The purchaser will continue to operate the clinics as franchised locations pursuant to a franchise agreement.
Concurrently, we sold regional developer rights to the Chicago area to the purchaser of our six Chicago clinics for $300,000.
Pursuant to the regional developer agreement, the limited liability company has agreed to open a minimum of 30 Chicago area
clinics over the next 10 years, with plans to open five to 10 clinics over the next 18 months. We have closed the remaining
five Chicago-area clinics, as well as three Company-managed clinics in upstate New York. We expect to recognize an additional
lease exit liability in the first quarter of 2017 related to these closures. These assets were designated as held for sale as
of December 31, 2016, and we recognized a loss on disposition or impairment of approximately $3.5 million. We made these
tactical decisions in the 4<sup>th</sup> quarter of 2016 to reduce our current cash usage, allowing us to focus
on accelerating the point at which we believe we will achieve cash-flow breakeven in 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, we
terminated 17 franchise licenses that were in default of various obligations under their respective franchise agreements. In conjunction
with these terminations, during the year ended December 31, 2016, we recognized approximately $0.5 million of revenue and $0.2
million of costs, respectively, which were previously deferred.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Factors Affecting Our Performance</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our operating results may fluctuate significantly
as a result of a variety of factors, including the timing of new clinic openings, markets in which they are contained and related
expenses, general economic conditions, consumer confidence in the economy, consumer preferences, and competitive factors.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Significant Accounting Polices and Estimates</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of consolidated financial statements
requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts
of revenues and expenses during the reporting period. We base our accounting estimates on historical experience and other factors
that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.&nbsp; We have discussed
the development and selection of significant accounting policies and estimates with our Audit Committee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Intangible Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired
franchise and regional developer rights and customer relationships.&nbsp;&nbsp;We amortize the fair value of re-acquired franchise
rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from
six to eight years. In the case of regional developer rights, we amortize the acquired regional developer rights over seven years.
The fair value of customer relationships is amortized over their estimated useful life of&nbsp;two&nbsp;years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Goodwill</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of
the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed
in Note 2 to the consolidated financial statements. Goodwill and intangible assets deemed to have indefinite lives are not
amortized but are subject to annual impairment tests. As required, we perform an annual impairment test of goodwill as of the
first day of the fourth quarter or more frequently if events or circumstances change that would more likely than not reduce
the fair value of a reporting unit below its carrying value. The Company recorded an impairment charge of $54,994 during the
year ended December 31, 2016 which represents the write-off of the goodwill associated with an acquired clinic in New
York.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Long-Lived Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We review our long-lived assets for impairment
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. We look primarily
to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments
of approximately $2.4 million and $0 were recorded for the years ended December 31, 2016 and 2015, respectively.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><B><I>Stock-Based Compensation</I></B></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We account for share based payments by recognizing
compensation expense based upon the estimated fair value of the awards on the date of grant. We determine the estimated grant-date
fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes
option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components
of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend
yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. We recognize compensation
costs ratably over the period of service using the straight-line method.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We generate revenue through initial franchise
fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from our
company-owned and managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Franchise Fees.</i> We require the entire
non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of
ten years. Initial franchise fees are recognized as revenue when we have substantially completed our initial services under the
franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;Our services under the franchise agreement include:
training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. We provide no
financing to franchisees and offer no guarantees on their behalf.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Regional Developer Fees</i>. During 2011,
we established a regional developer program to engage independent contractors to assist in developing specified geographical regions.
Under this program, regional developers pay a license fee ranging from $7,250 to 25% of the then current franchise fee, for each
franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum number of
franchises that the regional developer must develop. Regional developers receive fees ranging from $14,500 to $19,950 which are
collected from franchisees upon the sale of franchises within their region and a royalty of 3% of sales generated by franchised
clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue when we have
performed substantially all initial services required by the regional developer agreement, which generally is considered to be
upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of
franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer
agreement, we estimate the number of franchised clinics to be opened, which is typically consistent with the contracted minimum.
We reassess the number of clinics expected to be opened as the regional developer performs under its regional developer agreement.
When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised
on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected
remaining unopened franchised clinics within the region. Certain regional developer agreements provide that no additional fee is
required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements
require a supplemental payment. The franchisor&#8217;s services under regional developer agreements include site selection, grand
opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing
support to advertise for ownership opportunities. Several of the regional developer agreements grant us the option to repurchase
the regional developer&#8217;s license.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Revenues and Management Fees from Company
Clinics.&nbsp;&nbsp;</i>We earn revenues from clinics that we own and operate or manage throughout the United States.&nbsp; In
those states where we own and operate the clinic, revenues are recognized when services are performed. We offer a variety of membership
and wellness packages which feature discounted pricing as compared with single-visit pricing.&nbsp; Amounts collected up front
for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&nbsp;&nbsp;In
other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, we enter into a management
agreement with the doctor&#8217;s PC.&nbsp; Under the management agreement, we provide administrative and business management services
to the doctor&#8217;s PC in return for a monthly management fee.&nbsp; When the collectability of the full management fee is uncertain,
we recognize management fee revenue only to the extent of fees expected to be collected from the PCs.</p>

<p style="font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Royalties.</i> We collect royalties, as
stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2% of
gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee.
Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales period has
ended.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>IT Related Income and Software Fees.</i>&nbsp;&nbsp;We
collect a monthly computer software fee for use of our proprietary chiropractic software, computer support, and internet services
support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase
a clinic&#8217;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification
card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment
by the franchisee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Results of Operations</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Total Revenues</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Components of revenues for the year ended December
31, 2016 as compared to the year ended December 31, 2015, are as follows:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Change from<br> Prior Year</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent Change <br> from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; font-size: 10pt; text-align: left; padding-left: 10pt">Revenues and management fees from company clinics</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">8,578,048</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">3,651,273</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">4,926,775</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 9%; font-size: 10pt; text-align: right">134.9</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Royalty fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,973,079</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,515,203</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,457,876</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">32.3</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,286,809</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,471,259</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(184,450</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(7.5</td><td style="font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Advertising fund revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,866,406</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,191,124</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">675,282</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">56.7</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">IT related income and software fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">932,709</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">808,070</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">124,639</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15.4</td><td style="font-size: 10pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Regional developer fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">617,573</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">866,802</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(249,229</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(28.8</td><td style="font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">269,016</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">331,700</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(62,684</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="padding-bottom: 1.1pt; font-size: 10pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1.1pt; font-size: 10pt; text-align: right">(18.9</td><td style="font-size: 10pt; text-align: left; vertical-align: top">)%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">20,523,640</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,835,431</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,688,209</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">48.3</td><td style="font-size: 10pt; text-align: left; vertical-align: top">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The reasons for the significant changes in our components of total
revenues are as follows:&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Consolidated Results</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 94%; text-align: justify"><font style="font-size: 10pt">Total revenues increased by $6.7 million primarily due to the addition of 14 company-owned&nbsp;or managed clinics, and continued expansion and revenue growth of our franchise base.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Corporate Clinics</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 94%; text-align: justify"><font style="font-size: 10pt">Revenues and management fees from company-owned or managed clinics increased due to the number of company-owned or managed clinics in operation during 2016 compared to 2015.&nbsp;&nbsp;As of December 31, 2016 and 2015, there were 61 and 47 company-owned or managed clinics in operation, respectively. </font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"><i></i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Franchise Operations</i></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="width: 94%; text-align: justify"><font style="font-size: 10pt">Royalty fees have increased due to an increase in
    the number of franchised clinics in operation during the current period along with continued sales growth in existing
    franchised clinics.&nbsp;&nbsp;As of December 31, 2016 and 2015, there were 309 and 265 franchised clinics in operation,
    respectively.&nbsp;&nbsp;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify; width: 94%"><font style="font-size: 10pt">Franchise fees decreased due to the timing of franchise license terminations. In the year ended December 31, 2016 and 2015, we recognized revenue from terminations of $0.5 million and $1.0 million, respectively, offset by year to date openings.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify; width: 94%"><font style="font-size: 10pt">Regional developer fees decreased due to the timing of regional developer license acquisitions and terminations. We recognized revenue in relation to regional developer acquisitions or terminations of $0.1 million and $0.5 million during the years ended December 31, 2016 and 2015, respectively.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify; width: 94%"><font style="font-size: 10pt">IT related income and software fee and other revenues increased due to an increase in our franchise clinic base as described above.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Cost of Revenues</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Cost of Revenues</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,939,609</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,819,913</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">119,696</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">4.2</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2016, as compared
with the year ended December 31, 2015, the total cost of revenues increased due to increased regional developer royalties of $0.3
million triggered by an increase of royalty revenues of approximately 32% as compared to the prior year, offset by a decrease of
$0.2 million due to fewer regional developer commissions recognized in conjunction with franchise license terminations or openings
in the period as compared to prior year.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Selling and Marketing Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Selling and Marketing Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">4,419,180</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,843,613</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">1,575,567</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">55.4</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Selling and marketing expenses increased for
the year ended December 31, 2016, as compared to the year ended December 31, 2015, due to increased marketing efforts at company-owned
or managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Depreciation and Amortization Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Depreciation and Amortization Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">2,566,136</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">1,268,955</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">1,297,181</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">102.2</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation and amortization expenses increased
for the year ended December 31, 2016, as compared to the year ended December 31, 2015, primarily due to property and equipment
additions related to the acquisition of franchised clinics and development of company-owned or managed clinics and intangible asset
additions relating to our acquisitions of franchises and regional developer rights.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>General and Administrative Expenses</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">General and Administrative Expenses</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">22,101,083</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">16,219,392</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">5,881,691</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">36.3</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">General and administrative expenses increased
during the year ended December 31, 2016, compared to the year ended December 31, 2015, primarily due to the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase of approximately $2.8 million in occupancy costs due to the acquisition and development of additional company-owned or managed clinics</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase of approximately $2.4 million of payroll related expense of which $2.2 million relates to additional headcount from our company-owned or managed clinics.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 58px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">An increase of approximately $0.7 million in other miscellaneous expenses.</font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Loss from Operations</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Loss from Operations</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(15,022,738</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(9,316,442</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(5,706,296</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">61.2</td><td style="width: 1%; font-size: 10pt; text-align: left">%</td></tr>
</table>



<p style="font-size: 10pt; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Consolidated Results </i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Consolidated loss from operations increased
by $5.7 million for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily driven by the $5.9
million increase in operating loss in the corporate clinic segment period over period, discussed below; offset by net income from
franchised operations, discussed below.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Franchise Operations</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our franchise operations segment had net income
from operations of $4.6 million for the year ended December 31, 2016, an increase of $0.4 million, compared to net income from
operations of $4.2 million for the same period ended December 31, 2015. This increase was primarily driven by:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: middle">
    <td style="text-align: justify; width: 58px">&nbsp;</td>
    <td style="text-align: left; width: 24px; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $1.6 million in total revenues, due primarily to an approximately 32% increase in franchise royalty revenues, offset by</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $0.1 million in  royalties and commissions, paid to regional
    developers, and</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $1.0 million in support expense attributable to increased headcount to manage our national expansion.</td></tr>
</table>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i></i></b><i>Corporate Clinics</i></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our corporate clinics segment (i.e., company-owned
or managed clinics) had a loss from operations of $9.7 million for the year ended December 31, 2016, an increase of $5.9 million
compared to a loss from operations of $3.8 million for the same period ended December 31, 2015. This increase was primarily driven
by:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: middle">
    <td style="width: 58px">&nbsp;</td>
    <td style="width: 24px; text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td>A $3.5 million loss on disposition or  impairment for the portfolio of clinics in Illinois and New York deemed to be held
    of sale as of     December 31, 2016. The loss on disposition or impairment was made up of a $2.4 million impairment charge
    to     lower     the     carrying     costs of the property and equipment to its estimated fair value less cost to sell, a
    $0.7     million     write-off of     accounts     receivable deemed to be uncollectible for certain working capital advances
    made to     PC entities     in Illinois and     New York, $0.1     million of impairment charges related to goodwill and
    intangible     assets associated     with an acquired clinic     in New York, and     $0.3 million of a lease exit liability
    recorded for     certain abandoned leases     during the 4<font style="font-size: 10pt; font-weight: normal; font-style: normal"><sup>th</sup>
    quarter.</font></td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $2.2 million of payroll related expense due to increased headcount from additional company-owned or managed clinics.</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td>An increase of approximately $2.9 million in occupancy costs due to the acquisition and development of additional company-owned or managed clinics.</td></tr>
<tr style="vertical-align: middle">
    <td>&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $0.9 million in selling and marketing expenses due to the acquisition and development of additional company-owned or managed clinics.</td></tr>
<tr>
    <td style="vertical-align: middle; text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase of approximately $1.2 million in depreciation and amortization related to the acquisition and development of additional company-owned or managed clinics.</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: middle">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: left; vertical-align: top"><font style="font-family: Symbol; font-size: 10pt">&#183;</font></td>
    <td style="text-align: justify">An increase in revenues of approximately $5.1 million from company-owned or managed clinics, which offset the above costs.</td></tr>
</table>


<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Income Tax (Expense) Benefit</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Year Ended December 31,</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Change from</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Percent Change</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: center">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Prior Year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">from Prior Year</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Income Tax (Expense) Benefit</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(164,429</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">235,855</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(400,284</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(169.7</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
</table>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i></i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in our income tax (expense) benefit
related primarily to changes in the valuation allowance on our deferred tax assets and the impact of certain permanent differences
on taxable income. For the years ended December 31, 2016 and 2015, the effective rates were -1.1% and -2.6%, respectively. The
difference is due to an increased valuation allowance against our net deferred tax assets, in addition to state income taxes relating
to Voluntary Disclosure Agreements (&#8220;VDAs&#8221;) with various taxing jurisdictions and an adjustment to expected federal
income tax refunds.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Sources of Liquidity</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From 2012 until November 2014, when we completed
an initial public offering, we financed our business primarily through existing cash on hand and cash flows from operations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 14, 2014, we completed our IPO
of 3,000,000 shares of common stock at a price to the public of $6.50 per share. As a result of the IPO, we received aggregate
net proceeds, after deducting underwriting discounts, commissions and other offering expenses, of approximately $17.1 million.&nbsp;&nbsp;On
November 18, 2014, our underwriters exercised their option to purchase 450,000 additional shares of common stock to cover over-allotments,
pursuant to which we received aggregate net proceeds of approximately $2.7 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On November 25, 2015 we completed our follow-on
public offering of 2,272,727 shares of our common stock at a price to the public of $5.50 per share. On December 30, 2015 our underwriters
exercised their over-allotment option to purchase an additional 340,909 shares of common stock to cover over-allotments pursuant
to which we received aggregate net proceeds of approximately $13.0 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have used a significant amount of the net
proceeds from our public offerings for the development of company-owned or managed clinics.&nbsp; We accomplished this by developing
new clinics, and by repurchasing existing franchises. In addition, we have used proceeds from our offerings to repurchase existing
regional developer licenses and to continue to expand our franchised clinic business.&nbsp; We are holding the net proceeds in
cash or short-term bank deposits.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, we had cash
and short-term bank deposits of approximately $3.0 million. To preserve cash, we do not plan to add any company-owned or
managed clinics during the 2017 fiscal year. In addition, our tactical decisions made around the clinics in Chicago and New
York in January of 2017, significantly reduced our estimated cash needs for 2017 to approximately $2.0 million. The cash used
in 2016 included expenditures for the acquisition or development of 14 company-owned or managed clinics, and working capital losses in the Chicago and New York markets which amounted to approximately $2.8 million for the year ended
December 31, 2016. As we have no current plan to acquire or develop company-owned or managed clinics during 2017, and have
sold or closed the 14 clinics in the Chicago and New York markets, our projected use of cash in 2017 is significantly
lower than the amount of cash used in 2016.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January, 2017, we executed a Credit and
Security Agreement which provided a credit facility up to $5.0 million. We have drawn $1.0 million under the credit facility. See
Note 13 to our consolidated financial statements included in this report for additional discussion of the credit facility.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Analysis of Cash Flows</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash used in operating activities increased
by approximately $4.1 million to approximately $10.8 million for the year ended December 31, 2016, compared to approximately $6.8
million for the year ended December 31, 2015.&nbsp;&nbsp;The increase in cash used in operating activities was attributable primarily
to increased expenses caused by increased operating losses and working capital requirements of our 61 company-owned or managed
clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash used in investing activities was approximately
$2.7 million and $10.0 million during the years ended December 31, 2016, and 2015, respectively.&nbsp;&nbsp;For the year ended
December 31, 2016, this includes cash paid for acquisitions of approximately $0.8 million, cash paid for reacquisition and termination
of regional developer rights of approximately $0.3 million and purchases of property of equipment of approximately $1.6 million.
For the year ended December 31, 2015, this includes cash paid for acquisitions of approximately $4.9 million, cash paid for the
reacquisition and termination of regional developer rights of approximately $1.1 million and investments in property and equipment
of approximately $4.1 million.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Net cash (used in) provided by financing activities
was approximately ($0.2) million and $12.8 million during the years ended December 31, 2016 and 2015, respectively.&nbsp;&nbsp;For
the year ended December 31, 2016, this includes repayments on notes payable of approximately $0.4 million partially offset by treasury
stock sales of approximately $0.2 million. For the year ended December 31, 2015, this includes proceeds from the issuance of common
stock relating to our follow-on offering of approximately $14.4 million, partially offset by offering costs paid of approximately
$1.4 million and repayments on notes payable of approximately $0.2 million.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Recent Accounting Pronouncements</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">See Note 1, <i>Nature of Operations and Summary
of Significant Accounting Policies</i>, for information regarding recently issued accounting pronouncements that may impact our
financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Contractual Obligations and Risk</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes our contractual
obligations at December 31, 2016 and the effect that such obligations are expected to have on our liquidity and cash flows in future
periods:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="27" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Payments Due by Fiscal Year</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Total</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2019</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2020</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2021</td><td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Thereafter</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-size: 10pt; text-align: left">Operating leases</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">19,048,079</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">3,180,100</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">2,587,425</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">2,248,195</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,982,392</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">1,868,976</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 7%; font-size: 10pt; text-align: right">7,180,991</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Notes payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">333,249</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">333,249</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 1.1pt solid">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">19,381,328</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,513,349</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,587,425</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,248,195</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,982,392</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,868,976</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; border-bottom: Black 2.5pt double">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,180,991</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table>




<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, we
did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special
purpose entities that were established for the purpose of facilitating off-balance sheet arrangements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_010"></a>ITEM 7A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Not required for smaller reporting companies.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_011"></a>ITEM 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b><u>Page</u></b></font></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td style="vertical-align: bottom; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_027"><font style="font-size: 10pt">Report of Independent Registered Public
    Accounting Firm</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_027"><font style="font-size: 10pt">41</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_022"><font style="font-size: 10pt">Consolidated Balance Sheets as of December&nbsp;31,
    2016 and 2015</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_022"><font style="font-size: 10pt">42</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_023"><font style="font-size: 10pt">Consolidated Statements of Operations for
    the Years Ended December&nbsp;31, 2016 and 2015</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_023"><font style="font-size: 10pt">43</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_024"><font style="font-size: 10pt">Consolidated Statements of Stockholders&#8217;
    Equity for the Years Ended December&nbsp;31, 2016 and 2015</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_024"><font style="font-size: 10pt">44</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_025"><font style="font-size: 10pt">Consolidated Statements of Cash Flows for
    the Years Ended December&nbsp;31, 2016 and 2015</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_025"><font style="font-size: 10pt">45</font></a></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify"><a href="#a_026"><font style="font-size: 10pt">Notes to Consolidated Financial Statements</font></a></td>
    <td style="vertical-align: bottom; text-align: center"><a href="#a_026"><font style="font-size: 10pt">47</font></a></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><a name="a_027"></a>&nbsp;<b>Report of Independent Registered Public Accounting Firm</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">To the Board of Directors and Stockholders of</p>

<p style="font-size: 10pt; margin: 0pt 0">The Joint Corp. and Subsidiary</p>

<p style="font-size: 10pt; margin: 0pt 0">Scottsdale, Arizona</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">We have audited the accompanying consolidated
balance sheets of The Joint Corp. and&nbsp;Subsidiary (the &#8220;Company&#8221;) as of December&nbsp;31, 2016 and 2015 and the
related consolidated statements of operations, stockholders&#8217; equity, and cash flows for the years then ended. These financial
statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial
statements based on our audits.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">We conducted our audits in accordance with the
standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included
consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over
financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable
basis for our opinion.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">In our opinion, the consolidated financial statements
referred to above present fairly, in all material respects, the financial position of The Joint Corp.&nbsp;and Subsidiary as of
December&nbsp;31, 2016 and 2015, and the results of their operations and their cash flows for the years then ended, in conformity
with accounting principles generally accepted in the United States of America.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">/s/ EKS&amp;H LLLP</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Denver, Colorado</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">March 10, 2017</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;<b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><a name="a_022"></a><b>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<div data-td-taggable-table="" data-td-statement-type="balance-sheet"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2016</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: center">ASSETS</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Current assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">3,009,864</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">16,792,850</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">334,394</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">385,282</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,021,733</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">743,239</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Income taxes receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">42,014</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,981</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Notes receivable - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40,826</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">60,908</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred franchise costs - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">748,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">605,850</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">499,525</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">366,033</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,696,656</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">19,025,143</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Property and equipment, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,724,706</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,138,746</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Notes receivable, net of current portion and reserve</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">15,823</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred franchise costs, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">836,350</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,534,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Intangible assets, net</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,338,922</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,542,269</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Goodwill</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,750,338</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,466,937</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deposits and other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">707,889</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">638,710</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,054,861</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">33,362,328</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold">&nbsp;</td>
    <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Current liabilities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,054,946</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,996,971</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">299,997</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">375,529</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Co-op funds liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">73,246</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">201,078</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Payroll liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">750,421</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,493,375</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Notes payable - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">331,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">451,850</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred rent - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">215,450</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">334,560</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred revenue - current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,077,430</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,579,423</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other current liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">60,894</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">54,596</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,863,884</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,487,382</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Notes payable, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">130,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred rent, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,400,790</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">457,290</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Deferred revenue, net of current portion</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,231,712</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,369,702</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred tax liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">512,362</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">238,648</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">10,129,448</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,683,022</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Commitments and contingencies</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Stockholders' equity:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2016, and&nbsp;&nbsp;December 31, 2015</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,317,393 shares issued and 13,020,889 shares outstanding as of December 31, 2016 and 13,070,180 shares issued and 12,536,180 outstanding as of December 31, 2015</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,317</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,070</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Additional paid-in capital</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">36,398,588</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">35,267,376</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Treasury stock (296,504 shares as of December 31, 2016 and 534,000 as of December 31, 2015, at cost)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(503,118</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(791,638</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated deficit</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(28,983,374</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(13,809,502</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Total stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">6,925,413</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,679,306</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total liabilities and stockholders' equity</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,054,861</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">33,362,328</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><a name="a_023"></a><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<div data-td-taggable-table="" data-td-statement-type="income"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td nowrap style="font-size: 10pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left; padding-left: 10pt">Revenues and management fees from company clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">8,578,048</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">3,651,273</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Royalty fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,973,079</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,515,203</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,286,809</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,471,259</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Advertising fund revenue</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,866,406</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,191,124</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">IT related income and software fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">932,709</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">808,070</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Regional developer fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">617,573</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">866,802</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">269,016</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">331,700</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,523,640</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13,835,431</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Cost of revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise cost of revenues</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,717,691</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,642,451</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">IT cost of revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">221,918</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">177,462</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total cost of revenues</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2,939,609</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2,819,913</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Selling and marketing expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,419,180</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,843,613</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Depreciation and amortization</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566,136</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,268,955</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">General and administrative expenses</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">22,101,083</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">16,219,392</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Total selling, general and administrative expenses</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">29,086,399</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,331,960</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Loss on disposition or impairment</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">3,520,370</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Loss from operations</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,022,738</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(9,316,442</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Other (expense) income:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Bargain purchase gain</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">261,147</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other income, net</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13,295</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">22,119</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total other (expense) income</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,295</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">283,266</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Loss before income tax expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,009,443</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(9,033,176</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Income tax (expense) benefit</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(164,429</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">235,855</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net loss and comprehensive loss</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(8,797,321</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Loss per share:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(0.88</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Basic and diluted weighted average shares</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">10,042,001</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_024"></a>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<div data-td-taggable-table="" data-td-statement-type="stockholders-equity"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Common Stock</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Additional<br> Paid In</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Treasury Stock</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">Accumulated</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Shares</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Capital</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Shares</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Deficit</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid">Total</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; font-size: 10pt; padding-bottom: 1.1pt">Balances, December 31, 2014</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">10,196,510</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">10,197</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">21,420,975</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">534,000</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(791,638</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(5,012,181</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 6%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">15,627,353</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock-based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">825,145</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">825,145</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Issuance of common stock, net of offering costs of $1,351,403</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,613,636</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,614</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,020,981</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,023,595</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Issuance of vested restricted stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">259,589</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">260</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(260</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">445</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">534</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">534</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net loss</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(8,797,321</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(8,797,321</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Balances, December 31, 2015</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,070,180</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,070</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">35,267,376</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">534,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(791,638</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(13,809,502</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">20,679,306</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock-based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Issuance of vested restricted stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">162,441</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">162</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(162</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">37,824</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">38</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,893</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,931</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Issuance of common stock, offering costs adjustment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Purchases of treasury stock under employee stock plans</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">13,376</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Sale of treasury stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(161,911</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(250,872</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">371,911</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">210,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; text-indent: -10pt">Issuance of common stock for legal settlement</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">46,948</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">47</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">99,953</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">100,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net loss</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(15,173,872</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Balances, December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,317,393</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,317</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">36,398,588</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">296,504</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(503,118</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(28,983,374</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,925,413</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_025"></a>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<div data-td-taggable-table="" data-td-statement-type="cash-flows"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Cash flows from operating activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; font-size: 10pt; text-align: left">Net loss</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(15,173,872</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">(8,797,321</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">(Recovery) provision for bad debts</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(10,830</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">61,629</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Regional developer fees recognized upon acquisition of development rights</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(138,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(254,250</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Regional developer fees recognized upon termination of regional developer agreements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(282,750</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net franchise fees recognized upon termination of franchise agreements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(342,259</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(521,350</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Notes receivable issued for payment of transfer fees</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(59,850</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Depreciation and amortization</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,566,136</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,268,955</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gain on sale of property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(2,191</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(11,500</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Loss on disposition or impairment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,520,370</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Bargain purchase gain</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(261,147</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred income taxes</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock based compensation expense</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,123,481</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">825,145</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Cash paid for legal settlement</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">100,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Changes in operating assets and liabilities, net of effects from acquisitions:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">50,888</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(160,706</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(999,522</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(99,963</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Income taxes receivable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">28,967</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">324,833</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(133,492</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">9,892</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">361,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">127,550</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deposits and other assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">71,549</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(39,235</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts payable</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(953,084</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(291,480</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(75,532</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">165,602</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Co-op funds liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(127,832</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,474</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Payroll liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(742,954</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">875,431</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Other liabilities</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(19,130</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(105,973</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Deferred rent</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">824,390</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">246,686</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Deferred revenue</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(896,195</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="padding-bottom: 1.1pt; font-size: 10pt; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</td><td style="padding-bottom: 1.1pt; font-size: 10pt; text-align: right; border-bottom: Black 1.1pt solid">128,049</td><td style="font-size: 10pt; text-align: left; border-bottom: Black 1.1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net cash used in operating activities</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(10,847,312</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(6,796,479</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Cash flows from investing activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Cash paid for acquisitions</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(839,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4,925,525</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Reacquisition and termination of regional developer rights</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(325,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,075,500</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Purchase of property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,567,727</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4,065,946</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Proceeds received on sale of property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">11,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Payments received on notes receivable</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">35,905</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">42,388</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net cash used in investing activities</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(2,695,822</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(10,013,083</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Cash flows from financing activities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Proceeds from issuance of common stock - follow-on public offering</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,374,998</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Offering costs paid</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,351,403</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Issuance of common stock, offering costs adjustment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(1,042</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Purchases of treasury stock under employee stock plans</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(83,391</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Proceeds from sale of treasury stock</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">210,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Proceeds from exercise of stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">70,931</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">534</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Repayments on notes payable</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(436,350</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(218,500</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Net cash (used in) provided by financing activities</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(239,852</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">12,805,629</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Net decrease in cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(13,782,986</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4,003,933</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Cash at beginning of year</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">16,792,850</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,796,783</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash at end of year</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,009,864</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">16,792,850</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt"></font></p><div data-td-statement-type="note"><p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">During the year
ended December 31, 2016 and 2015, cash paid for income taxes was $11,250 and $0, respectively. During the year ended December
31, 2016 and 2015, cash paid for interest was $15,262 and $2,344, respectively.</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">Supplemental disclosure
of non-cash activity:</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">As of December
31, 2016, we had property and equipment purchases of $11,059 which were included in accounts payable. As of December 31, 2015,
we had property and equipment purchases of $1,109,464 and $117,509 which were included in accounts payable and accrued expenses,
respectively.</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">In connection with
our reacquisition and termination of regional developer rights during the year ended December 31, 2016 and 2015, we had deferred
revenue of $224,750 and $914,000, respectively, representing license fees collected upon the execution of the regional developer
agreements.&nbsp;&nbsp;We netted these amounts against the aggregate purchase price of the acquisitions (Note 6).</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">In connection with
our acquisitions of franchises during the year ended December 31, 2016, we acquired $293,014 of property and equipment, intangible
assets of $339,000, goodwill of $269,780, favorable leases of $140,728 and assumed deferred revenue associated with membership
packages paid in advance of $45,072 in exchange for $839,000 in cash and notes payable issued to the sellers for an aggregate
amount of $186,000. Additionally, at the time of these transactions, we carried deferred revenue of $29,000, representing franchise
fees collected upon the execution of franchise agreements, and deferred costs of $1,450, related to our acquisition of undeveloped
franchises. We netted these amounts against the aggregate purchase price of the acquisitions (Note 2).</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">In connection with
our acquisitions of franchises during the year ended December 31, 2015, we acquired $1,504,169 of property and equipment, intangible
assets of $1,942,180, goodwill of $1,830,833, favorable leases of $521,825, assumed unfavorable leases of $49,077, deferred revenue
associated with membership packages paid in advance of $106,908, and a deferred tax liability of $168,000 in exchange for $4,925,525
in cash and an aggregate amount of $800,350 in notes payable to the sellers.&nbsp;&nbsp;Additionally, at the time of these transactions,
we carried deferred revenue of $1,005,500, representing franchise fees collected upon the execution of franchise agreements, and
deferred costs of $493,500, related to our acquisition of undeveloped franchises.&nbsp;&nbsp;In accordance with ASC-952-605, we
netted these amounts against the aggregate purchase price of the acquisitions (Note 2).</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; font-size: 10pt; text-align: left"><font style="font-size: 9pt">Property and equipment</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 9pt">$</font></td><td style="width: 22%; font-size: 10pt; text-align: right"><font style="font-size: 9pt">(53,836</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 9pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">Intangible assets</font></td><td style="font-size: 10pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 9pt">4,820</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">Favorable leases</font></td><td style="font-size: 10pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 9pt">6,250</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-size: 9pt">Goodwill</font></td><td style="font-size: 10pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 9pt">68,616</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">Unfavorable leases</font></td><td style="font-size: 10pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 9pt">(25,850</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 9pt">)</font></td></tr>
</table></div>



<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt">During December
of 2016, we entered into a settlement agreement, whereby we resolved all pending litigation matters discussed in Note 11. Under
the terms of the settlement agreement, we agreed to a one-time settlement amount comprised of cash and 46,948 shares of our common
stock. The fair value of the total consideration related to common stock was $100,000. The fair value of the common stock was
measured using the closing price of our common stock on the settlement date. &nbsp;</font></p></div><p style="text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 9pt"></font></p>




<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><i>The accompanying notes are an integral part of these consolidated
financial statements.</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b>THE JOINT CORP. AND SUBSIDIARY</b></p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><a name="a_026"></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 1:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Nature of Operations and Summary of Significant Accounting Policies</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements
include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, LLC (collectively, the
&#8220;Company&#8221;), which was dormant for all periods presented.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions
between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from selling
and marketing expenses to general and administrative expenses for the year ended December 31, 2015 to conform to current year presentation.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Comprehensive Loss</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the
same for the years ended December 31, 2016 and 2015.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Nature of Operations</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was
formed on March 10, 2010. Its principal business purposes are owning, operating, managing and franchising chiropractic clinics,
selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations
throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and
various state authorities.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements
and as company-owned or managed for the years ended December 31, 2016 and 2015:</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold">Franchised clinics:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 16%; font-size: 10pt; text-align: right">265</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 16%; font-size: 10pt; text-align: right">242</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">56</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">54</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(6</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(24</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(6</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(7</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">309</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">265</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>


<p style="margin: 0">&nbsp;</p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 16%; font-size: 10pt; text-align: right">47</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 16%; font-size: 10pt; text-align: right">4</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">21</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">24</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(2</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">61</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">47</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">370</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">312</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Clinic licenses sold but not yet developed</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">115</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">168</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0"><b><i></I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>Management's Plans</I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, the Company had
cash and short-term bank deposits of approximately $3.0 million. To preserve cash, the Company does not plan to add any
company-owned or managed clinics during the 2017 fiscal year. Additionally, in December 2016, the Company made the decision
to close or sell 14 clinics in Chicago and New York. As a result, the Company has significantly reduced its estimated cash
needs for 2017 to approximately $2.0 million. The cash used in 2016 included expenditures for the acquisition or development
of 14 company-owned or managed clinics, and the working capital losses in the Chicago and New York markets which amounted to
approximately $2.8 million for the year ended December 31, 2016. As the Company has no current plans to acquire or develop
company-owned or managed clinics during 2017, and has sold or closed the 14 clinics in the Chicago and New York markets, the
Company&rsquo;s projected use of cash in 2017 is significantly lower than the amount of cash used in 2016. Furthermore, in
January 2017, the Company executed a Credit and Security Agreement which provided a credit facility of up to $5.0 million.
Taking into account these tactical decisions made by the Company&rsquo;s management, as well as the execution of the credit
facility, the Company has concluded that it can continue as a going concern for at least one year from the date that the
financial statements were available to be issued.</P>



<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><I>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Variable Interest Entities</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest
in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#8220;VIE&#8221;)
is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it
has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's
economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of
benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary
are accounted for under the equity method.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states in which the Company manages
clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized
under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management
services agreements with PCs under which the Company provides on an exclusive basis, all non-clinical services of the chiropractic
practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power
to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&#8217;s consolidated financial
statements</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments
purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitors its positions
with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout
the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company
has invested substantially all of the proceeds of its public offerings in short-term bank deposits. The Company had no cash equivalents
as of December 31, 2016 and 2015.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Restricted Cash</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees
and corporate clinics contribute to the Company&#8217;s National Marketing Fund and cash franchisees provide to various voluntary
regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with
the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Concentrations of Credit Risk</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time the Company grants credit
in the normal course of business to PCs or franchisees related to the working capital needs of the PC, collection of royalties,
or other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the PCs
or franchisees to reduce credit risk. As of December 31, 2016 and 2015, one PC entity, and six franchisees represented 24% and
31%, respectively, of outstanding accounts receivable. The Company did not have any PCs or franchisees that represented greater
than 10% of our revenues during the years ended December 31, 2016 and 2015.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Accounts Receivable</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due
from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for
which we perform management services for the repayment of working capital advances. The Company considers an allowance for
doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is
continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The
allowance is management&#8217;s best estimate of uncollectible amounts and is determined based on specific identification and
historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near
term from the amounts estimated in determining the allowance. As of December 31, 2016 and 2015, the Company had an allowance
for doubtful accounts of $131,830 and $142,660, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off
accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off
when it receives them. In December, 2016, the Company determined that certain working capital advances from its PC entities
in Illinois and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the
Company wrote-off $731,857 of accounts receivable to loss on disposition or impairment related to these entities during the
year ended December 31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Deferred Franchise Costs</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions
that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is
generally upon the opening of a clinic.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Property and Equipment</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost.
Depreciation is computed using the straight-line method over the estimated useful lives of three to seven years. Leasehold improvements
are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense
as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related
cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Software Developed</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development
costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company
for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application
has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software
is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The
Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in
additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are
expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally 5 years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Intangible Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired
franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired
franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which
range from six to eight years. The Company amortizes the acquired regional developer rights
over seven years. The fair value of customer relationships is amortized over their estimated useful life of&nbsp;two&nbsp;years.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of
$38,185 during the year ended December 31, 2016 related to closure of an acquired clinic in New York.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Goodwill</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase
price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note 2.&nbsp;&nbsp;Goodwill
and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required,
the Company performs an annual impairment test of goodwill as of the first day of the fourth quarter or more frequently if events
or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of
$54,994 during the year ended December 31, 2016 which represents the write-off of the goodwill associated with the closure of an
acquired clinic in New York.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Long-Lived Assets</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for
impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. The
Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have
been impaired. Impairments of approximately $2.4 million and $0 were recorded for the years ended December 31, 2016 and 2015, respectively.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Advertising Fund</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising
fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2% of clinic
sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets.
As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected
in excess of marketing expenditures are included in restricted cash on the Company&#8217;s consolidated balance sheets.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Co-Op Marketing Funds</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops
for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing
funds collected are segregated and used for the purposes specified by the Co-Ops&#8217; officers. The marketing funds are included
in restricted cash on the Company&#8217;s consolidated balance sheets.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Accounting for Costs Associated with Exit or Disposal Activities
</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">The Company recognizes a liability for the
cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability
is incurred.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">Costs to terminate an operating lease or other
contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred
under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be
incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date.
In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that
was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or
the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">As of December 31, 2016 the Company recognized
a liability of approximately $0.3 million related to operating leases that will no longer provide economic benefit to the entity,
net of estimated sublease income.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Deferred Rent</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate
offices and company-owned and managed clinics under operating leases, which may include rent holidays and rent escalation clauses.&nbsp;
It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The
Company records tenant improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction
to rent expense.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial
franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and
from its company-owned and managed clinics.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Franchise Fees.</i> The Company requires
the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial
term of ten years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services
under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#8217;s services under
the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing
operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Regional Developer Fees</i>. During 2011,
the Company established a regional developer program to engage independent contractors to assist in developing specified geographical
regions. Under this program, regional developers pay a license fee ranging from $7,250 to 25% of the then current franchise fee,
for each franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum
number of franchises that the regional developer must develop. Regional developers receive fees ranging from $14,500 to $19,950
which are collected from franchisees upon the sale of franchises within their region and a royalty of 3% of sales generated by
franchised clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue
when the Company has performed substantially all initial services required by the regional developer agreement, which generally
is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined
by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of
a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent
with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs
under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue
to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as
revenue upon the opening of, the expected remaining unopened franchised clinics within the region. Certain regional developer agreements
provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while
other regional developer agreements require a supplemental payment. The franchisor&#8217;s services under regional developer agreements
include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general
operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements
grant the Company the option to repurchase the regional developer&#8217;s license.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>&nbsp;</i>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Revenues and Management Fees from Company
Clinics.&nbsp;&nbsp;</i>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp;
In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company
offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp;
Amounts collected up front for membership and wellness packages are recorded as deferred revenue and recognized when the service
is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor,
the Company enters into a management agreement with the doctor&#8217;s PC.&nbsp; Under the management agreement, the Company provides
administrative and business management services to the doctor&#8217;s PC in return for a monthly management fee.&nbsp; When the
collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees
expected to be collected from the PCs.</p>

<p style="font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>Royalties.</i> The Company collects royalties,
as stipulated in the franchise agreement, equal to 7% of gross sales, and a marketing and advertising fee currently equal to 2%
of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee.
Royalties are recognized as revenue when earned. Royalties are collected bi-monthly two working days after each sales period has
ended.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><i>IT Related Income and Software Fees.</i>&nbsp;&nbsp;The
Company collects a monthly computer software fee for use of its proprietary chiropractic software, computer support, and internet
services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee
to purchase a clinic&#8217;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner
(patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon
receipt of equipment by the franchisee.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Advertising Costs</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred.
Advertising expenses for years ended December 31, 2016 and 2015 were $2,279,572 and $1,525,687, respectively.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Income Taxes</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences
between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally
to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred
tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible
when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available
to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount
expected to be realized.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income
taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax
position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company
measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based
on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Loss per Common Share</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by
dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share
is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Net loss</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">(15,173,872</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">(8,797,321</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">12,696,649</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">10,042,001</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">12,696,649</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10,042,001</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(1.20</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(0.88</td><td style="font-size: 10pt; text-align: left">)</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock
that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> &nbsp;December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">92,415</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">339,288</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">953,075</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">477,459</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Warrants</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">90,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">90,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Stock-Based Compensation</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share based payments
by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines
the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options
using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made
regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate,
volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to
the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Use of Estimates</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial
statements in conformity with accounting principles generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual
results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful
accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets,
classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets,
impairment of goodwill and intangible assets, and purchase price allocations.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In May, 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &#8220;<i>Revenue from Contracts with Customers</i>&#8221;,
which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods
or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective.
The new standard becomes effective for us on January 1, 2018. The Company has completed a preliminary review of ASU 2014-09 and does not expect the adoption of ASU 2014-09
to have a material impact on its revenues and management fees from company clinics or franchise royalty revenues. The Company is
currently evaluating the impact of the adoption of this standard on recognition of revenue from franchise agreements, advertising
fund revenue, and regional developer fee revenue. The Company is still evaluating its transition approach and expects to reach
a decision in the first half of fiscal 2017.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In August, 2014, the FASB issued ASU No. 2014-15,
&#8220;<i>Presentation of Financial Statements - Going Concern: Disclosures about an Entity&#8217;s Ability to Continue as a Going
Concern</i>.&#8221; The new standard requires management to perform interim and annual assessments of an entity&#8217;s ability
to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain
disclosures if conditions or events raise substantial doubt about the entity&#8217;s ability to continue as a going concern. The
new guidance is effective for annual periods ending after December 15, 2016, and interim periods thereafter. The Company adopted
this new standard as of December 31, 2016. The adoption of this guidance did not have a material impact on the Company&#8217;s
consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In April, 2015, the FASB issued&nbsp;ASU No.
2015-03, &#8220;<i>Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</i>.&#8221;&nbsp;
The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction
from the carrying amount of the related debt liability instead of being presented as an asset.&nbsp; Debt disclosures will include
the face amount of the debt liability and the effective interest rate.&nbsp; The update requires retrospective application and
represents a change in accounting principle.&nbsp; The update is effective for fiscal years beginning after December&nbsp;15, 2015.&nbsp;
ASU 2015-03 did not have a material impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In September, 2015, the FASB issued ASU No.
2015-16, &#8220;<i>Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments</i>.&#8221;
The update requires than an acquirer recognize adjustments to provisional amounts that are identified during the measurement period
in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional
amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since
the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes.
The Company adopted this ASU during the third quarter of 2015. Accordingly, the Company applied the amendments in this update to
the measurement period adjustments made during the year and disclosed the adjustments in Note 2.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In November, 2015, the FASB issued ASU No. 2015-17,
&#8220;<i>Income Taxes (Topic 470): Balance Sheet Classification of Deferred Taxes</i>.&#8221; The update eliminates the requirement
to separate deferred income tax assets and liabilities into current and noncurrent amounts within a classified balance sheet. Under
ASU 2015-17, the presentation of deferred income taxes is simplified, as all deferred income tax assets and liabilities are to
be classified as noncurrent. The existing requirement that deferred income tax assets and liabilities of a tax-paying component
of an entity be offset and presented as a single amount is not affected by ASU 2015-17. The Company has adopted the guidance under
ASU 2015-17 retrospectively and prior periods were retrospectively adjusted.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In January, 2016, the FASB issued ASU No. 2016-01,
&#8220;<i>Financial Instruments - Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities</i>,&#8221;
which addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU 2016-01
will be effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, and
early adoption is not permitted. The Company is currently evaluating the effect of adoption of this standard, if any, on its consolidated
financial position, results of operations or cash flows.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b>&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In February, 2016, the FASB issued ASU No. 2016-02,
&#8220;<i>Leases (Topic 842).&#8221;</i> The changes require that substantially all operating leases be recognized as assets and
liabilities on our balance sheet, which is a significant departure from the current standard, which classifies operating leases
as off balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations.
The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease
will be accounted for as a liability. The effective date is for fiscal years beginning after December 15, 2018. While we have not
quantified the impact this proposed standard would have on our consolidated financial statements, if our current operating leases
are instead recognized on the consolidated balance sheet, it will result in a significant increase in the liabilities reflected
on our consolidated balance sheet and in the interest expense and depreciation and amortization expense reflected in our consolidated
statements of operations, while reducing the amount of rent expense. This could potentially decrease our reported net income.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In March, 2016, the FASB issued ASU 2016-09,
&#8220;<I>Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting</I>&#8221; (&#8220;ASU 2016-09&#8221;),
which amends ASC Topic 718, Compensation &#8211; Stock Compensation (&#8220;ASC 718&#8221;). The standard is intended to simplify
several areas of accounting for share-based compensation arrangements, including the accounting for income taxes, classification
of excess tax benefits on the statement of cash flows, forfeitures, statutory tax withholding requirements, classification of
awards as either equity or liabilities, and classification of employee taxes paid on the statement of cash flows when an employer
withholds shares for tax-withholding purposes. ASU 2016-09 is effective for interim and annual reporting periods beginning January
1, 2017. Early adoption is permitted. The Company is currently evaluating the method of adoption and impact the update will have
on its consolidated financial statements and related disclosures.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In April, 2016, the FASB issued ASU No. 2016-10,
&#8220;<i>Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing</i>&#8221;, to clarify
the following two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The
effective date and transition requirements for these amendments are the same as the effective date and transition requirements
of ASU 2014-09. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In May, 2016, the FASB issued ASU No. 2016-12,
&#8220;<i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</i>&#8221;, to
clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications
and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted.
The effective date and transition requirements for these amendments are the same as the effective date and transition requirements
of ASU 2014-09. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In August, 2016, the FASB issued ASU No. 2016-15,
<i>&#8220;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments&#8221;. </i>This update
addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in
practice. This update is effective for annual and interim reporting periods beginning after December 15, 2017. Early adoption is
permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In November, 2016, the FASB issued ASU No. 2016-18,
&#8220;<i>Statement of Cash Flows (Topic 230): Restricted Cash&#8221;</i> (a consensus of the FASB Emerging Issues Task Force),
to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flow. The amendments
should be applied using a retrospective transition method, and are effective for fiscal years beginning after December 15, 2017,
including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its
consolidated financial statements.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In January, 2017, the FASB issued ASU No. 2017-01,
&#8220;<i>Business Combinations (Topic 805): Clarifying the Definition of a Business&#8221;,</i> to clarify the definition of a
business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for
as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal
years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently evaluating
the impact of these amendments on its consolidated financial statements.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 2:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Acquisitions</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Franchises acquired during 2016</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees
to re-acquire an aggregate of six developed franchises and one undeveloped franchise throughout California and New Mexico for an
aggregate purchase price of $1,025,000, subject to certain adjustments, consisting of cash of $839,000 and notes payable of $186,000.
The Company is operating the six developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic
license. At the time these transactions were consummated, the Company carried <font style="background-color: white">a deferred
revenue balance of $29,000, representing franchise fees collected upon the execution of the franchise agreements, and deferred
franchise costs of $1,450, related to an undeveloped franchise.&nbsp;&nbsp;The Company accounted for the franchise rights associated
with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted
against the aggregate purchase price.&nbsp;&nbsp;The remaining $997,450 was accounted for as consideration paid for the acquired
franchises.</font></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred approximately $75,000
of transaction costs related to these acquisitions for the year ended December 31, 2016, which are included in general and administrative
expenses in the accompanying consolidated statements of operations.</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Purchase Price Allocation</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following summarizes the aggregate estimated
fair values of the assets acquired and liabilities assumed during 2016 as of the acquisition date:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">293,014</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Intangible assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">339,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Favorable leases</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">140,728</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">269,780</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total assets acquired</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,042,522</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(45,072</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">997,450</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist
of reacquired franchise rights of $181,000 and customer relationships of $158,000, and will be amortized over their estimated useful
lives ranging from six to eight years and two years, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these
acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities.
All of the recorded goodwill is tax-deductible.&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Franchises acquired during 2015</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2015, the
Company entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of 24 developed and
35 undeveloped franchises throughout Arizona, California and New York for an aggregate purchase price of $5,725,875, subject to
certain adjustments, consisting of cash of $4,925,525 and notes payable of $800,350. Of the 24 developed franchises, the Company
is operating 22 as company-owned or managed clinics and has closed the remaining two clinics. The 35 undeveloped franchises have
been terminated and the Company may relocate them. At the time these transactions were consummated, the Company carried <font style="background-color: white">a
deferred revenue balance of $1,005,500, representing franchise fees collected upon the execution of the franchise agreements, and
deferred franchise costs of $493,500, related to undeveloped franchises.&nbsp;&nbsp;The Company accounted for the franchise rights
associated with the undeveloped franchises as a cancellation, and the respective deferred revenue and deferred franchise costs
were netted against the aggregate purchase price.&nbsp;&nbsp;The remaining $5,213,875 was accounted for as consideration paid for
the acquired franchises.</font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Additionally, in January 2015, in connection
with the default by a franchisee under its franchise agreement, the Company assumed substantially all of the assets of a clinic
in Tempe, Arizona in exchange for $25,000.&nbsp; The Company has accounted for this as a business combination.&nbsp; The Company
completed its valuation of the fair value of the assets acquired, including intangible assets, in September 2015. Because the net
assets acquired exceeded the consideration paid, the Company recognized a bargain purchase gain of $233,804 during the year ended
December 31, 2015.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company also recognized a bargain purchase
gain of $27,343 related to the acquisition of two developed franchises and seven undeveloped franchises in San Diego, California.
Total bargain purchase gain for the year ended December 31, 2015 was $261,147.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred $393,069 of transaction
costs related to these acquisitions for the year ended December 31, 2015 which are included in general and administrative expenses
in the accompanying consolidated statements of operations.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><i>Purchase Price Allocation</i></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The purchase price allocations for these acquisitions
are complete. The following summarizes the aggregate fair values of the assets acquired and liabilities assumed during 2015 as
of the acquisition date:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">1,450,333</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Intangible assets</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,947,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Favorable leases</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">528,075</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,899,449</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total assets acquired</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,824,857</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Unfavorable leases</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(74,927</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(106,908</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Net assets acquired</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,643,022</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred tax liability</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(168,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Bargain purchase gain</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(261,147</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">5,213,875</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>


<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist
of reacquired franchise rights of $1,449,000 and customer relationships of $498,000, and will be amortized over their estimated
useful lives ranging from six to eight years and two years, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these
acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities.
All of the recorded goodwill is tax-deductible.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Pro Forma Results of Operations (Unaudited)</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes selected unaudited
pro forma condensed consolidated statements of operations data for the year ended December 31, 2016 and 2015 as if the acquisitions
in 2016 had been completed on January 1, 2015.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table="">

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Pro Forma for the Year Ended</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2016</TD><TD NOWRAP STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" NOWRAP STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font-size: 10pt; text-align: left">Revenues, net</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 20%; font-size: 10pt; text-align: right">20,985,277</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 20%; font-size: 10pt; text-align: right">16,375,930</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(15,483,492</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(10,187,416</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>
</div>


<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">This selected unaudited pro forma consolidated
financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would
have been if the acquisitions had been completed on that date. Moreover, this information is not indicative of what the Company&#8217;s
future operating results will be. The information for 2015 and 2016 prior to the acquisitions is included based on prior accounting
records maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted
by the Company following the acquisitions. For 2016, this information includes actual data recorded in the Company&#8217;s consolidated
financial statements for the period subsequent to the date of the acquisitions. The Company&#8217;s consolidated statements of
operations for the year ended December 31, 2016 includes net revenue and net income of approximately $7.5 million and $0.7 million,
respectively, attributable to the acquisitions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The pro forma amounts included in the table
above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation
and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets
had been applied from January 1, 2015, together with the consequential tax impacts.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 3:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Notes Receivable</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective July, 2012, the Company sold a company-owned
clinic, including the license agreement, equipment, and customer base, in exchange for a $90,000 unsecured promissory note. The
note bears interest at 6% per annum for fifty-four months and requires monthly principal and interest payments over forty-two months,
beginning August 2013 and maturing January 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective July, 2015, the Company entered into
two license transfer agreements, in exchange for $10,000 and $29,925 in separate unsecured promissory notes.&nbsp; The non-interest
bearing notes require monthly principal payments over 24 months, beginning on September 1, 2015 and maturing on August 1, 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective July, 2015, the Company entered into
a license transfer agreement, in exchange for $29,925 in an unsecured promissory note.&nbsp; The note bears interest at 4.0% per
annum, and requires monthly principal payments over 12 months, beginning on August 1, 2015 and matured on July 1, 2016.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Effective May, 2016, the Company entered into three license transfer
agreements, in exchange for three separate $7,500 unsecured promissory notes.&nbsp; The non-interest bearing notes require monthly
principal payments over six months, beginning on May 1, 2017 and maturing on October 1, 2017.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The outstanding balance of the notes as of
December 31, 2016 and 2015 were $40,826 and $76,731, respectively.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b></b></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 73px; text-align: left"><b>Note 4:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Property and Equipment</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment consist of the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,083,039</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">963,299</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leasehold improvements</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,085,366</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,672,582</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">891,192</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">691,827</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">7,059,597</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,327,708</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(2,566,172</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1,098,438</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">4,493,425</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,229,270</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">231,281</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">1,909,476</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,724,706</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,138,746</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation expense was $1,818,403 and $792,794
for the years ended December 31, 2016 and 2015, respectively.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In December, 2016, the Company determined that
14 clinics from its Corporate Clinics segment, met the criteria for classification as held for sale. Accordingly, in December, 2016,
the Company recognized a $2.4 million impairment charge to lower the carrying costs of the property and equipment to its estimated
fair value less cost to sell which is recorded in the loss on disposition or impairment line of the accompanying consolidated statement
of operations. The Company completed the sale of the property in 2017 for nominal consideration.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 5:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Fair Value Consideration</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#8217;s financial instruments include
cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying
amounts of its financial instruments approximate their fair value due to their short maturities.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company does not use derivative financial
instruments to hedge exposures to cash-flow, market or foreign-currency risks.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Authoritative guidance defines fair value as
the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that
maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs
be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed
based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s
assumptions of what market participants would use in pricing the asset or liability developed based on the best information available
in the circumstances. The hierarchy is broken down into three levels based on reliability of the inputs as follows:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 7%; text-align: justify"><font style="font-size: 10pt">Level 1:</font></td>
    <td style="width: 91%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted prices in active markets;</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; width: 2%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 7%; text-align: justify"><font style="font-size: 10pt">Level 2:</font></td>
    <td style="vertical-align: bottom; width: 91%; text-align: justify"><font style="font-size: 10pt">Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&nbsp;and</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 2%; text-align: justify">&nbsp;</td>
    <td style="width: 7%; text-align: justify"><font style="font-size: 10pt">Level 3:</font></td>
    <td style="width: 91%; text-align: justify"><font style="font-size: 10pt">Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016 and 2015, the Company
does not have any financial instruments that are measured on a recurring basis as Level 1, 2 or 3.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of December 31, 2016, the Company had
non-recurring fair value measurements as a result of the sale subsequent to year end, the Company recorded the assets at the
lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of $3.5 million. The
inputs used to determine such fair values which were based on the offer price provided by a third party in connection with
the sale are classified within Level 3 in the hierarchy.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b></b></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 73px; text-align: left"><b>Note 6:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Intangible Assets</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year <font style="background-color: white">ended
December 31, 2015, the Company entered into several agreements to repurchase regional developer licenses, reacquiring rights in
Los Angeles County, San Diego County, and Orange County, California, Erie County, Monroe County, Nassau County, Suffolk County,
and Albany County, New York, and the regional developer license in New Jersey in exchange for cash consideration of $1,583,000.&nbsp;
The Company carried a deferred revenue balance associated with these transactions of $914,000, representing license fees collected
upon the execution of the regional developer agreements.&nbsp;&nbsp;In accordance with ASC 952-605, the Company accounted for the
development rights associated with the unsold or undeveloped franchises as cancellations, and the respective deferred revenue was
netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration
paid.&nbsp;&nbsp; During the year ended December 31, 2015, the revenue recognized as excess deferred regional developer fees totaled
$254,250. The remaining balance was accounted for as consideration paid for the reacquired development rights. As the deferred
revenue with respect to these regional developer rights had previously been taken into account for income tax purposes, the tax
basis in the reacquired development rights is equal to the cash consideration paid. </font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On January 1, 2016, the Company entered into
an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties
in California. The total consideration for the transaction was $275,000, paid in cash.<b>&nbsp;</b><font style="background-color: white">The
Company carried a deferred revenue balance associated with these transactions of $36,250, representing license fees collected upon
the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with
the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase
price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp; </font></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On June 1, 2016, the Company entered into an
agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration
for the transaction was $50,000, paid in cash.<b>&nbsp;</b><font style="background-color: white">The Company carried a deferred
revenue balance associated with these transactions of $188,500, representing license fees collected upon the execution of the regional
developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises
as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue
to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp;</font></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consisted of the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2016</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br> Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br> Amortization</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br> Value</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,911,750</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">444,795</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">1,466,955</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Customer relationships</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">701,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">509,042</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">191,958</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">923,250</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">243,241</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">680,009</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,536,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,197,078</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,338,922</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Amortization expense was $747,733 and $476,161
for the year ended December 31, 2016 and 2015, respectively.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company evaluates the recoverability of
finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such
assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts
to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of
intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment
charge as a result of the closure of a clinic acquired in 2015 of $38,185 related to certain reacquired franchise rights and customer
relationships during the year ended December 31, 2016 which is included on the loss on disposition or impairment line of the statement
of consolidated operations.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Estimated amortization expense for 2017 and subsequent years is
as follows:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; font-size: 10pt; text-align: left">2017</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 16%; font-size: 10pt; text-align: right">578,881</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2018</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">439,589</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2019</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">413,256</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2020</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">413,256</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">348,034</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">145,906</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,338,922</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p></div><p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 73px"><font style="font-size: 10pt"><b>Note 7:</b></font></td>
    <td style="width: 7px">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt"><b>Notes Payable</b></font></td></tr>
</table>
<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2015, the Company issued 12 notes payable
totaling $800,350 as a portion of the consideration paid in connection with the Company&#8217;s various acquisitions. Interest
rates range from 1.5% to 5.25% with maturities through February of 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2016, the Company issued two notes payable
totaling $186,000 as a portion of the consideration paid in connection with the Company&#8217;s various acquisitions. Interest
rates for both notes are 4.25% with maturities through May of 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maturities of notes payable are as follows
as of December 31, 2016:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; font-size: 10pt; text-align: left">2017</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 18%; font-size: 10pt; text-align: right">331,500</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">331,500</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 8:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Equity</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;<i>Stock Options</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On May 15, 2014, the Company adopted the 2014
Stock Plan (&#8220;2014 Plan&#8221;). The 2014 Plan is designed to supersede and replace the 2012 Plan, effective as of the adoption
date and set aside 1,513,000 shares of the Company&#8217;s common stock that may be granted under the 2014 Plan.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2015, the
Company granted 240,160 stock options to employees and certain non-employee members of its board of directors with exercise prices
ranging from $5.99 - $9.62.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company granted 660,000 stock options to employees with exercise prices ranging from $2.23 - $4.11.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#8217;s stock trading price is
the basis of fair value of its common stock used in determining the value of share based awards. To the extent the value of the
Company&#8217;s share based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies
with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical
volatility. The expected life of the options granted is based on the average of the vesting term and the contractual term of the
option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury 10-year yield curve
in effect at the date of the grant.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has computed the fair value of
all options granted during the years ended December 31, 2016 and 2015, using the following assumptions:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Years Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Expected volatility</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">42%</td><td style="font-size: 10pt; text-align: center">-</td><td style="font-size: 10pt; text-align: left">45%</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">44%</td><td style="font-size: 10pt; text-align: center">-</td><td style="font-size: 10pt; text-align: left">50%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Expected dividends</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">None</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">None</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Expected term (years)</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 5%; font-size: 10pt; text-align: right">&nbsp;</td><td style="width: 6%; font-size: 10pt; text-align: center">7</td><td style="width: 5%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 5%; font-size: 10pt; text-align: right">5.5</td><td style="width: 6%; font-size: 10pt; text-align: center"> -</td><td style="width: 5%; font-size: 10pt; text-align: left">7</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Risk-free rate</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">1.19%</td><td style="font-size: 10pt; text-align: center">-</td><td style="font-size: 10pt; text-align: left">1.68%</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">1.54%</td><td style="font-size: 10pt; text-align: center">-</td><td style="font-size: 10pt; text-align: left">2.01%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Forfeiture rate</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">20%</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: center">20%</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summarizes the stock
options:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of<br> Shares</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Exercise<br> Price</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Fair<br> Value</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br> Average<br> Remaining<br> Contractual Life</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2014</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">314,775</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2.23</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">0.92</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">9.2</td><td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Granted at market price</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">240,160</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8.16</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(445</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1.20</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(77,031</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">7.88</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">477,459</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4.30</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2.01</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">8.7</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Granted at market price</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">660,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3.22</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(37,824</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1.88</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(146,560</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4.34</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">953,075</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3.66</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1.86</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6.9</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">347,272</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4.07</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2.38</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3.9</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The intrinsic value of the Company&#8217;s
stock options outstanding was $347,724 at December 31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended December 31, 2016 and 2015,
stock based compensation expense for stock options was $561,559 and $328,772, respectively.&nbsp;&nbsp;Unrecognized stock-based
compensation expense for stock options for the year ended December 31, 2016 was $733,944, which is expected to be recognized ratably
over the next 3.26 years.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Restricted Stock</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2015, the Company granted restricted
stock to two employees to earn 8,000 shares of common stock. These shares vest over a four year period from grant date. The estimated
fair market value of these shares was valued at $9.62 per share, based on the Company&#8217;s stock trading price, totaling approximately
$76,960 to be recognized ratably as the stock is vested.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During 2016, the Company granted restricted
stock awards to seven members of the Board of Directors. The awards have been granted under The Joint Corp. 2014 Incentive Stock
Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) one year from the
Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for
each to earn 12,345 shares of common stock. The estimated fair market value of these shares was valued at $3.10 per share, based
on the Company&rsquo;s stock trading price, totaling approximately $268,000 to be recognized ratably as the stock is vested.</P>



<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summaries the restricted
stock activity:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 70%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Restricted Stock Awards</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Shares</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; font-size: 10pt">Outstanding at December 31, 2014</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 14%; font-size: 10pt; text-align: right">662,375</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Restricted stock awards granted</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited or exercised</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Granted at December 31, 2015</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">670,375</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards vested</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(331,087</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">339,288</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Awards granted</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">86,415</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Awards vested</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(162,440</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(170,848</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">92,415</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>




<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended December 31, 2016 and 2015,
stock based compensation expense for restricted stock awards was $561,922 and $496,373, respectively.&nbsp;&nbsp;Unrecognized stock
based compensation expense for restricted stock awards as of December 31, 2016 was $155,969 to be recognized ratably over 1.06
years.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Modifications</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&#8217;s former
chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment
exercise period of the stock options previously granted, extending the exercise period to December 31, 2017.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company modified the post-employment exercise period of stock options previously granted to the Company&#8217;s former chief executive
officer in connection with his separation from the Company. The modification extended the exercise period to May 13, 2020. In addition,
the Company accelerated the vesting of 9,733 shares of the previously granted restricted stock awards that were scheduled to vest
in July 2016. The remaining unvested restricted stock awards were forfeited upon separation.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">These modifications resulted in an approximately
$412,000 increase in stock-based compensation for the year ended December 31, 2016.</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Treasury Stock</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended December 31, 2016, the
Company acquired approximately 13,376 shares of treasury stock to satisfy minimum tax withholding related to vesting of restricted
stock awards. These shares were acquired at a total cost of $83,391.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In December, 2013, the Company exercised its right of first refusal
under the terms of a Stockholders Agreement dated March 10, 2010 to repurchase 534,000 shares of the Company&#8217;s common stock.
The shares were purchased for $0.45 per share or $240,000 in cash along with the issuance of an option to repurchase the 534,000
shares. The repurchased shares were recorded as treasury stock, at cost in the amount of $791,638, and were available for general
corporate purposes. The option is classified in equity as it is considered indexed to the Company&#8217;s stock and meets the criteria
for classification in equity.&nbsp;&nbsp;The option was granted to the seller for a term of 8 years.&nbsp;&nbsp;The option contained
the following exercise prices:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%; font-size: 10pt">Year 1</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">0.56</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Year 2</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0.68</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Year 3</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0.84</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Year 4</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.03</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Year 5</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.28</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Year 6</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.59</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Year 7</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.97</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">Year 8</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.45</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Consideration given in the form of the option was valued using a
Binomial Lattice-Based model resulting in a fair value of $1.03 per share option for a total fair value of $551,638. The option
was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions that
address the features underlying the instrument.</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">During December, 2016, the option holder partially
exercised the call option, and purchased 250,872 shares at a total repurchase price of $210,000. The Company reduced the cost
of treasury shares by approximately $113,000 related to the transaction, reduced the value of the option by approximately
$259,000, and reduced additional paid in capital by approximately $162,000.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Warrants</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In conjunction with the IPO, the Company issued
warrants to the underwriters for the purchase of 90,000 shares of common stock, which can be exercised between November 10, 2015
and November 10, 2018 at an exercise price of $8.125 per share.&nbsp; The fair value of the warrants was determined using the Black-Scholes
option valuation model. The warrants expire on November 10, 2018 and have a remaining contractual life of 1.9 years as of December
31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">The information below summarizes the warrants:</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><B>Number of <br>
    Units</B></td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><B>Weighted<br> Average<br>
    Exercise Price</B></td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><B>Weighted <br> Average
    <br> Remaining <br> Contractual Term<br> (in years)</B></td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><B>Intrinsic <br>
    Value</B></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt">Outstanding at December 31, 2014</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">90,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">8.13</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">3.9</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2015</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2.9</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1.9</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">90,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.13</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1.9</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><font style="font-size: 10pt"><i>Issuance of Common Stock for Legal Settlement</i></font></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During December, 2016, the Company entered
into a settlement agreement, whereby it resolved the pending litigation matter discussed in Note 11. Under the terms of the settlement
agreement, the Company agreed to a one-time settlement amount comprised of cash and newly issued shares of our common stock. The
amounts paid by the Company in this settlement was determined by the Company not to be material. The fair value of the total consideration
related to common stock was valued using the closing price of our common stock on the settlement date.</p>

<p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b><i>&nbsp;</i>&nbsp;</b></p></div><p style="font-size: 10pt; text-align: center; margin: 0pt 0"><b></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b></b></td></tr></table><div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 73px; text-align: left"><b>Note 9:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Income Taxes</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Income tax provision (benefit) reported in
the consolidated statements of operations is comprised of the following:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Current provision (benefit):</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt">Federal</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">22,800</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">(208,900</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">State, net of state tax credits</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">20,900</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(67,800</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total current provision (benefit)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">43,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(276,700</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Deferred provision:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Federal</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">97,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">State</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">23,300</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Total deferred provision</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">120,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">164,400</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(235,900</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following are the components of the Company&#8217;s
net deferred taxes for federal and state income taxes:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,509,400</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">1,988,200</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(553,900</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(664,000</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">51,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,781,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Accrued expenses</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">57,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">74,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Goodwill - Component 1</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(120,700</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Goodwill - Component 2</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">86,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">87,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(30,800</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(44,100</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">182,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">109,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Deferred rent</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">629,600</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">209,700</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Lease abandonment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">108,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">8,924,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,849,100</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Tax credits</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">14,200</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,500</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,300</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Asset basis difference related to property and equipment</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">630,900</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">167,500</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">11,496,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">5,574,400</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Less valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(11,617,100</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(5,574,400</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net non-current deferred tax liability</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(120,700</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">At December 31, 2016, the Company has federal
and state net operating losses of approximately $22,613,000 and $24,948,000, respectively. These net operating losses are available
to offset future taxable income and will begin to expire in 2035 for federal purposes and 2020 for state purposes.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following is a reconciliation of the statutory
federal income tax rate applied to pre-tax accounting net income (loss), compared to the income tax provision (benefit) in the
consolidated statement of operations:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">For the Years Ended December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax expense (benefit)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(5,106,100</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(34.00</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">(3,071,300</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 10%; font-size: 10pt; text-align: right">(34.00</td><td style="width: 1%; font-size: 10pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(735,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4.90</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(387,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(4.29</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Effect of increase in valuation allowance</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">6,042,900</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">40.24</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,519,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">38.97</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Permanent differences</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">108,800</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">0.72</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(58,800</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(0.65</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Uncertain tax positions</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(46,500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(0.51</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Effect of changed state rates for deferred</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(80,100</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(0.89</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other, net</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(145,700</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(0.97</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(111,500</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(1.23</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Provision (Benefit)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">164,400</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1.09</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(235,900</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2.60</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)%</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The state tax expense (benefit), penalties
and interest stem from resolution of various voluntary disclosure agreements with multiple states where we had not yet been in
compliance. In addition, we are responsible to pay certain minimum and franchise taxes to jurisdictions in which we do business.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in our income tax expense related primarily
to changes in pretax losses during the year ended December 31, 2016, as compared to year ended December 31, 2015, and the effective
rate was 1.1% and -2.6%, respectively. The difference is due to a valuation allowance on the Company's deferred tax assets, and
the impact of certain permanent differences on taxable income.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended December 31, 2016 and
2015, the Company recorded a liability for income taxes for operations and uncertain tax positions of approximately $40,000
and $66,000, respectively, of which $27,000 and $33,000 respectively, represent penalties and interest and are recorded in
the &#8220;other liabilities&#8221; section of the accompanying consolidated balance sheets. Interest and penalties
associated with tax positions are recorded in the period assessed as general and administrative expenses. Management made a
determination that the Company was not in compliance with several state and local tax jurisdictions in which the company was
doing business. Accordingly, management undertook to analyze its tax exposures, both income and otherwise, with respect to
jurisdictions in which compliance was deemed to be inadequate and the Company has entered into Voluntary Disclosure
Agreements (VDAs) with the taxing authorities.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table sets forth a reconciliation
of the beginning and ending amount of uncertain tax positions during the tax years ended December 31, 2016 and 2015:</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br> penalties</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br> penalties</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Unrecognized tax benefit - January 1</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">32,600</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">33,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">91,700</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">30,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">3,000</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Gross decreases - tax positions in prior period</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(19,400</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(6,200</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(59,100</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">-</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Unrecognized tax benefit - December 31</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,200</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">26,800</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">32,600</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">33,000</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our tax returns for tax years subject to examination
by tax authorities include 2012 through the current period for state and 2013 through the current period for federal reporting
purposes.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 10:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Related Party Transactions</b></td>
</tr></table>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company entered into consulting and legal
arrangements with certain stockholders related to services performed for the operations and transaction related activities of the
Company.&nbsp;&nbsp;Amounts paid to or for the benefit of these stockholders was approximately $461,000 and $643,000 for the years
ended December 31, 2016 and 2015, respectively.&nbsp;&nbsp;</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 11:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Commitments and Contingencies</b></td>
</tr></table>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Operating Leases</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases its corporate office space
and the space for each of the company-owned or managed clinics in the portfolio. During the year ended December 31, 2016, the Company
assumed 16 additional leases for clinic locations. These leases vary in length from 60 to 127 months and have monthly payments
ranging from $1,917 to  $7,498.</p>

<p style="font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Total rent expense for the years ended December
31, 2016 and 2015 was $3,389,971 and $1,574,803, respectively.</p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Future minimum annual lease payments are as follows:</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; font-size: 10pt; text-align: left">2017</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 20%; font-size: 10pt; text-align: right">3,180,100</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2018</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,587,425</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2019</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">2,248,195</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2020</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,982,392</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">1,868,976</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1.1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">7,180,991</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">19,048,079</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0">In December, 2016, the Company ceased use of
five undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs incurred based
on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties.
The Company classified all of the approximately $338,000 lease exit liability in other liabilities in the accompanying consolidated
balance sheets as of December 31, 2016, and related expense in Loss on disposition or impairment in the accompanying consolidated
statement of operations for the year ended December 31, 2016.</p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Litigation</i></b></p>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, the Company
is party to litigation from time to time.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On July 7, 2015 six franchisees who owned a
total of 13 franchise licenses ("Claimants") filed a Demand for Arbitration against the Company alleging breach of contract,
breach of implied covenant of good faith and fair dealing, wrongful termination, fraud, promissory fraud, negligent misrepresentation,
and claims under or arising out of violations of Section 31300, 31301, 31201 and 31202 of the California Franchise Investment Law.
The Company vigorously denied liability for all of Claimants' claims and asserted counterclaims against each Claimant for breach
of contract, breach of guaranty, among other claims, and sought a declaratory judgment that termination was proper because Claimants
failed to adhere to the development schedules in their respective franchise agreements. The Company, through its counterclaim,
sought damages for each unopened license, in accordance with the terms of the parties&#8217; franchise agreements. The parties
entered into a settlement agreement dated December 12, 2016, which included, among other things, a mutual general release of claims.
The arbitration was subsequently dismissed with prejudice, based on the parties' stipulation.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 12:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Segment Reporting</b></td>
</tr></table>

<p style="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An operating segment is defined as a component
of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision
Maker (&#8220;CODM&#8221;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief
Executive Officer.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has two operating business segments.
The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of December
31, 2016, the Company operated or managed 61 clinics under this segment. The Franchise Operations segment is comprised of the operating
activities of the franchise business unit. As of December 31, 2016, the franchise system consisted of 309 clinics in operation.
Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&#8217;s two operating
business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance
and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support
the Company as a publicly traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The tables below present financial information
for the Company&#8217;s two operating business segments (in thousands):</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt; font-weight: bold">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br> December 31,</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Revenues:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">8,550</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">3,492</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">11,974</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">10,344</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total revenues</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">20,524</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">13,836</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(9,736</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(3,773</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4,638</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">4,234</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total segment operating (loss) income</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(5,098</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">461</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2,186</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">986</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Corporate administration</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">380</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">283</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total depreciation and amortization</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,566</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,269</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Reconciliation of total segment
    operating (loss) income to consolidated loss before income taxes (in thousands):</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Total segment operating (loss) income</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">(5,098</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">461</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Unallocated corporate</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(9,925</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">(9,777</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Consolidated loss from operations</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(15,023</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">(9,316</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Bargain purchase gain</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">261</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other income, net</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">13</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">22</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loss before income tax expense</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(15,010</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(9,033</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<div data-td-taggable-table=""><table cellpadding="0" cellspacing="0" align="CENTER" style="border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td nowrap style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2016</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td>
    <td nowrap colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br> 2015</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Segment assets:</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 20pt">Corporate clinics</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">9,936</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td><td style="width: 2%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right">12,426</td><td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Franchise operations</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2,003</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">2,580</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt">Total segment assets</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">11,939</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">15,006</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">&nbsp;</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated cash and cash equivalents and restricted cash</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">3,344</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">17,178</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated property and equipment</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">781</td><td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt">&nbsp;</td>
    <td style="font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; text-align: right">802</td><td style="font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Other unallocated assets</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">991</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td>
    <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">376</td><td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,055</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">33,362</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td></tr>
</table></div>



<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&#8220;Unallocated cash and cash equivalents
and restricted cash&#8221; relates primarily to corporate cash and cash equivalents and restricted cash (see Note 1), &#8220;unallocated
property and equipment&#8221; relates primarily to corporate fixed assets, and &#8220;other unallocated assets&#8221; relates primarily
to deposits, prepaid and other assets.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<div data-td-statement-type="note"><table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 73px; text-align: left"><b>Note 13:</b></td><td style="width: 7px"></td><td style="text-align: justify"><b>Subsequent Events</b></td>
</tr></table>

<p style="font-size: 10pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; margin: 0pt 0"><b><i>Credit and Security Agreement</i></b></p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On January 3, 2017, the Company entered into
a Credit and Security Agreement (the &#8220;Credit Agreement&#8221;), and signed a revolving credit note payable to the lender.
Under the Credit Agreement, the Company is able to borrow up to an aggregate of $5,000,000 under revolving loans. Interest on the
unpaid outstanding principal amount of any revolving loans is at a rate equal to 10% per annum, provided, that the minimum amount
of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is $200,000. Interest is
due and payable on the last day of each fiscal quarter in an amount determined by the Company, but not less than $25,000. The lender&#8217;s
lending commitments under the Credit Agreement terminate in December 2019, unless sooner terminated in accordance with the provisions
of the Credit Agreement. The Company intends to use the credit facility for general working capital needs. The Company has drawn
$1,000,000 of the $5,000,000 available under the Credit Agreement.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><i>Clinic Sales</i></b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On January 6, 2017, the Company sold
the assets of six of its 11 clinics in the Chicago area for a nominal amount to a partnership that includes existing
Company franchisees. The purchaser will continue to operate the clinics as franchised locations pursuant to a franchise
agreement. The Company concurrently sold to the limited liability company regional developer rights to Chicago for $300,000.
Pursuant to the regional developer agreement, the limited liability company has agreed to open a minimum of 30 Chicago area clinics over
the next 10 years, with plans to open five to 10 clinics over the next 18 months. The Company has closed the remaining five
Chicago-area clinics, as well as three Company-managed clinics in upstate New York. These assets were deemed as held for sale
as of December 31, 2016, and accordingly the Company recognized a loss on impairment of approximately $3.5 million.</p></div><p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_012"></a>ITEM 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">None.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_013"></a>ITEM 9A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CONTROLS AND PROCEDURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Conclusion Regarding the Effectiveness of Disclosure Controls
and Procedures</b></p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We conducted an evaluation, under the supervision
and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness
of the design and operation of our disclosure controls and procedures as of December&nbsp;31, 2016. Disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that information
required to be disclosed in our reports filed under the Exchange Act, such as this Annual Report on Form 10-K, is recorded, processed,
summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures
also include, without limitation, controls and procedures that are designed to provide reasonable assurance that such information
is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate,
to allow timely decisions regarding required disclosure.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The evaluation of our disclosure controls and
procedures included a review of the control objectives and design, our implementation of the controls and the effect of the controls
on the information generated for use in this Annual Report on Form 10-K. After conducting this evaluation, our Chief Executive
Officer and Chief Financial Officer concluded that our disclosure controls and procedures, as defined by Rule 13a-15(e) under the
Exchange Act, were effective as of December 31, 2016 to provide reasonable assurance that information required to be disclosed
in this Annual Report on Form 10-K was recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms and was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial
Officer, as appropriate, to allow timely decisions regarding required disclosure.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 72 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Management's Report on Internal Control Over Financial Reporting
</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Management is responsible for establishing
and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act). Internal
control over financial reporting is the process designed under the Chief Executive Officer&#8217;s and the Chief Financial Officer&#8217;s
supervision, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles in the United States.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">There are inherent limitations in the effectiveness
of internal control over financial reporting, including the possibility that misstatements may not be prevented or detected. Accordingly,
an effective control system, no matter how well designed and operated, can provide only reasonable assurance of achieving the designed
control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls
and procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, within the Company have been detected. The design of any system of controls
is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Under the supervision and with the participation
of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness
of our internal control over financial reporting as of December&nbsp;31, 2016, as required by Exchange Act Rule 13a-15(c). In making
this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;)
in the 2013 Internal Control - Integrated Framework. Based on our assessment under the framework in Internal Control - Integrated
Framework (2013 framework), management concluded that our internal control over financial reporting was effective as of December
31, 2016.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>Changes in Internal Controls over Financial Reporting</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We identified and disclosed a material weakness
in our internal control over financial reporting for the years ended December 31, 2014 and 2015. In an effort to remediate deficiencies
in our internal control structure, during the year ended December 31, 2016, we took steps to enhance our internal controls over
financial reporting, including the hiring of additional resources to oversee financial reporting, the enhancement of segregation
of duties, and the engagement of third party consultants to aid in designing and implementing processes and procedures to compile,
reconcile and review accounts in a timely manner. During the fourth quarter of 2016, we successfully completed the testing necessary
to conclude that the material weakness has been remediated.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Except for the implementation of the remediation
measures noted above, there were no other changes in our internal control over financial reporting during the year ended December
31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We believe that a control system, no matter
how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation
of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been
detected.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_014"></a>ITEM 9B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
OTHER INFORMATION</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">None.</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>PART III</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_015"></a>ITEM 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in our Proxy Statement to be filed pursuant to Regulation 14A within 120 days after our year ended December 31, 2016
in connection with our 2017 Annual Meeting of Stockholders, or the 2017 Proxy Statement, and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><b><i>Code of Business Conduct and Ethics</i></b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">We have adopted a Code of Business Conduct
and Ethics that applies to employees, officers and directors, including our executive management team, such as our Chief Executive
Officer and Chief Financial Officer. This Code of Business Conduct and Ethics is posted on our website at www.thejoint.com. We
intend to satisfy the requirements under Item 5.05 of Form 8-K regarding disclosure of amendments to, or waivers from, provisions
of the Code of Business Conduct and Ethics by posting such information on our website.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_016"></a>ITEM 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
EXECUTIVE COMPENSATION</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2017 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_017"></a><b>ITEM 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this Item will
be included in the 2017 Proxy Statement and is incorporated herein by reference.&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_018"></a><b>ITEM 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2017 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_019"></a><b>ITEM 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information required by this item will
be included in the 2017 Proxy Statement and is incorporated herein by reference.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b>PART IV</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><a name="a_020"></a><b>ITEM 15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
EXHIBITS, FINANCIAL STATEMENT SCHEDULES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><font style="font-size: 10pt">(a)</font></td>
    <td style="vertical-align: top; width: 94%; text-align: justify"><font style="font-size: 10pt">Documents filed as part of this report.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><font style="font-size: 10pt">(1)</font></td>
    <td style="vertical-align: top; width: 94%; text-align: justify"><font style="font-size: 10pt"><i>Financial Statements</i>. The consolidated financial statements listed on the index to Item 8 of this Annual Report on Form 10-K are filed as a part of this Annual Report.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><font style="font-size: 10pt">(2)</font></td>
    <td style="vertical-align: top; width: 94%; text-align: justify"><font style="font-size: 10pt"><i>Financial Statement Schedules. </i>All financial statement schedules have been omitted since the information is either not applicable or required or is included in the financial statements or notes thereof.</font></td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 3%; text-align: justify">&nbsp;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><font style="font-size: 10pt">(3)</font></td>
    <td style="vertical-align: top; width: 94%; text-align: justify"><font style="font-size: 10pt"><i>Exhibits. </i>Those exhibits marked with a (*) refer to exhibits filed or furnished&nbsp;herewith. The other exhibits are incorporated herein by reference, as indicated in the following list. Those exhibits marked with a (+) refer to management contracts or compensatory plans or arrangements. Portions of the exhibits marked with a (&#937;) are the subject of a Confidential Treatment Request under 17 C.F.R. &#167;&#167; 200.80(b)(4), 200.83 and 240.24b-2.&nbsp;&nbsp;Omitted material for which confidential treatment has been requested has been filed separately with the SEC.</font></td></tr>
</table>
<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 74 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0"><b><a name="a_021"></a>SIGNATURES</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized on March 10, 2017.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2" style="text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 52%; text-align: justify">&nbsp;</td>
    <td style="width: 3%; text-align: justify"><font style="font-size: 10pt">&nbsp;By:</font></td>
    <td style="width: 29%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Peter D.&nbsp;&nbsp;Holt</font></td>
    <td style="width: 16%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Peter D. Holt</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2"><p style="font-size: 10pt; text-align: justify; margin: 0pt 0">President and Chief Executive Officer</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">(Principal Executive Officer)</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

</td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2" style="text-align: justify"><font style="font-size: 10pt"><b>The Joint Corp.</b></font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 52%; text-align: justify">&nbsp;</td>
    <td style="width: 2%; text-align: justify"><font style="font-size: 10pt">&nbsp;By:</font></td>
    <td style="width: 30%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ John P. Meloun</font></td>
    <td style="width: 16%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">John P. Meloun</font></td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td colspan="2"><p style="font-size: 10pt; text-align: justify; margin: 0pt 0">Chief Financial Officer</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">(Principal Financial Officer)</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

</td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;KNOW ALL PERSONS BY THESE PRESENTS, that
each person whose signature appears below constitutes and appoints Peter D. Holt and John P. Meloun, jointly and severally, his
or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments
to this Report on Form&nbsp;10-K, and to file the same, with exhibits thereto and other documents in connection therewith with
the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her
substitute or substitutes may do or cause to be done by virtue hereof.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 45pt; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="width: 30%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Signature</b></font></td>
    <td style="width: 5%; text-align: justify">&nbsp;</td>
    <td style="width: 40%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Title</b></font></td>
    <td style="width: 5%; text-align: justify">&nbsp;</td>
    <td style="width: 20%; border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt"><b>Date</b></font></td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Peter D. Holt</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">President , Chief Executive Officer and Director&nbsp;</font></td>
    <td>&nbsp;</td>
    <td><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Peter D. Holt</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">(Principal Executive Officer) and Director</font></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ John P. Meloun</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">Chief Financial Officer </font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">John P. Meloun</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td><font style="font-size: 10pt">(Principal Financial Officer)</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Ronald A. DaVella</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Lead Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Ronald A. DaVella</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ James H. Amos</font>, Jr.</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">James H. Amos</font>, Jr.</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Craig P. Colmar</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Craig P. Colmar</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Steven P. Colmar</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Steven P. Colmar</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Richard A. Kerley</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Richard A. Kerley</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ William R. Fields</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">William R. Fields</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="text-align: justify">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; text-align: justify"><font style="font-size: 10pt">/s/ Bret Sanders</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">Director</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><font style="font-size: 10pt">March 10, 2017</font></td></tr>
<tr>
    <td style="text-align: justify"><font style="font-size: 10pt">Bret Sanders</font></td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
</table>
<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><b>EXHIBIT INDEX&nbsp;</b></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; text-align: left"><b>Exhibit</b></td>
    <td style="vertical-align: middle; text-align: center">&nbsp;</td>
    <td style="vertical-align: middle">&nbsp;</td>
    <td style="vertical-align: middle"><font style="font-size: 8pt">&nbsp;</font></td>
    <td colspan="5" style="text-decoration: underline; vertical-align: top; text-align: center"><font style="font-size: 8pt">Incorporated
    by Reference</font></td>
    <td style="vertical-align: middle"><font style="font-size: 8pt">&nbsp;</font></td>
    <td style="text-align: right; vertical-align: top"><font style="font-size: 8pt">&nbsp;</font></td>
    <td style="vertical-align: top; text-align: center"><font style="font-size: 8pt">Provided</font></td></tr>
<tr>
    <td style="font-weight: bold; vertical-align: top; text-align: left; width: 7%"><u>Number</u></td>
    <td style="vertical-align: middle; width: 1%">&nbsp;</td>
    <td style="font-weight: bold; vertical-align: middle; width: 55%; text-align: center"><u>Description</u></td>
    <td style="vertical-align: middle; width: 1%"><font style="font-size: 8pt">&nbsp;</font></td>
    <td style="text-decoration: underline; vertical-align: top; width: 5%; text-align: center"><font style="font-size: 8pt">Form</font></td>
    <td style="text-align: center; width: 1%; vertical-align: top"><font style="font-size: 8pt">&nbsp;</font></td>
    <td style="text-decoration: underline; vertical-align: top; width: 12%; text-align: center"><font style="font-size: 8pt">File
    No.</font></td>
    <td style="text-align: center; width: 1%; vertical-align: top"><font style="font-size: 8pt">&nbsp;</font></td>
    <td nowrap style="text-decoration: underline; vertical-align: top; text-align: center; width: 5%"><font style="font-size: 8pt">Exhibit(s)</font></td>
    <td style="vertical-align: middle; width: 1%"><font style="font-size: 8pt">&nbsp;</font></td>
    <td style="text-decoration: underline; vertical-align: top; width: 6%; text-align: center"><font style="font-size: 8pt">Filing
    Date</font></td>
    <td style="text-decoration: underline; vertical-align: top; width: 5%; text-align: center"><font style="font-size: 8pt">Herewith</font></td></tr>
<tr>
    <td style="vertical-align: top; text-align: left">&nbsp;</td>
    <td style="vertical-align: middle; text-align: center">&nbsp;</td>
    <td style="vertical-align: middle">&nbsp;</td>
    <td style="vertical-align: middle">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left">&nbsp;</td>
    <td style="vertical-align: middle">&nbsp;</td>
    <td style="vertical-align: top; text-align: right">&nbsp;</td>
    <td style="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">&nbsp;3.1</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Amended and Restated Certificate of Incorporation of Registrant.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">3.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">&nbsp;3.2</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Amended and Restated Bylaws of Registrant, plus amendments.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">3(ii).1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;3/07/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">&nbsp;4.1</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Warrant to Purchase Common Stock issued to Feltl and Company, Inc. on November 14, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">4.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">&nbsp;4.2</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Warrant to Purchase Common Stock issued to Roth Capital Partners, LLC on November 14, 2014.&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">4.3</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Indemnification Agreement between Registrant and each of its directors and officers and related schedule.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.2#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">2012 Stock Plan.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.3#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Amended and Restated 2014 Incentive Stock Plan.&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.3</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.4#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Incentive Stock Option Agreement under 2014 Stock Plan.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.4</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.5#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.5</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.6#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Nonstatutory Stock Option Agreement under 2014 Stock Plan for Article 7, Annual Option Grants.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.6</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.7#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Restricted Stock Award.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.7</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.8</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Lease Agreement dated between Registrant and DTR 14, LLC, for Registrant&#8217;s office located at 16767 North Perimeter Drive, Suite 240, Scottsdale, Arizona 85260.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.5&nbsp;&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.9#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Agreement between Registrant and David Orwasher dated January 1, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.6</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.10#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Term Sheet between Registrant and John B. Richards, Chief Executive Officer of Registrant.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.7</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.11#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Term Sheet between Registrant and Catherine Hall, Chief Marketing Officer of Registrant.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.8</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.12#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Agreement between The Joint Corp. and Francis T. Joyce dated December 12, 2014</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">12/22/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.13#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Stock Option Agreement between Registrant and David Orwasher dated January 1, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.9</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.14#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Stock Option Agreement between Registrant and Catherine Hall dated May 15, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.15#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Restricted Stock Award Agreement between Registrant and John B. Richards dated January 1, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.11</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.16#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Restricted Stock Award Agreement between Registrant and David Orwasher dated January 1, 2014.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.12</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.17#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Restricted Stock Award Agreement between Registrant and Francis T. Joyce dated December 16, 2014</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-207632</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.14</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">10/27/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.18</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Registrant&#8217;s Franchise Disclosure Document.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.13</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.19</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Registrant&#8217;s Regional Developer License Agreement.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.14</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.20</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Form of Registrant&#8217;s Franchise Agreement.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.15</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.21#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Written Description of Management Services Arrangement between Registrant and Business Ventures Corp.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.16</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.22#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Written Description of Consulting Arrangement between Registrant and John Leonesio.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.17</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.23</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Indemnification Agreement between Registrant and former director Fred Gerretzen.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.18</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.24</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Indemnification Agreement between Registrant and former officer Ronald Record.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.19</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt; width: 7%">10.25</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt; width: 55%">Termination Agreement dated as of December 31, 2014 by The Joint Corp., Kairos Marketing, LLC and Chad Meisinger.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 5%">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 1%">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 12%">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt; width: 5%">2.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt; width: 6%">&nbsp;&nbsp;1/07/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt; width: 5%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.26</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of December 31, 2014 between The Joint Corp., The Joint RRC Corp., Raymond G. Espinoza, Chad Meisinger and Rob Morris.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;1/07/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.27</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of January 30, 2015 between The Joint Corp., TJSC, LLC, Theodore Amendola and Scott Lewandowski.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;2/05/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.28</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated February 17, 2015 by and among The Joint Corp., Roth &amp; Pelan Enterprises, LLC, Timothy Roth, Blue Sky &amp; Sunny Days, Inc., and Thomas Pelan.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;2/19/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.29</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of February 27, 2015 between The Joint Corp., The Joint San Gabriel Valley, Inc. and Vincent Huan.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;3/09/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.30</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of March 31, 2015 between The Joint Corp., The Joint Chiropractic Bell Towne, LLC, Marla R. Allan and Marc W. Payson.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;4/22/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.31</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Franchise Agreement Termination and Reinstatement Agreement dated as of as of April 30, 2015, by The Joint Corp., Stephanie McRae and South Bay Joint Development, Inc.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;5/05/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.32</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of April 30, 2015, between The Joint Corp., San Diego Joint Development, Inc., Stephanie McRae, and Elizabeth McRae.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;5/05/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.33</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Regional Developer Termination Agreement dated as of as of May 18, 2015, among The Joint Corp., Dennis Conklin, Eric Hua and&nbsp;&nbsp;Orange County Wellness, Inc.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;5/21/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.34</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of May 18, 2015, among First Light Junction, Inc., a California corporation, Eric Hua and Tracy Hua.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;5/21/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.35</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of June&nbsp;&nbsp;3, 2015, by and between The Joint Corp., a Delaware corporation, WHB Franchise Inc., a California corporation and William Bargfrede.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;6/05/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.36</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of June 5, 2015, by and among The Joint Corp., a Delaware corporation,&nbsp;&nbsp;&nbsp;Clear Path Ventures, Inc., a California corporation, Carol Warren, and Jodi Wolf.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;6/10/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.37</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of July 1, 2015, by and among The Joint Corp., a Delaware corporation, Chiro-Novo, LLC, an Arizona limited liability company, Kent L. Cooper, as trustee of The Kent L. Cooper Trust, Benjamin Cooper, as trustee of The Benjamin and Milena Cooper Family Trust dated May 2, 2006, Robert A. Cooper and Andrew C. Cooper.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;7/07/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.38</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Termination Agreement dated as of as of August 10, 2015, among The Joint Corp., a Delaware corporation and Align Group, LLC a New York limited liability company, and Marc Ressler.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;8/14/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.39</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of August 10, 2015, by and between The Joint Corp., a Delaware corporation, Chiro Group, LLC, a New York limited liability company, Marc Ressler, Angelo Marracino, Jesse Curry and Cleon Easton.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">2.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;8/14/2015</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.40</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of December 29, 2015, by and among The Joint Corp., a Delaware corporation, Forte Vita Ventures, Inc., a California corporation, Neil Sinay and Jennifer M. Sinay.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">1.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;1/05/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.41</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Regional Developer License Purchase Agreement, dated January 1, 2016, among the Company, Christina Ybanez and Mark Elias.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">1.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;1/07/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.42#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Agreement dated April 27, 2016, between The Joint Corp. and Peter Holt</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">5/3/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.43#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Separation Agreement dated April 29, 2016, between The Joint Corp. and David Orwasher</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">5/3/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.44</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of April 29, 2016, by and among The Joint Corp., a Delaware corporation, Guthrie Joint Venture NM, LLC, a New Mexico limited liability company and Ronald Guthrie</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">5/5/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.45</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset and Franchise Purchase Agreement dated as of May 6, 2016 by and among The Joint Corp., a Delaware corporation, T&amp;J Chiropractic Management, Inc., a California corporation, Vortex Financial Management, Inc., a California corporation, Anita Davis, Johnny Linderman and Ped Abghari aka Ted Abghari.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">5/12/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt; width: 7%">10.46#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt; width: 55%">Separation Agreement dated June 29, 2015, between The Joint Corp. and John Richards</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 5%">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 1%">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 12%">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt; width: 5%">10.1</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt; width: 6%">6/30/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt; width: 5%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.47#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Employment Agreement dated November 8, 2016, between The Joint Corp. and John Meloun</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">11/10/2016</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.48</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Credit and Security Agreement dated as of January 3, 2017, by and between The Joint Corp/, a Delaware corporation, and Tower 7 Partnership LLC, and Ohio limited liability company</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36724</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.1</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">1/9/2017</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.49</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Revolving Credit Note, dated January 3, 2017, by The Joint Corp., a Delaware corporation in favor of Tower 7 Partnership LLC</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36274</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.2</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">1/9/2017</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.50#</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Amended and Restated Employment Agreement dated January 3, 2017, between The Joint Corp., a Delaware corporation, and Peter Holt</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">8-K</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">001-36274</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">10.3</td>
    <td style="vertical-align: middle; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">1/9/2017</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">21.1</td>
    <td style="vertical-align: middle; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">List of subsidiaries of The Joint Corp.</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">S-1</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">333-198860</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">21.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;&nbsp;9/19/2014</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">23</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Consent of EKS&amp;H LLLP</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">31.1</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">31.2</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">32</td>
    <td style="vertical-align: middle; text-align: justify; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Certification by Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<TR>
    <TD STYLE="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">99.1</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Asset Purchase Agreement dated January 6<SUP>th</SUP>, 2017, by and between The Joint Corp., a Delaware corporation, Don Daniels, Larry Maddalena and Jody O&rsquo;Donnell.</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">99.2</TD>
    <TD STYLE="vertical-align: middle; text-align: justify; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">Assignment and Assumption Agreement dated February
    24, 2017, by and between The Joint Corp., a Delaware corporation, Don Daniels, Larry Maddalena and Jody O&rsquo;Donnell and
    Porter Partners, LLC.</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</TD></TR>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.INS</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Instance Document</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.SCH</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Taxonomy Extension Schema Document (4)</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.CAL</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Taxonomy Extension Calculation Linkbase Document (4)</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.DEF</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Taxonomy Extension Definition Linkbase Document (4)</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.LAB</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Taxonomy Extension Label Linkbase Document (4)</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
<tr>
    <td style="vertical-align: top; text-align: left; padding-top: 3pt; padding-bottom: 3pt">101.PRE</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">XBRL Taxonomy Extension Presentation Linkbase Document (4)</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="text-align: left; padding-top: 3pt; padding-bottom: 3pt; vertical-align: top">&nbsp;</td>
    <td style="vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: right; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</td>
    <td style="vertical-align: top; text-align: center; padding-top: 3pt; padding-bottom: 3pt">X</td></tr>
</table>


<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">___________________</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="width: 1%; font-size: 10pt"><font style="font-size: 10pt">#</font></td>
    <td style="width: 98%; font-size: 10pt"><font style="font-size: 10pt">Management contract or compensatory plan or arrangement.</font></td></tr>
</table>


<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>



<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></p>

<p style="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">75</p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div align="CENTER" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"></p>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>2
<FILENAME>exh_23.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>Exhibit 23</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">We consent to the incorporation by reference in the registration
statement (No. 333-208262) on Form S-8 of our report dated March 10, 2017 with respect to the consolidated balance sheets of The
Joint Corp. and Subsidiary as of December 31, 2016 and 2015, and the related consolidated statements of operations, stockholders'
equity, and cash flows for the years then ended, which report appears in the December 31, 2016 annual report on Form 10-K of The
Joint Corp. and Subsidiary. We also consent to the reference to our firm under the heading &quot;Experts&quot; in such registration
statements.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">/s/ EKS&amp;H LLLP</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">March 10, 2017</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Denver, Colorado</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exh_311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 31.1</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">I, Peter D. Holt, certify that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 10-K of The Joint Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 51%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Date: March 10, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ Peter D. Holt</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Peter D. Holt</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">President and Chief Executive Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exh_312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 31.2</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">I, John P. Meloun, certify that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form 10-K of The Joint Corp.;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%; text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 88%; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Date: March 10,&nbsp;2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ John P. Meloun</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">John P. Meloun</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Chief Financial Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Financial Officer)</P></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>exh_32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 27pt; margin: 0pt 0"><B>Exhibit 32</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&nbsp;1350,</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 27pt; margin: 0pt 0"><B>AS ADOPTED PURSUANT TO SECTION&nbsp;906 OF
THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">For purposes of Section&nbsp;1350 of Chapter
63 of Title 18 of the United States Code, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, each of the
undersigned officers of The Joint Corp., a Delaware corporation (&ldquo;Company&rdquo;), does hereby certify, to such officer&rsquo;s
knowledge, that:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">The Annual Report on Form 10-K for the fiscal
year ended December&nbsp;31, 2016 (&ldquo;Form 10-K&rdquo;) of the Company fully complies with the requirements of Section&nbsp;13(a)
or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-K fairly presents, in all material
respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: March 10, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ Peter D. Holt</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Peter D. Holt</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">President and Chief Executive Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 52%; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: March 10, 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; text-align: justify; text-indent: 27pt"><FONT STYLE="font-size: 10pt">/s/ John P. Meloun</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 27pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">John P. Meloun</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">Chief Financial Officer</P>
        <P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(Principal Financial Officer)</P></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>ASSET PURCHASE AGREEMENT</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">THIS ASSET PURCHASE AGREEMENT (&ldquo;<U>Agreement</U>&rdquo;)
is made and entered into effective as of the 6<SUP>th</SUP> day of January, 2017 (&ldquo;<U>Effective Date</U>&rdquo;), by and
between, <B>The Joint Corp., a Delaware corporation</B> (&ldquo;<U>Seller</U>&rdquo;) and <B>Don Daniels, Larry Maddalena and Jody
O'Donnell</B> (collectively referred to hereafter as the &ldquo;<U>Buyers</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">Background:</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Seller is a franchisor of chiropractic clinics and chiropractic service management organizations/companies throughout the
U.S. (&ldquo;Franchise System&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As part of its Franchise System, Seller currently owns and operates eleven (11) company-owned The Joint Chiropractic&trade;
locations in the State of Illinois (the &ldquo;IL Locations&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Seller is the chiropractic management service organization/company (&ldquo;MSO&rdquo;) for chiropractic practices (&ldquo;Practices&rdquo;
owned and operated by Direct Chiropractic, SC (the &ldquo;Existing PC&rdquo;) at the IL Locations.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Buyers desire to purchase and Seller desires to sell all the assets of the following IL Locations (&ldquo;the Subject Locations&rdquo;):</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 1in">Downers Grove (21014) located at 307 Ogden Ave., Downers Grove,
IL 60515.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 1in">Elston and Logan (21005) located at 2711 N. Elston Ave., Chicago,
IL 60647.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 1in">GlenPointe (21009) located at 3812 Willow
Road, Northbrook, IL 60062.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 1in">Glenview (21004) located at 1415 Waukegan
Road, Glenview, IL 60025.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0 0pt 1in">Schaumburg (21003) located at 1426 Meacham Rd., Schaumburg,
IL 60173.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 1in">Wheaton (21013) located at 280 Danada Square
West, Wheaton, IL 60189.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">E.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Seller is the named tenant for real property leases under which the Seller conduct business for each of the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">F.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Seller will sell to Buyers, and Buyers will purchase from Seller, all of Seller&rsquo;s interest in the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">Agreement:</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">NOW, THEREFORE, in consideration of the mutual
agreements, covenants and undertakings herein contained and other valuable consideration, the adequacy of which is acknowledged
by all parties, the parties hereby agree as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>Purchase and Sale</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 66pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as provided here, at the Closing (as hereinafter defined) of the transactions contemplated hereby, Seller shall sell,
assign, transfer and deliver to Buyers, and Buyers shall purchase and accept from Seller, the Assets, free and clear of any liens,
claims (including, without limitation, title claims and claims of taxing authorities), encumbrances, pledges, security interests
or charges of any kind whatsoever, and shall assume the obligations only as specifically stated herein, for the purchase price
set forth in Section 2 hereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">For purposes of this Agreement, &ldquo;<U>Assets</U>&rdquo; shall mean:</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">i.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>all of Seller&rsquo;s interest in equipment, machinery, tools, maintenance supplies, office equipment, leasehold improvements,
furniture, fixtures, inventories and supplies and other similar items of tangible personal property (together the &ldquo;<U>Personal
Property</U>&rdquo;) used or held for use by Seller in the Subject Locations, which is more particularly listed and described in
<B>Schedule 1(b)(i)</B> attached hereto and made a part hereof;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">ii.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>all of Seller&rsquo;s interest, if any, in any membership agreements, prepaid services packages and other agreements or
arrangements, if any, Seller has made with patients of the Subject Locations, together with any deposits or prepayments made by
any patients covered by such agreements or arrangements to the extent related to services to be performed after Closing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">iii.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>all of Seller&rsquo;s goodwill attributable to the Subject Locations;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">iv.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>all telephone numbers and domain names associated with the Subject Locations;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">v.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>to the extent transferable, all licenses, government approvals and permits and all other approvals and permits relating
to the Subject Locations;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">vi.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>all of Seller&rsquo;s interest as tenant (including leasehold improvements) under its leases for the premises occupied by
the Subject Locations (&ldquo;the <U>Leases</U>&rdquo;), copies of which have been provided electronically to Seller, and are made
a part hereof; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 76.5pt; margin: 0pt 0">vii.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>the agreements and contracts which Buyers has expressly agreed to assume and which are listed on <B><U>Schedule (1)(b)(vii)</U></B>
(together, the &ldquo;<U>Assumed Contracts</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Prior to, or within a reasonable time after
the Closing Date, Buyers will secure a professional service corporation (&ldquo;New PC&rdquo;) to assume the Practices of the Existing
PC at the Subject Locations. For this reason, Seller is not transferring any of its management or medical agreements with the Existing
PC to the Buyers as part of this Agreement or the transaction contemplated hereby. However, in the event all documents necessary
to have the New PC in place on or by the Closing Date have not been executed or finalized by the Closing Date, the Parties hereby
agree that any existing management agreements and/or medical direction agreements with the Existing PC shall be deemed to have
been assigned from Seller to Buyers as of the Closing Date. In such case, the Parties agree in good faith to execute any and all
documents necessary to memorialize the assignment of such agreements. The intent of this provision to ensure that a PC is in place
at all times for the Subject Locations, both before and after the Closing Date. Moreover, Buyers understand and acknowledge that
the Existing PC desires to terminate his management and medical direction agreements for the Subject Locations as soon as possible.
Nothing herein shall be a basis for the Buyers to unnecessarily delay the execution of the documents necessary to establish a relationship
with the New PC for the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 37.5pt"></TD><TD STYLE="width: 34.5pt"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Excluded Assets</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding anything to the contrary contained
in this Agreement, it is expressly acknowledged by Buyers that Seller will not be conveying to Buyers (a) any cash, cash equivalents,
working capital, or accounts receivable (other than accounts receivable under membership agreements or other arrangements described
in Section 1(b)(iii) above, for periods after Closing), (b) any of the proceeds of the transaction described in this Agreement,
(c) the items listed on the attached <B><U>Schedule (2)</U>,</B> and (d) any other assets, properties or rights of Seller owned
or used by Seller but not used in or directly related to the Subject Locations (collectively, the &ldquo;<U>Excluded Assets</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>No Assumption of Liabilities</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Except as expressly provided in this Agreement,
Buyers shall not assume any debts, liabilities or obligations of Seller or its shareholders, members, affiliates, officers, employees
or agents of any nature, whether known or unknown, fixed or contingent, including, but not limited to, debts, liabilities or obligations
with regard or in any way relating to any contracts (including, without limitation, any employee agreements), leases for real or
personal property, trade payables, tax liabilities, disclosure obligations, product liabilities, liabilities to any regulatory
authorities, liabilities relating to any claims, litigation or judgments, any pension, profit-sharing or other retirement plans,
any medical, dental, hospitalization, life, disability or other benefit plans, any stock ownership, stock purchase, deferred compensation,
performance share, bonus or other incentive plans, or any other similar plans, agreements, arrangements or understandings which
Seller, or any of its affiliates, maintain, sponsor or are required to make contributions to, in which any employee of Seller participates
or under which any such employee is entitled, by reason of such employment, to any benefits (collectively the (&ldquo;<U>Excluded
Liabilities</U>&rdquo;). For the avoidance of doubt, any liability under any lease for real property for a Subject Location, whether
or not assumed by Buyers, for the period before Closing, shall be an Excluded Liability.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding the foregoing, Buyers hereby
agrees to assume the obligation to operate as the MSO for the Subject Locations, and to ensure that such the Subject Locations
continue to operate as The Joint Chiropractic&trade; franchised locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>Payment of Purchase Price</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The purchase price to be paid by Buyers for
the Assets (the &ldquo;Purchase Price&rdquo;) is $6.00.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>Closing</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to the satisfaction or waiver of the
conditions described in Sections 9 and 10 the closing of the transactions described herein shall take place no later than January
6, 2017, at such time as the parties agree, and shall occur at the offices of Buyers. The date on which the Closing takes place
is referred to in this Agreement as the &ldquo;<U>Closing Date</U>.&rdquo; At the Closing, Seller shall deliver such bills of sale,
assignments, certificates and other documents and instruments as may reasonably be requested by Buyers to carry out the transfer
and assignment to Buyers of the Assets. Following the Closing, the parties shall cooperate fully with each other and shall make
available to the other, as reasonably requested and at the expense of the requesting party, and to any taxing or regulatory authority,
all information, records or documents relating to tax obligations and regulatory compliance matters of Seller for all periods on
or prior to the Closing, and shall preserve all such information, records and documents until the expiration of any applicable
statute of limitations and extensions thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>Representations and Warranties of Seller.</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Seller represents and warrants to Buyers as
follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization</U>.
Seller is a corporation duly organized and validly subsisting under the laws of the State of Delaware, and has full power and authority
to conduct its business as it is now being conducted, and to execute, deliver and perform this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority</U>.
Seller is not a party to, subject to, or bound by any agreement, judgment, order, writ, injunction, or decree of any court or governmental
body that prevents or impairs the carrying out of this Agreement. The execution, delivery and performance of this Agreement and
all other documents, instruments and agreements contemplated hereby have been duly authorized by Seller&rsquo;s Board of Directors.
All other actions (including all action required by state law and by the organizational documents of the entities comprising Seller)
necessary to authorize the execution, delivery and performance by Seller of this Agreement, the bills of sale transferring the
Assets, the assignments in connection herewith and the other documents, instruments and agreements necessary or appropriate to
carry out the transactions herein contemplated, have been taken by Seller. Upon the execution of this Agreement and the other documents
and instruments contemplated hereby by Seller, this Agreement and such other documents and instruments will be the valid and legally
binding obligations of Seller, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting
creditors&rsquo; rights generally, and subject, as to enforceability, to general principles of equity, including principles of
commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in
equity).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Consent or Approval Required</U>. Except as set forth on <B><U>Schedule 6(c)</U></B>, no authorization, consent, approval
or other order of, declaration to or filing with any third party, including any governmental body or authority is required for
the approval or consummation by Seller of the transactions contemplated by this Agreement. Seller agrees that assignment of any
Leases shall not be subject to or contingent upon any novation or any release of any principal obligor or guarantor thereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Taxes</U>. Each of the entities comprising Seller has filed when due in accordance with all applicable laws (or properly
and timely filed an extension therefor) all tax returns required under applicable statutes, rules or regulations to be filed by
it. As of the time of filing, such returns were accurate and complete in all material respects. All taxes due with respect to Seller
and the Assets, and all additional assessments received, have been paid. None of the entities comprising Seller is delinquent in
the payment of any such tax and none has requested any extension of time within which to file any tax return, which return has
not since been filed. There are no federal, state, local or other tax liens outstanding on any of the Assets being sold hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Title to and Condition of Assets</U>. Seller has good and marketable title to (or, with respect to any Assets that are
leased, a valid leasehold interest in) all of the Assets to be acquired by Buyers at the Closing, free from any liens, adverse
claims, security interest, rights of other parties or like encumbrances of any nature. The Assets consisting of physical property
are in good condition and working order, normal wear and tear excepted, and function properly for their intended uses.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Laws</U>. Neither any of the entities comprising Seller nor any of the Subject Locations is in violation
of, nor are they or any of them subject to any liability in respect of, any federal, state, county, township, city or municipal
laws, codes, regulations or ordinances (including without limitation those relating to environmental protection, health, hazardous
or toxic substances, fire or safety hazards, occupational safety, labor laws, employment discrimination, subdivision, building
or zoning) with respect to the conduct of the Subject Locations, nor has Seller received any notices of investigation or violation
pertaining to any such matters. Seller has, and all professional employees or agents of Seller have, all licenses, franchises,
permits, authorizations or approvals from all governmental or regulatory authorities required for the conduct of the Subject Locations
and neither Seller nor the professional employees or agents of Seller have violated any such license, franchise, permit, authorization
or approval or any terms or conditions thereof.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Litigation</U>. There is no action, suit or proceeding pending, threatened against or affecting the Assets, or relating
to or arising out of, the ownership or operation of the Assets, including claims by employees of the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employees</U>. Seller has provided a complete and correct list of the name, position, current rate of compensation and
any vacation or holiday pay and any other compensation arrangements or fringe benefits, of each current employee of Seller who
is directly employed in the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Contracts</U>. Seller has delivered to Buyers copies of any and all material contracts, leases, agreements, software
licensing agreements, or commitments with respect to the Assets or the Subject Locations. Except as set forth in <B><U>Schedule
6(i)</U></B>, no consent or approval of any third party is required for the assignment to Buyers of any contracts that Buyers is
assuming pursuant to Sections 1(b) of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Claims</U><I>. </I> Seller has no claims, demands, or causes of action for damages of any kind whatsoever, whether known
or unknown, against Buyers or its officers, directors, employees, agents, successors and assigns by reason of any event, occurrence
or omission arising under, or relating to, the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 30pt"><B>7.</B></TD><TD STYLE="text-align: justify"><B>Buyers&rsquo; Representations and Warranties</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 70.5pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Buyers represents and warrants to Seller as
follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization of Buyers</U>. Buyers are individuals. Buyers have full power and authority to conduct its business as it
is now being conducted, and to execute, deliver and perform this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorization</U>. None of the Buyers are a party to, subject to or bound by any agreement, judgment, order, writ, injunction,
or decree of any court or governmental body that prevents or impairs the carrying out of this Agreement. The execution, delivery
and performance of this Agreement and all other documents, instruments and agreements contemplated hereby have been duly authorized
by Buyers&rsquo; Board of Directors. All other actions (including all action required by state law and by the organizational documents
of Buyers) necessary to authorize the execution, delivery and performance by Buyers of this Agreement, the bill of sale transferring
the Assets, the assignments in connection herewith and the other documents, instruments and agreements necessary or appropriate
to carry out the transactions herein contemplated, have been taken by Buyers. Upon the execution of this Agreement and the other
documents and instruments contemplated hereby by Buyers, this Agreement and such other documents and instruments will be the valid
and legally binding obligations of Buyers, enforceable against it in accordance with their respective terms, subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors&rsquo; rights generally, and subject, as
to enforceability, to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing
(regardless of whether enforcement is sought in a proceeding at law or in equity).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Consent or Approval Required</U>. No authorization, consent, approval or other order of, declaration to or filing
with any governmental body or authority, including, without limitation, with respect to environmental matters, is required for
the consummation by Buyers of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Violation of Other Agreements</U>. Neither the execution and delivery of this Agreement nor compliance with the terms
and conditions of this Agreement by Buyers will breach or conflict with any of the terms, conditions or provisions of any agreement
or instrument to which Buyers is or may be bound or constitute a default thereunder or result in a termination of any such agreement
or instrument.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Capability</U>. Buyers will have at Closing, sufficient internal funds available to pay the Purchase Price
and any fees or expenses incurred by Buyers in connection with the transactions contemplated hereby.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">Pre-Closing Events</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General</U>. Pending Closing, the Parties shall use commercially reasonable efforts to take all actions that may be necessary
to close the transaction in accordance with the terms of this Agreement (but Buyers shall not be required to waive any of the Buyers
Closing Conditions, and Seller shall not be required to waive any of the Seller Closing Conditions).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Conduct of Business</U>. Pending Closing, Seller shall:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>conduct the business of the Subject Locations in the ordinary course and use commercially reasonable efforts, in consultation
with (but without being bound by) Buyers&rsquo; transition management team personnel, to maintain and grow the business of the
Subject Locations and to preserve their goodwill and advantageous relationships with patients, employees, suppliers and other persons
having business dealings with the Subject Locations; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>not take any affirmative action that results in the occurrence of an event of default under any contract or agreement to
which Seller is a party and take any reasonable action within Seller&rsquo;s control that would avoid the occurrence of such default.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Access to Information</U>. Pending Closing, Seller shall:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>cause Seller to afford Buyers and its representatives (including its lawyers, accountants, consultants and the like) reasonable
access during normal business hours, but without unreasonable interference with operations, to the Seller&rsquo;s Atlas records
and other documents relating to the Subject Locations;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>respond to reasonable inquires by Buyers and its representatives regarding Seller;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>cause Seller to furnish Buyers and its representatives with all information and copies of all documents concerning Seller
that Buyers and its representatives reasonably request; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>otherwise cooperate with Buyers in its due diligence activities.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Developments</U>. Pending Closing, Seller shall promptly give Notice to Buyers of:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any fact or circumstance of which Seller becomes aware that causes or constitutes a material inaccuracy in or material breach
of any of Seller&rsquo;s representations and warranties in Article 6 as of the date of this Agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any fact or circumstance of which Seller becomes aware that would cause or constitute a material inaccuracy in or material
breach of any of Seller&rsquo;s representations and warranties in Article 6 if those representations and warranties were made on
and as of the date of occurrence or discovery of the fact or circumstance; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the occurrence of any event of which Seller becomes aware that reasonably could be expected to make satisfaction of any
Buyers Closing Condition impossible or unlikely.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Supplements to Schedules</U>. Pending Closing, Seller may supplement or correct the Schedules to this Agreement as necessary
to ensure their completeness and accuracy. No supplement or correction to any Schedule or Schedules to this Agreement shall be
effective, however, to cure any breach or inaccuracy in any of the representations and warranties; but if Buyers does not exercise
its right to terminate this Agreement under Section 12 and closes the transaction, the supplement or correction shall constitute
an amendment of the Schedule or Schedules to which it relates for all purposes of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 34.5pt">9.</TD><TD STYLE="text-align: justify">Buyers Closing Conditions</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Except as provided herein, Buyers&rsquo; obligation
to close the transaction is subject to the satisfaction of each of the following conditions (the &ldquo;Buyers <U>Closing Conditions</U>&rdquo;)
at or prior to Closing:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller&rsquo;s
representations and warranties in Section 6, as qualified or limited by any exceptions in the Schedules to Section 6, are true
and correct on the Closing Date as if made at and as of Closing (other than representations and warranties that address matters
as of a certain date, which were true and correct as of that date);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
has executed and delivered all of the documents and instruments that they are required to execute and deliver or enter into prior
to or at Closing, and have performed, complied with or satisfied in all material respects all of the other obligations, agreements
and conditions under this Agreement that they are required to perform, comply with or satisfy at or prior to Closing, and Seller
shall have delivered to Buyers properly executed and notarized releases (in form and substance acceptable to Buyers, in its sole
and absolute discretion) from any and all third parties from whom waivers, releases and/or approvals are necessary (in Buyers&rsquo;
sole and absolute discretion) to effectuate the transfer of the Assets to Buyers free and clear of any and all third party interests,
claims, liens or security interests;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no
material adverse change in the Seller&rsquo;s assets, financial condition, operations, operating results or prospects has occurred
since the date of this Agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no
suit has been initiated or threatened by a third party that challenges or seeks damages or other relief in connection with the
transaction or that could have the effect of preventing, delaying, making illegal or otherwise interfering with the transaction;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Seller has obtained and delivered to Buyers all consents listed in Sections 6(c) and 6(i); except that, Buyers hereby agree
that if Seller is unable to obtain consent to the assignment of all or some of the Leases prior to the Closing Date, that this
will not be deemed a Closing Condition or grounds for delaying the Closing, and instead, nevertheless, Seller will be obligated
to provide consent to the assignment of any such Leases as soon as practicable after the Closing Date. If Seller is unable to obtain
the consent to the assignment of any Lease, the Parties agree that they will work in good faith with the lessor of any such Lease
to enter an alternative arrangement, such as a sublease agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
has obtained or started the process of obtaining consents to the assignment of, and estoppel letters under, the leases attached
hereto as <B><U>Schedule (1)(b)(vi)</U></B>, relating to the premises of the Subject Locations, in a form reasonably acceptable
to Buyers. Any fees born by the assignment of the Subject Location will be split in equal share between Buyer and Seller. and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
has delivered payoff letters and releases of security interests or liens from any secured lenders or lessors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Buyers may waive any condition specified in
this Section 9 by a written waiver delivered to Seller at any time prior to or at Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 30pt">10.</TD><TD STYLE="text-align: justify">Seller&rsquo;s Closing Conditions</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Seller&rsquo;s obligation to close the transaction
is subject to the satisfaction of each of the following conditions (the &ldquo;Seller Closing Conditions&rdquo;) at or prior to
Closing:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers&rsquo;
representations and warranties in Section 7 were true and correct as of the date of this Agreement and are true and correct on
the Closing Date as if made at and as of Closing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as provided in last paragraph of Section 1(b), Buyers shall execute a management agreement and a medical direction agreement with
the New PC for all of the Subject Locations on or before the Closing Date, and ensure that the New PC has filed the necessary documents
with the appropriate state agencies (including but not limited to, the Illinois Department of Financial and Professional Regulation
(&ldquo;IDFPR&rdquo;)) to assume the responsibilities as the new owner of the Practices at the Subject Locations;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
have executed and delivered all of the documents and instruments that they are required to execute and deliver or enter into prior
to or at Closing (including copies of the documents required in (b) above), and has performed, complied with or satisfied in all
material respects all of the other obligations, agreements and conditions under this Agreement that they are required to perform,
comply with or satisfy prior to or at Closing;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no
suit has been initiated or threatened by a third party since the date of this Agreement that challenges or seeks damages or other
relief in connection with the transaction or that could seeks to prevent the transaction;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
have executed The Joint Corp.&rsquo;s current form of Franchise Agreement for each of the Subject Locations; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
have identified a New PC and execute the documents necessary to transfer the Practices at the Subject Location to the New PC at
the Closing, or within a reasonably time after the Closing Date .</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Seller may waive any condition specified in
this Section 10 by a written waiver delivered to Buyers at any time prior to or at Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD STYLE="text-align: justify"><B>Reserved.</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">12.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Termination</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be terminated by Buyers, upon notice to Seller, if prior to or at Closing:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
defaults in the performance of any of its material obligations under this Agreement and the default is not cured within five business
days after Buyers give notice of the default to Seller; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Buyers Closing Condition is not satisfied as of January 6, 2017, or satisfaction of any Buyers Closing Condition is or becomes
impossible (other than as a result of Buyers&rsquo; breach of or failure to perform its obligations under this Agreement), and
Buyers do not waive satisfaction of the condition; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closing
does not occur on or before January 6, 2017 (other than as a result of Buyers&rsquo; breach of or failure to perform its obligations
under this Agreement).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be terminated by Seller, upon notice to Buyers, if prior to or at Closing:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
default in the performance of any of their material obligations under this Agreement and the default is not cured within five Business
Days after Seller gives notice of the default to Buyers;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Seller Closing Condition is not satisfied as of January 6, 2017, or satisfaction of any Seller Closing Condition is or becomes
impossible (other than as a result of Seller&rsquo;s breach of or failure to perform its obligations under this Agreement) and
Seller does not waive satisfaction of the condition; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closing
has not occurred by January 6, 2017 (other than as a result of Seller&rsquo;s breach of or failure to perform their obligations
under this Agreement); or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be terminated by the written agreement of the parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
right of termination under this Section 12 is in addition to any other rights that a party may have under this Agreement or otherwise,
and a party&rsquo;s exercise of its right of termination shall not be considered an election of remedies. Notwithstanding the termination
of this Agreement pursuant to this Section 12, the parties&rsquo; confidentiality obligations under Section 11(g) shall survive
termination and continue indefinitely.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification
of Buyers</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to Sections 15 and 16, Seller agrees to indemnify Buyers against and hold Buyers harmless from:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
loss, liability, damage, cost or expense, including reasonable attorneys&rsquo; fees and cost of investigation (&ldquo;Loss&rdquo;)
that Buyers may suffer or incur that is caused by, arises out of or relates to any inaccuracy in or breach of any representation
and warranty by Seller in Section 6 of this Agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Loss that Buyers may suffer or incur that is caused by, arises out of or relates to Seller&rsquo;s breach of or failure to perform
any of its obligations in this Agreement in any material respect; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iii) &#9;any Loss that Buyers may
suffer or incur that is caused by, arises out of or relates to the assertion against Buyers of an Excluded Liability.&#9;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Claims asserted by Buyers under subsections (i),
(ii) and (iii) above are hereinafter referred to as Buyers&rsquo; &ldquo;<U>Indemnification Claim(s)</U>.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
benefit of the indemnification obligations of Seller under this Section 13 shall extend to the respective officers, directors,
employees and agents of Buyers and its affiliates.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">14.<FONT STYLE="font-weight: normal">&#9;&#9;</FONT>Indemnification
of Seller</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to Sections 15 and 16, Buyers agrees to indemnify Seller and hold Seller harmless from:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Loss that Seller may suffer or incur that is caused by, arises out of or relates to any inaccuracy in or breach of any representation
and warranty by Buyers in Section 7 of this Agreement;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Loss that Seller may suffer or incur that is caused by, arises out of or relates to Buyers&rsquo; breach of or failure to perform
any of its obligations in this Agreement in any material respect; or</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
Loss that Seller may suffer or incur that is caused by, arises out of or relates to Buyers&rsquo; operation of the Continuing Franchise
after Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">Claims asserted by Sellers under subsections (i),
(ii) and (iii) above are hereinafter referred to as Seller&rsquo;s <U>Indemnification Claim(s)</U>.&rdquo;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 40.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 40.5pt; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
benefit of Buyers&rsquo; indemnification obligation under this Section 14 shall extend to the heirs and legal representatives of
Seller.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">15.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Reserved</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Survival</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Indemnification Claim under Sections 13(a)(i) and 14(a)(i) may be asserted at any time prior to the second anniversary of the Closing
Date, with the exception that:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
Indemnification Claim under Section 13(a)(i) in respect of any inaccuracy in or breach of any of the representations and warranties
in Section 6(d) (&ldquo;Taxes&rdquo;) may be asserted at any time prior to the expiration of the applicable statute of limitation;
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
Indemnification Claim under Section 13(a)(i) in respect of any inaccuracy in or breach of any of the representations and warranties
in Sections 6(b) (&ldquo;Authority&rdquo;) and 6(e) (&ldquo;Title to and Condition of Assets&rdquo;), may be asserted at any time
without limit, but only as to Indemnification Claims related to title to Assets, not condition of Assets.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Indemnification Claim under Sections 13(a)(ii) and (iii) and Sections 14(a)(ii) and (iii) may be asserted at any time without limit.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">17.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notice
of Indemnification Claim</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
indemnified party may assert an Indemnification Claim by giving written notice of the Indemnification Claim to the indemnifying
party. The indemnified party&rsquo;s notice shall provide reasonable detail of the facts giving rise to the Indemnification Claim
and a statement of the indemnified party&rsquo;s Loss or an estimate of the Loss that the indemnified party reasonably anticipates
that it will suffer. The indemnified party may amend or supplement its Indemnification Claim at any time, and more than once, by
written notice to the indemnifying party.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
or to the extent that the Indemnification Claim is not in respect of a Third Party Suit, Section 18 shall apply. If or to the extent
that the Indemnification Claim is in respect of a Third Party Suit, Section 19 shall apply.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">18.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Resolution
of Claims</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the indemnifying party does not object to an Indemnification Claim during the 30-day period following receipt of the indemnified
party&rsquo;s notice of its Indemnification Claim, the indemnified party&rsquo;s Indemnification Claim shall be considered undisputed,
and the indemnified party shall be entitled to recover the actual amount of its indemnifiable loss from the indemnifying party.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the indemnifying party gives notice to the indemnified party within the 30-day objection period that the indemnifying party objects
to the indemnified party&rsquo;s Indemnification Claim, the indemnifying party and the indemnified party shall attempt in good
faith to resolve their differences during the 30-day period following the indemnified party&rsquo;s receipt of the indemnifying
party&rsquo;s notice of its objection. If they fail to resolve their disagreement during this 30-day period, either of them may
unilaterally submit the disputed Indemnification Claim for non-binding arbitration before the American Arbitration Association
in Phoenix, Arizona in accordance with its rules for commercial arbitration in effect at the time, which shall be a condition precedent
to seeking resolution of the disputed Indemnification Claim before any court of competent jurisdiction. The award of the arbitrator
or panel of arbitrators may include attorneys&rsquo; fees to the prevailing party. The prevailing party may enforce the award of
the arbitrator or panel of arbitrators in any court of competent jurisdiction.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">19.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Third
Party Suits</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
shall promptly give notice to Seller of any suit, demand, or claim by a third person against Buyers, for which Buyers is entitled
to indemnification under Section 13(a) (a &ldquo;Third Party Suit&rdquo;), which may be given by notice of an Indemnification Claim
in respect of the Third Party Suit. Buyers&rsquo; failure or delay in giving this notice shall not relieve Seller from their indemnification
obligation under this Section 19(a) in respect of the Third Party Suit, except to the extent that Seller suffer or incur a loss
or are prejudiced by reason of Buyers&rsquo; failure or delay.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers
shall control the defense of any Third Party Suit. Seller shall be entitled to copies of all pleadings and, at their expense, may
participate in, but not control, the defense and employ their own counsel. Seller shall in any event reasonably cooperate in the
defense of the Third Party Suit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers&rsquo;
settlement of a Third Party Suit shall also be binding on Seller, in the same manner as if a final judgment in the amount of the
settlement had been entered by a court of competent jurisdiction, if, as part of the settlement, Seller receives a binding release
providing that any liability of Seller in respect of the Third Party Suit is being satisfied as part of the settlement. Buyers
shall give Seller at least 30 days&rsquo; prior notice of any proposed settlement, and during this 30-day period Seller may reject
the proposed settlement and instead assume the defense of the Third Party Suit if:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Third Party Suit seeks only money damages and does not seek injunctive or other equitable relief against Buyers;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
unconditionally acknowledges in writing to Buyers that Seller is obligated to indemnify Buyers in full in respect of the Third
Party Suit (except for any matters that are not subject to indemnification under this Agreement);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
counsel chosen by Seller to defend the Third Party Suit is reasonably satisfactory to Buyers;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
furnishes Buyers with security reasonably satisfactory to Buyers to assure that Seller has the financial resources to defend the
Third Party Suit and to satisfy their indemnification obligation in respect of the Third Party Suit;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 44.65pt; margin: 0pt 0 0pt 27.35pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 44.65pt; margin: 0pt 0 0pt 27.35pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
actively and diligently defends the Third Party Suit; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
consults with Buyers regarding the Third Party Suit at Buyers&rsquo; reasonable request.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If Seller assumes the defense of the Third Party
Suit, Buyers shall be entitled to copies of all pleadings and, at its expense, may participate in, but not control, the defense
and employ its own counsel.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
may settle a Third Party Suit in which, Seller controls the defense only if the following conditions are satisfied:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
terms of settlement do not require any admission by Seller or Buyers, in respect of any matters subject to indemnification under
Sections 13 or 14 of this Agreement, that in Buyers&rsquo; reasonable judgment would have an adverse effect on Buyers; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0 0pt 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
part of the settlement, Buyers receives a binding release providing that any liability of Buyers in respect of the Third Party
Suit is being satisfied as part of the settlement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyers&rsquo;
failure to defend a Third Party Suit shall not relieve Seller of their indemnification obligation under Section 13 of this Agreement
if Buyers gives Seller at least 30 days&rsquo; prior notice of Buyers&rsquo; intention not to defend the Third Party Suit and affords
Seller the opportunity to assume the defense without having to satisfy the conditions in Section 18(c) for assuming the defense.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">20.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Expenses</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each party shall pay its own expenses in connection
with the negotiation and preparation of this Agreement and the closing of the Transaction. In the event of termination of this
Agreement prior to Closing pursuant to Section 12, each party&rsquo;s obligation to pay its own expenses shall be subject to any
right of recovery as a result of a default under this Agreement by the other party.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">21.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Schedules</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Nothing in any Schedule to Section 6 shall be
considered adequate to constitute an exception to the related representation and warranty in Section 6 unless the Schedule describes
the relevant facts in reasonable detail. Any exception in a Schedule to Section 6 shall be considered an exception to any other
representation and warranty in Section 6 to which the exception relates if it is reasonably apparent on its face that the exception
in question relates to such other representation and warranty.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">22.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Parties&rsquo;
Review</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any knowledge acquired by a party (or that should
have been or could have been acquired) as a result of any due diligence or other review or investigation in connection with the
negotiation and execution of this Agreement and the closing of the transaction shall not limit that party&rsquo;s right to rely
on the other party&rsquo;s representations and warranties in this Agreement or circumscribe that party&rsquo;s entitlement to indemnification
under this Agreement.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">23.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Publicity</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any public announcement or similar publicity
regarding this Agreement or the transaction shall be issued only as, when and in the manner and form that Buyers determines.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">24.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notices</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
notices under this Agreement shall be in writing and sent by certified or registered mail, overnight messenger service, facsimile
or personal delivery, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">(i)&#9;if to Buyers:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 4%">Fax:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 22%">&nbsp;</TD>
    <TD STYLE="width: 56%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">with a required copy to:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 4%">Fax:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 22%">&nbsp;</TD>
    <TD STYLE="width: 56%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD NOWRAP>Attention:&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 2in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
to Seller, to:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">The Joint Corp.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">16767 N. Perimeter Dr. Suite 240</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Scottsdale, AZ 85260</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Fax: (480) 245-5960</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Attention: Mr.
Peter Holt</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 22%">&nbsp;</TD>
    <TD STYLE="width: 56%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 2in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 2in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 2in"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27pt; margin: 0pt 0 0pt 27.35pt">with a required copy to:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 4%">Fax:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 22%">&nbsp;</TD>
    <TD STYLE="width: 56%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD NOWRAP>Attention:&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 3.75in"></P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
notice sent by certified or registered mail shall be considered to have been given five business days after being deposited in
the mail. A notice sent by overnight courier service, facsimile or personal delivery shall be considered to have been given when
actually received by the intended recipient. A party may change its address for purposes of this Agreement by notice in accordance
with this Section 24.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">25.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Further
Assurances and Cooperation</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
parties agree to (i) furnish to one another other such further information, (ii) execute and deliver to one another such further
documents and (iii) do such other acts and things that any party reasonably requests for the purpose of carrying out the intent
of this Agreement and the documents and instruments referred to in this Agreement. For 45 days following the Closing, Seller shall
provide to Buyers such assistances as Buyers reasonably requests to help ensure a smooth and orderly transition of ownership of
the Subject Locations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
parties acknowledge that Seller may be required by applicable laws and regulations to include financial statements and information
relating to the Subject Locations in Seller&rsquo;s financial statements. Accordingly, the Buyers agree to cooperate with Seller
and to provide it with any information reasonably available to the Buyers to assist Seller in complying with its obligations under
such applicable laws and regulations.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">26.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Waiver</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The failure or any delay by any party in exercising
any right under this Agreement or any document referred to in this Agreement shall not operate as a waiver of that right, and no
single or partial exercise of any right shall preclude any other or further exercise of that right or the exercise of any other
right. All waivers shall be in writing and signed by the party to be charged with the waiver, and no waiver that may be given by
a party shall be applicable except in the specific instance for which it is given.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">27.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Entire
Agreement</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement supersedes all prior agreements
between the parties with respect to its subject matter and constitutes (together with (i) the Schedules, (ii) the Schedules and
(iii) the parties&rsquo; Closing Documents) a complete and exclusive statement of the terms of the agreement between the parties
with respect to its subject matter. This Agreement may not be amended except by a written agreement signed by the party to be charged
with the amendment.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">28.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Assignment</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No party may assign any of its rights under
this Agreement without the prior written consent of the other party.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">29.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
Third Party Beneficiaries</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Nothing in this Agreement shall be considered
to give any person other than the parties any legal or equitable right, claim or remedy under or in respect of this Agreement or
any provision of this Agreement. This Agreement and all of its provisions are for the sole and exclusive benefit of the parties
and their respective successors, permitted assigns, heirs and legal representatives.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">30.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Construction</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
references in this Agreement to &ldquo;Section&rdquo; or &ldquo;Sections&rdquo; refer to the corresponding section or sections
of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
words used in this Agreement shall be construed to be of the appropriate gender or number as the context requires.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise expressly provided, the word &ldquo;including&rdquo; does not limit the preceding words or terms.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
captions of articles and sections of this Agreement are for convenience only and shall not affect the construction or interpretation
of this Agreement.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">31.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Severability</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The invalidity or unenforceability of any term
or provision, or part of any term or provision, of this Agreement shall not affect the validity and enforceability of the other
terms and provisions of this Agreement, and this Agreement shall be construed in all respects as if the invalid or unenforceable
term or provision, or part, had been omitted. In the event that any provision of this Agreement is determined by a court of competent
jurisdiction to be unenforceable because it is too broad, such provision shall be interpreted to be only as broad as is enforceable.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">32.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Counterparts</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement may be signed in any number of
counterparts (including by facsimile or portable document format (pdf)), all of which together shall constitute one and the same
instrument.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">33.<FONT STYLE="font-weight: normal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Governing
Law</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement shall be governed by the internal
Laws of the State of Arizona, without giving effect to any choice of law provision or rule (whether of the State of Arizona or
any other state) that would cause the laws of any state other than the State of Arizona to govern this Agreement.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; margin: 0pt 0 0pt 0.5in">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Binding
Effect</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Agreement shall apply to, be binding in
all respects upon and inure to the benefit of parties and their respective heirs, legal representatives, successors and permitted
assigns.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>(signatures appear on the next page)</I></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I></I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I></I></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">IN WITNESS WHEREOF, the Parties hereto affix their
signatures and execute this Agreement as of the day and year first above written.</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>SELLER:</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>The Joint Corp.</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 8%">By:&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid">/s/ Peter Holt</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 10pt">Peter Holt</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 10pt">As its Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>BUYERS:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Don Daniels</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">Don Daniels, Individually</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Larry Maddalena</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">Larry Maddalena, Individually</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Jody O&rsquo;Donnell</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">Jody O&rsquo;Donnell, Individually </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>Signature Page to Asset Purchase Agreement</I></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"><I></I></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B><U>Schedule 1(b)(i)</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Personal Property</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All furnishings, store fixtures, chiropractic
equipment, computers, all section bamboo with hardware, mission statement with hardware, all adjustment tables, all front desk
pendant lights, baskets below tables for personal belongings, rail lighting directed at bamboo ring panels, all large adjusting
bay pendants, all telescoping art lights, restroom sconce light fixture, large dish pendant, lights if exposed ceiling (quantity
varies), lobby floor lamp, lobby furniture, chairs, sofa, end tables, coffee table, <B>water cooler (could be rented),</B> adjusting
bay furniture (all jump chairs), artificial trees / plants, computer package: all computers, CC swiper, keytag scanner, all-in-one
printer/scanner, Warhol flower prints (all), Abstract Figure art print (all), IKEA Framsta Panel wall OR Profile Panels, 1 sections
of glass upper cabinets (behind reception wall), 1 sections of lower cabinets (behind reception wall), Take5 with hardware, back
computer wall mount, A-Frame, T-Stand, Front Desk, front desk chair, miscellaneous cleaning supplies, miscellaneous clinic items
- ice packs, stress balls, extra apparel, paperwork, price sheets, membership packets, clipboards, etc., and any and all other
Assets considered pertinent to doing business as a &ldquo;The Joint&hellip;the chiropractic place&rdquo;.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B><U>Schedule (1)(b)(vii)</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Assumed Contracts</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">NONE</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B><U>Schedule (2)</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Excluded Assets</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">NONE</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B><U>Schedule 6(c)</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Required Consents or Approvals</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B><U>Clinic Location Name</U></B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><B><U>Clinic Location Number</U></B></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in"><B><U>Requirements</U></B></TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Schaumburg</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21003</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Landlord 30 day notice required.&nbsp;&nbsp;Fee of $500.&nbsp;&nbsp;Assignor remains liable.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Glenview</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21004</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Landlord 30 day notice required.&nbsp;&nbsp;&nbsp;&nbsp;Assignor remains liable. $2500 fee.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Elston and Logan</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21005</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Landlord 30 day notice required.&nbsp;&nbsp;&nbsp;&nbsp;Assignor remains liable.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Glen Pointe</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21009</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Landlord 30 day notice required.&nbsp;&nbsp;&nbsp;&nbsp;Assignor remains liable.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Wheaton</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21013</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">Assignor must request Landlord's approval of Transfer.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left; text-indent: 0in"><B>Downers Grove</B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">21014</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: left; text-indent: 0in">No consent required.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assignor remains liable. Should Assignor wish to be released from liability, financial documents from Assignee must be submitted to Landlord for release.</TD>
    <TD STYLE="text-align: justify; text-indent: 0.5in">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B><U>Schedule 6(i)</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>Consents for Assumed Contracts</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">NONE</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>exh_992.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: right; text-indent: 0in; margin: 0pt 0"><B>Exhibit 99.2</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>ASSIGNMENT AND ASSUMPTION AGREEMENT</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">This Assignment and Assumption Agreement
(&ldquo;Agreement&rdquo;) is made and entered into this  24th day of February, 2017 (&ldquo;the Effective Date&rdquo;), by
and between, <B>The Joint Corp.</B>, a Delaware corporation (&ldquo;Company&rdquo;) and <B>Don Daniels, Larry Maddalena and
Jody O'Donnell</B> (collectively referred to hereafter as the &ldquo;Assignors&rdquo;), and <B>Porter Partners, LLC</B>, a
Texas limited liability company (&ldquo;Assignee&rdquo;).</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">Background:</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WHEREAS, Company and Assignors entered an Asset Purchase Agreement, dated January 6, 2017 (&ldquo;APA&rdquo;);</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WHEREAS, Paragraph 28 of the APA allows for assignment of the APA only with the prior written consent of the non-assigning
party;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WHEREAS, Assignors desire to assign their rights and interest under the APA to Assignee; and</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0.5in; margin: 0pt 0">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WHEREAS, Company is willing to consent to the assignment of the APA from Assignors to Assignee upon the terms and conditions
of this Agreement;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0">Agreement:</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">NOW, THEREFORE, in consideration of the mutual
agreements, covenants and undertakings herein contained and other valuable consideration, the adequacy of which is acknowledged
by all parties, the parties hereby agree as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><I>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right
to Assign APA</I>. Assignors hereby covenant and warrant that they have the right to transfer all rights under the APA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Assignment
and Assumption</I>. Assignors hereby assign, transfer, and delegate unto Assignee all of Assignors&rsquo; right, title, and interest
in and to the APA (the &ldquo;<U>Assignment</U>&rdquo;). Assignee hereby accepts the Assignment and hereby assumes all such right,
title, and interest in and to the APA attached as <U>Exhibit A</U>, and any addenda or amendments relating thereto, including,
but not limited to, all of the rights and obligations of Assignors.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Consent
and Approval by Company</I>. Company hereby approves of, and consents to, the Assignment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Assignment Fee</I>. No fee is required by Company in connection with this Assignment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnity</I>.
Assignors and Assignee hereby agree to defend, indemnify, and hold Company harmless from and against any and all claims, demands,
costs, attorneys&rsquo; fees, or any other damages or injuries that Company may sustain as a result of any dispute or any kinds
arising in connection with this Assignment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Assignment and Assumption Agreement (APA)</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Waiver</I>. Company&rsquo;s approval
of the Assignment shall no way limit, waive, or alter any of Company&rsquo;s rights under the APA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Entire Agreement</I>. This Agreement supersedes
any prior or contemporaneous agreement, oral or written, with respect to the subject matter hereof. No representations, warranties,
agreements, or covenants have been made with respect to the subject matter hereof by any party hereto other than those set forth
herein, and the parties hereto shall not rely upon any representation, warranty, agreement, or covenant with respect to the subject
matter hereof other than those set forth herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 27.35pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Further Assurances</I>. Each
party hereto shall promptly do, execute, and deliver (or cause to be done, executed, and delivered) all further acts, documents,
and things in connection with this Agreement that any party may reasonably require for the purpose of giving effect to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governing
Law</I>. This Agreement shall in all respects be interpreted, enforced, and governed by the laws of the State of Arizona.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
other changes</I>. All other terms and conditions of the APA shall remain the same.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: 0in; margin: 0pt 0"><I>[Signatures on Next Pages]</I></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Assignment and Assumption Agreement (APA)</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 22.5pt; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the parties hereto
have executed this Agreement as of the Effective Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 22.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>COMPANY:</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>THE JOINT CORP.</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 8%">By:&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid">/s/ Peter Holt</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 10pt">Peter Holt</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="text-indent: 10pt">As its Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>ASSIGNORS:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Don Daniels</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>Don Daniels, Individually</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Larry Maddalena</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>Larry Maddalena, Individually</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Jody O&rsquo;Donnell</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>Jody O&rsquo;Donnell, Individually </B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>ASSIGNEE:</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2"><B>PORTER PARTNERS, LLC</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Jody O&rsquo;Donnell</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD NOWRAP>Print Name:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Its:&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B></B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Assignment and Assumption Agreement (APA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">- 3 -</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>jynt-20161231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:39PM UTC 2017-03-10--><xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:jynt="http://www.thejoint.com/20161231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:href="jynt-20161231.xsd" xlink:type="simple"/>
  <dei:AmendmentFlag contextRef="d_2016-01-01_2016-12-31" id="c-15">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="d_2016-01-01_2016-12-31" id="c-4">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="d_2016-01-01_2016-12-31" id="c-14">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="d_2016-01-01_2016-12-31" id="c-13">2016</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate contextRef="d_2016-01-01_2016-12-31" id="c-12">2016-12-31</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="d_2016-01-01_2016-12-31" id="c-11">10-K</dei:DocumentType>
  <dei:EntityCentralIndexKey contextRef="d_2016-01-01_2016-12-31" id="c-2">0001612630</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding contextRef="i_2017-03-01" decimals="INF" id="c-9" unitRef="xbrli-shares">13054531</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="d_2016-01-01_2016-12-31" id="c-6">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="d_2016-01-01_2016-12-31" id="c-5">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityPublicFloat contextRef="i_2016-06-30" decimals="-5" id="c-10" unitRef="iso4217-usd">21200000</dei:EntityPublicFloat>
  <dei:EntityRegistrantName contextRef="d_2016-01-01_2016-12-31" id="c-1">JOINT Corp</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers contextRef="d_2016-01-01_2016-12-31" id="c-7">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer contextRef="d_2016-01-01_2016-12-31" id="c-8">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:TradingSymbol contextRef="d_2016-01-01_2016-12-31" id="c-3">jynt</dei:TradingSymbol>
  <jynt:AdditionalLeasesAssumed contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652900" unitRef="xbrli-pure">16</jynt:AdditionalLeasesAssumed>
  <jynt:AdvertisingFundPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699106">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Fund&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:AdvertisingFundPolicyTextBlock>
  <jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment contextRef="i_2016-12-31" decimals="INF" id="c14652833" unitRef="iso4217-usd">630900</jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment>
  <jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment contextRef="i_2015-12-31" decimals="INF" id="c14652834" unitRef="iso4217-usd">167500</jynt:AssetBasisDifferenceRelatedToPropertyAndEquipment>
  <jynt:BinomialLatticeBasedModelFairValueSharePrice contextRef="i_2016-12-31" decimals="INF" id="c14652626" unitRef="iso4217-usd-per-xbrli-shares">1.03</jynt:BinomialLatticeBasedModelFairValueSharePrice>
  <jynt:BinomialLatticeBasedModelFairValueTotal contextRef="i_2016-12-31" decimals="INF" id="c14652627" unitRef="iso4217-usd">551638</jynt:BinomialLatticeBasedModelFairValueTotal>
  <jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652290" unitRef="iso4217-usd">997450</jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts>
  <jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652314" unitRef="iso4217-usd">5213875</jynt:BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651958" unitRef="iso4217-usd">140728</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651970" unitRef="iso4217-usd">521825</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652368" unitRef="iso4217-usd">140728</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652375" unitRef="iso4217-usd">528075</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment contextRef="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14651991" unitRef="iso4217-usd">6250</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment contextRef="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14651990" unitRef="iso4217-usd">4820</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment contextRef="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14651989" unitRef="iso4217-usd">-53836</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651971" unitRef="iso4217-usd">49077</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652378" unitRef="iso4217-usd">74927</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases>
  <jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment contextRef="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14651993" unitRef="iso4217-usd">25850</jynt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment>
  <jynt:CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14655768" unitRef="iso4217-usd">2800000</jynt:CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses>
  <jynt:ClassOfWarrantOrRightIssuedDuringPeriod contextRef="d_2014-11-14_2014-11-14" decimals="INF" id="c14652633" unitRef="xbrli-shares">90000</jynt:ClassOfWarrantOrRightIssuedDuringPeriod>
  <jynt:ClassOfWarrantsOrRightsOutstandingRemainingContractualLife contextRef="d_2016-01-01_2016-12-31" id="c14652641">P1Y328D</jynt:ClassOfWarrantsOrRightsOutstandingRemainingContractualLife>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652241" unitRef="xbrli-pure">6</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652242" unitRef="xbrli-pure">24</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652251" unitRef="xbrli-pure">6</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsAcquiredDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652252" unitRef="xbrli-pure">24</jynt:ClinicsAcquiredDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652243" unitRef="xbrli-pure">6</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652244" unitRef="xbrli-pure">7</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" id="c14652253" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:ClinicsClosedDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652254" unitRef="xbrli-pure">2</jynt:ClinicsClosedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652239" unitRef="xbrli-pure">56</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652240" unitRef="xbrli-pure">54</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652249" unitRef="xbrli-pure">8</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsOpenedDuringThePeriod contextRef="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652250" unitRef="xbrli-pure">21</jynt:ClinicsOpenedDuringThePeriod>
  <jynt:ClinicsSoldButNotYetOperational contextRef="i_2016-12-31" decimals="INF" id="c14652259" unitRef="xbrli-pure">115</jynt:ClinicsSoldButNotYetOperational>
  <jynt:ClinicsSoldButNotYetOperational contextRef="i_2015-12-31" decimals="INF" id="c14652260" unitRef="xbrli-pure">168</jynt:ClinicsSoldButNotYetOperational>
  <jynt:CoOpFundsLiabilityCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651602" unitRef="iso4217-usd">73246</jynt:CoOpFundsLiabilityCurrent>
  <jynt:CoOpFundsLiabilityCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651603" unitRef="iso4217-usd">201078</jynt:CoOpFundsLiabilityCurrent>
  <jynt:DeferredFranchiseCosts contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652289" unitRef="iso4217-usd">1450</jynt:DeferredFranchiseCosts>
  <jynt:DeferredFranchiseCosts contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652313" unitRef="iso4217-usd">493500</jynt:DeferredFranchiseCosts>
  <jynt:DeferredFranchiseCostsCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651576" unitRef="iso4217-usd">748300</jynt:DeferredFranchiseCostsCurrent>
  <jynt:DeferredFranchiseCostsCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651577" unitRef="iso4217-usd">605850</jynt:DeferredFranchiseCostsCurrent>
  <jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651963" unitRef="iso4217-usd">1450</jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice>
  <jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651977" unitRef="iso4217-usd">493500</jynt:DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice>
  <jynt:DeferredFranchiseCostsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651586" unitRef="iso4217-usd">836350</jynt:DeferredFranchiseCostsNoncurrent>
  <jynt:DeferredFranchiseCostsNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651587" unitRef="iso4217-usd">1534700</jynt:DeferredFranchiseCostsNoncurrent>
  <jynt:DeferredTaxAssetDeferredRentCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652823" unitRef="iso4217-usd">629600</jynt:DeferredTaxAssetDeferredRentCurrent>
  <jynt:DeferredTaxAssetDeferredRentCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652824" unitRef="iso4217-usd">209700</jynt:DeferredTaxAssetDeferredRentCurrent>
  <jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14652827" unitRef="iso4217-usd">8924800</jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent>
  <jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14652828" unitRef="iso4217-usd">1849100</jynt:DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent>
  <jynt:DeferredTaxAssetRestrictedStockCompensationCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652819" unitRef="iso4217-usd">-30800</jynt:DeferredTaxAssetRestrictedStockCompensationCurrent>
  <jynt:DeferredTaxAssetRestrictedStockCompensationCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652820" unitRef="iso4217-usd">-44100</jynt:DeferredTaxAssetRestrictedStockCompensationCurrent>
  <jynt:DeferredTaxAssetsAccruedExpensesCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652813" unitRef="iso4217-usd">57400</jynt:DeferredTaxAssetsAccruedExpensesCurrent>
  <jynt:DeferredTaxAssetsAccruedExpensesCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652814" unitRef="iso4217-usd">74900</jynt:DeferredTaxAssetsAccruedExpensesCurrent>
  <jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652811" unitRef="iso4217-usd">51400</jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent>
  <jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652812" unitRef="iso4217-usd">1781000</jynt:DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent>
  <jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652831" unitRef="iso4217-usd">6500</jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent>
  <jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652832" unitRef="iso4217-usd">1300</jynt:DeferredTaxAssetsCharitableContributionCarryoverCurrent>
  <jynt:DeferredTaxAssetsFranchiseCosts contextRef="i_2016-12-31" decimals="INF" id="c14652809" unitRef="iso4217-usd">-553900</jynt:DeferredTaxAssetsFranchiseCosts>
  <jynt:DeferredTaxAssetsFranchiseCosts contextRef="i_2015-12-31" decimals="INF" id="c14652810" unitRef="iso4217-usd">-664000</jynt:DeferredTaxAssetsFranchiseCosts>
  <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="i_2016-12-31" decimals="INF" id="c14652815" unitRef="iso4217-usd">-120700</jynt:DeferredTaxAssetsGoodwillComponent1>
  <jynt:DeferredTaxAssetsGoodwillComponent1 contextRef="i_2015-12-31" id="c14652816" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="i_2016-12-31" decimals="INF" id="c14652817" unitRef="iso4217-usd">86800</jynt:DeferredTaxAssetsGoodwillComponent2>
  <jynt:DeferredTaxAssetsGoodwillComponent2 contextRef="i_2015-12-31" decimals="INF" id="c14652818" unitRef="iso4217-usd">87000</jynt:DeferredTaxAssetsGoodwillComponent2>
  <jynt:DeferredTaxAssetsLeaseAbandonment contextRef="i_2016-12-31" decimals="INF" id="c14652825" unitRef="iso4217-usd">108900</jynt:DeferredTaxAssetsLeaseAbandonment>
  <jynt:DeferredTaxAssetsLeaseAbandonment contextRef="i_2015-12-31" id="c14652826" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14652821" unitRef="iso4217-usd">182100</jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent>
  <jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14652822" unitRef="iso4217-usd">109600</jynt:DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent>
  <jynt:DeferredTaxAssetsRevenueCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652807" unitRef="iso4217-usd">1509400</jynt:DeferredTaxAssetsRevenueCurrent>
  <jynt:DeferredTaxAssetsRevenueCurrent contextRef="i_2015-12-31" decimals="INF" id="c14652808" unitRef="iso4217-usd">1988200</jynt:DeferredTaxAssetsRevenueCurrent>
  <jynt:DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf contextRef="i_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653020" unitRef="xbrli-pure">5</jynt:DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf>
  <jynt:DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf contextRef="i_2017-01-06_StatementGeographicalAxis-UpStateNewYorkMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653021" unitRef="xbrli-pure">3</jynt:DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount contextRef="d_2016-01-01_2016-12-31" id="c14652861" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652863" unitRef="iso4217-usd">-80100</jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent contextRef="d_2016-01-01_2016-12-31" id="c14652862" unitRef="xbrli-pure" xs:nil="true"/>
  <jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652864" unitRef="xbrli-pure">-0.0089</jynt:EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent>
  <jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652853" unitRef="iso4217-usd">108800</jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount>
  <jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652855" unitRef="iso4217-usd">-58800</jynt:EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount>
  <jynt:EstimatedCashNeeds contextRef="d_2017-01-01_2017-12-31_StatementScenarioAxis-ScenarioForecastMember" decimals="INF" id="c14655765" unitRef="iso4217-usd">2000000</jynt:EstimatedCashNeeds>
  <jynt:ExcessDeferredRegionalFeesRevenueRecognized contextRef="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c14652486" unitRef="iso4217-usd">254250</jynt:ExcessDeferredRegionalFeesRevenueRecognized>
  <jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652092" unitRef="xbrli-pure">0.02</jynt:FranchiseMonthlyMarketingFeeGrossSalesPercentage>
  <jynt:FranchiseRoyaltyGrossSalesPercentage contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652105" unitRef="xbrli-pure">0.07</jynt:FranchiseRoyaltyGrossSalesPercentage>
  <jynt:ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699116">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;IT Related Income and Software Fees.&lt;/div&gt;&amp;nbsp;&amp;nbsp;The Company collects a monthly computer software fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&amp;#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&amp;nbsp;upon receipt of equipment by the franchisee.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock>
  <jynt:IncreaseDecreaseInCoOpFundsLiability contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651882" unitRef="iso4217-usd">-127832</jynt:IncreaseDecreaseInCoOpFundsLiability>
  <jynt:IncreaseDecreaseInCoOpFundsLiability contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651883" unitRef="iso4217-usd">14474</jynt:IncreaseDecreaseInCoOpFundsLiability>
  <jynt:IncreaseDecreaseInDeferredFranchiseCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651874" unitRef="iso4217-usd">-361600</jynt:IncreaseDecreaseInDeferredFranchiseCosts>
  <jynt:IncreaseDecreaseInDeferredFranchiseCosts contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651875" unitRef="iso4217-usd">-127550</jynt:IncreaseDecreaseInDeferredFranchiseCosts>
  <jynt:LeaseExitLiability contextRef="i_2016-12-31" decimals="INF" id="c14652095" unitRef="iso4217-usd">300000</jynt:LeaseExitLiability>
  <jynt:LeaseExitLiability contextRef="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c14652912" unitRef="iso4217-usd">338000</jynt:LeaseExitLiability>
  <jynt:LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement contextRef="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653005" unitRef="iso4217-usd">200000</jynt:LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement>
  <jynt:ManagementsPlanPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699060">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Management's Plans&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company had cash and short-term bank deposits of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.0&lt;/div&gt; million. To preserve cash, the Company does not plan to add any company-owned or managed clinics during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; fiscal year. Additionally, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company made the decision to close or sell &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics in Chicago and New York. As a result, the Company has significantly reduced its estimated cash needs for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; to approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.0&lt;/div&gt; million. The cash used in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; included expenditures for the acquisition or development of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; company-owned or managed clinics, and the working capital losses in the Chicago and New York markets which amounted to approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.8&lt;/div&gt; million for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; As the Company has no current plans to acquire or develop company-owned or managed clinics during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; and has sold or closed the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics in the Chicago and New York markets, the Company&amp;#x2019;s projected use of cash in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; is significantly lower than the amount of cash used in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; Furthermore, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the Company executed a Credit and Security Agreement which provided a credit facility of up to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5.0&lt;/div&gt; million. Taking into account these tactical decisions made by the Company&amp;#x2019;s management, as well as the execution of the credit facility, the Company has concluded that it can continue as a going concern for at least &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year from the date that the financial statements were available to be issued.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:ManagementsPlanPolicyPolicyTextBlock>
  <jynt:MinimumNumberOfClinicsToBeOpened contextRef="d_2017-01-06_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653015" unitRef="xbrli-pure">30</jynt:MinimumNumberOfClinicsToBeOpened>
  <jynt:NatureOfOperationsPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699059">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Nature of Operations&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Joint Corp., a Delaware corporation, was formed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2010.&lt;/div&gt; Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;242&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;54&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(7&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" margin: 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;21&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;312&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinic licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;168&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:NatureOfOperationsPolicyPolicyTextBlock>
  <jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651847" unitRef="iso4217-usd">342259</jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements>
  <jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651848" unitRef="iso4217-usd">521350</jynt:NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements>
  <jynt:NotesReceivableContractualTerm contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" id="c14652392">P4Y180D</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member" id="c14652402">P2Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingUnsecuredPromissoryNoteMember" id="c14652410">P1Y</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableContractualTerm contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" id="c14652419">P180D</jynt:NotesReceivableContractualTerm>
  <jynt:NotesReceivableInterestRate contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c14652391" unitRef="xbrli-pure">0.06</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableInterestRate contextRef="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingUnsecuredPromissoryNoteMember" decimals="INF" id="c14652409" unitRef="xbrli-pure">0.04</jynt:NotesReceivableInterestRate>
  <jynt:NotesReceivableIssuedForPaymentOfTransferFees contextRef="d_2016-01-01_2016-12-31" id="c14651849" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:NotesReceivableIssuedForPaymentOfTransferFees contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651850" unitRef="iso4217-usd">59850</jynt:NotesReceivableIssuedForPaymentOfTransferFees>
  <jynt:NotesReceivablePrincipalAndInterestTerm contextRef="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" id="c14652394">P3Y180D</jynt:NotesReceivablePrincipalAndInterestTerm>
  <jynt:NumberOfClinicsClassifiedAsHeldForSale contextRef="d_2016-12-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c14652438" unitRef="xbrli-pure">14</jynt:NumberOfClinicsClassifiedAsHeldForSale>
  <jynt:NumberOfClinicsDisposedOf contextRef="d_2017-01-06_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653012" unitRef="xbrli-pure">6</jynt:NumberOfClinicsDisposedOf>
  <jynt:NumberOfClinicsExpectedToOpen contextRef="i_2017-01-06_RangeAxis-MinimumMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653017" unitRef="xbrli-pure">5</jynt:NumberOfClinicsExpectedToOpen>
  <jynt:NumberOfClinicsExpectedToOpen contextRef="i_2017-01-06_RangeAxis-MaximumMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653018" unitRef="xbrli-pure">10</jynt:NumberOfClinicsExpectedToOpen>
  <jynt:NumberOfClinicsInOperation contextRef="i_2017-01-05_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653013" unitRef="xbrli-pure">11</jynt:NumberOfClinicsInOperation>
  <jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652282" unitRef="xbrli-pure">6</jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod>
  <jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652303" unitRef="xbrli-pure">24</jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod>
  <jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-SanDiegoCAMember" decimals="INF" id="c14652323" unitRef="xbrli-pure">2</jynt:NumberOfDevelopedFranchisesReacquiredDuringPeriod>
  <jynt:NumberOfFranchises contextRef="i_2015-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-SixFranchiseesMember" decimals="INF" id="c14652042" unitRef="xbrli-pure">6</jynt:NumberOfFranchises>
  <jynt:NumberOfFranchisesClosed contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652310" unitRef="xbrli-pure">2</jynt:NumberOfFranchisesClosed>
  <jynt:NumberOfLicenseTransferAgreements contextRef="d_2015-07-01_2015-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c14652399" unitRef="xbrli-pure">2</jynt:NumberOfLicenseTransferAgreements>
  <jynt:NumberOfLicenseTransferAgreements contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c14652416" unitRef="xbrli-pure">3</jynt:NumberOfLicenseTransferAgreements>
  <jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652530" unitRef="xbrli-pure">12</jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions>
  <jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652536" unitRef="xbrli-pure">2</jynt:NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions>
  <jynt:NumberOfPCEntities contextRef="i_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-OnePcEntityMember" decimals="INF" id="c14652039" unitRef="xbrli-pure">1</jynt:NumberOfPCEntities>
  <jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652287" unitRef="xbrli-pure">6</jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics>
  <jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652309" unitRef="xbrli-pure">22</jynt:NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics>
  <jynt:NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652311" unitRef="xbrli-pure">35</jynt:NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated>
  <jynt:NumberOfStoresToCloseOrSell contextRef="d_2016-12-01_2016-12-31_StatementGeographicalAxis-ChicagoAndNewYorkMember" decimals="INF" id="c14655763" unitRef="xbrli-pure">14</jynt:NumberOfStoresToCloseOrSell>
  <jynt:NumberOfUndevelopedFranchiseAgreementsTerminated contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c14652911" unitRef="xbrli-pure">5</jynt:NumberOfUndevelopedFranchiseAgreementsTerminated>
  <jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652283" unitRef="xbrli-pure">1</jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod>
  <jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652304" unitRef="xbrli-pure">35</jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod>
  <jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-SanDiegoCAMember" decimals="INF" id="c14652324" unitRef="xbrli-pure">7</jynt:NumberOfUndevelopedFranchisesReacquiredDuringThePeriod>
  <jynt:NumberOfUnsecuredPromissoryNotes contextRef="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c14652417" unitRef="xbrli-pure">3</jynt:NumberOfUnsecuredPromissoryNotes>
  <jynt:OperatingLeaseMonthlyRentExpense contextRef="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember" decimals="INF" id="c14652903" unitRef="iso4217-usd">1917</jynt:OperatingLeaseMonthlyRentExpense>
  <jynt:OperatingLeaseMonthlyRentExpense contextRef="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember" decimals="INF" id="c14652904" unitRef="iso4217-usd">7498</jynt:OperatingLeaseMonthlyRentExpense>
  <jynt:OptionExcercisePriceYearOne contextRef="i_2013-12-31" decimals="INF" id="c14652729" unitRef="iso4217-usd-per-xbrli-shares">0.56</jynt:OptionExcercisePriceYearOne>
  <jynt:OptionExercisePriceYearEight contextRef="i_2013-12-31" decimals="INF" id="c14652736" unitRef="iso4217-usd-per-xbrli-shares">2.45</jynt:OptionExercisePriceYearEight>
  <jynt:OptionExercisePriceYearFive contextRef="i_2013-12-31" decimals="INF" id="c14652733" unitRef="iso4217-usd-per-xbrli-shares">1.28</jynt:OptionExercisePriceYearFive>
  <jynt:OptionExercisePriceYearFour contextRef="i_2013-12-31" decimals="INF" id="c14652732" unitRef="iso4217-usd-per-xbrli-shares">1.03</jynt:OptionExercisePriceYearFour>
  <jynt:OptionExercisePriceYearSeven contextRef="i_2013-12-31" decimals="INF" id="c14652735" unitRef="iso4217-usd-per-xbrli-shares">1.97</jynt:OptionExercisePriceYearSeven>
  <jynt:OptionExercisePriceYearSix contextRef="i_2013-12-31" decimals="INF" id="c14652734" unitRef="iso4217-usd-per-xbrli-shares">1.59</jynt:OptionExercisePriceYearSix>
  <jynt:OptionExercisePriceYearThree contextRef="i_2013-12-31" decimals="INF" id="c14652731" unitRef="iso4217-usd-per-xbrli-shares">0.84</jynt:OptionExercisePriceYearThree>
  <jynt:OptionExercisePriceYearTwo contextRef="i_2013-12-31" decimals="INF" id="c14652730" unitRef="iso4217-usd-per-xbrli-shares">0.68</jynt:OptionExercisePriceYearTwo>
  <jynt:OptionToRepurchaseSharesChangeInFairValue contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14652632" unitRef="iso4217-usd">-259000</jynt:OptionToRepurchaseSharesChangeInFairValue>
  <jynt:PaymentsOfInitialPublicOfferingCosts contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14702121" unitRef="iso4217-usd">1351403</jynt:PaymentsOfInitialPublicOfferingCosts>
  <jynt:PaymentsOfInitialPublicOfferingCosts contextRef="d_2016-01-01_2016-12-31" id="c14651910" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:PaymentsOfInitialPublicOfferingCosts contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651911" unitRef="iso4217-usd">1351403</jynt:PaymentsOfInitialPublicOfferingCosts>
  <jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651897" unitRef="iso4217-usd">325000</jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights>
  <jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651898" unitRef="iso4217-usd">1075500</jynt:ReacquisitionAndTerminationOfRegionalDeveloperRights>
  <jynt:RegionalDeveloperFeesPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699113">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;Regional Developer Fees&lt;/div&gt;. During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2011,&lt;/div&gt; the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,250&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25%&lt;/div&gt; of the then current franchise fee, for each franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive fees ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$14,500&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$19,950&lt;/div&gt; which are collected from franchisees upon the sale of franchises within their region and a royalty of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3%&lt;/div&gt; of sales generated by franchised clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. The franchisor&amp;#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&amp;#x2019;s license.&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RegionalDeveloperFeesPolicyPolicyTextBlock>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651843" unitRef="iso4217-usd">138500</jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651844" unitRef="iso4217-usd">254250</jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements contextRef="d_2016-01-01_2016-12-31" id="c14651845" unitRef="iso4217-usd" xs:nil="true"/>
  <jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651846" unitRef="iso4217-usd">282750</jynt:RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements>
  <jynt:RegionalDeveloperFeesRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651675" unitRef="iso4217-usd">617573</jynt:RegionalDeveloperFeesRevenue>
  <jynt:RegionalDeveloperFeesRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651676" unitRef="iso4217-usd">866802</jynt:RegionalDeveloperFeesRevenue>
  <jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise contextRef="i_2016-12-31_RangeAxis-MinimumMember" decimals="INF" id="c14652102" unitRef="iso4217-usd">14500</jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise>
  <jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise contextRef="i_2016-12-31_RangeAxis-MaximumMember" decimals="INF" id="c14652103" unitRef="iso4217-usd">19950</jynt:RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise>
  <jynt:RegionalDevelopersLicenseFee contextRef="i_2016-12-31" decimals="INF" id="c14652100" unitRef="iso4217-usd">7250</jynt:RegionalDevelopersLicenseFee>
  <jynt:RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652101" unitRef="xbrli-pure">0.25</jynt:RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage>
  <jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652104" unitRef="xbrli-pure">0.03</jynt:RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage>
  <jynt:RepurchaseRightToDevelopFranchisesConsideration contextRef="d_2016-01-01_2016-01-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c14652489" unitRef="iso4217-usd">275000</jynt:RepurchaseRightToDevelopFranchisesConsideration>
  <jynt:RepurchaseRightToDevelopFranchisesConsideration contextRef="d_2016-06-01_2016-06-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember" decimals="INF" id="c14652493" unitRef="iso4217-usd">50000</jynt:RepurchaseRightToDevelopFranchisesConsideration>
  <jynt:RevenuesAndManagementFeesPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699114">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;Revenues and Management Fees from Company Clinics.&amp;nbsp;&amp;nbsp;&lt;/div&gt;The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&amp;nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&amp;nbsp; Amounts collected up front for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&amp;nbsp;&amp;nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&amp;#x2019;s PC.&amp;nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&amp;#x2019;s PC in return for a monthly management fee.&amp;nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RevenuesAndManagementFeesPolicyPolicyTextBlock>
  <jynt:RoyaltiesPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699115">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;Royalties.&lt;/div&gt; The Company collects royalties, as stipulated in the franchise agreement, equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7%&lt;/div&gt; of gross sales, and a marketing and advertising fee currently equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; working days after each sales period has ended.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</jynt:RoyaltiesPolicyPolicyTextBlock>
  <jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c14652674" unitRef="xbrli-pure">0.2</jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate>
  <jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c14652677" unitRef="xbrli-pure">0.2</jynt:ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2015-01-01_2015-12-31_RangeAxis-MinimumMember" decimals="INF" id="c14652558" unitRef="iso4217-usd-per-xbrli-shares">5.99</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2015-01-01_2015-12-31_RangeAxis-MaximumMember" decimals="INF" id="c14652559" unitRef="iso4217-usd-per-xbrli-shares">9.62</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember" decimals="INF" id="c14652563" unitRef="iso4217-usd-per-xbrli-shares">2.23</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember" decimals="INF" id="c14652564" unitRef="iso4217-usd-per-xbrli-shares">4.11</jynt:ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
  <jynt:ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652717" unitRef="iso4217-usd-per-xbrli-shares">2.38</jynt:ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652757" unitRef="xbrli-shares">90000</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652759">1.9</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms>
  <jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652758" unitRef="iso4217-usd-per-xbrli-shares">8.13</jynt:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice>
  <jynt:TimeFrameForTheMinimumNumberOfClinicsToBeOpened contextRef="d_2017-01-06_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" id="c14653016">P10Y</jynt:TimeFrameForTheMinimumNumberOfClinicsToBeOpened>
  <jynt:TimeFrameOfClinicsExpectedToBeOpen contextRef="d_2017-01-06_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" id="c14653019">P1Y180D</jynt:TimeFrameOfClinicsExpectedToBeOpen>
  <jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652882" unitRef="iso4217-usd">6200</jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties>
  <jynt:UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties contextRef="d_2015-01-01_2015-12-31" id="c14652884" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AccountsPayableCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651598" unitRef="iso4217-usd">1054946</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651599" unitRef="iso4217-usd">1996971</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651570" unitRef="iso4217-usd">1021733</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651571" unitRef="iso4217-usd">743239</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651600" unitRef="iso4217-usd">299997</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651601" unitRef="iso4217-usd">375529</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="i_2016-12-31" decimals="INF" id="c14652450" unitRef="iso4217-usd">2566172</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="i_2015-12-31" decimals="INF" id="c14652451" unitRef="iso4217-usd">1098438</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AdditionalPaidInCapital contextRef="i_2016-12-31" decimals="INF" id="c14651652" unitRef="iso4217-usd">36398588</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital contextRef="i_2015-12-31" decimals="INF" id="c14651653" unitRef="iso4217-usd">35267376</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651726" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651727" unitRef="iso4217-usd">825145</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651729" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651730" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651731" unitRef="iso4217-usd">825145</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651775" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651776" unitRef="iso4217-usd">1123481</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651778" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651779" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651780" unitRef="iso4217-usd">1123481</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651796" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651797" unitRef="iso4217-usd">1042</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651799" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651800" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651801" unitRef="iso4217-usd">1042</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699117">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Advertising costs are expensed as incurred. Advertising expenses for years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,279,572&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,525,687,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
  <us-gaap:AdvertisingExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652111" unitRef="iso4217-usd">2279572</us-gaap:AdvertisingExpense>
  <us-gaap:AdvertisingExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652112" unitRef="iso4217-usd">1525687</us-gaap:AdvertisingExpense>
  <us-gaap:AdvertisingRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651671" unitRef="iso4217-usd">1866406</us-gaap:AdvertisingRevenue>
  <us-gaap:AdvertisingRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651672" unitRef="iso4217-usd">1191124</us-gaap:AdvertisingRevenue>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652576" unitRef="iso4217-usd">561559</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652577" unitRef="iso4217-usd">328772</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652592" unitRef="iso4217-usd">561922</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652593" unitRef="iso4217-usd">496373</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i_2016-12-31" decimals="INF" id="c14652063" unitRef="iso4217-usd">131830</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="i_2015-12-31" decimals="INF" id="c14652064" unitRef="iso4217-usd">142660</us-gaap:AllowanceForDoubtfulAccountsReceivable>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652067" unitRef="iso4217-usd">731857</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652495" unitRef="iso4217-usd">747733</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652496" unitRef="iso4217-usd">476161</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember" decimals="INF" id="c14652272" unitRef="xbrli-shares">92415</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember" decimals="INF" id="c14652273" unitRef="xbrli-shares">339288</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember" decimals="INF" id="c14652274" unitRef="xbrli-shares">953075</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember" decimals="INF" id="c14652275" unitRef="xbrli-shares">477459</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember" decimals="INF" id="c14652276" unitRef="xbrli-shares">90000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember" decimals="INF" id="c14652277" unitRef="xbrli-shares">90000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:Assets contextRef="i_2016-12-31" decimals="INF" id="c14651594" unitRef="iso4217-usd">17054861</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2015-12-31" decimals="INF" id="c14651595" unitRef="iso4217-usd">33362328</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652986" unitRef="iso4217-usd">9936000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652987" unitRef="iso4217-usd">12426000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652988" unitRef="iso4217-usd">2003000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652989" unitRef="iso4217-usd">2580000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652990" unitRef="iso4217-usd">11939000</us-gaap:Assets>
  <us-gaap:Assets contextRef="i_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652991" unitRef="iso4217-usd">15006000</us-gaap:Assets>
  <us-gaap:AssetsCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651580" unitRef="iso4217-usd">5696656</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651581" unitRef="iso4217-usd">19025143</us-gaap:AssetsCurrent>
  <us-gaap:AssetsFairValueAdjustment contextRef="d_2016-01-01_2016-12-31" decimals="-3" id="c14652471" unitRef="iso4217-usd">3500000</us-gaap:AssetsFairValueAdjustment>
  <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-22">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Pro Forma for the Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31, 2016&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31, 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Revenues, net&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,985,277&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,375,930&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,483,492&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(10,187,416&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c14652386" unitRef="iso4217-usd">-15483492</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c14652387" unitRef="iso4217-usd">-10187416</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c14652384" unitRef="iso4217-usd">20985277</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember" decimals="INF" id="c14652385" unitRef="iso4217-usd">16375930</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c14652291" unitRef="iso4217-usd">75000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c14652328" unitRef="iso4217-usd">393069</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-TempeAZMember" decimals="INF" id="c14652319" unitRef="iso4217-usd">233804</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="d_2015-01-01_2015-01-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-SanDiegoCAMember" decimals="INF" id="c14652322" unitRef="iso4217-usd">27343</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652327" unitRef="iso4217-usd">261147</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="d_2016-01-01_2016-12-31" id="c14651701" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651702" unitRef="iso4217-usd">261147</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652284" unitRef="iso4217-usd">1025000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652305" unitRef="iso4217-usd">5725875</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="d_2015-01-01_2015-01-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-TempeAZMember" decimals="INF" id="c14652317" unitRef="iso4217-usd">25000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651961" unitRef="iso4217-usd">186000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651975" unitRef="iso4217-usd">800350</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652286" unitRef="iso4217-usd">186000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652307" unitRef="iso4217-usd">800350</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462455">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Acquisitions&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchises acquired during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; developed franchises and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; undeveloped franchise throughout California and New Mexico for an aggregate purchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,025,000,&lt;/div&gt; subject to certain adjustments, consisting of cash of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$839,000&lt;/div&gt; and notes payable of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000.&lt;/div&gt; The Company is operating the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic license. At the time these transactions were consummated, the Company carried &lt;div style="display: inline; background-color: white"&gt;a deferred revenue balance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,000,&lt;/div&gt; representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,450,&lt;/div&gt; related to an undeveloped franchise.&amp;nbsp;&amp;nbsp;The Company accounted for the franchise rights associated with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&amp;nbsp;&amp;nbsp;The remaining &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$997,450&lt;/div&gt; was accounted for as consideration paid for the acquired franchises.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company incurred approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$75,000&lt;/div&gt; of transaction costs related to these acquisitions for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; which are included in general and administrative expenses in the accompanying consolidated statements of operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Purchase Price Allocation&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; as of the acquisition date:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;293,014&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;140,728&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;269,780&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,042,522&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(45,072&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;997,450&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets in the table above consist of reacquired franchise rights of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$181,000&lt;/div&gt; and customer relationships of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$158,000,&lt;/div&gt; and will be amortized over their estimated useful lives ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; years, respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchises acquired during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt; developed and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35&lt;/div&gt; undeveloped franchises throughout Arizona, California and New York for an aggregate purchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,725,875,&lt;/div&gt; subject to certain adjustments, consisting of cash of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4,925,525&lt;/div&gt; and notes payable of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$800,350.&lt;/div&gt; Of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt; developed franchises, the Company is operating &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22&lt;/div&gt; as company-owned or managed clinics and has closed the remaining &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; clinics. The &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;35&lt;/div&gt; undeveloped franchises have been terminated and the Company &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; relocate them. At the time these transactions were consummated, the Company carried &lt;div style="display: inline; background-color: white"&gt;a deferred revenue balance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,005,500,&lt;/div&gt; representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$493,500,&lt;/div&gt; related to undeveloped franchises.&amp;nbsp;&amp;nbsp;The Company accounted for the franchise rights associated with the undeveloped franchises as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&amp;nbsp;&amp;nbsp;The remaining &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,213,875&lt;/div&gt; was accounted for as consideration paid for the acquired franchises.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 59 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Additionally, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; in connection with the default by a franchisee under its franchise agreement, the Company assumed substantially all of the assets of a clinic in Tempe, Arizona in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$25,000.&lt;/div&gt;&amp;nbsp; The Company has accounted for this as a business combination.&amp;nbsp; The Company completed its valuation of the fair value of the assets acquired, including intangible assets, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt; Because the net assets acquired exceeded the consideration paid, the Company recognized a bargain purchase gain of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$233,804&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company also recognized a bargain purchase gain of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$27,343&lt;/div&gt; related to the acquisition of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; developed franchises and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; undeveloped franchises in San Diego, California. Total bargain purchase gain for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$261,147.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company incurred &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$393,069&lt;/div&gt; of transaction costs related to these acquisitions for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; which are included in general and administrative expenses in the accompanying consolidated statements of operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Purchase Price Allocation&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The purchase price allocations for these acquisitions are complete. The following summarizes the aggregate fair values of the assets acquired and liabilities assumed during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; as of the acquisition date:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,450,333&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,947,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;528,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,899,449&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,824,857&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Unfavorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(74,927&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(106,908&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,643,022&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(168,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Bargain purchase gain&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(261,147&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,213,875&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets in the table above consist of reacquired franchise rights of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,449,000&lt;/div&gt; and customer relationships of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$498,000,&lt;/div&gt; and will be amortized over their estimated useful lives ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; years, respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Pro Forma Results of Operations (Unaudited)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; as if the acquisitions in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; had been completed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Pro Forma for the Year Ended&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31, 2016&lt;/td&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;December 31, 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Revenues, net&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,985,277&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,375,930&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,483,492&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(10,187,416&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 60 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;This selected unaudited pro forma consolidated financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would have been if the acquisitions had been completed on that date. Moreover, this information is not indicative of what the Company&amp;#x2019;s future operating results will be. The information for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; prior to the acquisitions is included based on prior accounting records maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted by the Company following the acquisitions. For &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; this information includes actual data recorded in the Company&amp;#x2019;s consolidated financial statements for the period subsequent to the date of the acquisitions. The Company&amp;#x2019;s consolidated statements of operations for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; includes net revenue and net income of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7.5&lt;/div&gt; million and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.7&lt;/div&gt; million, respectively, attributable to the acquisitions.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; together with the consequential tax impacts.&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652349" unitRef="iso4217-usd">7500000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
  <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652350" unitRef="iso4217-usd">700000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652370" unitRef="iso4217-usd">1042522</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652377" unitRef="iso4217-usd">5824857</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651959" unitRef="iso4217-usd">45072</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651972" unitRef="iso4217-usd">106908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652371" unitRef="iso4217-usd">45072</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652379" unitRef="iso4217-usd">106908</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651973" unitRef="iso4217-usd">168000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652381" unitRef="iso4217-usd">168000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651956" unitRef="iso4217-usd">339000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651968" unitRef="iso4217-usd">1942180</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652367" unitRef="iso4217-usd">339000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652374" unitRef="iso4217-usd">1947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652380" unitRef="iso4217-usd">5643022</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651955" unitRef="iso4217-usd">293014</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651967" unitRef="iso4217-usd">1504169</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652366" unitRef="iso4217-usd">293014</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652373" unitRef="iso4217-usd">1450333</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="d_2016-01-01_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c14651942" unitRef="iso4217-usd">11059</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="d_2015-01-01_2015-12-31_BalanceSheetLocationAxis-AccountsPayable1Member" decimals="INF" id="c14651945" unitRef="iso4217-usd">1109464</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="d_2015-01-01_2015-12-31_BalanceSheetLocationAxis-AccruedExpensesMember" decimals="INF" id="c14651946" unitRef="iso4217-usd">117509</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c14655760" unitRef="iso4217-usd">3009864</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2015-12-31" decimals="INF" id="c14651567" unitRef="iso4217-usd">16792850</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2014-12-31" decimals="INF" id="c14651927" unitRef="iso4217-usd">20796783</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652992" unitRef="iso4217-usd">3344000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="i_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652993" unitRef="iso4217-usd">17178000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651924" unitRef="iso4217-usd">-13782986</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651925" unitRef="iso4217-usd">-4003933</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699062">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Cash and Cash Equivalents&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company considers all highly liquid instruments purchased with an original maturity of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company has invested substantially all of the proceeds of its public offerings in short-term bank deposits. The Company had no cash equivalents as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699063">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Cash&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&amp;#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="i_2015-12-31" decimals="INF" id="c14652219" unitRef="iso4217-usd">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c14652223" unitRef="iso4217-usd">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462448">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; cash paid for income taxes was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$11,250&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0,&lt;/div&gt; respectively. During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; cash paid for interest was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$15,262&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,344,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Supplemental disclosure of non-cash activity:&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; we had property and equipment purchases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$11,059&lt;/div&gt; which were included in accounts payable. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; we had property and equipment purchases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,109,464&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$117,509&lt;/div&gt; which were included in accounts payable and accrued expenses, respectively.&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;In connection with our reacquisition and termination of regional developer rights during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; we had deferred revenue of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$224,750&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$914,000,&lt;/div&gt; respectively, representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;We netted these amounts against the aggregate purchase price of the acquisitions (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;In connection with our acquisitions of franchises during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; we acquired &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$293,014&lt;/div&gt; of property and equipment, intangible assets of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$339,000,&lt;/div&gt; goodwill of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$269,780,&lt;/div&gt; favorable leases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$140,728&lt;/div&gt; and assumed deferred revenue associated with membership packages paid in advance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$45,072&lt;/div&gt; in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$839,000&lt;/div&gt; in cash and notes payable issued to the sellers for an aggregate amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000.&lt;/div&gt; Additionally, at the time of these transactions, we carried deferred revenue of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,000,&lt;/div&gt; representing franchise fees collected upon the execution of franchise agreements, and deferred costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,450,&lt;/div&gt; related to our acquisition of undeveloped franchises. We netted these amounts against the aggregate purchase price of the acquisitions (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;In connection with our acquisitions of franchises during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; we acquired &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,504,169&lt;/div&gt; of property and equipment, intangible assets of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,942,180,&lt;/div&gt; goodwill of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,830,833,&lt;/div&gt; favorable leases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$521,825,&lt;/div&gt; assumed unfavorable leases of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$49,077,&lt;/div&gt; deferred revenue associated with membership packages paid in advance of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$106,908,&lt;/div&gt; and a deferred tax liability of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$168,000&lt;/div&gt; in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4,925,525&lt;/div&gt; in cash and an aggregate amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$800,350&lt;/div&gt; in notes payable to the sellers.&amp;nbsp;&amp;nbsp;Additionally, at the time of these transactions, we carried deferred revenue of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,005,500,&lt;/div&gt; representing franchise fees collected upon the execution of franchise agreements, and deferred costs of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$493,500,&lt;/div&gt; related to our acquisition of undeveloped franchises.&amp;nbsp;&amp;nbsp;In accordance with ASC-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;952&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;605,&lt;/div&gt; we netted these amounts against the aggregate purchase price of the acquisitions (Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 74%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Property and equipment&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 22%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;(53,836&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;)&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Intangible assets&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;4,820&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Favorable leases&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;6,250&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Goodwill&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;68,616&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Unfavorable leases&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;(25,850&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;)&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/div&gt; &lt;div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; we entered into a settlement agreement, whereby we resolved all pending litigation matters discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11.&lt;/div&gt; Under the terms of the settlement agreement, we agreed to a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt;-time settlement amount comprised of cash and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;46,948&lt;/div&gt; shares of our common stock. The fair value of the total consideration related to common stock was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$100,000.&lt;/div&gt; The fair value of the common stock was measured using the closing price of our common stock on the settlement date. &amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="i_2014-11-14" decimals="INF" id="c14652638" unitRef="iso4217-usd-per-xbrli-shares">8.125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:CommitmentsAndContingencies contextRef="i_2016-12-31" id="c14651629" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies contextRef="i_2015-12-31" id="c14651630" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462480">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Commitments and Contingencies&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Operating Leases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio. During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company assumed &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16&lt;/div&gt; additional leases for clinic locations. These leases vary in length from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;60&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;127&lt;/div&gt; months and have monthly payments ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,917&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,498.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Total rent expense for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3,389,971&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,574,803,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Future minimum annual lease payments are as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,180,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,587,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,248,195&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,982,392&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,868,976&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,180,991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;19,048,079&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company ceased use of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;five&lt;/div&gt; undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company classified all of the approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$338,000&lt;/div&gt; lease exit liability in other liabilities in the accompanying consolidated balance sheets as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; and related expense in Loss on disposition or impairment in the accompanying consolidated statement of operations for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Litigation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In the normal course of business, the Company is party to litigation from time to time.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; franchisees who owned a total of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13&lt;/div&gt; franchise licenses (&amp;quot;Claimants&amp;quot;) filed a Demand for Arbitration against the Company alleging breach of contract, breach of implied covenant of good faith and fair dealing, wrongful termination, fraud, promissory fraud, negligent misrepresentation, and claims under or arising out of violations of Section &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31300,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31301,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31201&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31202&lt;/div&gt; of the California Franchise Investment Law. The Company vigorously denied liability for all of Claimants' claims and asserted counterclaims against each Claimant for breach of contract, breach of guaranty, among other claims, and sought a declaratory judgment that termination was proper because Claimants failed to adhere to the development schedules in their respective franchise agreements. The Company, through its counterclaim, sought damages for each unopened license, in accordance with the terms of the parties&amp;#x2019; franchise agreements. The parties entered into a settlement agreement dated &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; which included, among other things, a mutual general release of claims. The arbitration was subsequently dismissed with prejudice, based on the parties' stipulation.&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="i_2016-12-31" decimals="INF" id="c14651644" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="i_2015-12-31" decimals="INF" id="c14651645" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="i_2016-12-31" decimals="INF" id="c14651646" unitRef="xbrli-shares">20000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="i_2015-12-31" decimals="INF" id="c14651647" unitRef="xbrli-shares">20000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="i_2016-12-31" decimals="INF" id="c14651648" unitRef="xbrli-shares">13317393</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="i_2015-12-31" decimals="INF" id="c14651649" unitRef="xbrli-shares">13070180</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="i_2016-12-31" decimals="INF" id="c14651650" unitRef="xbrli-shares">13020889</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="i_2015-12-31" decimals="INF" id="c14651651" unitRef="xbrli-shares">12536180</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="i_2016-12-31" decimals="INF" id="c14651642" unitRef="iso4217-usd">13317</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="i_2015-12-31" decimals="INF" id="c14651643" unitRef="iso4217-usd">13070</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699058">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;Net loss and comprehensive loss are the same for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="d_2016-01-01_2016-12-31" id="c14699064">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;From time to time the Company grants credit in the normal course of business to PCs or franchisees related to the working capital needs of the PC, collection of royalties, or other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the PCs or franchisees to reduce credit risk. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; PC entity, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; franchisees represented &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24%&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31%,&lt;/div&gt; respectively, of outstanding accounts receivable. The Company did not have any PCs or franchisees that represented greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; of our revenues during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-OnePcEntityMember" decimals="INF" id="c14652045" unitRef="xbrli-pure">0.24</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="d_2015-01-01_2015-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-SixFranchiseesMember" decimals="INF" id="c14652048" unitRef="xbrli-pure">0.31</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699057">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Principles of Consolidation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; LLC (collectively, the &amp;#x201c;Company&amp;#x201d;), which was dormant for all periods presented.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from selling and marketing expenses to general and administrative expenses for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; to conform to current year presentation.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699061">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&amp;nbsp;variable interest entity&amp;nbsp;(&amp;#x201c;VIE&amp;#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary are accounted for under the equity method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Certain states in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides on an exclusive basis, all non-clinical services of the chiropractic practice.&amp;nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&amp;#x2019;s consolidated financial statements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
  <us-gaap:ConstructionInProgressGross contextRef="i_2016-12-31" decimals="INF" id="c14652454" unitRef="iso4217-usd">231281</us-gaap:ConstructionInProgressGross>
  <us-gaap:ConstructionInProgressGross contextRef="i_2015-12-31" decimals="INF" id="c14652455" unitRef="iso4217-usd">1909476</us-gaap:ConstructionInProgressGross>
  <us-gaap:CooperativeAdvertisingPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699107">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Co-Op Marketing Funds&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&amp;#x2019; officers. The marketing funds are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CooperativeAdvertisingPolicy>
  <us-gaap:CostOfRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651686" unitRef="iso4217-usd">2939609</us-gaap:CostOfRevenue>
  <us-gaap:CostOfRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651687" unitRef="iso4217-usd">2819913</us-gaap:CostOfRevenue>
  <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699108">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounting for Costs Associated with Exit or Disposal Activities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;Costs to terminate an operating lease or other contracts are (a)&amp;nbsp;costs to terminate the contract before the end of its term or (b)&amp;nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; the Company recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million related to operating leases that will no longer provide economic benefit to the entity, net of estimated sublease income.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652792" unitRef="iso4217-usd">22800</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652793" unitRef="iso4217-usd">-208900</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652796" unitRef="iso4217-usd">43700</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652797" unitRef="iso4217-usd">-276700</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652794" unitRef="iso4217-usd">20900</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652795" unitRef="iso4217-usd">-67800</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:DebtDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462466">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 73px"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Notes Payable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company issued &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12&lt;/div&gt; notes payable totaling &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$800,350&lt;/div&gt; as a portion of the consideration paid in connection with the Company&amp;#x2019;s various acquisitions. Interest rates range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.5%&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.25%&lt;/div&gt; with maturities through &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February&lt;/div&gt; of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company issued &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; notes payable totaling &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$186,000&lt;/div&gt; as a portion of the consideration paid in connection with the Company&amp;#x2019;s various acquisitions. Interest rates for both notes are &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.25%&lt;/div&gt; with maturities through &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May&lt;/div&gt; of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maturities of notes payable are as follows as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 78%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;331,500&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;331,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DebtInstrumentFaceAmount contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c14652531" unitRef="iso4217-usd">800350</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c14652537" unitRef="iso4217-usd">186000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MinimumMember" decimals="INF" id="c14652532" unitRef="xbrli-pure">0.015</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MaximumMember" decimals="INF" id="c14652533" unitRef="xbrli-pure">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" decimals="INF" id="c14652538" unitRef="xbrli-pure">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653004" unitRef="xbrli-pure">0.1</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652799" unitRef="iso4217-usd">97400</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652800" unitRef="iso4217-usd">40800</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651859" unitRef="iso4217-usd">120700</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651860" unitRef="iso4217-usd">40800</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredRentCreditCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651608" unitRef="iso4217-usd">215450</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651609" unitRef="iso4217-usd">334560</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651618" unitRef="iso4217-usd">1400790</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRentCreditNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651619" unitRef="iso4217-usd">457290</us-gaap:DeferredRentCreditNoncurrent>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31" decimals="INF" id="c14651950" unitRef="iso4217-usd">224750</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2015-12-31" decimals="INF" id="c14651951" unitRef="iso4217-usd">914000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651962" unitRef="iso4217-usd">29000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651976" unitRef="iso4217-usd">1005500</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652288" unitRef="iso4217-usd">29000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652312" unitRef="iso4217-usd">1005500</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c14652481" unitRef="iso4217-usd">914000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-01-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c14652490" unitRef="iso4217-usd">36250</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="i_2016-06-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember" decimals="INF" id="c14652494" unitRef="iso4217-usd">188500</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenueCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651610" unitRef="iso4217-usd">3077430</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651611" unitRef="iso4217-usd">2579423</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651620" unitRef="iso4217-usd">2231712</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651621" unitRef="iso4217-usd">4369702</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652801" unitRef="iso4217-usd">23300</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" id="c14652802" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DeferredTaxAssetsGrossNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14652835" unitRef="iso4217-usd">11496400</us-gaap:DeferredTaxAssetsGrossNoncurrent>
  <us-gaap:DeferredTaxAssetsGrossNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14652836" unitRef="iso4217-usd">5574400</us-gaap:DeferredTaxAssetsGrossNoncurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="i_2016-12-31" decimals="INF" id="c14652829" unitRef="iso4217-usd">14000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="i_2015-12-31" decimals="INF" id="c14652830" unitRef="iso4217-usd">14200</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14652837" unitRef="iso4217-usd">11617100</us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent>
  <us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14652838" unitRef="iso4217-usd">5574400</us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651622" unitRef="iso4217-usd">120700</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="i_2015-12-31" id="c14651623" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DepositsAssetsNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651592" unitRef="iso4217-usd">707889</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651593" unitRef="iso4217-usd">638710</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:Depreciation contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652432" unitRef="iso4217-usd">1818403</us-gaap:Depreciation>
  <us-gaap:Depreciation contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652433" unitRef="iso4217-usd">792794</us-gaap:Depreciation>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651690" unitRef="iso4217-usd">2566136</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651691" unitRef="iso4217-usd">1268955</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652964" unitRef="iso4217-usd">2186000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652965" unitRef="iso4217-usd">986000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" id="c14652966" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" id="c14652967" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateMember" decimals="-3" id="c14652968" unitRef="iso4217-usd">380000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateMember" decimals="-3" id="c14652969" unitRef="iso4217-usd">283000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651714" unitRef="iso4217-usd-per-xbrli-shares">-1.20</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651715" unitRef="iso4217-usd-per-xbrli-shares">-0.88</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699119">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Loss per Common Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(8,797,321&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="d_2016-01-01_2016-12-31" decimals="3" id="c14652773" unitRef="xbrli-pure">0.011</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="d_2015-01-01_2015-12-31" decimals="3" id="c14652774" unitRef="xbrli-pure">0.026</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652842" unitRef="xbrli-pure">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652844" unitRef="xbrli-pure">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652850" unitRef="xbrli-pure">0.4024</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652852" unitRef="xbrli-pure">0.3897</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="d_2016-01-01_2016-12-31" id="c14652858" unitRef="xbrli-pure" xs:nil="true"/>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652860" unitRef="xbrli-pure">-0.0051</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652866" unitRef="xbrli-pure">-0.0097</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652868" unitRef="xbrli-pure">-0.0123</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652870" unitRef="xbrli-pure">0.0109</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652872" unitRef="xbrli-pure">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652846" unitRef="xbrli-pure">-0.049</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652848" unitRef="xbrli-pure">-0.0429</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="d_2016-01-01_2016-12-31" decimals="4" id="c14652854" unitRef="xbrli-pure">0.0072</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="d_2015-01-01_2015-12-31" decimals="4" id="c14652856" unitRef="xbrli-pure">-0.0065</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651604" unitRef="iso4217-usd">750421</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651605" unitRef="iso4217-usd">1493375</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652581">P3Y94D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" id="c14652597">P1Y21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="i_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652596" unitRef="iso4217-usd">155969</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652580" unitRef="iso4217-usd">733944</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462462">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Fair Value Consideration&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company&amp;#x2019;s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&amp;#x2019;s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; levels based on reliability of the inputs as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 2%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 7%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 91%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Observable inputs such as quoted prices in active markets;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;"&gt;  &lt;tr&gt; &lt;td style="vertical-align: top; width: 2%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="vertical-align: top; width: 7%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom; width: 91%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&amp;nbsp;and&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 2%; text-align: justify"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 7%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 91%; text-align: justify"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company does &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;no&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;t have any financial instruments that are measured on a recurring basis as Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2&lt;/div&gt; or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company had non-recurring fair value measurements as a result of the sale subsequent to year end, the Company recorded the assets at the lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.5&lt;/div&gt; million. The inputs used to determine such fair values which were based on the offer price provided by a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;third&lt;/div&gt; party in connection with the sale are classified within Level &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3&lt;/div&gt; in the hierarchy.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="i_2016-12-31" decimals="-3" id="c14652474" unitRef="iso4217-usd">0</us-gaap:FinancialInstrumentsOwnedAtFairValue>
  <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="i_2015-12-31" decimals="-3" id="c14652475" unitRef="iso4217-usd">0</us-gaap:FinancialInstrumentsOwnedAtFairValue>
  <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="i_2014-12-31" decimals="-3" id="c14652476" unitRef="iso4217-usd">0</us-gaap:FinancialInstrumentsOwnedAtFairValue>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-ComputerSoftwareIntangibleAssetMember" id="c14652072">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember" id="c14652073">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember" id="c14652074">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" id="c14652075">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" id="c14652076">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember" id="c14652297">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember" id="c14652298">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" id="c14652299">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember" id="c14652334">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember" id="c14652335">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" id="c14652336">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c14652510" unitRef="iso4217-usd">444795</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c14652513" unitRef="iso4217-usd">509042</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c14652516" unitRef="iso4217-usd">243241</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="i_2016-12-31" decimals="INF" id="c14652519" unitRef="iso4217-usd">1197078</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="i_2016-12-31" decimals="INF" id="c14652526" unitRef="iso4217-usd">145906</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="i_2016-12-31" decimals="INF" id="c14652521" unitRef="iso4217-usd">578881</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="i_2016-12-31" decimals="INF" id="c14652525" unitRef="iso4217-usd">348034</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="i_2016-12-31" decimals="INF" id="c14652524" unitRef="iso4217-usd">413256</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="i_2016-12-31" decimals="INF" id="c14652523" unitRef="iso4217-usd">413256</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="i_2016-12-31" decimals="INF" id="c14652522" unitRef="iso4217-usd">439589</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c14652509" unitRef="iso4217-usd">1911750</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c14652512" unitRef="iso4217-usd">701000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c14652515" unitRef="iso4217-usd">923250</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="i_2016-12-31" decimals="INF" id="c14652518" unitRef="iso4217-usd">3536000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31" decimals="INF" id="c14652527" unitRef="iso4217-usd">2338922</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c14652511" unitRef="iso4217-usd">1466955</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c14652514" unitRef="iso4217-usd">191958</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember" decimals="INF" id="c14652517" unitRef="iso4217-usd">680009</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c14652295" unitRef="iso4217-usd">181000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c14652296" unitRef="iso4217-usd">158000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember" decimals="INF" id="c14652332" unitRef="iso4217-usd">1449000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember" decimals="INF" id="c14652333" unitRef="iso4217-usd">498000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" decimals="INF" id="c14652480" unitRef="iso4217-usd">1583000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
  <us-gaap:FranchiseCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651682" unitRef="iso4217-usd">2717691</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseCosts contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651683" unitRef="iso4217-usd">2642451</us-gaap:FranchiseCosts>
  <us-gaap:FranchiseRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651669" unitRef="iso4217-usd">2286809</us-gaap:FranchiseRevenue>
  <us-gaap:FranchiseRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651670" unitRef="iso4217-usd">2471259</us-gaap:FranchiseRevenue>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651853" unitRef="iso4217-usd">2191</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651854" unitRef="iso4217-usd">11500</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14653024" unitRef="iso4217-usd">-3520370</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
  <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="d_2015-01-01_2015-12-31" id="c14651697" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651692" unitRef="iso4217-usd">22101083</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651693" unitRef="iso4217-usd">16219392</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill contextRef="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652369" unitRef="iso4217-usd">269780</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652376" unitRef="iso4217-usd">1899449</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="i_2016-12-31" decimals="INF" id="c14651590" unitRef="iso4217-usd">2750338</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="i_2015-12-31" decimals="INF" id="c14651591" unitRef="iso4217-usd">2466937</us-gaap:Goodwill>
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651957" unitRef="iso4217-usd">269780</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651969" unitRef="iso4217-usd">1830833</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699104">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&amp;nbsp;&amp;nbsp;Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; day of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fourth&lt;/div&gt; quarter or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$54,994&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:GoodwillPeriodIncreaseDecrease contextRef="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14651992" unitRef="iso4217-usd">68616</us-gaap:GoodwillPeriodIncreaseDecrease>
  <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652083" unitRef="iso4217-usd">54994</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c14652077" unitRef="iso4217-usd">38185</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c14652501" unitRef="iso4217-usd">38185</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652087" unitRef="iso4217-usd">2400000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652088" unitRef="iso4217-usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf contextRef="d_2016-12-01_2016-12-31_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember" decimals="INF" id="c14652440" unitRef="iso4217-usd">2400000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699105">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Long-Lived Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; not be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.4&lt;/div&gt; million and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; were recorded for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651707" unitRef="iso4217-usd">-15009443</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651708" unitRef="iso4217-usd">-9033176</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462474">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Income tax provision (benefit) reported in the consolidated statements of operations is comprised of the following:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Current provision (benefit):&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(208,900&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;State, net of state tax credits&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(67,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total current provision (benefit)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;43,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(276,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;97,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;State&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;23,300&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total deferred provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision (benefit)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(235,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following are the components of the Company&amp;#x2019;s net deferred taxes for federal and state income taxes:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Deferred revenue&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,509,400&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,988,200&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred franchise costs&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(553,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(664,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;51,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,781,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Accrued expenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;57,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;74,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - Component 1&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - Component 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;87,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(30,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(44,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Nonqualified stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;182,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;109,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred rent&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;629,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;209,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease abandonment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,924,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,849,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Tax credits&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Charitable contribution carryover&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Asset basis difference related to property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;630,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;167,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,496,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,574,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Less valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(11,617,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,574,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net non-current deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;At &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company has federal and state net operating losses of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$22,613,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$24,948,000,&lt;/div&gt; respectively. These net operating losses are available to offset future taxable income and will begin to expire in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2035&lt;/div&gt; for federal purposes and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2020&lt;/div&gt; for state purposes.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 68 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following is a reconciliation of the statutory federal income tax rate applied to pre-tax accounting net income (loss), compared to the income tax provision (benefit) in the consolidated statement of operations:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;For the Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Percent&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Percent&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Expected federal tax expense (benefit)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,106,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,071,300&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State tax provision, net of federal benefit&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(735,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.90&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(387,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.29&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of increase in valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,042,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40.24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,519,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;38.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Permanent differences&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(58,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.65&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Uncertain tax positions&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(46,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.51&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of changed state rates for deferred&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(80,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.89&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Other, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(145,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.97&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(111,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.23&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Provision (Benefit)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.09&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(235,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2.60&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The state tax expense (benefit), penalties and interest stem from resolution of various voluntary disclosure agreements with multiple states where we had not yet been in compliance. In addition, we are responsible to pay certain minimum and franchise taxes to jurisdictions in which we do business.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Changes in our income tax expense related primarily to changes in pretax losses during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; as compared to year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; and the effective rate was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.1%&lt;/div&gt; and -&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.6%,&lt;/div&gt; respectively. The difference is due to a valuation allowance on the Company's deferred tax assets, and the impact of certain permanent differences on taxable income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company recorded a liability for income taxes for operations and uncertain tax positions of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$66,000,&lt;/div&gt; respectively, of which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$27,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$33,000&lt;/div&gt; respectively, represent penalties and interest and are recorded in the &amp;#x201c;other liabilities&amp;#x201d; section of the accompanying consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Management made a determination that the Company was not in compliance with several state and local tax jurisdictions in which the company was doing business. Accordingly, management undertook to analyze its tax exposures, both income and otherwise, with respect to jurisdictions in which compliance was deemed to be inadequate and the Company has entered into Voluntary Disclosure Agreements (VDAs) with the taxing authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The following table sets forth a reconciliation of the beginning and ending amount of uncertain tax positions during the tax years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Unrecognized tax benefit - January 1&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;91,700&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;30,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Gross increases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Gross decreases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(19,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(59,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Unrecognized tax benefit - December 31&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Our tax returns for tax years subject to examination by tax authorities include &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2012&lt;/div&gt; through the current period for state and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2013&lt;/div&gt; through the current period for federal reporting purposes.&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2015-12-31" decimals="INF" id="c14652874" unitRef="iso4217-usd">33000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2014-12-31" decimals="INF" id="c14652876" unitRef="iso4217-usd">30000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="i_2016-12-31" decimals="INF" id="c14652886" unitRef="iso4217-usd">26800</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="d_2016-01-01_2016-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c14652780" unitRef="iso4217-usd">27000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
  <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="d_2015-01-01_2015-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember" decimals="INF" id="c14652781" unitRef="iso4217-usd">33000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651709" unitRef="iso4217-usd">164429</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651710" unitRef="iso4217-usd">-235855</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699118">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt; likelihood of being realized upon ultimate resolution.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652849" unitRef="iso4217-usd">6042900</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652851" unitRef="iso4217-usd">3519800</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652841" unitRef="iso4217-usd">-5106100</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652843" unitRef="iso4217-usd">-3071300</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="d_2016-01-01_2016-12-31" id="c14652857" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652859" unitRef="iso4217-usd">-46500</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
  <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652865" unitRef="iso4217-usd">-145700</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
  <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652867" unitRef="iso4217-usd">-111500</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652845" unitRef="iso4217-usd">-735500</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652847" unitRef="iso4217-usd">-387500</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxesPaid contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651933" unitRef="iso4217-usd">11250</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651934" unitRef="iso4217-usd">0</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesReceivable contextRef="i_2016-12-31" decimals="INF" id="c14651572" unitRef="iso4217-usd">42014</us-gaap:IncomeTaxesReceivable>
  <us-gaap:IncomeTaxesReceivable contextRef="i_2015-12-31" decimals="INF" id="c14651573" unitRef="iso4217-usd">70981</us-gaap:IncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651878" unitRef="iso4217-usd">-953084</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651879" unitRef="iso4217-usd">-291480</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651868" unitRef="iso4217-usd">999522</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651869" unitRef="iso4217-usd">99963</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651880" unitRef="iso4217-usd">-75532</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651881" unitRef="iso4217-usd">165602</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651890" unitRef="iso4217-usd">-896195</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651891" unitRef="iso4217-usd">128049</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651876" unitRef="iso4217-usd">-71549</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651877" unitRef="iso4217-usd">39235</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651884" unitRef="iso4217-usd">-742954</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651885" unitRef="iso4217-usd">875431</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651870" unitRef="iso4217-usd">-28967</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651871" unitRef="iso4217-usd">-324833</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
  <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651888" unitRef="iso4217-usd">824390</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
  <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651889" unitRef="iso4217-usd">246686</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651886" unitRef="iso4217-usd">-19130</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651887" unitRef="iso4217-usd">-105973</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651872" unitRef="iso4217-usd">133492</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651873" unitRef="iso4217-usd">-9892</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651866" unitRef="iso4217-usd">-50888</us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities>
  <us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651867" unitRef="iso4217-usd">160706</us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities>
  <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="d_2016-01-01_2016-12-31" id="c14652266" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="d_2015-01-01_2015-12-31" id="c14652267" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462463">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Intangible Assets&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year &lt;div style="display: inline; background-color: white"&gt;ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company entered into several agreements to repurchase regional developer licenses, reacquiring rights in Los Angeles County, San Diego County, and Orange County, California, Erie County, Monroe County, Nassau County, Suffolk County, and Albany County, New York, and the regional developer license in New Jersey in exchange for cash consideration of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,583,000.&lt;/div&gt;&amp;nbsp; The Company carried a deferred revenue balance associated with these transactions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$914,000,&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;In accordance with ASC &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;952&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;605,&lt;/div&gt; the Company accounted for the development rights associated with the unsold or undeveloped franchises as cancellations, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&amp;nbsp;&amp;nbsp; During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the revenue recognized as excess deferred regional developer fees totaled &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$254,250.&lt;/div&gt; The remaining balance was accounted for as consideration paid for the reacquired development rights. As the deferred revenue with respect to these regional developer rights had previously been taken into account for income tax purposes, the tax basis in the reacquired development rights is equal to the cash consideration paid. &lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties in California. The total consideration for the transaction was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$275,000,&lt;/div&gt; paid in cash.&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="display: inline; background-color: white"&gt;The Company carried a deferred revenue balance associated with these transactions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$36,250,&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&amp;nbsp;&amp;nbsp; &lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; June&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration for the transaction was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$50,000,&lt;/div&gt; paid in cash.&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;div style="display: inline; background-color: white"&gt;The Company carried a deferred revenue balance associated with these transactions of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$188,500,&lt;/div&gt; representing license fees collected upon the execution of the regional developer agreements.&amp;nbsp;&amp;nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&amp;nbsp;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consisted of the following:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;As of December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,911,750&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;444,795&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,466,955&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;509,042&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;191,958&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;923,250&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;243,241&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;680,009&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,197,078&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Amortization expense was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$747,733&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$476,161&lt;/div&gt; for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company evaluates the recoverability of finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment charge as a result of the closure of a clinic acquired in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; related to certain reacquired franchise rights and customer relationships during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; which is included on the loss on disposition or impairment line of the statement of consolidated operations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 63 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Estimated amortization expense for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; and subsequent years is as follows:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;578,881&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;439,589&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;348,034&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;145,906&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699103">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Intangible Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&amp;nbsp;&amp;nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years. The Company amortizes the acquired regional developer rights over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. The fair value of customer relationships is amortized over their estimated useful life of&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt;&amp;nbsp;years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; related to closure of an acquired clinic in New York.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="i_2016-12-31" decimals="INF" id="c14651588" unitRef="iso4217-usd">2338922</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="i_2015-12-31" decimals="INF" id="c14651589" unitRef="iso4217-usd">2542269</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:InterestPaid contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651938" unitRef="iso4217-usd">15262</us-gaap:InterestPaid>
  <us-gaap:InterestPaid contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651939" unitRef="iso4217-usd">2344</us-gaap:InterestPaid>
  <us-gaap:InternalUseSoftwarePolicy contextRef="d_2016-01-01_2016-12-31" id="c14699102">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Software Developed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5&lt;/div&gt; years.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InternalUseSoftwarePolicy>
  <us-gaap:LeasePolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699109">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Rent&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; include rent holidays and rent escalation clauses.&amp;nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&amp;nbsp; The Company records &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;tenant&lt;/div&gt; improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LeasePolicyTextBlock>
  <us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract contextRef="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember" id="c14652901">P5Y</us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
  <us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract contextRef="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember" id="c14652902">P10Y210D</us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
  <us-gaap:Liabilities contextRef="i_2016-12-31" decimals="INF" id="c14651626" unitRef="iso4217-usd">10129448</us-gaap:Liabilities>
  <us-gaap:Liabilities contextRef="i_2015-12-31" decimals="INF" id="c14651627" unitRef="iso4217-usd">12683022</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="i_2016-12-31" decimals="INF" id="c14651662" unitRef="iso4217-usd">17054861</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="i_2015-12-31" decimals="INF" id="c14651663" unitRef="iso4217-usd">33362328</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651614" unitRef="iso4217-usd">5863884</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651615" unitRef="iso4217-usd">7487382</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c14652778" unitRef="iso4217-usd">40000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="i_2015-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember" decimals="INF" id="c14652779" unitRef="iso4217-usd">66000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LineOfCredit contextRef="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653008" unitRef="iso4217-usd">1000000</us-gaap:LineOfCredit>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14655776" unitRef="iso4217-usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest contextRef="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_RangeAxis-MinimumMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653006" unitRef="iso4217-usd">25000</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
  <us-gaap:LitigationSettlementAmount contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651863" unitRef="iso4217-usd">-100000</us-gaap:LitigationSettlementAmount>
  <us-gaap:LitigationSettlementAmount contextRef="d_2015-01-01_2015-12-31" id="c14651864" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462459">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Notes Receivable&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2012,&lt;/div&gt; the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$90,000&lt;/div&gt; unsecured promissory note. The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6%&lt;/div&gt; per annum for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fifty&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;four&lt;/div&gt; months and requires monthly principal and interest payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;forty&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; months, beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2013&lt;/div&gt; and maturing &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; license transfer agreements, in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$10,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,925&lt;/div&gt; in separate unsecured promissory notes.&amp;nbsp; The non-interest bearing notes require monthly principal payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company entered into a license transfer agreement, in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$29,925&lt;/div&gt; in an unsecured promissory note.&amp;nbsp; The note bears interest at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.0%&lt;/div&gt; per annum, and requires monthly principal payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; and matured on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Effective &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company entered into &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; license transfer agreements, in exchange for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; separate &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,500&lt;/div&gt; unsecured promissory notes.&amp;nbsp; The non-interest bearing notes require monthly principal payments over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; months, beginning on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; and maturing on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; October&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The outstanding balance of the notes as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$40,826&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$76,731,&lt;/div&gt; respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
  <us-gaap:LongTermDebt contextRef="i_2016-12-31" decimals="INF" id="c14652545" unitRef="iso4217-usd">331500</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="i_2016-12-31" decimals="INF" id="c14652543" unitRef="iso4217-usd">331500</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:LongTermNotesPayable contextRef="i_2016-12-31" id="c14651616" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:LongTermNotesPayable contextRef="i_2015-12-31" decimals="INF" id="c14651617" unitRef="iso4217-usd">130000</us-gaap:LongTermNotesPayable>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651922" unitRef="iso4217-usd">-239852</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651923" unitRef="iso4217-usd">12805629</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651905" unitRef="iso4217-usd">-2695822</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651906" unitRef="iso4217-usd">-10013083</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651892" unitRef="iso4217-usd">-10847312</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651893" unitRef="iso4217-usd">-6796479</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651711" unitRef="iso4217-usd">-15173872</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651712" unitRef="iso4217-usd">-8797321</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651761" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c14651762" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651764" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c14651765" unitRef="iso4217-usd">-8797321</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651824" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c14651825" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651827" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NetIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c14651828" unitRef="iso4217-usd">-15173872</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699122">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Recent Accounting Pronouncements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014,&lt;/div&gt; the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/div&gt;&amp;#x201d;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for us on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt; The Company has completed a preliminary review of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; and does not expect the adoption of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; to have a material impact on its revenues and management fees from company clinics or franchise royalty revenues. The Company is currently evaluating the impact of the adoption of this standard on recognition of revenue from franchise agreements, advertising fund revenue, and regional developer fee revenue. The Company is still evaluating its transition approach and expects to reach a decision in the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; half of fiscal &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Presentation of Financial Statements - Going Concern: Disclosures about an Entity&amp;#x2019;s Ability to Continue as a Going Concern&lt;/div&gt;.&amp;#x201d; The new standard requires management to perform interim and annual assessments of an entity&amp;#x2019;s ability to continue as a going concern within &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&amp;#x2019;s ability to continue as a going concern. The new guidance is effective for annual periods ending after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; and interim periods thereafter. The Company adopted this new standard as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; The adoption of this guidance did not have a material impact on the Company&amp;#x2019;s consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued&amp;nbsp;ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;03,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Interest - Imputation of Interest (Subtopic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;835&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;30):&lt;/div&gt; Simplifying the Presentation of Debt Issuance Costs&lt;/div&gt;.&amp;#x201d;&amp;nbsp; The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset.&amp;nbsp; Debt disclosures will include the face amount of the debt liability and the effective interest rate.&amp;nbsp; The update requires retrospective application and represents a change in accounting principle.&amp;nbsp; The update is effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&amp;nbsp; ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;03&lt;/div&gt; did not have a material impact on the Company&amp;#x2019;s consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805):&lt;/div&gt; Simplifying the Accounting for Measurement-Period Adjustments&lt;/div&gt;.&amp;#x201d; The update requires than an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes. The Company adopted this ASU during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;third&lt;/div&gt; quarter of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt; Accordingly, the Company applied the amendments in this update to the measurement period adjustments made during the year and disclosed the adjustments in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;470):&lt;/div&gt; Balance Sheet Classification of Deferred Taxes&lt;/div&gt;.&amp;#x201d; The update eliminates the requirement to separate deferred income tax assets and liabilities into current and noncurrent amounts within a classified balance sheet. Under ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,&lt;/div&gt; the presentation of deferred income taxes is simplified, as all deferred income tax assets and liabilities are to be classified as noncurrent. The existing requirement that deferred income tax assets and liabilities of a tax-paying component of an entity be offset and presented as a single amount is not affected by ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17.&lt;/div&gt; The Company has adopted the guidance under ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17&lt;/div&gt; retrospectively and prior periods were retrospectively adjusted.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 57 --&gt; &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Financial Instruments - Overall (Subtopic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;825&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10),&lt;/div&gt; Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/div&gt;,&amp;#x201d; which addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01&lt;/div&gt; will be effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years, and early adoption is not permitted. The Company is currently evaluating the effect of adoption of this standard, if any, on its consolidated financial position, results of operations or cash flows.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;02,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Leases (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;842).&amp;#x201d;&lt;/div&gt;&lt;/div&gt; The changes require that substantially all operating leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard, which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt; While we have not quantified the impact this proposed standard would have on our consolidated financial statements, if our current operating leases are instead recognized on the consolidated balance sheet, it will result in a significant increase in the liabilities reflected on our consolidated balance sheet and in the interest expense and depreciation and amortization expense reflected in our consolidated statements of operations, while reducing the amount of rent expense. This could potentially decrease our reported net income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting&lt;/div&gt;&amp;#x201d; (&amp;#x201c;ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&amp;#x201d;),&lt;/div&gt; which amends ASC Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,&lt;/div&gt; Compensation &amp;#x2013; Stock Compensation (&amp;#x201c;ASC &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718&amp;#x201d;).&lt;/div&gt; The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the accounting for income taxes, classification of excess tax benefits on the statement of cash flows, forfeitures, statutory tax withholding requirements, classification of awards as either equity or liabilities, and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; is effective for interim and annual reporting periods beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt; Early adoption is permitted. The Company is currently evaluating the method of adoption and impact the update will have on its consolidated financial statements and related disclosures.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606):&lt;/div&gt; Identifying Performance Obligations and Licensing&lt;/div&gt;&amp;#x201d;, to clarify the following &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; aspects of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606:&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1)&lt;/div&gt; identifying performance obligations, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2)&lt;/div&gt; the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt; The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606):&lt;/div&gt; Narrow-Scope Improvements and Practical Expedients&lt;/div&gt;&amp;#x201d;, to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt; The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230):&lt;/div&gt; Classification of Certain Cash Receipts and Cash Payments&amp;#x201d;. &lt;/div&gt;This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt; Early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;18,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230):&lt;/div&gt; Restricted Cash&amp;#x201d;&lt;/div&gt; (a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flow. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 58 --&gt; &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805):&lt;/div&gt; Clarifying the Definition of a Business&amp;#x201d;,&lt;/div&gt; to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NonoperatingIncomeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651705" unitRef="iso4217-usd">13295</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651706" unitRef="iso4217-usd">283266</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651574" unitRef="iso4217-usd">40826</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651575" unitRef="iso4217-usd">60908</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="i_2016-12-31" id="c14651584" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651585" unitRef="iso4217-usd">15823</us-gaap:NotesAndLoansReceivableNetNoncurrent>
  <us-gaap:NotesPayableCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651606" unitRef="iso4217-usd">331500</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651607" unitRef="iso4217-usd">451850</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesReceivableNet contextRef="i_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c14652390" unitRef="iso4217-usd">90000</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote1Member" decimals="INF" id="c14652400" unitRef="iso4217-usd">10000</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member" decimals="INF" id="c14652401" unitRef="iso4217-usd">29925</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingUnsecuredPromissoryNoteMember" decimals="INF" id="c14652408" unitRef="iso4217-usd">29925</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" decimals="INF" id="c14652418" unitRef="iso4217-usd">7500</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2016-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c14652427" unitRef="iso4217-usd">40826</us-gaap:NotesReceivableNet>
  <us-gaap:NotesReceivableNet contextRef="i_2015-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember" decimals="INF" id="c14652428" unitRef="iso4217-usd">76731</us-gaap:NotesReceivableNet>
  <us-gaap:NumberOfOperatingSegments contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652938" unitRef="xbrli-pure">2</us-gaap:NumberOfOperatingSegments>
  <us-gaap:NumberOfReportableSegments contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652945" unitRef="xbrli-pure">2</us-gaap:NumberOfReportableSegments>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="INF" id="c14652941" unitRef="xbrli-pure">61</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="INF" id="c14652944" unitRef="xbrli-pure">309</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652237" unitRef="xbrli-pure">265</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2014-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652238" unitRef="xbrli-pure">242</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember" decimals="INF" id="c14652245" unitRef="xbrli-pure">309</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652247" unitRef="xbrli-pure">47</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2014-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652248" unitRef="xbrli-pure">4</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember" decimals="INF" id="c14652255" unitRef="xbrli-pure">61</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2016-12-31" decimals="INF" id="c14652257" unitRef="xbrli-pure">370</us-gaap:NumberOfStores>
  <us-gaap:NumberOfStores contextRef="i_2015-12-31" decimals="INF" id="c14652258" unitRef="xbrli-pure">312</us-gaap:NumberOfStores>
  <us-gaap:OpenTaxYear contextRef="d_2016-01-01_2016-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember_TaxPeriodAxis-EarliestTaxYearMember" id="c14652785">2012</us-gaap:OpenTaxYear>
  <us-gaap:OpenTaxYear contextRef="d_2016-01-01_2016-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember_TaxPeriodAxis-LatestTaxYearMember" id="c14652786">2013</us-gaap:OpenTaxYear>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651698" unitRef="iso4217-usd">-15022738</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651699" unitRef="iso4217-usd">-9316442</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652957" unitRef="iso4217-usd">-9736000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652958" unitRef="iso4217-usd">-3773000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652959" unitRef="iso4217-usd">4638000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652960" unitRef="iso4217-usd">4234000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652961" unitRef="iso4217-usd">-5098000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2015-01-01_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652962" unitRef="iso4217-usd">461000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember" decimals="-3" id="c14652975" unitRef="iso4217-usd">-9925000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="d_2015-01-01_2015-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember" decimals="-3" id="c14652976" unitRef="iso4217-usd">-9777000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="i_2016-12-31" decimals="INF" id="c14652936" unitRef="iso4217-usd">19048079</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="i_2016-12-31" decimals="INF" id="c14652930" unitRef="iso4217-usd">3180100</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="i_2016-12-31" decimals="INF" id="c14652934" unitRef="iso4217-usd">1868976</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="i_2016-12-31" decimals="INF" id="c14652933" unitRef="iso4217-usd">1982392</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="i_2016-12-31" decimals="INF" id="c14652932" unitRef="iso4217-usd">2248195</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="i_2016-12-31" decimals="INF" id="c14652931" unitRef="iso4217-usd">2587425</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="i_2016-12-31" decimals="INF" id="c14652935" unitRef="iso4217-usd">7180991</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652908" unitRef="iso4217-usd">3389971</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652909" unitRef="iso4217-usd">1574803</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLossCarryforwards contextRef="i_2016-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember" decimals="INF" id="c14652764" unitRef="iso4217-usd">22613000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards contextRef="i_2016-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember" decimals="INF" id="c14652765" unitRef="iso4217-usd">24948000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462450">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Nature of Operations and Summary of Significant Accounting Policies&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Principles of Consolidation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; LLC (collectively, the &amp;#x201c;Company&amp;#x201d;), which was dormant for all periods presented.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from selling and marketing expenses to general and administrative expenses for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; to conform to current year presentation.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;Net loss and comprehensive loss are the same for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Nature of Operations&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Joint Corp., a Delaware corporation, was formed on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2010.&lt;/div&gt; Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015:&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;242&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;54&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(7&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" margin: 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;21&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;312&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinic licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;168&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 51 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Management's Plans&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company had cash and short-term bank deposits of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.0&lt;/div&gt; million. To preserve cash, the Company does not plan to add any company-owned or managed clinics during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; fiscal year. Additionally, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company made the decision to close or sell &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics in Chicago and New York. As a result, the Company has significantly reduced its estimated cash needs for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; to approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.0&lt;/div&gt; million. The cash used in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; included expenditures for the acquisition or development of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; company-owned or managed clinics, and the working capital losses in the Chicago and New York markets which amounted to approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.8&lt;/div&gt; million for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; As the Company has no current plans to acquire or develop company-owned or managed clinics during &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; and has sold or closed the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics in the Chicago and New York markets, the Company&amp;#x2019;s projected use of cash in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; is significantly lower than the amount of cash used in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; Furthermore, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the Company executed a Credit and Security Agreement which provided a credit facility of up to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5.0&lt;/div&gt; million. Taking into account these tactical decisions made by the Company&amp;#x2019;s management, as well as the execution of the credit facility, the Company has concluded that it can continue as a going concern for at least &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year from the date that the financial statements were available to be issued.&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&amp;nbsp;variable interest entity&amp;nbsp;(&amp;#x201c;VIE&amp;#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary are accounted for under the equity method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Certain states in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides on an exclusive basis, all non-clinical services of the chiropractic practice.&amp;nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&amp;#x2019;s consolidated financial statements&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Cash and Cash Equivalents&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company considers all highly liquid instruments purchased with an original maturity of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company has invested substantially all of the proceeds of its public offerings in short-term bank deposits. The Company had no cash equivalents as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Cash&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&amp;#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;From time to time the Company grants credit in the normal course of business to PCs or franchisees related to the working capital needs of the PC, collection of royalties, or other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the PCs or franchisees to reduce credit risk. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; PC entity, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; franchisees represented &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24%&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31%,&lt;/div&gt; respectively, of outstanding accounts receivable. The Company did not have any PCs or franchisees that represented greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; of our revenues during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which we perform management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&amp;#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company had an allowance for doubtful accounts of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$131,830&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$142,660,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 52 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company determined that certain working capital advances from its PC entities in Illinois and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$731,857&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Franchise Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Property and Equipment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Software Developed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Intangible Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&amp;nbsp;&amp;nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;eight&lt;/div&gt; years. The Company amortizes the acquired regional developer rights over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. The fair value of customer relationships is amortized over their estimated useful life of&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt;&amp;nbsp;years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$38,185&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; related to closure of an acquired clinic in New York.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&amp;nbsp;&amp;nbsp;Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; day of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;fourth&lt;/div&gt; quarter or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company recorded an impairment charge of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$54,994&lt;/div&gt; during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 53 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Long-Lived Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; not be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.4&lt;/div&gt; million and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0&lt;/div&gt; were recorded for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Fund&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Co-Op Marketing Funds&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&amp;#x2019; officers. The marketing funds are included in restricted cash on the Company&amp;#x2019;s consolidated balance sheets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounting for Costs Associated with Exit or Disposal Activities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;Costs to terminate an operating lease or other contracts are (a)&amp;nbsp;costs to terminate the contract before the end of its term or (b)&amp;nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; the Company recognized a liability of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.3&lt;/div&gt; million related to operating leases that will no longer provide economic benefit to the entity, net of estimated sublease income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Rent&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; include rent holidays and rent escalation clauses.&amp;nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&amp;nbsp; The Company records &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;tenant&lt;/div&gt; improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Franchise Fees.&lt;/div&gt; The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&amp;nbsp;&amp;nbsp;The Company&amp;#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 54 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Regional Developer Fees&lt;/div&gt;. During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2011,&lt;/div&gt; the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$7,250&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;25%&lt;/div&gt; of the then current franchise fee, for each franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive fees ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$14,500&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$19,950&lt;/div&gt; which are collected from franchisees upon the sale of franchises within their region and a royalty of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3%&lt;/div&gt; of sales generated by franchised clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. The franchisor&amp;#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&amp;#x2019;s license.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenues and Management Fees from Company Clinics.&amp;nbsp;&amp;nbsp;&lt;/div&gt;The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&amp;nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&amp;nbsp; Amounts collected up front for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&amp;nbsp;&amp;nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&amp;#x2019;s PC.&amp;nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&amp;#x2019;s PC in return for a monthly management fee.&amp;nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Royalties.&lt;/div&gt; The Company collects royalties, as stipulated in the franchise agreement, equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7%&lt;/div&gt; of gross sales, and a marketing and advertising fee currently equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2%&lt;/div&gt; of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; working days after each sales period has ended.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;div style="display: inline; font-style: italic;"&gt;IT Related Income and Software Fees.&lt;/div&gt;&amp;nbsp;&amp;nbsp;The Company collects a monthly computer software fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&amp;#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&amp;nbsp;upon receipt of equipment by the franchisee.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Advertising Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Advertising costs are expensed as incurred. Advertising expenses for years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; were &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2,279,572&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,525,687,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 55 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt; likelihood of being realized upon ultimate resolution.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Loss per Common Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(8,797,321&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 56 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Recent Accounting Pronouncements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014,&lt;/div&gt; the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/div&gt;&amp;#x201d;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for us on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt; The Company has completed a preliminary review of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; and does not expect the adoption of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; to have a material impact on its revenues and management fees from company clinics or franchise royalty revenues. The Company is currently evaluating the impact of the adoption of this standard on recognition of revenue from franchise agreements, advertising fund revenue, and regional developer fee revenue. The Company is still evaluating its transition approach and expects to reach a decision in the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; half of fiscal &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Presentation of Financial Statements - Going Concern: Disclosures about an Entity&amp;#x2019;s Ability to Continue as a Going Concern&lt;/div&gt;.&amp;#x201d; The new standard requires management to perform interim and annual assessments of an entity&amp;#x2019;s ability to continue as a going concern within &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&amp;#x2019;s ability to continue as a going concern. The new guidance is effective for annual periods ending after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; and interim periods thereafter. The Company adopted this new standard as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; The adoption of this guidance did not have a material impact on the Company&amp;#x2019;s consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued&amp;nbsp;ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;03,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Interest - Imputation of Interest (Subtopic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;835&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;30):&lt;/div&gt; Simplifying the Presentation of Debt Issuance Costs&lt;/div&gt;.&amp;#x201d;&amp;nbsp; The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset.&amp;nbsp; Debt disclosures will include the face amount of the debt liability and the effective interest rate.&amp;nbsp; The update requires retrospective application and represents a change in accounting principle.&amp;nbsp; The update is effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt;&amp;nbsp; ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;03&lt;/div&gt; did not have a material impact on the Company&amp;#x2019;s consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; September,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;16,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805):&lt;/div&gt; Simplifying the Accounting for Measurement-Period Adjustments&lt;/div&gt;.&amp;#x201d; The update requires than an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes. The Company adopted this ASU during the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;third&lt;/div&gt; quarter of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015.&lt;/div&gt; Accordingly, the Company applied the amendments in this update to the measurement period adjustments made during the year and disclosed the adjustments in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Income Taxes (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;470):&lt;/div&gt; Balance Sheet Classification of Deferred Taxes&lt;/div&gt;.&amp;#x201d; The update eliminates the requirement to separate deferred income tax assets and liabilities into current and noncurrent amounts within a classified balance sheet. Under ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,&lt;/div&gt; the presentation of deferred income taxes is simplified, as all deferred income tax assets and liabilities are to be classified as noncurrent. The existing requirement that deferred income tax assets and liabilities of a tax-paying component of an entity be offset and presented as a single amount is not affected by ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17.&lt;/div&gt; The Company has adopted the guidance under ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17&lt;/div&gt; retrospectively and prior periods were retrospectively adjusted.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 57 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Financial Instruments - Overall (Subtopic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;825&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10),&lt;/div&gt; Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/div&gt;,&amp;#x201d; which addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01&lt;/div&gt; will be effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years, and early adoption is not permitted. The Company is currently evaluating the effect of adoption of this standard, if any, on its consolidated financial position, results of operations or cash flows.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; February,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;02,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Leases (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;842).&amp;#x201d;&lt;/div&gt;&lt;/div&gt; The changes require that substantially all operating leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard, which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018.&lt;/div&gt; While we have not quantified the impact this proposed standard would have on our consolidated financial statements, if our current operating leases are instead recognized on the consolidated balance sheet, it will result in a significant increase in the liabilities reflected on our consolidated balance sheet and in the interest expense and depreciation and amortization expense reflected in our consolidated statements of operations, while reducing the amount of rent expense. This could potentially decrease our reported net income.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting&lt;/div&gt;&amp;#x201d; (&amp;#x201c;ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&amp;#x201d;),&lt;/div&gt; which amends ASC Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718,&lt;/div&gt; Compensation &amp;#x2013; Stock Compensation (&amp;#x201c;ASC &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;718&amp;#x201d;).&lt;/div&gt; The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the accounting for income taxes, classification of excess tax benefits on the statement of cash flows, forfeitures, statutory tax withholding requirements, classification of awards as either equity or liabilities, and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09&lt;/div&gt; is effective for interim and annual reporting periods beginning &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt; Early adoption is permitted. The Company is currently evaluating the method of adoption and impact the update will have on its consolidated financial statements and related disclosures.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; April,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606):&lt;/div&gt; Identifying Performance Obligations and Licensing&lt;/div&gt;&amp;#x201d;, to clarify the following &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; aspects of Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606:&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1)&lt;/div&gt; identifying performance obligations, and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2)&lt;/div&gt; the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt; The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Revenue from Contracts with Customers (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;606):&lt;/div&gt; Narrow-Scope Improvements and Practical Expedients&lt;/div&gt;&amp;#x201d;, to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;09.&lt;/div&gt; The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; August,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic;"&gt;&amp;#x201c;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230):&lt;/div&gt; Classification of Certain Cash Receipts and Cash Payments&amp;#x201d;. &lt;/div&gt;This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt; Early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;18,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Statement of Cash Flows (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;230):&lt;/div&gt; Restricted Cash&amp;#x201d;&lt;/div&gt; (a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flow. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 58 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the FASB issued ASU No. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt;-&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;01,&lt;/div&gt; &amp;#x201c;&lt;div style="display: inline; font-style: italic;"&gt;Business Combinations (Topic &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;805):&lt;/div&gt; Clarifying the Definition of a Business&amp;#x201d;,&lt;/div&gt; to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:OtherAssets contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652996" unitRef="iso4217-usd">991000</us-gaap:OtherAssets>
  <us-gaap:OtherAssets contextRef="i_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652997" unitRef="iso4217-usd">376000</us-gaap:OtherAssets>
  <us-gaap:OtherIncome contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651677" unitRef="iso4217-usd">269016</us-gaap:OtherIncome>
  <us-gaap:OtherIncome contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651678" unitRef="iso4217-usd">331700</us-gaap:OtherIncome>
  <us-gaap:OtherLiabilitiesCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651612" unitRef="iso4217-usd">60894</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651613" unitRef="iso4217-usd">54596</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="i_2016-12-31" decimals="INF" id="c14651624" unitRef="iso4217-usd">512362</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="i_2015-12-31" decimals="INF" id="c14651625" unitRef="iso4217-usd">238648</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651703" unitRef="iso4217-usd">13295</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651704" unitRef="iso4217-usd">22119</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherSalesRevenueNet contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651665" unitRef="iso4217-usd">8578048</us-gaap:OtherSalesRevenueNet>
  <us-gaap:OtherSalesRevenueNet contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651666" unitRef="iso4217-usd">3651273</us-gaap:OtherSalesRevenueNet>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651914" unitRef="iso4217-usd">83391</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="d_2015-01-01_2015-12-31" id="c14651915" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651912" unitRef="iso4217-usd">1042</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="d_2015-01-01_2015-12-31" id="c14651913" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" decimals="INF" id="c14652285" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" decimals="INF" id="c14652306" unitRef="iso4217-usd">4925525</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651960" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember" decimals="INF" id="c14651974" unitRef="iso4217-usd">4925525</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651895" unitRef="iso4217-usd">839000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651896" unitRef="iso4217-usd">4925525</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651899" unitRef="iso4217-usd">1567727</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651900" unitRef="iso4217-usd">4065946</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="i_2016-12-31" decimals="INF" id="c14651634" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="i_2015-12-31" decimals="INF" id="c14651635" unitRef="iso4217-usd-per-xbrli-shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="i_2016-12-31" decimals="INF" id="c14651636" unitRef="xbrli-shares">50000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized contextRef="i_2015-12-31" decimals="INF" id="c14651637" unitRef="xbrli-shares">50000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="i_2016-12-31" decimals="INF" id="c14651638" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued contextRef="i_2015-12-31" decimals="INF" id="c14651639" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="i_2016-12-31" decimals="INF" id="c14651640" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="i_2015-12-31" decimals="INF" id="c14651641" unitRef="xbrli-shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue contextRef="i_2016-12-31" id="c14651632" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PreferredStockValue contextRef="i_2015-12-31" id="c14651633" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i_2016-12-31" decimals="INF" id="c14651578" unitRef="iso4217-usd">499525</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="i_2015-12-31" decimals="INF" id="c14651579" unitRef="iso4217-usd">366033</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromCollectionOfNotesReceivable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651903" unitRef="iso4217-usd">35905</us-gaap:ProceedsFromCollectionOfNotesReceivable>
  <us-gaap:ProceedsFromCollectionOfNotesReceivable contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651904" unitRef="iso4217-usd">42388</us-gaap:ProceedsFromCollectionOfNotesReceivable>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="d_2016-01-01_2016-12-31" id="c14651908" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651909" unitRef="iso4217-usd">14374998</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ProceedsFromSaleOfIntangibleAssets contextRef="d_2017-01-06_2017-01-06_FiniteLivedIntangibleAssetsByMajorClassAxis-ChicagoRegionalDeveloperRightsMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember" decimals="INF" id="c14653014" unitRef="iso4217-usd">300000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="d_2016-01-01_2016-12-31" id="c14651901" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651902" unitRef="iso4217-usd">11500</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfTreasuryStock contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651916" unitRef="iso4217-usd">210000</us-gaap:ProceedsFromSaleOfTreasuryStock>
  <us-gaap:ProceedsFromSaleOfTreasuryStock contextRef="d_2015-01-01_2015-12-31" id="c14651917" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651918" unitRef="iso4217-usd">70931</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651919" unitRef="iso4217-usd">534</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462460">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Property and Equipment&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment consist of the following:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Office and computer equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,083,039&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;963,299&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,085,366&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,672,582&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Software developed&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;891,192&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;691,827&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,059,597&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,327,708&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Accumulated depreciation&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,566,172&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,098,438&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,493,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,229,270&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Construction in progress&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;231,281&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,909,476&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,724,706&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,138,746&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Depreciation expense was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,818,403&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$792,794&lt;/div&gt; for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company determined that &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14&lt;/div&gt; clinics from its Corporate Clinics segment, met the criteria for classification as held for sale. Accordingly, in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company recognized a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.4&lt;/div&gt; million impairment charge to lower the carrying costs of the property and equipment to its estimated fair value less cost to sell which is recorded in the loss on disposition or impairment line of the accompanying consolidated statement of operations. The Company completed the sale of the property in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017&lt;/div&gt; for nominal consideration.&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember" decimals="INF" id="c14652442" unitRef="iso4217-usd">1083039</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember" decimals="INF" id="c14652443" unitRef="iso4217-usd">963299</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" decimals="INF" id="c14652444" unitRef="iso4217-usd">5085366</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember" decimals="INF" id="c14652445" unitRef="iso4217-usd">4672582</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember" decimals="INF" id="c14652446" unitRef="iso4217-usd">891192</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember" decimals="INF" id="c14652447" unitRef="iso4217-usd">691827</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2016-12-31" decimals="INF" id="c14652448" unitRef="iso4217-usd">7059597</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="i_2015-12-31" decimals="INF" id="c14652449" unitRef="iso4217-usd">6327708</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31" decimals="INF" id="c14651582" unitRef="iso4217-usd">4724706</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2015-12-31" decimals="INF" id="c14651583" unitRef="iso4217-usd">7138746</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember" decimals="INF" id="c14652452" unitRef="iso4217-usd">4493425</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember" decimals="INF" id="c14652453" unitRef="iso4217-usd">5229270</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652994" unitRef="iso4217-usd">781000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="i_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember" decimals="-3" id="c14652995" unitRef="iso4217-usd">802000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699067">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Property and Equipment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-23">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Office and computer equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,083,039&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;963,299&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Leasehold improvements&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,085,366&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,672,582&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Software developed&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;891,192&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;691,827&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,059,597&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,327,708&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Accumulated depreciation&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2,566,172&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1,098,438&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,493,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,229,270&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Construction in progress&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;231,281&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,909,476&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,724,706&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,138,746&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember" id="c14652070">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="d_2015-01-01_2015-12-31_RangeAxis-MaximumMember" id="c14652071">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651841" unitRef="iso4217-usd">-10830</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651842" unitRef="iso4217-usd">61629</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-38">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,936&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,426&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,003&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,580&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt"&gt;Total segment assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,939&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,006&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Unallocated cash and cash equivalents and restricted cash&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,344&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,178&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Unallocated property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;781&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;802&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Other unallocated assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;376&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"&gt;Total assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,055&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,362&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652890" unitRef="iso4217-usd">461000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652891" unitRef="iso4217-usd">643000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462479">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Related Party Transactions&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company entered into consulting and legal arrangements with certain stockholders related to services performed for the operations and transaction related activities of the Company.&amp;nbsp;&amp;nbsp;Amounts paid to or for the benefit of these stockholders was approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$461,000&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$643,000&lt;/div&gt; for the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; respectively.&amp;nbsp;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:RepaymentsOfNotesPayable contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651920" unitRef="iso4217-usd">436350</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfNotesPayable contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651921" unitRef="iso4217-usd">218500</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="i_2016-12-31" decimals="INF" id="c14651568" unitRef="iso4217-usd">334394</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="i_2015-12-31" decimals="INF" id="c14651569" unitRef="iso4217-usd">385282</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2016-12-31" decimals="INF" id="c14651658" unitRef="iso4217-usd">-28983374</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="i_2015-12-31" decimals="INF" id="c14651659" unitRef="iso4217-usd">-13809502</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="d_2016-01-01_2016-12-31" id="c14699111">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:RevenueRecognitionServicesCommissions contextRef="d_2016-01-01_2016-12-31" id="c14699066">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Deferred Franchise Costs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionServicesCommissions>
  <us-gaap:RevenueRecognitionServicesFranchiseFees contextRef="d_2016-01-01_2016-12-31" id="c14699112">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;Franchise Fees.&lt;/div&gt; The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;ten&lt;/div&gt; years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&amp;nbsp;&amp;nbsp;The Company&amp;#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionServicesFranchiseFees>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651679" unitRef="iso4217-usd">20523640</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651680" unitRef="iso4217-usd">13835431</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652950" unitRef="iso4217-usd">8550000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember" decimals="-3" id="c14652951" unitRef="iso4217-usd">3492000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652952" unitRef="iso4217-usd">11974000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember" decimals="-3" id="c14652953" unitRef="iso4217-usd">10344000</us-gaap:Revenues>
  <us-gaap:RoyaltyRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651667" unitRef="iso4217-usd">5973079</us-gaap:RoyaltyRevenue>
  <us-gaap:RoyaltyRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651668" unitRef="iso4217-usd">4515203</us-gaap:RoyaltyRevenue>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-20">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Unvested restricted stock&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Warrants&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-32">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Current provision (benefit):&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22,800&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(208,900&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;State, net of state tax credits&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(67,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total current provision (benefit)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;43,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(276,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred provision:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Federal&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;97,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;State&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;23,300&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total deferred provision&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision (benefit)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(235,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-33">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Deferred revenue&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,509,400&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,988,200&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred franchise costs&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(553,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(664,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Allowance for doubtful accounts&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;51,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,781,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Accrued expenses&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;57,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;74,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - Component 1&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Goodwill - Component 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;87,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock compensation&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(30,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(44,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Nonqualified stock options&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;182,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;109,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred rent&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;629,600&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;209,700&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease abandonment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,924,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,849,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Tax credits&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;14,200&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Charitable contribution carryover&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,300&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Asset basis difference related to property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;630,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;167,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,496,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,574,400&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Less valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(11,617,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,574,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net non-current deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(120,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-19">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Net loss&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,173,872&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(8,797,321&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Weighted average common shares outstanding - basic&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of dilutive securities:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Stock options&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding - diluted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,696,649&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,042,001&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Basic and diluted loss per share&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-34">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;For the Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Percent&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Percent&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Expected federal tax expense (benefit)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,106,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,071,300&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(34.00&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;State tax provision, net of federal benefit&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(735,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.90&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(387,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(4.29&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of increase in valuation allowance&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,042,900&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;40.24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,519,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;38.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Permanent differences&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;108,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.72&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(58,800&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.65&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Uncertain tax positions&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(46,500&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.51&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of changed state rates for deferred&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(80,100&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.89&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Other, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(145,700&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(0.97&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(111,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(1.23&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Provision (Benefit)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;164,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.09&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(235,900&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2.60&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)%&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-18">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Franchised clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;242&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;56&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;54&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(7&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;265&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; &amp;nbsp;December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;Company-owned or managed clinics:&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Clinics in operation at beginning of period&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Opened during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;21&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Acquired during the period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;24&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Closed during the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(2&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;47&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total clinics in operation at the end of the period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;370&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;312&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Clinic licenses sold but not yet developed&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;115&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;168&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFranchisorDisclosureTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-36">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 20%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,180,100&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,587,425&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,248,195&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,982,392&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,868,976&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7,180,991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;19,048,079&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-24">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;As of December 31, 2016&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Gross Carrying&lt;br /&gt; Amount&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Accumulated&lt;br /&gt; Amortization&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Net Carrying&lt;br /&gt; Value&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Amortized intangible assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 52%; font-size: 10pt; text-align: left"&gt;Reacquired franchise rights&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,911,750&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;444,795&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,466,955&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Customer relationships&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;701,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;509,042&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;191,958&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Reacquired development rights&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;923,250&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;243,241&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;680,009&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,536,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,197,078&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-26">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 78%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 18%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;331,500&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;331,500&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" id="c-17">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 74%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Property and equipment&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 22%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;(53,836&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;)&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Intangible assets&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;4,820&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Favorable leases&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;6,250&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Goodwill&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;68,616&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;Unfavorable leases&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;$&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;(25,850&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-size: 9pt"&gt;)&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-21">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;293,014&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;140,728&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;269,780&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,042,522&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(45,072&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;997,450&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;Property and equipment&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,450,333&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Intangible assets&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,947,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Favorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;528,075&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Goodwill&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,899,449&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Total assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,824,857&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Unfavorable leases&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(74,927&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Deferred membership revenue&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(106,908&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Net assets acquired&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,643,022&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax liability&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(168,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Bargain purchase gain&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(261,147&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Net purchase price&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5,213,875&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-37">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Revenues:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,550&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,492&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,974&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,344&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total revenues&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,524&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,836&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment operating (loss) income:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,736&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,773&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,638&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,234&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,098&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;461&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Depreciation and amortization:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,186&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;986&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Corporate administration&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;380&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;283&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total depreciation and amortization&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,566&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,269&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Reconciliation of total segment operating (loss) income to consolidated loss before income taxes (in thousands):&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,098&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;461&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Unallocated corporate&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,925&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,777&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Consolidated loss from operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,023&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,316&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Bargain purchase gain&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;261&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Other income, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Loss before income tax expense&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,010&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,033&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-28">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Number of&lt;br /&gt; Shares&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise&lt;br /&gt; Price&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Fair&lt;br /&gt; Value&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Remaining&lt;br /&gt; Contractual Life&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 44%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;314,775&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.23&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.92&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9.2&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;240,160&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.16&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(445&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(77,031&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7.88&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.30&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.7&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.22&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,824&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(146,560&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.34&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.66&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.86&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;347,272&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.07&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.38&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-27">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected volatility&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;44%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected dividends&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Expected term (years)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.5&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; -&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Risk-free rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.19%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.68%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.54%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Forfeiture rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-29">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid"&gt;Restricted Stock Awards&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Shares&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 82%; font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;662,375&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited or exercised&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Granted at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;670,375&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(331,087&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,415&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(162,440&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(170,848&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-31">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Number of &lt;br /&gt; Units&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise Price&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Remaining &lt;br /&gt; Contractual Term&lt;br /&gt; (in years)&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Intrinsic &lt;br /&gt; Value&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.9&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ScheduleOfTreasuryStockByClassTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-30">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 84%; font-size: 10pt"&gt;Year 1&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.56&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.68&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 3&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.84&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 4&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.03&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 5&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.28&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 6&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.59&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 7&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 8&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.45&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
  <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-35">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Tax&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Interest/&lt;br /&gt; penalties&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Unrecognized tax benefit - January 1&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;91,700&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;30,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Gross increases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Gross decreases - tax positions in prior period&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(19,400&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(6,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(59,100&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Unrecognized tax benefit - December 31&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,200&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;26,800&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;32,600&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
  <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="d_2016-01-01_2016-12-31" id="c-25">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 80%; font-size: 10pt; text-align: left"&gt;2017&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 16%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;578,881&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2018&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;439,589&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2019&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;413,256&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;348,034&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Thereafter&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;145,906&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,338,922&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462482">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&amp;#x201c;CODM&amp;#x201d;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments. The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company operated or managed &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;61&lt;/div&gt; clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the franchise system consisted of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;309&lt;/div&gt; clinics in operation. Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&amp;#x2019;s &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support the Company as a publicly traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 70 --&gt;   &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The tables below present financial information for the Company&amp;#x2019;s &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; operating business segments (in thousands):&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Year Ended&lt;br /&gt; December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Revenues:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,550&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,492&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,974&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,344&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total revenues&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20,524&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,836&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment operating (loss) income:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,736&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(3,773&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,638&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4,234&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,098&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;461&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Depreciation and amortization:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,186&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;986&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Corporate administration&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;380&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;283&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total depreciation and amortization&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,566&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,269&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Reconciliation of total segment operating (loss) income to consolidated loss before income taxes (in thousands):&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Total segment operating (loss) income&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(5,098&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;461&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Unallocated corporate&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,925&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,777&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Consolidated loss from operations&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,023&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,316&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Bargain purchase gain&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;261&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt"&gt;Other income, net&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;22&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;Loss before income tax expense&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(15,010&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(9,033&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;December 31,&lt;br /&gt; 2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Segment assets:&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Corporate clinics&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,936&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,426&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Franchise operations&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,003&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2,580&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt"&gt;Total segment assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11,939&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,006&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Unallocated cash and cash equivalents and restricted cash&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,344&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,178&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;Unallocated property and equipment&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;781&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;802&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt"&gt;Other unallocated assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;991&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;376&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"&gt;Total assets&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;17,055&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;33,362&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;#x201c;Unallocated cash and cash equivalents and restricted cash&amp;#x201d; relates primarily to corporate cash and cash equivalents and restricted cash (see Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1),&lt;/div&gt; &amp;#x201c;unallocated property and equipment&amp;#x201d; relates primarily to corporate fixed assets, and &amp;#x201c;other unallocated assets&amp;#x201d; relates primarily to deposits, prepaid and other assets.&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:SellingAndMarketingExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651688" unitRef="iso4217-usd">4419180</us-gaap:SellingAndMarketingExpense>
  <us-gaap:SellingAndMarketingExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651689" unitRef="iso4217-usd">2843613</us-gaap:SellingAndMarketingExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651694" unitRef="iso4217-usd">29086399</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651695" unitRef="iso4217-usd">20331960</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ShareBasedCompensation contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651861" unitRef="iso4217-usd">1123481</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651862" unitRef="iso4217-usd">825145</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652608" unitRef="iso4217-usd">412000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" id="c14652585">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" id="c14656187">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652727" unitRef="xbrli-shares">170848</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652720" unitRef="xbrli-shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652722" unitRef="xbrli-shares">670375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652725" unitRef="xbrli-shares">86415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652741" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652749" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652742" unitRef="iso4217-usd-per-xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652750" unitRef="iso4217-usd-per-xbrli-shares" xs:nil="true"/>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2014-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652719" unitRef="xbrli-shares">662375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2015-12-31" decimals="INF" id="c14652724" unitRef="xbrli-shares">339288</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652728" unitRef="xbrli-shares">92415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2014-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652737" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652745" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652753" unitRef="xbrli-shares">90000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2014-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652738" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652746" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" decimals="INF" id="c14652754" unitRef="iso4217-usd-per-xbrli-shares">8.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2014-01-01_2014-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652739">P3Y328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652747">P2Y328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember" id="c14652755">P1Y328D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652723" unitRef="xbrli-shares">331087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652726" unitRef="xbrli-shares">162440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c14652656" unitRef="xbrli-pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="4" id="c14652659" unitRef="xbrli-pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c14652649" unitRef="xbrli-pure">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c14652651" unitRef="xbrli-pure">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c14652652" unitRef="xbrli-pure">0.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c14652654" unitRef="xbrli-pure">0.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c14652667" unitRef="xbrli-pure">0.0119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c14652669" unitRef="xbrli-pure">0.0168</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" decimals="4" id="c14652670" unitRef="xbrli-pure">0.0154</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" decimals="4" id="c14652672" unitRef="xbrli-pure">0.0201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652584" unitRef="xbrli-shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14656188" unitRef="xbrli-shares">12345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="i_2014-05-15_PlanNameAxis-The2012PlanMember" decimals="INF" id="c14652553" unitRef="xbrli-shares">1513000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652715" unitRef="xbrli-shares">347272</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652716" unitRef="iso4217-usd-per-xbrli-shares">4.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652691" unitRef="xbrli-shares">77031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652707" unitRef="xbrli-shares">146560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652692" unitRef="iso4217-usd-per-xbrli-shares">7.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652708" unitRef="iso4217-usd-per-xbrli-shares">4.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652557" unitRef="xbrli-shares">240160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652562" unitRef="xbrli-shares">660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652683" unitRef="xbrli-shares">240160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652699" unitRef="xbrli-shares">660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="i_2016-12-31" decimals="INF" id="c14652570" unitRef="iso4217-usd">347724</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652679" unitRef="xbrli-shares">314775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652695" unitRef="xbrli-shares">477459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652711" unitRef="xbrli-shares">953075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652680" unitRef="iso4217-usd-per-xbrli-shares">2.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652696" unitRef="iso4217-usd-per-xbrli-shares">4.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652712" unitRef="iso4217-usd-per-xbrli-shares">3.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652688" unitRef="iso4217-usd-per-xbrli-shares">1.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652704" unitRef="iso4217-usd-per-xbrli-shares">1.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652684" unitRef="iso4217-usd-per-xbrli-shares">8.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652700" unitRef="iso4217-usd-per-xbrli-shares">3.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="d_2016-01-01_2016-12-31" id="c14699120">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SharePrice contextRef="i_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652586" unitRef="iso4217-usd-per-xbrli-shares">9.62</us-gaap:SharePrice>
  <us-gaap:SharePrice contextRef="i_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14656189" unitRef="iso4217-usd-per-xbrli-shares">3.10</us-gaap:SharePrice>
  <us-gaap:SharePrice contextRef="i_2013-12-31" decimals="INF" id="c14652620" unitRef="iso4217-usd-per-xbrli-shares">0.45</us-gaap:SharePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-FormerChiefExecutiveOfficerMember" decimals="INF" id="c14652606" unitRef="xbrli-shares">9733</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14652587" unitRef="iso4217-usd">76960</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember" decimals="INF" id="c14656190" unitRef="iso4217-usd">268000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652662">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember" id="c14652664">P5Y182D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember" id="c14652666">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652718">P3Y328D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2014-01-01_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652682">P9Y73D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652698">P8Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" id="c14652714">P6Y328D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2014-01-01_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652681" unitRef="iso4217-usd-per-xbrli-shares">0.92</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652697" unitRef="iso4217-usd-per-xbrli-shares">2.01</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652713" unitRef="iso4217-usd-per-xbrli-shares">1.86</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
  <us-gaap:SharesOutstanding contextRef="i_2014-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651718" unitRef="xbrli-shares">10196510</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2014-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651721" unitRef="xbrli-shares">534000</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651767" unitRef="xbrli-shares">13070180</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651770" unitRef="xbrli-shares">534000</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651830" unitRef="xbrli-shares">13317393</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651833" unitRef="xbrli-shares">296504</us-gaap:SharesOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c14651984" unitRef="xbrli-shares">46948</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651732" unitRef="xbrli-shares">2613636</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651735" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651816" unitRef="xbrli-shares">46948</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651746" unitRef="xbrli-shares">259589</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651749" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651781" unitRef="xbrli-shares">162441</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652687" unitRef="xbrli-shares">445</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember" decimals="INF" id="c14652703" unitRef="xbrli-shares">37824</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651754" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651755" unitRef="xbrli-shares">534</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651757" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651758" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651759" unitRef="xbrli-shares">534</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651789" unitRef="xbrli-shares">38</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651790" unitRef="xbrli-shares">70893</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651792" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651793" unitRef="xbrli-shares" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651794" unitRef="xbrli-shares">70931</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c14652629" unitRef="xbrli-shares">250872</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651812" unitRef="xbrli-shares">250872</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c14651985" unitRef="iso4217-usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651733" unitRef="iso4217-usd">2614</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651734" unitRef="iso4217-usd">13020981</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651736" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651737" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651738" unitRef="iso4217-usd">13023595</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651817" unitRef="iso4217-usd">47</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651818" unitRef="iso4217-usd">99953</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651820" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651821" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651822" unitRef="iso4217-usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651747" unitRef="iso4217-usd">260</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651748" unitRef="iso4217-usd">-260</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651750" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651751" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2015-01-01_2015-12-31" id="c14651752" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651782" unitRef="iso4217-usd">162</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651783" unitRef="iso4217-usd">-162</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651785" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651786" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="d_2016-01-01_2016-12-31" id="c14651787" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651753" unitRef="iso4217-usd">445</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" id="c14651756" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651788" unitRef="iso4217-usd">37824</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31" decimals="INF" id="c14652630" unitRef="iso4217-usd">210000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14652631" unitRef="iso4217-usd">113000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14656236" unitRef="iso4217-usd">162000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651810" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651811" unitRef="iso4217-usd">-161911</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651813" unitRef="iso4217-usd">371911</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651814" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651815" unitRef="iso4217-usd">210000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="d_2013-01-01_2013-12-31" decimals="INF" id="c14652619" unitRef="xbrli-shares">534000</us-gaap:StockRepurchasedDuringPeriodShares>
  <us-gaap:StockRepurchasedDuringPeriodValue contextRef="d_2013-01-01_2013-12-31" decimals="INF" id="c14652621" unitRef="iso4217-usd">240000</us-gaap:StockRepurchasedDuringPeriodValue>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31" decimals="INF" id="c14651660" unitRef="iso4217-usd">6925413</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31" decimals="INF" id="c14651661" unitRef="iso4217-usd">20679306</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2014-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651719" unitRef="iso4217-usd">10197</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2014-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651720" unitRef="iso4217-usd">21420975</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2014-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651722" unitRef="iso4217-usd">-791638</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2014-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c14651723" unitRef="iso4217-usd">-5012181</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2014-12-31" decimals="INF" id="c14651724" unitRef="iso4217-usd">15627353</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651768" unitRef="iso4217-usd">13070</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651769" unitRef="iso4217-usd">35267376</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651771" unitRef="iso4217-usd">-791638</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c14651772" unitRef="iso4217-usd">-13809502</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" decimals="INF" id="c14651831" unitRef="iso4217-usd">13317</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" decimals="INF" id="c14651832" unitRef="iso4217-usd">36398588</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651834" unitRef="iso4217-usd">-503118</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="i_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" decimals="INF" id="c14651835" unitRef="iso4217-usd">-28983374</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462468">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Equity&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;div style="display: inline; font-style: italic;"&gt;Stock Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;15,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014,&lt;/div&gt; the Company adopted the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Stock Plan &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(&amp;#x201c;2014&lt;/div&gt; Plan&amp;#x201d;). The &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Plan is designed to supersede and replace the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2012&lt;/div&gt; Plan, effective as of the adoption date and set aside &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1,513,000&lt;/div&gt; shares of the Company&amp;#x2019;s common stock that &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; may&lt;/div&gt; be granted under the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Plan.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company granted &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;240,160&lt;/div&gt; stock options to employees and certain non-employee members of its board of directors with exercise prices ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5.99&lt;/div&gt; - &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$9.62.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company granted &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt; stock options to employees with exercise prices ranging from &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$2.23&lt;/div&gt; - &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$4.11.&lt;/div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company&amp;#x2019;s stock trading price is the basis of fair value of its common stock used in determining the value of share based awards. To the extent the value of the Company&amp;#x2019;s share based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical volatility. The expected life of the options granted is based on the average of the vesting term and the contractual term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10&lt;/div&gt;-year yield curve in effect at the date of the grant.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 64 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company has computed the fair value of all options granted during the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; using the following assumptions:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Years Ended December 31,&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2016&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;2015&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected volatility&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;42%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;45%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;44%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;50%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected dividends&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;None&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; font-size: 10pt; text-align: left"&gt;Expected term (years)&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;5.5&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 6%; font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; -&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 5%; font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Risk-free rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.19%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.68%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.54%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Forfeiture rate&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;20%&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The information below summarizes the stock options:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Number of&lt;br /&gt; Shares&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise&lt;br /&gt; Price&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Fair&lt;br /&gt; Value&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Remaining&lt;br /&gt; Contractual Life&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 44%; font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;314,775&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.23&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.92&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9.2&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;240,160&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.16&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(445&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.20&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(77,031&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;7.88&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;477,459&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.30&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.01&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.7&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Granted at market price&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;660,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.22&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Exercised&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(37,824&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.88&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Cancelled&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(146,560&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.34&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;953,075&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.66&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.86&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;347,272&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;4.07&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.38&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The intrinsic value of the Company&amp;#x2019;s stock options outstanding was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$347,724&lt;/div&gt; at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; stock based compensation expense for stock options was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$561,559&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$328,772,&lt;/div&gt; respectively.&amp;nbsp;&amp;nbsp;Unrecognized stock-based compensation expense for stock options for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$733,944,&lt;/div&gt; which is expected to be recognized ratably over the next &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.26&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Restricted Stock&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company granted restricted stock to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;two&lt;/div&gt; employees to earn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,000&lt;/div&gt; shares of common stock. These shares vest over a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;four&lt;/div&gt; year period from grant date. The estimated fair market value of these shares was valued at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$9.62&lt;/div&gt; per share, based on the Company&amp;#x2019;s stock trading price, totaling approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$76,960&lt;/div&gt; to be recognized ratably as the stock is vested.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company granted restricted stock awards to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;seven&lt;/div&gt; members of the Board of Directors. The awards have been granted under The Joint Corp. &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2014&lt;/div&gt; Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt; year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;12,345&lt;/div&gt; shares of common stock. The estimated fair market value of these shares was valued at &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.10&lt;/div&gt; per share, based on the Company&amp;#x2019;s stock trading price, totaling approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$268,000&lt;/div&gt; to be recognized ratably as the stock is vested.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 65 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The information below summaries the restricted stock activity:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid"&gt;Restricted Stock Awards&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid"&gt;Shares&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 82%; font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 14%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;662,375&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Restricted stock awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8,000&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited or exercised&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Granted at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;670,375&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(331,087&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;339,288&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards granted&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;86,415&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Awards vested&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(162,440&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt"&gt;Awards forfeited&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;(170,848&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;92,415&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;For the years ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; stock based compensation expense for restricted stock awards was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$561,922&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$496,373,&lt;/div&gt; respectively.&amp;nbsp;&amp;nbsp;Unrecognized stock based compensation expense for restricted stock awards as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; was &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$155,969&lt;/div&gt; to be recognized ratably over &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.06&lt;/div&gt; years.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Modifications&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&amp;#x2019;s former chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment exercise period of the stock options previously granted, extending the exercise period to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company modified the post-employment exercise period of stock options previously granted to the Company&amp;#x2019;s former chief executive officer in connection with his separation from the Company. The modification extended the exercise period to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; May&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2020.&lt;/div&gt; In addition, the Company accelerated the vesting of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;9,733&lt;/div&gt; shares of the previously granted restricted stock awards that were scheduled to vest in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; July&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt; The remaining unvested restricted stock awards were forfeited upon separation.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;These modifications resulted in an approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$412,000&lt;/div&gt; increase in stock-based compensation for the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Treasury Stock&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company acquired approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13,376&lt;/div&gt; shares of treasury stock to satisfy minimum tax withholding related to vesting of restricted stock awards. These shares were acquired at a total cost of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$83,391.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2013,&lt;/div&gt; the Company exercised its right of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;first&lt;/div&gt; refusal under the terms of a Stockholders Agreement dated &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; March&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2010&lt;/div&gt; to repurchase &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;534,000&lt;/div&gt; shares of the Company&amp;#x2019;s common stock. The shares were purchased for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$0.45&lt;/div&gt; per share or &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$240,000&lt;/div&gt; in cash along with the issuance of an option to repurchase the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;534,000&lt;/div&gt; shares. The repurchased shares were recorded as treasury stock, at cost in the amount of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$791,638,&lt;/div&gt; and were available for general corporate purposes. The option is classified in equity as it is considered indexed to the Company&amp;#x2019;s stock and meets the criteria for classification in equity.&amp;nbsp;&amp;nbsp;The option was granted to the seller for a term of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8&lt;/div&gt; years.&amp;nbsp;&amp;nbsp;The option contained the following exercise prices:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 84%; font-size: 10pt"&gt;Year 1&lt;/td&gt; &lt;td style="width: 2%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.56&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 2&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.68&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 3&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;0.84&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 4&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.03&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 5&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.28&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 6&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.59&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Year 7&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.97&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Year 8&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.45&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 66 --&gt;   &lt;!-- Field: /Page --&gt;  &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1.03&lt;/div&gt; per share option for a total fair value of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$551,638.&lt;/div&gt; The option was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions that address the features underlying the instrument.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the option holder partially exercised the call option, and purchased &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;250,872&lt;/div&gt; shares at a total repurchase price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$210,000.&lt;/div&gt; The Company reduced the cost of treasury shares by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$113,000&lt;/div&gt; related to the transaction, reduced the value of the option by approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$259,000,&lt;/div&gt; and reduced additional paid in capital by approximately $162,000.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;In conjunction with the IPO, the Company issued warrants to the underwriters for the purchase of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt; shares of common stock, which can be exercised between &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018&lt;/div&gt; at an exercise price of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$8.125&lt;/div&gt; per share.&amp;nbsp; The fair value of the warrants was determined using the Black-Scholes option valuation model. The warrants expire on &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; November&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2018&lt;/div&gt; and have a remaining contractual life of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt; years as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;The information below summarizes the warrants:&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"&gt;  &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Number of &lt;br /&gt; Units&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Weighted&lt;br /&gt; Average&lt;br /&gt; Exercise Price&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Weighted &lt;br /&gt; Average &lt;br /&gt; Remaining &lt;br /&gt; Contractual Term&lt;br /&gt; (in years)&lt;/div&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Intrinsic &lt;br /&gt; Value&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td nowrap="nowrap" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td nowrap="nowrap" colspan="3" style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3.9&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="width: 10%; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2015&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;Granted&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 1.1pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Outstanding at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Exercisable at December 31, 2016&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;90,000&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;8.13&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;1.9&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;-&lt;/div&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&amp;nbsp;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-size: 10pt"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Issuance of Common Stock for Legal Settlement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;During &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company entered into a settlement agreement, whereby it resolved the pending litigation matter discussed in Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11.&lt;/div&gt; Under the terms of the settlement agreement, the Company agreed to a &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;one&lt;/div&gt;-time settlement amount comprised of cash and newly issued shares of our common stock. The amounts paid by the Company in this settlement was determined by the Company not to be material. The fair value of the total consideration related to common stock was valued using the closing price of our common stock on the settlement date.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="d_2016-01-01_2016-12-31" id="s462485">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;table cellspacing="0" cellpadding="0" style="; font-size: 10pt;"&gt;  &lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 73px; text-align: left"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Note &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;13:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;td style="width: 7px"&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;Subsequent Events&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Credit and Security Agreement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;3,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the Company entered into a Credit and Security Agreement (the &amp;#x201c;Credit Agreement&amp;#x201d;), and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,000,000&lt;/div&gt; under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10%&lt;/div&gt; per annum, provided, that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$200,000.&lt;/div&gt; Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but not less than &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$25,000.&lt;/div&gt; The lender&amp;#x2019;s lending commitments under the Credit Agreement terminate in &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2019,&lt;/div&gt; unless sooner terminated in accordance with the provisions of the Credit Agreement. The Company intends to use the credit facility for general working capital needs. The Company has drawn &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$1,000,000&lt;/div&gt; of the &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$5,000,000&lt;/div&gt; available under the Credit Agreement.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Clinic Sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;On &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; January&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;6,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2017,&lt;/div&gt; the Company sold the assets of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;six&lt;/div&gt; of its &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;11&lt;/div&gt; clinics in the Chicago area for a nominal amount to a partnership that includes existing Company franchisees. The purchaser will continue to operate the clinics as franchised locations pursuant to a franchise agreement. The Company concurrently sold to the limited liability company regional developer rights to Chicago for &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$300,000.&lt;/div&gt; Pursuant to the regional developer agreement, the limited liability company has agreed to open a minimum of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;30&lt;/div&gt; Chicago area clinics over the next &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10&lt;/div&gt; years, with plans to open &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;five&lt;/div&gt; to &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;10&lt;/div&gt; clinics over the next &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;18&lt;/div&gt; months. The Company has closed the remaining &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;five&lt;/div&gt; Chicago-area clinics, as well as &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;three&lt;/div&gt; Company-managed clinics in upstate New York. These assets were deemed as held for sale as of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; and accordingly the Company recognized a loss on impairment of approximately &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$3.5&lt;/div&gt; million.&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:TechnologyServicesCosts contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651684" unitRef="iso4217-usd">221918</us-gaap:TechnologyServicesCosts>
  <us-gaap:TechnologyServicesCosts contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651685" unitRef="iso4217-usd">177462</us-gaap:TechnologyServicesCosts>
  <us-gaap:TechnologyServicesRevenue contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651673" unitRef="iso4217-usd">932709</us-gaap:TechnologyServicesRevenue>
  <us-gaap:TechnologyServicesRevenue contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651674" unitRef="iso4217-usd">808070</us-gaap:TechnologyServicesRevenue>
  <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="d_2016-01-01_2016-12-31" id="c14699065">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which we perform management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&amp;#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2015,&lt;/div&gt; the Company had an allowance for doubtful accounts of &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$131,830&lt;/div&gt; and &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$142,660,&lt;/div&gt; respectively.&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;!-- Field: Page; Sequence: 52 --&gt; &lt;!-- Field: /Page --&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016,&lt;/div&gt; the Company determined that certain working capital advances from its PC entities in Illinois and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;$731,857&lt;/div&gt; of accounts receivable to loss on disposition or impairment related to these entities during the year ended &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt; December&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;31,&lt;/div&gt; &lt;div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"&gt;2016.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
  <us-gaap:TreasuryStockRetiredCostMethodAmount contextRef="d_2013-01-01_2013-12-31" decimals="INF" id="c14652623" unitRef="iso4217-usd">791638</us-gaap:TreasuryStockRetiredCostMethodAmount>
  <us-gaap:TreasuryStockSharesAcquired contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652613" unitRef="xbrli-shares">13376</us-gaap:TreasuryStockSharesAcquired>
  <us-gaap:TreasuryStockSharesAcquired contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651805" unitRef="xbrli-shares">13376</us-gaap:TreasuryStockSharesAcquired>
  <us-gaap:TreasuryStockValue contextRef="i_2016-12-31" decimals="INF" id="c14651654" unitRef="iso4217-usd">503118</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValue contextRef="i_2015-12-31" decimals="INF" id="c14651655" unitRef="iso4217-usd">791638</us-gaap:TreasuryStockValue>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652614" unitRef="iso4217-usd">83391</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember" id="c14651803" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember" id="c14651804" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember" decimals="INF" id="c14651806" unitRef="iso4217-usd">83391</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember" id="c14651807" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2015-12-31" decimals="INF" id="c14652873" unitRef="iso4217-usd">32600</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2014-12-31" decimals="INF" id="c14652875" unitRef="iso4217-usd">91700</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefits contextRef="i_2016-12-31" decimals="INF" id="c14652885" unitRef="iso4217-usd">13200</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652881" unitRef="iso4217-usd">19400</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652883" unitRef="iso4217-usd">59100</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="d_2016-01-01_2016-12-31" id="c14652878" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652880" unitRef="iso4217-usd">3000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="d_2016-01-01_2016-12-31" id="c14652877" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="d_2015-01-01_2015-12-31" id="c14652879" unitRef="iso4217-usd" xs:nil="true"/>
  <us-gaap:UseOfEstimates contextRef="d_2016-01-01_2016-12-31" id="c14699121">&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style="display: inline; font-family: times new roman; font-size: 10pt"&gt;&lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&lt;div style="display: inline; font-weight: bold;"&gt;&lt;div style="display: inline; font-style: italic;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"&gt;The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652268" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652269" unitRef="xbrli-shares">10042001</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14651716" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14651717" unitRef="xbrli-shares">10042001</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="d_2016-01-01_2016-12-31" decimals="INF" id="c14652263" unitRef="xbrli-shares">12696649</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="d_2015-01-01_2015-12-31" decimals="INF" id="c14652264" unitRef="xbrli-shares">10042001</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"/>
  <xbrli:unit id="xbrli-shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="xbrli-pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-usd">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="iso4217-usd-per-xbrli-shares">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:context id="d_2012-07-01_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2012-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2013-01-01_2013-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>
      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2014-01-01_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2014-01-01_2014-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2014-11-14_2014-11-14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-11-14</xbrli:startDate>
      <xbrli:endDate>2014-11-14</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-01-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-SanDiegoCAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:SanDiegoCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-01-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-TempeAZMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:TempeAZMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BalanceSheetLocationAxis-AccountsPayable1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jynt:AccountsPayable1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BalanceSheetLocationAxis-AccruedExpensesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jynt:AccruedExpensesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-SanDiegoCAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:SanDiegoCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_StatementGeographicalAxis-TempeAZMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:TempeAZMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:TheJointRRCCorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-SixFranchiseesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">jynt:SixFranchiseesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:FranchiseRightsAndCustomerRelationshipsReacquiredMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-01-01_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingUnsecuredPromissoryNoteMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:InterestBearingUnsecuredPromissoryNoteMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>
      <xbrli:endDate>2015-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-07-01_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>
      <xbrli:endDate>2015-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2015-07-01_2015-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>
      <xbrli:endDate>2015-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-01-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-01-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_AwardTypeAxis-RestrictedStockMember_TitleOfIndividualAxis-FormerChiefExecutiveOfficerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">jynt:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BalanceSheetLocationAxis-AccountsPayable1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jynt:AccountsPayable1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_BusinessAcquisitionAxis-TheJointRRCCorpMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:TheJointRRCCorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-OnePcEntityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">jynt:OnePcEntityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-CorporateNonSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-ComputerSoftwareIntangibleAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:DevelopmentRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsAndCustomerRelationshipsReacquiredMember_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:FranchiseRightsAndCustomerRelationshipsReacquiredMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember_TaxPeriodAxis-LatestTaxYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember_TaxPeriodAxis-EarliestTaxYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-01-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-05-01_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-05-01</xbrli:startDate>
      <xbrli:endDate>2016-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-06-01_2016-06-02_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInVirginiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-06-01</xbrli:startDate>
      <xbrli:endDate>2016-06-02</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-07-01_2016-09-30_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-07-01</xbrli:startDate>
      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_IncomeStatementLocationAxis-LossOnDispositionOrImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jynt:LossOnDispositionOrImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2016-12-01_2016-12-31_StatementGeographicalAxis-ChicagoAndNewYorkMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoAndNewYorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-12-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-01_2017-12-31_StatementScenarioAxis-ScenarioForecastMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_RangeAxis-MinimumMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-03</xbrli:startDate>
      <xbrli:endDate>2017-01-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-03_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-03</xbrli:startDate>
      <xbrli:endDate>2017-01-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-06_2017-01-06_FiniteLivedIntangibleAssetsByMajorClassAxis-ChicagoRegionalDeveloperRightsMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:ChicagoRegionalDeveloperRightsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-06</xbrli:startDate>
      <xbrli:endDate>2017-01-06</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="d_2017-01-06_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-06</xbrli:startDate>
      <xbrli:endDate>2017-01-06</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2012-07-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2013-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-05-15_PlanNameAxis-The2012PlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">jynt:The2012PlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-05-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-11-14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-14</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2014-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-InterestBearingUnsecuredPromissoryNoteMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:InterestBearingUnsecuredPromissoryNoteMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-07-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNote2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNote2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-07-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-SixFranchiseesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">jynt:SixFranchiseesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_DeferredRevenueArrangementTypeAxis-FranchiseMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2015-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-01-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchisesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-01-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-05-31_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">jynt:NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-05-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-06-02_DeferredRevenueArrangementTypeAxis-FranchisesMember_FiniteLivedIntangibleAssetsByMajorClassAxis-RegionalDeveloperRightsInVirginiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchisesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:RegionalDeveloperRightsInVirginiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-06-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-06-30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_AwardTypeAxis-EmployeeStockOptionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_AwardTypeAxis-RestrictedStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_BalanceSheetLocationAxis-OtherLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_BusinessAcquisitionAxis-ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jynt:ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_ConcentrationRiskByBenchmarkAxis-AccountsReceivableMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-OnePcEntityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">jynt:OnePcEntityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_ConsolidationItemsAxis-OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_DebtInstrumentAxis-NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jynt:NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_DeferredRevenueArrangementTypeAxis-FranchiseFeesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">jynt:FranchiseFeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-CustomerRelationshipsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-DevelopmentRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jynt:DevelopmentRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FiniteLivedIntangibleAssetsByMajorClassAxis-FranchiseRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FranchiseRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FranchisorDisclosureAxis-EntityOperatedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:EntityOperatedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_FranchisorDisclosureAxis-FranchisedUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FranchisorDisclosureAxis">us-gaap:FranchisedUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-CompanyOwnedClinicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jynt:CompanyOwnedClinicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_IncomeTaxAuthorityAxis-DomesticCountryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_IncomeTaxAuthorityAxis-StateAndLocalJurisdictionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_NonmonetaryTransactionTypeAxis-GoodsAndServicesExchangedForEquityInstrumentMember_StatementEquityComponentsAxis-WarrantMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:GoodsAndServicesExchangedForEquityInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-LeaseholdImprovementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-OfficeEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">jynt:PropertyPlantAndEquipmentExcludingConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_PropertyPlantAndEquipmentByTypeAxis-SoftwareDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_RangeAxis-MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_RangeAxis-MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementBusinessSegmentsAxis-CorporateClinicsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:CorporateClinicsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementBusinessSegmentsAxis-FranchiseOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jynt:FranchiseOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2016-12-31_StatementEquityComponentsAxis-TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-03_CreditFacilityAxis-RevolvingCreditFacilityMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-05_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-06_RangeAxis-MaximumMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-06_RangeAxis-MinimumMember_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-06_StatementGeographicalAxis-ChicagoIllinoisMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:ChicagoIllinoisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-01-06_StatementGeographicalAxis-UpStateNewYorkMember_SubsequentEventTypeAxis-SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">jynt:UpStateNewYorkMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="i_2017-03-01">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001612630</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>jynt-20161231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:39PM UTC 2017-03-10--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:jynt="http://www.thejoint.com/20161231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.thejoint.com/20161231">
  <xsd:import namespace="http://fasb.org/us-roles/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20161231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20161231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20161231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jynt-20161231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.thejoint.com/20161231/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-balance-sheets-parentheticals" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statement-of-operations" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">003 - Statement - Consolidated Statement of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">004 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Parentheticals)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-consolidated-statements-of-cash-flows" roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-disclosure-of-noncash-information" roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">007 - Disclosure - Supplemental Disclosure of Non-cash Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">008 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions" roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">009 - Disclosure - Note 2 - Acquisitions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-notes-receivable" roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">010 - Disclosure - Note 3 - Notes Receivable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment" roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">011 - Disclosure - Note 4 - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-fair-value-consideration-" roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">012 - Disclosure - Note 5 - Fair Value Consideration</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets" roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">013 - Disclosure - Note 6 - Intangible Assets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-notes-payable" roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">014 - Disclosure - Note 7 - Notes Payable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">015 - Disclosure - Note 8 - Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">016 - Disclosure - Note 9 - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-related-party-transactions" roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">017 - Disclosure - Note 10 - Related Party Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies" roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">018 - Disclosure - Note 11 - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting" roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">019 - Disclosure - Note 12 - Segment Reporting</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-subsequent-events-" roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">020 - Disclosure - Note 13 - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">021 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-disclosure-of-noncash-information-tables" roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">022 - Disclosure - Supplemental Disclosure of Non-cash Information (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">023 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">024 - Disclosure - Note 2 - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">025 - Disclosure - Note 4 - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">026 - Disclosure - Note 6 - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-notes-payable-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">027 - Disclosure - Note 7 - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">028 - Disclosure - Note 8 - Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">029 - Disclosure - Note 9 - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">030 - Disclosure - Note 11 - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-tables" roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">031 - Disclosure - Note 12 - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-disclosure-of-noncash-information-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">032 - Disclosure - Supplemental Disclosure of Non-cash Information (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">033 - Disclosure - Supplemental Cash Flow Information - Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">034 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">035 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">036 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">037 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">038 - Disclosure - Note 2 - Acquisitions (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">039 - Disclosure - Note 2 - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-2-acquisitions-supplemental-pro-forma-information-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">040 - Disclosure - Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-3-notes-receivable-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">041 - Disclosure - Note 3 - Notes Receivable (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">042 - Disclosure - Note 4 - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">043 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-5-fair-value-consideration-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">044 - Disclosure - Note 5 - Fair Value Consideration (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">045 - Disclosure - Note 6 - Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-intangible-assets-acquired-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">046 - Disclosure - Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-6-intangible-assets-estimated-amortization-expense-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">047 - Disclosure - Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-notes-payable-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">048 - Disclosure - Note 7 - Notes Payable (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-7-notes-payable-maturities-of-notes-payable-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">049 - Disclosure - Note 7 - Notes Payable - Maturities of Notes Payable (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">050 - Disclosure - Note 8 - Equity (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-fair-value-assumptions-of-options-granted-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">051 - Disclosure - Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-stock-options-activity-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">052 - Disclosure - Note 8 - Equity - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-restricted-stock-activity-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">053 - Disclosure - Note 8 - Equity - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-stock-repurchase-option-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">054 - Disclosure - Note 8 - Equity - Stock Repurchase Option (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-8-equity-warrants-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">055 - Disclosure - Note 8 - Equity - Warrants (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">056 - Disclosure - Note 9 - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-income-tax-provision-benefit-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">057 - Disclosure - Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-net-deferred-taxes-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">058 - Disclosure - Note 9 - Income Taxes - Net Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">059 - Disclosure - Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-9-income-taxes-uncertain-tax-benefits-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">060 - Disclosure - Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-10-related-party-transactions-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">061 - Disclosure - Note 10 - Related Party Transactions (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">062 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">063 - Disclosure - Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">064 - Disclosure - Note 12 - Segment Reporting (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-segment-reporting-financial-information-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">065 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-12-segment-reporting-segment-reporting-information-assets-details" roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">066 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
      <link:roleType id="statement-note-13-subsequent-events-details-textual" roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">067 - Disclosure - Note 13 - Subsequent Events (Details Textual)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="jynt_AccountsPayable1Member" name="AccountsPayable1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_AccruedExpensesMember" name="AccruedExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AdditionalLeasesAssumed" name="AdditionalLeasesAssumed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AdvertisingFundPolicyTextBlock" name="AdvertisingFundPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" name="AssetBasisDifferenceRelatedToPropertyAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BinomialLatticeBasedModelFairValueSharePrice" name="BinomialLatticeBasedModelFairValueSharePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BinomialLatticeBasedModelFairValueTotal" name="BinomialLatticeBasedModelFairValueTotal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" name="BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" name="CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ChicagoAndNewYorkMember" name="ChicagoAndNewYorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ChicagoIllinoisMember" name="ChicagoIllinoisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ChicagoRegionalDeveloperRightsMember" name="ChicagoRegionalDeveloperRightsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" name="ClassOfWarrantOrRightIssuedDuringPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" name="ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsAcquiredDuringThePeriod" name="ClinicsAcquiredDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsClosedDuringThePeriod" name="ClinicsClosedDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsOpenedDuringThePeriod" name="ClinicsOpenedDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ClinicsSoldButNotYetOperational" name="ClinicsSoldButNotYetOperational" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_CoOpFundsLiabilityCurrent" name="CoOpFundsLiabilityCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_CompanyOwnedClinicMember" name="CompanyOwnedClinicMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_CorporateClinicsMember" name="CorporateClinicsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_DeferredFranchiseCosts" name="DeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsCurrent" name="DeferredFranchiseCostsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" name="DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredFranchiseCostsNoncurrent" name="DeferredFranchiseCostsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetDeferredRentCurrent" name="DeferredTaxAssetDeferredRentCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" name="DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" name="DeferredTaxAssetRestrictedStockCompensationCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsAccruedExpensesCurrent" name="DeferredTaxAssetsAccruedExpensesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" name="DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" name="DeferredTaxAssetsCharitableContributionCarryoverCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsFranchiseCosts" name="DeferredTaxAssetsFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsGoodwillComponent1" name="DeferredTaxAssetsGoodwillComponent1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsGoodwillComponent2" name="DeferredTaxAssetsGoodwillComponent2" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsLeaseAbandonment" name="DeferredTaxAssetsLeaseAbandonment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" name="DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_DeferredTaxAssetsRevenueCurrent" name="DeferredTaxAssetsRevenueCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_DevelopmentRightsMember" name="DevelopmentRightsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" name="DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" name="EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" name="EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" name="EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_EstimatedCashNeeds" name="EstimatedCashNeeds" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ExcessDeferredRegionalFeesRevenueRecognized" name="ExcessDeferredRegionalFeesRevenueRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FormerChiefExecutiveOfficerMember" name="FormerChiefExecutiveOfficerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseFeesMember" name="FranchiseFeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseMember" name="FranchiseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" name="FranchiseMonthlyMarketingFeeGrossSalesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseOperationsMember" name="FranchiseOperationsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" name="FranchiseRightsAndCustomerRelationshipsReacquiredMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_FranchiseRoyaltyGrossSalesPercentage" name="FranchiseRoyaltyGrossSalesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_FranchisesMember" name="FranchisesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" name="ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_IncreaseDecreaseInCoOpFundsLiability" name="IncreaseDecreaseInCoOpFundsLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_IncreaseDecreaseInDeferredFranchiseCosts" name="IncreaseDecreaseInDeferredFranchiseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_InterestBearingUnsecuredPromissoryNoteMember" name="InterestBearingUnsecuredPromissoryNoteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_LeaseExitLiability" name="LeaseExitLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" name="LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_LossOnDispositionOrImpairmentMember" name="LossOnDispositionOrImpairmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ManagementsPlanPolicyPolicyTextBlock" name="ManagementsPlanPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_MinimumNumberOfClinicsToBeOpened" name="MinimumNumberOfClinicsToBeOpened" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NatureOfOperationsPolicyPolicyTextBlock" name="NatureOfOperationsPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" name="NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" name="NoninterestBearingUnsecuredPromissoryNote1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" name="NoninterestBearingUnsecuredPromissoryNote2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" name="NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" name="NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivableContractualTerm" name="NotesReceivableContractualTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivableInterestRate" name="NotesReceivableInterestRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivableIssuedForPaymentOfTransferFees" name="NotesReceivableIssuedForPaymentOfTransferFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NotesReceivablePrincipalAndInterestTerm" name="NotesReceivablePrincipalAndInterestTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfClinicsClassifiedAsHeldForSale" name="NumberOfClinicsClassifiedAsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfClinicsDisposedOf" name="NumberOfClinicsDisposedOf" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfClinicsExpectedToOpen" name="NumberOfClinicsExpectedToOpen" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfClinicsInOperation" name="NumberOfClinicsInOperation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" name="NumberOfDevelopedFranchisesReacquiredDuringPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfFranchises" name="NumberOfFranchises" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfFranchisesClosed" name="NumberOfFranchisesClosed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfLicenseTransferAgreements" name="NumberOfLicenseTransferAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" name="NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfPCEntities" name="NumberOfPCEntities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" name="NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" name="NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfStoresToCloseOrSell" name="NumberOfStoresToCloseOrSell" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" name="NumberOfUndevelopedFranchiseAgreementsTerminated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" name="NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_NumberOfUnsecuredPromissoryNotes" name="NumberOfUnsecuredPromissoryNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_OnePcEntityMember" name="OnePcEntityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_OperatingLeaseMonthlyRentExpense" name="OperatingLeaseMonthlyRentExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_OptionExcercisePriceYearOne" name="OptionExcercisePriceYearOne" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearEight" name="OptionExercisePriceYearEight" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearFive" name="OptionExercisePriceYearFive" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearFour" name="OptionExercisePriceYearFour" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearSeven" name="OptionExercisePriceYearSeven" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearSix" name="OptionExercisePriceYearSix" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearThree" name="OptionExercisePriceYearThree" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionExercisePriceYearTwo" name="OptionExercisePriceYearTwo" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_OptionToRepurchaseSharesChangeInFairValue" name="OptionToRepurchaseSharesChangeInFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_PaymentsOfInitialPublicOfferingCosts" name="PaymentsOfInitialPublicOfferingCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" name="PropertyPlantAndEquipmentExcludingConstructionInProgressMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" name="ReacquisitionAndTerminationOfRegionalDeveloperRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" name="ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" name="ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" name="RegionalDeveloperFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" name="RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" name="RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDeveloperFeesRevenue" name="RegionalDeveloperFeesRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" name="RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_RegionalDeveloperRightsInVirginiaMember" name="RegionalDeveloperRightsInVirginiaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" name="RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_RegionalDevelopersLicenseFee" name="RegionalDevelopersLicenseFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
  <xsd:element id="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" name="RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" name="RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RepurchaseRightToDevelopFranchisesConsideration" name="RepurchaseRightToDevelopFranchisesConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" name="RevenuesAndManagementFeesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_RoyaltiesPolicyPolicyTextBlock" name="RoyaltiesPolicyPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_SanDiegoCAMember" name="SanDiegoCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" name="ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" name="ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" nillable="true" substitutionGroup="xbrli:item" type="us-types:durationStringItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
  <xsd:element abstract="true" id="jynt_SixFranchiseesMember" name="SixFranchiseesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_TempeAZMember" name="TempeAZMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_The2012PlanMember" name="The2012PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_TheJointRRCCorpMember" name="TheJointRRCCorpMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" name="TimeFrameForTheMinimumNumberOfClinicsToBeOpened" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_TimeFrameOfClinicsExpectedToBeOpen" name="TimeFrameOfClinicsExpectedToBeOpen" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
  <xsd:element id="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" name="UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_UpStateNewYorkMember" name="UpStateNewYorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" name="statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" name="statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-11-commitments-and-contingencies-tables" name="statement-statement-note-11-commitments-and-contingencies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" name="statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" name="statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-12-segment-reporting-tables" name="statement-statement-note-12-segment-reporting-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" name="statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" name="statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-2-acquisitions-tables" name="statement-statement-note-2-acquisitions-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" name="statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-4-property-and-equipment-tables" name="statement-statement-note-4-property-and-equipment-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" name="statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" name="statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-6-intangible-assets-tables" name="statement-statement-note-6-intangible-assets-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" name="statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-7-notes-payable-tables" name="statement-statement-note-7-notes-payable-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" name="statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" name="statement-statement-note-8-equity-restricted-stock-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-stock-options-activity-details" name="statement-statement-note-8-equity-stock-options-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" name="statement-statement-note-8-equity-stock-repurchase-option-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-tables" name="statement-statement-note-8-equity-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-8-equity-warrants-details" name="statement-statement-note-8-equity-warrants-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" name="statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" name="statement-statement-note-9-income-taxes-net-deferred-taxes-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" name="statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-tables" name="statement-statement-note-9-income-taxes-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" name="statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" name="statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" name="statement-statement-supplemental-disclosure-of-noncash-information-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>jynt-20161231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:41PM UTC 2017-03-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:href="jynt-20161231.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TreasuryStockValue" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-operations" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20161231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationSettlementAmount" xlink:label="us-gaap_LitigationSettlementAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:calculationArc order="0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_LitigationSettlementAmount" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ShareBasedCompensation" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:type="arc"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="arc"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:type="arc"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="arc"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="arc"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="24" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="25" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="arc"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:calculationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="arc"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="arc"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="arc"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="arc"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="arc"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="arc"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="arc"/>
    <link:calculationArc order="0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="arc"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>jynt-20161231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:40PM UTC 2017-03-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-document-and-entity-information" xlink:href="jynt-20161231.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="jynt-20161231.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccruedExpensesMember" xlink:label="jynt_AccruedExpensesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccruedExpensesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoAndNewYorkMember" xlink:label="jynt_ChicagoAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OnePcEntityMember" xlink:label="jynt_OnePcEntityMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SixFranchiseesMember" xlink:label="jynt_SixFranchiseesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_ChicagoAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_MajorCustomersAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="jynt_OnePcEntityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="jynt_SixFranchiseesMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SanDiegoCAMember" xlink:label="jynt_SanDiegoCAMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TempeAZMember" xlink:label="jynt_TempeAZMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_TempeAZMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_SanDiegoCAMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable" xlink:href="jynt-20161231.xsd#statement-note-3-notes-receivable" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-" xlink:href="jynt-20161231.xsd#statement-note-5-fair-value-consideration-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMember" xlink:label="jynt_FranchiseMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity" xlink:href="jynt-20161231.xsd#statement-note-8-equity" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_The2012PlanMember" xlink:label="jynt_The2012PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="jynt_The2012PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions" xlink:href="jynt-20161231.xsd#statement-note-10-related-party-transactions" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-" xlink:href="jynt-20161231.xsd#statement-note-13-subsequent-events-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoIllinoisMember" xlink:label="jynt_ChicagoIllinoisMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoRegionalDeveloperRightsMember" xlink:label="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UpStateNewYorkMember" xlink:label="jynt_UpStateNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_ChicagoIllinoisMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_UpStateNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies" xlink:href="jynt-20161231.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:label="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasePolicyTextBlock" xlink:label="us-gaap_LeasePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_AdvertisingFundPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CooperativeAdvertisingPolicy" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LeasePolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:definitionArc order="28" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:definitionArc order="29" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:definitionArc order="30" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-tables" xlink:href="jynt-20161231.xsd#statement-note-8-equity-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-tables" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccruedExpensesMember" xlink:label="jynt_AccruedExpensesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="jynt_AccruedExpensesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxesPaid" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoAndNewYorkMember" xlink:label="jynt_ChicagoAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EstimatedCashNeeds" xlink:label="jynt_EstimatedCashNeeds" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfStoresToCloseOrSell" xlink:label="jynt_NumberOfStoresToCloseOrSell" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OnePcEntityMember" xlink:label="jynt_OnePcEntityMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SixFranchiseesMember" xlink:label="jynt_SixFranchiseesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_ChicagoAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-default" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_MajorCustomersAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="jynt_OnePcEntityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="jynt_SixFranchiseesMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfStoresToCloseOrSell" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EstimatedCashNeeds" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfPCEntities" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchises" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFee" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdvertisingExpense" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchisesClosed" xlink:label="jynt_NumberOfFranchisesClosed" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SanDiegoCAMember" xlink:label="jynt_SanDiegoCAMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TempeAZMember" xlink:label="jynt_TempeAZMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_TempeAZMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_SanDiegoCAMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchisesClosed" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual" xlink:href="jynt-20161231.xsd#statement-note-3-notes-receivable-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesReceivableNet" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableInterestRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableContractualTerm" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfLicenseTransferAgreements" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual" xlink:href="jynt-20161231.xsd#statement-note-5-fair-value-consideration-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMember" xlink:label="jynt_FranchiseMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchiseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual" xlink:href="jynt-20161231.xsd#statement-note-8-equity-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_The2012PlanMember" xlink:label="jynt_The2012PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="jynt_The2012PlanMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc"/>
    <link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc"/>
    <link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="arc"/>
    <link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="arc"/>
    <link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="24" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="arc"/>
    <link:definitionArc order="25" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="arc"/>
    <link:definitionArc order="26" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc"/>
    <link:definitionArc order="27" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OpenTaxYear" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual" xlink:href="jynt-20161231.xsd#statement-note-10-related-party-transactions-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdditionalLeasesAssumed" xlink:label="jynt_AdditionalLeasesAssumed" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OperatingLeaseMonthlyRentExpense" xlink:label="jynt_OperatingLeaseMonthlyRentExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AdditionalLeasesAssumed" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OperatingLeaseMonthlyRentExpense" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfReportableSegments" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual" xlink:href="jynt-20161231.xsd#statement-note-13-subsequent-events-details-textual" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoIllinoisMember" xlink:label="jynt_ChicagoIllinoisMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoRegionalDeveloperRightsMember" xlink:label="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_MinimumNumberOfClinicsToBeOpened" xlink:label="jynt_MinimumNumberOfClinicsToBeOpened" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsDisposedOf" xlink:label="jynt_NumberOfClinicsDisposedOf" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsExpectedToOpen" xlink:label="jynt_NumberOfClinicsExpectedToOpen" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsInOperation" xlink:label="jynt_NumberOfClinicsInOperation" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UpStateNewYorkMember" xlink:label="jynt_UpStateNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain-default" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_ChicagoIllinoisMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain-default" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="jynt_UpStateNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCredit" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsDisposedOf" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsInOperation" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_MinimumNumberOfClinicsToBeOpened" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsExpectedToOpen" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:href="jynt-20161231.xsd#statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebt" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-stock-repurchase-option-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExcercisePriceYearOne" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearTwo" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearThree" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFour" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFive" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSix" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSeven" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearEight" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-stock-options-activity-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-restricted-stock-activity-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:href="jynt-20161231.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_TreasuryStockValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-operations" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenueAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20161231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationSettlementAmount" xlink:label="us-gaap_LitigationSettlementAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_LitigationSettlementAmount" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FranchisorDisclosureAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_FranchisedUnitsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_EntityOperatedUnitsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsOpenedDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsClosedDuringThePeriod" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsSoldButNotYetOperational" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="jynt_TheJointRRCCorpMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConstructionInProgressGross" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-warrants-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain-default" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain-default" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain-default" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_CorporateMember" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_CorporateNonSegmentMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain-default" xlink:type="arc"/>
    <link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>jynt-20161231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:39PM UTC 2017-03-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DocumentAndEntityInformation" xlink:label="jynt_DocumentAndEntityInformation" xlink:type="locator"/>
    <link:label xlink:label="jynt_DocumentAndEntityInformation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DocumentAndEntityInformation" xlink:to="jynt_DocumentAndEntityInformation-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoteToFinancialStatementDetailsTextual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note To Financial Statement Details Textual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="jynt_NoteToFinancialStatementDetailsTextual-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-significant-accounting-policies-policies" xlink:label="jynt_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-significant-accounting-policies-policies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementsignificantaccountingpoliciespolicies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-significant-accounting-policies-policies" xlink:to="jynt_statement-statement-significant-accounting-policies-policies-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:label="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementsupplementaldisclosureofnoncashinformationtables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:to="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciestables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-tables" xlink:label="jynt_statement-statement-note-2-acquisitions-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote2acquisitionstables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-tables" xlink:to="jynt_statement-statement-note-2-acquisitions-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-4-property-and-equipment-tables" xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote4propertyandequipmenttables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:to="jynt_statement-statement-note-4-property-and-equipment-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-tables" xlink:label="jynt_statement-statement-note-6-intangible-assets-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote6intangibleassetstables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-tables" xlink:to="jynt_statement-statement-note-6-intangible-assets-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentReportingDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-7-notes-payable-tables" xlink:label="jynt_statement-statement-note-7-notes-payable-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-7-notes-payable-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote7notespayabletables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-7-notes-payable-tables" xlink:to="jynt_statement-statement-note-7-notes-payable-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-tables" xlink:label="jynt_statement-statement-note-8-equity-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equitytables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-tables" xlink:to="jynt_statement-statement-note-8-equity-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-tables" xlink:label="jynt_statement-statement-note-9-income-taxes-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote9incometaxestables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-tables" xlink:to="jynt_statement-statement-note-9-income-taxes-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote11commitmentsandcontingenciestables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:to="jynt_statement-statement-note-11-commitments-and-contingencies-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-tables" xlink:label="jynt_statement-statement-note-12-segment-reporting-tables" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-tables-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote12segmentreportingtables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-tables" xlink:to="jynt_statement-statement-note-12-segment-reporting-tables-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:label="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementsupplementalcashflowinformationvalueofassetsacquiredandliabilitiesassumeddetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:to="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInDeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciesclinicsinoperationunderfranchiseagreementsorcompanyownedormanageddetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciesearningslosspercommonsharedetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciespotentialsharesofcommonstockexcludedfromdilutednetlosspersharedetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:to="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:label="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote2acquisitionsassetsacquiredandliabilitiesassumeddetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:to="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote2acquisitionssupplementalproformainformationdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:to="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote4propertyandequipmentsummaryofpropertyandequipmentdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:to="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccruedLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote6intangibleassetsintangibleassetsacquireddetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:to="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote6intangibleassetsestimatedamortizationexpensedetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:to="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:label="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote7notespayablematuritiesofnotespayabledetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:to="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equityfairvalueassumptionsofoptionsgranteddetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:to="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NumberOfStores</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stores</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Clinics in operation at beginning of period</link:label>
    <link:label xlink:label="us-gaap_NumberOfStores-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Clinics in operation at the end of the period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStores" xlink:to="us-gaap_NumberOfStores-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equitystockoptionsactivitydetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:to="jynt_statement-statement-note-8-equity-stock-options-activity-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equityrestrictedstockactivitydetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:to="jynt_statement-statement-note-8-equity-restricted-stock-activity-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equitystockrepurchaseoptiondetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:to="jynt_statement-statement-note-8-equity-stock-repurchase-option-details-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-warrants-details" xlink:label="jynt_statement-statement-note-8-equity-warrants-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-8-equity-warrants-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote8equitywarrantsdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-8-equity-warrants-details" xlink:to="jynt_statement-statement-note-8-equity-warrants-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisedUnitsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchised Units [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisedUnitsMember" xlink:to="us-gaap_FranchisedUnitsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote9incometaxesincometaxprovisionbenefitdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:to="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EntityOperatedUnitsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Operated Units [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityOperatedUnitsMember" xlink:to="us-gaap_EntityOperatedUnitsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote9incometaxesnetdeferredtaxesdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:to="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract</link:label>
    <link:label xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Term of Contract</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisorDisclosureAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote9incometaxesreconciliationofthestatutoryfederalincometaxratedetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:to="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchisorDisclosureDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchisor Disclosure [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisorDisclosureDomain" xlink:to="us-gaap_FranchisorDisclosureDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote9incometaxesuncertaintaxbenefitsdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:to="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Franchisor Disclosure [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote11commitmentsandcontingenciessummaryoffutureminimumrentalpaymentsforoperatingleasesdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:to="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote12segmentreportingsegmentreportingfinancialinformationdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:to="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PolicyTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_PolicyTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_PolicyTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="locator"/>
    <link:label xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">statementnote12segmentreportingsegmentreportinginformationassetsdetails</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:to="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatements" xlink:label="jynt_NotesToFinancialStatements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesToFinancialStatements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesToFinancialStatements" xlink:to="jynt_NotesToFinancialStatements-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesToFinancialStatementsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes To Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="jynt_NotesToFinancialStatementsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccountsPayable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ConcentrationRiskPercentage1</link:label>
    <link:label xlink:label="us-gaap_ConcentrationRiskPercentage1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetUsefulLife</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockSharesAcquired-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans (in shares)</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockSharesAcquired-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Revenues</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label xlink:label="us-gaap_Revenues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Sale of treasury stock (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label xlink:label="us-gaap_SharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashEquivalentsAtCarryingValue</link:label>
    <link:label xlink:label="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash at beginning of year</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash at end of year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInOtherDeferredLiability</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllocatedShareBasedCompensationExpense</link:label>
    <link:label xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsGrossNoncurrent</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FinancialInstrumentsOwnedAtFairValue</link:label>
    <link:label xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments, Owned, at Fair Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInDepositOtherAssets</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CustomerConcentrationRiskMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</link:label>
    <link:label xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, offering costs adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockRetiredCostMethodAmount</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesReceivableNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NotesReceivableNet</link:label>
    <link:label xlink:label="us-gaap_NotesReceivableNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableNet" xlink:to="us-gaap_NotesReceivableNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockValueAcquiredCostMethod</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TreasuryStockValue</link:label>
    <link:label xlink:label="us-gaap_TreasuryStockValue-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (296,504 shares as of December 31, 2016 and 534,000 as of December 31, 2015, at cost)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockRepurchasedDuringPeriodShares</link:label>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockRepurchasedDuringPeriodValue</link:label>
    <link:label xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of treasury stock</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income taxes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseRevenue" xlink:to="us-gaap_FranchiseRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RoyaltyRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="us-gaap_RoyaltyRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred franchise costs - current portion</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred current net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsCurrent" xlink:to="jynt_DeferredFranchiseCostsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_CoOpFundsLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-op funds liability</link:label>
    <link:label xlink:label="jynt_CoOpFundsLiabilityCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CoOpFundsLiabilityCurrent" xlink:to="jynt_CoOpFundsLiabilityCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred franchise costs, net of current portion</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred noncurrent net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsNoncurrent" xlink:to="jynt_DeferredFranchiseCostsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TechnologyServicesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT related income and software fees</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyServicesRevenue" xlink:to="us-gaap_TechnologyServicesRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherSalesRevenueNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues and management fees from company clinics</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSalesRevenueNet" xlink:to="us-gaap_OtherSalesRevenueNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of vested restricted stock (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FairValueDisclosuresTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivable</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasePolicyTextBlock" xlink:label="us-gaap_LeasePolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeasePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasePolicyTextBlock" xlink:to="us-gaap_LeasePolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of vested restricted stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities</link:label>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising fund revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingRevenue" xlink:to="us-gaap_AdvertisingRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted at Market Price, Number of Shares (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional developer fees</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRevenue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of regional development fees revenue recognized.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesRevenue" xlink:to="jynt_RegionalDeveloperFeesRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InternalUseSoftwarePolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesAndStockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CooperativeAdvertisingPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cooperative Advertising Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CooperativeAdvertisingPolicy" xlink:to="us-gaap_CooperativeAdvertisingPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Costs, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</link:label>
    <link:label xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State, net of state tax credits</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Regional developer fees recognized upon acquisition of development rights</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of regional developer fees recognized upon acquisition of development rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Regional developer fees recognized upon termination of regional developer agreements</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of regional developer fees recognized upon acquisition of development rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:type="locator"/>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_IncreaseDecreaseInCoOpFundsLiability</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-op funds liability</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase (decrease) in co-op funds liability during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_IncreaseDecreaseInDeferredFranchiseCosts</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase (decrease) during the reporting period in deferred franchise costs.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise Costs Netted Against Aggregate Purchase Price</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred franchise costs netted against the aggregate purchase price of acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AssetsFairValueAdjustment</link:label>
    <link:label xlink:label="us-gaap_AssetsFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueAdjustment" xlink:to="us-gaap_AssetsFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentFederalTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseFeesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Fees [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseFeesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to franchise fees collected upon the execution of franchise agreements.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseFeesMember" xlink:to="jynt_FranchiseFeesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfFranchises</link:label>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Franchises</link:label>
    <link:label xlink:label="jynt_NumberOfFranchises-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfFranchises" xlink:to="jynt_NumberOfFranchises-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SixFranchiseesMember" xlink:label="jynt_SixFranchiseesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_SixFranchiseesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Six Franchisees [Member]</link:label>
    <link:label xlink:label="jynt_SixFranchiseesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information related to six franchisees.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SixFranchiseesMember" xlink:to="jynt_SixFranchiseesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CurrentIncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current provision (benefit)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfPCEntities</link:label>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of PC Entities</link:label>
    <link:label xlink:label="jynt_NumberOfPCEntities-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of PC entities.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfPCEntities" xlink:to="jynt_NumberOfPCEntities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage</link:label>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Monthly Marketing Fee Gross Sales Percentage</link:label>
    <link:label xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepositsAssetsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred provision</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionServicesCommissions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Services, Commissions [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesCommissions" xlink:to="us-gaap_RevenueRecognitionServicesCommissions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Services, Franchise Fees [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers License Fee Current Franchise Fee Percentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The percentage of the then current franchise fee regional developers pay as a license fee.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers Royalty Sales Generated by Franchises Percentage</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_FranchiseRoyaltyGrossSalesPercentage</link:label>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Franchise Royalty Gross Sales Percentage</link:label>
    <link:label xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_AdvertisingFundPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Fund, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_AdvertisingFundPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the advertising fund.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AdvertisingFundPolicyTextBlock" xlink:to="jynt_AdvertisingFundPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues and Management Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the revenues and management fees from the Company clinics.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for regional developer fees.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT Related Income And Software Fees, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for income and software fees related to information technology.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for the royalties from franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsClosedDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Closed during the period</link:label>
    <link:label xlink:label="jynt_ClinicsClosedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics closed during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsClosedDuringThePeriod" xlink:to="jynt_ClinicsClosedDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsOpenedDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opened during the period</link:label>
    <link:label xlink:label="jynt_ClinicsOpenedDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of number of clinics opened during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsOpenedDuringThePeriod" xlink:to="jynt_ClinicsOpenedDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensation</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsSoldButNotYetOperational-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsSoldButNotYetOperational</link:label>
    <link:label xlink:label="jynt_ClinicsSoldButNotYetOperational-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinic licenses sold but not yet developed</link:label>
    <link:label xlink:label="jynt_ClinicsSoldButNotYetOperational-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics that have been sold as franchises, but are not yet operational.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsSoldButNotYetOperational" xlink:to="jynt_ClinicsSoldButNotYetOperational-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredFranchiseCosts</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Franchise Costs</link:label>
    <link:label xlink:label="jynt_DeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred costs incurred and are directly related to generating franchise revenues.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredFranchiseCosts" xlink:to="jynt_DeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherIncome-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_TheJointRRCCorpMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Joint RRC Corp [Member]</link:label>
    <link:label xlink:label="jynt_TheJointRRCCorpMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Entity acquired by the company.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TheJointRRCCorpMember" xlink:to="jynt_TheJointRRCCorpMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, interest and penalties</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, interest and penalties</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchisesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchises [Member]</link:label>
    <link:label xlink:label="jynt_FranchisesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about the Company's franchises.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchisesMember" xlink:to="jynt_FranchisesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchisesClosed" xlink:label="jynt_NumberOfFranchisesClosed" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfFranchisesClosed-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfFranchisesClosed</link:label>
    <link:label xlink:label="jynt_NumberOfFranchisesClosed-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Franchises Closed</link:label>
    <link:label xlink:label="jynt_NumberOfFranchisesClosed-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of franchises that were closed.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfFranchisesClosed" xlink:to="jynt_NumberOfFranchisesClosed-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes receivable, net of current portion and reserve</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unfavorable leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the unfavorable leases in a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,317,393 shares issued and 13,020,889 shares outstanding as of December 31, 2016 and 13,070,180 shares issued and 12,536,180 outstanding as of December 31, 2015</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_TableTextBlock</link:label>
    <link:label xlink:label="us-gaap_TableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Tables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_TableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivableContractualTerm</link:label>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Contractual Term</link:label>
    <link:label xlink:label="jynt_NotesReceivableContractualTerm-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The contractual term stated in note receivable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivableContractualTerm" xlink:to="jynt_NotesReceivableContractualTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivableInterestRate</link:label>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:label xlink:label="jynt_NotesReceivableInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the per annum interest rate stated in notes receivable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivableInterestRate" xlink:to="jynt_NotesReceivableInterestRate-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_CompanyOwnedClinicMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company-owned Clinic [Member]</link:label>
    <link:label xlink:label="jynt_CompanyOwnedClinicMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the sale of the Company-owned clinic.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CompanyOwnedClinicMember" xlink:to="jynt_CompanyOwnedClinicMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivablePrincipalAndInterestTerm</link:label>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Receivable, Principal and Interest, Term</link:label>
    <link:label xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the term over which principal and interest are to be paid.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivablePrincipalAndInterestTerm" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DepreciationDepletionAndAmortization-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label xlink:label="us-gaap_DepreciationDepletionAndAmortization-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Depreciation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Depreciation</link:label>
    <link:label xlink:label="us-gaap_Depreciation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevenuesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TempeAZMember" xlink:label="jynt_TempeAZMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_TempeAZMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tempe, AZ [Member]</link:label>
    <link:label xlink:label="jynt_TempeAZMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Tempe, Arizona.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TempeAZMember" xlink:to="jynt_TempeAZMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AssetsCurrent</link:label>
    <link:label xlink:label="us-gaap_AssetsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SanDiegoCAMember" xlink:label="jynt_SanDiegoCAMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_SanDiegoCAMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">San Diego, CA [Member]</link:label>
    <link:label xlink:label="jynt_SanDiegoCAMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents San Diego, California.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SanDiegoCAMember" xlink:to="jynt_SanDiegoCAMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OtherNonoperatingIncomeExpense</link:label>
    <link:label xlink:label="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on disposition or impairment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NonoperatingIncomeExpense</link:label>
    <link:label xlink:label="us-gaap_NonoperatingIncomeExpense-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other (expense) income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StateAndLocalJurisdictionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2016, and December 31, 2015</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxAuthorityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_CurrentFiscalYearEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DomesticCountryMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_DevelopmentRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Rights [Member]</link:label>
    <link:label xlink:label="jynt_DevelopmentRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rights, generally of limited duration, that the entity has obtained through an arrangement related to the regional developer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DevelopmentRightsMember" xlink:to="jynt_DevelopmentRightsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxAuthorityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesIssued-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:type="locator"/>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RepurchaseRightToDevelopFranchisesConsideration</link:label>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase Right to Develop Franchises, Consideration</link:label>
    <link:label xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consideration paid or payable for repurchasing development rights to develop franchises in certain areas.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalPeriodFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentFiscalYearFocus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goods and Services Exchanged for Equity Instrument [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information relating to a non-interest bearing unsecured promissory note maturing October 1, 2017.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUnsecuredPromissoryNotes</link:label>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Unsecured Promissory Notes</link:label>
    <link:label xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of unsecured promissory notes received during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUnsecuredPromissoryNotes" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OpenTaxYear-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OpenTaxYear</link:label>
    <link:label xlink:label="us-gaap_OpenTaxYear-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Rights in Virginia [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about regional developer rights in Virginia.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrants or Rights, Outstanding, Remaining Contractual Life</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the remaining contractual life for warrants outstanding.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingIncomeLoss</link:label>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label xlink:label="us-gaap_OperatingIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income (loss)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfCashFlowsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClassOfWarrantOrRightIssuedDuringPeriod</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Issued During Period</link:label>
    <link:label xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of warrants or rights issued during period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefits</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, tax</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefits-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax benefit, tax</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CostOfRevenue</link:label>
    <link:label xlink:label="us-gaap_CostOfRevenue-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified stock options</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from non-qualified stock options and carryforwards classified as non-current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_InterestPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_InterestPaid</link:label>
    <link:label xlink:label="us-gaap_InterestPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BinomialLatticeBasedModelFairValueSharePrice</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Binomial Lattice-based Model, Fair Value, Share Price</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the fair value share price derived from the binomial lattice-based model.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxesPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxesPaid</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxesPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityPublicFloat-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityFilerCategory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PropertyPlantAndEquipmentUsefulLife</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:type="locator"/>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BinomialLatticeBasedModelFairValueTotal</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Binomial Lattice-based Model, Fair Value, Total</link:label>
    <link:label xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the total value of the option determined by the binomial lattice-based model.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BinomialLatticeBasedModelFairValueTotal" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCurrentReportingStatus-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_The2012PlanMember" xlink:label="jynt_The2012PlanMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_The2012PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2012 Plan [Member]</link:label>
    <link:label xlink:label="jynt_The2012PlanMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to the 2012 Plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_The2012PlanMember" xlink:to="jynt_The2012PlanMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</link:label>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross decreases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityVoluntaryFilers-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityWellKnownSeasonedIssuer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross increases - tax positions in prior period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseCosts" xlink:to="us-gaap_FranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LatestTaxYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LatestTaxYearMember" xlink:to="us-gaap_LatestTaxYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue</link:label>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Fair Value (in dollars per share)</link:label>
    <link:label xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The weighted-average fair value as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarliestTaxYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the forfeiture rate in determine the fair value for the share-based compensation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</link:label>
    <link:label xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TaxPeriodAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TaxPeriodDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodDomain" xlink:to="us-gaap_TaxPeriodDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExcercisePriceYearOne-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 1 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExcercisePriceYearOne-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in the first year.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExcercisePriceYearOne" xlink:to="jynt_OptionExcercisePriceYearOne-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LeaseholdImprovementsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearThree-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 3 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearThree-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year three.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearThree" xlink:to="jynt_OptionExercisePriceYearThree-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 2 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearTwo-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year two.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearTwo" xlink:to="jynt_OptionExercisePriceYearTwo-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearFive-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 5 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearFive-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year five.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearFive" xlink:to="jynt_OptionExercisePriceYearFive-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearFour-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 4 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearFour-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year four.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearFour" xlink:to="jynt_OptionExercisePriceYearFour-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearSeven-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 7 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearSeven-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year seven.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearSeven" xlink:to="jynt_OptionExercisePriceYearSeven-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapital-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearSix-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 6 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearSix-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year six.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearSix" xlink:to="jynt_OptionExercisePriceYearSix-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TechnologyServicesCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IT cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyServicesCosts" xlink:to="us-gaap_TechnologyServicesCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionExercisePriceYearEight-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year 8 (in dollars per share)</link:label>
    <link:label xlink:label="jynt_OptionExercisePriceYearEight-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the option exercise price in year eight.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionExercisePriceYearEight" xlink:to="jynt_OptionExercisePriceYearEight-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OperatingLeaseMonthlyRentExpense" xlink:label="jynt_OperatingLeaseMonthlyRentExpense" xlink:type="locator"/>
    <link:label xlink:label="jynt_OperatingLeaseMonthlyRentExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_OperatingLeaseMonthlyRentExpense</link:label>
    <link:label xlink:label="jynt_OperatingLeaseMonthlyRentExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Monthly Rent Expense</link:label>
    <link:label xlink:label="jynt_OperatingLeaseMonthlyRentExpense-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the monthly rent expense for the operating lease.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OperatingLeaseMonthlyRentExpense" xlink:to="jynt_OperatingLeaseMonthlyRentExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="dei_EntityCommonStockSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Number of Units (in shares)</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of shares into which fully or partially vested equity instruments other than option outstanding as of the balance sheet date can be currently converted under the option plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes receivable - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLossCarryforwards</link:label>
    <link:label xlink:label="us-gaap_OperatingLossCarryforwards-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsReceivableNetCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfLicenseTransferAgreements</link:label>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of License Transfer Agreements</link:label>
    <link:label xlink:label="jynt_NumberOfLicenseTransferAgreements-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of license transfer agreements the Company entered into.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfLicenseTransferAgreements" xlink:to="jynt_NumberOfLicenseTransferAgreements-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision (Benefit)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The weighted average exercise price of exercisable awards on equity-based plans excluding option plans.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of increase in valuation allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_Liabilities</link:label>
    <link:label xlink:label="us-gaap_Liabilities-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment, Excluding Construction in Progress [Member]</link:label>
    <link:label xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale, not including construction in progress.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingencies-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term for exercisable equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AssetsCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</link:label>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net decrease in cash</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bargain purchase gain</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Bargain Purchase, Gain Recognized, Amount</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Bargain purchase gain</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConcentrationRiskCreditRisk-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</link:label>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsOfStockIssuanceCosts</link:label>
    <link:label xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, offering costs adjustment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:type="locator"/>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights</link:label>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reacquisition and termination of regional developer rights</link:label>
    <link:label xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow for the reacquisition and termination of regional developer rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net assets acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State tax provision, net of federal benefit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</link:label>
    <link:label xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax expense (benefit)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of increase in valuation allowance, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsForRepurchaseOfCommonStock</link:label>
    <link:label xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock under employee stock plans</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_StockholdersEquity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label xlink:label="us-gaap_StockholdersEquity-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred membership revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RetainedEarningsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TreasuryStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromStockOptionsExercised-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock - follow-on public offering</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdditionalPaidInCapitalMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CostOfRevenueAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of revenues:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenueAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of treasury stock</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommonStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementEquityComponentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EquityComponentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DeferredRevenue</link:label>
    <link:label xlink:label="us-gaap_DeferredRevenue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected dividends</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationSettlementAmount" xlink:label="us-gaap_LitigationSettlementAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LitigationSettlementAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LitigationSettlementAmount</link:label>
    <link:label xlink:label="us-gaap_LitigationSettlementAmount-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash paid for legal settlement</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementAmount" xlink:to="us-gaap_LitigationSettlementAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationNondeductibleExpense</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermDebt-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LongTermDebt</link:label>
    <link:label xlink:label="us-gaap_LongTermDebt-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationConsiderationTransferred1</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected term (years) (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences, amount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual Term (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and Other Accounts Receivable, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCredit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCredit</link:label>
    <link:label xlink:label="us-gaap_LineOfCredit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected federal tax expense (benefit), amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State tax provision, net of federal benefit, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPO, net offering costs</link:label>
    <link:label xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Offering costs paid</link:label>
    <link:label xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow associated with the costs of initial public offering.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested, beginning balance (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested, beginning balance (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards forfeited (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountingPoliciesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</link:label>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax expense</link:label>
    <link:label xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Number of Units (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Awards vested (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OnePcEntityMember" xlink:label="jynt_OnePcEntityMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_OnePcEntityMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One PC Entity [Member]</link:label>
    <link:label xlink:label="jynt_OnePcEntityMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the single PC Entity that is a major customer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OnePcEntityMember" xlink:to="jynt_OnePcEntityMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OfficeEquipmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SoftwareDevelopmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BalanceSheetLocationDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</link:label>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BalanceSheetLocationAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_LossOnDispositionOrImpairmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Disposition or Impairment [Member]</link:label>
    <link:label xlink:label="jynt_LossOnDispositionOrImpairmentMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing loss on disposition or impairment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LossOnDispositionOrImpairmentMember" xlink:to="jynt_LossOnDispositionOrImpairmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfClinicsClassifiedAsHeldForSale</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Clinics Classified as Held for Sale</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics that met the requirements for the classification of held for sale.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual Life (Year)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RevolvingCreditFacilityMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</link:label>
    <link:label xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Write-offs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CreditFacilityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Rights and Customer Relationships, Reacquired [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to reacquired franchise rights and customer relationships.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Fair Value (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CreditFacilityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ReceivableTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivableTypeDomain" xlink:to="us-gaap_ReceivableTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cancelled, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercised, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementLocationDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementLocationAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MaximumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease abandonment</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from abandoned lease obligations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MinimumMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RangeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RangeMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_MajorCustomersAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_MajorCustomersAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NameOfMajorCustomerDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NameOfMajorCustomerDomain" xlink:to="us-gaap_NameOfMajorCustomerDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Number of Shares (in shares)</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled, Number of Shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FranchiseRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Rights [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchiseRightsMember" xlink:to="us-gaap_FranchiseRightsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability" xlink:type="locator"/>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LeaseExitLiability</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Exit Liability</link:label>
    <link:label xlink:label="jynt_LeaseExitLiability-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LeaseExitLiability" xlink:to="jynt_LeaseExitLiability-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reacquisitions of Franchises Throughout California and New Mexico [Member}</link:label>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to the reacquisitions by the Company of franchises throughout California and New Mexico.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_OperatingLeasesRentExpenseNet</link:label>
    <link:label xlink:label="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_RepaymentsOfNotesPayable</link:label>
    <link:label xlink:label="us-gaap_RepaymentsOfNotesPayable-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments on notes payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:type="locator"/>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties</link:label>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross decreases - tax positions in prior period</link:label>
    <link:label xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of decrease in unrecognized tax benefits interest and penalties resulting from tax positions taken in prior period tax returns.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:type="locator"/>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement</link:label>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement</link:label>
    <link:label xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The minimum amount of interest to be paid of the term of the line of credit agreement.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill - Component 2</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</link:label>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill - Component 1</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to the lesser value of the book value of goodwill and the tax value of goodwill.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted weighted average shares (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CustomerRelationshipsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Anti-dilutive Securities (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</link:label>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharePrice</link:label>
    <link:label xlink:label="us-gaap_SharePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</link:label>
    <link:label xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareBasicAndDiluted-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic and diluted loss per share (in dollars per share)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementGeographicalAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AwardTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentGeographicalDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_RelatedPartyTransactionAmountsOfTransaction</link:label>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScenarioForecastMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioForecastMember" xlink:to="us-gaap_ScenarioForecastMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</link:label>
    <link:label xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScenarioUnspecifiedDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementScenarioAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsFranchiseCosts</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred franchise costs</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the franchise costs in the deferred tax assets, current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsFranchiseCosts" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsRevenueCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred revenue of the deferred tax assets current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsRevenueCurrent" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsAccruedExpensesCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the accrued expenses of the deferred tax assets current portion.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the current portion of the allowance for doubtful account in the deferred tax assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetDeferredRentCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred rent in the deferred tax assets current.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetDeferredRentCurrent" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetRestrictedStockCompensationCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock compensation</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the current deferred tax asset of restricted stock compensation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CorporateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateMember" xlink:to="us-gaap_CorporateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementBusinessSegmentsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SegmentDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charitable contribution carryover</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred tax assets current for charitable contributions carryover.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deferred tax asset net operating loss carryforward noncurrent.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment</link:label>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset basis difference related to property and equipment</link:label>
    <link:label xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the asset basis difference in property and equipment for deferred tax assets.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]</link:label>
    <link:label xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to notes payable delivered as a portion of the consideration paid in connection with the Company's various acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of changed state rates for deferred</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the effect of reduced state rates on the deferred taxes in the effective income tax reconciliation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:type="locator"/>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of changed state rates for deferred, amount</link:label>
    <link:label xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the effect of reduced state tax rates on the deferred tax amount, for the effective income tax reconciliation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions</link:label>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions</link:label>
    <link:label xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of notes payable delivered during the period as a portion of the consideration paid in connection with the Company's various acquisitions.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersLicenseFee</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers License Fee</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersLicenseFee-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum amount of license fees that must be paid by regional developers.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersLicenseFee" xlink:to="jynt_RegionalDevelopersLicenseFee-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GoodwillPeriodIncreaseDecrease</link:label>
    <link:label xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:type="locator"/>
    <link:label xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NotesReceivableIssuedForPaymentOfTransferFees</link:label>
    <link:label xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Notes receivable issued for payment of transfer fees</link:label>
    <link:label xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of notes receivable issued for payment of transfer fees.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:to="jynt_NotesReceivableIssuedForPaymentOfTransferFees-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</link:label>
    <link:label xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of franchise fees collected upon sale of franchise.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CorporateNonSegmentMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNonSegmentMember" xlink:to="us-gaap_CorporateNonSegmentMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</link:label>
    <link:label xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OperatingSegmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note 2 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents non-interest bearing unsecured promissory note 2.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeStatementAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationItemsAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-interest Bearing Unsecured Promissory Note 1 [Member]</link:label>
    <link:label xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents non-interest bearing unsecured promissory note 1.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationItemsDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationItemsDomain" xlink:to="us-gaap_ConsolidationItemsDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GoodwillAcquiredDuringPeriod</link:label>
    <link:label xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Bearing Unsecured Promissory Note [Member]</link:label>
    <link:label xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents an interest bearing unsecured promissory note.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:to="jynt_InterestBearingUnsecuredPromissoryNoteMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net non-current deferred tax liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:type="locator"/>
    <link:label xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf</link:label>
    <link:label xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Number of Clinics to be Disposed of</link:label>
    <link:label xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of company-owned or managed clinics attributable to disposal group held for sale or disposed of, including discontinued operation.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:to="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRentCreditNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred rent, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueNoncurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TitleOfIndividualAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FormerChiefExecutiveOfficerMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Chief Executive Officer [Member]</link:label>
    <link:label xlink:label="jynt_FormerChiefExecutiveOfficerMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the former chief executive officer.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FormerChiefExecutiveOfficerMember" xlink:to="jynt_FormerChiefExecutiveOfficerMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for acquisitions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquireBusinessesGross</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LongTermNotesPayable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_IncomeTaxExpenseBenefit</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax (expense) benefit</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total income tax provision (benefit)</link:label>
    <link:label xlink:label="us-gaap_IncomeTaxExpenseBenefit-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision (Benefit), amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LiabilitiesCurrent</link:label>
    <link:label xlink:label="us-gaap_LiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FinitelivedIntangibleAssetsAcquired1</link:label>
    <link:label xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProceedsFromCollectionOfNotesReceivable</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments received on notes receivable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_MinimumNumberOfClinicsToBeOpened" xlink:label="jynt_MinimumNumberOfClinicsToBeOpened" xlink:type="locator"/>
    <link:label xlink:label="jynt_MinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_MinimumNumberOfClinicsToBeOpened</link:label>
    <link:label xlink:label="jynt_MinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum Number of Clinics to be Opened</link:label>
    <link:label xlink:label="jynt_MinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the minimum number of clinics to be opened.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_MinimumNumberOfClinicsToBeOpened" xlink:to="jynt_MinimumNumberOfClinicsToBeOpened-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsDisposedOf" xlink:label="jynt_NumberOfClinicsDisposedOf" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfClinicsDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfClinicsDisposedOf</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Clinics Disposed of</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clinics disposed of during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfClinicsDisposedOf" xlink:to="jynt_NumberOfClinicsDisposedOf-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsExpectedToOpen" xlink:label="jynt_NumberOfClinicsExpectedToOpen" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfClinicsExpectedToOpen-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfClinicsExpectedToOpen</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsExpectedToOpen-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Clinics Expected to Open</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsExpectedToOpen-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of clients that are expected to be opened over a specified period of time.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfClinicsExpectedToOpen" xlink:to="jynt_NumberOfClinicsExpectedToOpen-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:type="locator"/>
    <link:label xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_TimeFrameOfClinicsExpectedToBeOpen</link:label>
    <link:label xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time Frame of Clinics Expected to be Open</link:label>
    <link:label xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The stated time frame in which the company expects new clinics to be opened.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:to="jynt_TimeFrameOfClinicsExpectedToBeOpen-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRentCreditCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred rent - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoIllinoisMember" xlink:label="jynt_ChicagoIllinoisMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ChicagoIllinoisMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chicago, Illinois [Member]</link:label>
    <link:label xlink:label="jynt_ChicagoIllinoisMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the city of Chicago, Illinois.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ChicagoIllinoisMember" xlink:to="jynt_ChicagoIllinoisMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DeferredRevenueCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred revenue - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsInOperation" xlink:label="jynt_NumberOfClinicsInOperation" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfClinicsInOperation-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfClinicsInOperation</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsInOperation-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Clinics in Operation</link:label>
    <link:label xlink:label="jynt_NumberOfClinicsInOperation-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of clinics in operation as of the balance sheet date.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfClinicsInOperation" xlink:to="jynt_NumberOfClinicsInOperation-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoRegionalDeveloperRightsMember" xlink:label="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ChicagoRegionalDeveloperRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chicago Regional Developer Rights [Member]</link:label>
    <link:label xlink:label="jynt_ChicagoRegionalDeveloperRightsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information pertaining to the Chicago regional developer rights.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ChicagoRegionalDeveloperRightsMember" xlink:to="jynt_ChicagoRegionalDeveloperRightsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMember" xlink:label="jynt_FranchiseMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the Franchise clinics operating segment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseMember" xlink:to="jynt_FranchiseMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UpStateNewYorkMember" xlink:label="jynt_UpStateNewYorkMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_UpStateNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upstate New York [Member]</link:label>
    <link:label xlink:label="jynt_UpStateNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents upstate New York.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_UpStateNewYorkMember" xlink:to="jynt_UpStateNewYorkMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:label xlink:label="jynt_AccountsPayable1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:label xlink:label="jynt_AccountsPayable1Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing accounts payable.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AccountsPayable1Member" xlink:to="jynt_AccountsPayable1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:type="locator"/>
    <link:label xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened</link:label>
    <link:label xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time Frame for the Minimum Number of Clinics to be Opened</link:label>
    <link:label xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the time frame for the stated minimum number of clinics to open.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:to="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_FranchiseOperationsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise Operations [Member]</link:label>
    <link:label xlink:label="jynt_FranchiseOperationsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the franchise operations segment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_FranchiseOperationsMember" xlink:to="jynt_FranchiseOperationsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccruedExpensesMember" xlink:label="jynt_AccruedExpensesMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_AccruedExpensesMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses [Member]</link:label>
    <link:label xlink:label="jynt_AccruedExpensesMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents Accrued expenses.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AccruedExpensesMember" xlink:to="jynt_AccruedExpensesMember-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_CorporateClinicsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Clinics [Member]</link:label>
    <link:label xlink:label="jynt_CorporateClinicsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the corporate clinics segment.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CorporateClinicsMember" xlink:to="jynt_CorporateClinicsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NotesPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes payable - current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EstimatedCashNeeds" xlink:label="jynt_EstimatedCashNeeds" xlink:type="locator"/>
    <link:label xlink:label="jynt_EstimatedCashNeeds-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_EstimatedCashNeeds</link:label>
    <link:label xlink:label="jynt_EstimatedCashNeeds-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Cash Needs</link:label>
    <link:label xlink:label="jynt_EstimatedCashNeeds-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of estimated cash needs during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_EstimatedCashNeeds" xlink:to="jynt_EstimatedCashNeeds-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfStoresToCloseOrSell" xlink:label="jynt_NumberOfStoresToCloseOrSell" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfStoresToCloseOrSell-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfStoresToCloseOrSell</link:label>
    <link:label xlink:label="jynt_NumberOfStoresToCloseOrSell-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stores to Close or Sell</link:label>
    <link:label xlink:label="jynt_NumberOfStoresToCloseOrSell-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of stores to close or sell during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfStoresToCloseOrSell" xlink:to="jynt_NumberOfStoresToCloseOrSell-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoAndNewYorkMember" xlink:label="jynt_ChicagoAndNewYorkMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ChicagoAndNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chicago and New York [Member]</link:label>
    <link:label xlink:label="jynt_ChicagoAndNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about geographical area of Chicago and New York.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ChicagoAndNewYorkMember" xlink:to="jynt_ChicagoAndNewYorkMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_CapitalExpendituresIncurredButNotYetPaid</link:label>
    <link:label xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentInterestRateStatedPercentage</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUndevelopedFranchiseAgreementsTerminated</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Undeveloped Franchise Agreements Terminated</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of franchise agreements terminated for an undeveloped franchise.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:label="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_ManagementsPlanPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management's Plan, Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_ManagementsPlanPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for management's plan.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:to="jynt_ManagementsPlanPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DebtInstrumentFaceAmount</link:label>
    <link:label xlink:label="us-gaap_DebtInstrumentFaceAmount-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payroll liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccountsPayableCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccruedLiabilitiesCurrent-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventTypeAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventTypeDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:type="locator"/>
    <link:label xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses</link:label>
    <link:label xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Used for Investing Activities Including Working Capital Losses</link:label>
    <link:label xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of cash used for investing activities including working capital losses.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:to="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProceedsFromSaleOfIntangibleAssets</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:type="locator"/>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_OptionToRepurchaseSharesChangeInFairValue</link:label>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to Repurchase Shares, Change in Fair Value</link:label>
    <link:label xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of change in fair value for options to repurchase shares.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SubsequentEventsTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds received on sale of property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations Policy [Policy Text Block]</link:label>
    <link:label xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for nature of operations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Favorable leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Favorable Leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the favorable leases in a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtInstrumentNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ClinicsAcquiredDuringThePeriod</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired during the period</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquired during the period</link:label>
    <link:label xlink:label="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of clinics acquired during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ClinicsAcquiredDuringThePeriod" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod</link:label>
    <link:label xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Developed Franchises Reacquired During Period</link:label>
    <link:label xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the aggregate number of developed franchises reacquired by the Company during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:to="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Undeveloped Franchises Reacquired During the Period</link:label>
    <link:label xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the aggregate number of undeveloped franchises reacquired by the Company during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reacquired Undeveloped Franchises that Have Been Terminated and May Be Relocated</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of the reacquired undeveloped franchises that have been terminated and the Company may relocate them.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:to="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:type="locator"/>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics</link:label>
    <link:label xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of the reacquired developed franchises that the Company is operating as company-owned or managed clinics.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reacquisitions of Franchises Throughout Arizona, California and New York [Member]</link:label>
    <link:label xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information pertaining to the 2015 reacquisitions by the Company of franchises throughout Arizona, California, and New York.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net purchase price</link:label>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs</link:label>
    <link:label xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</link:label>
    <link:label xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member]</link:label>
    <link:label xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents information about regional developer rights in Los Angeles County, California, in San Diego, California, and in New Jersey.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LiabilitiesCurrentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label xlink:label="us-gaap_Assets-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_BusinessCombinationAcquisitionRelatedCosts</link:label>
    <link:label xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdditionalLeasesAssumed" xlink:label="jynt_AdditionalLeasesAssumed" xlink:type="locator"/>
    <link:label xlink:label="jynt_AdditionalLeasesAssumed-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_AdditionalLeasesAssumed</link:label>
    <link:label xlink:label="jynt_AdditionalLeasesAssumed-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Leases Assumed</link:label>
    <link:label xlink:label="jynt_AdditionalLeasesAssumed-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the number of additional leases assumed during the period by the Company for clinic locations.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_AdditionalLeasesAssumed" xlink:to="jynt_AdditionalLeasesAssumed-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</link:label>
    <link:label xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="locator"/>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</link:label>
    <link:label xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the per share amount at which grantees can acquire shares of common stock by exercise of options.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</link:label>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Interest</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other unallocated assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:type="locator"/>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements</link:label>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net franchise fees recognized upon termination of franchise agreements</link:label>
    <link:label xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The element that represents net franchise fees recognized upon termination of franchise agreements.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AmortizationOfIntangibleAssets</link:label>
    <link:label xlink:label="us-gaap_AmortizationOfIntangibleAssets-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</link:label>
    <link:label xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_FiniteLivedIntangibleAssetsNet</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Carrying Value</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss and comprehensive loss</link:label>
    <link:label xlink:label="us-gaap_NetIncomeLoss-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AdvertisingExpense</link:label>
    <link:label xlink:label="us-gaap_AdvertisingExpense-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:type="locator"/>
    <link:label xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_ExcessDeferredRegionalFeesRevenueRecognized</link:label>
    <link:label xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess Deferred Regional Fees Revenue Recognized</link:label>
    <link:label xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of excess deferred regional developer fees revenue recognized during the period.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:to="jynt_ExcessDeferredRegionalFeesRevenueRecognized-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_Goodwill-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label xlink:label="us-gaap_Goodwill-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_WarrantMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</link:label>
    <link:label xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_RestrictedStockMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated property and equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EmployeeStockOptionMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ConstructionInProgressGross-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressGross" xlink:to="us-gaap_ConstructionInProgressGross-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DebtDisclosureTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_SellingGeneralAndAdministrativeExpense</link:label>
    <link:label xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total selling, general and administrative expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_ProvisionForDoubtfulAccounts</link:label>
    <link:label xlink:label="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Recovery) provision for bad debts</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_SellingAndMarketingExpense-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and marketing expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_DisclosureTextBlockAbstract</link:label>
    <link:label xlink:label="us-gaap_DisclosureTextBlockAbstract-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes to Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_OtherIncomeAndExpensesAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other (expense) income:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This element represents the amount of a fair value adjustment realized during the reporting period to property, plant and equipment acquired in connection with a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Favorable leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of a fair value adjustment realized during the reporting period to favorable leases acquired in connection with a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_UseOfEstimates-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of a fair value adjustment realized during the reporting period to intangible assets, other than goodwill, acquired in connection with a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NumberOfReportableSegments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NumberOfReportableSegments</link:label>
    <link:label xlink:label="us-gaap_NumberOfReportableSegments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock-label" xlink:type="arc"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:type="locator"/>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unfavorable leases</link:label>
    <link:label xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of a fair value adjustment realized during the reporting period to unfavorable leases acquired in connection with a business combination.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">us-gaap_NumberOfOperatingSegments</link:label>
    <link:label xlink:label="us-gaap_NumberOfOperatingSegments-label" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments-label" xlink:type="arc"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:label xlink:label="us-gaap_EarningsPerShareAbstract-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss per share:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>jynt-20161231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 05:39PM UTC 2017-03-10--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-document-and-entity-information" xlink:href="jynt-20161231.xsd#statement-document-and-entity-information" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-document-and-entity-information" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DocumentAndEntityInformation" xlink:label="jynt_DocumentAndEntityInformation" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_DocumentAndEntityInformation" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals" xlink:href="jynt-20161231.xsd#statement-consolidated-balance-sheets-parentheticals" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccruedExpensesMember" xlink:label="jynt_AccruedExpensesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccruedExpensesMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoAndNewYorkMember" xlink:label="jynt_ChicagoAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OnePcEntityMember" xlink:label="jynt_OnePcEntityMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SixFranchiseesMember" xlink:label="jynt_SixFranchiseesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_ChicagoAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_MajorCustomersAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="jynt_OnePcEntityMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="jynt_SixFranchiseesMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SanDiegoCAMember" xlink:label="jynt_SanDiegoCAMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TempeAZMember" xlink:label="jynt_TempeAZMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_TempeAZMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_SanDiegoCAMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable" xlink:href="jynt-20161231.xsd#statement-note-3-notes-receivable" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-" xlink:href="jynt-20161231.xsd#statement-note-5-fair-value-consideration-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMember" xlink:label="jynt_FranchiseMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity" xlink:href="jynt-20161231.xsd#statement-note-8-equity" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_The2012PlanMember" xlink:label="jynt_The2012PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="jynt_The2012PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions" xlink:href="jynt-20161231.xsd#statement-note-10-related-party-transactions" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-" xlink:href="jynt-20161231.xsd#statement-note-13-subsequent-events-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoIllinoisMember" xlink:label="jynt_ChicagoIllinoisMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoRegionalDeveloperRightsMember" xlink:label="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesToFinancialStatementsAbstract" xlink:label="jynt_NotesToFinancialStatementsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UpStateNewYorkMember" xlink:label="jynt_UpStateNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NotesToFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_ChicagoIllinoisMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_UpStateNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies" xlink:href="jynt-20161231.xsd#statement-significant-accounting-policies-policies" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdvertisingFundPolicyTextBlock" xlink:label="jynt_AdvertisingFundPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:label="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:label="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:label="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:label="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:label="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RoyaltiesPolicyPolicyTextBlock" xlink:label="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-significant-accounting-policies-policies" xlink:label="jynt_statement-statement-significant-accounting-policies-policies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CooperativeAdvertisingPolicy" xlink:label="us-gaap_CooperativeAdvertisingPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasePolicyTextBlock" xlink:label="us-gaap_LeasePolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PolicyTextBlockAbstract" xlink:label="us-gaap_PolicyTextBlockAbstract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesCommissions" xlink:label="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:label="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-significant-accounting-policies-policies" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PolicyTextBlockAbstract-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PolicyTextBlockAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_NatureOfOperationsPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ManagementsPlanPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesCommissions" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_AdvertisingFundPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CooperativeAdvertisingPolicy" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LeasePolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionServicesFranchiseFees" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RegionalDeveloperFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_RoyaltiesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc"/>
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:type="arc"/>
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:label="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-supplemental-disclosure-of-noncash-information-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:label="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-tables" xlink:label="jynt_statement-statement-note-2-acquisitions-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-4-property-and-equipment-tables" xlink:label="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-4-property-and-equipment-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-tables" xlink:label="jynt_statement-statement-note-6-intangible-assets-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-7-notes-payable-tables" xlink:label="jynt_statement-statement-note-7-notes-payable-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-7-notes-payable-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-tables" xlink:href="jynt-20161231.xsd#statement-note-8-equity-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-tables" xlink:label="jynt_statement-statement-note-8-equity-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-tables" xlink:label="jynt_statement-statement-note-9-income-taxes-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-tables" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-tables" xlink:label="jynt_statement-statement-note-12-segment-reporting-tables" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TableTextBlock" xlink:label="us-gaap_TableTextBlock-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-tables" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TableTextBlock-2" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TableTextBlock" xlink:to="us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:href="jynt-20161231.xsd#statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccountsPayable1Member" xlink:label="jynt_AccountsPayable1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AccruedExpensesMember" xlink:label="jynt_AccruedExpensesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice" xlink:label="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseFeesMember" xlink:label="jynt_FranchiseFeesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccountsPayable1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="jynt_AccruedExpensesMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseFeesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxesPaid-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses" xlink:label="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoAndNewYorkMember" xlink:label="jynt_ChicagoAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EstimatedCashNeeds" xlink:label="jynt_EstimatedCashNeeds-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage" xlink:label="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRoyaltyGrossSalesPercentage" xlink:label="jynt_FranchiseRoyaltyGrossSalesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchises" xlink:label="jynt_NumberOfFranchises-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfPCEntities" xlink:label="jynt_NumberOfPCEntities-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfStoresToCloseOrSell" xlink:label="jynt_NumberOfStoresToCloseOrSell-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OnePcEntityMember" xlink:label="jynt_OnePcEntityMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise" xlink:label="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFee" xlink:label="jynt_RegionalDevelopersLicenseFee-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage" xlink:label="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage" xlink:label="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SixFranchiseesMember" xlink:label="jynt_SixFranchiseesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="us-gaap_NameOfMajorCustomerDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_NameOfMajorCustomerDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_ChicagoAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioForecastMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_MajorCustomersAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="jynt_OnePcEntityMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="jynt_SixFranchiseesMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfStoresToCloseOrSell-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EstimatedCashNeeds-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfPCEntities-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchises-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFee-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise-2" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_FranchiseRoyaltyGrossSalesPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdvertisingExpense-2" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCosts" xlink:label="jynt_DeferredFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod" xlink:label="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfFranchisesClosed" xlink:label="jynt_NumberOfFranchisesClosed-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics" xlink:label="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated" xlink:label="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod" xlink:label="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SanDiegoCAMember" xlink:label="jynt_SanDiegoCAMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TempeAZMember" xlink:label="jynt_TempeAZMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_TempeAZMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_SanDiegoCAMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfFranchisesClosed-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual" xlink:href="jynt-20161231.xsd#statement-note-3-notes-receivable-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CompanyOwnedClinicMember" xlink:label="jynt_CompanyOwnedClinicMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:label="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:label="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableContractualTerm" xlink:label="jynt_NotesReceivableContractualTerm-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableInterestRate" xlink:label="jynt_NotesReceivableInterestRate-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivablePrincipalAndInterestTerm" xlink:label="jynt_NotesReceivablePrincipalAndInterestTerm-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfLicenseTransferAgreements" xlink:label="jynt_NumberOfLicenseTransferAgreements-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUnsecuredPromissoryNotes" xlink:label="jynt_NumberOfUnsecuredPromissoryNotes-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableNet" xlink:label="us-gaap_NotesReceivableNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="us-gaap_ReceivableTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_ReceivableTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="jynt_CompanyOwnedClinicMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote1Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNote2Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_InterestBearingUnsecuredPromissoryNoteMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NotesReceivableNet-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableInterestRate-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivableContractualTerm-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NotesReceivablePrincipalAndInterestTerm-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfLicenseTransferAgreements-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUnsecuredPromissoryNotes-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsClassifiedAsHeldForSale" xlink:label="jynt_NumberOfClinicsClassifiedAsHeldForSale-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsClassifiedAsHeldForSale-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual" xlink:href="jynt-20161231.xsd#statement-note-5-fair-value-consideration-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueAdjustment-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ExcessDeferredRegionalFeesRevenueRecognized" xlink:label="jynt_ExcessDeferredRegionalFeesRevenueRecognized-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseMember" xlink:label="jynt_FranchiseMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:label="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchisesMember" xlink:label="jynt_FranchisesMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LossOnDispositionOrImpairmentMember" xlink:label="jynt_LossOnDispositionOrImpairmentMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:label="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperRightsInVirginiaMember" xlink:label="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RepurchaseRightToDevelopFranchisesConsideration" xlink:label="jynt_RepurchaseRightToDevelopFranchisesConsideration-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchiseMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="jynt_FranchisesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_RegionalDeveloperRightsInVirginiaMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="jynt_LossOnDispositionOrImpairmentMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ExcessDeferredRegionalFeesRevenueRecognized-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_RepurchaseRightToDevelopFranchisesConsideration-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:label="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions" xlink:label="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual" xlink:href="jynt-20161231.xsd#statement-note-8-equity-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueSharePrice" xlink:label="jynt_BinomialLatticeBasedModelFairValueSharePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BinomialLatticeBasedModelFairValueTotal" xlink:label="jynt_BinomialLatticeBasedModelFairValueTotal-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife" xlink:label="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FormerChiefExecutiveOfficerMember" xlink:label="jynt_FormerChiefExecutiveOfficerMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionToRepurchaseSharesChangeInFairValue" xlink:label="jynt_OptionToRepurchaseSharesChangeInFairValue-n2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_The2012PlanMember" xlink:label="jynt_The2012PlanMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:label="us-gaap_TreasuryStockRetiredCostMethodAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-2" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PlanNameAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="jynt_The2012PlanMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TitleOfIndividualAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="jynt_FormerChiefExecutiveOfficerMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod-2" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockRetiredCostMethodAmount-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueSharePrice-2" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BinomialLatticeBasedModelFairValueTotal-2" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-2" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued-2" xlink:type="arc"/>
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionToRepurchaseSharesChangeInFairValue-n2" xlink:type="arc"/>
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantOrRightIssuedDuringPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1-2" xlink:type="arc"/>
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_EarliestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_LatestTaxYearMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLossCarryforwards-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OpenTaxYear-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual" xlink:href="jynt-20161231.xsd#statement-note-10-related-party-transactions-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AdditionalLeasesAssumed" xlink:label="jynt_AdditionalLeasesAssumed-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LeaseExitLiability" xlink:label="jynt_LeaseExitLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfUndevelopedFranchiseAgreementsTerminated" xlink:label="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OperatingLeaseMonthlyRentExpense" xlink:label="jynt_OperatingLeaseMonthlyRentExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AdditionalLeasesAssumed-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OperatingLeaseMonthlyRentExpense-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfUndevelopedFranchiseAgreementsTerminated-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LeaseExitLiability-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfOperatingSegments-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfReportableSegments-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual" xlink:href="jynt-20161231.xsd#statement-note-13-subsequent-events-details-textual" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoIllinoisMember" xlink:label="jynt_ChicagoIllinoisMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ChicagoRegionalDeveloperRightsMember" xlink:label="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf" xlink:label="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement" xlink:label="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_MinimumNumberOfClinicsToBeOpened" xlink:label="jynt_MinimumNumberOfClinicsToBeOpened-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NoteToFinancialStatementDetailsTextual" xlink:label="jynt_NoteToFinancialStatementDetailsTextual" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsDisposedOf" xlink:label="jynt_NumberOfClinicsDisposedOf-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsExpectedToOpen" xlink:label="jynt_NumberOfClinicsExpectedToOpen-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NumberOfClinicsInOperation" xlink:label="jynt_NumberOfClinicsInOperation-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened" xlink:label="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TimeFrameOfClinicsExpectedToBeOpen" xlink:label="jynt_TimeFrameOfClinicsExpectedToBeOpen-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UpStateNewYorkMember" xlink:label="jynt_UpStateNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_NoteToFinancialStatementDetailsTextual" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_RevolvingCreditFacilityMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementGeographicalAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_ChicagoIllinoisMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_ChicagoRegionalDeveloperRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="jynt_UpStateNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LineOfCredit-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsDisposedOf-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsInOperation-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_MinimumNumberOfClinicsToBeOpened-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_NumberOfClinicsExpectedToOpen-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_TimeFrameOfClinicsExpectedToBeOpen-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:href="jynt-20161231.xsd#statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:label="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment-n8" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:label="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases" xlink:label="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-n7" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:label="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:label="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Goodwill-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets-3" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue-n7" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases-n7" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet-3" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent-n7" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-n7" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-estimated-amortization-expense-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:href="jynt-20161231.xsd#statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:label="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-7-notes-payable-maturities-of-notes-payable-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebt-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-stock-repurchase-option-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExcercisePriceYearOne" xlink:label="jynt_OptionExcercisePriceYearOne" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearEight" xlink:label="jynt_OptionExercisePriceYearEight" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFive" xlink:label="jynt_OptionExercisePriceYearFive" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearFour" xlink:label="jynt_OptionExercisePriceYearFour" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSeven" xlink:label="jynt_OptionExercisePriceYearSeven" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearSix" xlink:label="jynt_OptionExercisePriceYearSix" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearThree" xlink:label="jynt_OptionExercisePriceYearThree" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_OptionExercisePriceYearTwo" xlink:label="jynt_OptionExercisePriceYearTwo" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:label="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-stock-repurchase-option-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExcercisePriceYearOne" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearTwo" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearThree" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFour" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearFive" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSix" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearSeven" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_OptionExercisePriceYearEight" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:href="jynt-20161231.xsd#statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:label="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-stock-options-activity-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue" xlink:label="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:label="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n8" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-stock-options-activity-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised-n8" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber-5" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice-5" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber-2" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-restricted-stock-activity-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:label="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-restricted-stock-activity-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod-n7" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod-n7" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:href="jynt-20161231.xsd#statement-consolidated-balance-sheets-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CoOpFundsLiabilityCurrent" xlink:label="jynt_CoOpFundsLiabilityCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsCurrent" xlink:label="jynt_DeferredFranchiseCostsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredFranchiseCostsNoncurrent" xlink:label="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue-n7" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="jynt_DeferredFranchiseCostsNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Goodwill" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets-3" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="jynt_CoOpFundsLiabilityCurrent" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditCurrent" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent-3" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermNotesPayable" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities-3" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_TreasuryStockValue-n7" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-operations" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRevenue" xlink:label="jynt_RegionalDeveloperFeesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingRevenue" xlink:label="us-gaap_AdvertisingRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseCosts" xlink:label="us-gaap_FranchiseCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRevenue" xlink:label="us-gaap_FranchiseRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="us-gaap_OtherSalesRevenueNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="us-gaap_TechnologyServicesCosts" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TechnologyServicesRevenue" xlink:label="us-gaap_TechnologyServicesRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherSalesRevenueNet" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RoyaltyRevenue" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_FranchiseRevenue" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_AdvertisingRevenue" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_TechnologyServicesRevenue" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="jynt_RegionalDeveloperFeesRevenue" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_OtherIncome" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues-3" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostOfRevenueAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_FranchiseCosts" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_TechnologyServicesCosts" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenue-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense-3" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n7" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_OperatingIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit-n7" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_NetIncomeLoss-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:href="jynt-20161231.xsd#statement-consolidated-statements-of-cash-flows" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInCoOpFundsLiability" xlink:label="jynt_IncreaseDecreaseInCoOpFundsLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_IncreaseDecreaseInDeferredFranchiseCosts" xlink:label="jynt_IncreaseDecreaseInDeferredFranchiseCosts-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements" xlink:label="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_NotesReceivableIssuedForPaymentOfTransferFees" xlink:label="jynt_NotesReceivableIssuedForPaymentOfTransferFees-n7" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PaymentsOfInitialPublicOfferingCosts" xlink:label="jynt_PaymentsOfInitialPublicOfferingCosts-n7" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights" xlink:label="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements" xlink:label="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:label="us-gaap_IncreaseDecreaseInOtherDeferredLiability-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LitigationSettlementAmount" xlink:label="us-gaap_LitigationSettlementAmount-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:label="us-gaap_ProceedsFromCollectionOfNotesReceivable-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:label="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements-n7" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jynt_NotesReceivableIssuedForPaymentOfTransferFees-n7" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment-n7" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges-n7" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-n7" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_LitigationSettlementAmount-n7" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities-n8" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInDeferredFranchiseCosts-n8" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="jynt_IncreaseDecreaseInCoOpFundsLiability-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherDeferredLiability-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired-n8" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights-n8" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromCollectionOfNotesReceivable-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations-3" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="jynt_PaymentsOfInitialPublicOfferingCosts-n7" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts-n7" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock-n7" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfTreasuryStock" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable-n8" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations-3" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease-3" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-4" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:label="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:label="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-fair-value-assumptions-of-options-granted-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:href="jynt-20161231.xsd#statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod-n7" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_TreasuryStockMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding-5" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity-5" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts-n7" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod-n7" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued-n7" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsAcquiredDuringThePeriod" xlink:label="jynt_ClinicsAcquiredDuringThePeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsClosedDuringThePeriod" xlink:label="jynt_ClinicsClosedDuringThePeriod-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsOpenedDuringThePeriod" xlink:label="jynt_ClinicsOpenedDuringThePeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_ClinicsSoldButNotYetOperational" xlink:label="jynt_ClinicsSoldButNotYetOperational-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EntityOperatedUnitsMember" xlink:label="us-gaap_EntityOperatedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisedUnitsMember" xlink:label="us-gaap_FranchisedUnitsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureAxis" xlink:label="us-gaap_FranchisorDisclosureAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchisorDisclosureDomain" xlink:label="us-gaap_FranchisorDisclosureDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStores" xlink:label="us-gaap_NumberOfStores-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisorDisclosureDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FranchisorDisclosureAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_FranchisedUnitsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FranchisorDisclosureAxis" xlink:to="us-gaap_EntityOperatedUnitsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsOpenedDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsClosedDuringThePeriod-n8" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-5" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsAcquiredDuringThePeriod-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NumberOfStores-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_ClinicsSoldButNotYetOperational-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:href="jynt-20161231.xsd#statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_TheJointRRCCorpMember" xlink:label="jynt_TheJointRRCCorpMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:label="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-2-acquisitions-supplemental-pro-forma-information-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="jynt_TheJointRRCCorpMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:href="jynt-20161231.xsd#statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:label="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:label="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressGross" xlink:label="us-gaap_ConstructionInProgressGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-4-property-and-equipment-summary-of-property-and-equipment-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment-n7" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConstructionInProgressGross" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details" xlink:href="jynt-20161231.xsd#statement-note-8-equity-warrants-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice" xlink:label="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-8-equity-warrants-details" xlink:label="jynt_statement-statement-note-8-equity-warrants-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:label="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis" xlink:label="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain" xlink:label="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-8-equity-warrants-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber-5" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue-5" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties" xlink:label="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-n8" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:label="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits-4" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits-5" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-uncertain-tax-benefits-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits-4" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-4" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions-n7" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties-n8" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits-5" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued-5" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-information-assets-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:href="jynt-20161231.xsd#statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:label="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding-3" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:href="jynt-20161231.xsd#statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DevelopmentRightsMember" xlink:label="jynt_DevelopmentRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:label="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FranchiseRightsMember" xlink:label="us-gaap_FranchiseRightsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-6-intangible-assets-intangible-assets-acquired-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FranchiseRightsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_CustomerRelationshipsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="jynt_DevelopmentRightsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:label="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-income-tax-provision-benefit-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit-3" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit-3" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-3" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment" xlink:label="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetDeferredRentCurrent" xlink:label="jynt_DeferredTaxAssetDeferredRentCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent" xlink:label="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetRestrictedStockCompensationCurrent" xlink:label="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAccruedExpensesCurrent" xlink:label="jynt_DeferredTaxAssetsAccruedExpensesCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent" xlink:label="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent" xlink:label="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsFranchiseCosts" xlink:label="jynt_DeferredTaxAssetsFranchiseCosts-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent1" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsGoodwillComponent2" xlink:label="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsLeaseAbandonment" xlink:label="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent" xlink:label="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_DeferredTaxAssetsRevenueCurrent" xlink:label="jynt_DeferredTaxAssetsRevenueCurrent-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:label="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGrossNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsGrossNoncurrent-3" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-n8" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent-n9" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-net-deferred-taxes-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsRevenueCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsFranchiseCosts-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsAccruedExpensesCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent1" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsGoodwillComponent2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetRestrictedStockCompensationCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetDeferredRentCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsLeaseAbandonment" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards-2" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossNoncurrent-3" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent-n8" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent-n9" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:href="jynt-20161231.xsd#statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:label="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount" xlink:label="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:label="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-n7" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate-n7" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance-2" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount-2" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome-2" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense-2" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense-2" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount-2" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems-2" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments-2" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit-2" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent-2" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:href="jynt-20161231.xsd#statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="extended">
    <link:loc xlink:href="jynt-20161231.xsd#jynt_CorporateClinicsMember" xlink:label="jynt_CorporateClinicsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_FranchiseOperationsMember" xlink:label="jynt_FranchiseOperationsMember" xlink:type="locator"/>
    <link:loc xlink:href="jynt-20161231.xsd#jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:label="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="us-gaap_ConsolidationItemsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="us-gaap_ConsolidationItemsDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues-2" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:type="locator"/>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:type="locator"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="jynt_statement-statement-note-12-segment-reporting-segment-reporting-financial-information-details" xlink:to="us-gaap_StatementTable" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_ConsolidationItemsDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_CorporateClinicsMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="jynt_FranchiseOperationsMember" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ConsolidationItemsAxis" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_OperatingSegmentsMember" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_CorporateMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConsolidationItemsAxis" xlink:to="us-gaap_CorporateNonSegmentMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:type="arc"/>
    <link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Revenues-2" xlink:type="arc"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss-2" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization-2" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount-2" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense-2" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-2" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>business.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 business.jpg
M_]C_X  02D9)1@ ! 0$ VP#;  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !A 8<# 2(  A$! Q$!_\0
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M&Z,)4X)IPU31%5>G/Y\_1,8;48."")1(;R$?"/+ETVWVY<^7(1'KS'4Z31<
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MA:S;D<Y * =M_ORTH0;KNE2H-4%G"Q@$2HH)'65,!0$QA*FF4QA I0$P[!R
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M.7N[]^8_?MZZIBL7]/=[>@??7V::04/R_B'E\=_G]>>J:BIMN8[=?/;8>O\
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MN.EJ,M]H=W-FQ(@;T4B!33\P3W6,N35LCTRH,\R>4U@:.U0S", C=ESG3Y"
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MLO*E<#.6=X_,Y4?-$9<[62FUGAUA6:).C.!,43CJY<Z<6R&4<6P&$,<88H>
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MWW<HL_2^KI.!W'=8B95!W'^+24SMT9<')G+@SD! 0<&64%<!*  405$WI-P
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MD"C^L?ZBFI>#GGS5T9@^4,R62FHJ-E74VC&IG.U<-3,A5Z61F:S'544IRU,
MEGWQ)-E*:674 =%818HV]SF)L.M58U8Z]^.P*(03'33()I?/*[LRRS(S7GFK
M&S-E]'RRE*ZMRW5OB56;IPK0L9MI(>EQ4*I196:9[9[$I(9IJK'DF930UE%B
MZJT;@-CLT<'C3*V%8#-=FXCX?/)<'W7&SU"LDJZ3]""?V>5E(ILE&-YJ*8Q,
M2M"-I!Y9IQHFRE$Y<CE B LC:P;5N"G-T?Q*U#A\RKB+)K&>?&86.R56F)UQ
MY=7>.4W(FG)^E.9"04JLLNBQ;ORL5S/W# 9!LHV<#XT5DB[[QRMX@?PK.(-D
MEFG';F^Y$XI9S)MG3A<NU EIO&.F+2/KEHDTXE"7;3KP+#=JT$DVB",$WTY"
MF;R:3-2*>@*F85V+:_9-_!\R8QR;BY2.Q[BG$D;DB1G,M4J-FJ^YI+M.Y3K.
MQM92>1DVBC>$173;(R)$C/)(X1+<JC]4$#8#<S745]RU\R&>&^QS)$B$(.22
M1"/"J&V,?20TP&+$4[318\=0-,CME_>E<B@;WKNS+)=J/)KQ4]Q"N Y=[.+6
MUC1I%:"NN8-UFY^7;!25[X<X[+5L(L2UGV#9[X2LVP_AK6/;-=R(E>$K+UHO
M'$$RPKB?)]HI>"[Q;8*P%EV$0O=:G#PTQ.-HYM=H^$<F:FLZ,="N/SIO7D7C
M(LBU>E8^) $?%2C>"3BIE\HR.%X_"]K<9*A8"(M$_6P"-(-;@9UBC(Q<A9)1
M5^2%@$W35PD8$Y>19KIK"9LJD1RFHD3LWPUQDC1./_\ $<R1'Y4PY"-[+5L\
M+8TL*^8L>(1<M:LPVXUXQ0O'.7%@*Q>&(U9 K-J$.L2LO/ PFO5'*I4C:@\,
MTE(Y?X4.+?A=BLJ5VN\3MURM4;F#ZZW]E"%S74:SO'S-'87^8D$XV0<L99N[
MG&[9W*E;3!)$@D448K/G#<UN;KC9E*):MT2'$RRKY103#$C+>,B]YG3=W*8T
MD2K:ICR-A J5I@H4L,<<QRXK^R/)^\JV2VYG':V]KVEM%619M/#CV+<CFL?P
M^CHTD5AGAM<S$[E"@(=9;(CHDMT>-;GG1(,71>2X,>**(RS%X-?X7MZ&4YV,
M>3<!5!18F5GX=@W7=/)2#DR/1A9=@W0;+G5<Q\BX2*9(Z8F]*'@T]6G@/XO:
M5CN:RK:L"WJ#H]<.]"?E'K1F5Y#MXYVNR>R4C!$>'GVL,@X;+@::4C BC(IF
M=D>&:;+CT_>2C#''_P!K#AAM]_K.1<^XRXE&%DMB]1M#*YM<84VU7^OEAL:N
M[5%N7;!V\6 $'+F+9/'*$82)(W+LQ/'*N=AI.LSV ^,7CFXI,TYLQY*8#L%.
MS)34H$F2X29L5[EIA$D36\.!CU*16G64W3'#4()=L_BVR;(&":K RL8\=.4!
M3YYNA*!$94N5\25(C"[I/WE\^'=OK!CJ?\7J)+>,HYD%2CE*'1R_XR*_O(M2
M%V&9,E#FN<?-C&AMJJOLI"6U!W;(@K?)0,S2CYL5:C26N4K+O%1=I%+6-EJX
M;5_!K(25TKAE7N!GBUM,739V!P7=)"!R!7'ENJ<ZFBP)"R=:81S:5=3*DHH^
M(RC61&#QJL0\JLR,N9PDB@11<X):GAN!?BSL&,R9?AL(VV0H"U>&W-99N,49
M\^JQ4!<C8H^N#)%LDA#>K!ZP609Q"S<Z E6(<R9BF'?J]O[?4?P?L2U*NY4I
M3*16RS(WN^U&O95JY[BYQ]:A5)5(][7HV<&P*E),R$<\F*T+05HTS1-Y*-$2
M1XG3WRX2J)P_8"S%PY72LRF#E<0SN%6B+WB.R-GM5WD*QY LE2DF\KC6O8]-
M>F4)48Z*75]%(1LU3%XJ,CD5FJLJC8@:I:E8YXN(,"?,0=:<D>TN84*."#*?
MWL5(I'O:4Q+4" DSQ/CK$'''.+L-+)'&DB<]D2&7^P[)UU=T520V9(,>=E?)
MMS=6$V\K K52\Z-CC$^)#CY5G.FUM#)#8I:2+"12Q=Z2)7GLJV0P);3SNX0X
M7<^<1ZTRGA?&D[=T*\5$9V4:F81D%$*.0,9LW?S\V\C89L\=%*8S9DH^!VN4
M!.DB8H"8-H<&_AB\1^7)S/%8G:C9\>6/"-"E;":(E*\@_<6B\$8LY.JX[9G&
M<C4FKFXQ[E1Y%6!$\E%E;MS* 5<#AMLA6<?267^".:X/\59"QK YXQ#Q0W"U
M9&H3K)M5KL;EVNN&*L3$V.IV]U*M*M;V=<<)H-DT4)91F#6/3DDU .>+!TZ<
M-]EGJCG_ (E\)\1?$AC26OV5>":RX'I>2'&1XZ:QU#VN2B( U6I,U?6)"Q3%
MS6V[=[$/'!C+$1>LU6K5V_6<,P=E66:+HP;M:V5612P7$='A.@RI=JR%'EP$
M2U<F_P"[R84Z$:1('L1QH,2B49Y!6':++RWV7Y)BS,D-S)69GLXEZ..RPNF7
ME5596+=3ZJ\<_*K']Q6PKKJDN(<"!(0UA(=)E)(9(A0(Q83Y>BC7A,L-?X<,
M[Y<R3CG,\//8ZN$+3*Q.0[:H*XMC9QA=&]2R#$9(<N7JED;R4>[=(1L#_I])
M1LK,JD*\4.TW.%LXNX&N+',](+D;&N$K;9::OZU^6S*?Y7'$GA8F4*\"M-)>
M08/[)ZL=%9-4T&U?E!5)5$#"JDH0N_&$L6R=7_#Z_$,QS.Y#Q -MGKIC]"MQ
M09@HJJ]B/A&[J3M]>P**\XFYDFB\>W,O7';9 Q;8H*2,/ZVN<I-7_EFGWWBD
M8<&^<.$O-V,*;6L*8,QS2)B&L>6JSCJ0X>\A451P:PS\M"3[YJY.PD%!8*I3
M47&RKJ90BT3F;.&IV0J,[-=B$]@%LRK8-+T\9EM-!,=5QXXZ"LF10[D<MKQN
MG3"2HPB][42'C2U8(IW,C*XNRG+TN#EZ:6GS.8SLBP+,F4Z6=4!S186,C/>8
MZ>TF]]DU)(\H5'3@J[.3&;5-D+"L:M#2HL 9K-.$3]B]BWSR,DFCEA(QSMPQ
M?L'B*C9VR>M%CMW31TW6*15NY;+IJ(KHJD*HDJ0R9RE,40!$9(X#MX1 P[;%
M$! 1WZ; .V^^_+D&X?7:[#[Y!3B)MC^YV6J6&ZND<O+U6Y3K^(=TR:S0YAK&
M>F69W*RY$Z^JRE+F=M)0LK+E1@RRKF)?28H1Q7!R9IJ2/$%/7B#4S%;;<TO=
M*IN1[+CM-G:ZNAG6[.ECUN,<4F'LTJXF9R);&9O9"P5-Q)QSH/4(^VA0VC^2
M=^ G9R;A8KU8\<;\D,<ESB2W <5Q&&5&QA.C/4H6/$U#F>X?=QDWI&;(W:^-
MU>3TLPM."19_WMR>L8R/4BFCC"CG@M>^SDLL@,C3# ED?!A"'(6PD1^Z1C;V
M0/9YQF*(;E, @(<A 0$! ?:'4-4@3.81 I1-X0W,)0$0*7S-MT#W[:[5*NG3
M7(YK?&A3IMQ8^"&UKW1A=;]CR_C+9IIZUPCZRQOCUZ6&C[5>ZU(MJ<55L_A0
M4DGS!%)V680]<>.L88ER5-OL74*T8_B;;<K^\O%UG,_-Z9D^C8\7G9]Y8B.X
M%7)]<F:+,A8,6OJ:+"/;G?.B4%@]+<&;]A'NWRZ\CE.S*4H5(VM$Y$< ;MNR
M",8RF'*>J',0#1"$TD,@AE<]=\\T9&L1QGM%U2]F40,ML8^8I8G.9..-!Y:E
MR3R8L4]2,;H4,$Y\J7)("Y!+/%&+6&"'9/(5S(HB2>?^)L-V++SVP-8&3K\,
ME6(AK-2DC97SB/CRM7,W%PYDD56S%^HJY:MI!W8'2/HB^"OP$\^(915DFV7Q
M5OX1'80Z[ /8?+;< 'G[0 =7Y>X]<DM*6IE#1E9K=JM-P&OP419(N>2AVL=+
M#Z2%*HP>+/#L(I&0:L(Z5>M6S:<;IF=QIW215S)V#R_?R_SKH(^\<XA5*QP2
M(-!!:QFL=S&JP['F&0C3/WJ*CM-$&K%9J[BN/-K!L8+(\1L0HYD=QUES"%,@
M[ 1GL+ ,"$>-'+#$D56O;MJ]\AI6F<@N#,5/2>>WZ?U]NH^D#MO]-4M@^]]O
M+I[NW] U2,'A'E[P\P^OU_OHA5TXZ:IU^_KQ3AC+1C7<."+TZ:^7VGP7"OT@
M>0Z .'NTCW$-N8[![_CY?M[]3^,?KS]W;8-_OESYZ='-7HGQ5%Z>?CY=>&$H
MT3HJ>:?:^OCA7XB^8:E,< Z<Q^GW[-4-^NXAR^]_KMMY]QT>(//Z#[]+5$7I
MZ*O'#(/KQ5/X\?G\/>81$>NC4/$'F'S#4/&7[^]_II;2+Q54X^:8EHOA\O3]
MT^*8J%+N/L^_O_.C4@'\AVWZ_#S$.GSYZ-214T_JT\.&O@NO#T3X8BJ.5>"Z
M)_Q]_+JN+)?J !]]PY=1W^H^8\A^OES;2KAN&PCSWZCY;"/??RV\^H .IW95
M%%#  "(!N'/?MSW]O?;SW^ I 0,4 '80  Z;"&W]P'X_76<[5W'BB+HOBG31
M>/733CYZ^&.S"-C1-1SDUTY?KS3Y^V+A9N"B!0\6W3;GW[;"/7EMN/[CJXF[
MC;;EV$?8/?;V]_,/=VL1$% $ Z[#L',>?M'?V\P#W\AV#>Y6AQ$NQMNP]>>X
M@'SZ@';]M4[]6.3QX(BHODG/5?#Q37QUQF3XS435%U1=>'@G#^.'IIY7,18A
M@W$0#S^_OVZJ 8H]#!Y==,8'$.O/E\?G_GW=]1](/?GSW_K_ )^>^BV3%1$U
M1%]U\?'3P\/'@FO#&*L5.BZ?/]/=?EA[$Q0[_+[^'Q#4OI WV^?;KS#;KORT
MTE4'IS#E\-^?3N'PY[ZG!3?ON "'O_3ISY[AV^.I+,5=-$1.2KQUZISX:)Y^
MO'AB/=T3777X</BG[X<O& ^8[[;\M@$.?3F//W#[^6H^D#IL(_+X=.F_/V;\
MM-WI!WY>0\O?OU'EL'N#?]0/&.W,.VW7W[[=.X_>^DDG5--EJZ<]%5->7/UZ
M^>GAA;E.''7X\_37KAP%7X^S??ES#Y /Z;=1U$J@#UV]X=/CIO YC#\^OQ'K
M]/[CJN01Y_#S\_ERYCMRU,9E5=--%7P\-4\?VPRB1&_#Z^*_KA9N ]! ?CH$
MP=QW'W\]40 1Z!J;P#MY#O[.G;OR]O7^I*/7P1??1=?OP3Z8JV6IS=[<-?O[
MUQ$3^0??T_S[N<AA$W\P[^7LY= ^'[^W41*(=0Y>?/;^OO\ \:CX=PY"&_7;
MO\?;\.NJWJJHNG!=//7YZKRY?+$T1J<M/K\\-Z@"("&X["'81VW]OW^^FQ0#
M@([;[\N?4=N?MWW_ $V$=7 )-^H;^[N'(=N74/[[:HB@41Y@/+F("'LVZ=MO
MAU#03AOXHB*B=/KX^G/WP6*0C.#DX)RZ]4Y_MAH044WW'?P^?/Y^WEY?4-].
MB:IB^?F ARY]>8]N0#[/9J86Y0Z<NO;OWZ[[>X.F^IO1    "'+S#OY^_P"_
M9IFH4>O!VJ+QYJG'3GK[:Z=,,4K"+KII[+]IIQY=/G6]-OON.X]1$0'<>?W]
M[ZG*KV^>P]O=T'^_S1"02[\Q]_Q >NWSZ[ZD\0@//S\MM_/8>FP=O?\ )TDD
M:O%/+U3ARTTU7Y<>7#%&Z8O%/OEX:?#^=7'QA[='C#R'3<*H@/,0VV#O]-^@
M[>SSU$%!Y;B(=M]^WTV^]@U+ONJZ(BI[KHFFB+ZZ>JKQ]=5N-$U7KRXKITTY
M>_\ /1P\8>0_3^NCT@>T/OWZ2 H/GO\ (/=V[]N7/MRU'QCY!]_'4DD>*)\=
M.'#HJ>?CU3$-UY*FFG7^?IRQF'"68['@;)E9RQ4(RJ2UGJ+E9]"-[I7V]FA&
M\B=NJ@VDC1;HZ:9I&+54*_B7A%2+QTDW:OFYRK($$'+/F<[;Q&9+F<KWF*IT
M3:K"5$TT%)K;:KQ<D^(991Q,O6#958',U)*KG6E)-=51T_6V57.8X;C@\IMP
M]O?]M3@(AT_S[_OEVVU2V-"?.;9=W'W](ZPVRM-3)%4B%W&U_P#24B[>SRVN
M//EJ_C=PE([+;;*4VA?8I;.JD(O<G6: 2,DU1<ED)'1 H37:0?Y>7#%?1N/3
M?EY:I";R$>X;]-_;L'?R\MO:.H"81#;?[^^7]^>CU+_]VO'HGIX)_P \N/+&
M/N_/Y?SBKX@#GN'P'G]- & >X:H#R 1\M43*;;B'3W<_U$/CTZ]]061LKHNJ
M\>/%%\$^]%X^_&2"UY*OJO).7S_CPPNT:0@L([  B'S[;<NO/K_40U-Z0>O?
MS =O+OS^/PVU-)+%3KKX*FGAY^O5>7GIA;EWBGWIY^OP\\+-43&$1WWZ=.VW
ME\>WZ<MM4O2=QWZ<_=[]PY??/?E*)QWY>W;K\Q[>X/IRWU%934Y(JKY<N2??
M#T\\2:)47CST]OU_3KB)C"'(.7M_I_7_ #J'I#!Y=_OK]]]4Q';GV]_WV]O,
M>7??5$1W'?Y?KR_7]QZZ&>=SEY[/737^$X</WQ<C43S]<*?&8>^WN /H/7[W
MU+N/M'5$#;=.PCN&_P ?+8-NH_3D(Z@)QW#<=MNG;Z=.^H[QRHG'7YZ_?_&F
M'1$Z(GLF%&XAR >6_P .6H";S'W;C_7[\])A4\QW]VW?E[NGZ\M2>D#R^O??
M[^/+3*5>2JB>_+EPT5?T_3$D8NO)$\]$^_YPI\?/D&_3[^^_NY@'#W??L^_V
M0BH&_,W].?+8/;S_ +[Z!4_]P]]O,=NOO#MOTWY;[CJO>HB\'+KK\5Z\/KKB
MS=.\_@OW^_EA<*GE\Q_?SZ>>I?2COU+N'0._PY^W?^^D?I0W'^+GUV#?O[.W
M[:IF4 .GD(\_9^H_']],IT3JO'3FOCUZ\//UX],.@5Y:+X)PT3Z8</2#Y!]]
M/OO[-'I Y=.OG\P //[V#?3;Z<O00^/Z?,=@#?V^6VCTP>6VP]A ?+V;[=>@
M;]^6F4^JHG'IUZ\/+GJO/Z<L/N'>"_+[ZIAS!3V!O\P^/(?AR'1IO!3<HCSZ
M\^H[;]!V[[_ >^VVC5C3+HFBN]N/5.NB^2_#R16W"+S3RXZ+U3R7QU]-5PPK
M_P#JF^_/5 W0?</Z:-&DS_3_ ./Z8W1<F^B_1N*J?4W_ ,?_ -BZ<T.IO<'Z
MZ-&@R?U+_N7Z-Q1)Z_?_ ,<.!>@>X/TU'1HU)G]*>_U7&7@U$.AO=^X:-&G;
MR3T3Z89>7NWZIB<__P#G_P#;4W_$O_;^H:-&I-YIZI]<5]6^J?1F*I.H^[]P
MTJ+U/[_W'1HT:'^I/_+Z-Q2_E[+]6X4$Z? /U-J?1HT6O/V;]$P(_P#J7V^B
M8-0#I\3?J.C1IL2'U]OUP=P]P_J74BG;X_MHT:6)MY)Z)],0#^0WO_IJ31HT
MSN2^B_3#X@?J;W'_ %#2<W0?</Z:-&LTO/W=]4Q-G-?3]4PE6_G'W!J)/Y0^
M/ZCHT:I3F[U_1,%+_1[-_3%8G0/_ )#_ /U'531HT^*L3DZ_$/T-JKHT:+#S
M;Z)]4P/@T:-&KF\T]4^N%B4_\H_#]0TF/T#W_L.C1H9W3_P__G%K.2^OZ)BG
MV#WC^A=5]&C2Q/!J'<?<'ZFT:-+"Q _\H_#]0TF/T#W_ +#HT:JZI_O7ZMP[
M>:>J?7$^I#] ]_[#HT:DO)GJWZ83>:>J?7%+1HT:JQ?A.;^;_N']#:D[D]P_
MH&C1J'5GHOT3%[>2>B?3$?\ G_V_OH-_Q_\ D'[Z-&JUY^S?HF)-YIZI]<(_
M^?\ W?OJJ7H'N#]-&C4&_P"K_<OZ8N7E[M^J85$_D'W%T:-&B&\OA_\ JW Z
'<W>OZ)C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>clinics.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clinics.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)R:61G970@
M06QL:7-O;@  !9 #  (    4   0J) $  (    4   0O)*1  (    #-3D
M )*2  (    #-3D  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %Z ?X# 2(  A$! Q$!_\0
M'P !   %!0$               8'" D* 0(#! 4+_\0 4!   00" 0,# 08#
M!@,%!0$1 0(#! 4&$0 '$B$($S%!"105(E%A,G&!%B-"D:'PL<'1%R0S4F(*
M-'+A\24F.$-3@A@WHF-S=H.2LK6VU?_$ !X! 0  !P$! 0             #
M! 4&!P@) 0(*_\0 2!$  @$# P($! ,%!08$! <  0(#! 41 !(A!C$'$R)!
M"!1183)Q@14C0I&A)%*QT? )%C-BP>$T@I+Q%T-$<B5&4V1T@\/_V@ , P$
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MW(<%*NR '#.A6"6ZOTITI7=85\MKML\$-<M(]7$M0K[7BB95E!9%81D%D&'
M+$^G.#JS?%7Q3L?A)T_2]3]0TM94VJ6Y4ENGDMZTTE53?.EA%,L,\T32(0CE
MA&&.$Y RIUF9-+!4O2PI/@I[1O0(^21L?0^=Z&_Y<[',6[I#]O?U$J0Q"ZU=
M$<=RUA(9:D9'T\N)F,6B6VPHN.NXW=-7%=)>=4$=K4:\K6=ETI:2.U(N=])_
MMD?1#U(^Z0;G/+?I7=R2VG\-ZD8W:5L(+=>:8T,GJ6;C%VVT//!*ES+>(I"
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M453.W4ONI0VI"5*"B$GGKP[2OL(J)L"9%F0W0I3,J+)8D1WDI!)4T\TXIMP
M#9*5=H'DG7GC37?XYQ!Y!/Y=J&B>X:(T/D^"2 #X)4  ?KKFJ7FU?"M^2GQ^
M;1'_ )BG83X\CN(\$'ZCC37)QS:%;.M?&]DD#6OV^H_?X_RYKW?L=?KM.O\
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M83EI@KN["(I:9,U*WV,9@)D6%HS[Z8D251$@'9TDDZV%)/E)04K&A]3W)2H
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MQ1HLVY3K_=;SITD?=6Q&CINKS(SLW*>F\(KD"#+S=G\1:C2%0W76ZO'L@R&
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M!R\  #0  'P!X _IQQIISC=^-^/ /T^NOI_K_O7.3G7>4D*"2H E*B 2!XV
M5:)V=;UX_4#?GGH[C\P3GZ#D_P!,Z^'_  ,,X)&U2.26;A0/S8@?KSQJT5]M
M+A]=F?H]:@NRW(N0U_5_I[*PQ"(:Y#$_(IBK6C>K;&0AB0FLK7<;M[R8_8O)
M;0P["9'NAQQEI>(I?]-\YQ@K7;XS9MQFR?\ O\9C\0K5H2>U3OW^O,F*PWOR
M#+<C*UK\N_',NO[5SJ;61L"P3H\PJ<N^S#)XV;S#%;BB)#Q;"WG HV4E]'N)
M-CD,NE9@18*OOKZHDI]13#@R?<LB:_Z_)_K_ "W]?U^O,_\ A3U1<^F[-+!$
MB24LU69S!*O#Y51D2?CCP 00HQDDY)[<F?CBJ;1=?%.W48D$M9:>FJ6CKQ#_
M ,2GG>KJ:R-')(&3#.G'?*L.V";3!4A1( \A1!T1V[!T=J3W)3\?*U('R1W?
M70^3O7Z_T_;ES2_Z=8/DQ4Y<XU5R9*B>Z8Q$:@V(&@"M%A##,I2P?&G%J&OH
M0.29O?3/C\D..X]?6=6\OO(BSVV+2$E0'Y0TL*@S$M_^HN30-^3\#F>K=XGV
MR8*EP@>@X )4*T29V@X;?O=!V!*[L?F0-(Y+.A_\/4IP#Z:@E6/(X&T,H)SQ
MD@<?4ZHQXY/"Y]/W4.I4MR)$KLAC)*OS5<U#;Y2E(T?N4],)TK\@J##\E'Y@
MD(40HF2%@%5=A(JK-M==90WE,2X,Q)BR8[P'=[:VE@A9[?/<ES0!\I22$B]:
M#J*R7,8HKC#,^%)C =7 ;MD%<<G(&">VI-[96H"Q@+(,9="K*,^_!SC]-:<<
M CM"M I/PKSI7\B#H_(^.:CR1KQL^//Q_4G_ )\K*D$@@C'!'Y9'T!_7C^O&
MI,QR1Y+J4"\Y;L?OQD]_]9UUK%:D0WBD=RBRI"!I1)6\DLI'Y0==Q<[ 2/"E
M)/DC1YTH2VA#:!VH;0AM \[[6TA"2=@$DA.R=>22>=.6KN>AL^%%4I#B@?/Y
M(O\ WD[^O:%MMD[\;[>[P='N_I\? ^!H D D:^A\^=^=_IR C!IGQGTKMSQC
M.0>#_G],X]S-2KY=%2H&#;VDF8C.#NVA>"!VP><?J?;<CMV0KR%#M"2=!:B1
MI)\'8/S_  J[2 LI*4DBLG,>AO2FF]'> =>\1S7(<NS>_P"L#_3[*XDFD.-4
M>+F)@-7E\K'*V&\_/?O7H$F>P'<G5*89M/=6AFNCML!*J-V^W9"CH$?\"#Y'
MP?CP#O1T?D B;KG6#(E]$H'09V#4IQ"OZI6?5EJP;;?3>.Y!:XY7XM)BK<$D
M0C7?A=:R\ (2I:I1?*Y"TN-H32+S2W&>HL;V^>6#Y:\13UJHVU*B@^7FBG@?
M +%F9TVJ, Y)+ #!N?I*Y]/T%+U1!>Z&&JJ*_IZKI;)-,DCR45X>6 TM32LN
MU*=D03B28F5LL@6(C+"3X(^0 1HZ"A]"-#8^-Z_UYN"M$* '<E(2E2DI44^/
MD=P(([@A7:I*DE2$[V-@[?/U^?K\_/\ 4 _Y@']1QO7Z?U /_'E<9%92A4%>
MVUU## / *G@]OT/(Y&K.5MC97..1AL$X.1@Y4@G'<[>_L-<Y6EQ24^VV$_D!
M![B= I)THE*O! * -]H\?F'CF3+_ .S]XD6,3]2F<J2 FRRK <2CE,QU0[,?
MIKJX?0Y!5MMIU']IX:Q-)=?EMJ2AU82PA/,90'7U T=[4 0-?4['P/J/C7,P
M_P"Q Q(4'HO;OU!Q*LXZF9O<("W8SJ%1ZE^%BC?M>PGW$!MRCD,NMREN.H?:
M?]OL86TV,(^/-1'1]"F!(H$>ONEOA1E0(5%.[3R;MN,@QKA3SZN^.-;D_ Y;
M9+AXTQU'[TP6?IN\5^ Q6,2,::C4R!  6=ZM0N0>%8'D#-XUL[2/V)&][WH_
M/]>;^;$#M!'Z'_3Q_IS?S2<_;_7]!_AKLF.PP,< 8SG&!]3SISC+:3\_J?'P
M "=D:! \GSL[._/Z:Y..->ZX2R.]*DGM _PCNT=[WL=P3Y!UOM)\GS\<X7H,
M>2T69+;<AI1!6T\RT\TL!06E*FWD.)(24CM&M)(VD)/GG<XXTU+#J;0UB\*O
M9K>&TN5SZ:EGS*>CF5,&8F7.B1G'H42,W(8?2RXMY(2TM"%%I9#B$]P')C0@
M1$C!2 VH,-!38)(;4$#N0-DG23M(!)T!K9UOD.YNQ:RL6MX]')$2W>CA$"05
M)2&WU.(&^Y1&B$%9&O/CQR*$ A"0?)UY.B//UT"3H;^//&FM_'''&FG'''&F
MG'''&FI)>HTN(Z"=<5,LKD/)Z/\ 4MUEAO9<?<1AMN$,M@)5I;BRAM/Y5$E7
M@'XY\\.*HJCQ%$%),5E78?E/>RT5 D@':5)*2-?._C6C]'/J W[V&Y@T&T/%
MS%KYOV5Z4A\.5$U)86D[!2Z=!22-*'@@@<^<LA+Q22^P67TZ#T?QWL/*)]UM
M6A\H<)0E(! 0$_S.T?PW2J?]YH%!9E>V%F[*OHJX^<X/>93D9!&X9XYYE_[0
MR$>;X9U8P"(NHH&!X*AGM05CD8PVWC![8.M..;M>==JM_IOS_P#V\T/QO6AK
M>_/QY\[)UK]_VYM+SZC@D+C<1@@ ]B>=<UDC=_P+N/T4JS'Z856).?L#K@?9
M1(;+:^Y/E*T.(44N-.(.T+0KR-@_(((5]><"G),72I(0]')05RAV-.M!;@0E
M;K*1VJ:3LK<>!;2E()*?ISM+>C-(#KTF.RG_  J><0A"B=#25+(23Y^ >>U5
M45YD#RH5'17-[)5"7,,>HIK"V>57A7:N5]W@PY+CD(*(2IXMK8W^7N\Z-+GJ
MJ.)O--?30,2"1-5P1$$8'*-(' ('N!D<@@:K5#;[O5!8(+95UD9. D='5.PW
M$ F,K"3O]7I R"V"<]CY2NWQVE*AK8*3W @^4J[AL?F2=@;V-:Y-_ICUYZQ]
M&HUHQTMZC9+A#%V_$=M8E/*:,.<_#[U1)JX4UB7$9L(G<D1K*,RS8-#\B9/M
M:0(4O.C_ %3PB# R7*.F>?XGB-F6([5[D^)9!1T<F?*0XNJ8C3;.#%C?>)3+
M3^HR'5NE#2W$QTH;6M,&*VA12%).B#M(_+W :\>3O1W^8>#\@#P!"BEME]@F
MC8T-TA1U26/<E3"K @Y5U$D6]<8 )! 8G[ZF)(;YT;<Z6=?VM9*Z6C2K@=TJ
M;=7B"I+QLH+K&Z*RHR28W*Z,4&=Q*^A;S["TL[&TN9TNTM[&6_.L;.=(<E3;
M"=+>6_-FRY+JENOR);J@ZZMQ1VYW* '< /,YJ5$C1.]$GS\[/SY^?]>:<JT:
M+%''$B(D<2+'&J#"A5[8&!C/)P,@>QU07G>5VEF>22>0EYI78NTLK'+RDL2V
MZ0^N3+,6D9WSZL#)R^Q?Q5-7Z=LURL9*_9'+NH\Z.YC27F'8.,.XY7PXA>$=
M#"9$&UOV)3$R:)#SK4NN8II$?VRMQL7C\;4PCJ!C'>V)$A^!D3$=LJ6##;^Z
MQ795BTV$E"U=C:*QQ2E(6VFQ26U *6%6I_L>J2!7>C^/:L?</OF1]2\YG3A'
M90B:VY6/U]%'9LG HJ<>$2"S(C C\D&1" &D%1N:WB+Q$7\1Q9^+%RRH1)GX
MT_/#JJY=HF,XTW MT,N,.N4UBAU4>R0T\EY+'_>8P^]QH[C>AO7\S5?5'5+_
M (B;M(HR",84#!![@=LC@\G7</P+A2V^&/ARI0B/_=VR,O;)-31-,W(.!Y1D
M,4@[B1&49 !-7X__  ?R?!^3L_'U)))/ZG9V?KS?R'\8N6\@Q^FNT#V_Q.OB
MRBTI'M+9>=:294=32G'5-N,/>XRMLN.*0I!3[B]=QB#F*P-OI/=21_K/\C]\
MZV5!! (Y! (_49U*;)NE;&4Y$BUL+R::E=G3VLN@2RAEJ2_1-,_<8JI\-R),
M<K'9L:-.L:^6N6S.+!A.=M=)EQ7_ &^H]!)O<0M8U<DJM8HCVU/V=J5BTII+
M5K ;0HA0'WB5%3%7_=K*VI3S2DEMQ6H^Y!^>9 [C&)W-Y&KOQB5 808M:"X!
M*ER7FXD9MYQIF0N/&]Z2@S)/M*1&A^^^[VM(6H11)(6C).?+*^7]L8Q[?8?7
MZ:A-%&%DR  X._Z$'.<X_/GOJGG$DKSJ^I/P:4[&J*"77Y%<6K&P^S,CO)<A
MXN$+:+:)DM"W47B'7$2ZJL;$1;#,Z>%QJKPZ$I2-$D(!.AY \ $H [MDZTD)
M.]Z3LZ!DCTXSNMEX1:7>1M,XM/H7K&QRRML&:^O50)F./VS*9GW1PQ'VWH#Z
M9#4]#F[):#)6@..+')7-6]IGS+>6SK_(HM7<-Q[/'::BR"\QR)55$J.I,,2G
M*&=4R[.TFQ7FY\Y^P6MB-)?5"A1D"")3\X(JFX3$Y 5% +.0%7MCV]_8 ?GS
MJFK+36FF"C<X=V*1Q+EV/!;@X' ())('.!J?.<9U68^MFN-?)N;F="D/1Z>,
M(B0[$*VXY7.F35(BQ(3S[K36PMV1(/NHC19*V7$)M^^LK,J='0[(D]3T8NW'
MM%I:QW":!Q]J;>Y:'.ZF-7D,G[I;M+BQ%1;&VLZZJC.UT"#8RVGW&WV%\==\
MD]/OI]Q)[K5U<8%H_B1+N+OY3<VV;Y?/NV$K>JZ/"DYA<6<IRQ,MQLQ(<62Q
M%K0^Y./W%L.2TX]W6W[0!CKQE<_+\GJ+:LB0)=C4X#A%>M,J/3XK[[+S,VRG
MO2XU8,AMY"5/7<AI+;;[S+3$6.J!"@N.WQTMT7>;H\==26^JJ(::5!)-&H,0
M?>-JABW);*@<#Z9'&M:?B&\;[)T5TQ<+4KT-=?KS2/3T=BJI(7D%+*ICFK*X
M;VCBHH\MY2EFG:H&?)VX8Q4ALA#:5.)<6EM*%+2D!*E-E96XG1T ZXXM7;YT
M G1^=[B-)*?D;!) [^P#1\I3^=._GP% CR2 2!19=^IO(Y/>UCE!5U#2AVIE
MV3SMI*1HE(<#+:Z^$E1 &DEI]L>?[Q9^9.7?4+/,F[D6V4W3T8CW%1([ZJNO
M<'\)"XE>(S;R?\(#X>^2.XZ',]47AYU#5H#4QQVY'PK?,_O'Y(P@6-9 &8_A
M8D 8[C.N/LE91 3R2U('G3232&F_XE.&='C6G+;2HWA1D>H$C@]]7"KWJOBV
M+21.O,V8CV;24!L-63LFZ2EEE<524(@NNSDJ7'660V$I*&UO-H[4.:3)"Z]4
M[5:J<G#*JPDRK&+80)-I=.MUS3\6>T6Y*/N:$2+"4B02VM:'UPW'%MI45A8*
MC1=VH.U);0G?E1"0>XJ.]DZ^OR-?S _3<5J/U/G]/'_#7^7+ZMWA?98#$UPF
MFK"J*LU,$$"I(,[E+C#YP0>!MP5(/?4M)U)51EO)^8,C-YCM55<M05D(53*L
M;%D65T5-W/L!^5?_ $KZR-]0%V-5-@)H[2#'KYI93/4[%MD*$EIYZ'%6EI]#
ML!Y3X<2XE]YF/-0XF4&I!2B<,Z>VVE^7/EA"%J;2]+FR4?F=DEN,TMZ0\][?
MO23IL*=?2"L]RB%*2E5I2?(+$?W>Y3:O<:CL/-K2VIA3RVVO=0Z?$8 Z*UH[
M2HH1^8J0CMF!$S_-V:Y=*J_M;J!+916-4UM'_M0U-6ZXRU&A1X]BQ,FK?D/)
M;:B-Q74NN/+:;B),M44IMF_>'#1S54]KEA^7AC::2.=W\TQ(-SA2$93A!QZ@
M<#/&JA35$=:M(DIKHI*VJ6E6GIO-J )=R8:FIXM[N[MR%5-VX\9QK-4]$_7>
MKNO3+@<*1*5<YEBKDSITYCL3W%6\NPHY<F/0H6WVK,>*_C:J6TGW#Y1!KH#Y
ME6#L5276&8:Z[^J:AQCJ+B& 3+ZXSNZR@N5\_H?T8FUUE?N,O1I2H,&XO_=C
MRG;>59*09L=B[PRKAXU"MK&Q=?1&A+M+0'H=Q[U>>HOIG0]+Z!5YTRQVJA+I
MNJ&13HU]2,QC;.Q7,KQU^TEU\&9*L5R#,ES,#QJ=']NP=E*RZS4N9#-9?T]-
M_HVZ0^G=EFQIJK^TF>+K_NT[J#D$>.N[49*$IL8]/'80B#CE=*4!W1*UI$U^
M.&8MK/L4Q6"WJ+<J6AI:BKD>I68O42^1!3DL%R_>7.%7# Y +'@GD=^V?AMU
M)UC?+#TY:8+'4TU';+5;[??>I^H&:DDJKA24\(JFL5J=#4W16E)B:IJQ1TVT
MML=G!&JA^G5(*;#J&(<<J,/?3"0[+QJCD&=6U$N0I3\F&S.+49,U;2W"W)E"
M.A$A\/.H[DN!:H]T!\ #^G.-D -I 24@;&CLGY/DD^23^I))^=GG+RA_GW]\
M?7WUG4 @ %40@ %8QA%/N$&3A0?PC)P/<Z<<<<:]TY /4_,H73O <QSVR@S[
M.!AF+WN3S*ZJ::>LI\>DKWK%Z' :D/1V'9<E$;VF&WGV65.*'NNMM]RN1]R'
MLIQRGRVCM,;R"OC6U%>5\ZJN*J:@/0K*MGQG(TJ'*860AUIY#G:H$=X'\"DD
MD\] !(#?AR,\XXSR,_<<:@U/G?+S_+MLJ##*('(SLF*,(FQ[[9"I_36)#U8Z
MF9CURZKY5UCS*\E/RLEB55;1XM'4T,7P[%J?[^Y25M$R4NS56"V;!9O;9Z>M
MFZL%S+)BOK6I:($:!N1CU$Z>KZ3]1>H'2Q5D+A'3W+[K&XM@VTICW:QAV/94
MJ%-N.O*W$HK2NKWS[KBE/1?<*RI\@0=S/5MC@BH*1*9=L/R\3+GDDN@9R3P2
M,]N  .P[ZX&>),]_J>O.JGZHJWKK[#>:RBN-2_!>>DE9-JJ.%1(VC"J"0.<=
M\:<<<<FV52.5![#) )&2.1GL?I]-62=C%=ZKM!&1C&X<#U?7..><_P!-<;JV
MVFUN.J2AI*275+)" VA#CRRHC92A*6RIQ022$CQO0'+5]]:(R6YN+R0E+IM[
M.78H"QWI#,AY]<9(]SN)[6%QTG^'^$_( )N%]7;LX_TZRB>VX6I#U>JJB*"^
MQ29-NZS7H<0=':VD/N.Z!![&U@'9&K;_ &A(2D)#80 D(2.U*0!H)[?H$_ '
MTUS+OA=;P9+C72('CC:.&GW<@8]39'8D@KS[8&-4^XRRPTD**QC,LCEO+.T&
M- IC!P<9!.<CN._MKJ*@Q]E37NQU'>S'><9!/T*FPM3:]'?;W)_*"0/D\T2S
M,;(*):'$@C:9$<*5H'^$.QU,K)(\!90L@Z/MKUVGN\#Y_3]Q\CF8#"ASW&<^
MYP,_8>PP./MJD_/38PWENH &'0,,* /?\N?J>3SKRW?OWWMEZ3&1(0B,\VD0
M9!=6''0PDE+,K[L0KVFU@E*E*.QI)^G.)\<:]X/QB20!)C/,DD>/XNPM[\?(
M60=>"?&^_P#E\[!&QI7@>=_KO9W_ %_?@*[04)V$'Y2%*2#]?(0I/U_37[\^
M(XGC#!9%;<=QRN.< <$9XQ]A[:C-605*QK-3G,2[0T),:A>.2G(]^_''YZX&
MI##^O:>;<WO^!:"= $[UW Z\:_GSGV3VA1(3H$*()2 0#L^-Z\@$ZUL^#X.N
MLY#C.J[GH[*R3_$MI/<#Y\]X 6"-D[[OGS]!SSY$-#;T5J.]+92M3ZGPU)6I
M"HZ(^B.U];J$_P!\(X_*G^'O&AW>/3),AQM+8&05X )(!(SSG_MJ)!3T4\FQ
M*J5"L,LJA8_,"2( 0=W!YP,X';Z9SKV%)[21L']"""#_ )$Z/['7-.=93$Y"
M%!N=[A VEMZ*VYI9"]H#C2F.U(/8!M)\ _KL<??8MG2F8K@5W=J@\Y'6D);2
MH?E6AU+GN. M_E4GL2KO(/;S[$A !>,J.,GO@\#D#[]\=L_R@_(EN%JZ)F(!
M"F4J3P"0<D8/?CZ\#GMW0>TA1WX.SKY\>?&O._TUS.I^S2PQ>#^ASTW52XPB
MR9O3J'E$]MR&U!D??<LDS<E=^\LQRMIQ] MD,F45J<FH93*6>]Y:4X)S#DJ8
MXU#$*47)+J8H3&0U9.%;J?'MQF)#4I\^Z1'9:9:4])<*4--J<4E!^BAT8Q9C
M!^D?2[#XT=N(QB^ 8?0MQ6FW&6F$UE! AJ:;:>6X\T$+84GVGG%N-]J4*42D
MDZS?$=<4-OZ<MRD_VBJK*IA@C/RT"A>X]FD.?8^WMKHE_L_;!*E]\0;](D>(
MK3:K3$\;B0;JBN-=)]2"WR46<8R P/<:FLD['ZZ\>?V_J>;N;$:[01]?/]>;
M^:J?ZYUT^!! ([$ C/Y:<<<<:]TYHH]H)_0;YKS:M7:E2M;T"=?KSQLA6P<'
M!P?H<=_TT R<#N>!J7/5-BLGX=(AVMZO&X;UYB0-LA]$9;3[664;T2,7W%MH
M;9LI3;-7)*E &-->2.XD)5%L3(:28S[T6UKI+6R/=CSHCS?=OR.]M]8\$Z\G
M9(((!\<MO_:^NP5_9Z]>X\U]J.F8>F\>,'5*2)$MGJS@\UF.DI(45NB&KPE2
M=H0OR!LG"XB9)D%3'77U60WM?!*OSQ(%Q808RUH40HN1XLAIIP]P)_O4N?.^
M9;\/_"JJZ\M=9<HKM3VU:.X-1;*B"6;S@((9?,7R?4!F0C.W'U/ &M4O';XH
MK=X)]1V?IZHZ6K;])=+0+P9Z6LBI1#$]3+2I&WFQ2*QW02-P 2"O/U^CLW80
MG?\ P9+#OT_NWFUZ/[]JSK^O.<O(_P#,G_\ K2?/Z>"?]_3GSF:GJ1U"H5ER
MDSW-:A:B2I=;E=]#6HG]5QK!E8!\[ 4$GZ@\B-WKQUO?3V.]9>JZD:UVCJ'F
M" !^@*+I) \[^?GR-<OD_#A=2?W?5%M(]R:"X YX^B'V/^CP<-I_M".F,#S/
M#R]HP/*_M:D8GMSE:7 ']?MVU]$+WT_M_G_\OI]?H/KS4/(/U\_3]_WWX'_+
M]">?.L/6+K&23_VP]5O)W_\ I,S?_P#[O!ZP=8#_ !=7^JI_3?4K-U'_ /SH
MY /PY7X?_F*SX_\ XUPSSC!QY)_,_P"L39_V@G1I48Z$ZBW8'_UU"![9[(YQ
M_P"3/([9X^BF7D $[\ $_P"0W]=?R\Z_RV>;!*;/Z_Y? UO9WK0U]#Y_4>#K
MYWU=UVZVT\R)85W6GJM#EP)+$R+)3U"RYXQY,5U+[#X;E7#S"RRXA*PAYM;2
MNWM<0I!*37F]]L;ZZ7*BEJX?4'%*YZIKGJ^=<1\!Q^1;9$XOM#=I<F<W(BL6
M,4!:VQ6UE17R'I#LA<!Q! Y3*[X?.KH#%\E7VBO1FQ(_F3THC/&%VS1AG)&>
M5& 2 ?J*_9/CS\,:V*L>\V/J>RO JM3B*F@NBU&2 P+1R4OE,,X"E6!Y.\<
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M/L)4A:TNK"W4(6'4$T2"Z6>Z7&LMU'61UTU)L2[QQ+YU+3PR$(T<DO !<93
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MI894-C\)(Y /)'/;&O2,'&0>.<9X/&5.0/4#P0,X((]M:I_Q?_"?^7//)[[
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M/2Q*J1TL$5-$J#$8B@01Q*B]U54 &#].V,:<<<<^=3&G'''&FG.-Q(.MI[B
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M!*8.<?4:IMVI6D45JY)P$E7C"J  C XSR0<@GOC&O+_PG8/R-'Z?R_RW_/\
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MU3\_"CL*2 G>]K24)/@*UVJ4% Z.E!)^0#SJUY)90ZH+"GW'I![]DZD.N.M
M$I2>P-+;"/&@D #P-#64[[,60YX_(PZH;(&U)05( *B "I82D'SY/P?CG,TC
MVVFD) "6FT-IUKR&T@#>E*&]#]?@:^F^5H^J55X]()'U).!CZ8[D_P#OJT1Z
M*&0>]1*J#[>5S^?)<#/V/VUNT?Z?K]/\^.;PGN4$)5H*( )WV[(&N[0\ '^)
M6M) )/@<J.P;TI=<^H'3B3U6Q;"DVF*,Q[J3!:7=4D3(LABXVU[V2S,5QF38
M-761Q<>;[A9O5D)\LK:> ;7[>U2M;<J*VQQS7"IAI8IIOE8S*P0M4XW>7EB
M<C. .2=3]FZ>O/4$LU/9+76W6IAIGJV@H4$LD<"+G?(O'O[*06[*"Q U3?VJ
M"0K1[22 ?H2/D<TYSI6L,I4@I<8>3WH)!(^/"@%!*DJ ^A /T(!V!P<G58.
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MM+#:S:J]4=,7SP6O_3EPL/4LCW"YVI;K35M-'\E5PA*]Z*6G,:555NAG,:O
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M<3&:+&*Y^7B?4R#EMC9^T_E%DY7#$ZIZ<+&).DQV7!9P[AHZ\$G?GQ]?H?\
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M94\F$"*-*7<L4TDE1*/)BA@9\@L=K2!4C]1!-J,=O>2HE(U\G0UL?56M #1
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MN8XTPJ@'8" ==9<[WDD1H<B4V01W%L18R@!HD.RQ'+H !)[8ZTZ&P2GR9Q=
M^J&6],.N6 =0Z29D4G*ZZ_5*K(>&AN[S.RERFU5JON+<R)/<MG"_*99FP(\(
MKM(CDJI<F0TSEN\E@KVUA3;S:-$*3W K3L$$#904JV?HM"FUI.E(6A0"A.?
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MM/MOQ7VFWV7-I 6CL"P5@&VOEF+66'7T^@MD[DQE!V/)2E3;5C#=[U,6+ 4
M@M3$@N]K9U'7W,K"%%M)OM1>A-,K*[BLL\CM:NBKNF3/45$VQA4]7.4TY<1*
MY518"SG(K*IYF5)?2M4MWW$%I+02Z\O7*#^L736/G%(X*X 9#1&4Y13%K:"Y
MS"2M2ZF0Z5)9^[V+:&%MN=Z66Y[+3_<B-M?+RZ%ZNCM=S^7,LAMU85-0K@J
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MP@C8)WSPY70[JE%5* QO[PW& ]IR':43YF@Z4H1FS,9D*"3L%J2VPLD%2 2
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M=I0@G;M4% F%#'!TVHA*3_ .\A/G25J([G2DJ+9<< "2XE"5A*0"H[V'^_\
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M6$B0S3/UMK<M4]W40(LAN#7.*D5<]I$)A=C(LG'EOM6 "=Z&M:V?IY_R _\
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MY$:BZ>YCTWE27%/&RPCJ+FSJ65!Y4OVVJ?+[C*:%B,M]Q6XD2M8CGN[$H0E
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MQIIQQQQIIQQQQIIQQQQIIQQQQIIQQQQIIQQQQIIQQQQIIQQQQIIQQQQIIS0
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MZ]TXXXXTUM4D*&CO7['7.)Q"4LN:)2.Q1[B=]OY3Y_-X.OW\?KSGYL=!+:P
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MDJ+%E.L25LMOMO*]D>TH*')Q<X74!>O!WHZ4-['D?I\_'D>-^-GGTKO$R2Q
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MXXTTXXXXTTXXXXTTXXXXTTXXXXTTYHH;&MZYKQQVUX0",'L?T_PUQ+&O)/T
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MOGJMH[ =G9/U^/ )T/Z;(_EKG)QP2223RQ[L>6/;NQ]1[#WU$5%7A5  " *
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M0*^3;R6X<.-CLZM]V'6QS%4AM#4U'NQF"VXYS]"1]R!D#]3@9]N^FKBONHV
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M8RI_'9S5:MJ!'R"NR=I3;28LB.J0BRK&$R#(CNQY4)V1#?CK9>4GDW1\(_\
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0<<<<::<<<<::<<<<::__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>monthly_sales.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 monthly_sales.jpg
M_]C_X  02D9)1@ ! 0$ E0"5  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %T FL# 2(  A$! Q$!_\0
M'@ ! 0 " P$! 0$           0'" ,%!@(!"0K_Q !6$   !@$! P8)!PH$
M P8%!0$  0(#! 4&!Q%4E!(3%!73U @A,5-5DI.5TA<V05+1U>06(E%A<76%
MM+7P(R0S@24RD1A"=*&QP31BLN'Q-45E@H2S_\0 &@$!  ,! 0$
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M_9B\ !!U55^C8'!Q^S#JJK]&P.#C]F+P $'557Z-@<''[,.JJOT; X./V8O
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M]\8X)7>@YJ?OC'!*[T +0$7-3]\8X)7>@YJ?OC'!*[T +?[_ +_O_P!0_O\
MO^__ %$7-3]\8X)7>@YJ?OC'!*[T +0_^WZOM$7-3]\8X)7>@YJ?OC'!*[T
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MOY"..[
M
M                  /;]&S;^L  &K6HGA04>G>K=-IW8X_/E8\J#7O9GGD=
M]/5."S<AFK@XK'NF>94:8MQ(9>0[-Z0A, S87(;YETW4;1-N(=0AQM25H6E*
MT*29*2I"BVI4DR,R-*B\9&1F1EXR,R%O)P<O$JQ;LBF5=695ZV/-M-60WK^%
MOK))QDX2U/I.$]=9Q;IXW(8F9;E4X]T;+<.WTLB"VG";2:UM+M'WCVCM*<91
M;4HM'V-,]5_G_?\ \*_HM<-S"/;^DOV^4:9ZK_/^_P#X5_1:X4T]_P#/?ZEP
MVQQGYN8_^Y*K^0CCNQTF,_-S'_W)5?R$<=V/0!*4V&:WFREQC<C/-QY#9/M&
MMA]YMMUIEY/*Y3;KC3K;C;:R)2VW$+21I41G4-.<FT%S&YG9S(KIT:GC6^;(
MRBD2W:KESUS747I6US/DKKXSDEN1"LZ^NQ_'),E98S)JNEP;M$)4.OA ;@*D
M,(4I*WV4J1S?+2IQ"31SI\EOE$:MJ><41DWRMG+/Q)VF/M+C:^63:T+-M1H6
M2%)4:%EL,T+V&?)66TMJ5;#+:6TAI7D&@6IF49-5Y3*O*:(J.>8.VM6[/LWB
MO/RQI:>NJ&+)QE"&#5IC-K7K/&EDA]$J1*4;)5;YR9<K,&B>F&2Z<,63619
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M/>YOMB[, 6@(NA'O<WVQ=F'0CWN;[8NS %H"+H1[W-]L79AT(][F^V+LP!:
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M<,,WS;'&?FYC_P"Y*K^0CCNQTF,_-S'_ -R57\A''=@
M
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M=@
M                                                     !F1>7Z3
MV?[@  U0UEY.;ZW:$:7I+G8--:66KV2M>,VNCXFST#&4.&1&1.'?V29C2%["
M4<$U)/E(+9M=L+Q>+R;/_(:HZ-&K-=;-=-37-CM?5657I3C+^TE-+BXM'Z;D
M#C&WQI5UY8.1G3+82E13V[>21C:\:_*_@_!8.M/"PZE:NKC)9&5O+O4T_+G7
M*Z-+;T]516DDD8W#_C_'9[_];F6.I^Z>-C)8U#C]HV1K=NO]5DG[L_-A;=NP
MMOZ=GC_W_2/T &0;.DO9:^O]?N +;])[?U^0              :9ZK_/^_\
MX5_1:X;F#3/5?Y_W_P#"OZ+7 #;'&?FYC_[DJOY"..['28S\W,?_ ')5?R$<
M=V  P)*UN5'D9G&+&=DS$\MJ\<11SK9=9D]O"MYC]367D&CD5*W7X5[:PIQX
MO(C/R*N_JV%R(]LS8Q+2IK\]CQ;>GN(-3+6Q33,JL;BQ9MI<]]U^7+;GQND*
MA.0G9CKYP&8#\R;-@0H9,P8<^=.G1XS<J;*== Q+E'A(8_C651<35C]K/F6C
M^:QZ:2Q)AM1ISNFM=7VN>$]SIDY#*KA63151J0]UW+8ELI*$RF-*E^UTOU=I
M-5&I$BG@3X4?J>BR6L<F\T:K'',E5:-5%BIMHS.%)=D4MFS)KG5+>C<RTX;B
MVY#:A?\ (]IJI3;C^(54J0TEDD3)2'7YJ5-,LQW7$2G'3=:=GQXT:/;.,J;5
M<QX\>/:],8CLMH]30XGC>+E-+'J6!3IL'DORTP6290XMM)H:0E!'R&6&4FHF
M(K"6XS!+7S+*.6OE =NY.A-+-MV9%;6GQ*0Y(90M)_H-*ED9?[D/CK*NW^%Q
M3':"T !%UE7;_"XICM ZRKM_A<4QV@M  1=95V_PN*8[0.LJ[?X7%,=H+0 $
M765=O\+BF.T#K*NW^%Q3':"T !%UE7;_  N*8[0.LJ[?X7%,=H+0 $765=O\
M+BF.T#K*NW^%Q3':"T !%UE7;_"XICM ZRKM_A<4QV@M  1=95V_PN*8[0.L
MJ[?X7%,=H+0 $765=O\ "XICM ZRKM_A<4QV@M  1=95V_PN*8[0.LJ[?X7%
M,=H+0 $765=O\+BF.T#K*NW^%Q3':"T !%UE7;_"XICM ZRKM_A<4QV@M  1
M=95V_P +BF.T#K*NW^%Q3':"T !%UE7;_"XICM ZRKM_A<4QV@M  1=95V_P
MN*8[0.LJ[?X7%,=H+0 $765=O\+BF.T#K*NW^%Q3':"T !%UE7;_  N*8[0.
MLJ[?X7%,=H+0 $765=O\+BF.T#K*NW^%Q3':"T !%UE7;_"XICM ZRKM_A<4
MQV@M  1=95V_PN*8[0.LJ[?X7%,=H+0 $765=O\ "XICM ZRKM_A<4QV@M
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MAUIQS3&A:)I7Y29ID;JJ?!L(I'F)-_E%Z^@TL,1F$N'T:MB*4F3<W$GFX%3
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M-S!IGJO\_P"__A7]%K@!MCC/S<Q_]R57\A''=CI,9^;F/_N2J_D(X[L
M
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M=@Y1J[+BDLTM/(Y34J#A%3*1SBVUF@[RP-I:3.&E1;@E]!$7BV>(]O\ Y?\
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M[SN"D? +@ $/3T;O.X*1\ =/1N\[@I'P"X !#T]&[SN"D? '3T;O.X*1\ N
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M%+Z)+6E]"'IZ-WG<%(^ .GHW>=P4CX!< X.R'IZ-WG<%(^ .GHW>=P4CX!<
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M2
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MB/8>SR&9&1[#\>PR/R&0 _0
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M"?[^+0 $7(L=YA<$_P!_#D6.\PN"?[^+0 $7(L=YA<$_W\.18[S"X)_OXM
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M!/\ ?Q:  BY%CO,+@G^_AR+'>87!/]_%H "+D6.\PN"?[^'(L=YA<$_W\6@
M(N18[S"X)_OX<BQWF%P3_?Q:  BY%CO,+@G^_AR+'>87!/\ ?Q:  BY%CO,+
M@G^_AR+'>87!/]_%H "+D6.\PN"?[^'(L=YA<$_W\6@ .-HGB1L?6VMS:>U3
M3:FD;/H_,6Z\HC+Z3Y9[?T$--]5_G_?_ ,*_HM<-S!IGJO\ /^__ (5_1:X
M;8XS\W,?_<E5_(1QW8Z3&?FYC_[DJOY"..[   '2%DN.G)FP^O:<I=;/C55A
M&.RAI?A6<R*S-B5\EI3Q+9FRHDAB3'BN)2\\PZAQM"DJ(P!W8#K)%W31'9#$
MJWK(ST7HG2FI$^*R[&ZP<-J!TA#CJ5,]-=2IN)SA)Z2XE2&>6HC(J8TZ%,5)
M3$EQ92H;ZXLM,:0T^J+*025+C2$M+6;$A"5)4IEPDN))23-)$9;0*@
M                                                !BK5763"='Z=
MBRRF9(>L+)\H6/8Q31G+3*,GLU^)FMHJ:/MDS)#BS2E3FQN+'(^7)?906T=?
MK5JRQI;CD8Z^O7D6=91,308!A\99%,R+(I2=C#:MFTX]7!29S;>>HN:AP677
M5'MY!'YG2'0F-B<E.H&H4X\]UGN8Q+OLQMMLIJG.09O.X_A4-\E,XYCD)2N8
MCQX"&GIB6^D3G7G7#V:N+B45X\<_D7-42G*&-BU-1OS9P_.XSDM4XU;:C9D=
M9MS?IU0E)2E#'R\W)MR)<?QJK>1&$99.5:G*G"A-ZAN"T[<B:VZZ>T4DN]DD
MM1EX.+IEJ;KXZU=:Y2'L,T^=64BLT6H+)1OSHBE)<CGJ'D$)2#L)"T;.DT=6
MXBL:/:TZ_)VJV;9TM)48Y5PJ2AK85145K"(L"MKX[42'$CM[20TQ'90AIM);
M3,R2DMJC-2C-1F9]I^P!!F<C?F*%34*,6K?H8="Z8]6O&U';=EFO$[[93NF_
MS3>R?"XVC#<[=SR,JW]MF7M3OL_3MI*%:>^M5<85Q3TH@  431
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MY=]UWRJ;'L>C/DRXR[-B8XJV6S>7'.+7SV169VZV;%]"EMG&@5[27%\R9C.
M "1R,ZM9J3.EM$?D;;3#-"?V<[$<7ZRS'QT1_P!)3O5K^X"X !#T1_TE.]6O
M[@'1'_24[U:_N N  0]$?])3O5K^X!T1_P!)3O5K^X"X !#T1_TE.]6O[@'1
M'_24[U:_N N  0]$?])3O5K^X!T1_P!)3O5K^X"X !#T1_TE.]6O[@'1'_24
M[U:_N N  0]$?])3O5K^X!T1_P!)3O5K^X"X !#T1_TE.]6O[@'1'_24[U:_
MN N  0]$?])3O5K^X!T1_P!)3O5K^X"X !#T1_TE.]6O[@'1'_24[U:_N N
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M:S3G)^/>4F_U\L_-GD\9^+]?E_;^D?H *I<
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MT?M7NT%H "+JZ'YH_:O=H'5T/S1^U>[06@ (NKH?FC]J]V@=70_-'[5[M!:
M BZNA^:/VKW:!U=#\T?M7NT%H "+JZ'YH_:O=H'5T/S1^U>[06@ (NKH?FC]
MJ]V@=70_-'[5[M!:  BZNA^:/VKW:!U=#\T?M7NT%H "+JZ'YH_:O=H'5T/S
M1^U>[06@ (NKH?FC]J]V@=70_-'[5[M!:  BZNA^:/VKW:!U=#\T?M7NT%H
M"+JZ'YH_:O=H'5T/S1^U>[06@ (NKH?FC]J]V@=70_-'[5[M!:  BZNA^:/V
MKW:!U=#\T?M7NT%H "+JZ'YH_:O=H'5T/S1^U>[06@ (NKH?FC]J]V@=70_-
M'[5[M!:  BZNA^:/VKW:!U=#\T?M7NT%H "+JZ'YH_:O=H'5T/S1^U>[06@
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MWMVOC#IL/>XWMVOC %(";IL/>XWMVOC#IL/>XWMVOC %(";IL/>XWMVOH_\
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M[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2
MFZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[
M=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#W
MN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!
M2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN
M-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;
M#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KX
MP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#
MWN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2 FZ;#WN-[=KXP
MZ;#WN-[=KXP!2 FZ;#WN-[=KXPZ;#WN-[=KXP!2-,]5_G_?_ ,*_HM<-R4.-
MNI);2T.(/:1*0I*TF9>4B4DS+Q?3XQIMJO\ /^__ (5_1:X ;8XS\W,?_<E5
M_(1QW8Z3&?FYC_[DJOY"..[  8SGZ18192+J;*A62["]LZZVF6*;ZZ3/:DTS
M\N93,09!3N7"JZF?/L+*NI6.341K"PG3$0>>ER%.9,  8C7H7I>^]'ES,:1/
MGQ4N$S939UB_8-N2HT>':/M2CE$XP_?1(D6-D;D?F3OX\:/'MBELLM-H]ABV
M#8IA:9B,8I8M.B<;)/MQN<YM+,4G$Q(<=#BUHB0(A.O'$KXJ68<53[YL,(-Y
MPU>L  ?!M-F9F;:#,_&9FE)F?[3,MH_.9:\TWZB?L'(/PU$7T_3L_9^W]0#:
M7NSXYEKS3?J)^P.9:\TWZB?L'F<DSG#</C.2\IRBBQ^.TCG%N6UG$@D2/TDE
M]U"U?L2DS_00P;,\,#0:.X;,'*I^1.;3)*<6QC)<C)PR\7^&JHJI:%[?^Z:5
M&2OH%RGC\[(@[*,/)MK3T[(462K3\>'-1Z;\KQO?E?<HW<EQ^//T[LW&KLUO
MTY70]37_ ,%)S_V-F.9:\TWZB?L#F6O--^HG[!J[_P!J.-/V'BVBNO&5-K_T
MI$/3Z33QED?C)7/9-*I"2@R\>U9),B,MI$?B'$K57PC\F44;#/!T;QA+^TDW
MVJ^H-'60X?Z''*#$&<GN9A^4S9)^$7BV=((S\5K_  3/BE*Z./C0?7<\G-Q*
ME%/V<HRN[K7NTH.7Z-^"H^>XYMQIEDY,_I#'P\J;D_M%NJ,&W]/GU^IM-S+.
MW;S3>WR?\B?L$LN36P&5R)KT*(PV7*<>E.,1V4)^E2W732A!$7CVJ40UC1I'
MX0&7*-_4+PA9..1WBY2L<T9Q*NQ>-%4?B-LLIR5[)\AG)V&?^*ANK(S\?,D>
MQ0IB^"'I&[(3-RP\QU$GEXW)6>9KDF0MO'X]IN5TBP34IY6WQI:@-H_^781$
M7OP?&U?O'*JR2EJ5>!BVWO2;WUMR'BU2\+PXN2>TUM#X[E+OW;B951:\69V3
M52O_ "IJ]:Y?UC^AZ7)O"5T)Q:0N!-SVAGVJ2_-J,?Y616KAD>SDMP:9J:\I
M6TR+D["/Z/*/*?\ :KP627_!,#U;OUG_ *90-,,C03A["\:5S(<5"2/:?C4I
M);/UF1'G+&M-L!PUIMC%<-QNA::+\SJRHA1%I\A?ZK3).'XB+_F69F?CV^,S
M'M=A?H+_ *?3^S9_[AZW"5[C'!S\GWU9=G58^UI:W35BVZ\[>O7E]%OZGBHY
MVQ;GGX.-OWKIP[,C7\KK<BEO^M*_M[ZFGJOKMFQKCZ::!KQMA9FVG)M9K5K&
MX+"O(4A&,TA6F0V+1>(^0:JY2MG)YQ)*,RYD:1>$-?I*1EGA)KQ]<G\]^FTQ
MTUQ&I@1#47YS,&URYG+KAU"2,R2_)5SI["7R$^0;6["_00?^O_H/(\LZ-+#P
M./Q?&G.>+7GVRUKR[.062H2_[J(4K7T3]_7Q'K><[/Y#*;_AAD6854=ZVHUX
M,L=RC^EL[6ON:I)\$ZBLCV9MJYKQGT9?C>KKS4B14U3RCV[>77X56XFP:#V[
M"09&1)\1\H_SA[G%/!HT)PN4S84&F6+M6C!\INWGUZ+BX)7UU6ML<V>XKZ>4
MY(49GX]NWQC.@"*SE^3LK=,L[(C2WOT:K)4T[^[JJ<*]_KU_0EJX7BZIJV.%
M1.U:U==#UK?'WLM[S?\ 5G B-':0EMMAAM"4DE*4-(2E)$6PB2DDD1$7T$7B
M(??,M>;;]1/V#D 9VV]N3V_O]7^K_5FFDHI**44O9)))?R2\''S+7FF_43]@
M<RUYIOU$_8.0 /3CYEKS3?J)^P.9:\TWZB?L'(  X^9:\TWZB?L#F6O--^HG
M[!R  ./F6O--^HG[ YEKS3?J)^P<@ #CYEKS3?J)^P.9:\TWZB?L'(  X^9:
M\TWZB?L#F6O--^HG[!R  ./F6O--^HG[ YEKS3?J)^P<@ #CYEKS3?J)^P.9
M:\TWZB?L'(  X^9:\TWZB?L#F6O--^HG[!R  ./F6O--^HG[ YEKS3?J)^P<
M@ #CYEKS3?J)^P.9:\TWZB?L'(  X^9:\TWZB?L#F6O--^HG[!R  ./F6O--
M^HG[ YEKS3?J)^P<@ #CYEKS3?J)^P.9:\TWZB?L'(  X^9:\TWZB?L#F6O-
M-^HG[!R  ./F6O--^HG[ YEKS3?J)^P<@ #CYEKS3?J)^P.9:\TWZB?L'(
MX^9:\TWZB?L#F6O--^HG[!R  ./F6O--^HG[ YEKS3?J)^P<@ #CYEKS3?J)
M^P.9:\TWZB?L'(  X^9:\TWZB?L#F6O--^HG[!R  ./F6O--^HG[ YEKS3?J
M)^P<@ #CYEKS3?J)^P.9:\TWZB?L'(  X^9:\TWZB?L#F6O--^HG[!R  ./F
M6O--^HG[ YEKS3?J)^P<@ #CYEKS3?J)^P.9:\TWZB?L'(  X^9:\TWZB?L#
MF6O--^HG[!R  /Q*4I+8E))+]"2(B_Z%L(:::K_/^_\ X5_1:X;F#3/5?Y_W
M_P#"OZ+7 #;'&?FYC_[DJOY"..['28S\W,?_ ')5?R$<=V      ,;ZGYU,T
M^HH5Y'I';:*Y<0H-K*(YAQ*&M?2\M^YL45L&RL%0VEM-Q37&@O)8>ELR)BH\
M!J5)9ZS3/5>+J1(MF8]0Y6MPJZFNZ^1TYJ>U94M[)NH<"2LVF&.A3>D4$\WZ
M]1OFU'7#D$^M,DDH ]?F])?Y%C<ZIQC*Y>$W,I4;HV1P:^NM)4%MJ4R[)0U#
MM6)$):I4=#D;G'&E*9YWGF_ST)& $^#9DE@KE9+X16MURA9GS\6+?5&.Q'-I
M[3036/TM>M#9EXB)+IJ26S\_:6T;/*G1B6I/^.M3:E(4;<.8ZDEEXE)Y;3"T
M&9>0]BCV'XO*/SI\;;MY$O:?_P#'S^["[C\AE8E?IX\JZTK':I^A1*U3:BMJ
MZ=<K4EU34>_5-N22DVRAD\9B9EGJ9$;+'T4.GKW1I<4V_-,9JMR>WN3CV:TF
M]):P7CG@NZ*8[*;LEX>QDMRVKEE=YG+F9;:&YY37TB]?F\G:K\[DMI0DC\A$
M0SI$K*ZO:2Q @0X3*2(DM1(S,9I)%Y"2VRA"2(O(1$1$1>(A^]/C[2/DR_%Y
M/^'S_I__ ,P%/CEXB3+]WS^[#C(SLS+DY9.5D7R?N[;9S]M:TFVEK2UI>-+[
M'=''X.+%1Q\3'J2_T503_OK?GZ^?+\LLV;"_-(OV%L("V_3XOU>7^_T_2(^L
M(_U9?N^?W8.L(_U9?N^?W852XDEX2TOLBT!%UA'^K+]WS^[!UA'^K+]WS^[
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MG]V %H"+K"/]67[OG]V#K"/]67[OG]V %H"+K"/]67[OG]V#K"/]67[OG]V
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M7[OG]V %H"+K"/\ 5E^[Y_=@ZPC_ %9?N^?W8 6@(NL(_P!67[OG]V#K"/\
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M&8MBR+&<B-R&PZGG":@'7.N&I:'7UMFE*0/53LUB0,#=SU5=82X3./IR$ZV
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MO\_[_P#A7]%K@!MCC/S<Q_\ <E5_(1QW8Z3&?FYC_P"Y*K^0CCNP
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+:LU&6Q)DD@ #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>potential.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 potential.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %6 E@# 2(  A$! Q$!_\0
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M'9RL<UT%!HY$3IZT<V.261J<.((,BM>V-%&Y@5]6,Y6O9U66/JXI]0GD?R5
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M9V/VFGM,@'U4U"T+%P,=P/%<YS$:HHB2:;&6;HSW:?X4K2'#8VM4D0RP937
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M43^TK$9U;-\(FSPB,;QD:M>B\<WXV*U6\*O+EB(G#D7V7CE%_7G7O\03_P!
M?_"7]O\ T_\ M_E7G83%]<OZ@TJRHW@IQN18I71.\N4&8I^9J(O=O;3B]VJB
MHJ=_GY^43K'4O\H9YQ0[>"TH_@EQ^7+SM>&[,AD;R8R_[2F.@9$+C$\;S%U$
MDK;%;$N)S!T'<Q1T=*LR.3PZAQ&;1QR/*JKF!'OE8\EWW(BR%G=(R%K4E:\H
MB)LBP-B5KH71S-8YCW_LW*CXAG$AS?4$H""R0)1X.'N32/GAE5(8FIN"A=WE
M>LSFM3Q57-[JGY%1WZ=U1.7WPL[3UXJET=F0-),R"JKCJM\(PEB33N&96*D3
MEA.B?2]6\,=RJ=D]UO!NYKT)SX?H"1Z?A\*KV(BIS]7/5>4YXX7[_;\]Y$_U
MR_J"CPS3OX+<;59!%),_QY0YDJ^,;'/=\?S.)W^&KV153NO[TZYX?K@_4,GD
MBB@X(\;YIIY(XH8HN3V9R22RRO;''''&W3:N>^1[D:QC4<YSG(C4551.M?$T
MM%.,UJ2#*TX:9X[FO?,CX5:C'3(UCW+Z;72-1Z_"(Y4:J]U3JIXG935DU/D-
M#9EC6M5,(<$3&9(3[*R#5DK%]$ETT3GCS,1'1$0*G=O9\7[DW9?A&VG5AV11
M7A)*1B$C,+DBM"XS6\C;(*RO<]@7.5GD<,3WM'V<C7+PFK*W\]$YX O/_JU_
M)$_-'>W/Z\*J<KS^FIVR_7*^H4.K&$\#N.@LRS(.\<GDYFD)$$ZN5JPSQ/TV
MCHY&/162,=^9KT\>RKV3KD7ZXOU"$_\ O%N-G[OE>4.8I_N__<;_ /7]W\>L
M@XAQRQ7D;@V,;.SG(,K'R6]JX!K>2I)IQ82S<:.GJ&6B-;3-="0<ZKC-GCC5
M(VR2.B;Y,15=#7?FG:/46Q2<3JS[&Y FIZJ['*NI(B;")#63BRBOFCBAC?&V
M>ODFC\(FM:R=&.:KF^3F_P 7V,V-R&X_AIT/*XV0QV2F6$=+KF "77/44X0)
MGHU>=C2M<HG. -7,1W;CCZK#,EF/>HT\/=O*.;XG>W541>'*Y$7W3V5O/'/O
M^6I!L^N9]05T\HZ<%>-WG"R&1RKRAS'LK9_4\/%4TZO?_2G]^Z)V[?"?"]N-
MWUT?J!-B)F7@MQN\0UD;,G]*#,N_>-GJ.5$_F<1/[#D=\JG_  ]DZU_R!L%D
M/DC<2Y_N01HFK8&-:R&9!HVQ+^=RM9%.21.U$1>_J^DGBQC>WS/"2*-,)*\=
M([2:2!Y$LY4GH.)%6%G>62-5<KGQMBB1ZQL<^1C&N1ZHCG =\).T+6O5P,F1
M6*_EWSWD:(CWB9RY8;43D@U1>RIPB\JC4762E[/5J<*'G]Q?GRG/^-^W'_\
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M9$EAG[Q1QO8D2L)@F9)^5R*D\[9BFO:UJ3>BQL*5T+(Z5:03'8Q;J0 2NK!
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M/$T0ER3/E@K#XFPL9$]TG]5!=(QS&/8Z'N])$:C4DK'W 9/^]&_O_6M/1?\
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MI(G*U3^RJQ[6N3^]/CLO7:_H5X:C>_\ //RF_=\?TAM@)V^4^/\ 5_[E^?\
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MOALBO<;RG.=CY+JO-:&OIB2K2COL9GM)6C);2$0/-LQT4EK(R'0N%FD;.TR
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M659/?$31RP&V=[>91DV2$'-D*FE+L;(AY<(KR99R7QM54<WH:KHZ'7^W-/\
M(W@-G^@];YYHF;/&43OYO,1VGA=S!L'&PL8O9KR.FOJVU'MQ1F%L"M5MEL(Y
MBI_%49+*Z27WU@OI2ZJX=:;UG0<5\7R3D[RBSK%R1:O6^\>5FT<PR'8-WA)V
M+7>59)KCBH$<I>Y[.YJX,AL<CHRKF# L>HZ=(3\<NY9X YH/_4DT5N_']?\
M"C3F6Z8X5:(^H/R:P;)MYY?N73FHK/B?D6D-:P"XSC]1I@A^,9I/2[.RL\NT
MS"CSNA=BEU8-6RJ2*ZOJ!*5]X=A'WRP#*CQL.I]BJUU1?.CUTJ#6R(=9>2'K
M(COC!A2ZR!#?T&4+3N86:)KWHWR%&%I>^P^6R@-=(?9.:\7+T<YKGC:BIPJO
M1SOM[KRJ,_-.$_+4B[GZT'U0]0<NN PW)'F5K%>.&P=]XQB&ZWZKT;KO$<-(
MUI'DE+3G93L'8.8X]DC\=?=#9#+-DHN.WF-B4@%/[K'28RFSGL]Q^I.3''7?
MIF0UVCMZ:DV_88DZ)N4 ZUV%BN:EX\L\\XT"W(^/6EA-7,G(%(@AD*9$R66"
M5D;G.8Y$_,&^GUPJXNZ!V1E^N?K%:CS8GC?L.3',)UYR-U3MW)0< PC)"B;
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MRK9C% /0@6U-D=2--,<U8H3&Q-EBAR<9I_GB6-6@G\K-7QGEC.'/(J="!0W
M\4@JN*L!K23+XFO)!+>P 6= PAW!3^L\%YJM:S40]P)\Z*"9$P/,B221F)/B
MK!KH HTQ'H D49[JUJ5F(*2V0QAXHR!*%C)2*D8\4QZW0V-5?ZS'1.4ZJY[O
M=CDY:Y5:-W5514Y:J<HOW7E.-;0>3O*>NT!Q:XRZ[%P#:NQLQWMG>S&8]BVJ
MA* DNU!UU]RN\A2[7(LNQ,)X8T%A7&#P.E/21]?)(Z"*0.!SM==ARNS&RBCC
M&X:\Q()F/>YKG8AJT5$=*,0-(U9Y=PQI$B13R.9,R1OC(R-6.17L[Q&P3C#E
MW&#D[PJQ*3<>29_AV0E[[N;6BN''M'AVL[45E'EF?4S3;.V(K9,TIQJ"&^ 8
M?)'-9U'OT[,); -N#F?-62AK,9.2#/,T25Q3(WRCSD/;&$J2P1PN6*65[1'.
MF9,[U91W.D8GK/>A=N*W-)(,U6TGR<0.W.;!TFGB H[=(S;6IH;L;B698CWG
M5K;1&*5/PQH-&M$-S7]O'LC1O&C6,DH1'E4O8HN54Y6]5&U41>J,1$15_5R+
MPY$2&0?*/8$<B33\*N5D\D+70"(RFT['"(+W[1MAC=N)W:21GAZTK557HQK$
M5&,[==@WE=F,CA72\->7XDK97,C4?&],R(LDL3FJS]OMV6-RJU'JUS6-=^GB
MY/+Q6;Z(BHGZ+W3]>WZ_P7Y[]_CM_P"OZTZR<V&*"9?!B,-![N>K6-_:EP#K
MY.<J(G;UO+Y7Y5$[_'3H%QK(&A<J9M:(WAKE1U3CCU56\/:KE^5LYZJB<?;[
M>WMPFJ6R )]XC$XXXX(;W3V7E?Q/O]T_SIJ%XG+'/ W2,/X=<NIO=&OCKFNQ
M;3:2)"T9KV0N=!MT=CYG>@40_P F>+&N;%&]R,[O[[^7&8,1/4X8<OT:J^/>
M+$M3$JCE153O'!N.14^&K^9R(B=NRK^G4PB$KS(EAE?"]BN8]/"9C'L?&Y%C
MDCEB>DL3XWHCF2QN:]CD16N3].J5 MC!8M!BL()Q)1YIQ9"(U*)B]!X\<L!4
MD9(RRM52&.@E<UTJM1S9Y'O8DLMM:+)0=&-S>T*-ZHP;TK,<>J/5/L9KJ].6
M*O#&N:Y>5<P:L;[*[SRQW+_WJU/9.40QT3[I^2/5%Y_L_3^S4.?Z5^80^P8O
M#GF(X8*59',7 M9-<K&"$0,5SDW [U'>I*QZ^2=G.:LGR]&]5F+ESF,\;)8>
M&'+UT<C4>Q5Q;4<:JQR(YJJR3<C9&=T5%[/:UW\4[]2^GBL?3E_K@:*L;D1S
M 96JB(BKW7S/D[K_ +R(J_HB=^R=@!.X0*N[.=[.!5<J?J_T8_GLJJJ)Y?*H
MB_'S\]^O0X_D[2H)^:VC&N8KN4I\=145O1B(G$$BJU.4X148J)]N4^QY8_")
MZ5B(G/V.?GGZ?_2;^GM[_O\ ?VU#$3ECF;7%2-X8<N7^L7*YRMQO4*KY1,C'
M5CD7<C41S%@5BHBJB(U/E>L7:_V5=;6YWU99^KMI:>)H>*N30OK-G5V(@6MF
M-9;6QE1K&LBQO*,P%D ]8,H61Y$XI*$0/;Z'I*V1^Q( H1D4S)9QHW(;8=VO
MEC1W_=$Q456]U<BKW15[HG?NBK^[J'YGB7]02K]J>^!K>(%DKY!%#D5_;<M?
M^R?[@<EC457,?W8UDB]D_.C$<CM!>5=Q&_A<\O*9MI'_ (KH.\$L&GB,>KCN
M>QREAQ@2&JPJH[A"\*B*CD7\KPB"<TR,CM&Y(Q/J:0COIX;V]G/<G/'/NJ<^
MR?;4O+$<EH!CW'%S(T:5?12()/5[,55B1RCQ(BR)W8B^HSLKD[R-15=UW7&$
M]E1U4<B?O7U:W_/^_P#=^G5.#'E.#:TBT/?_ &HB(UCKXN[VN5LL+U;7L>U/
M]:JL<U5:OE&_Y1W62\-P^PSFWGIJXL$%@-'=Y';65BA\@=51X^!(?8V1,52!
M9V<\4+61#M@ KC"YB"AXH8)'O1KG G6==4ULRYL9BU]=$C>IDR#$:1! &U7O
M>_JIW\(BHWJWERN5$1JNXYUZ_M^B>R<JOV_)$]U7]D_/V36-X$D?5 O9!)(K
M9H9)(FK&LK&LG5[E[JY(U]-$7X8YWSW5JN3MVJD1,,L22*U8D]585;*U&.;*
MUZL]-?E6^2N;V:B*JN^/'LOQU]MQT>8"T/K\^J3\1HQ&6AN2U@%[4US* I*\
MD&UD+L*F0TB,V"[HTG90,)-IIK<("X96GDLC9UC]>A0QW(4]AA"V])9W"E/,
MR*I/FKG5J7=W[T[U2WG-#AK*4\JQ&\VW$ ,2H4$-,8$DZ%C[N[<$&)\7.L/<
MCX3#=9&24X7=4X8URL4ZF&Y581%:1&KV:B*U%UF^@F-7AT:0BK[<()_**G'L
MOT^RHO\ G3]4U1@R!I_>DH84,PHZ5\<3?;N:K(V1#>HURPDN1)G0.D1'2(J(
M[Q1C&HUO7V 2*HT;?NQ2]EG;"B>BU7#1$21P/1/8_F8L+8E23Y\_)%^?+NM:
M@"M?)HZ7&)O\6SK&0%8UA-<3 %#&01,'*V_9*Y@P;VDD#2#0'!1QDL+$@D"+
M;#QA15HA575V&1U8]J_$ZZYCKDK<L+L9:>RN%H0+/[?78]8&#Q$7 1P,P9<4
M-I7RAD2V800\3I^KR[D[>"%%E$SK$DCD'SZA;ZM<QZ.>!??PVG#7-4X_H4;7
MHA6<M5%U[Z*6OT>F.KD<B(GB(U5_1?J1O/*([[+PO"I]TUT*^!TR%/AL3$13
M2/+Q]HG97)$[Q[/"<J=D<O9.R=V]E^43OUUH5M1QWOA(#EC6UGA1Q44BS.2>
MXD'59%A=%%W1LJ^",C:G9&HJ*O?O5E"&0J]=#DH!4(=W:U3YZ@Y2ZUUCCLKZ
M>[%C,8%*/&@5G6DP,L"9H:BS2:KFIC[&"]HY;*WFRAN]\$MS7/"82.3XG*-.
M_P _4B/E\Y$*@C6)\S5\F/A[M17=GHB(C5#49%17L=Q*2W@62 1&$+768) Q
MOE1FSXCR>.0;Q-D1G"DC1[NS@D:]$ZKSJP0!0N:CQD&OOPA&N:J]51%^Z)SP
MJ^_"K]EU;V68'C6;4QF&;$QFESK%;Z,J>QQRX#6VJ27Q'0'0+/46,T@#VC$2
M)+!*V'UAB81YHI(Y&L?U%W@_#./QAP8J,MI@E!9[*IAJZW7WOV[':38>4@5P
M%=+)(A3(JL"O$&%$G(FA8+%Z S8?R]3$@G%]S+-&?0"O%]<2-88(HW30RL"F
M<]ZML&JY$DC1J*U58GRB_G3XA_P3=7?T=\.]:P%9-+EFVW2M64%',<W:65NB
M>Q)&/F8B^3G,59%7LYJ^2HB(FCG BLSK'BC8(12XSE(%.QPO(04>UPQT9A#,
M=YC-"8TAS!%<HV^4G1J*1RZN,571R-7[(87TI]D51GY5$YXY^GW5.?LBK]DU
M+R D5Y%60CZI8HB'2N4,*: @=R@E(Q)VR=Y!G-D?'Y0RMCFCD\$<C7=NLBXO
ML[*,?+C"J\KR86N;:OF975]F;$$T9T0OO9$"=,P14>CY7*J1N>LG[2)/58Q[
M<<1*&A!1K+L: QY#X%D@?"^4M6%^W#2P@CD>EBY(8HAH5;#'/Z"^G#/&YWJ)
MRCPY#:V(S)*@HAQ4;A@I*>4]9)'^)4DRRUL8I!PDDD#$[OCC(9&R)CE,B<_T
MF;>[K:BX@&B7D.NF0WL*I"28D>2$#5&\3Y*O.L@<%PVJ1PR%9T$Y%(I&JUW&
M;4V]G1RQ3*J=+@F$]A.\62>,I.CV/\171R">\3E8WNSMP[CW^R<3JWYLVQDU
M)"+JP>\&Q?-VY"%E=S$&6X!E.-&\2W:9!*DT#3K0DU[2+2T@666 8ESI9'N9
M+#H+Y=,EO];U&#61<0%#GFX=-:XS- C2:J O$<DVMC57<CGS0.D:0'859;H2
MQ862.9#.0TB-Z,D:_:)C]9E63EXUA&4Y%=8OJO*LOJ*4<0YDS<<+?%:5\=U;
M!'6K0AC'51-IWF'25X0QH;2B(W2.BF2P^7W"O5,]4%K6ZV/397B]HR7(<?N\
M7+#J,JPNTI[*23'[BNNP+,L<"[JYWL,$*C&4=\L"I(/+#))&[D5GGP];PLWV
MQX>'FF2\8686-46"Y150PQ\? 64VV;)44T!VB/!'+BV0I !&L7$(!L'TKV,)
MTQQ_XCM@YGP[Y_B-T.CI]R<OQJTDRHD;#+F0EID_HFQJQQ+!M5*@)-@S$9,K
MI2G>RN%&$9TWUSG&CS.W=HK4N TN&,TSF!&26)%F_'HL=K;+'+U1:J.IE(@2
MOJZ&K'FBA%6LA@8C8TBBB<V)D;43LD:X,&RUCRG'T>3L(FE<C46KL@FJ.QR0
M"N].(:)BMD1S4;*J+ZKW_LU<BM1-8-MGO)+C+26&1[9M1N37'FJJXA,BSZ@(
MI,(W!A-(<&107I-UC]<3 #F(GLBQ[&<ZCL1LE#C>?9+!W@8L6QC"LGU\N*"R
M8!1XR?BMC=:]S "UK;0W(1K,R@R._P BQV9IED=<#R@U[<S* &KXO 4>BCIJ
MWT8TJAG,Z'U63[AP1 I<9HX^938T<D^Q7,;T=!:!224X(GHF14MZVUJD'%>T
M-E564J,U[31BJ$[58G,KT+(J*R=(.-XWJQ5='=V]FC1S",>HR#(QR\*P@V.7
M^9$5JIJHU6*6190H+,,LR[$\VR%&=)5AO*+]C8$PEJCB)FERQU[O40UTC.XB
M,D<0UG9W4K*WB#E+(%:_)<>#)*<DLM?%5FR*).X>".4=JPRL2162,=WD8QOJ
M.[N:U._4;7VL=U:5L&3EV,U2MDC#S9<_R9K5 L,OILMG,,",+/$<=2V54-]J
M*CC1M<!%*(-##%+$P;83'CO%NGRT^T)WT;8XA:ZYN<'RO!LFSXJYHY1[N.52
M,I/*L)WH)*7 (8).*HL0AAIA=@9-.](!84!N5G?Q UTFD%78Q!Q-CPR7225-
MC!R53]7]4+*,2D8V(P(4^D#?,4ZH4RO1&M$)7XI;;>T[9_\ %6.3LJ=(:-8*
M L)E3Z-1<^5/'$81)*F<\7'E,)!-&Y&_[8Y4@3L/5V7X1<SXE)1F7T0$0+5O
MAJ"P)K'/+JXIH$BB@0HJ,KRD)A1SXDC=Z$R,>[Q<G6+;7$9RL;RH*[Q:<^E;
M36U/G]6#4&-]6KC (B-EGBA9 2Q\H!/I2Q2.266*>%D#O-84?GG=^9Z8DV-D
MFR-6Q8AG5)DM-A&0XYG(%E9Y!%:%TN(8K%BEOC>1A6"L'<"M$!*!+3$11$%2
MRSDH1XC1C1]^Q[0O\&HZ_3^ ,F&Q0:QI*:PM<%S#8>-Q.L+S&KHZNM(XK.*T
ME(E"K!<:#A!OJZ07'BI:Z.-[9VR,1V9?%/D.U=?B=7FV+P;Z\RG$TMJIU1*E
M61),<$J'!?*OZV#6-+ '*BED2F-#$D (X;HHR*)SBA<G"=AL@W@K<KS/ Q5-
M-C%%<CA)'R;(J^B>,U@T\N!4P9M]*BQ)LP483&G:^<)P5<-Y5:,C2+Y4<?W%
MMCB1LN/,>)^0V^(YM-M'(G<4<4L:&@.R.KQ/?6"24K]C4V 92VWR7$<S-QV^
MPVGU7L&O]M821#GD5$39RIS7_IY_1:^FI2?3HXF8^#F5./9<N]WAUFR>8&U;
M&WFRW,<YVM;>^N3*BVS8]'65W3X<;>VP-8Q\SQ9+,V_O44@^^L3B]!_TF>!5
M(WZL_P!HW37$6.6\7-*S<PCY,A/QJXO\_P"16]\XR?7]3G.03TS[ ::IP#$0
M+],6I8R!4QNSLL>F8R908)Y?8!R9W!@N@./6Z=T;+R2+$L&UMK/,<LR&_>5,
M'*$'549L[&U\HWD8^W,(2 *F&KV2V)EJ0&+7PS&3P1.AAE#%;<F[R@R3$!#.
M=D491PX!)40$I:B(PSR&:&H4ZURM(J.:2,]G"\<Z0CQ)'(:.A0'2,>1']1%D
MAF19'@,\*R(\N.Y\>4 ZC\H9 7D$83F$8][7(Y?#S]3WZ^/(C3_(OG]25'%+
M$\?WUQ,V%0Z;X9\A+O4>/Y;D_'[ ,T!@'WAE&69L;=9#C<INTA0,,L]?40@L
M$C:S*(([ZODFK3 W0CXSU(/+?'0>:W(PVUW7O7,MBYKEV-[0W!9VI>6UU.S+
M+*MQ):3'_O)V,854UM5 '+38SBXD%'2K!"ZH8UD8\Z24X78!@]%HBM%WGJ;$
M]PE[UQ2QRO<U!MYQV36F59/EA]+D<5UF%I;6%C9&9/6A@4X/NG3P$BR">4:#
MD,5&RCR ^L-E+_"^/XI@V-")24U!AV.C/'H\=IL=KZC'ZNJJ1VS1MA!&"JX&
M11-C:UC>[&IXHG4Z]C_A]E8KD5=DN0Q(5I!F87'F#;,%#-Z#)9TBNGL$&,?B
M2$E?!5!))<QA$E.D*U1LZ<HVRN'':^,(;QHT[N#-(B=V,1$1.&KVY<Y7+_O>
MJ)]U7AMO=Q9I6!DW0$\0P<'[.0825KWRNFC>LC9'*U[6H,Q\:>FBH]7.57=D
M[04R#.<JX-\L.$&]>&VO[2OVGL;D3A^'9_CNM;:DU[KK;..9I,!4WVL=@ SF
MUF"LM=C$6(T-#D>10P,!MZQML9:,-!#FCG =E]559;3XS8Y'0!Y!E5>8_'JB
M9\C#KB/'VRE72A0H7Y3)6#&#3%HUO:&.9CG=T5>V+SZJRWOR'X<<4<+J+[.,
M_P LY!<=-GY?1XA079;<1TEKO:..Y+G6P<HR0=4J\5IJD2A(9"299AV!I<:C
M5L<LKEC<\>_T.@L-J\T6SD5@S5D*2Z%*E!A2CQ+,;HLF'"CO.971I]BQ0Q0(
M%6R4CS6'&-Z.'VQJQ2MG1E9W5I'IV8CE;R-4X<]>.4<UGLKD7VY]OSU^@<!.
M04"&24'+7%$"#SDU\TL$TP,\T3))@YIA9)AI919'.@DD&FE@>]CG0R21JUZ]
MOK^(J+^B]^WPOSW^4_<O]_7]ZY'Z76G3ITZ-&HA;;TIO/.]J0Y#BF\+C#-8Q
M5.O9'853W%U2V$V446S:2VS4N2RJ84D^QY!JT&UQ@>J0I(I+^V=9%QQ,AB(9
M@-VA?J'"D9*M-R=PX:'(<MN[A9KIUEDA -#."U,;I:<>? 00<==26:.F/^QQ
M"!7XKGPE"P-=%$-LYZ=&C6J%ND_JG50&47S>56MKC)'XF*M/0#8M3$TYF5 4
M]0'/!"/<:]J*ZK!LBH;T^"6.4*1;LNMG/+CHXIZ:*^':(YP9Q4-+RSD;^ K'
M)]'Z-QS) L1G<VSQG:F/Y?CU[N'(L?;3U-=CPTMWCH>1T-2;42CQVA60H-8#
MA4]'42ILFZ=&C6O$70W+&AS2MFQGDX^;"H0-P5UG5YX1?Y%D]R7G@5@/@=ZR
M<\1M;7V&M3*S$#JD"K'BJ"%-S6#TD@-"\I'8/9F<?^.U-;\F-J8TA6M\/E/V
MCM7(K]0,8'C!DG(*M;'),D963."!$? &MK<1C&GK TDIGNR'-6R>9_-WC5P)
MTU9[LY.9^#AN)0R_;:.GB@=<9CGN0R,\QL4P+$1%?:Y7D)3?SH#7P/C$&;*?
M93A5\$Y47DEY8;1Y-?5%O8-Q[_U-LO1/T\Z:WQP_C=QUS9M=26&R;H<=DT6W
MN1V-@6=PLADEM+*W7>$W4@5&.#[4]];9V#G'F*_!L,L\^R6MQFK+%BGL#(QT
MV>7P0H@T17.(8J_S/<C59'CLY-*D.& 3>Q$5,65+##'Y#.1.>48Q%;W(J)RK
M6-54[*B>Z\?9/=?;6W7*/Y2?PO7,K?'M&:,YD\K,0IIE!EW'HC4N(.U3:6GJ
M11>QQO(=I[,UD9?QL>Z5DED%5+6/DCC]D6;$1'+TG_E%VDOV$0/ GZD19DS'
MO4>?5?'^KCC2-6)(GO#^3,0TJ,61GYH7R-7S:O=._6G(J"<&M\((1'"U\4$L
M0XT: MB' ?',V*"%OJ#M:R&#Q;&Q1XT3LUBM;^7KKEV#G'P1QPI!*&C")Y#9
ME@@4<MI<#84('A-A=WD@9*_N]&HZ*-5555$6=$;X+L.  ([/+\F/-1H4D/AQ
MZR'',\CE1ZQP%C6+Q-:UKU:A)1U7A.515ZHG5R([E=TCA:U$Y;W<1RHGM]^J
M-1>/VZ\\<)QSSK:B'_*:-*W&=Y#K3'^ _/*SS;$ZNINLDH)JOC+7FT]9?>X6
ME)*=+R0E$1;!@I#XX&%.(;'$DKXFQR,<Z]8/Y1+@;9'167T[.?PTS6,D],"K
MXNVWY)/-&N58^3 _BBNBD:GPO]GNJ)Y-Z\O-%*56<^]_F!ERFB':"U9;Y)9U
MHY!#\5MPK:\!K\:84)'-$X,NA8N23Q6HL!:3DM*A'>#XS,FH<^;'ZD6VNFA4
MS!ZM\EZL,SG61PB0-*LB'HD"S.F$AB,)]9A)!+94GCA>CY$65K\+V&V[R?*=
MP,2E$W/KI."6KH[KXT:E#B]Q7R)TH$+Y7:DKB,E6$8,9S;@+D R+(&5C&N<Q
M1-7EY1SZ;"L/S9+O$YP,P-<QQ4$.R>;**<M(08SFNJA48^)#G>5A*V2TIF2&
M.7MXU:B/F%]13^4$9/LOCQ)HSC7QYYG<6MW\@-A8+I[ MV9M)HW'F87/>9,#
M+E9M7/@FW]CY2-=,P\*\B&,!H(EJWSH;]TKYXAYG:T.-MSDN2YSR=UOO7D5R
MHW!D6L=QT0V)99L/8Q&P+1<<RO0VL;*H4X_);&&8>RI#J$X$&SIX!"75QMM
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M]J) 498OMTY(S)8$E]Q#A"PO;M;<!_K5JF5\@%Q%;"ATAYHMG7R1P5I@]A-
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M:2THS"0\O,Q0BJ*]K!#,?4M2.Z@M2VO=7,#,AD2K/!M$%B97W D&%*')DHK
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MM7*<R-S^_P"57)*G$R?=%_)%;60X<\V5(525.&TU97BR5N/5F, 8]3U [9(
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M[==[JUJP"P-KZX>OJ<A-,D0,:&,4SU"")8H92R8H(8;1OFY@%=8FR001(L0
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M).KU61Q#$:B-57+\(G=4[RUR&JV%Q'RFEL;0G38!V4?=(@YZ7!LIO!5QH$$
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MR&:!S961YK.C%1OEXN5_9SOGX5JM5SL%L*BMQT!\8Q3+2UMDHYZD>.IG*\I
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M2! ]Q"=RK)FD@LKYN%W[I=P5U3CK2"H6N/=S N'&".PKK>Q)2$8-)TDEG+]
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M@C&1-'C#M9Y!T4"Q=!:&1C;.NH@KZPK;JY&2 BPA.I#2+:ML(37?G&QY_MC
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M"1SXE8V(&\&[F,_&>+'-E=N(US"MV9M7V-E;3($1T*)CT))$.?<L$Z=$;.?
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M->QT[X'O;$UR+(YB*B]8\*P7/!9[\@>A/L!:PAA]DY@$S)V26O>>2%K&++&
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MW1>%]D^_Y_V:X^,>D.0%QQBT?;4G-'/L2H[756#D5^*!:ITA9!4-<=1UR15
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MZKY+<TB FI6PIU7.&Z,Z9%E1"NM7QI7RXCI)!,ZC5]&W@\?%F5(*RH(67U;
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M5L_A?Q)-\L\W+S')XU96X;637AKL)^2PV,!_$M;/2(M=<Q) Q,C8ZV.Y\?\
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M4N.3HQ7-G=UE5#=Y(4831LN1*'[FX&<['![6.< L(!"87R5KY:Z1HI8L"H/
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M*LBYC!E>;-YI(<C, 1M31XK;:@N*V[L,LEV7CV=921;L/GQ^\QT_';""M'L
MZFVR*E?2FE R.6Z*:K[@BZ8<_(VQ3OU< ;!Y<^^?$#Q4JI9S&,[N)WW03/A&
M#?*B^@A560B2,=,Q&M\V1.>BS)&BO7OM)SSEURAEQ70>&Y7].:CGHDEQ8S%
MB.3>!'1WH-;1BTHE8>UF*Q*&(7%> $%PDR/AFF@A0J.>&&6.1F_AU?9XY;P]
MR=SS6,K A2%B53_,&13Y!9 ,X!A L0#EH-U/8OKR/"V2!\@KAQRN>'D*OS\6
M>.;9S8=1MWL1L^>3N&TSK/(TKL5RG'\FQ6I##BS(9I4&0*JCVGSZ.V<QY9,*
M:",&+)E"8"2]LHM(U[C9^U+JEU?6B8!16$]SCMO5+>E9=B%8&'@]SF^18\-'
M04^4 1W0\-OL7+C8_)3;*WO;B0JW(..&0B/GSZPVGHG/\HP8"RP5Z4E:-C@M
MU7X]*?2TP%T%CI5JU_X@6\JO7LB*#%"3A+*F,2F.J!QZ^>M!:U5C)O??/("2
M^>W%^!5!K>R&?:T]R$%R9K+II!X\SECG"&EQR*OK4#= 0G^+$$AE>Z)RN58X
M5;B_%+?G)L2AR5N,<6L?R L#',@RIEE)O>@(^UU,,?NIII 'XS/.?8"RE-@9
M&C939'^#8H8G,>B3@N<3V5RC,Z_*X_S;%[/$J2)>VN&5.,63)9*RP=*;5MMP
M/AS:<%9D"(T<.V!!C2T$V*,-E!*K),2$%%>YSB6&6$"\Q>LE8/F<R71QK+):
M0+HM?DM)+AI+F0[V(V/-FRZ%CW(^@?-F5[3RF'F4\Q$+%DP@O\K U%]7OB3O
MS:FU:[1V'X'29MG^-9^+7PV-,7E>O*/,L@AK,G"#FI+.JQ',%?28M9V(3,@D
MFJ9Y@*2JGE+^WA[^_P"29?2TV-H['MP?44Y,X;?8YMSD#&3BVF:_,@&P7K-2
M7!E9EV1;+=":]UO7D[+R%!AZ[[@,"?-CU&ZQ8Z>OR5JKYP-_;4M\\T[-LC)M
M&:!*JB<>M\>P+:]YMW%,O H,DL9R@8(E&N\$DJF3QW5;!!)39"ROJX9@D%/<
M$CWO;[-_Y*;R?-Y$_24U]BUV8.7D/&G8N>:(+=&K$G2A"(!SS#6S1,7P9$'C
MF<A4@"Q-;$H=-#&U/.*15@G&CY!%=*%D=%(H9JRCR6QI-@.R,\4\K[$+R2?5
M399WK$F17OEV,ATN<XJ37.,V0TQ7)WTA8(/+!V^ 9<N5T]]!BR@N;CUE0"@C
M@18U01@13Z^ICNCEL(%@V+%J(/RRJC@'6#D.)&>(>_'>>YL9T#K:WVAEX%Q9
M45-98S53AT3J..PD)RO)JG%:UZ3Y)=X[1""Q6-R+,>99W0 P@+)R'RJL:1NB
MX_ZBNBRL3I,KAQS89X>19_4Z_IZB*OP],G99VI! L=M=8[-FL-OAE8&0*1ZB
MY@/CUS*.V*QK:PVO('+DGP4(*; \4T8<L:7Q]0<J&,B"3Q<CV^<4K7QO\7M:
M]ODU>SFHY.RHB]=.6DI9_/UZBLF]65)Y/5 %D]2=J1(V9_G$OG*U(8421W=Z
M)%&B.1&-[96F4U  SZG7%*LK[*QBR3-;40*2:$)!<&O_ "MI [3':6RCKC#H
M0AWR5MEDX,90AY UA[4>QM!H2JP12EN?_",\8R*C(+&HO<LN3\>UU8[2FQR#
M"[VKNCL2KCA:^0T%V2P4=0B2SG!RQSG6H0$0!#+(LT:O;(0R;"T=*OZT]6OY
M5;\UXB_E5T;U;\P_HKX87*GZ*Z*)R_,;%2DK@N$NR#\6+B&,+E'V.7&/Q$M#
M5K>?AN8A"YJ#[JHOOOLTI34(DK/7]E),B2/A5Z(J&C40#^?6N0,DLJ:35^\O
ML%*9K@2YV.3AU'3ZYK5V3K6IVP')+D=]EM5[F7&<.N1"LOK*\,VZJ"$F@AK#
M6-CFEOS4W,356Z"]/AX8)E7K[GP?,<ZHA[<*EK['&PL$NFXYDM5FM&M_->TE
MM7WZ3TSUAK3ZE;,:4-+7UO!KI2/"#D8Z-XHSXWN1SXWP1.8]S8D@:Y[7,5KE
M; UL+55%5(FMC1?!$;U\I7@-(86T(1"HVS,C)0:%"&-(?ZD[63(SU&MF?^>5
MK7(DCOS/15^>C1KM].G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:M+/<#PO:.
M%93KG8^+46;X%F]%9XQE^(Y-7#6^/Y'C]P+(%:5%O6F1RC& FBS20S0RL5%:
M[NG9R-<GABYG\6)OI;<I1]-*28G#7D'/:7_$O(KLIA2:\RZ*:4_-N-=I;%VQ
M-B0%3QF#W6LR+0,=Q>/$RX_&:>=4/Z]Y74?N3W%[2/,/368:'W_A%;F^O\RK
M2 B8"H88[BA.?$]@638A=K%(=C&64LSFF4F0U3X+"O+C8^.16+)')H\BH8>1
MU9ZR8G5"</ =&M<2*=JHHSCY3GE%3A[45$(-7,54Y14=79K=O(MELZK,UQYR
MF]/VBW%00Y0P[VG.J)+K)OC5>6O1&FC%<PGI9HH\I!D42C?X@I7-C)@,&:7$
ML(L-=*.\"PFA;6QD$EI&(C8O =\)!94\,;7>@]Y)*2QI)-ZT>UL/</%S N-.
M;:SUYL$ZUN,DP?)T20[$\WBL+_*+[&W@ODE?-C458#[AS1PX8$(C##@CBC<1
M*YLI4NF"MP[=7%W=NS.'G)RCS2ESS!S<LSO5V79O9X_D46Q>.A><VV.Z\R^+
M-J244?(CXX@7 7)YU#CA3CQS89:]A%>;VR!$<()(KQ)?=!2J^:</MXD LDE5
M_OQAWQMF(KR/)\SE8CHT8Q)PUFC<Z/IAZ3*K_:RTR.$RHJ)UG.ANJ'6MH&;(
ME!KC!4?:M,.9&\8YHWA([SC*_B.%B*C!HCNSEU@6V_Q=81MGE@<NR^AQ&OM6
MY:/%<;F4$&&?) 20D,+*:^34W'JI=/.'8!(V'*CA:2?/.U"%/ZE:RT^)K6M6
M,ONB(G?V!R=^W[^WME[=_P!?U_?UQ_<61E@EQ0&+*&:-(JJ":G[%SW#EHB>@
MUSOZF00J(BHJN\%1LBM2-:FUS5:UR+^56HJ?';X_N3^'RB=OGY^.B^*]^_BO
MPJ+W[+\?O1?[OXIT@\3R:?AF58]EU.Q&6V,7M7?URD<YX%G5$^/81FG&-1$?
M'>8#6F&PPWO$YS&E8J]TE%EV)P<XQ+),,NCO)3Y30VV/67A&%LAL*W@'KY!(
MSB-*-DH(Y#B1B$$5@SM8]PWHWJMUQY?22+*ULIGE#(D4J)663O"18HYT:JM$
M5O=8IHW_ *]^S^R_/7R3D./&#SB%LF*$*AD')&(I[": @>9BQS0S12!/CEBE
MC<YDD<C7,D8Y6O:K55.K)$1/<62HG;^N1I\(G;_N<!_#X^.R)_=\)_#KO]3[
M+_2=;Z)V$_#MIGHK4:]'4>7HCD<U.R*U<Y7E%15147V5/V7VY]A_HN=B2,:3
M^-MW$57.XZW6&>W5ZHGO_ GW1$^_M[^_"<\) F^J;+AM=DY1KL6]ROBM9%S&
M99KN "T+NM"DGSOFL<JUZ-(.DUGKF69[2+W#(4)-Q^60JXI&N 0L2//6V\RD
MR'C?LO.-4Y9 A).H\RR?",OHY(+"%I8V*V-E3V(,BQD02N0B*%T2.8KVR)V<
MQDC'-;GB2**9CXY8XY&2,='(R1C7L>QR*US'M<BHYKFJJ*U>Z*BJB_"KUKYS
M[7F1<89<KRS7%3;91QPS1EH_;FG*..0JSUNRXBFCO-C:DK6-F_Q:R,DD[*,&
M#':-XQ_<J=K96R01P^S3/&[M9D?+;&EH\:OY1H+TK:!MD+'YC(0@1Q0XT:ZM
M;@T K  $*+&9-;6J$;(<>-#1HVOD+C6V4KX=MO)&%X_=Y+E.VOH+H!9=JZ 7
M+,&-:^J*2WBR:&KITL<<9+EEF6(A1/G%,=QK6,:9#=)#!L#5?%>_VQ@NC-@V
M&_\ ;-K@F64VMME[(UGGF0)G@N2W]2M=EE;'37ZR@S8Q7NO6^M9 BP%M*@B'
M&?Z$HR.;LSL4F2*"!DSV-G)B@D=#XQ2I"YKEE5DJHY8WJB*Y9&(DB,16QN9(
MJ2-B+]/ZYDNN)FII&^O(!6#9/CM$9.(\!]KC6-YGD%%C-JHDR,EA6PH0*\E[
M)8XY'322R.8GG\R\M(F3L"8JR,8I35>L4CX9.[FSM;VDC5KT7S<SR5J_+>Z+
MW1>W2(R*5.+;2X4L[",KIT\$=C1!&K&^H<U'O\8QN(1&#$USS=RH,0Q.=U$U
MC7$V@HJ"#M_C^24T(XIN98IBEK:GD65A8*<I*>-):,+IDF4.'$4\V=*9&KV@
MA.E6$^<P/FG2"E[8P8XC58/%'$CNRO5B*CY'(B(CI7JJND?V_61ZN>JJJJY>
MNSV3^'\$_P"#].J/(^Q!C5RI'801-<Y>[G0&-B;W<JIXI)$5(R-/GLP7U%3X
M1%557OPEC3-8L<T;O4:CF)YM5RHY/)/CNJ]^WRJ+\I^_].DTX;U3MV\B.7A5
M:JK[\<^_LG^7V1$73OB()O D8H%:WV&]J,X3V3AG"JQR<^R]'*B+QS]TU]D?
MZ1-_\V__ .Q7KCJU1L54]RHU&M#<JN5$1$1T"JJN7X1$1.ZJOPB=U_1.N0C_
M $B;_P";?_\ 8KUUA$10!.Z(Y$$B<J*G=/B)BI\?/RB]E3X[HORG5R.[QN:]
M45>A&O5OV5>J*[KS^7;CCGA>.>>%XXU;E#\ZJ+MU\L8[$=QSQW4:(O'*=N.>
M>O*=OMV;SRF^RK,%.JP"PB8"Q9Q85B(&FB(@E:D?@JQS0N?&]&O:YJJURHCF
MJU5[HJ)YA>,C378MLU8)QHXOZ2')%&MD%DE?W3<^8HJN>TJ)OROZ(D:=D[)W
M54[KZ(..T<<>D\":QJ,1:R=Z-1$[>3[,][W?"?"N<YSW?/;NOPB(G;KSN\:I
M718ALWP[+(G)#DBK45ZM;W7=68-3R[+W5%1_=>R+V1/+NBMZEON^^5=X3C+X
MP425;6E.0,='-5J&GP)#FA\I.C4:CRM9Y'JQB>SWJQO+FP&V>])CV\TKULA_
MI*/"]P1GEM:42K'K;O#VE.H@N*3A1@<;PL4S_NUB$=PCI&3#V4L;XT,#:KFN
M:CT"F1S%<U41[50_X<WOW3^_JZ:C.\X#-C]3*;LAU82%-$QUO<-&F2%63I#/
M"ZPE\HW>GZ;D:]$5CNWBBIW7^+C-KV^#@OU_? 2O9.Z=_P#WPQ55$[JB=T1>
MR)W1/GJW#@+.F,8LZ#EML%D]-8'O@1DHS&KZ2.G5R.=)&Y[T:G9$;#*BHJ,[
MMT64_"Q\2>U^-6>:9'A$VBHZ5@95C.AY'B\QT4:2HP!2#Q*B\EGD!822U5Z@
M.T(TD&,T0!D>KGXW\5WPP;J952X5C^;1\BO[PA8-9!G8SF$-LMSXDHSXP)ES
M0PXX#N0' VO. AC. &.XD@HF+,5W.#-P;.N@.P#'CJP[W8Y$M>6? 0/.H<[@
M>[IR2&>W0AK93/ZG)YB1$1L=#-)$],T83D>^N3.LLOQO':G!ZS%4LP@;8=;
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M5DDM!5P=MZC.(%1CRRYA&///$<%VEP:_F'GI52HA@#AC!,6RX5\ MIUH%]E
M .F,OL\M7!<,.O=G 4D6)I63R8N#!(=E!E84VOR"V.GGI[:R,C"K0;HH:Z-0
M%]$7:.KJNP^3-*B6F;LIM<5FQH:*<?"BP!;8NG)?3G6QV%QY13L#KQQ(KJ#
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M& DPF>-\L4+5T"XQL[^4C<E,LE,V/],WZ<F ZPOH[#%3<<Y#98_)+"LIQC"
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M,NZ,Q?'+#+&KF2Q2,5',D8Y6/:J.:JHJ*O87X.ZM'YA#:8*&C"P"0,,A\9I
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MGH?D-B#)9>.!I#17JLDLL4&%)DVBR@]!Q_%/JWPS!:9"'1SA+K6R[7];A=(
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M[+W7KDCO3\8639KNC/RC!EF4^(R!P8T.BOHM;+D$;%C1XQI9R":8L8LQ0J5
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M2!V\9=LD8]%9LR2TJK22NQ]U6RH=%753P/LX MY7VU+,?$#!3G%W<M=#>2C
MSA#WU.$\@&2#VZ^3^S=79WKH'-J^"BXO;.R;8&,9WG3\BL\: UCEFVLVI<AJ
M\HR<BALQZX+!_O%;# N0V09YN)A2VHU<4'5W)U?;S+V;IO)M/8WC$QMOCI%?
M;F1PT\5>(67-22CM?8(A94DD$4M4&&R1LUC&,/&Z.6(!\K92X"2L)7GVF:&?
M%\BC/O*(H><.T6=LCP"Z6<)X!8!@,#8A[)B22(EBT<.5CXIFL=$QSEB9(7.=
MH=B,LPQN:"R,&"0HO>K)D=3/96XVV\MI@JIOST=L%TF0);60P89IG5[U$<)#
MR&"4G##XS SG'\KE8;!V^#E>02AQ;.!1VU0>[MP0*,1+]5@1JR6UA/65(#,M
M(G26IHK2":,$I@2LE#M6HPBDJ=;5>H<ZDVO#D>'RW*9%A&<3V9A-SD5I83ML
M\69#-=4U^VU*L$(EK<EKK?\ $ TL0ID\PQ3 4PO5[AS;",OJO:U'VG(L=R,\
MHLK(P 2KJ68"AR[&8:S(620#G1785;EMK"DK!ZPN?VXQYLBE50(XVN[@[RAA
MX68UL+'LJ2[KKGB8;G68U]=; 2-?DO&FQRVV*Q4[&R@H"!KT.RJ2DJ3GQ1P$
M@D0UD!$4),44H\J]S?4FTG]2>\U-B_#'"MP;WW8=BI2FZ%P;6F10YMCURZV!
M*6?*\KR&LJ=>U^)5LS06$Y@S+H*NNDF\G'-(GAC'AWOQB%94X=B%WM?E,Z+(
MLJ>'82JJIL5MXEY9CM'4\J2CE(0<630N/*!Y0RCQIC FE$B0I3Y1G/I\-V28
M169Q,P;?W;7$)M08EGZW*\K0F,VV*&J(ECD*5T^I"(;#Q;:4$5< 7H8<Y22@
MP72K,38-"?J<M>9&M="<> Z.GUOAE)D-)CM%+28\?GV04W\X>5:XMLGO\%2,
MD>Z%R8\V"ZRJPR FOLBKL.\R>"A9/"D-<*._UF?2(T.1KGASIS;.P<7%I=_;
M_P!;85L[;"/HEI2\=/R>@K[4+!*X$Z!+FCJ,=!F$A)HRR9$9>_<BO2'22(4;
M6-]*#Z"L&O2L9YA_4W%HM[<QS!Z.WP_6UR%CUSK'C"ZHNA\DI!L9'KD.J[[9
M-=9!@&'9>.<16U944@%$A36SW-AZANFDI(EN "&OK%ME:%$$92#"($< PA$%
MH8XQ#$U6O\+32"J-KSRGF,]%5R+I"[N9=@60WA(6UN(DPS!H,F82##D2C2;.
MV-(E2)"65NXLF8K"@')? KH;)DD%?6##'$_NZ0\KITZ=;O31Z=.G3HT:=.G3
MHT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=
M.G3HT:=.G3O_ .O9>C1ITZ=.C1IU\O8R1CHY&M>Q[58]CVHYCV.14<QS7(K7
M-<U5:YJHJ*BJB]?73HT:U;\G?HU_3\Y265AE]_I,/4>V3T=([=W'$^;1FU7F
M*U4C.M[_  1E<#F$T2JW]CG-1DX<K&-AF&DA3PZTI[P^B)SVT>R2YXU[FP'F
M=A@$\A<&N-T#!Z.W<,&V*2)E?5[.H(KG6V:F,C?ZD<F18O@3B9/*&<]'/2=/
M7ITZU%K04UV-1VE=&E\MZH5[.LAB?H.0-6''_8PB)^J+IQ\!W=W+VODI)P3,
MKO'D\GE+"C2?-527\\JLNGF-D5<M57\Y$0BIRO"HJJNOSSLVV=:Z0R(;">5>
MI]K\3<P*G:('#O?$#,7PF_*5_I*F';9A4W6&7CNG_90S4V532R/=&QX\4CT9
MUDP*Q"LAX2Z\F X(F)LPQH<\)0A$3OELD)$$DD<K'?JU[%<QR?HY57MU[N\T
MP7"=D8[98AL+#\7SO%+@>42VQG,:&JR6@LQ9F+',.=47(IM>7#(Q5:Z.<=[7
M(O94ZT@;X_D^7$3+C;/+^*F4[&X.["/=(5*FG[1V3::LSG)^5UUH+/2+C !A
M'N1J$0X-%@Q$J>4J%L*>XA6ENMF(A/(6AL7QWKV5D6Q13 155.$;)"UIAM:G
M/"O$=?LJ\\<+/[;3^DFO(:QX.Z^'1K<"*QA;_$%; L48WA'$-26!W0)9G^ZN
M6/8U8D7V:%$5.N@YSV,3NYS6_KV[JB=^WZ]NZI^G[_X?OZIHZ,D/,7LQZ(.&
MG?LUR(OD4O;O\_/S\_W=NI)[!^E;]5O3^1RU4.I-*<O\<E8YE#L#5&R:S4MO
M&/$]?&/,=?;;'A'I;6;YE=)BV6Y562(K6MD%5'0MLT7@E]5YA$[H/I]K DS(
M6IZW);1D$2>BDO=7*/92KY.\T:U/33OV^5_1>F])MEF('%$VI4RHB)Y@RX3A
M/3E%Y&KY W\?;_;&#<G/VYY1)B0/C8^'"SC0IQ-P@UC7O4CX5C1Y(.PC?@E:
MHY 8]/*!W1[FHJQY,@3O91%=[ZQ>L;.RJC&=T^?[#?\ 6_/\%^?CX^/UZP]]
M,JT&K-;45V:]@P0G(;<%@5(Y)',@&AW/D,DSW^FV216Q1Q.<JLC>O;X\5_?,
M!>"GU9NR]^ H?9$551O)_2[G*G955&HA3.[G)\-17M3NJ=_COUBWCG].3ZL^
MC=;OP6QX#/R F3-=@94IX/)+1XHZ09EF5SDPX?I$7;Y%F"'LHQII.Z,EEC?)
M&B,5J=3+^"4-?MYFF=FW*ENQBFR/ )^. GO_ *VYTB=,B(]@F0$G*TK (0K'
M&&T:^-45>>&N@C\>F^^W.Z-9M,;:W)HN5S\2RJRNK",.!;06 8@*Q\)3.M8-
M=Y!F+'(-S8[B/:B<N1J*U5^=U\P.*M=MS8@%AR*TU7GA9,8&?7V>Q<5K+&O/
M&9%": > ?:#EAF!DLD'(&)AAFBEC<U\3'(K4CQ=<ON*\UI++#R+TI+$\05J2
M1[,Q%S%<V0A59YQVSD56HY/-J+W3].W947KU.?1AX0;"X_<9MKU7+;16#8EM
M+97+'>FY0\;LY<'V18T^&9\7CT^/!&Y-4165?+/&X _N,,4YD3%9*L<3YW1M
MVZ?S.:B_VJ]<?\A\8_?^O_@OIU]Z-WI6Z.V;MFWP(43&ZV73@KL@B$D$LI</
M&"-'722!.UD='SA &8[4$-&*16L1O'&H:[/;JVNT6[+]WZZK@VEP=;\A*B:\
MXJYK\C&9LIB/ ]9*-C^H<H?Q5558U'N5%77YI>(<X,MV_FN=4^B-+8OM"NP"
M_N\;6PBY!X/C]G> C$5RPY778T50F6/X8L5CC2OMHI# ")720,-=-#(Q,X1;
M'YAD0Q30\,ZQ\<S(Y6=^2^"M7PD:CV*YKL7[M56JU53]6]^R]E^.O7%]4CZ3
M51R\Q37VQ^,(.HM+<M-)Y!/;8-F-MBS*+%-AXA;5A=/E>H]HV>&T\]^_%+D,
MIEC2V45?<DXMD0 I]<"UA5@LGFXUQGU\F49MHG<.)R:EY)Z4/3&MLZBM; 8P
MRK(@;$@&68L?$YK<IUWE(D@]GBN5"QI":$1'$3&.4U['(;X</AOVDW(RN^QO
M.WRX[&557)Q5*RZ/53ITH;YC+P$CU*SH\EPA-@R0,CBCD\93]1D0#W)(?,_C
MSWE9B]-88IF$ZHRDE]?ID]=,QS";2C93O'6&QPU&]^("FQE:0EC FAL+"Q+U
MA1I/GYE*UD7DV%S&>;Y)PTJE= ,L;V?TE\#^$FF\V.\EQ;]WMWHJ)W_5%=\]
M^NK:[-Y?Q02"S\-JR%2XG0)*G)3!9(HE)7VD<D[FXMVBC]:9C/-_9B.5/)S6
MHKDV!1=ONAG\/95RI\]OE9K-%7M^_NB)\_O1/X=?+FQ3V,T4C62L^WQ(^-Z(
MYOC*1.BHYCNZ*CO2[+W147Q\5_1>IG?ZW=\/*(G469,=YO&U790CD56+V;]/
MRUO*+UX_F1>%5?[6F_UP#XI5:]CMP(*L(C^R)A6$>_?CM_\ M[\T_N_+6LW-
M*;E=NC)=,TE_QNJ-;T6"[VU7M&_RB7>.)9>@]+B%U.8;!%1UM+6F&$3PK+Z+
M("?/SB:Q6+ZOFR?)646+QQX_;A-]P5#'W52'>/A(LO=$]1$=W])&]D1/[7DG
MPU46K-K):J7VHP4)K)GRJ,Q;2P@+C$29\RQKZB$0K"$V=81VN('C[K! BQMD
M\F=4.FJ)WP0'UWVAXRVEF^2TFE6-X%<*<:0Z%P))SYIDA;'&,%$Q3B2GCCC#
MR23-[YEC\.V7[4X:.A^'#<ENUL3YM9WV8S<NCQ,H'+"M?$B@''/-QR8"*V.V
M.22YR((CV?XRHGC36T7Q!X9GV:7&8_%1A=EO%8R:.II,>^1RA8>ZM2!,DF>X
MX<=F8_',AA2G":KV%=V1'.3E&N3..EMT6VOB<F*BHZVR6P'K1ECD+*%;&@WO
MYD=Y)&1ZGFI"M5JHU&HU'(KE<O:PLBM[')+DVX5 1)<BNK#(WP)&1.@JG6GW
M=PC9/4B65&*6D"3>G'W:WU5C145O7=%U^,GWB6O-K9&!Y)CF"V8XY%^A%;FF
M15-=>TN/'02 ,DCL3J+(Z2U1&M?$.#8"2E2C^M$U]JWN&0UTE+!:["PQU@R&
M:. 2?,L.)C&&BR>NP^RF]*E24Z>(:^4:I**A4EE60]&6DH2>Z5FYI<YQS;C#
M+#,;7)\7W-W?#C;R9=84F4U]&[+BTY%*,$2L.T42)-?6U_IH,2NH?++EQPQ2
M()TH)"(FYL*/<G.H>(4TN1M9L^?)6IBM??17W+,,CVSF"+(L;%#EG28K)T@Y
MYLB?=F9%AG>9B/0'B;3+&G/LC2BGEA0J)!!"C4#GD]1&I*2KW+[R-&(J3^FO
MY'>*-1_?NY43^326%144\2*'-YR#-3NR8=6K%&\Q55/.5455A]/MW_+W5ZJO
MCXKW*JBF FR99LEQYE92U)-Q>RUF6XC<-KJT5T,9=V0.$6?91UT0CHI7DL&]
M%L"QS-9^T[NY[7$<@>RGJR\KH&%3Y!7T-*0Z@R.8JUL;"EK;@1L(@X<'N(R\
M:OJF^BL(!(*N8"U!)AD05"Y1DC"S+!;S;[.-[MLHL+;C??=+%Y@7)D>312V8
M;G'9HJ."V?77LTM'%C@6'%='*ZEAI*B%BG-$<XR,TMK>R=B^X> [(;K9K6[E
M[!;791&F#-B4<1*B10Y")E[;DK[7'&"OI9CNLRBF!';S'Q98Y$<!T0+G:S+H
M+;-;KZZ)R7((YBZVSK9*RS8''%(54303LG8@0\DL7NF.(B2$AJSO(,8X8@97
M>C'!+:.9R8;G.UK#,'!7-)C9>55UC;58JC/N9Z]6Q074@[Y&$""2W DA1L,8
MT<J#6$[G33&.8\=G3U_KZFMG7)%KE^%XW78+!@%QF>2,?:6YU*!ME1X,'^\4
M*5@5W'<9(XJ-T=8L4<-/$V*2S-K8(TAZPQD3H6FO(K<B$R]9#+8(:WQDV:>G
MN0\?R.ZQ:UB"(:@4$U2VXH[2 4I&H"<X: P<L^$F*>=!;R;K;(8I4T^2[E4(
MMU\VRS%8>.90'$GPI^+0;!E8R%;V09-NUBU\HTL!05[6,<58<<G884<97K?8
M3&]QMVLCR/ -EMQ8VV>-8E=S,LQ@EY*GP<REU)+=ZU41C:%IAV:UPB1Y5D%3
M>&/8&BO7U"NC"#-SDSHK4U!C46<:(R^C(J*!**OSVD@OVWEI!)D39GTM\A1A
MLT@Y!<3H!C0'"JD<#(#8QADB(ZAE@.LWYAF%-2T_VNM!R$@L7[C>HY:Q;21D
MID)4!*#DF.FL'QD#R.A8\0\X@9&/]Q*Y[NS2Q3PQP722((*USQVUS&JXLQK7
M+#/!+"Q5;'/ K%>**.DY#I(NSI&MDEB6Y8%FG?8QNEDJPABT>QJJQAJRR0#F
MNGB(1[VA1J1)ZH[H5]W'.DKXB!WQQHU$[9?!-C6[&/Q=Q<N@6>WDO):J4:KP
M:F-5K4((X%+CF12)T1Y#^CG5R1SRZH8JJ0Z0QYF/"(B^1S,G^,G<#8>7*VBH
M,PK]ZF8E>@;+W3R>!;!R5_10KE&+.C6131Y,F+=LLX\6\G%MFK!DQXA1RWPA
M'9R;>TQ:Z:OVT\]I5F+?XW!;,F JIQA4GC*LZZ<2*5\T2&R0LB#G?)Z$4D+3
M86R-\9(%=C/'8L<*LJQ[J6"P>75QP@2+6#MA<]K?>.>LYL<4;G*/$KA7-61?
M'W",5GGVDS+F>;9?L/%,9K<COG''4X _V!5K*J0ISHPXAI9BS'C+;DB6$44$
M]DTZU>GJ+%+)*I\0\G4?X%L:P*MA*>R2.M-!@)6!9ABJEHY40KWO?$0B3B1C
M>M"^2.(=[@5?),R>)Q+NF4M-E<C^%;?3:7,[RKQZXPB_RJMK!L22ME @CL8H
MJ:V@6KK0$9HK"/ LS6U6>2X\)'#:7NYL,@]20I]\<=^+'8'=W!Z:SR.ISNAQ
M.TO"O]&"!-L'P)RW]1+K!U!)+G5\BPBLI[2+! *8T1&\QQK*$YU?X"8[QFO=
M,\IN,.V1Q\$Y.89NK8VT@'Y3Y R6&&[!SW*,OU7DVN+FL=)-+C%H'*1CF4+6
M>,XEFZ82S@E\Z^!LF\FU-:85K_';:\()H[:RRGVH&/F,%G?'CU=7O->=-)$Y
M71.@MA1X5]21WJB60C_-KU:UVL/:V/9KKGEAI3D-BX%YD&%9O4V&C=QQQUSK
M8#%\*,NR3M>YNMBT8RR IX<R*F'N;!CI '0N'C,,'A1STW;[MI,B$T=AU)<T
M>)YEE=<=/C]%; W,A,P\E5*0$5!4UK@0I[\X $&"GR$,?WGM#()##Q7S012-
MFC+OL<^'^WF$BSXE?7$S(L_,8];41"9#9XJ-AK6IF-D0&*6PJC)=RA63"C)(
M^9Q)20FA.22S7,;;?%[S=Z'?55G9V-O9Q:B-#P=F1Y"\6.5%Q+=7598@4G&:
MVOFOBUE9#@/$445HQ1A3&N8..YL#+40&P^]31/M2R'CQ5K2\9L&U941)X<H;
MD%,1Y XMF@QT'HGO@DD#;(-*R2%8(9(\%<AN5E'QZQ,C#<9Q?,MF[@WS2VVF
M-;X7FF<'S9-EUOF.30V^7W\F1#XT]<?9BH>:2F0S3"#U\$!?VJ0>86$:$"8V
M&Z<W)F1%Z?28B]!1I\74ZK+66NL%L[8^"JK2*IEG*,VQ5\ S/N($,<""BAJ9
M'WE65I,)Z3'&[2^HKRVV/ENHLL.Q/CSB.&\7=%$VT)]!CX.R,5B&BVUDN(4E
MZP@IEX?=@-]G<5=I4O)$NH8SD(GM'(!<RW(ME=UF5$_ <<C7MKEMU<09=]!B
MVV-3*^* _%YE<RM,^F)9ROE@C/!:7 WH1\ ;3%D!COBJB,GQO.,2R<6%Y_;L
MB3\>I(;!QY5_"R.OIZ\D);6KHXTNIE6T.,)[IC/!7PBM0))J$>,/E5Z;1-):
M%R3D5A-C:5-N/JZ>MO:XG(:/#+<NFHQ+\G",=IKNIHQQL:<5!6I%3^_83;3F
MV\%O=V%T(0+(E%]HR!=:IR'2M/!N^MW8X/(Z(NO6YQF+(),AGR1AYPE.90RS
M%2T4E5  >L3K&2<3) ;6N8>IU/\ >4 O0.GQ'SJOPX_,*&_KX" +2DL[P0,R
M]K2&C6.*BAE7[IG6Y+B1C J@D(DV&)RQ!B0J0=[:+M-+@Y^H+"75&5[63)Z,
M:[QNTK$_ :R)-DD<A=T/CLTE@._QD%!+"AMC195$DFE=6'-B;$X66>-,6VU.
MR>-9;E.0W%M#J,7PV?16JCAOM<A'*"2')L'Q^(AS37'<*JLFG1/4F\WF8UK5
M5K%UM79;CW[J+%H*N*W+)\;$Z$1"QHBV!K"?6P4KGGD2XX8L19)X$>0^8V/#
M:%H54JC!W'B\?*,1*B!#-2?(9G.R^G8IF5-MS(ZN^K\K!LB80X*U1IK![[0<
M@(\^NL8 9*ZEG&";9UP-G!WN"NQ'[[W[M^!N*60T]%RQN1GVTEX)-=#X_KP"
MJR .NBFCH:*>DHX9#R,<6&-2K!] >0) 2Q]B2DN+\98?-+"<K XW@R,&D'19
MG>3S5D#D7U47Y;"]JN9^1?51414C_=@WAAFY>K]O\M[^H.J*[)L4Y27-[6/L
M'B,&[7VO,,+D83[F&9S:XR,PD<J3T7RLAEF?"K"(V/;N<%J,2W"V_H-P9&#4
M&#NR%,QJZ"<V^L31K/':VEDAQZQFSS3A/8^2>I.U(5BUDF/X M(%0]AE6F]N
MWZ[;9U:[8XUD%OELJHKJ<UP!U02(6#E4J+Y[*K'"#Z@4ME<$X6BL(I90C,,1
MS3HG+&[U]^9AM@'>H-ECNO[VR!Q/'(:=S0,=M[2"^JKIP=K9=[8&M-2)D)L$
M48DX\;'#F@O83$1$LT,L6-OZ3V1LFFS+>=MA E/7.4.6 :ZL88;VI@HB*^J$
M@>*2"#9P1L.B=.L"AHZ5D\A'A-[E_EL'@W5<[9UIE67:3QJXR&ZN"Y\-"]1@
M]-)C;18"'/N"B;6:O8\A1[&*TK@PGD2P3F!1'.@<PB&#&FH-9;;R+#,ZT;M#
M[IB..OJ:^XI[*) #+60RUR \\B)QL,APUJ(TVM=-8BSG0&PQSPP/5P]@R4?,
MHIN'WN*BOV5>$R8DB!'Q:TDOF+8662XO<.4-Q-KZ])JB;(4<AO2?' AVB><0
M2(",0>FV!F>XVWJ1\0-,M<7DXAD\:Y;230$B6%-D%:9KT\L8HQS!**1P8T W
M,5YU=(?'(I/(2-6D-:<FL#Q*NS/7ASJ^FV5<5(#:ZOM@[(<60B2.N#NKH"<4
MJO":\MCJ\BTB9*>/##!%/^QD@C2%G+3C?IM.6&DM;[+SO,KO;.*8[4<GW5&*
MSUF*1C'7N>E8/:6L68G6./BF5,\@^1)+1#PH8]D,$9M39AVDI=+)V]&Y:Z\L
MS,/PN3<UIB&*Y;?5U(118W>K6%!#6%H@QP<8P90L4,DZM(8Z$J2-'/\ ))W]
MT<NI?8&0G9CS[T@9='W@.7MX][5DM[L\U_W;*O7R['UK\;16V'J%MJ+$NVR&
M05OI$"+.00Y&Q/>O4?,"E[<9Q>XEM/%J;/$V[>Y0@< O+:O@564Y(R1D#HI2
MUEDJ>&SGUT$K;)S)D HDK0N<YKY+ANU*W=C&MZ*FDR_>F3GV!9+6[PP*(FYM
M/MK++8,IXL^-76M!#RV.6)S2"2?&%$ D6>AB6H3A80C%<Y=A@%30#U>)G6(8
MA>4V6*[86XK:S.0AG561XSZ(6JL6H[HNL.:^'+YRCV9!96E.<M(7'"L<,\$"
M2V-VE:FL*_-3<=IM1+=V#!@#X*NJV]77UZD,%J8/:SV4%/C=N;06(*1PR7%"
M:*?*II0;OM[)F*/%A+&:@DK,:$Z":>!*VZKRR!E/M99*LM31#B8(Y7VS6$&%
M3P#3+"YK1A84CE<[Q?%$^6_+:N/QS=--L'$D)Q$3)H)R9IW63G6,%Y&JK:V<
M<0=G)/7H<7-5L@G!.&:DC9TD'B:Y?5?.SJ]R86ZJX[>7VX"U-G80X&UULUV'
M7]L\JUP8]_D4U_D]304,;H0,TPH,*V6#V\T"9VD,1FV8U3S-OXUIB&3 ]4''
M+JWW7CS_ )_5X[#EPK6,7#<2"J4X0V]W9B[%A-679U3K0;$;/K',[DLRRODR
M#)**DV/ Y]7KZ7% J2.PO@+[$<@H+&YK0\F$+6L#IK"=H-&.1+"0<.8386X[
M,<2K&,KC&S8K,"%N+BJM;FBQG#Q;9*Y+AM=<W;Z3&[HW(@I<[96BN.(J5Q^L
MQHH*RAGBM2W279?L(+"S%K9GND)16=-R)QH#!8:(:#.**EGLHLG/MWW)-F12
M,)G<&?9$0A6J_<+VR]XV>)Y<@CI7FL@_8(WK'N1;3 J^-&>Z1R<"RH<ZK[*Q
MDU]L0RFK'R8CE9LC6SS6%1=6(4QD-?(,HIL;F2BGU4D[I_?/@:\FO(<5KRX#
MEE/F-KDH4QZJL79ECJ/QSY8+&)4JSR"-EK::#!B0;'PR$@$/'C2 %*Z&T)I,
M.1)B')[!#FU7G&WN5899V63VM_;5%?09!13;.JN'7J,B5<K'XUE8+YJ^4$1O
M1QY$EA8[X9G%>(X!2PI!"ZTMQ,Y \F6:@LKTJPWQL?#MAZ7P30>M<LJ,KR.\
MUGE;;S-*:;(X"Y 7@W_A5XU7,2],CQ:O>VXS@0VDPLBLMA?77]*;Z1W%;Z7&
MJ7@:6PBP'VQL6DI9]O['RZU=?YI>G0^K8QXRTQ)7UE1CF.%'3 @55! ,(6HL
M5C9265D^0Y_FH_DNFJ<MY!<^.;7.S*8I[O7NI,?L..6E\BN:P$*1YN79A%=W
MC,=/H<3K*')0Z"@PR&N6RGNIKVEJ\EK!"1BTNB"XO=UU!@4(%8)E;$ECF08+
MC"A&CB?%A."2062XD&"\IU@Q3F,4XXWD(\32(,A'JQ%2]N+E4S+LMN;:62T(
MXLQ&-=>28\V[=Z.'#JF/N+"(T<:QM/2UL04ZP ( II@NE,CA4SF:=.G3JYI#
M:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:=.G3HT:U]5
MNP+/(=A9[?9AR3FU'98+OQFMZ#4\_P""TH;G%(2*."D$M*"W#9E%Q<;('LIC
M:K) K<>&N8;!("(1!5$>I99G.[-!:C(\@CPG C13<+WEE&%X]6Y78GY?BQ.E
M"_9O"V[5M!@CIH\IE<R.%P$@[Z6Q5E1+]SEG84S8>9@F$6.1@YA88=BIV75D
M:0UV4F8]4$Y'7PHCT](&[G#DLQ(NTDB>G 5&WM(].WYG=^O_ #=:^]SD1GX%
MPWW>80.%RTK\,4GN<I&<CFN'R*?V/JW<#D>]'16;BHU1[D5O9R]4M1R#8Q5]
MVB>Q51.54J@$)#*KN7*YQ1ND.:J]&N>K6L<KB$)ZY45[G(GLI6/1%54X$A2$
M4/#5:WJUCVA:[CN]@T5SD^EK((W7,?;.);CP[4F0:QQ(\DB/7[LVM:C)XJD-
MKMFVI\-,W#W979515HZBK818SHHZZRFR"\BL:X".H6,99K\W-F5Q8;LR#7]S
MO4[CUB&*::I]B8]? 3XE7ORK(;#(<IKKPVQ+RVO-@MJ'"@Z2F=88W6N#FG=>
M-GL#88B 5ZF 9AN(6-U4Y)88KC9^14$;X:*^,HZPFZI89$5LD53:3BR'5T;V
MN5KV!SPL<BJBM5%[=<>2X/A>:,!CS'$<8RQE82AM:S):"IO6UY;516E MM!"
MD$(:K6JV<=(Y4\4_/\=5+[HWV1'(:0_E%>B((K7- SAKDY6,KD(U5^ISFHG=
MKD:1GC?97<JJHHHS4]FJOD$]CSO]VJB))1KF*B)U8UZHC5:BL?#6TY;R8S;V
MN*I9X9E)%;D/%+'<8OG%MK2MB5N]C:X#(,N J!C5C2$464NXJHZILP$"-=$4
M^6&%R]1ZR_F[N&_PK<(5&'KG!LIQD.KR#%K.ON3\JB7%X=L4N!W)"78 =IA5
MVCH+>O=-:5UV+/7O-+#EH8"Q'%#[1['7N W%L%?V^#X?:WM=$##7W5CC-*=;
M 0UAD5C6Q!6)04I@L5?800G QP3,:(9#$4.D<\;'IUV:QUM&F2(S7N#L3,FJ
MS+T;B= U,J8YRO<W)$2O3[XUSW*]S;3W2*Y5<J=U55]YY>KW?4BO*[HG#$ZJ
MT*!9RQJ(G#QO(149U5"/$T?5W*")U:QJ<<M0"*Y45RJC%=YU^IR\]V.1C$<J
MN16M(YZN3JL)R.968@YH74$XUKLVDK]BV&GB*JKRFREV*7E%9@C\OES\#&GA
M+"[6I4S48,DA'OTQUR9*ZS?'V 6RJ+FOO$BJI;Z[UIJYE43AO'395K]KRK*7
M'LQ'?6028L-6@#%4GH+D5::.1:OEG+=6CAI'6_XPG5;%-BL.O, 'M67T&#8?
M!>15#<?BN8<9I8[6.A9#[9M(RQ8$TME0T;^KMK6S($V']DD/I_EZ_K=?8$T=
MHC<(Q!HK*ZBIVC-QJF:.VIQ8AQ>,U;84"]-M=CI3WDT0*-]M4$.=-7Q#R.5R
M^L5$<U7IW1'A5WMT1S1C(A45J+[>8_C.O#D1C%?&;R-K7.\>BN:Y&?0JL(C?
M?MU>\HU8Y55.7(('D G*?6_I)<B$<YK=; OU!-BV;=ME :AH1P\4K,D/PIEI
ME@,%D61BVS:77! .44\%E-D$,5E-:2F/LX**N&QXV(>H,BLU+@.DD-R!OL_K
MZ?CK0Y!L)VL;+.-M#XUL/)-;V0U4)#7?@G-[E1:FTS&MM&C"//J:M'3V 3I9
M'L>UK8_4:ULGOYNM?>YOS%P7#5+RIPS\H*_#%)[G)'!2QSANOY_8^K<.$GBB
MF&=8N(6"6..2)6O8UR=S*L*PW.@(JK-L2QG,:N EIL%;E5#5Y"!"8R.2)A<0
M=L*6/&2R*66-A#(TE;'+(QKT;(]%HX7H!%X<X;XKRJO*(5 &:0C5Z\<(8:*)
MW"<*B-56\J_M5S]1U3EK2,DM$B(B^+S \0U3GW50DY*WE>555^KV;UU97?-3
M9.GA2L/J0!]X1 ;$VO58]LS*;O'J$*^P76E1A-F7 =D(Y&.XS87PQ^5'T9N2
M"O:,#%CY5@=2'31&1PYN#Y;;-)S962Z_PD;7<>V\0U23*5E)H^8"GYGI^NV8
M*=-(P8G%FA4QA;JFP,;8/A,@E84.P:(20@J:).MM=F4U/CAF X45CV/3P%4%
M"3BU'/3490J]Q2:>KE!<#63C+\P3!0020K\QN;U4EQ#$U(D*7%\=4J:Z&R24
ME:2M4B7(@@658=]),HWJ/NA*R..N&M'.4Z %C!(IV#M;&@G/'#G*Y48-G?AJ
M*Y6/BH0JM1.J/* 9V*U>W4I$,CU<YZ:\=PO\J=>7&=PBJJ)W8=1L157GJ(KQ
M.Y3KV&Q1]41K-:S<9YH; V+2BAV53C>)Y5%LO1T0HF'9!86 Y.+[$RPND<PV
MY^VVV-Y#2OFKYX$M\8R"=EZ.LR-"HUACE*_F \P=PXOKK&S]CAX=F]_L2?:6
M-ZY,HEL!I3]N4>?"X]B>O,A@8YD(L=O#;^Z"0(8<N*AI)YY%E(]1Z;'J_66M
MZAA,=5K["*QAMR+D1C*_%*$)A>0 R^X"O26C 1I/<ASHDPMG*CS1Y422&=CT
M[]6C::$UI:9;B&7+2)72X5D5IF=704BP4N*FYQ:P2#2YM>4=:,/!<Y4/!,0P
M:W-?).U9WR3)/+' ^&IBM1414X:YZ^3A57J-P8PG(/MR[NSQ&(-ZN3L=PGD3
MHI6J.Y5'=>.6M9X^4]U>Q\A_UJWA.A%(%I&HWZ0L>UGXB"<F7 E+4,1;!($/
M46!34%1Z#(6L3/<H.DCGR) DWFD*2/>](_'S<YW=5[/3IT*O*JO")RJKPGV3
MG\D_9/RUXB<(B<JO"(G*_=>/S7]UTZ=.G7FO=.G3IT:-.G3IT:-.G3IT:-.M
M77U+/IAX/]03','R.ESL[0W)K39-@7ICD#044>1ET05U+729-@^;XF^VHA<_
MUQEL=6'#<8U9V<"AS1-LJ<D,M26F;1>G61$ERH$D$V%)/$F13#D1I48KP2 '
M$Y'C*$HW->,C'M1S7-<BHJ(J+KQ41R*UR(K5145%3E%1?NBI^:+KP*F ;_T=
MO[8W$GE3C-)C^[-=XYCV6 9M@7OK#7^Z=6W5C;!T6S<#")ADL:&.8YA%-D>.
MVTIY6.WP1(K92H)&2C9"1M0V-7CDQ#S1>4CB?6;[IKU1/44ETKO6G1ZM:DL1
M7FUZ,1/%%C;X[-?Y1%J['L-ON"?,NKI2*?*<;WX/QLVEL8&69@<>DMM8EFUC
M4XUF@[(I!9:-^WJ?$'TEP<^%M!=VKXHI/\=O\=:]FV.05'N8QRM(#5CG-:JI
M_71^RM54547]R?[_ ,)W5.NL'PV;BV>XNWQI%]);.OZ"S-56$LS6-+,"X(I<
M&:1L=S?&1PC+&<1 ,\Y892<N?W5$/;PF1)7X:*P)6(1J>ZHUW/5[$7]$7ZD3
MEW".1/9.$3J51#EDD]XV2,PESG1RRQ+!&4/&YZ0^U8KGK UD:H]09'*1"LDD
MK_-7OD=W;!1F-@=,*XJ5"$>(V.)LDT94;))V2PR.5%%E8V%RL)8^-T3T:K'M
M?XKUVB((B(G1S-\F+V5/E6N:Y/[+V/:K7LD:J]V/8YKFJB*U47YZC9LKD[H7
M2>0 4^UMK8U1VAA38*\%YQ!UA6HT6=9S<BJ*>,V:C"9 ]RRWEJ(-6,8]OJ$C
MO>QCGWMK"JIH#UO)U="K7N:$LRU/&C1/Q5:U62"2WC"JD[>,?9SNSE:U_*KR
MNL8PA'\"8]SONB,:KE3CCE4ZIS[?=5_+4G!<TS"<TX&SR7)BW%21VC'V.0&6
M<KVLFBD8ADI)A!4CX[+US Y"'._:)(^)R30O5J?*<LGLWM^\69C11A7#J3<&
M?U99BBB)DA:YI",24B*$B16+'YSPQ2O1TD$3V1 DY2<=,ER,5<<WUJ^S>=$#
M0!_;-BTG<BVF)L"&5D,(UFU92Y(_"1K6M5SD2-C%5TC6NS6.Z=; )SBSE]P4
M-!.UU@:KI84<]6-5?616^*O>OZ]T[KV[?':$]S\5&R%1NW'V:=MU86=O+RVG
MQ2#D5?18>?')4J[D0(\8X9K[)#EAQ26(QG<.&]X_$4; N<QJ+,+&O@YW%RG9
MFPWMKLUP9*&LQ:\RVRHB6]V[)H4*A#8R#1),(%*>("?*CUIC0QFFC$09 D4R
M-<Y691(RC*S+Z&U*)>1<PTLU5%=SVA$ES'5^^KREKX[1XBFM#2< )Z0^KV8T
M:")OC"QL:=.(C,[D;(Q@3<NLC8Y?N;PJJPO+)WK#H,: 5/$,WRG<RPACDADG
MA=VGB9&Q[_3:B4>R$:Q61".(0\J$B&"62TL6MA:R!TCYD1LTGFL<WMT\58B+
MZB=W)_KJ]J?<V2:BGN;P*F6R^ZUT I++YMPX8+VDLDZR0$,D2-O>1[HGND\8
MW(B+W3NU'.'OEGM-LQ6P/E>U5Q=ONAW4M+K%L1%8TN.DALKRRI61&J(S+&N*
M<,H<B+*#$.Q\B)S),P(B$$WFQ.SG^&"SL&GS[$<8;1R:9KJ?)<BC5%UD26;Y
M30 QL%J@JNQ?'-%8RPCGL(Y6!DC4 I!'L"6RLFRG9U:=6P9#D&=A0DJYIPV0
M%7@C)A(A94!DG@,;"DL$!0T40[I46")[.T2I*R/JPG9 3;S26%G?S1&2NC8-
M%;EPDQJ JK($^/W!#IGCEQ2J6]82X7>Y)D9*UA*.9UF?:F\KS:Q4)MG2 "E2
M8XP"*&DDG5L(DD\TI)!#S27JU9(RB$"<Q[4?,/Z:L[JKH[;Q#4V9;"Q')\AQ
M:$*WQ_%I8 K4?W'J9!)%Z2E%U8=>D3Y2GA"^FXF0ET!2CO?$-&::R1\?$3<6
MEI[>-ALS$]P\DW/OKNBM9^4Q+.-(=)QM*:QDPHL5R2"$D$\T,1);1'CA<T)(
M:Q2'28-J]U-K9;L7F9N')MJ,'V<I:.\JJC$;"@%!B1\F6[K(<R84;JV.   1
MY9A1R&!+.))/KW30@6$1SITD93QII.+U;C-!6"$["S?'!K<@>I>,3D$>9T<\
M;92[Z]F:J5]?%;B.8RL5[7R4Q:N$KT&)D*77,(>86=E!DKY@[:&G)F97DPPD
M3!S5SC7>V#9.QT*L2,D))RHHWPV3)1B62.B=&Y9D:VXC9!D>G[O8>890/KS$
MQZLB^Q-Q4!+[0B* 5'C32,C]!:BDM948*#('(5:$PE2N$!BBF#>36*_B7C.,
MXAEVTH\DH-G-FUQ>VU._'SC*SM-0NKS\I"O"I6%G$DP8\^*4"!7PF F $L."
M(@=&R/HSC.=)C>*;)RL>A;C1,<@5$Z_SLD85934$(Q]O+RAB5*T@Y:6QK2MF
MDAVU,.#)6L\+H\J2T\Z+#=6\;[*NP:NS#XBZV^RW"<JRV\W AT&%LF%R#)KR
M=-+N5071Y\#*Y,$>* KY%4.949%86\T%@;T\@ R0XA9([&'6N9:FORT X]ME
M;4L+H3[VB<^,8BR"BL&R3#L66,>016H:;)%#!.-!*]S6/5$D;*DM>1^3ZNR@
MS7V2XG=XW:QA515>*RI]L0;C\E83!, OVX=CCJ*:-I#TA]4<-RMA8D+G-9&G
M4$S!;:06)SVUY*0+&5"Z%2XI_&!&N<&D2HZ,UAL;?;R^M.*WPE=W'F<U$=1:
MW-<>R P^#$,BI[.:N,$IL@@&?*:['[%T$DXP]G&.JH)82,G'B]F:Z!ZHL"*J
MM:B=0_Q/XN;S&:' VGH)F;9+AQLJ^<6F9Y!87%1;Q\DL9LT'FK_3.D!EC=9D
M$242R<IGQ(R(PGC:H^GV:_!IC.49-G@_G]9@>*9O'P\%'C^)8S6U5Q7%Q>G@
MP)0HDPDH<0\0@ZH970@5[VB%,DE4@7H57RRYF;8NMM;]X$Z6HJ[&*\[DQ35&
M5[*L<YJ@2\7H](Z??8["V]9OCLIQZWWMA0!.BQM#I'Q0P6*F%#1K!V;*?D5A
MVKM8.P7 M44Q$I%'6966RJE?=WH0%+L,.!MBE&9-/,V-<D?":<;]K,0EY<I5
MDU\15D=.7Y]]H[.+V-S6T)'=YGBXD?%+3>78GGN59+<T6*T%?B6<U,-5KG"H
M98X!8B,FGD&)OCX#6N,;6*CY3#(/21VVOBCR=I,'_'Y./7N#[0HK:E<"2#BV
M7AV\M?>A1%-K)IK0!I"5,3D)*A-=&,41-%Z'HQH\2-_4HMO+K(]R,CQG*A;(
MFR["YE,,$"=,FTT840D*+-\@#5$HTRRL*MEJ20X,H2O(2-(BM>?M#(S7)K/=
ME<9VUJ<YK9>]-$S<#!LF-5CV[@U]M(^?02$J#-EAREH(M9'LZ\%E)!:0)<08
MA6='.C@*]'BDDO3?+.->(18F'IVHPS(KJPJ@DV$)+<9C< CF45;(%23S%C9>
M)!+8C,R'(J]SE4R5@SO9N+A9$V!>KM?2V&P:_P ;WAK^FI+NES,?6N0YGB=3
M<V]A58394L15O[BODKI46D%%SHIP\U>0<1*.3Z4/D+7U2UJZW=L['P76U&#D
M.T\YP?#@F-KD$@OK1@*$(^R 2<L>&1'$&)ZJ#0RC"5Q3 HO4D]Q^T1[-A/$C
MD5C>88E#I*[&PK+M:; @+(U[E$EM#'B&/V=FDMBDQ9 =>TBPJ;&[FJ2DA>:B
MQF,@DC2""7S%B'M_NO*F9I;3)E?2TP\B@'J\19-I VF.4M^V,L*&Q\6QCR(\
MAD[RJAW/8H6G<PG0+$\L>;F\/PFX=@6WF&#Q9BYS<[97$?*-V(OKP0<ZS+;V
MSDND6Q'1ZR0A8RT8HRMJ6=VRGU[2J*QD31-AS(QTECCP3)"0,(HQ1<@I["O)
MK))C%IRJ=UC6V1",'#LPVN.R=M<$F2G2#*?;UK(J:QFDJHF!)B/>6\,.Q3DI
MQ]UQK["6:OU'FN&YA?E#64]O<)E&ZJLD]^/X]56QU[./4F-I\ER2[?$QH\^6
M'$^E8Q'L"@;'(;=>L,3U=956(XMGDV7W<#K\3)@@JTFMI<3R>LFD%^WU1\D4
MT]A)*SWOI016+!R)%1LHD'<F-^C7ZK>S=PX;1Z+$QB@R6FQ=,Q9E]1M&3'ZU
M:E^78X2:)BU94V1\31HS!I$GELB))Q0B!IYQI("6P3HJ:N,SS_*LOM:>U_AZ
M#)G5D2NM XY"K:^NK5@U38XI\<=4XT&)8N<<8+=D-_21,\X58,C$<-S;+;GX
M<<!V5H]U<9P^QE0Z7(:W*,>+?5$L][D34R>&<U7)C74.JO"TQHT:3)I)5F..
MX%26+8F277F=&E;=I\_PO$!*4:XNJFCEOKY*P&+(LOK:>*VLA[ I6 5R2E3.
MG);,B,8((DY$KV^G(WR>Y$U=;9Y)E<>K?F]D>-5-3?Y5:;MU%#0XU.<\B$X2
M\TGCEU>V'G!Z!2BC8[C%V8MBD:C#RC,?)ZOBYCXJ\#M&\7N1^&465<G2MKXE
M_/#RPXQ<0<(PC6Q0,EQLVTV"I0>W-QX1G&TM?;/[9=@>86>%YKGV&8%>8/60
MU67@5,ZAB6^/5UE['\ _D>?#+!+F;)!N6?+6?(@Y3XL:NAWZ:A,J*JUJI:.R
MK[-MEK&[%R:0FG,LJQA%B-&.&$:L8->-)%ZTCPY#D.;9?A]!M[D=U2DP3&UJ
MWUN+4N+5='"%(J7O0<I947O/*66$\Q)R/DH \B627X&R.[RPH)OYBM+E5_N'
M@6 WM!N3=OOFDSF\W#M,GLTBY#CUA4R8_P NDUL:G9\OGR8-A5N2.XL<-:RO
M<=\4B(SRQ;RR[5.$;N!VCNMUOENIM^Z[IMF8R^FS3+*;(->IB./T]?;XZ'04
M%W64^2 6[#:VR\PB([F F*U]Q!($.\AM]UV:_3D,P>KV(F?R8U2Y3*^KIA;3
M;.QJ[(FV0A!(Q3+.@#S$JU A'>Z J2>P'B%'$(')FEBBG:KO7AJ/^2?_ $H<
M'# 'VS2;WY.RU L8-*FX-V9;4UM(#"YKH@ZJIU)/K4: 9G96^WE>0,YCO%8?
MRL5NQ"E^B%])&@Q9F'5_T_>-;Z-L:1]K/ QKRX>B,6/SER:[GL<EFF5JKWGE
MMWSJ[\ZR*_\ -TW"85)]+# W*+Z(Z*,4=5KIQXP'QH_9@&-CJ]1A*@6A80@T
M1CW,>]PG$(]ZJ$WQ6UZ7V1V:[)[6Y%$OI,NU:W,L=KKNVCW=JZ-+MI)KIL*/
M-G5YK-]O*BUYW(6(.='C"G-A0(\)OBBU9I+B?M2J'R# 379GB9_O2H+P+=&T
MR@9T -AKS '0"YL+(QS"?6<1Z[XIE1/%C6H0TALI]^<-.( V%\?=J<*<1PS
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M7K57K3C;N\.HQNBAQC/==W]!@6Q<9/S7--[+L/%(B\EPR[I*J36.!PY-E$.
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MV29$*)D<UR3N5)R1[1U%=:0%P;+TN#+."L)!CCAIB7E Y!&:9%7DU]D1"X2
MN ET2(5ZKAY&+)',D\$DD<D=;[3F7X?C&#9=($)%C>5@$EA7]>2/=11S2JR,
MD0Z3T4:'D*3(C'>\8]C6Q$AM80Z!XX\8-AOA;LL3W_)G&9RP_)*RSN#4L3**
MB?&FY-D5JM@$3JQAR1X$B-!"5;8<B025W,\(&1"&19X9L?$-\7^.Y%L#4[=8
MR)D')<DKJ"OGFQRX@%KJ:CI15<LL6:X82S&6,X@VUKH8?0JX$8YWS$$Q*T_2
ML-HYQ-A$>(6N4W\N/49<I@F'RS*4+Z4<A4P 4 X\4Y!$$0[O(.&&2: ,J#UD
M:GM96MQ1>["RE:">K^\6$6"$7(US88FDT,@A,T5>36MM'1HY[$/CC*7W$<$R
MPEA00PS1S3AC/CPQMW;#M2X_E.7C-KLVV#CH=@=CNO5R2FQC*=G0UDXWW3&\
M%JSE*L\AM!ZPHBTCHL5JK^P1M>79I7O8.9+!K0TG]0;D1R7VT+@&I.#NPMF9
M/EF+69>-ZSUQ]VRVZM"[+($J:V[LKF&E:+@6'BB W"9)<V%+*+(>BF3$U]=
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MJ5I1]7M)^(UR/]]*^OW"S:MREN:Q\GNGY1R-#W,JQE2IL\(P"B+#LSG*\EC
M-#".%)A37'BR8B+',)XU5NORJN1'U2-"8;BM*N!G7F3Y-LW$)KJ:>@CI"IL$
M,MX)HP[#*![.<N!<RJ;%$,GHY89U)05\5B1''*%.FNF_!^J7SRXBIF<NH-P;
MMXK<=LLL;E^Q<-UF6^JJ+XP6,:[84^@A%6Y&$JI6&W%@#27$>(M7S+)J8+*P
M<5^GPSZ"/T>4,OCR. FB;$S([^+);,BUJKFTD^YQ%$FJP!Q]T0M55DD%S./I
M*Q1*>RC]* \$F 8:.+9EBNH];:^UF-I[6>$XIK'6U9CQF,4.&Z_QNCQ7&,<J
M3!IQGC4>.U5>/1@1L0B69(8Z]1Y)G.?/#+YR(_4X[BE7C32K!0Q9$A'-D3)3
MT-)*QS^_C5ZM^EG*,5S6=4(\;"$[$:CD<K=WXC]R=XB"!>SPU-#' ,$?&*%#
M0:1O XR$*>(AG,F&=( ^0$LEI'Q/4'%%40BD:_PJ_P GGW#P3^H9RHUGA=GJ
M_%N/Q7 K%"=A\+^'^-X\?:X[>9M>8W@N/;LY5[&VW-$XC96X8KC%,9]A7Y )
MC<=$%/36U7!D5E7'G5OOQZU._3K^B[P;^F-?9'G/'/"KV;:.:810X/F&R\YN
MF9#DMN!46!]M8E@,C"!K<9FRNR+%)R8/' ZZK/2BQ^)@,#*QOJ[8NE-I@].G
M3IT:-.O/?M?^3"?2/V_O.OWK>Z>SJDL'9?E6<YIK[%]G9!7:TV9D.67$]Z=-
MEU&6EC; !C6!,JB5^"W^&B.&](,V(L:)D2>A#IUZBJB\HJHOVY151>.47CV_
M=$7^U$7\M&K.U_KW!M4X9CFNM:8CCV!X)B%6+28QB.*50=)0454%&D0P-=6
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M_P#J<_AY_P#).K_^J<B_;_V@_L_O_?WV=_X4RY_VF*S_ )<E?^BW3_"F7/\
MM,5G_+DK_P!%NM8GX*S+_8EDW_$-K_FG3\%9E_L2R;_B&U_S3H^0T7_!1?\
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M/*,XGF?6U9N0*DQM>-!$!8"$F/D',-%9'VGK"R$MT6;]K#':<1X[<9(#E]2
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ME!IU";]FJXZ^WN(!J^NCHY/.ME%K)5#6-Z$$1D#S,D9- 0Z*9KQY%14#;8A
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M(<B_WS_^)#_Z'4R?Z8M%_L)MO^-@_P#->G],6B_V$VW_ !L'_FO4-OP#G?\
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(TZ=.G1HU_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775343600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Mar. 01, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JOINT Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001612630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">jynt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,054,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775949680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,009,864<span></span>
</td>
<td class="nump">$ 16,792,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">334,394<span></span>
</td>
<td class="nump">385,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,021,733<span></span>
</td>
<td class="nump">743,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">42,014<span></span>
</td>
<td class="nump">70,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Notes receivable - current portion</a></td>
<td class="nump">40,826<span></span>
</td>
<td class="nump">60,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsCurrent', window );">Deferred franchise costs - current portion</a></td>
<td class="nump">748,300<span></span>
</td>
<td class="nump">605,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">499,525<span></span>
</td>
<td class="nump">366,033<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">5,696,656<span></span>
</td>
<td class="nump">19,025,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,724,706<span></span>
</td>
<td class="nump">7,138,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Notes receivable, net of current portion and reserve</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsNoncurrent', window );">Deferred franchise costs, net of current portion</a></td>
<td class="nump">836,350<span></span>
</td>
<td class="nump">1,534,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,338,922<span></span>
</td>
<td class="nump">2,542,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,750,338<span></span>
</td>
<td class="nump">2,466,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">707,889<span></span>
</td>
<td class="nump">638,710<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">17,054,861<span></span>
</td>
<td class="nump">33,362,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,054,946<span></span>
</td>
<td class="nump">1,996,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">299,997<span></span>
</td>
<td class="nump">375,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_CoOpFundsLiabilityCurrent', window );">Co-op funds liability</a></td>
<td class="nump">73,246<span></span>
</td>
<td class="nump">201,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll liabilities</a></td>
<td class="nump">750,421<span></span>
</td>
<td class="nump">1,493,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - current portion</a></td>
<td class="nump">331,500<span></span>
</td>
<td class="nump">451,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent - current portion</a></td>
<td class="nump">215,450<span></span>
</td>
<td class="nump">334,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue - current portion</a></td>
<td class="nump">3,077,430<span></span>
</td>
<td class="nump">2,579,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">60,894<span></span>
</td>
<td class="nump">54,596<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,863,884<span></span>
</td>
<td class="nump">7,487,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">130,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, net of current portion</a></td>
<td class="nump">1,400,790<span></span>
</td>
<td class="nump">457,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">2,231,712<span></span>
</td>
<td class="nump">4,369,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred tax liability</a></td>
<td class="nump">120,700<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">512,362<span></span>
</td>
<td class="nump">238,648<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">10,129,448<span></span>
</td>
<td class="nump">12,683,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2016, and December 31, 2015</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 20,000,000 shares authorized, 13,317,393 shares issued and 13,020,889 shares outstanding as of December 31, 2016 and 13,070,180 shares issued and 12,536,180 outstanding as of December 31, 2015</a></td>
<td class="nump">13,317<span></span>
</td>
<td class="nump">13,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">36,398,588<span></span>
</td>
<td class="nump">35,267,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock (296,504 shares as of December 31, 2016 and 534,000 as of December 31, 2015, at cost)</a></td>
<td class="num">(503,118)<span></span>
</td>
<td class="num">(791,638)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(28,983,374)<span></span>
</td>
<td class="num">(13,809,502)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">6,925,413<span></span>
</td>
<td class="nump">20,679,306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 17,054,861<span></span>
</td>
<td class="nump">$ 33,362,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CoOpFundsLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of Co-op funds liability (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CoOpFundsLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred current net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred noncurrent net amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through a franchise arrangement having an indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Company (holder) a definite sum of money within one year from the balance sheet date (or the normal operating cycle, whichever is longer), net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65884687&amp;loc=d3e4531-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date more than one year from the balance sheet date, net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775464096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Series A preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Series A preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Series A preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Series A preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">13,317,393<span></span>
</td>
<td class="nump">13,070,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">13,020,889<span></span>
</td>
<td class="nump">12,536,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775827264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Revenues and management fees from company clinics</a></td>
<td class="nump">$ 8,578,048<span></span>
</td>
<td class="nump">$ 3,651,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyRevenue', window );">Royalty fees</a></td>
<td class="nump">5,973,079<span></span>
</td>
<td class="nump">4,515,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseRevenue', window );">Franchise fees</a></td>
<td class="nump">2,286,809<span></span>
</td>
<td class="nump">2,471,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingRevenue', window );">Advertising fund revenue</a></td>
<td class="nump">1,866,406<span></span>
</td>
<td class="nump">1,191,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesRevenue', window );">IT related income and software fees</a></td>
<td class="nump">932,709<span></span>
</td>
<td class="nump">808,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRevenue', window );">Regional developer fees</a></td>
<td class="nump">617,573<span></span>
</td>
<td class="nump">866,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">269,016<span></span>
</td>
<td class="nump">331,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,523,640<span></span>
</td>
<td class="nump">13,835,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchiseCosts', window );">Franchise cost of revenues</a></td>
<td class="nump">2,717,691<span></span>
</td>
<td class="nump">2,642,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesCosts', window );">IT cost of revenues</a></td>
<td class="nump">221,918<span></span>
</td>
<td class="nump">177,462<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">2,939,609<span></span>
</td>
<td class="nump">2,819,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expenses</a></td>
<td class="nump">4,419,180<span></span>
</td>
<td class="nump">2,843,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,566,136<span></span>
</td>
<td class="nump">1,268,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">22,101,083<span></span>
</td>
<td class="nump">16,219,392<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total selling, general and administrative expenses</a></td>
<td class="nump">29,086,399<span></span>
</td>
<td class="nump">20,331,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on disposition or impairment</a></td>
<td class="nump">3,520,370<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(15,022,738)<span></span>
</td>
<td class="num">(9,316,442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">261,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="nump">22,119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="nump">283,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">(15,009,443)<span></span>
</td>
<td class="num">(9,033,176)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">(164,429)<span></span>
</td>
<td class="nump">235,855<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (15,173,872)<span></span>
</td>
<td class="num">$ (8,797,321)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (1.20)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average shares (in shares)</a></td>
<td class="nump">12,696,649<span></span>
</td>
<td class="nump">10,042,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of regional development fees revenue recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from the sale of advertising time (such as television and radio) or space (newspaper or magazine pages). May also include advertising, marketing and promotional services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating franchise revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchiseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from consideration (often a percentage of the franchisee's sales) received for the right to operate a business using the entity's name, merchandise, services, methodologies, promotional support, marketing, and supplies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058139&amp;loc=d3e68564-108043<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchiseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred in providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 76<br> -URI http://asc.fasb.org/extlink&amp;oid=68047459&amp;loc=d3e132428-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TechnologyServicesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 605<br> -Section 25<br> -Paragraph 76<br> -URI http://asc.fasb.org/extlink&amp;oid=68047459&amp;loc=d3e132428-111767<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TechnologyServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775512960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2014</a></td>
<td class="nump">10,196,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2014</a></td>
<td class="nump">$ 10,197<span></span>
</td>
<td class="nump">$ 21,420,975<span></span>
</td>
<td class="num">$ (791,638)<span></span>
</td>
<td class="num">$ (5,012,181)<span></span>
</td>
<td class="nump">$ 15,627,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">825,145<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">825,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">2,613,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 2,614<span></span>
</td>
<td class="nump">13,020,981<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,023,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of vested restricted stock (in shares)</a></td>
<td class="nump">259,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of vested restricted stock</a></td>
<td class="nump">$ 260<span></span>
</td>
<td class="num">$ (260)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (8,797,321)<span></span>
</td>
<td class="num">$ (8,797,321)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2015</a></td>
<td class="nump">13,070,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2015</a></td>
<td class="nump">$ 13,070<span></span>
</td>
<td class="nump">35,267,376<span></span>
</td>
<td class="num">$ (791,638)<span></span>
</td>
<td class="num">(13,809,502)<span></span>
</td>
<td class="nump">20,679,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,123,481<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,123,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">46,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">99,953<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of vested restricted stock (in shares)</a></td>
<td class="nump">162,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of vested restricted stock</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="num">$ (162)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 37,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">70,893<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">70,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (15,173,872)<span></span>
</td>
<td class="num">$ (15,173,872)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2016</a></td>
<td class="nump">13,317,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2016</a></td>
<td class="nump">$ 13,317<span></span>
</td>
<td class="nump">36,398,588<span></span>
</td>
<td class="num">$ (503,118)<span></span>
</td>
<td class="num">(28,983,374)<span></span>
</td>
<td class="nump">6,925,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock, offering costs adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,042)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (83,391)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (83,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock under employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Sale of treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (161,911)<span></span>
</td>
<td class="nump">$ 371,911<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Sale of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66904339&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of treasury stock (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938698096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_PaymentsOfInitialPublicOfferingCosts', window );">IPO, net offering costs</a></td>
<td class="nump">$ 1,351,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_PaymentsOfInitialPublicOfferingCosts', window );">IPO, net offering costs</a></td>
<td class="nump">$ 1,351,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_PaymentsOfInitialPublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the costs of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_PaymentsOfInitialPublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775509328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,173,872)<span></span>
</td>
<td class="num">$ (8,797,321)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">(Recovery) provision for bad debts</a></td>
<td class="num">(10,830)<span></span>
</td>
<td class="nump">61,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights', window );">Regional developer fees recognized upon acquisition of development rights</a></td>
<td class="num">(138,500)<span></span>
</td>
<td class="num">(254,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements', window );">Regional developer fees recognized upon termination of regional developer agreements</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(282,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements', window );">Net franchise fees recognized upon termination of franchise agreements</a></td>
<td class="num">(342,259)<span></span>
</td>
<td class="num">(521,350)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableIssuedForPaymentOfTransferFees', window );">Notes receivable issued for payment of transfer fees</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(59,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,566,136<span></span>
</td>
<td class="nump">1,268,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of property and equipment</a></td>
<td class="num">(2,191)<span></span>
</td>
<td class="num">(11,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Loss on disposition or impairment</a></td>
<td class="nump">3,520,370<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(261,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">120,700<span></span>
</td>
<td class="nump">40,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">1,123,481<span></span>
</td>
<td class="nump">825,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmount', window );">Cash paid for legal settlement</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities', window );">Restricted cash</a></td>
<td class="nump">50,888<span></span>
</td>
<td class="num">(160,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(999,522)<span></span>
</td>
<td class="num">(99,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">28,967<span></span>
</td>
<td class="nump">324,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(133,492)<span></span>
</td>
<td class="nump">9,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_IncreaseDecreaseInDeferredFranchiseCosts', window );">Deferred franchise costs</a></td>
<td class="nump">361,600<span></span>
</td>
<td class="nump">127,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits and other assets</a></td>
<td class="nump">71,549<span></span>
</td>
<td class="num">(39,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(953,084)<span></span>
</td>
<td class="num">(291,480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(75,532)<span></span>
</td>
<td class="nump">165,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_IncreaseDecreaseInCoOpFundsLiability', window );">Co-op funds liability</a></td>
<td class="num">(127,832)<span></span>
</td>
<td class="nump">14,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Payroll liabilities</a></td>
<td class="num">(742,954)<span></span>
</td>
<td class="nump">875,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(19,130)<span></span>
</td>
<td class="num">(105,973)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred rent</a></td>
<td class="nump">824,390<span></span>
</td>
<td class="nump">246,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(896,195)<span></span>
</td>
<td class="nump">128,049<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
<td class="num">(10,847,312)<span></span>
</td>
<td class="num">(6,796,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions</a></td>
<td class="num">(839,000)<span></span>
</td>
<td class="num">(4,925,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights', window );">Reacquisition and termination of regional developer rights</a></td>
<td class="num">(325,000)<span></span>
</td>
<td class="num">(1,075,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,567,727)<span></span>
</td>
<td class="num">(4,065,946)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds received on sale of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Payments received on notes receivable</a></td>
<td class="nump">35,905<span></span>
</td>
<td class="nump">42,388<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(2,695,822)<span></span>
</td>
<td class="num">(10,013,083)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock - follow-on public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,374,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_PaymentsOfInitialPublicOfferingCosts', window );">Offering costs paid</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,351,403)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance of common stock, offering costs adjustment</a></td>
<td class="num">(1,042)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock under employee stock plans</a></td>
<td class="num">(83,391)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTreasuryStock', window );">Proceeds from sale of treasury stock</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">70,931<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments on notes payable</a></td>
<td class="num">(436,350)<span></span>
</td>
<td class="num">(218,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(239,852)<span></span>
</td>
<td class="nump">12,805,629<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net decrease in cash</a></td>
<td class="num">(13,782,986)<span></span>
</td>
<td class="num">(4,003,933)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at beginning of year</a></td>
<td class="nump">16,792,850<span></span>
</td>
<td class="nump">20,796,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at end of year</a></td>
<td class="nump">$ 3,009,864<span></span>
</td>
<td class="nump">$ 16,792,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncreaseDecreaseInCoOpFundsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase (decrease) in co-op funds liability during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncreaseDecreaseInCoOpFundsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_IncreaseDecreaseInDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the increase (decrease) during the reporting period in deferred franchise costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_IncreaseDecreaseInDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The element that represents net franchise fees recognized upon termination of franchise agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NetFranchiseFeesRecognizedUponTerminationOfFranchiseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivableIssuedForPaymentOfTransferFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of notes receivable issued for payment of transfer fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivableIssuedForPaymentOfTransferFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_PaymentsOfInitialPublicOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the costs of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_PaymentsOfInitialPublicOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the reacquisition and termination of regional developer rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ReacquisitionAndTerminationOfRegionalDeveloperRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of regional developer fees recognized upon acquisition of development rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfDevelopmentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of regional developer fees recognized upon acquisition of development rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesRecognizedUponAcquisitionOfRegionalDeveloperAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities. This may include cash restricted for regulatory purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of judgment or settlement awarded to (against) the entity in respect of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of an equity stock that has been previously reacquired by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771106656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Non-cash Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> cash paid for income taxes was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0,</div> respectively. During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> cash paid for interest was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,262</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,344,</div> respectively.</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">Supplemental disclosure of non-cash activity:</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we had property and equipment purchases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,059</div> which were included in accounts payable. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> we had property and equipment purchases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,109,464</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$117,509</div> which were included in accounts payable and accrued expenses, respectively.</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">In connection with our reacquisition and termination of regional developer rights during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> we had deferred revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$224,750</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$914,000,</div> respectively, representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;We netted these amounts against the aggregate purchase price of the acquisitions (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6).</div></div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">In connection with our acquisitions of franchises during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we acquired <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$293,014</div> of property and equipment, intangible assets of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$339,000,</div> goodwill of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$269,780,</div> favorable leases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$140,728</div> and assumed deferred revenue associated with membership packages paid in advance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$45,072</div> in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$839,000</div> in cash and notes payable issued to the sellers for an aggregate amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000.</div> Additionally, at the time of these transactions, we carried deferred revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,000,</div> representing franchise fees collected upon the execution of franchise agreements, and deferred costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,450,</div> related to our acquisition of undeveloped franchises. We netted these amounts against the aggregate purchase price of the acquisitions (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2).</div></div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">In connection with our acquisitions of franchises during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> we acquired <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,504,169</div> of property and equipment, intangible assets of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,942,180,</div> goodwill of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,830,833,</div> favorable leases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$521,825,</div> assumed unfavorable leases of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$49,077,</div> deferred revenue associated with membership packages paid in advance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$106,908,</div> and a deferred tax liability of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$168,000</div> in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,925,525</div> in cash and an aggregate amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$800,350</div> in notes payable to the sellers.&nbsp;&nbsp;Additionally, at the time of these transactions, we carried deferred revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,005,500,</div> representing franchise fees collected upon the execution of franchise agreements, and deferred costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$493,500,</div> related to our acquisition of undeveloped franchises.&nbsp;&nbsp;In accordance with ASC-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">952</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> we netted these amounts against the aggregate purchase price of the acquisitions (Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2).</div></div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Property and equipment</div></td> <td style="width: 2%; font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="width: 22%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">(53,836</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Intangible assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">4,820</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Favorable leases</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">6,250</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">Goodwill</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">68,616</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Unfavorable leases</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">(25,850</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">)</div></td> </tr>  </table> </div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div> <div style=" text-align: left; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-size: 9pt">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we entered into a settlement agreement, whereby we resolved all pending litigation matters discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.</div> Under the terms of the settlement agreement, we agreed to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time settlement amount comprised of cash and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,948</div> shares of our common stock. The fair value of the total consideration related to common stock was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000.</div> The fair value of the common stock was measured using the closing price of our common stock on the settlement date. &nbsp;</div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938720992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Nature of Operations and Summary of Significant Accounting Policies</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> LLC (collectively, the &#x201c;Company&#x201d;), which was dormant for all periods presented.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from selling and marketing expenses to general and administrative expenses for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> to conform to current year presentation.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Comprehensive Loss</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the same for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was formed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010.</div> Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">242</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" margin: 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">312</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinic licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">168</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <!-- Field: Page; Sequence: 51 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Management's Plans</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had cash and short-term bank deposits of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.0</div> million. To preserve cash, the Company does not plan to add any company-owned or managed clinics during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> fiscal year. Additionally, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company made the decision to close or sell <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics in Chicago and New York. As a result, the Company has significantly reduced its estimated cash needs for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million. The cash used in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> included expenditures for the acquisition or development of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> company-owned or managed clinics, and the working capital losses in the Chicago and New York markets which amounted to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.8</div> million for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> As the Company has no current plans to acquire or develop company-owned or managed clinics during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and has sold or closed the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics in the Chicago and New York markets, the Company&#x2019;s projected use of cash in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> is significantly lower than the amount of cash used in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Furthermore, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company executed a Credit and Security Agreement which provided a credit facility of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.0</div> million. Taking into account these tactical decisions made by the Company&#x2019;s management, as well as the execution of the credit facility, the Company has concluded that it can continue as a going concern for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the date that the financial statements were available to be issued.</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Variable Interest Entities</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#x201c;VIE&#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary are accounted for under the equity method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides on an exclusive basis, all non-clinical services of the chiropractic practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&#x2019;s consolidated financial statements</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments purchased with an original maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company has invested substantially all of the proceeds of its public offerings in short-term bank deposits. The Company had no cash equivalents as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Cash</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentrations of Credit Risk</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time the Company grants credit in the normal course of business to PCs or franchisees related to the working capital needs of the PC, collection of royalties, or other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the PCs or franchisees to reduce credit risk. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> PC entity, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> franchisees represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31%,</div> respectively, of outstanding accounts receivable. The Company did not have any PCs or franchisees that represented greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our revenues during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounts Receivable</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which we perform management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had an allowance for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$131,830</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$142,660,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 52 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company determined that certain working capital advances from its PC entities in Illinois and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$731,857</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Franchise Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Software Developed</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years. The Company amortizes the acquired regional developer rights over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. The fair value of customer relationships is amortized over their estimated useful life of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>&nbsp;years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> related to closure of an acquired clinic in New York.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Goodwill</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>&nbsp;&nbsp;Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$54,994</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 53 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Long-Lived Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.4</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> were recorded for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Fund</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&#x2019;s consolidated balance sheets.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Co-Op Marketing Funds</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The marketing funds are included in restricted cash on the Company&#x2019;s consolidated balance sheets.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounting for Costs Associated with Exit or Disposal Activities </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">Costs to terminate an operating lease or other contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> the Company recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million related to operating leases that will no longer provide economic benefit to the entity, net of estimated sublease income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Rent</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> include rent holidays and rent escalation clauses.&nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The Company records <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">tenant</div> improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Franchise Fees.</div> The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;"></div></div> <!-- Field: Page; Sequence: 54 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;"></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Regional Developer Fees</div>. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,250</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the then current franchise fee, for each franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive fees ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,500</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,950</div> which are collected from franchisees upon the sale of franchises within their region and a royalty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3%</div> of sales generated by franchised clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. The franchisor&#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&#x2019;s license.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">&nbsp;</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Revenues and Management Fees from Company Clinics.&nbsp;&nbsp;</div>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp; Amounts collected up front for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&#x2019;s PC.&nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&#x2019;s PC in return for a monthly management fee.&nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.</div> <div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">Royalties.</div> The Company collects royalties, as stipulated in the franchise agreement, equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7%</div> of gross sales, and a marketing and advertising fee currently equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> working days after each sales period has ended.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"><div style="display: inline; font-style: italic;">IT Related Income and Software Fees.</div>&nbsp;&nbsp;The Company collects a monthly computer software fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the franchisee.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred. Advertising expenses for years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,279,572</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,525,687,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 55 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income Taxes</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood of being realized upon ultimate resolution.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Loss per Common Share</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,797,321</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.88</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Stock-Based Compensation</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 56 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>&#x201d;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for us on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company has completed a preliminary review of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> and does not expect the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to have a material impact on its revenues and management fees from company clinics or franchise royalty revenues. The Company is currently evaluating the impact of the adoption of this standard on recognition of revenue from franchise agreements, advertising fund revenue, and regional developer fee revenue. The Company is still evaluating its transition approach and expects to reach a decision in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> half of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;<div style="display: inline; font-style: italic;">Presentation of Financial Statements - Going Concern: Disclosures about an Entity&#x2019;s Ability to Continue as a Going Concern</div>.&#x201d; The new standard requires management to perform interim and annual assessments of an entity&#x2019;s ability to continue as a going concern within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. The new guidance is effective for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods thereafter. The Company adopted this new standard as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued&nbsp;ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03,</div> &#x201c;<div style="display: inline; font-style: italic;">Interest - Imputation of Interest (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">835</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30):</div> Simplifying the Presentation of Debt Issuance Costs</div>.&#x201d;&nbsp; The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset.&nbsp; Debt disclosures will include the face amount of the debt liability and the effective interest rate.&nbsp; The update requires retrospective application and represents a change in accounting principle.&nbsp; The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div>&nbsp; ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> did not have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805):</div> Simplifying the Accounting for Measurement-Period Adjustments</div>.&#x201d; The update requires than an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes. The Company adopted this ASU during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Accordingly, the Company applied the amendments in this update to the measurement period adjustments made during the year and disclosed the adjustments in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> &#x201c;<div style="display: inline; font-style: italic;">Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">470):</div> Balance Sheet Classification of Deferred Taxes</div>.&#x201d; The update eliminates the requirement to separate deferred income tax assets and liabilities into current and noncurrent amounts within a classified balance sheet. Under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> the presentation of deferred income taxes is simplified, as all deferred income tax assets and liabilities are to be classified as noncurrent. The existing requirement that deferred income tax assets and liabilities of a tax-paying component of an entity be offset and presented as a single amount is not affected by ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.</div> The Company has adopted the guidance under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> retrospectively and prior periods were retrospectively adjusted.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 57 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Financial Instruments - Overall (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10),</div> Recognition and Measurement of Financial Assets and Financial Liabilities</div>,&#x201d; which addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> will be effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years, and early adoption is not permitted. The Company is currently evaluating the effect of adoption of this standard, if any, on its consolidated financial position, results of operations or cash flows.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842).&#x201d;</div></div> The changes require that substantially all operating leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard, which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> While we have not quantified the impact this proposed standard would have on our consolidated financial statements, if our current operating leases are instead recognized on the consolidated balance sheet, it will result in a significant increase in the liabilities reflected on our consolidated balance sheet and in the interest expense and depreciation and amortization expense reflected in our consolidated statements of operations, while reducing the amount of rent expense. This could potentially decrease our reported net income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting</div>&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;),</div> which amends ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation &#x2013; Stock Compensation (&#x201c;ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718&#x201d;).</div> The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the accounting for income taxes, classification of excess tax benefits on the statement of cash flows, forfeitures, statutory tax withholding requirements, classification of awards as either equity or liabilities, and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for interim and annual reporting periods beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Early adoption is permitted. The Company is currently evaluating the method of adoption and impact the update will have on its consolidated financial statements and related disclosures.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606):</div> Identifying Performance Obligations and Licensing</div>&#x201d;, to clarify the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> aspects of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606:</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div> identifying performance obligations, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606):</div> Narrow-Scope Improvements and Practical Expedients</div>&#x201d;, to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Classification of Certain Cash Receipts and Cash Payments&#x201d;. </div>This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;<div style="display: inline; font-style: italic;">Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Restricted Cash&#x201d;</div> (a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flow. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 58 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805):</div> Clarifying the Definition of a Business&#x201d;,</div> to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6711477536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Acquisitions</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Franchises acquired during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company continued to execute its growth strategy and entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> developed franchises and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> undeveloped franchise throughout California and New Mexico for an aggregate purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,025,000,</div> subject to certain adjustments, consisting of cash of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$839,000</div> and notes payable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000.</div> The Company is operating the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> developed franchises as company-owned or managed clinics and has terminated the undeveloped clinic license. At the time these transactions were consummated, the Company carried <div style="display: inline; background-color: white">a deferred revenue balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,000,</div> representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,450,</div> related to an undeveloped franchise.&nbsp;&nbsp;The Company accounted for the franchise rights associated with the undeveloped franchise as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&nbsp;&nbsp;The remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$997,450</div> was accounted for as consideration paid for the acquired franchises.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$75,000</div> of transaction costs related to these acquisitions for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> which are included in general and administrative expenses in the accompanying consolidated statements of operations.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Purchase Price Allocation</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> as of the acquisition date:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">293,014</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,728</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,780</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,042,522</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,072</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">997,450</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist of reacquired franchise rights of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$181,000</div> and customer relationships of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$158,000,</div> and will be amortized over their estimated useful lives ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> years, respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Franchises acquired during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div></div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company entered into a series of unrelated transactions with existing franchisees to re-acquire an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> developed and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div> undeveloped franchises throughout Arizona, California and New York for an aggregate purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,725,875,</div> subject to certain adjustments, consisting of cash of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,925,525</div> and notes payable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$800,350.</div> Of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> developed franchises, the Company is operating <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div> as company-owned or managed clinics and has closed the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> clinics. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35</div> undeveloped franchises have been terminated and the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> relocate them. At the time these transactions were consummated, the Company carried <div style="display: inline; background-color: white">a deferred revenue balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,005,500,</div> representing franchise fees collected upon the execution of the franchise agreements, and deferred franchise costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$493,500,</div> related to undeveloped franchises.&nbsp;&nbsp;The Company accounted for the franchise rights associated with the undeveloped franchises as a cancellation, and the respective deferred revenue and deferred franchise costs were netted against the aggregate purchase price.&nbsp;&nbsp;The remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,213,875</div> was accounted for as consideration paid for the acquired franchises.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 59 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Additionally, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> in connection with the default by a franchisee under its franchise agreement, the Company assumed substantially all of the assets of a clinic in Tempe, Arizona in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$25,000.</div>&nbsp; The Company has accounted for this as a business combination.&nbsp; The Company completed its valuation of the fair value of the assets acquired, including intangible assets, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Because the net assets acquired exceeded the consideration paid, the Company recognized a bargain purchase gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$233,804</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company also recognized a bargain purchase gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27,343</div> related to the acquisition of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> developed franchises and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> undeveloped franchises in San Diego, California. Total bargain purchase gain for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$261,147.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company incurred <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$393,069</div> of transaction costs related to these acquisitions for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> which are included in general and administrative expenses in the accompanying consolidated statements of operations.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic;">Purchase Price Allocation</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The purchase price allocations for these acquisitions are complete. The following summarizes the aggregate fair values of the assets acquired and liabilities assumed during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> as of the acquisition date:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,450,333</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,947,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">528,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,899,449</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,824,857</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Unfavorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(74,927</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(106,908</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,643,022</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred tax liability</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(168,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Bargain purchase gain</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(261,147</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,213,875</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets in the table above consist of reacquired franchise rights of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,449,000</div> and customer relationships of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$498,000,</div> and will be amortized over their estimated useful lives ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> years, respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Pro Forma Results of Operations (Unaudited)</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> as if the acquisitions in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> had been completed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Pro Forma for the Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2016</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Revenues, net</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,985,277</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,375,930</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net loss</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,483,492</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,187,416</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 60 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">This selected unaudited pro forma consolidated financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would have been if the acquisitions had been completed on that date. Moreover, this information is not indicative of what the Company&#x2019;s future operating results will be. The information for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> prior to the acquisitions is included based on prior accounting records maintained by the acquired companies. In some cases, accounting policies differed materially from accounting policies adopted by the Company following the acquisitions. For <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> this information includes actual data recorded in the Company&#x2019;s consolidated financial statements for the period subsequent to the date of the acquisitions. The Company&#x2019;s consolidated statements of operations for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> includes net revenue and net income of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.5</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.7</div> million, respectively, attributable to the acquisitions.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> together with the consequential tax impacts.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938712448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Notes Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Notes Receivable</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$90,000</div> unsecured promissory note. The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> per annum for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fifty</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> months and requires monthly principal and interest payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">forty</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> months, beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> and maturing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> license transfer agreements, in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,925</div> in separate unsecured promissory notes.&nbsp; The non-interest bearing notes require monthly principal payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company entered into a license transfer agreement, in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$29,925</div> in an unsecured promissory note.&nbsp; The note bears interest at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.0%</div> per annum, and requires monthly principal payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and matured on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> license transfer agreements, in exchange for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> separate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,500</div> unsecured promissory notes.&nbsp; The non-interest bearing notes require monthly principal payments over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months, beginning on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and maturing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The outstanding balance of the notes as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,826</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$76,731,</div> respectively.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5066-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5162-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938713168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Property and Equipment</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment consist of the following:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083,039</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">963,299</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Leasehold improvements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,085,366</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,672,582</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">891,192</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">691,827</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,059,597</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,327,708</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,566,172</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,098,438</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,493,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,229,270</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,281</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,909,476</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,724,706</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,138,746</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Depreciation expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,818,403</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$792,794</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company determined that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics from its Corporate Clinics segment, met the criteria for classification as held for sale. Accordingly, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recognized a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.4</div> million impairment charge to lower the carrying costs of the property and equipment to its estimated fair value less cost to sell which is recorded in the loss on disposition or impairment line of the accompanying consolidated statement of operations. The Company completed the sale of the property in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> for nominal consideration.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938872048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Fair Value Consideration<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Fair Value Consideration</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#x2019;s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels based on reliability of the inputs as follows:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;">  <tr style="vertical-align: top"> <td style="width: 2%; text-align: justify">&nbsp;</td> <td style="width: 7%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div></div></td> <td style="width: 91%; text-align: justify"><div style="display: inline; font-size: 10pt">Observable inputs such as quoted prices in active markets;</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;</div> <table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;">  <tr> <td style="vertical-align: top; width: 2%; text-align: justify">&nbsp;</td> <td style="vertical-align: top; width: 7%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div></div></td> <td style="vertical-align: bottom; width: 91%; text-align: justify"><div style="display: inline; font-size: 10pt">Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly;&nbsp;and</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <table cellspacing="0" cellpadding="0" style="; border-collapse: collapse; font-size: 10pt;">  <tr style="vertical-align: top"> <td style="width: 2%; text-align: justify">&nbsp;</td> <td style="width: 7%; text-align: justify"><div style="display: inline; font-size: 10pt">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3:</div></div></td> <td style="width: 91%; text-align: justify"><div style="display: inline; font-size: 10pt">Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div></div>t have any financial instruments that are measured on a recurring basis as Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had non-recurring fair value measurements as a result of the sale subsequent to year end, the Company recorded the assets at the lesser of their carrying values and their fair value less costs to sell, which resulted in a write-down of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.5</div> million. The inputs used to determine such fair values which were based on the offer price provided by a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party in connection with the sale are classified within Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> in the hierarchy.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13504-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938729344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Intangible Assets</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year <div style="display: inline; background-color: white">ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company entered into several agreements to repurchase regional developer licenses, reacquiring rights in Los Angeles County, San Diego County, and Orange County, California, Erie County, Monroe County, Nassau County, Suffolk County, and Albany County, New York, and the regional developer license in New Jersey in exchange for cash consideration of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,583,000.</div>&nbsp; The Company carried a deferred revenue balance associated with these transactions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$914,000,</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;In accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">952</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div> the Company accounted for the development rights associated with the unsold or undeveloped franchises as cancellations, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp; During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the revenue recognized as excess deferred regional developer fees totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$254,250.</div> The remaining balance was accounted for as consideration paid for the reacquired development rights. As the deferred revenue with respect to these regional developer rights had previously been taken into account for income tax purposes, the tax basis in the reacquired development rights is equal to the cash consideration paid. </div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in San Bernardino and Riverside Counties in California. The total consideration for the transaction was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$275,000,</div> paid in cash.<div style="display: inline; font-weight: bold;">&nbsp;</div><div style="display: inline; background-color: white">The Company carried a deferred revenue balance associated with these transactions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$36,250,</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp; </div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into an agreement under which it repurchased the regional development rights to develop franchises in Virginia. The total consideration for the transaction was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50,000,</div> paid in cash.<div style="display: inline; font-weight: bold;">&nbsp;</div><div style="display: inline; background-color: white">The Company carried a deferred revenue balance associated with these transactions of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$188,500,</div> representing license fees collected upon the execution of the regional developer agreements.&nbsp;&nbsp;The Company accounted for the development rights associated with the unsold or undeveloped franchises as a cancellation, and the respective deferred revenue was netted against the aggregate purchase price or recognized as revenue to the extent deferred revenue was in excess of the cash consideration paid.&nbsp;&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consisted of the following:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,911,750</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">444,795</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,466,955</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">509,042</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191,958</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">923,250</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">243,241</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,009</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197,078</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Amortization expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$747,733</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$476,161</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company evaluates the recoverability of finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. The Company recorded an impairment charge as a result of the closure of a clinic acquired in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> related to certain reacquired franchise rights and customer relationships during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> which is included on the loss on disposition or impairment line of the statement of consolidated operations.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 63 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Estimated amortization expense for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and subsequent years is as follows:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">578,881</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2018</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">439,589</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">348,034</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,906</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938762736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top"> <td style="width: 73px"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7:</div></div></div></td> <td style="width: 7px">&nbsp;</td> <td style="text-align: justify"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-weight: bold;">Notes Payable</div></div></td> </tr>  </table> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> notes payable totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$800,350</div> as a portion of the consideration paid in connection with the Company&#x2019;s various acquisitions. Interest rates range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.5%</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.25%</div> with maturities through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> notes payable totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$186,000</div> as a portion of the consideration paid in connection with the Company&#x2019;s various acquisitions. Interest rates for both notes are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.25%</div> with maturities through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maturities of notes payable are as follows as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 18%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">331,500</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">331,500</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938785488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Equity</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;<div style="display: inline; font-style: italic;">Stock Options</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company adopted the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Stock Plan <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(&#x201c;2014</div> Plan&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Plan is designed to supersede and replace the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012</div> Plan, effective as of the adoption date and set aside <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,513,000</div> shares of the Company&#x2019;s common stock that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be granted under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Plan.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,160</div> stock options to employees and certain non-employee members of its board of directors with exercise prices ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.99</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.62.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div> stock options to employees with exercise prices ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.23</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.11.</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company&#x2019;s stock trading price is the basis of fair value of its common stock used in determining the value of share based awards. To the extent the value of the Company&#x2019;s share based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical volatility. The expected life of the options granted is based on the average of the vesting term and the contractual term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year yield curve in effect at the date of the grant.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 64 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has computed the fair value of all options granted during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> using the following assumptions:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Expected volatility</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Expected dividends</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Expected term (years)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> -</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Risk-free rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.54%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01%</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Forfeiture rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summarizes the stock options:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Fair<br /> Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Remaining<br /> Contractual Life</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2014</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">314,775</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.23</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.92</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.2</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,160</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.16</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(445</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.20</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77,031</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.30</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.7</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.22</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,824</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.88</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(146,560</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.34</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.66</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.86</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">347,272</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.07</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.38</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The intrinsic value of the Company&#x2019;s stock options outstanding was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$347,724</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> stock based compensation expense for stock options was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$561,559</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$328,772,</div> respectively.&nbsp;&nbsp;Unrecognized stock-based compensation expense for stock options for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$733,944,</div> which is expected to be recognized ratably over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.26</div> years.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Stock</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company granted restricted stock to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> employees to earn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000</div> shares of common stock. These shares vest over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> year period from grant date. The estimated fair market value of these shares was valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.62</div> per share, based on the Company&#x2019;s stock trading price, totaling approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$76,960</div> to be recognized ratably as the stock is vested.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company granted restricted stock awards to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> members of the Board of Directors. The awards have been granted under The Joint Corp. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> Incentive Stock Plan pursuant to the Director Compensation Policy of the Company. The awards shall vest on the earlier of (i) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the Grant Date and (ii) the date of the next annual meeting of the shareholders of the Company occurring after the Grant Date, for each to earn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,345</div> shares of common stock. The estimated fair market value of these shares was valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.10</div> per share, based on the Company&#x2019;s stock trading price, totaling approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$268,000</div> to be recognized ratably as the stock is vested.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 65 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The information below summaries the restricted stock activity:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Restricted Stock Awards</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Shares</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; font-size: 10pt">Outstanding at December 31, 2014</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">662,375</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Restricted stock awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited or exercised</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Granted at December 31, 2015</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">670,375</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards vested</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(331,087</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,415</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(162,440</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170,848</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> stock based compensation expense for restricted stock awards was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$561,922</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$496,373,</div> respectively.&nbsp;&nbsp;Unrecognized stock based compensation expense for restricted stock awards as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$155,969</div> to be recognized ratably over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.06</div> years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Modifications</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company accelerated the vesting of all unvested stock options and restricted stock awards granted to the Company&#x2019;s former chief development officer in connection with his separation from the Company. In addition, the Company modified the post-employment exercise period of the stock options previously granted, extending the exercise period to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company modified the post-employment exercise period of stock options previously granted to the Company&#x2019;s former chief executive officer in connection with his separation from the Company. The modification extended the exercise period to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> In addition, the Company accelerated the vesting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,733</div> shares of the previously granted restricted stock awards that were scheduled to vest in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The remaining unvested restricted stock awards were forfeited upon separation.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">These modifications resulted in an approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$412,000</div> increase in stock-based compensation for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Treasury Stock</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company acquired approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,376</div> shares of treasury stock to satisfy minimum tax withholding related to vesting of restricted stock awards. These shares were acquired at a total cost of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$83,391.</div></div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013,</div> the Company exercised its right of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> refusal under the terms of a Stockholders Agreement dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> to repurchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,000</div> shares of the Company&#x2019;s common stock. The shares were purchased for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.45</div> per share or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$240,000</div> in cash along with the issuance of an option to repurchase the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,000</div> shares. The repurchased shares were recorded as treasury stock, at cost in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$791,638,</div> and were available for general corporate purposes. The option is classified in equity as it is considered indexed to the Company&#x2019;s stock and meets the criteria for classification in equity.&nbsp;&nbsp;The option was granted to the seller for a term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> years.&nbsp;&nbsp;The option contained the following exercise prices:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 84%; font-size: 10pt">Year 1</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.56</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 3</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 4</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.03</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 5</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.28</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 6</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.59</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 7</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 8</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.45</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 66 -->   <!-- Field: /Page -->  <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.03</div> per share option for a total fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$551,638.</div> The option was valued using the Binomial Lattice-Based valuation methodology because that model embodies all of the relevant assumptions that address the features underlying the instrument.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the option holder partially exercised the call option, and purchased <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,872</div> shares at a total repurchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$210,000.</div> The Company reduced the cost of treasury shares by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$113,000</div> related to the transaction, reduced the value of the option by approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$259,000,</div> and reduced additional paid in capital by approximately $162,000.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Warrants</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In conjunction with the IPO, the Company issued warrants to the underwriters for the purchase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div> shares of common stock, which can be exercised between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.125</div> per share.&nbsp; The fair value of the warrants was determined using the Black-Scholes option valuation model. The warrants expire on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and have a remaining contractual life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div> years as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The information below summarizes the warrants:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Number of <br /> Units</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise Price</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Weighted <br /> Average <br /> Remaining <br /> Contractual Term<br /> (in years)</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Intrinsic <br /> Value</div></td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt">Outstanding at December 31, 2014</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.9</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-size: 10pt"><div style="display: inline; font-style: italic;">Issuance of Common Stock for Legal Settlement</div></div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a settlement agreement, whereby it resolved the pending litigation matter discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.</div> Under the terms of the settlement agreement, the Company agreed to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time settlement amount comprised of cash and newly issued shares of our common stock. The amounts paid by the Company in this settlement was determined by the Company not to be material. The fair value of the total consideration related to common stock was valued using the closing price of our common stock on the settlement date.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938600256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Income Taxes</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Income tax provision (benefit) reported in the consolidated statements of operations is comprised of the following:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Current provision (benefit):</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt">Federal</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(208,900</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">State, net of state tax credits</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,900</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(67,800</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total current provision (benefit)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(276,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Federal</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">97,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">State</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,300</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total deferred provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(235,900</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following are the components of the Company&#x2019;s net deferred taxes for federal and state income taxes:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,509,400</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,988,200</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(553,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(664,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,781,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Accrued expenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">74,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Goodwill - Component 1</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Goodwill - Component 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(44,100</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">182,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred rent</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">629,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Lease abandonment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,924,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,849,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Tax credits</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,200</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Asset basis difference related to property and equipment</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">630,900</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">167,500</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,496,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,574,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Less valuation allowance</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,617,100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,574,400</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net non-current deferred tax liability</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company has federal and state net operating losses of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22,613,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$24,948,000,</div> respectively. These net operating losses are available to offset future taxable income and will begin to expire in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2035</div> for federal purposes and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020</div> for state purposes.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 68 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following is a reconciliation of the statutory federal income tax rate applied to pre-tax accounting net income (loss), compared to the income tax provision (benefit) in the consolidated statement of operations:</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">For the Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax expense (benefit)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,106,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,071,300</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(735,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.90</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(387,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.29</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Effect of increase in valuation allowance</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,042,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,519,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Permanent differences</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(58,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.65</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Uncertain tax positions</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.51</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of changed state rates for deferred</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(80,100</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.89</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other, net</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(145,700</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.97</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(111,500</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.23</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Provision (Benefit)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.09</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(235,900</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2.60</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)%</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The state tax expense (benefit), penalties and interest stem from resolution of various voluntary disclosure agreements with multiple states where we had not yet been in compliance. In addition, we are responsible to pay certain minimum and franchise taxes to jurisdictions in which we do business.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Changes in our income tax expense related primarily to changes in pretax losses during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> as compared to year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> and the effective rate was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.1%</div> and -<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.6%,</div> respectively. The difference is due to a valuation allowance on the Company's deferred tax assets, and the impact of certain permanent differences on taxable income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company recorded a liability for income taxes for operations and uncertain tax positions of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$66,000,</div> respectively, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$27,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$33,000</div> respectively, represent penalties and interest and are recorded in the &#x201c;other liabilities&#x201d; section of the accompanying consolidated balance sheets. Interest and penalties associated with tax positions are recorded in the period assessed as general and administrative expenses. Management made a determination that the Company was not in compliance with several state and local tax jurisdictions in which the company was doing business. Accordingly, management undertook to analyze its tax exposures, both income and otherwise, with respect to jurisdictions in which compliance was deemed to be inadequate and the Company has entered into Voluntary Disclosure Agreements (VDAs) with the taxing authorities.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The following table sets forth a reconciliation of the beginning and ending amount of uncertain tax positions during the tax years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br /> penalties</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br /> penalties</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Unrecognized tax benefit - January 1</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91,700</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Gross decreases - tax positions in prior period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,400</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,200</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(59,100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Unrecognized tax benefit - December 31</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Our tax returns for tax years subject to examination by tax authorities include <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012</div> through the current period for state and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> through the current period for federal reporting purposes.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938781168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Related Party Transactions</div></td> </tr>  </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company entered into consulting and legal arrangements with certain stockholders related to services performed for the operations and transaction related activities of the Company.&nbsp;&nbsp;Amounts paid to or for the benefit of these stockholders was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$461,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$643,000</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.&nbsp;&nbsp;</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6596874288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Commitments and Contingencies</div></td> </tr>  </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Operating Leases</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio. During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company assumed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div> additional leases for clinic locations. These leases vary in length from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">127</div> months and have monthly payments ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,917</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,498.</div></div> <div style=" font-size: 10pt; text-align: right; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Total rent expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,389,971</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,574,803,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Future minimum annual lease payments are as follows:</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,180,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2018</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,587,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,248,195</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,982,392</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,868,976</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,180,991</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,048,079</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 27.8pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company ceased use of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> undeveloped clinic locations from its corporate clinics segment and recognized a liability for lease exit costs incurred based on the remaining lease rental due, reduced by estimated sublease rental income that could be reasonably obtained for the properties. The Company classified all of the approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$338,000</div> lease exit liability in other liabilities in the accompanying consolidated balance sheets as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and related expense in Loss on disposition or impairment in the accompanying consolidated statement of operations for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Litigation</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In the normal course of business, the Company is party to litigation from time to time.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> franchisees who owned a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> franchise licenses (&quot;Claimants&quot;) filed a Demand for Arbitration against the Company alleging breach of contract, breach of implied covenant of good faith and fair dealing, wrongful termination, fraud, promissory fraud, negligent misrepresentation, and claims under or arising out of violations of Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31300,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31301,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31201</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31202</div> of the California Franchise Investment Law. The Company vigorously denied liability for all of Claimants' claims and asserted counterclaims against each Claimant for breach of contract, breach of guaranty, among other claims, and sought a declaratory judgment that termination was proper because Claimants failed to adhere to the development schedules in their respective franchise agreements. The Company, through its counterclaim, sought damages for each unopened license, in accordance with the terms of the parties&#x2019; franchise agreements. The parties entered into a settlement agreement dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> which included, among other things, a mutual general release of claims. The arbitration was subsequently dismissed with prejudice, based on the parties' stipulation.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938777376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Segment Reporting</div></td> </tr>  </table> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments. The Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company operated or managed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div> clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the franchise system consisted of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div> clinics in operation. Corporate is a non-operating segment that develops and implements strategic initiatives and supports the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments by centralizing key administrative functions such as finance and treasury, information technology, insurance and risk management, litigation and human resources. Corporate also provides the necessary administrative functions to support the Company as a publicly traded company. A portion of the expenses incurred by Corporate are allocated to the operating segments.&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 70 -->   <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The tables below present financial information for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> operating business segments (in thousands):</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Revenues:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,550</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,492</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,974</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,344</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total revenues</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,524</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,836</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,736</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,773</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,638</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,234</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total segment operating (loss) income</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,098</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">461</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,186</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">986</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Corporate administration</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">283</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total depreciation and amortization</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,566</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,269</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Reconciliation of total segment operating (loss) income to consolidated loss before income taxes (in thousands):</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Total segment operating (loss) income</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,098</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">461</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Unallocated corporate</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,925</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,777</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Consolidated loss from operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,023</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,316</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Bargain purchase gain</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">261</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other income, net</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loss before income tax expense</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,010</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,033</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;">  <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Segment assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 20pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,936</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,426</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,003</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,580</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt">Total segment assets</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,939</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,006</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated cash and cash equivalents and restricted cash</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,344</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,178</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">781</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">802</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Other unallocated assets</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">991</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">376</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,055</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,362</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr>  </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&#x201c;Unallocated cash and cash equivalents and restricted cash&#x201d; relates primarily to corporate cash and cash equivalents and restricted cash (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1),</div> &#x201c;unallocated property and equipment&#x201d; relates primarily to corporate fixed assets, and &#x201c;other unallocated assets&#x201d; relates primarily to deposits, prepaid and other assets.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771134464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellspacing="0" cellpadding="0" style="; font-size: 10pt;">  <tr style="vertical-align: top; text-align: justify"> <td style="width: 73px; text-align: left"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13:</div></div></td> <td style="width: 7px"></td> <td style="text-align: justify"><div style="display: inline; font-weight: bold;">Subsequent Events</div></td> </tr>  </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit and Security Agreement</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company entered into a Credit and Security Agreement (the &#x201c;Credit Agreement&#x201d;), and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000,000</div> under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per annum, provided, that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$200,000.</div> Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but not less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$25,000.</div> The lender&#x2019;s lending commitments under the Credit Agreement terminate in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> unless sooner terminated in accordance with the provisions of the Credit Agreement. The Company intends to use the credit facility for general working capital needs. The Company has drawn <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,000,000</div> of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000,000</div> available under the Credit Agreement.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Clinic Sales</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company sold the assets of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> of its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> clinics in the Chicago area for a nominal amount to a partnership that includes existing Company franchisees. The purchaser will continue to operate the clinics as franchised locations pursuant to a franchise agreement. The Company concurrently sold to the limited liability company regional developer rights to Chicago for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$300,000.</div> Pursuant to the regional developer agreement, the limited liability company has agreed to open a minimum of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> Chicago area clinics over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> years, with plans to open <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> clinics over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> months. The Company has closed the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> Chicago-area clinics, as well as <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> Company-managed clinics in upstate New York. These assets were deemed as held for sale as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and accordingly the Company recognized a loss on impairment of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.5</div> million.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775789200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The accompanying consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> LLC (collectively, the &#x201c;Company&#x201d;), which was dormant for all periods presented.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from selling and marketing expenses to general and administrative expenses for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> to conform to current year presentation.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Comprehensive Loss</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;Net loss and comprehensive loss are the same for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NatureOfOperationsPolicyPolicyTextBlock', window );">Nature of Operations Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Joint Corp., a Delaware corporation, was formed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010.</div> Its principal business purposes are owning, operating, managing and franchising chiropractic clinics, selling regional developer rights and supporting the operations of owned, managed and franchised chiropractic clinics at locations throughout the United States of America. The franchising of chiropractic clinics is regulated by the Federal Trade Commission and various state authorities.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">242</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">312</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinic licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">168</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ManagementsPlanPolicyPolicyTextBlock', window );">Management's Plan, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Management's Plans</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had cash and short-term bank deposits of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.0</div> million. To preserve cash, the Company does not plan to add any company-owned or managed clinics during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> fiscal year. Additionally, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company made the decision to close or sell <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics in Chicago and New York. As a result, the Company has significantly reduced its estimated cash needs for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million. The cash used in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> included expenditures for the acquisition or development of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> company-owned or managed clinics, and the working capital losses in the Chicago and New York markets which amounted to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.8</div> million for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> As the Company has no current plans to acquire or develop company-owned or managed clinics during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and has sold or closed the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> clinics in the Chicago and New York markets, the Company&#x2019;s projected use of cash in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> is significantly lower than the amount of cash used in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Furthermore, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company executed a Credit and Security Agreement which provided a credit facility of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.0</div> million. Taking into account these tactical decisions made by the Company&#x2019;s management, as well as the execution of the credit facility, the Company has concluded that it can continue as a going concern for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year from the date that the financial statements were available to be issued.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Variable Interest Entities</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a&nbsp;variable interest entity&nbsp;(&#x201c;VIE&#x201d;) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and are not the primary beneficiary are accounted for under the equity method.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Certain states in which the Company manages clinics, regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with PCs under which the Company provides on an exclusive basis, all non-clinical services of the chiropractic practice.&nbsp;The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activity of the PCs is not included in the Company&#x2019;s consolidated financial statements</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Cash and Cash Equivalents</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company considers all highly liquid instruments purchased with an original maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. As of the balance sheet date and periodically throughout the period, the Company has maintained balances in various operating accounts in excess of federally insured limits. The Company has invested substantially all of the proceeds of its public offerings in short-term bank deposits. The Company had no cash equivalents as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Restricted Cash</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Restricted cash relates to cash franchisees and corporate clinics contribute to the Company&#x2019;s National Marketing Fund and cash franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Franchise Disclosure Document with a focus on regional and national marketing and advertising.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentrations of Credit Risk</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">From time to time the Company grants credit in the normal course of business to PCs or franchisees related to the working capital needs of the PC, collection of royalties, or other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the PCs or franchisees to reduce credit risk. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> PC entity, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> franchisees represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31%,</div> respectively, of outstanding accounts receivable. The Company did not have any PCs or franchisees that represented greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of our revenues during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade and Other Accounts Receivable, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounts Receivable</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Accounts receivable represent amounts due from franchisees for initial franchise fees, royalty fees, marketing and advertising expenses and amounts due from PCs for which we perform management services for the repayment of working capital advances. The Company considers an allowance for doubtful accounts based on the creditworthiness of the franchisee or named entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management&#x2019;s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. The losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had an allowance for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$131,830</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$142,660,</div> respectively.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 52 --> <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company writes off accounts receivable when it deems them uncollectible and records recoveries of accounts receivable previously written off when it receives them. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company determined that certain working capital advances from its PC entities in Illinois and New York were no longer collectible as a result of the sale or closure of the related clinics. Accordingly, the Company wrote-off <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$731,857</div> of accounts receivable to loss on disposition or impairment related to these entities during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionServicesCommissions', window );">Revenue Recognition, Services, Commissions [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Franchise Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are expensed when the respective revenue is recognized, which is generally upon the opening of a clinic.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal Use Software, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Software Developed</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> years.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships.&nbsp;&nbsp;The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eight</div> years. The Company amortizes the acquired regional developer rights over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> years. The fair value of customer relationships is amortized over their estimated useful life of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>&nbsp;years.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$38,185</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> related to closure of an acquired clinic in New York.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Goodwill</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions discussed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div>&nbsp;&nbsp;Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter or more frequently if events or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$54,994</div> during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> which represents the write-off of the goodwill associated with the closure of an acquired clinic in New York.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Long-Lived Assets</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets have been impaired. Impairments of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.4</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> were recorded for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AdvertisingFundPolicyTextBlock', window );">Advertising Fund, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Fund</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of clinic sales. The Company segregates the marketing funds collected which are included in restricted cash on its consolidated balance sheets. As amounts are expended from the fund, the Company recognizes advertising fund revenue and a related expense. Amounts collected in excess of marketing expenditures are included in restricted cash on the Company&#x2019;s consolidated balance sheets.&nbsp;</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CooperativeAdvertisingPolicy', window );">Cooperative Advertising Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Co-Op Marketing Funds</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops&#x2019; officers. The marketing funds are included in restricted cash on the Company&#x2019;s consolidated balance sheets.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Accounting for Costs Associated with Exit or Disposal Activities </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">Costs to terminate an operating lease or other contracts are (a)&nbsp;costs to terminate the contract before the end of its term or (b)&nbsp;costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows shall be recognized as an adjustment to the liability in the period of the change.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 24.5pt; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> the Company recognized a liability of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million related to operating leases that will no longer provide economic benefit to the entity, net of estimated sublease income.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasePolicyTextBlock', window );">Lease, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Deferred Rent</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company leases office space for its corporate offices and company-owned and managed clinics under operating leases, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> include rent holidays and rent escalation clauses.&nbsp; It recognizes rent holiday periods and scheduled rent increases on a straight-line basis over the term of the lease.&nbsp; The Company records <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">tenant</div> improvement allowances as deferred rent and amortizes the allowance over the term of the lease, as a reduction to rent expense.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionServicesFranchiseFees', window );">Revenue Recognition, Services, Franchise Fees [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Franchise Fees.</div> The Company requires the entire non-refundable initial franchise fee to be paid upon execution of a franchise agreement, which typically has an initial term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years. Initial franchise fees are recognized as revenue when the Company has substantially completed its initial services under the franchise agreement, which typically occurs upon opening of the clinic.&nbsp;&nbsp;The Company&#x2019;s services under the franchise agreement include: training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. The Company provides no financing to franchisees and offers no guarantees on their behalf.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDeveloperFeesPolicyPolicyTextBlock', window );">Regional Developer Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Regional Developer Fees</div>. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> the Company established a regional developer program to engage independent contractors to assist in developing specified geographical regions. Under this program, regional developers pay a license fee ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,250</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the then current franchise fee, for each franchise they receive the right to develop within the region. Each regional developer agreement establishes a minimum number of franchises that the regional developer must develop. Regional developers receive fees ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,500</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,950</div> which are collected from franchisees upon the sale of franchises within their region and a royalty of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3%</div> of sales generated by franchised clinics in their region. Regional developer license fees paid to us are non-refundable and are recognized as revenue when the Company has performed substantially all initial services required by the regional developer agreement, which generally is considered to be upon the opening of each franchised clinic. Accordingly, revenue is recognized on a pro-rata basis determined by the number of franchised clinics to be opened in the area covered by the regional developer agreement. Upon the execution of a regional developer agreement, the Company estimates the number of franchised clinics to be opened, which is typically consistent with the contracted minimum. The Company reassesses the number of clinics expected to be opened as the regional developer performs under its regional developer agreement. When a material change to the original estimate becomes apparent, the amount of revenue to be recognized per clinic is revised on a prospective basis, and the unrecognized fees are allocated among, and recognized as revenue upon the opening of, the expected remaining unopened franchised clinics within the region. Certain regional developer agreements provide that no additional fee is required for franchises developed by the regional developer above the contracted minimum, while other regional developer agreements require a supplemental payment. The franchisor&#x2019;s services under regional developer agreements include site selection, grand opening support for the clinics, sales support for identification of qualified franchisees, general operational support and marketing support to advertise for ownership opportunities. Several of the regional developer agreements grant the Company the option to repurchase the regional developer&#x2019;s license.&nbsp;</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock', window );">Revenues and Management Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Revenues and Management Fees from Company Clinics.&nbsp;&nbsp;</div>The Company earns revenues from clinics that it owns and operates or manages throughout the United States.&nbsp; In those states where the Company owns and operates the clinic, revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.&nbsp; Amounts collected up front for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.&nbsp;&nbsp;In other states where state law requires the chiropractic practice to be owned by a licensed chiropractor, the Company enters into a management agreement with the doctor&#x2019;s PC.&nbsp; Under the management agreement, the Company provides administrative and business management services to the doctor&#x2019;s PC in return for a monthly management fee.&nbsp; When the collectability of the full management fee is uncertain, the Company recognizes management fee revenue only to the extent of fees expected to be collected from the PCs.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RoyaltiesPolicyPolicyTextBlock', window );">Royalties, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Royalties.</div> The Company collects royalties, as stipulated in the franchise agreement, equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7%</div> of gross sales, and a marketing and advertising fee currently equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> of gross sales. Certain franchisees with franchise agreements acquired during the formation of the Company pay a monthly flat fee. Royalties are recognized as revenue when earned. Royalties are collected bi-monthly <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> working days after each sales period has ended.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock', window );">IT Related Income And Software Fees, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">IT Related Income and Software Fees.</div>&nbsp;&nbsp;The Company collects a monthly computer software fee for use of its proprietary chiropractic software, computer support, and internet services support. These fees are recognized on a monthly basis as services are provided. IT related revenue represents a flat fee to purchase a clinic&#x2019;s computer equipment, operating software, preinstalled chiropractic system software, key card scanner (patient identification card), credit card scanner and credit card receipt printer. These fees are recognized as revenue&nbsp;upon receipt of equipment by the franchisee.</div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Advertising Costs</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Advertising costs are expensed as incurred. Advertising expenses for years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,279,572</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,525,687,</div> respectively.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Income Taxes</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> likelihood of being realized upon ultimate resolution.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Loss per Common Share</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,797,321</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.88</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive:</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Stock-Based Compensation</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets, and purchase price allocations.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 45pt 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>&#x201d;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard becomes effective for us on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company has completed a preliminary review of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> and does not expect the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to have a material impact on its revenues and management fees from company clinics or franchise royalty revenues. The Company is currently evaluating the impact of the adoption of this standard on recognition of revenue from franchise agreements, advertising fund revenue, and regional developer fee revenue. The Company is still evaluating its transition approach and expects to reach a decision in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> half of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> &#x201c;<div style="display: inline; font-style: italic;">Presentation of Financial Statements - Going Concern: Disclosures about an Entity&#x2019;s Ability to Continue as a Going Concern</div>.&#x201d; The new standard requires management to perform interim and annual assessments of an entity&#x2019;s ability to continue as a going concern within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. The new guidance is effective for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods thereafter. The Company adopted this new standard as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued&nbsp;ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03,</div> &#x201c;<div style="display: inline; font-style: italic;">Interest - Imputation of Interest (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">835</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30):</div> Simplifying the Presentation of Debt Issuance Costs</div>.&#x201d;&nbsp; The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset.&nbsp; Debt disclosures will include the face amount of the debt liability and the effective interest rate.&nbsp; The update requires retrospective application and represents a change in accounting principle.&nbsp; The update is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div>&nbsp; ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> did not have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805):</div> Simplifying the Accounting for Measurement-Period Adjustments</div>.&#x201d; The update requires than an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes. The Company adopted this ASU during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Accordingly, the Company applied the amendments in this update to the measurement period adjustments made during the year and disclosed the adjustments in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> &#x201c;<div style="display: inline; font-style: italic;">Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">470):</div> Balance Sheet Classification of Deferred Taxes</div>.&#x201d; The update eliminates the requirement to separate deferred income tax assets and liabilities into current and noncurrent amounts within a classified balance sheet. Under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> the presentation of deferred income taxes is simplified, as all deferred income tax assets and liabilities are to be classified as noncurrent. The existing requirement that deferred income tax assets and liabilities of a tax-paying component of an entity be offset and presented as a single amount is not affected by ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.</div> The Company has adopted the guidance under ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> retrospectively and prior periods were retrospectively adjusted.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 57 --> <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Financial Instruments - Overall (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10),</div> Recognition and Measurement of Financial Assets and Financial Liabilities</div>,&#x201d; which addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> will be effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years, and early adoption is not permitted. The Company is currently evaluating the effect of adoption of this standard, if any, on its consolidated financial position, results of operations or cash flows.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div>&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842).&#x201d;</div></div> The changes require that substantially all operating leases be recognized as assets and liabilities on our balance sheet, which is a significant departure from the current standard, which classifies operating leases as off balance sheet transactions and accounts for only the current year operating lease expense in the statement of operations. The right to use the leased property is to be capitalized as an asset and the expected lease payments over the life of the lease will be accounted for as a liability. The effective date is for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> While we have not quantified the impact this proposed standard would have on our consolidated financial statements, if our current operating leases are instead recognized on the consolidated balance sheet, it will result in a significant increase in the liabilities reflected on our consolidated balance sheet and in the interest expense and depreciation and amortization expense reflected in our consolidated statements of operations, while reducing the amount of rent expense. This could potentially decrease our reported net income.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;<div style="display: inline; font-style: italic;">Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting</div>&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;),</div> which amends ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation &#x2013; Stock Compensation (&#x201c;ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718&#x201d;).</div> The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the accounting for income taxes, classification of excess tax benefits on the statement of cash flows, forfeitures, statutory tax withholding requirements, classification of awards as either equity or liabilities, and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for interim and annual reporting periods beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Early adoption is permitted. The Company is currently evaluating the method of adoption and impact the update will have on its consolidated financial statements and related disclosures.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606):</div> Identifying Performance Obligations and Licensing</div>&#x201d;, to clarify the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> aspects of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606:</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div> identifying performance obligations, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> the licensing implementation guidance. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,</div> &#x201c;<div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606):</div> Narrow-Scope Improvements and Practical Expedients</div>&#x201d;, to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">&#x201c;Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Classification of Certain Cash Receipts and Cash Payments&#x201d;. </div>This update addresses how certain cash inflows and outflows are classified in the statement of cash flows to eliminate existing diversity in practice. This update is effective for annual and interim reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Early adoption is permitted. The Company is currently evaluating the impact of this amendment on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> &#x201c;<div style="display: inline; font-style: italic;">Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230):</div> Restricted Cash&#x201d;</div> (a consensus of the FASB Emerging Issues Task Force), to provide guidance on the presentation of restricted cash or restricted cash equivalents in the statement of cash flow. The amendments should be applied using a retrospective transition method, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 58 --> <!-- Field: /Page --> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; text-indent: 15pt; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the FASB issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> &#x201c;<div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805):</div> Clarifying the Definition of a Business&#x201d;,</div> to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments should be applied prospectively, and are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.</div></div></div></div></div></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AdvertisingFundPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the advertising fund.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AdvertisingFundPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income and software fees related to information technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ITRelatedIncomeAndSoftwareFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ManagementsPlanPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for management's plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ManagementsPlanPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NatureOfOperationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NatureOfOperationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDeveloperFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for regional developer fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDeveloperFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the revenues and management fees from the Company clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RevenuesAndManagementFeesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RoyaltiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the royalties from franchises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RoyaltiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054294&amp;loc=d3e8384-108330<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68072981&amp;loc=d3e8275-108329<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68064133&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64801991&amp;loc=SL6759159-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64801991&amp;loc=d3e5728-111685<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=64801991&amp;loc=SL6759068-111685<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CooperativeAdvertisingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for offsetting cash consideration received from a vendor arising from cooperative advertising arrangements against advertising expense when such consideration represents a reimbursement of a specific, incremental, identifiable cost incurred by the entity in selling the vendor's products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cooperative Advertising<br> -URI http://asc.fasb.org/extlink&amp;oid=51574790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 50<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68069731&amp;loc=d3e63739-111659<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Consideration<br> -URI http://asc.fasb.org/extlink&amp;oid=34715922<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CooperativeAdvertisingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6389767&amp;loc=d3e17916-109280<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements (both lessor and lessee). This disclosure may address (1) lease classification (that is, operating versus capital), (2) how the term of a lease is determined (for example, the circumstances in which a renewal option is considered part of the lease term), (3) how rental revenue or expense is recognized for a lease that contains rent escalations, (4) an entity's accounting treatment for deferred rent, including that which arises from lease incentives, rent abatements, rent holidays, or tenant allowances (5) an entity's accounting treatment for contingent rental payments and (6) an entity's policy for reviewing, at least annually, the residual values of sales-type and direct-finance leases. The disclosure also may indicate how the entity accounts for its capital leases, leveraged leases or sale-leaseback transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453394&amp;loc=d3e39740-112701<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14754-158437<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6456037&amp;loc=d3e48589-112741<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionServicesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for commission revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 20<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=68047264&amp;loc=d3e48393-111629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionServicesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionServicesFranchiseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for franchising fees, which is consideration or a share of proceeds paid to the entity by another party for the right to operate a business using the entity's name, merchandise, and supplies. Furthermore, discloses whether the installment or cost recovery method is being used to account for franchise fee revenue if no basis exists for estimating the collectability of specific franchise fees, the sales price of such franchises, the revenue and related costs deferred, the periods in which the fees will become payable by the franchisee, and fees originally deferred but later recognized because uncertainties regarding the collectability of the fees have been resolved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 952<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68064525&amp;loc=d3e68593-108044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionServicesFranchiseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65890831&amp;loc=d3e10133-111534<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5212-111524<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5093-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938721280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Non-cash Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">293,014</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,728</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,780</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,042,522</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,072</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">997,450</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,450,333</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,947,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">528,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,899,449</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,824,857</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Unfavorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(74,927</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(106,908</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,643,022</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred tax liability</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(168,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Bargain purchase gain</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(261,147</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,213,875</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Property and equipment</div></td> <td style="width: 2%; font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="width: 22%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">(53,836</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Intangible assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">4,820</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Favorable leases</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">6,250</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">Goodwill</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">68,616</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">Unfavorable leases</div></td> <td style="font-size: 10pt"><div style="display: inline; font-size: 9pt">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-size: 9pt">(25,850</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-size: 9pt">)</div></td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6711531168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock', window );">Schedule of Franchisor Disclosure [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Franchised clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">242</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">309</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">265</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">Company-owned or managed clinics:</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-size: 10pt; text-align: left; padding-left: 10pt">Clinics in operation at beginning of period</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Opened during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Acquired during the period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Closed during the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">61</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total clinics in operation at the end of the period</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">370</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">312</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Clinic licenses sold but not yet developed</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">168</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Net loss</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,173,872</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,797,321</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Weighted average common shares outstanding - basic</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of dilutive securities:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Stock options</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Weighted average common shares outstanding - diluted</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,696,649</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,042,001</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Basic and diluted loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.20</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.88</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> &nbsp;December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Unvested restricted stock</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Warrants</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of franchisors that are included in the discussion of the nature of an entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFranchisorDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938756464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">293,014</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,728</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,780</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,042,522</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,072</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">997,450</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">Property and equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,450,333</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Intangible assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,947,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Favorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">528,075</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Goodwill</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,899,449</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,824,857</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Unfavorable leases</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(74,927</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Deferred membership revenue</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(106,908</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net assets acquired</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,643,022</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred tax liability</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(168,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Bargain purchase gain</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(261,147</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Net purchase price</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,213,875</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Pro Forma for the Year Ended</td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2016</td> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</td> <td colspan="3" nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Revenues, net</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,985,277</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16,375,930</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Net loss</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,483,492</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,187,416</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771112208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Office and computer equipment</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,083,039</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">963,299</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Leasehold improvements</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,085,366</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,672,582</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Software developed</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">891,192</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">691,827</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,059,597</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,327,708</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Accumulated depreciation</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,566,172</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,098,438</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,493,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,229,270</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Construction in progress</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">231,281</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,909,476</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,724,706</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,138,746</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938765856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="11" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">As of December 31, 2016</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Gross Carrying<br /> Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Accumulated<br /> Amortization</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Net Carrying<br /> Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Amortized intangible assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-align: left">Reacquired franchise rights</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,911,750</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">444,795</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,466,955</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Customer relationships</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">701,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">509,042</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">191,958</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Reacquired development rights</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">923,250</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">243,241</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,009</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,536,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,197,078</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 16%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">578,881</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2018</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">439,589</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">413,256</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">348,034</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,906</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,338,922</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771313632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 18%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">331,500</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">331,500</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938763552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; text-align: right">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Expected volatility</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Expected dividends</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Expected term (years)</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 5%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.5</div></td> <td style="width: 6%; font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> -</div></td> <td style="width: 5%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Risk-free rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.68%</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.54%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01%</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Forfeiture rate</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20%</div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Fair<br /> Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted<br /> Average<br /> Remaining<br /> Contractual Life</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2014</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">314,775</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.23</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.92</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.2</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">240,160</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.16</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(445</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.20</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(77,031</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">477,459</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.30</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.01</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.7</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Granted at market price</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">660,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.22</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(37,824</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.88</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Cancelled</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(146,560</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.34</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">953,075</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.66</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.86</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">347,272</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.07</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.38</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.1pt solid">Restricted Stock Awards</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Shares</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; font-size: 10pt">Outstanding at December 31, 2014</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">662,375</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Restricted stock awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited or exercised</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Granted at December 31, 2015</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">670,375</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards vested</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(331,087</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">339,288</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Awards granted</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,415</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Awards vested</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(162,440</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Awards forfeited</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170,848</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,415</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 84%; font-size: 10pt">Year 1</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.56</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.68</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 3</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.84</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 4</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.03</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 5</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.28</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 6</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.59</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Year 7</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Year 8</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.45</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Number of <br /> Units</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Weighted<br /> Average<br /> Exercise Price</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Weighted <br /> Average <br /> Remaining <br /> Contractual Term<br /> (in years)</div></td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; text-align: center; border-bottom: Black 1.1pt solid"><div style="display: inline; font-weight: bold;">Intrinsic <br /> Value</div></td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt">Outstanding at December 31, 2014</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.9</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2015</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Granted</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Exercisable at December 31, 2016</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.13</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771171728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Current provision (benefit):</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt">Federal</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,800</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(208,900</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">State, net of state tax credits</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,900</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(67,800</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Total current provision (benefit)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(276,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred provision:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Federal</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">97,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">State</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,300</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total deferred provision</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">120,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(235,900</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left">Deferred revenue</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,509,400</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,988,200</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Deferred franchise costs</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(553,900</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(664,000</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Allowance for doubtful accounts</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,781,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Accrued expenses</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">74,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Goodwill - Component 1</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Goodwill - Component 2</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Restricted stock compensation</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(44,100</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Nonqualified stock options</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">182,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Deferred rent</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">629,600</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">209,700</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Lease abandonment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Net operating loss carryforwards</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,924,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,849,100</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Tax credits</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,200</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Charitable contribution carryover</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,500</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,300</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Asset basis difference related to property and equipment</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">630,900</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">167,500</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,496,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,574,400</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Less valuation allowance</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,617,100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,574,400</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net non-current deferred tax liability</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120,700</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="15" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">For the Years Ended December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Percent</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Expected federal tax expense (benefit)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,106,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,071,300</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34.00</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">State tax provision, net of federal benefit</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(735,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.90</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(387,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4.29</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Effect of increase in valuation allowance</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,042,900</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.24</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,519,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38.97</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Permanent differences</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">108,800</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.72</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(58,800</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.65</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Uncertain tax positions</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46,500</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.51</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Effect of changed state rates for deferred</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(80,100</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.89</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Other, net</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(145,700</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.97</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(111,500</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1.23</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Provision (Benefit)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">164,400</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.09</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">%</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(235,900</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2.60</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)%</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br /> penalties</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Tax</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Interest/<br /> penalties</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left">Unrecognized tax benefit - January 1</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91,700</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,000</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Gross increases - tax positions in prior period</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt">Gross decreases - tax positions in prior period</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,400</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,200</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(59,100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Unrecognized tax benefit - December 31</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,200</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26,800</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32,600</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=75116239&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938660480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">2017</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 20%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,180,100</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2018</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,587,425</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2019</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,248,195</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">2020</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,982,392</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2021</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,868,976</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt">Thereafter</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,180,991</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt">Total</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,048,079</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6921645136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlock', window );"><strong>Notes Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="7" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Year Ended<br /> December 31,</td> </tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Revenues:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,550</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,492</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,974</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,344</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total revenues</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,524</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,836</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Segment operating (loss) income:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,736</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,773</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,638</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,234</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total segment operating (loss) income</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,098</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">461</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Depreciation and amortization:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Corporate clinics</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,186</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">986</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Franchise operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Corporate administration</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">380</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">283</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total depreciation and amortization</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,566</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,269</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Reconciliation of total segment operating (loss) income to consolidated loss before income taxes (in thousands):</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Total segment operating (loss) income</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,098</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">461</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Unallocated corporate</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,925</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,777</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Consolidated loss from operations</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,023</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,316</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Bargain purchase gain</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">261</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 10pt">Other income, net</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loss before income tax expense</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,010</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,033</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse;"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2016</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td nowrap="nowrap" colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2015</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Segment assets:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-size: 10pt; text-align: left; padding-left: 20pt">Corporate clinics</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,936</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,426</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Franchise operations</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,003</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,580</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 30pt">Total segment assets</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,939</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,006</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated cash and cash equivalents and restricted cash</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,344</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,178</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Unallocated property and equipment</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">781</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">802</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; padding-left: 20pt">Other unallocated assets</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">991</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">376</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,055</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,362</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8813-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775778656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Non-cash Information (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,262<span></span>
</td>
<td class="nump">2,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">$ 224,750<span></span>
</td>
<td class="nump">224,750<span></span>
</td>
<td class="nump">914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
<td class="nump">4,925,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">46,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">13,023,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember', window );">Franchise Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="nump">1,005,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">293,014<span></span>
</td>
<td class="nump">293,014<span></span>
</td>
<td class="nump">1,504,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="nump">339,000<span></span>
</td>
<td class="nump">339,000<span></span>
</td>
<td class="nump">1,942,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,780<span></span>
</td>
<td class="nump">1,830,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Favorable Leases</a></td>
<td class="nump">140,728<span></span>
</td>
<td class="nump">140,728<span></span>
</td>
<td class="nump">521,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">45,072<span></span>
</td>
<td class="nump">45,072<span></span>
</td>
<td class="nump">106,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
<td class="nump">4,925,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,000<span></span>
</td>
<td class="nump">800,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice', window );">Deferred Franchise Costs Netted Against Aggregate Purchase Price</a></td>
<td class="nump">$ 1,450<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">493,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member', window );">Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,059<span></span>
</td>
<td class="nump">1,109,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=jynt_AccruedExpensesMember', window );">Accrued Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the favorable leases in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the unfavorable leases in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred franchise costs netted against the aggregate purchase price of acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCostsNettedAgainstAggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary difference assumed at the acquisition date that are classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=jynt_AccountsPayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=jynt_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=jynt_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6767007424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Cash Flow Information - Value of Assets Acquired and Liabilities Assumed (Details) - Reacquisitions of Franchises Throughout Arizona, California and New York [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment', window );">Property and equipment</a></td>
<td class="num">$ (53,836)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment', window );">Intangible assets</a></td>
<td class="nump">4,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment', window );">Favorable leases</a></td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="nump">68,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment', window );">Unfavorable leases</a></td>
<td class="num">$ (25,850)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of a fair value adjustment realized during the reporting period to favorable leases acquired in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeasesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of a fair value adjustment realized during the reporting period to intangible assets, other than goodwill, acquired in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of a fair value adjustment realized during the reporting period to property, plant and equipment acquired in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of a fair value adjustment realized during the reporting period to unfavorable leases acquired in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeasesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783284128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 03, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="nump">$ 3,009,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,009,864<span></span>
</td>
<td class="nump">$ 16,792,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,796,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses', window );">Cash Used for Investing Activities Including Working Capital Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for Doubtful Accounts Receivable</a></td>
<td class="nump">131,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,830<span></span>
</td>
<td class="nump">142,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Allowance for Doubtful Accounts Receivable, Write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">731,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, Written off Related to Sale of Business Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of Long-Lived Assets Held-for-use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage', window );">Franchise Monthly Marketing Fee Gross Sales Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersLicenseFee', window );">Regional Developers License Fee</a></td>
<td class="nump">7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage', window );">Regional Developers License Fee Current Franchise Fee Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage', window );">Regional Developers Royalty Sales Generated by Franchises Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_FranchiseRoyaltyGrossSalesPercentage', window );">Franchise Royalty Gross Sales Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,279,572<span></span>
</td>
<td class="nump">1,525,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash Equivalents, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember', window );">Development Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember', window );">Franchise Rights and Customer Relationships, Reacquired [Member] | Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise', window );">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</a></td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise', window );">Regional Developers, Franchise Fees Collected Upon Sale of Franchise</a></td>
<td class="nump">$ 19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | One PC Entity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfPCEntities', window );">Number of PC Entities</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Six Franchisees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfFranchises', window );">Number of Franchises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EstimatedCashNeeds', window );">Estimated Cash Needs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=jynt_ChicagoAndNewYorkMember', window );">Chicago and New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfStoresToCloseOrSell', window );">Number of Stores to Close or Sell</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash used for investing activities including working capital losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_CashUsedForInvestingActivitiesIncludingWorkingCapitalLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EstimatedCashNeeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of estimated cash needs during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EstimatedCashNeeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales a franchise pays for monthly marketing fees as stipulated in the typical franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseMonthlyMarketingFeeGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_FranchiseRoyaltyGrossSalesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross sales collected as royalties from franchises typically collected bi-monthly two working days after each sales period has ended as stipulated in the franchise agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_FranchiseRoyaltyGrossSalesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfFranchises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of franchises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfFranchises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfPCEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of PC entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfPCEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfStoresToCloseOrSell">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores to close or sell during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfStoresToCloseOrSell</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of franchise fees collected upon sale of franchise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersFranchiseFeesCollectedUponSaleOfFranchise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of license fees that must be paid by regional developers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the then current franchise fee regional developers pay as a license fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersLicenseFeeCurrentFranchiseFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of sales generated by franchised clinics in their region regional developers receive as royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RegionalDevelopersRoyaltySalesGeneratedByFranchisesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68075217&amp;loc=SL9156395-115594<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68048823&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Impairment<br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=jynt_OnePcEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=jynt_OnePcEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=jynt_SixFranchiseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=jynt_SixFranchiseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_ChicagoAndNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_ChicagoAndNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6934320160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at beginning of period</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsSoldButNotYetOperational', window );">Clinic licenses sold but not yet developed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember', window );">Franchised Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at beginning of period</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened during the period</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember', window );">Entity Operated Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at beginning of period</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsOpenedDuringThePeriod', window );">Opened during the period</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsClosedDuringThePeriod', window );">Closed during the period</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Clinics in operation at the end of the period</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClinicsAcquiredDuringThePeriod', window );">Acquired during the period</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsAcquiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsAcquiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsClosedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of clinics closed during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsClosedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsOpenedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of number of clinics opened during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsOpenedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClinicsSoldButNotYetOperational">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that have been sold as franchises, but are not yet operational.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClinicsSoldButNotYetOperational</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_FranchisedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorDisclosureAxis=us-gaap_EntityOperatedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775663360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,173,872)<span></span>
</td>
<td class="num">$ (8,797,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">12,696,649<span></span>
</td>
<td class="nump">10,042,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Stock options (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">12,696,649<span></span>
</td>
<td class="nump">10,042,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (1.20)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1757-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Treasury Stock Method<br> -URI http://asc.fasb.org/extlink&amp;oid=6527216<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Call Option<br> -URI http://asc.fasb.org/extlink&amp;oid=6506649<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Warrant<br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938635600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">92,415<span></span>
</td>
<td class="nump">339,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">953,075<span></span>
</td>
<td class="nump">477,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive Securities (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783023152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,750<span></span>
</td>
<td class="nump">$ 914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business Combination, Bargain Purchase, Gain Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 261,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member}</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod', window );">Number of Developed Franchises Reacquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod', window );">Number of Undeveloped Franchises Reacquired During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics', window );">Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCosts', window );">Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member} | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod', window );">Number of Developed Franchises Reacquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod', window );">Number of Undeveloped Franchises Reacquired During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,725,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,925,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics', window );">Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,005,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredFranchiseCosts', window );">Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,213,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfFranchisesClosed', window );">Number of Franchises Closed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated', window );">Number of Reacquired Undeveloped Franchises that Have Been Terminated and May Be Relocated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business Combination, Bargain Purchase, Gain Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | Tempe, AZ [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business Combination, Bargain Purchase, Gain Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | San Diego, CA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod', window );">Number of Developed Franchises Reacquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod', window );">Number of Undeveloped Franchises Reacquired During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business Combination, Bargain Purchase, Gain Recognized, Amount</a></td>
<td class="nump">$ 27,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,449,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | Franchise Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | Franchise Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred costs incurred and are directly related to generating franchise revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate number of developed franchises reacquired by the Company during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfDevelopedFranchisesReacquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfFranchisesClosed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of franchises that were closed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfFranchisesClosed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of the reacquired developed franchises that the Company is operating as company-owned or managed clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfReacquiredDevelopedFranchisesOperatedAsCompanyOwnedOrManagedClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of the reacquired undeveloped franchises that have been terminated and the Company may relocate them.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfReacquiredUndevelopedFranchisesThatHaveBeenTerminatedAndMayBeRelocated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate number of undeveloped franchises reacquired by the Company during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUndevelopedFranchisesReacquiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_TempeAZMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_TempeAZMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_SanDiegoCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_SanDiegoCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6934246128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,750,338<span></span>
</td>
<td class="nump">$ 2,466,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(261,147)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember', window );">Reacquisitions of Franchises Throughout California and New Mexico [Member}</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">293,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases', window );">Favorable leases</a></td>
<td class="nump">140,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">269,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">1,042,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred membership revenue</a></td>
<td class="num">(45,072)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Net purchase price</a></td>
<td class="nump">$ 997,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember', window );">Reacquisitions of Franchises Throughout Arizona, California and New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,947,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases', window );">Favorable leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">528,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,899,449<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,824,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred membership revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts', window );">Net purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,213,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases', window );">Unfavorable leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,927)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,643,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Bargain purchase gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (261,147)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of the deferred revenue and deferred franchise costs related to the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationConsiderationTransferredNetOfDeferredRevenueAndDeferredFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the favorable leases in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFavorableLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the unfavorable leases in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnfavorableLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary difference assumed at the acquisition date that are classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutCaliforniaAndNewMexicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_ReacquisitionsOfFranchisesThroughoutArizonaCaliforniaAndNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938828592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Acquisitions - Supplemental Pro Forma Information (Details) - The Joint RRC Corp [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues, net</a></td>
<td class="nump">$ 20,985,277<span></span>
</td>
<td class="nump">$ 16,375,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,483,492)<span></span>
</td>
<td class="num">$ (10,187,416)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jynt_TheJointRRCCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jynt_TheJointRRCCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775612448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Notes Receivable (Details Textual)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member', window );">Non-interest Bearing Unsecured Promissory Note 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member', window );">Non-interest Bearing Unsecured Promissory Note 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingUnsecuredPromissoryNoteMember', window );">Interest Bearing Unsecured Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member', window );">Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfLicenseTransferAgreements', window );">Number of License Transfer Agreements</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUnsecuredPromissoryNotes', window );">Number of Unsecured Promissory Notes</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember', window );">Company-owned Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Financing Receivable, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="nump">$ 40,826<span></span>
</td>
<td class="nump">$ 76,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableInterestRate', window );">Notes Receivable, Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivableContractualTerm', window );">Notes Receivable, Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NotesReceivablePrincipalAndInterestTerm', window );">Notes Receivable, Principal and Interest, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfLicenseTransferAgreements', window );">Number of License Transfer Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivableContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contractual term stated in note receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivableContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per annum interest rate stated in notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NotesReceivablePrincipalAndInterestTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the term over which principal and interest are to be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NotesReceivablePrincipalAndInterestTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfLicenseTransferAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of license transfer agreements the Company entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfLicenseTransferAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUnsecuredPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of unsecured promissory notes received during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUnsecuredPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNote2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingUnsecuredPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_InterestBearingUnsecuredPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=jynt_NoninterestBearingUnsecuredPromissoryNoteMaturingOctober12017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jynt_CompanyOwnedClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938719696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Property and Equipment (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,818,403<span></span>
</td>
<td class="nump">$ 792,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember', window );">Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of Long-Lived Assets to be Disposed of</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsClassifiedAsHeldForSale', window );">Number of Clinics Classified as Held for Sale</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinicsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clinics that met the requirements for the classification of held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinicsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2611-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783061200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 4 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 7,059,597<span></span>
</td>
<td class="nump">$ 6,327,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(2,566,172)<span></span>
</td>
<td class="num">(1,098,438)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">4,724,706<span></span>
</td>
<td class="nump">7,138,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">231,281<span></span>
</td>
<td class="nump">1,909,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,083,039<span></span>
</td>
<td class="nump">963,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,085,366<span></span>
</td>
<td class="nump">4,672,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">891,192<span></span>
</td>
<td class="nump">691,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember', window );">Property Plant and Equipment, Excluding Construction in Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 4,493,425<span></span>
</td>
<td class="nump">$ 5,229,270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=jynt_PropertyPlantAndEquipmentExcludingConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6935488656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Fair Value Consideration (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueAdjustment', window );">Assets, Fair Value Adjustment</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial Instruments, Owned, at Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6782008560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Intangible Assets (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 02, 2016</div></th>
<th class="th"><div>Jan. 02, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,750<span></span>
</td>
<td class="nump">$ 914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747,733<span></span>
</td>
<td class="nump">476,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember', window );">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RepurchaseRightToDevelopFranchisesConsideration', window );">Repurchase Right to Develop Franchises, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember', window );">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member] | Franchise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ExcessDeferredRegionalFeesRevenueRecognized', window );">Excess Deferred Regional Fees Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember', window );">Regional Developer Rights in Los Angeles County, San Diego, and New Jersey [Member] | Franchises [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember', window );">Regional Developer Rights in Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_RepurchaseRightToDevelopFranchisesConsideration', window );">Repurchase Right to Develop Franchises, Consideration</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember', window );">Regional Developer Rights in Virginia [Member] | Franchises [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">$ 188,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember', window );">Franchise Rights and Customer Relationships, Reacquired [Member] | Loss on Disposition or Impairment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
<td class="nump">$ 38,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ExcessDeferredRegionalFeesRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of excess deferred regional developer fees revenue recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ExcessDeferredRegionalFeesRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_RepurchaseRightToDevelopFranchisesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration paid or payable for repurchasing development rights to develop franchises in certain areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_RepurchaseRightToDevelopFranchisesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInLosAngelesCountySanDiegoAndNewJerseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchiseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=jynt_FranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_RegionalDeveloperRightsInVirginiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_FranchiseRightsAndCustomerRelationshipsReacquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jynt_LossOnDispositionOrImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783054816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 6 - Intangible Assets - Intangible Assets Acquired (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,536,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,197,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">2,338,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember', window );">Franchise Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,911,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">444,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">1,466,955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">701,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">509,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">191,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember', window );">Development Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">923,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">243,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 680,009<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FranchiseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_DevelopmentRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938651008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 6 - Intangible Assets - Estimated Amortization Expense (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 578,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2018</a></td>
<td class="nump">439,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2019</a></td>
<td class="nump">413,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2020</a></td>
<td class="nump">413,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2021</a></td>
<td class="nump">348,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">145,906<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 2,338,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6934300208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Notes Payable (Details Textual)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions', window );">Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 186,000<span></span>
</td>
<td class="nump">$ 800,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember', window );">Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of notes payable delivered during the period as a portion of the consideration paid in connection with the Company's various acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfNotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jynt_NotesPayableDeliveredAsAPortionOfTheConsiderationPaidInConnectionWithAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938662256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 7 - Notes Payable - Maturities of Notes Payable (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 331,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 331,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6782647168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2014</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>May 15, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347,724<span></span>
</td>
<td class="nump">$ 347,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury Stock, Retired, Cost Method, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 791,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BinomialLatticeBasedModelFairValueSharePrice', window );">Binomial Lattice-based Model, Fair Value, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="nump">$ 1.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_BinomialLatticeBasedModelFairValueTotal', window );">Binomial Lattice-based Model, Fair Value, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 551,638<span></span>
</td>
<td class="nump">$ 551,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Stock Issued During Period, Shares, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Class of Warrant Or Right, Issued During Period</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 8.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife', window );">Class of Warrants or Rights, Outstanding, Remaining Contractual Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 328 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Stock Issued During Period, Shares, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000<span></span>
</td>
<td class="nump">$ 371,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionToRepurchaseSharesChangeInFairValue', window );">Option to Repurchase Shares, Change in Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Stock Issued During Period, Value, Treasury Stock Reissued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,000<span></span>
</td>
<td class="num">$ (161,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 561,559<span></span>
</td>
<td class="nump">$ 328,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,944<span></span>
</td>
<td class="nump">$ 733,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 94 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 561,922<span></span>
</td>
<td class="nump">$ 496,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,345<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="nump">$ 9.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,000<span></span>
</td>
<td class="nump">$ 76,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,969<span></span>
</td>
<td class="nump">155,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Former Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 5.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">$ 9.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=jynt_The2012PlanMember', window );">The 2012 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BinomialLatticeBasedModelFairValueSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the fair value share price derived from the binomial lattice-based model.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BinomialLatticeBasedModelFairValueSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_BinomialLatticeBasedModelFairValueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total value of the option determined by the binomial lattice-based model.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_BinomialLatticeBasedModelFairValueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClassOfWarrantOrRightIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of warrants or rights issued during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClassOfWarrantOrRightIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remaining contractual life for warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ClassOfWarrantsOrRightsOutstandingRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionToRepurchaseSharesChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of change in fair value for options to repurchase shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionToRepurchaseSharesChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional share-based compensation cost recognized as a result of an occurrence of an event that accelerates its recognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of compensation cost was accelerated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized and expensed compensation cost from equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of treasury stock (units) reissued during the period, excluding reissuance of shares (units) held in treasury used to satisfy equity-based compensation obligations exercised by the holders of such rights. Upon reissuance of shares (units) from treasury, either the common or preferred stock (unit) reissued is outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=jynt_FormerChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=jynt_FormerChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=jynt_The2012PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=jynt_The2012PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6769666032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Fair Value Assumptions of Options Granted (Details) - Employee Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 182 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">1.19%<span></span>
</td>
<td class="nump">1.54%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) (Year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">1.68%<span></span>
</td>
<td class="nump">2.01%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the forfeiture rate in determine the fair value for the share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedCompensationArrangementBySharebasedPaymentAwardForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6769463536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Stock Options Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted at Market Price, Number of Shares (in shares)</a></td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Number of Shares (in shares)</a></td>
<td class="num">(70,931)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Shares (in shares)</a></td>
<td class="nump">477,459<span></span>
</td>
<td class="nump">314,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.30<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Fair Value (in dollars per share)</a></td>
<td class="nump">$ 1.86<span></span>
</td>
<td class="nump">$ 2.01<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted Average Remaining Contractual Life (Year)</a></td>
<td class="text">6 years 328 days<span></span>
</td>
<td class="text">8 years 255 days<span></span>
</td>
<td class="text">9 years 73 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted at Market Price, Number of Shares (in shares)</a></td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 3.22<span></span>
</td>
<td class="nump">$ 8.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Number of Shares (in shares)</a></td>
<td class="num">(37,824)<span></span>
</td>
<td class="num">(445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled, Number of Shares (in shares)</a></td>
<td class="num">(146,560)<span></span>
</td>
<td class="num">(77,031)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.34<span></span>
</td>
<td class="nump">$ 7.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Shares (in shares)</a></td>
<td class="nump">953,075<span></span>
</td>
<td class="nump">477,459<span></span>
</td>
<td class="nump">314,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 3.66<span></span>
</td>
<td class="nump">$ 4.30<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</a></td>
<td class="nump">660,000<span></span>
</td>
<td class="nump">240,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted at Market Price, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 3.22<span></span>
</td>
<td class="nump">$ 8.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">1.88<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.34<span></span>
</td>
<td class="nump">$ 7.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Number of Shares (in shares)</a></td>
<td class="nump">347,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 4.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue', window );">Exercisable, Weighted Average Fair Value (in dollars per share)</a></td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted Average Remaining Contractual Life (Year)</a></td>
<td class="text">3 years 328 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average fair value as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_ShareBasedcompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938757712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Restricted Stock Activity (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="nump">339,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">670,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">86,415<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards vested (in shares)</a></td>
<td class="num">(162,440)<span></span>
</td>
<td class="num">(331,087)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="nump">92,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Awards forfeited (in shares)</a></td>
<td class="num">(170,848)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6934734944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 8 - Equity - Stock Repurchase Option (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExcercisePriceYearOne', window );">Year 1 (in dollars per share)</a></td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearTwo', window );">Year 2 (in dollars per share)</a></td>
<td class="nump">0.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearThree', window );">Year 3 (in dollars per share)</a></td>
<td class="nump">0.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearFour', window );">Year 4 (in dollars per share)</a></td>
<td class="nump">1.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearFive', window );">Year 5 (in dollars per share)</a></td>
<td class="nump">1.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearSix', window );">Year 6 (in dollars per share)</a></td>
<td class="nump">1.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearSeven', window );">Year 7 (in dollars per share)</a></td>
<td class="nump">1.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OptionExercisePriceYearEight', window );">Year 8 (in dollars per share)</a></td>
<td class="nump">$ 2.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExcercisePriceYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in the first year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExcercisePriceYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearEight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year eight.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearEight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year five.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year four.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearSeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year seven.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearSeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year six.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OptionExercisePriceYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the option exercise price in year two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OptionExercisePriceYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775813440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Equity - Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="nump">339,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Number of Units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">670,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember', window );">Goods and Services Exchanged for Equity Instrument [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding, Weighted Average Remaining Contractual Term (Year)</a></td>
<td class="text">1 year 328 days<span></span>
</td>
<td class="text">2 years 328 days<span></span>
</td>
<td class="text">3 years 328 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Number of Units (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="nump">$ 8.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber', window );">Exercisable, Number of Units (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 8.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms', window );">Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested equity instruments other than option outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for exercisable equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of exercisable awards on equity-based plans excluding option plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsexercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_GoodsAndServicesExchangedForEquityInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6770009440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liability for Uncertainty in Income Taxes, Noncurrent</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">$ 66,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 22,613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 24,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938856576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 22,800<span></span>
</td>
<td class="num">$ (208,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State, net of state tax credits</a></td>
<td class="nump">20,900<span></span>
</td>
<td class="num">(67,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision (benefit)</a></td>
<td class="nump">43,700<span></span>
</td>
<td class="num">(276,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">97,400<span></span>
</td>
<td class="nump">40,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">23,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred provision</a></td>
<td class="nump">120,700<span></span>
</td>
<td class="nump">40,800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision (benefit)</a></td>
<td class="nump">$ 164,429<span></span>
</td>
<td class="num">$ (235,855)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6782685216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Net Deferred Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 1,509,400<span></span>
</td>
<td class="nump">$ 1,988,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsFranchiseCosts', window );">Deferred franchise costs</a></td>
<td class="num">(553,900)<span></span>
</td>
<td class="num">(664,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">51,400<span></span>
</td>
<td class="nump">1,781,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsAccruedExpensesCurrent', window );">Accrued expenses</a></td>
<td class="nump">57,400<span></span>
</td>
<td class="nump">74,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent1', window );">Goodwill - Component 1</a></td>
<td class="num">(120,700)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsGoodwillComponent2', window );">Goodwill - Component 2</a></td>
<td class="nump">86,800<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetRestrictedStockCompensationCurrent', window );">Restricted stock compensation</a></td>
<td class="num">(30,800)<span></span>
</td>
<td class="num">(44,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent', window );">Nonqualified stock options</a></td>
<td class="nump">182,100<span></span>
</td>
<td class="nump">109,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetDeferredRentCurrent', window );">Deferred rent</a></td>
<td class="nump">629,600<span></span>
</td>
<td class="nump">209,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsLeaseAbandonment', window );">Lease abandonment</a></td>
<td class="nump">108,900<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent', window );">Net operating loss carryforwards</a></td>
<td class="nump">8,924,800<span></span>
</td>
<td class="nump">1,849,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent', window );">Charitable contribution carryover</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment', window );">Asset basis difference related to property and equipment</a></td>
<td class="nump">630,900<span></span>
</td>
<td class="nump">167,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossNoncurrent', window );"></a></td>
<td class="nump">11,496,400<span></span>
</td>
<td class="nump">5,574,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent', window );">Less valuation allowance</a></td>
<td class="num">(11,617,100)<span></span>
</td>
<td class="num">(5,574,400)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Net non-current deferred tax liability</a></td>
<td class="num">$ (120,700)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the asset basis difference in property and equipment for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AssetBasisDifferenceRelatedToPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetDeferredRentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred rent in the deferred tax assets current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetDeferredRentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred tax asset net operating loss carryforward noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetNetOperatingLossCarryforwardsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetRestrictedStockCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the current deferred tax asset of restricted stock compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetRestrictedStockCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsAccruedExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the accrued expenses of the deferred tax assets current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsAccruedExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the current portion of the allowance for doubtful account in the deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsAllowanceForDoubtfulAccountsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred tax assets current for charitable contributions carryover.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsCharitableContributionCarryoverCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsFranchiseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the franchise costs in the deferred tax assets, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsFranchiseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the lesser value of the book value of goodwill and the tax value of goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsGoodwillComponent2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the difference between the book value and the taxable value of goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsGoodwillComponent2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsLeaseAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from abandoned lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsLeaseAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from non-qualified stock options and carryforwards classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsNonqualifiedStockOptionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DeferredTaxAssetsRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred revenue of the deferred tax assets current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DeferredTaxAssetsRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Carryforwards<br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31928-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6782672176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax expense (benefit), amount</a></td>
<td class="num">$ (5,106,100)<span></span>
</td>
<td class="num">$ (3,071,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Expected federal tax expense (benefit)</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax provision, net of federal benefit, amount</a></td>
<td class="num">$ (735,500)<span></span>
</td>
<td class="num">$ (387,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax provision, net of federal benefit</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="num">(4.29%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effect of increase in valuation allowance, amount</a></td>
<td class="nump">$ 6,042,900<span></span>
</td>
<td class="nump">$ 3,519,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effect of increase in valuation allowance</a></td>
<td class="nump">40.24%<span></span>
</td>
<td class="nump">38.97%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount', window );">Permanent differences, amount</a></td>
<td class="nump">$ 108,800<span></span>
</td>
<td class="num">$ (58,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome', window );">Permanent differences</a></td>
<td class="nump">0.72%<span></span>
</td>
<td class="num">(0.65%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Uncertain tax positions, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (46,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Uncertain tax positions</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(0.51%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount', window );">Effect of changed state rates for deferred, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (80,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent', window );">Effect of changed state rates for deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(0.89%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net, amount</a></td>
<td class="num">$ (145,700)<span></span>
</td>
<td class="num">$ (111,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(0.97%)<span></span>
</td>
<td class="num">(1.23%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit), amount</a></td>
<td class="nump">$ 164,429<span></span>
</td>
<td class="num">$ (235,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Provision (Benefit)</a></td>
<td class="nump">1.09%<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effect of reduced state tax rates on the deferred tax amount, for the effective income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the effect of reduced state rates on the deferred taxes in the effective income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateEffectOfReducedStateRatesForDeferredTaxesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_EffectiveIncomeTaxRateReconciliationTaxExemptIncomeExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6768577088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Income Taxes - Uncertain Tax Benefits (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax benefit, tax</a></td>
<td class="nump">$ 32,600<span></span>
</td>
<td class="nump">$ 91,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Uncertain tax benefit, interest and penalties</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases - tax positions in prior period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Gross increases - tax positions in prior period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases - tax positions in prior period</a></td>
<td class="num">(19,400)<span></span>
</td>
<td class="num">(59,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties', window );">Gross decreases - tax positions in prior period</a></td>
<td class="num">(6,200)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Uncertain tax benefit, tax</a></td>
<td class="nump">13,200<span></span>
</td>
<td class="nump">32,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Uncertain tax benefit, interest and penalties</a></td>
<td class="nump">$ 26,800<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits interest and penalties resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_UnrecognizedTaxBenefitsDecreaseResultingFromPriorPeriodTaxPositionsInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Unrecognized Tax Benefit<br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775475504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Related Party Transactions (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related Party Transaction, Amounts of Transaction</a></td>
<td class="nump">$ 461,000<span></span>
</td>
<td class="nump">$ 643,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6782676448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies (Details Textual)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_AdditionalLeasesAssumed', window );">Additional Leases Assumed</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 3,389,971<span></span>
</td>
<td class="nump">$ 1,574,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LeaseExitLiability', window );">Lease Exit Liability</a></td>
<td class="nump">$ 338,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfUndevelopedFranchiseAgreementsTerminated', window );">Number of Undeveloped Franchise Agreements Terminated</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Lessee Leasing Arrangements, Operating Leases, Term of Contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OperatingLeaseMonthlyRentExpense', window );">Operating Lease, Monthly Rent Expense</a></td>
<td class="nump">$ 1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Lessee Leasing Arrangements, Operating Leases, Term of Contract</a></td>
<td class="text">10 years 210 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_OperatingLeaseMonthlyRentExpense', window );">Operating Lease, Monthly Rent Expense</a></td>
<td class="nump">$ 7,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_AdditionalLeasesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of additional leases assumed during the period by the Company for clinic locations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_AdditionalLeasesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LeaseExitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability attributable to the exit of a lease agreement as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LeaseExitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfUndevelopedFranchiseAgreementsTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of franchise agreements terminated for an undeveloped franchise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfUndevelopedFranchiseAgreementsTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_OperatingLeaseMonthlyRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monthly rent expense for the operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_OperatingLeaseMonthlyRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6938748608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">$ 3,180,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">2,587,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">2,248,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">1,982,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">1,868,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">7,180,991<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 19,048,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6937104080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of Stores</a></td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6770184416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 20,523,640<span></span>
</td>
<td class="nump">$ 13,835,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(15,022,738)<span></span>
</td>
<td class="num">(9,316,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,566,136<span></span>
</td>
<td class="nump">1,268,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business Combination, Bargain Purchase, Gain Recognized, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">261,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">13,295<span></span>
</td>
<td class="nump">22,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">(15,009,443)<span></span>
</td>
<td class="num">(9,033,176)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(5,098,000)<span></span>
</td>
<td class="nump">461,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(9,925,000)<span></span>
</td>
<td class="num">(9,777,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,550,000<span></span>
</td>
<td class="nump">3,492,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(9,736,000)<span></span>
</td>
<td class="num">(3,773,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,186,000<span></span>
</td>
<td class="nump">986,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">11,974,000<span></span>
</td>
<td class="nump">10,344,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">4,638,000<span></span>
</td>
<td class="nump">4,234,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 380,000<span></span>
</td>
<td class="nump">$ 283,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6527-128477<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6571-128477<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6770385776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 17,054,861<span></span>
</td>
<td class="nump">$ 33,362,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="nump">3,009,864<span></span>
</td>
<td class="nump">16,792,850<span></span>
</td>
<td class="nump">$ 20,796,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Unallocated property and equipment</a></td>
<td class="nump">4,724,706<span></span>
</td>
<td class="nump">7,138,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,939,000<span></span>
</td>
<td class="nump">15,006,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="nump">3,344,000<span></span>
</td>
<td class="nump">17,178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Unallocated property and equipment</a></td>
<td class="nump">781,000<span></span>
</td>
<td class="nump">802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other unallocated assets</a></td>
<td class="nump">991,000<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember', window );">Corporate Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,936,000<span></span>
</td>
<td class="nump">12,426,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember', window );">Franchise Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 2,003,000<span></span>
</td>
<td class="nump">$ 2,580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_CorporateClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jynt_FranchiseOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6769791552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Subsequent Events (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 06, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 03, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 05, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Gain (Loss) on Sale of Assets and Asset Impairment Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,520,370)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chicago, Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsDisposedOf', window );">Number of Clinics Disposed of</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsInOperation', window );">Number of Clinics in Operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_MinimumNumberOfClinicsToBeOpened', window );">Minimum Number of Clinics to be Opened</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened', window );">Time Frame for the Minimum Number of Clinics to be Opened</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_TimeFrameOfClinicsExpectedToBeOpen', window );">Time Frame of Clinics Expected to be Open</a></td>
<td class="text">1 year 180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf', window );">Disposal Group, Including Discontinued Operation, Number of Clinics to be Disposed of</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chicago, Illinois [Member] | Chicago Regional Developer Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from Sale of Intangible Assets</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Upstate New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf', window );">Disposal Group, Including Discontinued Operation, Number of Clinics to be Disposed of</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member] | Chicago, Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsExpectedToOpen', window );">Number of Clinics Expected to Open</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member] | Chicago, Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_NumberOfClinicsExpectedToOpen', window );">Number of Clinics Expected to Open</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement', window );">Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest', window );">Line of Credit Facility, Periodic Payment, Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of company-owned or managed clinics attributable to disposal group held for sale or disposed of, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_DisposalGroupIncludingDiscontinuedOperationNumberOfClinicsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount of interest to be paid of the term of the line of credit agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_LineOfCreditFacilityMinimumInterestPaymentOverLifeOfCreditAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_MinimumNumberOfClinicsToBeOpened">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of clinics to be opened.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_MinimumNumberOfClinicsToBeOpened</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinicsDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clinics disposed of during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinicsDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinicsExpectedToOpen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of clients that are expected to be opened over a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinicsExpectedToOpen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_NumberOfClinicsInOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of clinics in operation as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_NumberOfClinicsInOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the time frame for the stated minimum number of clinics to open.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_TimeFrameForTheMinimumNumberOfClinicsToBeOpened</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jynt_TimeFrameOfClinicsExpectedToBeOpen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The stated time frame in which the company expects new clinics to be opened.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jynt_TimeFrameOfClinicsExpectedToBeOpen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jynt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_ChicagoIllinoisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_ChicagoIllinoisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_ChicagoRegionalDeveloperRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jynt_ChicagoRegionalDeveloperRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=jynt_UpStateNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=jynt_UpStateNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>86
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_QNPKZW;N_^L?%54#7PZR[4%U!+ P04    "  5B6I*F5R<(Q &  "<)P
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M5WS%1,H5B:QQH(3K7^]PX8*V8Q:)TJ+786PZ/=Z&E3@?P]P!X1@03@'!ZFY
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M=I[VJ9:2B0L<N3$?M<5IBEX55M-9W4I*%3D7^R_QW"63%SEY05'THH#4X?G
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M.1!)\M0N0ZA=4B;%>]Z*P5@1.[R8F7BDQP&8A WGU, "DSR]RQ!Z9T!DTPS
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M@H82,!2%(:TY>P4'+PEX211K7C+TDH&7)+QD71$[(B_&Z1+H/%FN&;(&<\$
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M3&Y&J;',UQFANS @LI4C'$E#S,'%FJ_*00$X*0@5EC &+H.<-DC ,4!I*@-
M+0)(6-8N[ZE"7<;499#9!HDX!C3ELFO6KH#0FG%MJO45YBZ#[#9(S#$Z@_ A
M1I)9!5(Z$WQVM1F#X<L@P55@ 2*U+6$ WOJFC3%X&1Q$!)D*L@8J^RSW4DL@
M<\1G2>RE(8Q=!J<1068Y#'A*(?NDDE.D+%N%@NA4.Z/#['4&3-[*!M!A5CK
MRB!9"43JS3N 2<?1Y5SI:X=!Z0 H@SIY!'FP,@3SX++W,[5.QH1T(,5E.3><
M3EW+*Y7GQDL0J[;W<Y5S60!;M7-S$+:LSEA L*H=3%D'*"N/3>Z=AB=9L#,&
MP:IV,%X=P&N42Y'3T(PFL^H<+?-<LX.QZ@!6Y=GXO0-)K>/ \N!LB81D4Y6N
M#M/5 ;I&N00Y=(C+.<E-PA((Q^S(5\_"'4:L XB-:I8A<'),E),\T4129PSG
MVH[;8\1ZD-Y&.=^\3EL+AS,E]0Z!DDQ)VV*-_!YCVP-L1[DB'47GURYL3.DK
MB4H@5/X/KA9GMVB;MG^>+ASWLX?N=3N,]U5G3T^7FA]IO(43S^_M]?)P-?DC
MS.&F]/>F?UYM][,OW3!TF^DF[JGKAK88-1]*Q[VTS>/IQ[I]&L:OL7SO#S>4
MAQ]#MSO>OBY.5\!W_P%02P,$%     @ %8EJ2NC_'E>X 0  T@,  !@   !X
M;"]W;W)K<VAE971S+W-H965T."YX;6QM4]MNW" 0_17$!P0OZW8W*]M2-E'4
M2JVT2M7DF;7'-@H7%_ Z^?L =APG]0LPPYPS9X8A&[1YMBV 0R]2*)OCUKGN
M0(@M6Y#,7ND.E+^IM9',>=,TQ'8&6!5!4A":)-^)9%SA(HN^DRDRW3O!%9P,
MLKV4S+P>0>@AQQO\[GC@3>N"@Q19QQKX ^YO=S+>(C-+Q24HR[5"!NH<WVP.
MQS3$QX!'#H-=G%&HY*SU<S!^5CE.@B 04+K P/QV@5L0(A!Y&?\F3CRG#,#E
M^9W]/M;N:SDS"[=://'*M3G>8U1!S7KA'O3P Z9ZOF$T%?\++B!\>%#B<Y1:
MV+BBLK=.RXG%2Y'L9=RYBOLPWJ37$VP=0"< G0'[F(>,B:+R.^98D1D](#/V
MOF/AB3<'ZGM3!F=L1;SSXJWW7HK-;I>12R":8HYC#%W&S!'$L\\IZ%J*(_T/
M3M?AVU6%VPC??E*X7R=(5PG22)!^(KC^4N)*S#[YDH0L>BK!-'&:+"IUK^(D
M+[SSP-[0^"8?X>.T_V:FX<JBLW;^96/_:ZT=>"G)E1^AUG^PV1!0NW#<^;,9
MQVPTG.ZF'T3F;UR\ 5!+ P04    "  5B6I*EH-'IK,!  #2 P  &    'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;&U3VV[;, S]%4$?4,5*U@:!;:#I4'3
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M,1Y?-O:_-L8#IK*[P1%J\8,MAH3:A^,=GNTT9I/A33__(+9\X^(O4$L#!!0
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M_,O&_M>(#GPJNQL_0JW_8(NAH';A>._/9AJSR7#8SS^(+=^X^ -02P,$%
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M9)^R:Q":,*<1PQ>89$8PKSZ'X&LA3OP_.E^G;U<SW$;Z=AE]?U@7V*T*[*+
M[I\2#Q]*7,-\_A"$+7JJP=1QFBPIL&_C)"^\\\#>\?@F[_!QVG\(4\O6D@LZ
M_[*Q_Q6B Y_*YL:/4.,_V&PHJ%PX[OW9C&,V&@Z[Z0>Q^1OG?P%02P,$%
M  @ %8EJ2K_Q16(R P  ] \  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL=9?O;ILP%,5?!?$ !=O\2:LD4M-IVJ1-JCIM^TP3)T$%S(R3=&\_8PA+
MS;E? CC']]KX=ZZXRXO2;]U12A.\UU73K<*C,>U#%'7;HZR+[DZULK'_[)6N
M"V,?]2'J6BV+G9M45Q&/XRRJB[()UTLW]JS72W4R5=G(9QUTI[HN]-^-K-1E
M%;+P.O!2'HZF'XC6R[8XR!_2_&R?M7V*IBB[LI9-5ZHFT'*_"A_9PT8D_02G
M^%7*2W=S'_1;>57JK7_XNEN%<;\B6<FMZ4,4]G*63[*J^DAV'7_&H.&4LY]X
M>W^-_MEMWF[FM>CDDZI^ESMS7(6+,-C)?7&JS(NZ?)'CAM(P&'?_39YE9>7]
M2FR.K:HZ]QML3YU1]1C%+J4NWH=KV;CK98Q_G88G\'$"]R9$0R*W\D^%*=9+
MK2Z!'EY^6_1GS!ZX?3?;?M"]"O>?77QG1\]KSN-E=.X#C9K-H.$W&C8I(AM]
M2L%1B@V?3>=XNH K%&ZZ^+!"(G\" R0N0/(A />VB#0")TEADA0$2+PD2)/B
M)!E,DH$ F9<$:7*<)(=)<A!@X25!FGN<9 &3+.8!A(\=TA '?P^3W(, _L$C
M#7'P+,8.BD$(_^BAB#A[1CB5@1#^Z4,1<?P,VO61<1#"!P"*" (8]C43\Q#)
MK/0@$0$!P_9GP-N)CP$441S@"L" O9,9!TA$<8"+  ,.3V8<(!'% :X##)@\
MF7& 1!0'N!0PX/-TQ@$241S@:L" U=,9!TA$<,!Q/># ZJG/ 101''!<#SBP
M>NIS $4$!QS7 PZLGOH<0!'! <?U@ .K9SX'4$1]C>!ZP('5,Y\#**(XP/6
M ZMG,PZ0B.( UP,.K)[-.$ BB@-<#SBP>C;C (DH#G ]X,#J^8P#)*(XP/6
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M9I52%IR5U8,[L<:](W/ H;)^F[B]'J=I#*SJIH>"S*]5_A=02P,$%     @
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MIG@.!%36;W=NK\>W/ 96==.8DOF_(O\+4$L#!!0    ( !6):DHPQK?'MP$
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M;#$$-"X<O_BSF<9L,ISNYQ]$EF]<_@-02P,$%     @ %8EJ2FV%, [" 0
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MH"R.MU3RIHV*+,2.NLC4U8JFA:,FYBHEUW\.(%2?1ZOH'GAN+K7U 5ID';_
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MIGYN*9F:_PYGD @/E6".PD@7OZ3HG3=J4L%2E/@8SU;'<YCT+[1U I\(_(K
MQD2Q\J_"BSRU9B!VG'TGPA5O]QQG4X1@'$7\A\4[C)[S)-FF[!R$)LQAQ/ %
MYA/!4'U.P==2'/A_=+Y.3U8K3"(]6=+O;]<%=JL"NRBP^Z=%?M7B&B:Y2L(6
M,U5@Z[A-CA2FUW&3%]%Y81]XO)-/^+CM/X2M6^W(R7B\V3C_RA@/6,KF!E>H
MP0<V.Q(J'\PO:-MQS4;'FVYZ06Q^QOE?4$L#!!0    ( !6):DK3B8LXQ $
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M ,8)XS*;:4\&>6> =X(WH 3+&+GCG$Z@FQ/H?^/K^V Y@-D623EW4NF, %/
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MRDQ3/1?C,1X7BG?3#87F:[+X!U!+ P04    "  5B6I*4L%,W(D$  !@%P
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M&;?7U7#F.]PTY7$\SPXNA^J+_P!02P,$%     @ %8EJ2A;[\CE) P  - \
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M+^HYKGZ0(F]F5*<=E)?_ 5!+ P04    "  5B6I*9X+)MT$"  "F!@  &0
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M'Z9]/B?.%6B%T8,65^L)/!H43LIL<[T7;@XY0_%N&+%HG//E'U!+ P04
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MWAENA[,0FIN8X,DD7IK[?Y[4_*SM,#5C.5Z"XT2+;KK@H_E?1O$74$L#!!0
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M)")(FZRJ5FJE:*MNGQTR"6AM3&TG;/^^MB&4)4Z[+]@SG#ESQI=QWG'Q*BL
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M(XZLU]J!I\QN?&N#_Q.+(Z!WP=QZVZ27D1RGQ_G1D^7G-1]02P,$%     @
M%8EJ2M4G;O;X!   *AH  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL
ME9G;;N,V$(9?Q?#]6N)9"AP#S;$%6B#81=MK)69B8R7+E91X^_:E#O%*G)^V
MZXM84O[A#,F93R-Y>2BK[_7&VF;VH\AW]?5\TS3[JRBJ7S:VR.I%N;<[]Y_7
MLBJRQIU6;U&]KVRV[HR*/.)QK*,BV^[FJV5W[:E:+<OW)M_N[%,UJ]^+(JO^
MO;%Y>;B>L_GGA:_;MTW37HA6RWWV9K_9YL_]4^7.HN,HZVUA=_6VW,TJ^WH]
M_X5=/:JX->@4?VWMH1X=S]JI/)?E]_;DM_7U/&XCLKE]:=HA,O?U86]MGK<C
MN3C^&0:='WVVAN/CS]$?NLF[R3QGM;TM\[^WZV9S/4_FL[5]S=[SYFMY^-4.
M$U+SV3#[W^V'S9V\C<3Y>"GSNOL[>WFOF[(81G&A%-F/_GN[Z[X/P_B?9MB
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M% @FB6,%BUC@3J<5%D5!RFB_$-%XB@C'B<LG2B0=QZ1HXC@F12./'HP %>X
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MA[4_;X/5*4(/D:S^1FWJ8NMGLCQ<[I[F21A-O9,*U&&6+2888%"/\&3T/D4
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M&+&7_85S!5JD_Z3E%7K^#QL&%V66J5Z+;@AV&\6;?L![PZ^,[!]02P,$%
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MO[V42FA&=J]/U5'_&)@&E=@K\YKJ]V[HB(>!DNW8[0?33X[5?U!+ P04
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M)EW ])K5%"9$!HQ%A= MF)459F6!R18PIB:*%B0?2F88L14CO@/#U!@8L?5
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ME^-K,0ZTZ*>',)I?X^H?4$L#!!0    ( !6):DK_"F=@$0(  !H&   9
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MS:9'V]'KBF*X2*[.4:]9=QHTTJ"WBHVOP!/)UI>DD R:Q$(.I"A(BEH'9.2
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M,W1*<32N26U;=>=_US&RZ>\VR7#!6OT'4$L#!!0    ( !6):DI;LX,:[@(
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M;2[ON^$</ P$;\T9/QK_:"S_ U!+ P04    "  5B6I*?.RMY!-;  "2@@$
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MFI^R-"JC#UH&3V]0JZLUZ\8H"CK8:!'B)KKTI0B4C[!H4Q190K'AHM+2V$2
MI+-' >-T S7B\BM*(CJ1(8@%UY:YA,+-M7"V,)' W@5EHYM.MW 7I7UXM$L'
MA]EO<#D:CQ)C;/A($$@6.Y" -&9J 457:6(Q'@3^V<3+F, &D\VL(QN$^CI'
MM%'2%-Z<)"LC+A5;'3[R*N@P*VTE)PF6@[+Y25#AJ^WM7;^YU9_'$=K6;N>:
MU? >3@)TJ&>\W:##T$Z%YM\X0'O3#9WQ+,O(,@&]+=#"B)8FG7CR6@\8?\2]
MB]"R1#&%\>056LHPAA'^G8=S^"YY%;12RDU$!#=  U,+>:&&\%$MPRC(7N%U
MCP(L3/NC3/N=R?O66A$/UA9FY :ROMFEYYS[3-U(9[L#BC"0.,[FX02C5B.,
M\@RGLRQ40_U$Z$[>7!0QB.@31F9LLGD6:_86<_@;'B-1J6YZLD?H78_GD,5J
MDR&LA CF+'9G3%@HK&.$(5V/Z .U[3>]"J;HE$6^438,=1YN;-\)YQ3UZ&;T
MFY:&+,,D#KMGTL8428H%V\?Q>117B+4O5'Q<U;2FJPX[W5+"):_I7=(]*'!E
MN15SK39(]@Q#;>-G$FCA74X(ZDQ"'B3[0F?3+5;$IG!M3<T_Y^6*S0<5<CD4
M[<T\14]BF]AO(,"(G4V9N87B+3&8IK(N4$]#XY%Q92T]RRT,7NX*/!:+C8Z3
M@=T6ZV%+95;6//&6L/&-[X86Z5\;24]=GMBSNM_1]"BF3;[6UJ8U)F0- [!&
MO\"-6%ON451:E7^@$P$6<2WQ(TJ/ME^DK;_&&,5&TJO)9%1\R76\O<C7\!II
M,XP(PDRZY5S:%(L[#FBXA[O/*,2JKX[6P)=^TYVTV)$4][%H1"Y6=$XR[]H=
M,,#6  P(R<V46X->H:K;;(Q(A:M$T17!+1YEDAM@!2?C5X$& E"9\)3>SXG[
M.N=?I?[<B8E(6\9A&9<@BR_51NO,3%E?E>Y_JM+]K3A1J\TV0HH3'0BGK8M"
M,#2B6Q@1,GN6J# \"LCAH=H4ROY(8 0H=+7'P,H3ONI@UG33Q4,#$J02C49V
M"*:Y0G3 [U%P#)IYE"7A+,-01_A[%F;S+$SB"/[\O0N,T+\^IW1E+!#B:3J?
MAM-TCK&ZXS0.$97JC18D]32;8K%EZCX3/ *5HWX*_SNH9X7CX.][)VP$+L(H
M'O/TQZ/9##[A =H17:PW3P^JDX[&XG=!0H!HP'1,U# T7>JAP#DO%CEJ#Z1M
MZ$4S1,#154[7CR0M;\I3M;QG_HW_==V'5#"/PQ0>P%R9&%:@O2/S":)Z38(T
MR\)T,@]^SVL.V)@SO)C\P^@,/]"IO["36WM9-F\ \PF= M?AU;XT67E%.]^,
M5M$Q]^%] E+;LE%L:"F>:8HX:3-*[8]N.FW2LZ?T9M<J:U:1-X)UL__>5O@=
M&T/8("GI!M!N;VMMI :CY?VPRF%9KQ9W%25BT._4*#YP7RV+%>F9:&"L.?QI
MM3"!A.Z"2 ^A]E7!_;N]EVY)T\R7>.'>PKII31/6J%JK['JR+&''89LT>_>!
M5*"5I(G84 Q&8]6AF*CAA!@Z!3N.>EYH1 %BZVB5>"J+U5+?7_2;K O:^D<:
MKD")%-8$V=?/I\S.$<G;B?WXVF<EXHSZ3$8MVA3/38[<XLD8H(U^*L;(':[;
M4? KASN]D<5L)#*D>,AK+1G+!;TSXP8?PE )5)C9>&6L9P\FO<<X1^#WXF%C
MI #,JRD$7H$V_QR%CD6NXD_M0!"..OG#T('*I##+SZ*FW()6($5-F,PMX6/'
MW,3W:Q*0*&\6S8/D]6!#A=IOB>T0-S!*YWJ((\;71OO,O^1NMNFB?RJM=*;A
MX" !7?,AUQ KY>6#QP8X0MAVX(N;$OV08@^AX.J."P .N:0:+33I++NHI70W
M]N+2^@5A,BYT>O<(]:'M?T"VJYPYK"@Z6+;X=<>3@TN[4 YJC%#K)*O5U;K:
M:E?H.XQE>&+T(/YO,)Z'VK0B9@!E%*43<2&^N48G,+"^/1NI]_6_[.#!_ 9B
MN>?;6WBWU1DZ.O9*!#P-?JS8>(#KNSYKI2CGUVB&!&F8H;RU7?Q<%AMH]$+9
M.DF$;K5%T7_:>H CXL <3SP.3@*6>:624$E*&">AR=4X#=ZA%*LGHW\XO@(B
MKQY MIHE(#B,3\Z</B<CU2!V=(5\10<*J<YP8#^HP$Y@L=>B#37!\2=N?3R!
MIC=W9;U4;=*X?\$ $Z>UKB5$&DDS')]^1#Z,U =L3S9?+18)38CD;W;OG173
M?!I\^$P<TUZ'&-H:G^AWG?6@P05OB^O:[2D.@Y_9^*CFG<8G(\E <5J:C9C2
M:PP'MYN9AVW1ZU1$.?O+,]Q2$Y\#Q/1& 1"1IB4BG(!"V(=-^E!Y,6&013/Z
MC_IFI![IG*6L0VIJO)C/M]_9E%69CJ=(#8\5?CH+HI,@/E''<V2??MU#_*P>
M[":M8ZY;A6V0/*$V3I+!'9+F8N_)R%P2UDW#BCZOS;!+QDSI&9'Q'F?,;=";
M7AT#49T/8*'X>K)#SI^9TQR?M7HUYF/+4R]:.JWCGE .(04Q(,?$'/EX(CG_
M+AX /I:[EZ?R3J(3OXL8<#2?H\(T;HF/VBN5/\ A_*)B4(\RZMHW0 T)<TD7
MXKF^$#MJ:D=!S6_%N^L5R[4@WXUV<,R-*/)TUK87*T"!+KCA-(+"X"(%*"@&
M'><A* V!C4%OAA>18C^)8V/MO*<%(_^WVI5CP74X(5M'1Z(X"M2^N,,4\9,U
M?KB&/Q<Z$(@4OH$HG!LDEDBH9C)C4C 1,LBS]!QU0$CI DJPCM^*-B']?L/)
M(<H\NY$<!Q X%UJW4SXGL@0]@4Q_BUMHVU*!0)25DYS;3?Z9,!ZK!Q3 M^N2
MW2&80J]#AF2L6GC#=)/\RZFQ68]VG,;)GJ<1^4X:@#AQ- &:F(2SC+ N'#R+
M$3X&)(!K"D^C#VW'T?3B7T O<82VKTE@X#173ZC5VLFLA%\R82Z@A1B118[B
M!!H8NY$[$T^<G^W>A-%Y@%Z9C61ADB8T.0ZK<K/XC^)I%$9I-O*SEJ,$S^'4
M P^S@YGTR]XJ)*)+FIRVS[&3W:S\7H;T(FQHTL^&F/\F2>(YX8BMDOE9T22>
MD9U+'],HG,WG89K.>Y@14&B<4JR[!]7D.$/"Q>SY04XE "["JMP>IBF"\<>!
MOXP"O"^P+R>!%SHX.!92Z>.%Y@R\.#?$E1-(FOG_S_@AD&;P%E-4,%&1#!%M
M%(SC7]?Y=HFFE9W&YJ:0D*VM>@7]H@2-D?<Y:9H6&J85%@X_Y_L A8C!F#ZU
M1?F)/3G5DF5M=EMRF9!RU3,*(8@-XW ^ T+,,CR\TS !OC]/QEU'13I+PG0N
MCHH(JTS -1Y-R5Y?[EXHGT&)UL,.^R<'7R<(CFSPJ]6VV2@,![28J%1>Y=\L
M*6-(PB8?E1/0SB%D0G@DBY1!D"F=2%L,*%SRCXJUBA\-&N7 HO=57:")$9,B
M:/BF:)S. J:AH*\%$]XZ65+:I"#N7<\PV6')/-UN'Q?'$$>/:0'DV=$$HVTR
ME=<F^Z"SV#I)RC:/J8N;E3806HD#)F.)S)<*IL@DOFEXS[M"SZ/#"<@';35O
MPN"70[CTXLWI;)U*C:'+2<DWE@VO8U0>"&=PPX\U"= **.=1YRSZ-;0$ ; (
M-L]D=+I@ZSD:\>BQ,, B?VP(9&AY\U[S JI;<N8,1UR"2)T_;5>LKL:H,;$K
M:?H*SN@-A?EM:Z0<-'K!A<&J.#Z<M.!&1K[V0&[#=XXB;A/5,Q D470T4ISB
M2-*PME;XFU--I*/QJR"*VV]-Z-% V]9,$Y9-@I.N^+]'&84PX94(3ZB^@P^+
M366&)B*>[?&TY%KR;]/2]A6U87$1=*Q9C(=R&F)VGI=J4J :?\*:!^:2G@H)
M:V;3R6[[>GI)SP[,G+.$DHU]F9ZU%Z3UQP>.\6M%M+5ER#%<-^-DCOKB- GC
M^9PM=(0DTLIP ]T ;J]D.@W2<)J!=CJ+?5DTLSD(8G!]3>>(XI<%&2(XAI-Y
M%L"-!T)_!E+@>5\VVS$T.YV&$2FUQS XD*C2!,7&-$2%)@6RA!L4"#3.QH35
MMJFW+$79J5 Q3#V>12@%(T9D-B4(OPS1&<?X.0NC9!9FZ;2=>:C\KBAX(2)A
M!)V/$Z"G>1QFWKP%/C">]- H=;ZBS('84S&5J&$"=/D6>>IOQ%,O)&G9"Q9J
M/;<GY.<0'4[.>CNV]2YSEVJQPH:_4'XB#'AM16WP%YX<W-#!WK4>TZ7>\DX-
M/49JL,%C):"WG;C1J)AN_V@MJY2D)UCWV7*K1.T2G?? EA6"1]G-G=?B$05#
M%S7,@WBAOU?$?2J6MQ0O*7LF0!ZG-X3F*K[TBBX#4"#6IUQU;O%$/F24T"5>
MBKNYW98,?X&UN-"E;]_*$L!!"I!UKW, ,N,?HQ>P(#^59+@0?GC)Z!(*/-S.
M&#A660'4[ FEV(E3?O5DXPSJ.$L5'I"#D($QD&N3@65%A8N\ATNKYV1"[-#W
M<U<"38)2)PF+:V!EC08"X98HMM<L $,^Y;#+6C??LI1;7>,!D$ _:HA"=T%T
M<A[=KMV'*70#54*6A=1LJ'R0^[#DL%*0H(X\' 4?W#'4^J,,W5TYWL(M0QJK
MZ AM6* ,7[57H<63=8R:M$GZ0'4M(7H<U@8BB*1$%9A/:<F80NPC4/\]*]<9
MM2UV=CF'[5=6TOI7SM(W20KM91@U(\^;H$_E>[<SP9CT#(V!=G%=5W\46&KG
M<<U 3BS._$R8$M&99P,Y,K!1@3$2$4,X-71:)=WI[])&? 87![X82AH+10;B
MT'8T$)I05FL_)."6<X97E&B.RA'_]7>B<.X7Y%3?1MIY.1S9!^N[X;C==653
MCDZ1U-A<A40V4/ ?IX]0G#-M#;%A7$5K^W=A14"'^$60]#Y($'\3\9@FWBMU
MBF[=;@ZL6^FIFR3[]9+=],R3>[NW;1CCW5$F(WAF#22M48Q];\23%',&,!&]
MHSN1W)&)O\>^N?"^+,E$VVM1[F:$L8FJ!29+R:V$@1Q2W]MU877,U4+_K'ZC
MV8P-W+U9S<72(ROW$=Z/-9I@+I0888NH:* Q/^@D;4>;/0L^#A@+4=B>1Q$#
MA =I"L+H?,)F7!!YYY.)]M*V\Z>#;,S^E@G(LN,T#B*0K.>3F=V96^PDF,<)
MYY&D\&\:!=,9[@;*^0G5)R5E,4!9'23T;(;VJ3 !J7@>QVJ.'JDX2T&"3T F
M!J$ZC*91[PFV][S@&#.Y626JWPJIN<',GD)">EP; 54U@<VA[W9D^AZ>WBM<
MFWI"%PNKDKT9VV^TES'W+9*8C3+^SU$PR6;A##01C&8(T@04H1D%VLR#-,+]
MP>6*Q_8?49"D,]#(4ES"NLAO4&6+T@FH,E,QT-M;Y>5\F3:-7/H+++PNKE]"
MA<W.VMTH)L<D$,4&FCT:35X%DQ$F-:G($-'[S2M39<E@9W20TN/O<_7D>RV$
MX[ZU= #.ZVCDG/?:"<[4MB1)1%8):XE/]>*J'[U+.X,'WWB+TGI+1M$[7[_0
MLS/5( >Z?! IZL.:C2J35GB6 G>E/]1_@&^$DXCN%47GZ2$.RS$<]S'BW<Z!
MA\Q'TWBT?_ !@CVQ<6H4(^\8(=*]3[>4F/(ZEV2 DE&X6LE:[>A!2<,S >E*
M)^CB5)EX0RL<F\.F82R2^OIEHQ*?6L'$SC"=)K L3+6BD$6=@ HOVP&^Y4:A
MD]B(2OJ)4N7O<5$75J>6A<J]+ L)Y6E 25G!8FN<0(I15O OSG)0\HEUEQ5K
MRJ542\QP8PH%!J6V+8[FWX66VBQ ,C,;WCWM8<)XY$[@-4> %X2JTI+,5:Z#
M/*Z*Z5!JLHH>[P)[M-OFSCMIP'1)2!*RP1T8&J(SLE]'5]"T*GT3M0-:[G(K
MU<4-.<<8N>[,.T4QAC,>0_(N-;WN);J6WJC9F)T(TO@5L*04.&6:XB=,+7K3
MC25OL A-P?_1/]+*'M/03N#*F(S0!I41DJ6UL-$HFF.[T6@Z>X5\G'J)1^/H
M%;K';@I"WN%G8^@;_]]UIER#</+8=92WXG[A(M'Y23HMQOWPP2ZHOG&6*84/
M(%9E*%8QJPG&HWD<S$<QR'>\*Y;.2>Q%<;;9"&]W*6:T#([3=!*<!)0S<X'B
MQ&J%WV8@+"68-91A"LV.X9A<$I#W1HA\1^L&766]PU&L,AG!Y6X-)\G0"T\C
M@HZM$47I-)Q,T3,.7:2[AC35:2YPSXVF: R%!J?!=#17O?%]ZGLU >$OQHQ<
M= UD-)MD!LW,9<,W0.^8AC3,.UL)(+;%GP1,[".+/;;6$5+;WH?I:#*%ZPY7
M/HEG0!&QWWN7).$<ZQ7!:D]ML%V^95O2#(HF'(- WAJZ LG5,(?%;PDQ',Y"
MY(CG+<*:2"A2CB*\ 2608?"(:$FYD[]D2B8Y8SWG:^B*,W1VGI/I-$;_L]V.
M=,'M*![&@Y7&;_BX%TM.)56T>6H3LWL&IMF8NI)&)#?K&*6L\0P#-G:>(I6O
M==X9VY2RN3KM1C"S-,7SX(SZ.(*AS-+9[CZG*E7L8)I#F?PHG:-W/_'27#0!
M47XZAV,'\OS[:JFS%O8U$7@<T=D!LAC)BTE(>L<HF),V1RX]/F2?2-F^;XV+
MG<PL5C'*G1W2F4:Q/Z;3NDQ;YVGW&&%\"3IM9O#O/'+Q-V'XG*30KI<23)*4
MY<SQ"$\<LG92G-77&6C.4U"<0(JG6(Z(+@C0N^BOF/Z:RF]\><Q2_BLE1CE.
M^"]2VT>Q/,E,%'@-_47!':-YQG^17HV#:?M5;DMD$2*C$*AO6S1!5DA<5 &A
MY,$/):*U@$#T<[Y!!'>)7R?ISP(LH=(1;=GDB 9^-)G0Y$?=XE,Z+GLRI@39
MHYA=R2,LK):(W#Z1H%^=%/FN!XV4JMI:?%^5)GU4+TH0$R7+$>9KW=B1*+HL
MI/C(5?2XVN2)\PTL,=S=L>\'V <O6>XCGJ@!#TLF[_2EMY/ERH2.4-)(Z-8T
MC/-4_K>3%;8;B4<H6AS<S+333"3-[!0 _*_9-:A;5=UQ6W^F<@Q7NIIK'_5)
M[3.OSCTG0Z[)=W%MN.JW%U"UYV?MW)IW%M"'QJT^E@3_D^&4OMX -<F;K^G^
MW.'/-^+_!3D#-[YQG 5OBR75S@)^$X<SVJ7C>#P+YQ0U2;D6NAPN%\$@4 \"
M5VHH-@T>/)YF].Z)JNW3WV.0)F&&K\08;D'OZ.!-_;@9%L:BHTUG3.W3<((8
MV#O\H2PO2^=UD)W&U+:\QL^5PSN"L74I=88KD$QD!=KQAZK:EYORVY57UU2+
MJ 4Y0@ L,B]&(\#9V% <O5O8+?M+)E@T[*9BCIW/9F%,MVD/5/3Q! 1XGM+Q
M=)I*5.SY#MQVX/W80Q1F$KQ_WO6K3WB#,)QW;%4T/*4%H26"Z_)8;<@)I?9Y
MGHE1+,.]FG'XL2-@MO)"CY.QT!OH6V%$GT!)_6]0_!F-KZTM1+.8'L+*GU-[
MD8A(IS%_&\.O.$:*8PGR:]BB:DV\)Y+S<$HF_39"#-N&8?58:D3K:DICBT!D
MG%.WGZP#PWX9_ =WZP+$[I*#^W1]"\J6QC8I27I*)L6(")X\0F+0,O@Y72QD
M3P30-.%C&DTYJ"J"7051$_=M$DXRIOJ?T2CTV06N@<T# 2#*9)F/S1L<,TU%
M9.2\+_UAV$<V 2#K/_?<$E0'%3I2HD.*Q2Q9>HC'R80-WNW3B-BW@:HR;X"1
MV$J0;[9LHI(39QU_,CJHR$%:MN*4TG)-_"0>7WGC&+?Y)&2#FA2YVMP5N_C)
M(&-O\_4SK2_L8<PY9Q?$)=RYE(#8_E-;:=2T<7C*RV S.]A'#*Z734U ,X</
MK_ 'U/.9X.P?KC3OUY/5]X+J2\'7'&<)I9/0^1S-N:%99KZ*Y_#O&QO"0Q=<
M]E'@E-*:YL301Y@#$TZB.1TRD$M!9(;)W^?$1FP4+3RU^,QX!-+I\62F. ;(
MZFBB^=6?NDV"T'$Z58,%.3]J#99!]!3W9L@Y8IZ*]JF!V5@M+2@#.%L*'>45
M.T:W3*9^G6<4LQ9%JL<(+5 G&,VG:.H']XX"V7P>O&I?5<?Q:$I[]4D.0.'?
M_3" +QC:3877<M8R:,)2Q@'^K%9;=:#<DCU6;>9N4:I[U"@>5JK,E90=>RPH
M9E=5Z>/8;HG@+KD,Q#N#NQWB\PSEU3R@!B1I# ^@A*I=H[B;[;T@ZZG+CF]:
M>/1?("\VRW*AX A,/91EI8W@!@P#LXNVM7VFU;(I]FJ@KC'XRKP&S(.X':.%
M[5V"V>,LB4;1*Y#-IZ_"EOU@E_E M-6CZ515<N8K]"A)M,G(R: 0!RF5-?)S
M4%-0DB'5EVW_9P_R@;T ^,,^14 -;\.;4N70?]?YZ]>UE2%FXY.=FM@%M$[&
M=)FC.TZ4#E#>,_Z&%XH]]HKGX(%OSX"#A[1?0'2CQ'I7%8C?_>YQ-)>K\GA*
M-SY>H'-A#:=#<[(6"X]]0F^#D#X5(;T[SP] O72W%9MMK3+2] 98^!U=4#6\
M]PR:F@[()-<?VDS\5:11&%) D)<YBAR?K$"+[CO]3[Z YA6-SP:&THXHL"OL
MX<TLU@_*IR.-TT8<87ZFBU98?MI6"0*%HBUU=PH#$]VI.&''.:H&W&IV.FSN
M_%[%M')D)8=WRMD4:+X;B7)I#8X2P#K&MJGDWE+"G,_J-I Q$44LJM^7&X,N
MPQ ;MW#5>JJ!#S[\$EL>G0T/2&63P=X*<(1-!I*#Z,.M%5A;Y5$T(+=8DL-@
M"PW7Z]7HN\!@@?.6U0%V5M@)N,2C.*-"]QAU  K6?#82)9;$;#MJ9#\K,UP&
M83*;A_,LHD"Q#'64!.X93G R=RG6S1*<;(TYU@Z2,,$08212#AG-,+(_HTA[
MBE.)PQC$]V@N@CMJJ'&8S&..50'E: JJ4C:U0RDR:G ^CW1(18212YAV.O<%
MR]]@<.,11K3T8 -X;'@_PUF3,JSO=E32Z]HC*=B4;O^5:>2F6[J/@^G0,*Z@
M5#"%!2UW48*W,_X3X3_P&_TWMJ E8AFY_Q@BML15<4OZPT<5..F$DW0?>(GC
M%I^Y'6/=7J,*-_(SE2Z[H?A@PM[1AA+R=J^9 S]P6JDN4H?29(WE9>SX]U;.
MG@G#E?IHNK ;%X;%,'*%P']7%C?6^8?593'Z??X'K+$*<KGX\/J]@6K!>U&B
MS9P*O@3:96:ZE/8Z(?WHZ%<U,PJNAHI=J'AZ'M6;+\6"$1XYP:9VVT!_H2\4
MQA,R%U(M<5569,,):6R45EB\_@55?*-KL\*FO-"(*B7UC,K2MRN%'@6S<$*Q
MB9Q_:I"KK>L/M)MYEJ*%/4E3S<H$DII27"=QRG+.+)EJ8C.KSDJXR.?^81RC
M4VK*^:])F&6H1'D'DZ(_ _X;)VHHS7!_K"Z/YS-J/*6]&$B'] \O!NZ&+I\Y
M_-<[K%.Z9=6+^1*9LDZJ36; 9F>)-GD.96-B7Q/VT8?Q=$Z0Z1WY?J]9MXMY
M"S2HE$!H 0@?TWT'&B(,I3DY>^ZB_KH62(7"KDA[S%F%)[2_&2K+%\Z@B M;
M2XGYT&/2HN&EA)*@_?G_IR!01Y+6J6#<445')TG,4+O.A/7URWG7Z$ \8?(;
M)PF9L_NRZA19J[!?'YG ;!/:NACNTAY*0<=I0A?NN+/6$I!Z1 >.LO-PA.-I
M>VU5 6/Z4%@%C!DWKUV%!,\U'MHC! >+LEFKJ1Z#8S:+@AG<;+RP6^L%&2!>
M\NBJ;2%'4 _CR825FF0:*Q2I9P]>(82I^L=M'=ZL_D$+<HP%2OE>/.FYJ3''
M^,J4M'A#@<;.3=U]X-G7<W+F]J8*#!,\/\,)/P7GRE9C1_PG"@[KB./]R3X]
M?A4<Q6/ET%4 +YJ:4<0+&3A&K _F72X@$%SE>!U9_4Q5/R00@1R:J/83[)#%
M.?@79,D;+G'O+7G-&1S.8EJHE#8 HDJ#/U:?3KIO^I[^Y_EU0Y&$W6WXWO >
M,E/1&T_!/^7?_OW[_M+@B9*_TVJ&R\?::)W[@)=:^)K*6P,-8U,_5:#?$G,9
ML;B$JBPHAYC=0QH+5ELIER4AH;5?X/. L*9 6B/,R4!L#QORDXR%BRY><4>]
M-?42^L9CAF A!D@E17&++NPU&@47HH=+ND?#Z-%P#0J&I\Y(*U8KI=.;BDO:
M7P4'7_!<!1K!7+.?BW:]B5WAS1ZM%X[F'32 3;V3ZV1_$FF_3Y>/QOA0F=CF
M=_Y:_)%-?G^(.CARV%:^D=!C"X9E[Y'[F9.WS0X]A* BO ;F_,A(24R ;  F
MC9/,*=6Z$[#3A5+R0I!;P/5&*]>7J!2>L<H4&C,V8]GV:_G[KW,+:5Q?Y=I.
M8)L^+WR#S#>6&19+?K!5,9XB4$.,Z[IN!PS+ Y-I,$D9$;#V/G \)7\!!H9>
M "$-/$,"5\_8*%)ZK2,1Y#U42G"$UM0O=AA,GKL0:1:D_:LP"^)H:!&FB';1
M._U36)^#YP[")(Q)@B .6[5LC.8 =7O"B6-&1'5^K[<;[3HQF:L1(<3.G(03
M4][G/QH"H3B$"3DO-X.IE&.V!MF" <,8L)$HY@>F^ W\,?.99%@H4*_P=S9\
M"0HFT(PGRJ=S&?\&IY\X@8;A983@0Z;?TP8*!>=KE:2*Q<39^$MP%SKUH.*;
M1_O3**CN<[5I?2EMD,=0-7-=J*3[>YPUFW<7=#M2?;'/:E3=5I0UX[=W;Y0Q
M@ZTC0O1M%8XZ@4>I DP+Y,!(%B-KGF3,V7>,U"[5?D$SQG6UN7,BE @2""0$
MH/AF0\<>B^ZQI?21\?DY\UC$&MLTSAUPACM!D1F9!*&E@+_(:_ 84*ZN4M>U
MYF"1/K+-7Z^4#0^!SJZ;JK[FA'RLV*TAPYO&6.9Q ,+Z:T9IJQ0F@O.FKB.C
MBVO#V^CCQ'AC79A8;F\'%F*8K%25=JZGX]\2LMFR="8WEJDX6'!*F$+4O] .
M#M*16H46377--96V%IX6BMEMHV@"]XHC^>"&PX+<] 7&L:@"P"KG&XNWVX]H
M]\EUP9$%>%]</XD[IE"'KP+MG=UD/ ]V;X/@0$E[\.)-T30,566)$93<>7D!
M1'V%Z9KPB18&MJ(9B?VW48[JMKF72J[:WB(+R%\/N>OZQO:[1495@S(WJK5!
M:!@@OY,<1_$\(64"42@-K3"I]+HZ*Y."O6IJQ5W[(0QS]?1OL4"VRI_J6%M:
MAO62'M=U/98FV]4EQUPH?/<QE?8I_QY39$/[F2?K"8/$UH8Z&ZQVZF-8SJ6@
ME'GZ\,8H\P>)XGV-M)/2)3B[H=V[ YX K&A5PM/+%H"+LCF9$JG )T":H5JV
MFVVM5\:K\/HE]H%I6K%S+[(8W?8^=@PBRKHBH#1&J"Z4WM(U<^E@-PU.V=WV
M7Z24<:>ZL+'2V)W(V<*VW%"5=K7A;K7B$4_)#(B8C]VX#+!O0&4CEZ-*($6N
M6S,4C3YQQHIG.6->5XLM)Z0340"37FR)/>@1$V:1ZK>WE+-+&ECI8*TLQYB7
M%RIK$/]QB$IJ-<66"],03*OC_&JQCUL.W)<ZK.4.;QLV@6S!+E)8M!SM%%U?
MU7^0()$_E"ACKXMB:?&=4%4M%#NW5<E35_VUP1S9 =%FHBR/(PM>/2GI0<^"
MN"O&7Y)UH5J7FZJ6DO2:-2'J:&E'TGBF98K]2<.8EKH+W02SPM!V%J>OX*=7
M(5GI]F0770S#<V6Y,:B#A]"%YW73I$'FLJI"*GRMI2HU8"\'8S/UE&FE/7R2
MO_H+FK>0OIS>< ^,P_%1>_F\][I2\+&JT),*U^R2'O1M80!YKH3UKL(W[31B
M)H1'C,GB Z&D9[U.!*F3HSA>2,WG3W>%%7LJ=1[E!)"S5.&)-JK\,U&U=IX:
M<% ^8JJ(.E_:>O2(&@0"&:( J?GARTL0ZO*-^(DP6%G@4EEJYM&91DJ[&)+F
M\P2XI"#X):[,,P'Q^EK2BEX[*<&^T-[7A7&+64GHMA[@2#IHZ_U#B6;5^K9B
M)$DXZ#P+T0,P6D@B:EJ5D_"[FBL5*C:'M@]*E-;ROYJ*J3?@01O0R[6+%QQ%
M\,4,<X.C- XQ^[=%AI0A1:6:?1!ZC"I6;DB[(_9UWUUWDMGQ(FL4\(K2PSS-
M/2!!P:V[XHZQ5C'VK'H1'8D[<K/RT)" N)N(%.Z:!UQAQ*D#C8XU/KDA1P61
M)M#LP\=T)H"YH;E@<6\>A>%H"ZLKC:Q%P5IE3Y);DZ\XZ]^V.XHRIVLAZPJW
M&/LJ&*DJZZ.T2Y$J/*W2KE"F 2+@FE/&LESD+F<M!Z%*#W-N' )(BM,E^9TR
M?W%91VV'NET>=+@>G*DD9XY5JQ*8%JLYN_H],C@L*+Y0-(ZP0 +4+WC%%"/)
M'EZK+O7?6;W' *SB,5\)2[*!3JD-OARX&._O3/]XQ"JK7'-5=]<"M7UJ>H-&
MFU!V?R6.<*7Q]X&?<IST??59>4!:/B%Z%:4Q*J!0L]N@;$-,2]EB#\994:/H
MB37W%&3K(62A85Y?:YMEZZ[4B]68*,L.,JP@V#:;1N486TMLE1(WGMU..@SP
M+5(#=,,DIX.,KW01J^BS"M14D40R3B4.6*)"*WUC)#Q#5YA0X7^U.+2P^PW9
M3Z@0G)E8?Q'T#TRA+81OU->QK,!=P<8ANR5J/V0;D5(=$):F9HL(%:LK;T1O
M#[NT2K%:NJJ!QL-E;!@Z>VKU2G;=;7)5FE=AL*N:>TL%"M/08,C\#TN.>I9T
M)P4A.0:3^)6TH5#,T>-H^H!KE*!>/"5#6@0DW-G$Y2JY8/MPB\*OE'1>W^6Z
M'IZZH$I2(:^Y6,*=;,F2 $H:!;Z#H<*DWAE,]!MA\#E#VWA C85?4T&$G ,(
M6ZR@Q1='#G="AK=F?["B<S^UZ)-*A3NMO<HUZAPR"LU" V*A HV$'+1L"2::
M@]X 29F[Q7%X.FB%5! .,=E^1DRV0UB%"WS8"\]GG76JLW'JP<[K*6PO&'=D
M1/""YG6(3%9/-+Q.>5M?OZK A[J5@"_K+6QC$VGY?K A52P==6M5"\:40M"(
MFABR+MYO74*$+SP5'6C79V5R7-N8>'SW,2YC#X1==\=^M*M5>BA!_7X(%>@V
M]0?9<[U:Q9>%I1MUZK7H9>_4]=5TA%>V: G*G=*A,;T52@FR"T]@G.JV$3L/
MUUT;":($@KN E'?84D_2<.[#!W<.AU4FM$83TD,%HB0V\3/6-*7#IM=]_]5V
M7NX,'Y5$CI)W2J<RCQ_&5#0I4L^ 5Z2UIWQ7!)TC#/2CO;,6SBVS !KI#K)L
M=-YU#.P&7YIVUC9!W.#S-Z2E\[WPG>9!_7:+ZL8V]=^0:@T"""4GL(C"3.D>
M& C:ETU+-P7Q^/B5:[43X014!WL^A]C]/+92N.'N+7M$PWX!>SW:ME:F$GNN
M!F&M1$ET(8)*9Y4Z7%@9)2B<'+GVLJ3H8<NUT76Z6&M$ Q?5MF!5JRFDU!8;
M0$@@[!2U:93X4%C2($Y)#!>2+5*KO>GTQ^C61L#NAA!6>_@Z%*PM+"PNB;M#
MR!7/.YBW;Q!DW>81YY9WIF;+_7:QH6"'@WB%%26'2W5X[UW.*$7";91XM0>L
M\G3:5@CR:$A3S6NW$G$2-# QA.)2&1.Q9/>&7=WF1E#2.<==M-R=9BRE+5[Q
M;-$$3<8:"L^VDQ\X7T9;F!>ZB"K2 ;JX%VX#VKN+?FN),;8B0W#,#&%8D\M:
M6B \?KD7N<(Q.Q^TZF&\O+IQ)8X;680:QE7%0LK:4ZZ2RL34KFR,YYT=.FPD
M^0N- [$SJ>12JTZ@7!^X_*=42H'* ;Q;:TC'QH3%0G/*Q&Q5$ CU/27=F<GB
MYFF",F8(Y0E09M,.H"0O3"Y%!M"F*K">'?I2!"IE*%BUIQ!$G6F>R]@LF":2
M\7*ZFQL)71  =Q$3Z4:I+8,C-F0D>W:=$=:M=T'9;&W*13F+TCX\VC6-P^PW
M61Z-1TX:*:7E'<*!M$7N(P[,9B>2SM=*X%/$ULWO,Y&4)AZ-(T7;&7Q,O9TC
MWBB!&V424M2<ZC]>\^0AKE;G]=9461GC\B?\Y.:N)F367O>)JP79?A7RC3DR
MC#0>!N\^:95:I4>T:@)I79/;Y%Q\(%'!DQU>Y$-MN\9&^Q:=1GLL9_N-$>Z9
MVZ>LSVN]/F]I+H=LFK<)I/T(;=N,ISYYA;9Z GDXBN;A'+Y+',E-)5K1<IE0
MO$.'Y _('6I<E?]F,KM0@J<S/D,T!ZR/>FD49*] 7$6EU%%Q/ND<;D'..L?$
M!45>AVZ)VUS>;<ZA/EM2OF"+V?/4!A&.K&]VV6_.?7Y,9&'[9/;&89S-PPE"
M\$58"#B<SMSBY :;[#"KC(5HIAEP*_>+K<_Z!B%'IP7"HO( \)K04-Q*U^Y4
ML25\+#?"1S!*#-B.B.A\<]J=,:M"8P"F6I#X1_5$+&-YK_5-#&Y%KNLD*@Y[
M8_ONB='UF9?H-ZUKC-I5:7LF;?Q)9+A@#RI!K($R0*++0D7V8[%-:[KJ,B(I
M3*2 :WJ7;!L48*IJKAJO4L\PU#9^)OT3WFT(>J\S"7FP6Z_9,J$+*E9AN<1,
M[BZ"&-S<H%)OYBEV&') 4"VQ#OB/'!M+R:2IJ+JB3U8HQ=*SW"+ B"QDU[8E
MR4>Y:EI6/^4Z$7\Z>R98]FF1_K719&S($PW.4)M$?1+;UCV@*5Q6E6-G48E!
M56!5_H%N9JKMPW&>RA1HORAE2$',;:0H$]G3NQ ?_!H9'PS21]@./]@4BSL.
M/+P'V<X8W%1?'9V<A=JF.VDQLBL69M&(@</RE>3UYCBQ09/J;)@IMP:]0E-:
MLS$J ZX214$&MWB4576DR=BY:=_D->H@#8)',?SQ5]^OE+&#?$"A61+<_P\Y
MPGRNU&\*9?].+/3:T7G]Q+#KBI36*O5'=O!1L$-/%1*^E>!BM=G&QG;2&N \
MEZNM3IS=-:+;\C/=2:R38* T$-Q#A>4.6+U>8FLEE;ZVQ\#&#R[&H$XE892T
M:OS)-XR%: 'VC?Q9Z)V"QU&6$/ L)=_.PFR>A4F,6%T:956M5/_ZG-*EM,!L
MV^E\&D[3.289(=K8>!Q9H%]ZF@VG4I:8"W_5 AG$].V#>E[*1OC[9K*A6LK=
M#>.=.B*D,,D]'B.Z^\YBV7R>9?/TH S]<!4-4F +DE7$@D4'40U#TZ4>"G"2
M8I&C_DWZN@WK)D3 <=9.UP14 ]^<JN4]\V_\KVM!Z7:0S05N6R%]MW=$0=8K
M-'T-0BQXM/*/X[7&P9TRG[FP4"=#*9\B#@^,BT2*X!R9 YSB.$9!8;:;[[^#
M[+(A&I2E<_FTX#'5M<.OZ) 08P;H^$?P@F3X2GER*<%8%,+9*5VI0K":3IOT
M["F]V?64F4WC?6=CBI2KL\L8-!IXI[>U-K*G,<O\L,IA6:\6=Q6EV/).J2*
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MLAM!4(453*93A$_.$'LV]F4\S>8@A,$23N'?&0B%".@Z#R?S#,23),["#"3
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M<F]P<R]A<' N>&UL4$L! A0#%     @ %8EJ2D,8P#WN    *P(  !$
M         ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %8EJ
M2IE<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  5B6I*_"A*$Z<"   #"@  &
M@ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %8EJ
M2O\$/J4]!0  9QD  !@              ( !U L  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( !6):DHP4^LN.P(  &<'   8
M      "  4<1  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M"  5B6I*D;H5@V($  #Y$@  &               @ &X$P  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ %8EJ2@BA6K[<!   K!D  !@
M             ( !4!@  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( !6):DHW@A91QP$  $$$   8              "  6(=  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  5B6I*BQ_XZ^H%   .
M'@  &               @ %?'P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ %8EJ2NC_'E>X 0  T@,  !@              ( !?R4
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !6):DJ6@T>F
MLP$  -(#   8              "  6TG  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    "  5B6I*4'2 WK<!  #2 P  &0
M@ %6*0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !6)
M:DK?FO_7MP$  -(#   9              "  40K  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ %8EJ2B$=1'"V 0  T@,  !D
M         ( !,BT  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    "  5B6I*B8Q6Z+<!  #2 P  &0              @ $?+P  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( !6):DH-5KWVM@$  -(#
M   9              "  0TQ  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ %8EJ2NA/%8*V 0  T@,  !D              ( !^C(
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  5B6I*B\74
MP[8!  #2 P  &0              @ 'G-   >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( !6):DKH>@%@N $  -(#   9
M  "  =0V  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M%8EJ2B!E\\6X 0  T@,  !D              ( !PS@  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    "  5B6I*%>K;EK8!  #2 P  &0
M            @ &R.@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( !6):DI@N)/$MP$  -(#   9              "  9\\  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ %8EJ2@N)3:BX 0
MT@,  !D              ( !C3X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    "  5B6I*O_%%8C(#  #T#P  &0              @ %\
M0   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !6):DIB
M6565T $  +D$   9              "  >5#  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ %8EJ2G<;I8O/ 0  G 0  !D
M     ( ![$4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !6):DJ/)T#'Z $  &8%   9              "
M <)/  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ %8EJ
M2BR>3P'? 0   04  !D              ( !X5$  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    "  5B6I*\AL <[(!  #2 P  &0
M        @ 'W4P  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( !6):DK3B8LXQ $  #<$   9              "  >!5  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ %8EJ2@=)*3JP P  /!
M !D              ( !VU<  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    "  5B6I*A&)!5O@!   R!0  &0              @ '"6P
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !6):DI2P4S<
MB00  & 7   9              "  ?%=  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ %8EJ2A;[\CE) P  - \  !D
M ( !L6(  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  5
MB6I*9X+)MT$"  "F!@  &0              @ $Q9@  >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( !6):DJ\%,-K&0(   4&   9
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M970T,BYX;6Q02P$"% ,4    "  5B6I*EB_T-QP"  #S!0  &0
M    @ $+>0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M !6):DKW/NHLC0(  )L(   9              "  5Y[  !X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ %8EJ2LY1(07F 0  X@0  !D
M             ( !(GX  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    "  5B6I*U^&CIZ,"  #."0  &0              @ $_@   >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !6):DIG)J4[;P(
M '$(   9              "  1F#  !X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ %8EJ2LD6!G,  @  D@4  !D              ( !
MOX4  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  5B6I*
MOX:/6R\"  "F!@  &0              @ 'VAP  >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( !6):DK/-^EVJ0$  (4#   9
M      "  5R*  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ %8EJ2M4G;O;X!   *AH  !D              ( !/(P  'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    "  5B6I*)S%?.6 "  "-"
M&0              @ %KD0  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( !6):DJ,UK@_N0,   X1   9              "  0*4  !X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ %8EJ2I9* B-8
M @  ;0<  !D              ( !\I<  'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    "  5B6I*[F16E ("  #X!0  &0
M@ &!F@  >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !6)
M:DK%CD%RQP(  #D+   9              "  ;J<  !X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ %8EJ2D!HC9!V @  <0@  !D
M         ( !N)\  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
M    "  5B6I*$BSIMF,"  !Y!P  &0              @ %EH@  >&PO=V]R
M:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( !6):DJ&])"=#@,  'X,
M   9              "  ?^D  !X;"]W;W)K<VAE971S+W-H965T-3DN>&UL
M4$L! A0#%     @ %8EJ2GKL["@- P  ?@P  !D              ( !1*@
M 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  5B6I*BST3
MD&0"  #Z!P  &0              @ &(JP  >&PO=V]R:W-H965T<R]S:&5E
M=#8Q+GAM;%!+ 0(4 Q0    ( !6):DKF_+NDU $  "<$   9
M  "  2.N  !X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M%8EJ2FMB@5Q\ @  ;@@  !D              ( !+K   'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    "  5B6I*JW!!<@4"  "9!0  &0
M            @ 'AL@  >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( !6):DK_"F=@$0(  !H&   9              "  1VU  !X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ %8EJ2@E,5"A, P
M? T  !D              ( !9;<  'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    "  5B6I*[*XD@Z0"  !L"0  &0              @ 'H
MN@  >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( !6):DI;
MLX,:[@(  '0,   9              "  <.]  !X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ %8EJ2GSLK>036P  DH(! !0
M     ( !Z,   'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ %8EJ
M2G!Q[:U9 @  7 P   T              ( !+1P! 'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    "  5B6I*[PAF4?4$  #A+   #P              @ &Q'@$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ %8EJ2O(8\K!  @  \2@  !H
M             ( !TR,! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ %8EJ2@)0:OC^ 0  *B@  !,              ( !2R8! %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     $T 30 -%0  >B@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>193</ContextCount>
  <ElementCount>432</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-balance-sheets-parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statement of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-operations</Role>
      <ShortName>Consolidated Statement of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-</Role>
      <ShortName>Consolidated Statement of Changes in Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-statement-of-changes-in-stockholders-equity-deficit-parentheticals</Role>
      <ShortName>Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-consolidated-statements-of-cash-flows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Supplemental Disclosure of Non-cash Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information</Role>
      <ShortName>Supplemental Disclosure of Non-cash Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 2 - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions</Role>
      <ShortName>Note 2 - Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Note 3 - Notes Receivable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable</Role>
      <ShortName>Note 3 - Notes Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 4 - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment</Role>
      <ShortName>Note 4 - Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 5 - Fair Value Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-</Role>
      <ShortName>Note 5 - Fair Value Consideration</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 6 - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets</Role>
      <ShortName>Note 6 - Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 7 - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable</Role>
      <ShortName>Note 7 - Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 8 - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity</Role>
      <ShortName>Note 8 - Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 9 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes</Role>
      <ShortName>Note 9 - Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Note 10 - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions</Role>
      <ShortName>Note 10 - Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Note 11 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies</Role>
      <ShortName>Note 11 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Note 12 - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting</Role>
      <ShortName>Note 12 - Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Note 13 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-</Role>
      <ShortName>Note 13 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-significant-accounting-policies-policies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Supplemental Disclosure of Non-cash Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables</Role>
      <ShortName>Supplemental Disclosure of Non-cash Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Note 2 - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables</Role>
      <ShortName>Note 2 - Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Note 4 - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables</Role>
      <ShortName>Note 4 - Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Note 6 - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables</Role>
      <ShortName>Note 6 - Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Note 7 - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables</Role>
      <ShortName>Note 7 - Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Note 8 - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-tables</Role>
      <ShortName>Note 8 - Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-8-equity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Note 9 - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables</Role>
      <ShortName>Note 9 - Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Note 11 - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables</Role>
      <ShortName>Note 11 - Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Note 12 - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables</Role>
      <ShortName>Note 12 - Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Supplemental Disclosure of Non-cash Information (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-details-textual</Role>
      <ShortName>Supplemental Disclosure of Non-cash Information (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-supplemental-disclosure-of-noncash-information-tables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Supplemental Cash Flow Information - Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-supplemental-cash-flow-information-value-of-assets-acquired-and-liabilities-assumed-details</Role>
      <ShortName>Supplemental Cash Flow Information - Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-clinics-in-operation-under-franchise-agreements-or-companyowned-or-managed-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-earnings-loss-per-common-share-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-potential-shares-of-common-stock-excluded-from-diluted-net-loss-per-share-details</Role>
      <ShortName>Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Note 2 - Acquisitions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-details-textual</Role>
      <ShortName>Note 2 - Acquisitions (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-tables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Note 2 - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-assets-acquired-and-liabilities-assumed-details</Role>
      <ShortName>Note 2 - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-2-acquisitions-supplemental-pro-forma-information-details</Role>
      <ShortName>Note 2 - Acquisitions - Supplemental Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Note 3 - Notes Receivable (Details Textual)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable-details-textual</Role>
      <ShortName>Note 3 - Notes Receivable (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-3-notes-receivable</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Note 4 - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-details-textual</Role>
      <ShortName>Note 4 - Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-tables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details</Role>
      <ShortName>Note 4 - Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Note 5 - Fair Value Consideration (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-details-textual</Role>
      <ShortName>Note 5 - Fair Value Consideration (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-5-fair-value-consideration-</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Note 6 - Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-details-textual</Role>
      <ShortName>Note 6 - Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-tables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-intangible-assets-acquired-details</Role>
      <ShortName>Note 6 - Intangible Assets - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-6-intangible-assets-estimated-amortization-expense-details</Role>
      <ShortName>Note 6 - Intangible Assets - Estimated Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Note 7 - Notes Payable (Details Textual)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-details-textual</Role>
      <ShortName>Note 7 - Notes Payable (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-tables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Note 7 - Notes Payable - Maturities of Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-7-notes-payable-maturities-of-notes-payable-details</Role>
      <ShortName>Note 7 - Notes Payable - Maturities of Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Note 8 - Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-details-textual</Role>
      <ShortName>Note 8 - Equity (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-8-equity-tables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-fair-value-assumptions-of-options-granted-details</Role>
      <ShortName>Note 8 - Equity - Fair Value Assumptions of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Note 8 - Equity - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-options-activity-details</Role>
      <ShortName>Note 8 - Equity - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Note 8 - Equity - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-restricted-stock-activity-details</Role>
      <ShortName>Note 8 - Equity - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Note 8 - Equity - Stock Repurchase Option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-stock-repurchase-option-details</Role>
      <ShortName>Note 8 - Equity - Stock Repurchase Option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Note 8 - Equity - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-8-equity-warrants-details</Role>
      <ShortName>Note 8 - Equity - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Note 9 - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-details-textual</Role>
      <ShortName>Note 9 - Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-tables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-income-tax-provision-benefit-details</Role>
      <ShortName>Note 9 - Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Note 9 - Income Taxes - Net Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-net-deferred-taxes-details</Role>
      <ShortName>Note 9 - Income Taxes - Net Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-reconciliation-of-the-statutory-federal-income-tax-rate-details</Role>
      <ShortName>Note 9 - Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-9-income-taxes-uncertain-tax-benefits-details</Role>
      <ShortName>Note 9 - Income Taxes - Uncertain Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Note 10 - Related Party Transactions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions-details-textual</Role>
      <ShortName>Note 10 - Related Party Transactions (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-10-related-party-transactions</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Note 11 - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-details-textual</Role>
      <ShortName>Note 11 - Commitments and Contingencies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-tables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-11-commitments-and-contingencies-summary-of-future-minimum-rental-payments-for-operating-leases-details</Role>
      <ShortName>Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - Note 12 - Segment Reporting (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-details-textual</Role>
      <ShortName>Note 12 - Segment Reporting (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-tables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-financial-information-details</Role>
      <ShortName>Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-12-segment-reporting-segment-reporting-information-assets-details</Role>
      <ShortName>Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="jynt-20161231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Note 13 - Subsequent Events (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-details-textual</Role>
      <ShortName>Note 13 - Subsequent Events (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.thejoint.com/20161231/role/statement-note-13-subsequent-events-</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>jynt-20161231.xml</File>
    <File>jynt-20161231.xsd</File>
    <File>jynt-20161231_cal.xml</File>
    <File>jynt-20161231_def.xml</File>
    <File>jynt-20161231_lab.xml</File>
    <File>jynt-20161231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>92
<FILENAME>0001171843-17-001428-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-17-001428-xbrl.zip
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M/H4$.$^=8%8&HS+!_.PWR8/O#2[]T(D7%P/F[G4UN;P8,&O&=')I,=)=NYN
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M?=3P!QC6 85EA4W@*XFOAQ\)_^.6ZR18V.R;2WAR,/8HN0AIW.B<\D<V>7\
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MS")2>E=1NHI>^KC,\U?Q)U==EG89IV;0".&GZ2OEL)-;,G&\ $D08M#,($Z
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MZ-#=E($^CHK/?5;(=_]EE2781YEB7(;:'N;5E$[+,Z*JK,X95ZIJIT60\;A
MQW#$ZH(JG\#Y*?@&6\8TI'B0@R5QIG!X>F:N0#A>[1_L'[1SN0(U"+$/E@"<
M6T*)'=2B1\) KU:7=D,4\A#..2 :>'IS7*P5SD^L\&\W? KPL!@!\Z$@N5FE
M;\EE&7ELL%96Q:R@-V0-;Z09<>!H5K14\&<=+%G]>@5B.7M.')>P+]!ZP29T
MN**8JDEP!2GQ_19 5/0*?!F_P+*D5^),>+["QH(WN;PF.A893_RX,R=L5**@
M%MGY/8A]K(7.[H:8MX1DGG8ND &[$D"/R@&X$>6F;8%7A0(_YH*.KB6W'6E
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MS@^9_#^$<1Q.2D^Z0- G.&7\?,;_S>=9JD:8$JZC6.R6AQ8-M6@O22DANAQ
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MQ>!)%/DD3@?+/&<W)&)*@1<C:::>MYOIPZQ^@(V4H%JQ3.;R.%1=*5_&[H)
MK="\;JLX*IHO]HS-:*YIMEJ)=GHQ1&^9T3>QX-2:Y/"<V0U--D_<OB_"&T+"
MPS:C5\X)+X;P+7-\TSP?M7(FJTW->WFT;IG)F]-Z91KD/FF]:$XUSI406^*F
M;.A6Q8JJLY8$4S=)AA":G)JF]51-M3:;>N'F,VO3?4=&D])=?C0-L2Y>FG:T
MN,1=K=)YV!):F[:M]:I+O#ZA=@ZM^'I>A2/6QN V(VY>)_0ZZXS0 &)AUHXJ
MR]J>Z;L1P.)RLX8E;TUAK+ :^I[+H+D"V#FD>6_K#/Z5<-I+HGELS=Z:LKL#
M5.RY-62Y*<]ND_\D#GPR>G:O9_3F :C/AED.1P/5:(DI8<L8&ZNM 4A>TZ"(
M=UC76U!=*%WL8M=8%>&%=:H!H0II)I2EO@,W47B)UT-705X5;). BJZJ[BN6
M(N;^+^+[4VS!$XQ^/@/^P;_IU!ED?[-[80"$8&[E60;" U8;C;I8@,R94A@Y
M^Y1>L;+QH^QI=A,P</SLDODAC.-P4GK2S9ZLA;5ZK1V[J]^KN]B74BR[?'9X
ML,GX@!=0 PA@GJTS5_E*G9/NG932+)O^@^\ )P 0$E,_#!1@&HEQ3=[G!QM2
M2Y_P9GP>N#=Q]$I)#=(:A$^1,_WYC/_;!NFSH !)4SI2?G%>A7 +J%X!18QM
M.!!FA!E&$5C_+JJ-,'HK1:.''U59[ZB:U5$-XZ<Z+GWRW'C\5C+4?RPHLBIB
M/AE6*V1W0 ?&8C9.!ZX9M[$DI$,HC4'[834X\JK!6,_138.4U@[DZ-B6T8'3
MX4+ P6X(L@:53PNU9*&47D<SC8ZMR:TOU+9*X+>Q%Y,&^Y, L*\DEOR0TL;[
MU>;[W+J<<C3<\:-B='1+Z^BVVHP]FJ'^TXGFRV@N=Q3+[.C5"+R=T[PL?F^8
M12^."5OSE++RB$.SMT$(KP+L@OH9RRDW<3#7C,:S%,;D7Z$7Q+>W%^@S6NFX
MU,1NK:YB -,#SR\E0#T..T.]QM^[.]2%/K*N(@/O >OM%?4U MYVB+2XH:,,
MM@J8*LUPKHU)VPC;O2ZQT,>L]&##M\LQ,AMC>Q%.'KR ET,KWKTEK-)&\TP=
M$=*WQ"E!5&H@1^_S9C$7V)\VC +/X2VSOI!G;Q"F];HX;^8.T,\A;VS+J]#Q
M%K98^J/2J2,-95I]\2%VVJ4]M]:GUNZHO 9K-:%R/_+^#@-GGMB_A]&W%DBM
MJ4(/N0:,W+/W0NL/3C1RO. F[0?V"WPN6H6N<4NW7[J+2]C=D\F4]/_?:NHJ
M8G>^IEFROI2Z#:C4 J7AXP$IG37MN^@W8&5A:*EJ:F7O]M'2N@6N7DI H>VB
M]A1%K]G$CX&"R[LOF\+$S:6IIOM;WF7YS^*6N"TM0*4#(RLPR[N6*0<U-I:9
M"F+34Y'5E<:"$-]=4NJ81%P6VJZ&J1I6.4CM*,AUV-VG^3XOUIP'X,%29<6K
M-,^SD?Q^3'L4I@>34AGF/ ^BTHAZ94$'N[<L;VI3PM2@MU]2U0CP[DDE;D=O
MR;)FO!!2'<NN("[-]++Y[G ;A[@(8;OL^=&C S^D240VB-R@>D_5C;WUC2R"
M-\K!&O/!'.F<B[<\_,)EQ:5-'$YKBP,LN:<UM>FSZ IILU(,7\.XC=QQ]>W2
M_.IEMVCF]/EL^8,B&FY(DK*';QFDV=W W.7 ;@I"".I!;%J#XN"E.PHUMM#:
ML?U"#;LI&W)PFM8SPX[KH#0L5/*Q:-.)Y49.U4;VPL35.>-*=]L@]L!^90VD
MR3,9)*#7L3WZ* J?XK'$W,ED-&/E.EB0$FMXRUI_4Y@8^\P/P2Z(N/=7BHN>
M-&F;5C#8*&LX6V[@"N]'I)M*-(PM.:-11$;8I1*&VS]1J/=<(8D+5KP?3EG?
M[$+AM%*A) Q(!90DJ $&UBPSXJ3"?&,0@@$G<:N8MR\OTW*:NH)8?_N62/N#
MTI%5HP,V=I7K:/+P)QG$N/1I&W3)*4JE=9 3:<HI .? H>.6X+4T&Z&M (N$
M#<#$H=@CF-ET+='.ZB$LXF[4'LA;%@+/!/E89 7OR1B(W? )FR,!*_)N]G"L
MX=DEC*C8;QB4R 1M>507@$&9X?FC$D")EU?G4C]FCZ#]C1]0$"H*AK!VRP%-
M)A,<KU/5;4X$"FJU#"]&/SWET4\.H,N/*GGGYP?'QVS[ECA"M1=%*<(^"Y0$
M5;6*O:MIJ?ET,@UY8W*NUKVB_W5=YVS>(#Q'MGB$EP]K2W7HQ@*NZ<82HFJK
M58[G)8,F_U06&H=70\!WTOCM CT6?83\2T/L7 '/L%UKGC%+)(.'@;4"/-2Q
M\RBG'+Y0%)5:Y)JEU&5\') 8IW?0AT\YWXLTN1#C*&MNU\9JV;:)ZU59KB<D
M3X7<3#.43O^@4;UB(7*COM EPG)<&YG6!RB^5]'7F6_'F4ZC\-E#-=5*-_@?
M3&-A5T/Q+]1GRGLE >,:MNQ'RM?I9)RW9)S#UC,8LVJ-P#HL>1<^2",>Y<&T
MB%.)\RA*-GI!*E'I1LQK/V99= 3='NDU!U/G89Z3>+Y#(:O[U,;IN.:8F]V#
M2KRC9EIE"1#>\J2[-V?+MCIG&&(E(%QV9@]%,#2=VT8(C,HL)6GH>)'TB-ES
M-#,+')Z2F:MD9#:_<-#B[\GDD/X7W$LR6 LE)2%WOVV/U(=8WN]EIL)+N\<L
MR#8RHZR5B2BY!S[KB,9=+%D[M)7^[2/+O%%ZQY1YH]I:1U;TM2X,7D':35&#
M+%7FA\H%V7JD-IE%6W0 [0__-K(SF\%XZ3R&$5.S/G;R/?%*HY0^7>Z8JO4R
M>*6Y-EG(@S[/,J&QH?R3Y_MK8"D>K,E2UZ= G^=)T-LKZ9W-U>J.UK,[IM50
M2>V?AL>CQNY#;+TZ=W8YZ;(FNJPCZVK'4'>:?GH,VFP>L&4J*8OCDR;,XT3'
MWC3SV9Y4WH&3=76C(YL-N7-7-%R:RMN:IIOG)_7<F!:9]=7+@"W8M!AV8]9A
M0TANF( AN8/3Y+9SM,F?-?<?+1!OM8*M"RQ[=<ZC SCA%D[7F<N=.ZN<A_"1
M9&$,Z*>,R.+M5G;?V%8X@5(;VC  S,,)B?CE#]X!P+;7&E"&M7BEC5#A,4-Z
M $+RNNH81 !J%BGL127/=4+),/$EWWLD5,*H>WX+'DX.$ L1ARU,RIZK3,L[
M<[43GQ0_A8MS=\0-E%Z?W&='8,!Y@%J<W<B!G >$WZ-F 0/S=Z?L+CR.(^\A
MX1J"7[%*3V'T;1A&/(0$OR@'R-!90   8&V\V!MDH0\1"_! )L=;6XDZCUB^
M5PJG4Y 5#,N'-\[QCBL;,X=UE$'O45!4SUWX+@&X 9[S'=[1G>*+=]"1K<GG
MEWQ)>0KV;8.CQ,&^KR=^5ZU<[91"$MO9$[5J(\7:0#%:CME-,Z\Z=<&[F'XE
M'4?HKM$Q5:-CF<8+"=W5.S; :ZC5Y3A4\*X%1JUFS 7O7@];"M,5BD3!D=7P
MV$HH<0OPS;7_7"-@&-/]2!9BV5Z X[SEFX)US@*RCT7)C!TX=#X0$I3#JK.
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MR:PZQ+E@'#0V?8)C(&4Q\-FI;*-Y.+0@&KJ3QN.C.O;F+P+:XN@[,HT/X<A
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M\KDL*U5L5D"T Q2,!B@8AT"!_4K[23P.(^9TW(CZO1+H55!5F?^G%MKYR;>
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M+?W[ZE/%4L)DN@@[7T=9?Y7<TF0 P/,(-.[X=7;GN530 $9J##\?=PCC@O5
ML<))7M><%^ED5N_8P;P%V(A@60;TK?2C\U-:TOP)W9^AY +8@[2=/1J(/%L\
MGX!Y3B<AT*1D ('5B\G(Z6OPV']2B0#:X<0;9'=!+/P?K8L?'_B,X8.?I1EB
M_/X##:,']L,$_0]L]88L#H3D-U4(0&J#L"HB_#X(71]DX4U.GC@M4)"^?5[*
M)J&\H5+E[LT-47N@\W@IRS$C*2+L2=&2L/JHW!1,2PHD>2,D9 Z <D+B<;@/
M6_F(Y#FS4!E_LT04?HPH4YU7V:=9W0@LYS#"N/V,WY$/>5N?P=B+PO0+:<!(
MS%+FF;"EE1W*CU 2/7IH%S^P:@Z/GLN+1/AD!#)'4IT*/#5R>&T*OD8,6,EW
MGEC9 WAQ2,"<9K7>LRH7_-XZPLN%<^DN 8SPF@$A C:CR&<(/"4IXM5L6Y3/
M2O8*IP!/VLE +M)>>+H#CL_!6Z1@BANK$N" ]GB&DRN+HWIPJ(?I%W!@"<*@
MRRF,ZB:;)>M\4*9:1O'S@F'NYZ!G%[I(,"].+YN1(&-O6F3X,'JP<N^HQ'AB
M$RHREN94*W-.*L:K=5$Z/KOYI4#\3OF96?D"V>-C9]DIV7WZP@G7?D=7NP0.
M9&@O,Y\7K>XX2MAY\RJXB4+@(4I_B3":;OV@:54W!/DG9^]535&MJBM7-/,6
M(*Z,I080!?DE9^\56[9UL[<1C&FTPR/INZQT&":F;G9>4>23M_DTXO<9Y-6]
MGDI?<G?3)>Q>^VQ2=!P&SQW6F,IC#2C?U4!I@P+WZ)B@M3+BI@2C#_>J.866
M81MHGJ^+=;;\U,A)7^/^N[GH*RR-A786;+G2 *_N7(\G618;\[SM4/@!A[@P
M60@8X:8M): <1VPGQ-D36JZ+E8 -A+AAF ;W,H)-Q;=51*F2Q\O;+T4IO/.3
MXE3EO1FWM\AC4+ NFV'3[;I:K:I5EYAXKYC?56A\/;SE,1[-MA%Q"I'5$^[,
MMF;WY$I"6&G>M4!:O))>"I(I!,E28"/4&H-$^Y2&8'O!POX&TO#IV8NOHX^L
M^I7C]W-+\#JZ)7Q#9^$R=,M[844^I3V=1OP>=^HTC(2I9=#Q3 2E0@;YF0ZE
M$$^\F1Q*A2!*[>[J[1*G_=PI5<>*LZN:'>85->E"14WNN$)'U=P:,M\ 7T8W
M6\;\U,Q.YEZIO[('RMQC\=SX R\ZDC5GSCHALIO?JENG5'BRJ.6Y<R^7F$A[
MK$\KG).+#$;;IP5<T#-5BIE/BUUDP?19_1AN /WH_%3 /%@<*?=#HH?U@< *
M\^](P-J1X\K@PSC\CP^+0^&R/GD^B[ '8!*2.I/S,JN%8S*?!;F(NW:RHJML
M!F0B+,^4.W=3+VN69\#=UN=2?XXAUX/$V1$<V"H=)F-57HOJL]R?Q(KJ=K&F
M#N\#?A7D40Q%S1$<+A6"3"IXF_K!V E&_.*\RO&XG'7]R=,T"!?Y"L\ 'OW6
M'48$(.,+C(1Q*#>ST1_(AY@7ITP>N2T]2":LN@F>+X9#=)0Q+SV'#2WIQ(_S
MCHH.!A=[-/6V$R^MSD)P7V-%M_A?:;M[&*BHH\L,\2%V^:HG*+KY4M0F*='F
MX2[KBMSCB&"^<K5P2DS9>]AV7+<E5HM,HUBT79Q9/J^6_@,CTD?A*R5FS>T.
M9?T8A'#R!_&(,L_^"DV'U?;FI#:O?LW+7K=Z(M[5"6[N9,@#8"Z)BY%*]\[S
M)QZ8]"&ER%8G:M6TA05"5-6JU-!9#L>60*]SY@:@A95$NJILV=N"S;.B=T]J
MH?-"U\P:F 5@; ?RFH06.C>ZJMG;%FA6VJH?N)_1W;=[<HMO<>0Z%ED.S4X0
M6)/XPCN>;L^LD\UU,/A('N*: F_-O4=4[ZEZK[<OWU'1B+3<>'2^,6DZY\(P
MJ7VPHAU.'$[/\@U\L96H-GU>XPB]@9-E\;3^-02[>/_[M/FV\3ZWK).GF1&H
M08^>&GOR$,2ETHTS8]UG&B*]K''-"PTV^\C3+%NQ6@UQ@Q>/%Z_;/QA*M>IN
MP-A@RMF E\5NAQP_@,[N:$:U=0F>(Z5I&)5+ . 5C^>FW2H 4B\+@@_28@5Y
MM$GM#1$&\H4)C#OX*_%XXPP6FI.&<44L)"EBQV5V2&YA!<Z-:N8OF/'[G]4
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MMW,I4[Z-(!IYCZSC'*]3A_U>L&U@&&/Y*E9ATL71L)1=%09>&QI?A9V/.QN
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MT3&I,*X0A$%;MN/004XLW[-GGN\ECWOLYP:<:#\1MDV>^O' B9H%/Z_ 9@T
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M\T8V-;>^LB YHF7S@WBD?*[QPOD<(?LQQ9@I50DZ8A5B?8_X6CC*^2_;X4-
MCBQ7F""N,EYX=XY0]AH78TA/= UNI7RQERA[ +4'1LF"JA8>8V$;P"<L=FQ?
M& "^#7I&=_M;'Y*LC4%LO ++P[S0Y6^*T0)*?2;>Z8EF[+&IX]IY'4>N>Q8M
MI>N>>*4/O^X^K*->CA2^Z4WWEF AW'-+T\;D>U[L9QO-"?&[P,V[V>73&Z;<
MD@58;LH;JU#[7EP<;EO4J'&+5&E>V8)9RO YV-[7$<56R'C[+/<\O2/^!K/\
M/+\189TJZOA?7_%=U]^]N/T;'*9ENOR-'*1Z5_III_OBKU^&_]0IWH6>4\S)
M_EXVIQ[,J=OY9Z_;>7O@B655E+NX($>]4:F/K-/M30>#B49O-M861#SM&1OU
MQJ5$]$:3?D=WA%8AXCIP;Q/8UR#)0%;'[\#<3QYW8L^H5TK9N#,<3$;=0LH*
M"=B7W J,'/7+R.WW^Z->OU>\FMN1>X,WH"#9B9_=01F!P\FH/YD,"ND3(VY/
M4066=8=E%(T'DW%_4KSU-E+T^#Z,?@^$>^6;_?V+*#Z,/X7\^KB!>?]ZPUM'
MW2X82SZ&W U!TN4S%E!K)$@Q4S:UWGA<ZO\>=.!_ZQ.K0/@!9SP\PHQ+7>RC
MT:%F'#"0Q:#)O8(IC4D]]/_%OW]O.S0&3>8KNP_]>Y#IYG=\3O^Z576 [Q!V
MX-OCBJN4W.=/<:#?Z93'/#J=_*IG4RF?I"*4*[<W8111%Z8;&POVBN34J9DP
M'(]+E=IP$Q.>FNK33/I")K/G?+$?49'+2,ZZ'2%YM ^[2HRI ^ZE4C;VAD\R
ML805>1XFWAT=^%N6)#Y9/[P)SYZQOTFY)FQWU[9 &1&[$UL4&=2I*U.#UO?X
M=>#YO[Y(HI2]^#E'0&BC8$K (D3O*FAMDI!?F<.\>_2D%N6M5G>3Q8-1;S \
MFI,L*_W52WWSI<!BS/5DX$HUODFX*G0>;*CH'?=7W\LRC7?SW> *U9'F\7KC
MQ6]3D>QX]?W%Y@?+>+@'2V(KVZB;J-V4Q?VCAN#>S>>B[V0-_J&_I_[C"3*
M>N6M;JECIYWSK7%_6DNXKV2&EFQ#JEJ)MK)H3<M,99V18X7WTESP!- P@F%J
MR#*;=O*@H=B7E#D$4+0"0>C%<1@](MR/@.G!?UDS#O$@K0([J8'6T5\,,JE-
M:Q"D2ZL>U(NY-T\,=V6[AC'#U,RY6\*#"^D2I02TF'_F/V(4.W"\E8C?JK59
M<;.EMA196(W:^91+7!5L:L$V!?%%0= :I-5U>@<'NGYQM0[(N+03GBE:AXRV
M@]2.'NN?]KC4U7QYD:#GH'6'%1O,UR]-I":G;N=SHSOXNM:N06=WUW5V33"L
MO6EKVC/S+##MBJUL"C^66@YQ/E(6A$%;:2@T)E!:T9-2KQ6HM;HU66_PA%()
MZ\ 6M&[9*CE%]OTIDN^'Y;JL'F:?1(F?@M.-^GR>ZM/>H,Y.HLV*=8H=;+B'
MKBF3$]U(!U>=DCMIZZDK6MVZK-L["UWV;,1KB2+CN;0U2:%GP.;1CZC%SDQA
M_6:?0E^-SN>ZMP#U=\X7OG4"U8VK!OT\;@VK.HA_S&M>'@7A5+KQ-_LY2.QU
MY.B:;WB?G21\'I?IW!7O!!>O4V7-AVF"%6 4BYOQI"R9Q<RECQW7@^+PC)$3
MZFL79 S[ ,JF#K4XZ+0FO5/,^*?QJ#7.KV]ICR3]WUJBT"[Y-_D4GN .T[G?
MLMDN";2]X: T7;7?[PZ-M"9MJ'(B?B,U@MF57YDT(3[/OTBSXD/P"2C\]L#\
M>_8;:?C=J-Z0EUQ.]=:T%4^35NR+_<CSCTJIUW."RQ+?GDC/JC)>E93D\G3X
M?BYUK6!(DZA/++FQX\67*+SW7.:^>?P]9NZ'X+V'):]8=H#;GZ<T Z5>D,)G
MG[/2[#T1.'JEZ?/M7G\Z&6K)U?L1>MQ);X?ST2O=[-W>I#,<]::USOI#<,^K
MN8^[U)U2P=3NC:;#2>_IM:Y(Z7%GO=U:EZ?(8IHI'-=)O]9IJ\JAHR[V9%I^
MKKN=R0 4[=.K79'4XTY[J]6>3,N3BD?CZ6@P?OID[SKK#X$3+ME'[&BUW]J-
MN]WRM8.O^Y.QN7;9R%L1M15GQ]WR#3493\?]7O<X-/WK5G;]XD5/Z$P+ S0T
M*&4>_ER& =5&K57U=<>C,DYN-!,.3>.U0L= P*@/@0#]***WC,FUTOLMHDZ.
MCZ5<W2DW_M!4?F58$<3<=W:$SJPG:X^ [G(%>, M7%" NL<6GO2.P>RM::R\
MA2>],B;72N\36WA26L]:*Y5;;^%)K[1X;%O5\'#M4+-5&!<T8 #_% ! O/)\
M7RB77@-?U[SQQ/!U VQ=<#*@%W0Z!8F5'3/+/&=EWJP#>)0/!W)3Z.>NS^?]
MH:X U0F\RH/U0+%P*MB^OFMNT>%O(^S*FQ#^8[U\?WW[YI7EQ7'*W.('?U]A
M6USKY?7M[Z^L3^%531/2YU-#<41GFELUW*S_[SM0XNQQ:.]9D J@>HGG@7!W
MR<*Z$65-YLE5@[J_**Q[F1YE!QCSQQ)L0I,1(#X<DT8U$H_$D/"(Z).<B";G
MU"%]QO@[$-E'8BZJ^#V'S5MZB'UW%R(4$#P1L^B>T)(0VUG2S&N<8$-(Z#[@
MAX-1ZAA'\\B[H4@1I!(.SEWJN11G\@+K]ZO;*^MOU]=?%$C@C*%]$5M,)G:(
M6BH0[;'8CNO/T#S2N*Z,H9,4<IPB3C4QD>QUY"9$R92@E%CHIZ-PPJI[L%ZP
MEW![7*BH6 MHN2&:(*$\:_Q0NN%* FX^%UZ D%C8<"9MS%> 7X+RP<X P)$P
M(!0V(11B#6J-,+CF##XC.>E(Z%J!OP:G6^L2$C[:?O*H7F,BEGJP+3F(A_]H
M,>PQP2';<#4D&?.UM4D6B+@JY0M\I@LL3:02=5H3%BW;R7:I,AUQG1"RU)6_
MD0FN:_TX8+KRF;4I@/0$F:J1CWPC(<U)LE<@I6T0[1R 5LEVPJT%SN-]+\8'
M!4;N\3?!W(MRZ:H+VY\C[^8>HM'](+GZ9]HHJ+Z,XS.Q6\$B508IR,V+-3GS
MU0B',#F_@*4(.\J6PBN[!"CG46RUK;^%*%C )'58!-LMRV, P3P+4\0]M-Z1
ML9D1-?TEMJXYBA**&Q'&8!SJT'BA/JLKW:9=-^>RY/],%R"L.(O K%OR2@5O
MR6$8@P![22&(=AR+W,=Y9A6;A-H9H8Y!Z%THFE,AH62*>W6<L# P<U.I,XU0
M1G2]HH9;:K'B;+$XS#2>ABOK6ET!EBFU"J-@DT)V=[5E].8X2>YG)26*V@85
ML(W*2P?_QG:,B5AV@N;>F9V9N9[9^7E+7:RB!!ME//V,NL]><*;9VE$_0?*X
MPCN \R39GZC6OSGL=[2/" /?B\T#V^0$'KU @U9BS4)51\KU7+IJE!O:6IF
M>8RQQR"A_>+:%DF;"^]>5I,QM8H\_SR*&S5;*N-WK4;5L&:CJM,_O%&E</W:
MUH?E*LVL*_7%RUO0H>'*<VI@ZJ1?-T_[G5<&^)AU"[+&AX,G+]=YJY/273_
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M2YZZZUOSH-UUB(N.:=U\2&*)90G&JJJREDTE2(G !0RLVU;6BJL%2QO8=](
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MY/-(F_L28< L>:3M@5ES5 A\\:?.F#:3TZ;S0<F?+KH_\!Q>@0*#<^AXW+5
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M/*!'N$$PDU#A,5ES<3.@5/<KZS:W=9DK#?W(Y2Q>V5%B"&_#/KJR\OH$]7/
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MB\!D=A1EQ;8QBQ.5!E4^\[W,TVYY+ E?)Z%=Q*G@S8:DHTP,ETT6EU.=GZP
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M_;!@E-AEE&-H:GZM8"&#Y0).8V]%X&L8VW[\BBC@52?PN215PFEMM")6.N!
M8RLTML(^MH+^[__Y.8W;=[:]>OTYNK,#46!PH]X'?UP'K@YY_'FNBJ^S+AMO
M550!GK[-ZB6RC.4O\#X'#M@WT'-O_-#YXZ__]_]8UO^HT?&0B0)O#%_ 4U_9
M_-<7WK_P2M;N]MK][K\,LJ@)ZO5W+VY_EN4?M^R.J/F-MN$+:@X$BQ;_^J+=
M?V%Y[J\OG.Y@-.Q-IZ,75@IR@P\1AX->=]Q.8_?%7Z?3;J?3T;B2T;4%P<.#
M$SPN([@_'FU!L$"?T@EV.8<[7?B_QFR=F ^?WFO4=$?C4FIZHRF\(4<-'W0+
M:H89-<,*U$Q*>=/OCM=X4TJ-AB1P(PJ+RG;B)G*Z_S][;]KCMK$T"G^_P/T/
M?'QR  ?@R-PI.D\,C,=VX',3SV#L),C[)>"0K1%/*%+A,C/*KW^KFXM(B91(
M<9<:.,M8HMC55=6U=Y50!H["S35I!YK]14^$K *B>+$,,EF2M5VJU87LR[8U
MUREH$Z12X'A!5(1RZ+8+GPY@!>P)<BG3BW-%FI\(('R97E^+6/-C?+FKV2%5
MN5)J\Z*@R3O@EH+1#.1:)UGE2GE $'A>:P#R5YQECPL4OJ"@J0!42GEA+JMS
M;H\9=I8_!<!Z,E$I57 B?"VH8AT DZS1)]>[1\FPZ]L%F"XKUXENLC3#I\:7
M$GXNBAJ_!?8X*,U!+\)T%M8RVC,O_EO'LG]\%7@A>O6F&)#;!5DU&1=!ID4T
MQEZIQN$Y2=A'7A$,3: ]AK R050)8=_<ZZB[]/O47_H)G*%*2/LS^<WUUBDC
M!M@]RKII8-$F@R[];TO/#1_!_PINP#, K\JQ=#!IOZ#G7]"+9;C[EEJ>&H(P
M+Y<-HI8SU8YML2E"]NG2""'7GO6/Z^B[>/G#]?XZBA61*Q5(DB;(LB!W@!80
M9'#4=7\9?V-6XIFD\6DL#:^W]]2^;=:(8"O%SB>$"FSWW?.I<"UPQ-YFVD1#
M :>TCP:U5,C788%.\5!+[LZU-DYZSW0]N)]6SFC=#=W%_47N;!PO<,R/\.EZ
MM6NEGT(>K50MRN#""NJ![90"U=YF:M$&V*F4-IPB:Y+2PF:\^,@3G7^G>[<>
M"?"8O^EVB.[ 2%R2"I\3G#NQY.A? 5Q7+P^>;5U%MU=?O>-F')<U^"H!U<Y&
M*MC58LF1[V,CY '_.@R6KD?:F9Q$B>P9SP,L<WF9=7#Q9H!6P;3:%Z"?H^32
M2=B<EP)Y!,!HT=.!JX)!K6O@;L. - B(I^+61I_$G0IA9N6&8%9 I,1W#"81
M 0<PF"5JF:]WV)FJLER![Z:(I_EN'L*]#.)P#&B<3%"Z06A5+H_T2IJ6MT^.
M0] "R,=Y1U9+C1!143A1; 2R:R!D^I\\=W43W2HAZ1D\Y<4GM;]/^H/=-(ZH
ME<<115GC<CBO!$]+FZAI/I7['H(XG[>XB216\AFGI77[+GRP+>-V <=O5_R4
MTB(+=QG''SE_)\-3$ZWE)K8DJG H2S![$*CRO> HY>WBLP,B]=$"*A2DW\@F
M5+())?OG)UPF@'ZVGI"Y^_OWFU_T_[H>*:8G?NW-TC+T1_<>/9*)7Q_  [:Q
M!7V/T\.QH_MGFOO\";F/GK[&O[&S/_]LVY;C6NGSX8-/:I:"CT]9)WKG\V-N
MM,B5QTI%;M<P.H:Z8ZANZ)ME.85ORLBU(:K)RN5!5%X^C-7*_M7N#[]YI,_X
MIIT8>JGW+O#'^"('2$.HCT6#RW+'U1D!KWM++A;X'U^09UA^XUB.QI>:%BJG
MB7P)\HH@:0QX/;[E2T6P+$I-P"YFZ6VA1UK(45T6^)(B2 KWZEVE$IV%OK)L
M^#"P5OBN*GIF ';=^6&WH#*MP PB2P'9MK_6<6/+'U^!@X'_O8X*O\B_XS7W
M7A,7,9'RH<!+'GL"+&#)GM1K!NZZL(#S55IZ%)C);Y\M,UB^951Q_9+_C8T6
M6ZB/XF&_M7A/<_RDMV550^3OP#RPY_7+J\,/EN'P1)0D#$M*XU)N/03SF\#;
M$OP-X9V)7!,JGT23PP+*JD92Y!A?IT@[UQQLZ-(N9$-@HVBE+2>FPB(K'':%
M!UD99"W"57VI['AP/1-Y5_@JO[[V =;DKVHRY,$- G>5DQB.^PPVY(^OHO]/
M%RJ4='E,%AZN/33NGQHFWO95! T\...KK+ +*6P=$ 8X$LN@+EP]2]<(NS\P
M,5H3@-[;.B@7 A9#JN@(<$F1*2-&]=(/'O.&P)=>W:(8V6)$+I-Z(^/0+K \
M(5CJ4 6X KC@T7-#Q\0BR/7>,M[CPVN!DUA!G+."+']_P!I1I'_OFS[%U@DX
MY):!TMXB81#W-]VJUD,F@+"_3F6*Q*_@*X/ZW?%W'=TW&8!0W09I5K/.<G.1
MY<1<T](6\5$#R91.!^BD*2(K:/U3J:E ^'UI!:A("E0#C(R P<V#\=V#M$U2
MBQ*T%C2-W]0GQ\APLF565)1J/-,9!BZ9!A*KJ (KSX5^:-"']CX*XR'S]:N[
M")YQR8,9A[+-&L@XT2K.NTJE%FR;"JWA6GURZ%SC65ZKR)]]XI"2OP_R*T#^
MN:".A?Q]61M4EYTPHX/E9(V5M8K,0NV)+HXK*PHJJW)S:D^0=UT;1K@*X_D(
MF4%E5*T,RZ>OP>A5%)97>S8LOJ>$'YCP/,MI<U82*TJHS@A/+8GQ:C&)E321
ME0296A(#1H<$06,%E:.6!'D7;I 1>*$1=0G%'5_=1]QSEBJ48?E4$'E6F/-C
M<5 I^?M.3VF<QDIJQ2#V^40H]OE)F,E-5%:SUQ4BEKR",=WPP495,7L@[]9T
MC7Y-&%6 _W)-^/(4]%'2#TYZE>7!"%&E\9#^4 'A< 5NYU.^]R$364HGWC_K
M?@^5K]_Q[)P'?YH3<]OM9[C<=ZHFL*J6&S'#Q -SXN:.T1SF[D$9JJ6C.,24
M6F4 6N,2O?Q6P?M)&WVVWN%Y7 >\GV[&"0N/8ZQ!TN_31 $>B.'@<>I+/>@!
MGOS,*L: ]UJ&'TUKPSU$;UQO[7IXP,I-_)4?=:=D<8MZ KP!"\ B.I%&.^/,
M02XOD1VUP<4SS68,[OWI80L(=ZRU+IC6\4PXW E![T-_"+,\J5>6;9/X"H!C
M>=&-@"6<1M+_V':?4:1:#-WS-M&E4#](9R^LBZ\4P"\QTR X\:NHZRR\FGDB
M-\MM1+I1^>0I']DV\[RTC"7N<8M1X9G;X4 V;EP%H$5-DN-&SEX64HR5!!;<
M;)F@-+ZZNNUYFQO/$'<%A._S/7:W _*B*7,VVMMD+VRZVUR<G!G'Q:.0[/R\
MOPIM>^O<U*IXQVN_G5BN"V_I[]YOTENM4>EP^LW1_F"2=*"'W5SD1*W"CHNZ
M@]7<H]SI'DMOTFN**&@];;$.&=,ZT.RTS H;+>_ERLUE45'&1\Q3=UK: DQ2
M5$&>"^.C:5(,&%]KK\BZI9>+YQK/:SUMLPY!3]MF:6-K1>/GN8YAW5/S(* '
MKBO+FJSU!.G1^\D :>G]9)!YJLK-6X9TMWENU=XR\U(%)*F"I')59-9^Y]Q:
M4%9H)S,O52$J+\Y5J0<HZ\B:TF<^OL3S$K()P,_.79S^.WY2Y7)R29HHY7L!
M=4JNH1%1WM1=$#1!Y?KCB/:F'93:#^J<WVUET2EMV]M2>:]03FA[2V36QN:$
M!@T86$WC%+6K%@WTC1?YQHIQP^(,QPG=($[PX<GO*G:1*/C['-M&X!M#)+!B
M,GI  CHS)I>4P4.+HHO!R9S+:%2FIV."7)'0333>D@&7*HHR;2-&H8\6H<W8
MUA,BT:;N R_!TD,H'Z9S>UC6QRVT<\O& Z"*KUD2O.LK/+_ZGQJ(]9?P"_@[
M#FG9^-T,#C(S;BGF%]O0&ND'=N8)AU]T/)W+(:/?,*N3CHM>/+B<1$1-,I8\
MSC7J>/HKF=QBXK?]ETR*!<$'^CT:-KY+-$-?$P[Y!T^Y_GV)\' N,!DPCM,(
MH^OMGC!,?_+J '?+9@DY/!15UY,H*IGV5E)R3U[AH17 84:Q_"10&CKQY'<<
M^GS$D]MA$1)OM?QX7ED4A[7([)324&-;?U>P<';LEHK6SBEVSI4@=M^%JOW&
M,E7*GW)53K2O#.TK0_O*T+XR)Y9-TKXRQ]\UJGXEM*_,-.A$^\K0OC+U.(;V
ME1F>!K2O#.TK,^Z+.[2OS$63G_:5H;J,]I69# UH7QG:5V8*:H7VE;E4PM.^
M,E2+T;XRXZ<![2M#^\I,0:'0OC(737[:5X;VE1EC<Q':5^9B23_>OC+1WTE;
MF2QX%4KIZA;1_4I*0G_&%:$5JNC^O->=Q^AFRR^68ZW"57(!8GOE@5.Y5^_N
MQ#\J +M=O 5H]\=G9J'57\J@Y0%:M2&T3Y8/!N<GU_L O!# 4]=)(6:S\:1S
MJ6Q\[KLK<C\Z!W8I%$W@K365=%Y^G5OA%4$[!=Q[!# 9EAV%!&\7T01C,L\T
MNH3SS;W)M 0XJ2I4G-.J4%H52JM"AZ@*[2Q.$)4J1#(BON?P]AR"2D,"-3P$
M0Z*E,Z^Q5BWM5H3@?X$?P*7!KZ234]SDJ1P3M%:S0JTFJXD5O0-:3SM48$E@
M):%_(HU"OY68$J7BX9.G.\;2\E&F418-C X<%V>Y?*_1<6"0$K\?XLOSBHF[
M<XJ(GRC'Q$2.?7,!VTF3RMBPGQPKUXVBCI.#>1YLI(JW6:C\.A>BRZ"TSB:3
M=X(I1IUG&E,8?TSA]#C"KXYNVZX1-:+0_65T8Q?_@6_K/NDV2EI,>,@//,M(
M'AR*Y ?DZFBDILB*4JX]\_1/VA30SJLLKUYFG?V!4UW<W/L<)';G#*56K6*;
MRBF>%/;GW$3NX';N#J?G^C8 G#%AYG1/U"4^L^B.IM%RUPLEO7@^A:X=92I(
MY=R1"%]C,48+)!M:SIQ<\6X/+8P]'[J+X*DJ32Y\#E<5>VJIX&[!(;F)?*>#
M@_3-TQU?)]>)KE>D./%VD?FL67FG,->X\C$B^8;G-8!J<3=UBC]A-Z7%JHHD
M=KH;OV#H4?7Z3U]2!$G5NB\!S99\[I:$QFON'YA(XQY1X(&[+FR1>Z#82!77
M+V6GL0H>]KMO?W$#Q/2@F+BW>]*I:O&'NGYY=?C!,B2>B).881G"L4R690_!
M?6C$[%2;C6<GLI'"4]*%.'#)Y+/0QE,52#C*1H_8^/,\7+P?]5A^MH(E'!@O
MP-V,_0 .-^XEASP_[9=,!LYY3Y8!1W*-O 6P"XIF$N*VR-MZ%[)"D!%YR0OP
M/Y^LP$+I +P8UED&5^E?L: "R\,B:\,ZR5H/R$$+*XC?XJ,\O'B,K;Y>>^X+
M:<EM;WHX+]^!+F%!_.9(W=-(6Q#\>TO3D;;=#Z4<@-;'1MH6'*,R,7[44"C2
M][N&PEK?$.EQN\!ZR;_3-Y$>;F*Q\9I0;K&)BBCG;)QB"$Z%L]9%'$THM<4$
M?BYS)\"99/IN=']Y[9#_^[A-!UX'-_$8T=_(+-!31G$II</-1%$2-2D+<RUH
M6MY*A7E=2NGT,W$.EK+0VE:P2D3F1]USX D_TTCI V@APSII)IHBEQ+B"JS\
MN2BJ.5H<@Z$YS,<QKLBE&+_BQ3FGR9S0!.8GY(3H/AKHBR50PU%+/,_344OT
MC2V^<=]8'WRJ4GQJF,RQ.>BXG>W\F:SK\PC^ ;ZC@WV7"#W!TG/#QR6@$U $
MKL\BK=-?(.2S\-PC8 Z^2+KM>LD7[D:WL<O",KI)(@)D9- B))4YY.4L\_E;
MZN-$ U_8? -^/^GE&[T3?Y>.AH^G;E^YSWA>/?X*N%''TW+B"T8]#H\Y*H*/
M2>ROL7\(A%A9OD^\P=H#\A0JM>D;.Y7:52,X_8IRL(H0GH?%;"\1W;A^L!_$
M:D^>CT-TIQO?2F4\FPM+[S7XM_@&@I$1*,%2CZ9[D<B014+J_PV=*-9$PEAD
M9!N8]CA I&?>2B9VP0_C(60F\XSGB$4SP1(W.E49%EZ?2+9_\.2PYZ5E+/&'
MD7*Q[0T3KETGB7UA$S=:+A+;@TKM C%<57*GO/<)5%5]BUN@LIN^L<D;M[(/
M,V!^9F+6Q/-P126<VFCZHH/'^S&.ZUQY")MF)+I3:.OA2/)#+#K(^44OR B)
MZ-@5%H\>(K'QY.P'FS5.!\'!7^((LY,N$ V"[&7(9O&LR\^%5FT\OC 187CD
M8B+;4KF7H!/OR \?_$!W\)M@C]@NM1$Q:0,_W6J:   DQ[,Q*V',!>??\R.,
M9Z0E_GTB+PMBEQF"DP__]0)R1_O!KPA&,HGQ+<Y&6,F:Z8,HRE3 GA<+EO&M
M )0&LA'1(RS)F"1=+M\ UDS7BRWSZ$H<_-)U'EWRTFWJPP_7:]<+9CE>Q=-X
M+!/SOLLL+#PBDTP==?= <1<+G," QQY#';X+\!>1CK$\8-NE;B]:4RQ5%$A.
M&Q2JD*;=EQ2U-*8D<+(@*A*W!VAE2&J%<Y5Y:=B9%^>B+(G\Z9 4M/GZBJ?_
MDE'V> HM\OUDWCEIII7VF;B)O,"C0]#E4NCGLLSM5 8T16/KP)=&TD5)$QH!
M7QOS*<_?IL?Z./RE+;EX7E.E?K%_T@;$T@UPHE1I R10LDGB40VE@J*6P2-K
MJLBIF2YG^87K 55/0)3G3B29EP5.K ;45V.)S-!&MXMK4+:F98?8[_@*9HA'
MDN,?7Z+YP;BFZH:$D.)2JR22?H>\KTO]I#(<XTK@:!NV:;1A4_MI.O8'V)#,
M1UPA@ %*6XYM8=[M2G9JZ?.YT:>GIG 7VPUOJ*9W]8?N_NH\(1^[2IF[NJ0D
MZ6BM7*^-I^J\=%0=J#2!E?B*9?)GTR9LLM0218T5YA7O X^H85C#^;M?\8%G
MW'6]GE^7?-$4O Z64^EHFP%[\ZLJ*\D5FPL-?3Y/[2+S.ZESIJ.PJYU);K>6
MF![)LR5 G7M?[4<MRJ(B^->N$Q7+?B;E--_TEX]1RO9]5/G_#<-Z4OA#["Q#
M2<,?DPQ_T.C&T$X^C6X,:"&5Z(R;T/-PFG.=C!!A7L>7KKZG_?W/U[J9<B^^
M V&[J+($F;AN:UQ!GJGU@A<$=E[5.CV;2-S4B 0Z8,YJG9&I]0'2G4^L)?ER
M%HQX<F78Q_]B OV%,3QD6K2+U]#\*G#5N94V\CHWZK]6U.HZI2T<MB[#&B8/
MHFY<1KG5?0[69>>L)(FL2H.7@UH>JM(V"<9@;IPA+U /^.P\X&J I;>M4BU#
M(SJ4GR>8UST:T)D.E3I7S)K*2M0R&M(TY:H[.4,?R.H*YDC(A;K6 P=61%:D
M@95+I?[56 @_BOAP)LQB[EG 5(55Z0DK<#2\0HV('HT(JDO:\_*H?K]$FHQ"
M]1Z:'A%IY*AK&LG)-LE]T#$5+6M\1:H>-J#S2<Z'\*\%46Z8DS\%>P=3/=4+
MU&L7D)=5HB>A<OAY-.;DVC%_MO0'RR8E[PVJT$5:A3Z-,FA:A7XAQ=BT"GWD
M_-8%,B<$RS@['Z3)Y+BS7#D&:>%N!7N;E3FMNL5-"ZP'HY,VAU,T )W&4CNR
MTZF71F^K.%6R+%9WJD[TF"CFBS"O*%+;MZK'4)98 MJU;;O/<#X1@\> 81<\
M6(0VHQL&F:A&6:8"R\@\+9@96,>J\[V1>MUA8&#%>FT87@AZ->Y,3\]HI3-*
MB]J&)8 JM6W/C#R317[TD^N:SY9M,U=,&FEF>,HP50RQ#FI(J G<8C'8T*>T
MH1HM/)H"99 *##)7^JLMH@0H(H Z'6NW/65ZO],QE\P= 1-8#VA99D6=*K9>
M%4A5:B7$2Q++CSRHU%"??G&=OT/X<&&EYY,VN*T1PY@+;7,(5:KU*,!IK')Y
M6C63EG4"RB@5&$41>F042H$""@AP5'N[7C*P7OT9Z7A0W8/NF*ZSHF>TJC"O
MT=:,GM'+C2*UITB_X)9QT1@UYY&Q7=]G#-WS-@O7>]8]DYK!E2(;K"9(-+HT
M<#IU+FG].2-#MU,[H;GC17-'Z^4Q]'C6)4#E<L*ASV:+7<:7.F ENK$"/_"L
MAV@2-U&Q+D!$>:>*Z\K*].P.JEHK-UD9^NB>KE8/W7 A=^-@-=_R&=/",\P1
M+C[TD*WCO$[@XDN]8$0'&S+E'/T=6NM:3N]E7B#O7G"(M/'R!9.?5]3JFN,L
M6Q50;7<"U_"LI"FT\'+8RE=65FNT9ACZ:'9C=OR,?)]YTNV0U(HP>G+K@>J5
MH8L\>5;AU>K!ILZ:^E/*]WW#K9Y<&NTTA\[;'N&\@N,Z5\G$A[0E(6Z!9,<M
M1C8-^)GVOVDFPNK4J7?7_X82?%R)S1YZ7)W6\JA6IZ*R=D>[DWK?Z[YEP(L^
MX&&_^-VGMCOB-=KNJ 6_)<?2DVYW] ?2/>:C8R(3 _3@,6\BZ%*8:3^DH=L"
MT7Y((^>W+I Y(5C&V0\)V_6X2J@<<[2_3A7S6V9Y563GJE#-+FL^PY02J!:!
MYJRJJ:PH\'W1IZ\0Y!E&HX<$:G@(AD3+4"FMW\DY1B:CPUKZ(ZZN6:U<A_&Q
M5^<S;ACX@>Y@^XRY(GE[XQP(VKG4XP56T116D;1J4N\23U7W1.!83A)8CJNH
M>H8^PPTK63\N%L@@8\M-'(6QGA#C(R/T2%B'#FX\WX-TGNJI<H9W^S%^*$.M
MKR?=0J8)O]&%S6GM&"7\\%5CIX^IVB;<:IG;9I1,:<#  V7Z^EALS-8\G6]S
MCDQ0TYOH.0%,ZV!';#Y3M(S1829%"^2>2:QIHUO;:^1%^G@H*AX(\8]&&K[F
M9\)Y-!*;!+:YV7S>*;9/JR6J50946DM$XE;6$TH'L-WK ;I'ANL8EFV1DNT&
M\],D6E TC8(57NZG<..3ZS'!$C&XLLB/2HL86D0T:)'7^(J(^MOX5(J(SJEV
MZWJ%QYM<Y-9!51OU+E2?S]XIV8>((,05/=*\<DD/'L!+^CPO$.Q,M\E5EWC>
M2959W^4U1(/697&CJLN269Y3JM^\ZZ!NKE?ZU'GIN @E2K/NB/3O<5%I<J=(
M9#FU1E<7>HHNXQ0-'-G\&N@!(EIS[;E/EF^Y#LLXB!0')3HU5J/G$*KNGGM4
M46Z[=1:=G%!M<L),HV@?0%S.:W3\H9AOE>&%5HN&Q]GQ8*=BU7(,CS0ZMYQ&
M?5HNF7,44I] NYX/20.)FPD2Q?]@^!=9F==H__!A:3"?:6H_^!_8S;I#L&LR
M.'+;RY1V$:\ZGX.>TB$IP,VJWIBFZ.\D_-[Z :#^5<52*D6^$/_J5]!'7J"#
M3T5"@:YOT8&,(YM?1'%/<3\JW+^66A\201531<4DMWI1?6P3@K?1/F.I.X]D
M3#!.4WGP/SZ@Q4M;FU)^H4*2XI[BOEA.SKG.9ZE3Q!<KJ/D%9*8.E7C>!H C
M4DE18^^TJT G]\\DN6';;3HV8()DYRKG%BC-SX7F/,_W/WV*DGUPLL\$<6":
MCVF:T;:-QUU2T\F\?G_T+L119J73(!HE,I6F0VQH7YB)<\",Z[LMT(%+&V.E
M^ID<]]>"*#<<A'HATW[.[9B_%F9*[V0_>*^D1IN.VATVRGIU?/)TQUA:ONM]
ML'S#=OW00PV&_<QI;X[CK#W2J_IT_D_13LE;DE."3,8 +K:,&NV7>Z$=G0TT
M[K8>3:?0'+UZF7<Q=_HFWT0\B^]BN&ODQ7<Q N8!/5H.[O>$<[CPA>4>R-0.
M,1NESDN5,=U.%:J6I'6)$DJJ2J22NAHT-,8R]UT9(21,<;M&#J@W,_2P/,#M
MM(X)!)I)37E(5JJQ$*T?Z +Y/=W/&EDR>^?\7AM_AY9'3_"IT8!63S"M/ZD6
M@6GUY(XZV5,XV$38&NBNW^CHTI3EH%*!YJC/A>!#UZ*,S,BH-I>I++Z !1ER
M3!Q=H#)M+"PN-LINTLE-$R9]Y:A4O[.;BO->E=!!\T@TCS2A/-*-NP(4;:[<
M9QQK<ST&>%5_I%DEFE7JU0"D6:5IIBJDBMX)32H-3JG>"36&8!=-*;7'0:U.
MAZ(9I7I^TD3FR].,THB9B*:$AZSIF,8!IAFF2P_)C6:8.B5\W\GO?BE/,TV4
MQ?NV@)H,5J?";<*4KQJHZC?/U)^%UBA),V+#?4B@AH=@2+2,5%MO[Z)^<T%2
M)'FLSO4SO0/;3BV(2AL=7##U^28^2+L8I'IZ8@J)HF6\>CKC*C,@%_"491\;
MU";S$ 8@ @)F@^#HHB=D@Y:FX?Q*76'X5H<,G-?!ZA[[2D_YT-/Z<1SOHE':
M?R,,X-E?X*BNPM4]<@ [=_IF!7_XGUSO-K*AG<>?\2P]__3&'*)RKHTY&M9
MJ4?+1E*F :RJY8PW1'G,\>':PJAF-HLL7Z?7\UE4QR2L,Z=RODKBEI7G*BL)
M/>G:\5AKP"$:Y9!*'")(<Y;7)L(AC06'P%&VJ&(@LMI<8$6MIQ%X8Q(<<;4:
MY9!C'#)7YJRF]E27U9_@*,]@?@.4('T!)G>-?=*$: ?,IQ++5]-&DQ$?1( =
MR1XU8%+:!+>1:-18#HPJ3NV[[W'K<9C3HREE 9K/\!+GT8)'KWT?!?ZU8_[D
MNN:S9=NGAV,$Z5S#,3DY4.VRY.FF1([+N[D)R//]7 6\]G%N/'MEE2FZ%MGQ
MO=51DZ*G2YD_>:[O,S>ZYVT >@Q4>K?X>@4JL,ZDJ//!RK5AA*O0UH.=Z]:
M$N"]?TBAQT4BY@L*BIGE-]T.T2C,KD+5&Q,.F:!P$@W'Z$3%5;^%/F)_DJ;
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M8CR^YA;BP^"8X,98\8R !N'[4]"N:*4W0]ZI*B>VH=JK;GEP#+<33=YE;.[
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M _*Y%>M#=#P=I"CE&.,451.YW1L)#4'JXA);29>FZ [;;H*G%_A/#G:4YC)
MCD@"IZF[KEHOVZE[(Z\TF'6E:KRR5][6RQ[*=,V!;90'GF2.%_B]9'L[^S@(
M4GG^'\QB5=S+Z+4C0%J][G@H_ZSN2NA>X#_YM"JEDD?$,T]$M67AV<W=S7)S
MNXO3VBQ3<6 ;Y4*'%^><)G.[L>*&&^GB&FJYMX]OH0X!_\E>G%A*#U$1M;D\
M;YFONKE36RIO006(/#_('FJ?C;E8ZIU<"7-M+HKJ;KBPUD:^N 'Z8/F&[0)J
MT3?8TGL;GJD>>?<E19! ,7343APW<@77 MFVO]9QM]T?7X&9A?^]UDTS^7>\
MYMYKHI[/#.FL''C)8T_("RQ#MY-6RH&[+NRM_"KMRAR8R6^?+3-8OF54<?V2
M_XV-%C5:;>\WM,:$V.T 7:6K=?Y]EK,$-RC(/^FX'O!6M,S\[<'VM(%Y8,_K
MEU>''RS#X8DHB3CT$(QO F]+X#>$5\;;J+N]WN<YJ$[N@L[$N8.S;WU^Z_1P
ML)A?],VA+76P)"^S/:^(/9W\FD&VK;SIKG$;</Q9/[#D0(F8&O?)[F'UUX21
M__4"4!C[H& @M@^8/WP?=2\? "D$'98/!@9NM(Z)XS)^N ;]CTQ$NK=["( P
M4']4$_8 9!FT6" #=X1F]+2[/6$GW-2=].G'H/HH@.\MLP] >5;F19;CN!RT
M430U@3!F_"VEM1_\7'-]>$H/^A ^JQWA\Q#/., #&APS[H(_$/O-^I/T0VB7
M*/I,$+Q!NL<@^(79!\T_((-X#SWK )$?0.O(Y5HGX?,>X) XEE=V! (YYLG
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M!T^,IKUH+)0&P2GA*>$IX2GA+Y3PU-D:LYU(T4+10M%R#LY6Y;17]5[%HXF
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M8DT>[>,@9Y29'^[\X1KJ\T_P[*5%\RB7(>[MYV0G _\3V'0K[M67-^[-G/%
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MTO6H%33<<<W3Q_EC3*>@W,'VR]]!<(E@DC5 ^ZO/J;NDEOZM"N]Y_IUA&\H
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M^DIS68Z4/> 2,*>YQ#=W<RZ]?LZE=Y-RN>=P.P7+P4"MV*8S*!LU5P!X9P4
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M)T5U-#NR=0F^F+8^'*.R5#"F$P+__@=02P,$%     @ %8EJ2A9G. $.$@
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MQGT F[#9%^K'5)KO\I/_ 5!+ P04    "  5B6I*W]>"E+QK   %;@D %0
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M2"D@7KV$V4Z2KR.CN94&$K:)>C_SQ7VF$5O3X)J?6'\9IG2R2&B9NO61)H7
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MZ\;I"Q,;OW,,$Q:<@T]H['?'CD=V['S/=@.&E=L!![6BX]$5ZB$!7%'0B<L
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M,C1T&0(!T,9"RU"8K0-8 )DPG]*@<CN-(NJ79N$C9XLFA&J][<+;GI]:;PP
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MJ2EGT%U&O4&"=(DCM5NJZ#!,VTV.<O[O_\=;)^PY+"ZL*O6_GIH'*E^P5?E
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MF=W:7:JJWXO_//%=Q7_S_P%02P,$%     @ %8EJ2AR-/V'4D@  8TD( !4
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M.)0&U+5 B(3NBHC:'V:#Z'-V+HF[,-];*WZEX\F\N)0:H//T)C78N7<DX>F
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MBKA_$%**#B=S+2\UM' J>(!V3(T@88J-U*B<%_QH>!1EOR:"GM4_-"PK,@S
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M5-8QX82#/F991D6G&_G*P2TX^D+C;>.AWP_?/V\$,-W&^(NI4CY,F%<MIK@
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MP!7IWHRS8E'G?P=R.$X0E^E2+(P''^>Z=^NS#W07;$.E4MEBLHI>],Q*9^M
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MN3N*\9U@%J9'.3NGX!>6)>^WU6=6_8U6=3]*\$Z-'(13GQB<A4-3^SP.AW#
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M[2/3V)Q );7KT/!J=\G6_#XP^-PV/MRT2/;1M.X?U]IRT"UD\K.$'>KY;(+
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MTK:*W*X6(2$-0J3&Z.P!4"("IP4!K(A :T$$8F2.R[82S+2$I<KD>9$L3S:
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M$DD,@]XOZ9(6!4WNHY?SLJ15^9'R\_?\(<H3E@,7]H6W*W^$"62?G-QY$5"
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M*F_X%O.]SA^%SBOO. O4#68^T^/01:UOD$;FZ-R^;JZC2&!NG997A2D/V6!
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M3KZO>;FA<;I,:3+ND9L:;WC^G<SK[PCL@ [L))ND<<]!.$&X662%GB2UB="
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M?DSY3[^Q\@_^'WF'_XE5?'\P&NUE/QPJ(@P_;9#K. M\YH%E(7F!"G.IG@D
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MVB,L[X75V^E(+N8SUO-%T8Y8BUO\9$  %$-H22!#&J0CB+14B#5Z0 >1A$!
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MH@=&K(LZ:XN2?NUJDGY.#O2&'9),%3^J^QKV7#DSO/?8T,'\I >P(@"!_-Z
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M"VL/B*X@'-)K5D2^$L=J0QIY^X9*?RN49/@95<(%Y(ALV]T$@PG5HO/J5G_
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M>P-;(LAU'<[KT=UR_RJ0'W;+Z^B-K(OM[@O ,__:C.9U9:\K>UW9Z\KZ=&7
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M8#8F7( =O\C?)0<#CM/X)7VY^=_7N174<&\N> ('9OQ2_ "U1.!P.BWQMTA
MAR,W?E%?@%R_:<H'4(>J\_9C^4\V20\U_[O5>H,/.&"]-U6B.M5\.U;R*MV.
M7UE%UK:'ZB[TSD44T/P"!<R:]B7)$-7=4417[AIG&4FW+)R<3V*;_KW49DLP
M:.9W?-+;CC$D^>][(/^].?(_!7EII)V%.:$DO*-#_=P#1_)ASZS\'SN^#L^-
M4(4W3X/R"F'"#H]$?H_>RR@>3;4[,!XH* #*CIOK).N>KJ<0;\IXOMV<0/!X
M7;54IJLK?^_,&-,EE2!*(W8CH;).FHKG-6Y:(86\/B:3:G?O^)2$W!&*'?W
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M&]V$#Q6<]PS-^0',*J<RFRV.?L=Q(2J,8/0M04<B+7QHPMA#$\;EL? .=.]
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M76^]S3>@.ZYGFCNYZ-C3ER2EY%W2MC@4O!DF;MF#=^PF#1*Z83(THUNR9%M
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M0X<E\&17>$'G0DF(RK@$%,W)KES:<:6T)B.]\B#M;$[<!),*([J*2T)V__]
M)ZJOWB:B =VTDOD9Y?LZGRQ+MZS5MR#IMR"-LL\D">&D X?2RLX#RO(4ARRK
M+"?AUTNR9@=*N3L4/H)\%*U,9/4S:/5IF"E0SNFJF=PX)M\"NMMN2'I%BJ=\
M4<33J@*%&NWR<?0R<KFB&GB9_'I)DBH3EGURMH[),TI5>($-I9>=?2S<)<E.
MJG]!NN@E[R,AT3<<LP3D#4DH&N] )/*[#4+D^W9$:D7RCKW@.7T*DH@DO-L1
MW$D'@?3T_[,(XM+>5QZI=5JYV@4#&$;OBGU SR@ID,HY\+I+K^1!#==R":Y-
MJ -4+C3ALSQL0Q9QQEUDT&XVN&'WM-$?+NG_X_R5> 7EK+FW#8[S/8FL2G2E
MZN[$ ?4/*!KCY,5B0]S>X> )QYB]@*O"8&.W2?+!>Y^]]]E[G\?D).S[NO4^
M9^]S]CYG[W-N;8YOH\&<D<.YC<7DC#(V>K/IG9'KN8L-5Y_CV:;4J78V0'U>
MYA%BTW;=J/N71[&]U)T[8,1^=A.Q%G97,&2_N D9P(T+ANB#>V>4V/< ERD=
ME;E;>M+AN(U?&.]HX89#Y:I@WLY!#<?-$>&\<U 1'#'U %%;X_E4'6IPC.#R
M^H<*HP0MRV]EV^+JQW4%!PXNS+\!;@1K#.82,QX]FJ*04D<)+6=D3_;0H4JS
M?Y&3=#M95''GQXEF[/GZ?D),>YK<7!QJKPQT"E:]IO= F.-GM ];?J 35;^=
M+1Y05(1U;#S[?<8,7X>UBK+IFAF_FD(O>AFXUQ"3CA3=HS3D!,KT.[(V5A]>
MK;HR0AVM-W4236V@4_V@\#&-A OUM-':Q!3UNL<'?6,6\*&GNR2^QQT_KQIS
MG. ]C#Q)?K8;&:J*)$O: " +=4!)81:3\5 05JB4$[$3,F?%L.H3HP,R3</9
M#D'U4OS^H1A>W$N;H4;!^OY7R;(4D9NOVKZ&M1V2YDQ$U&55\(:T'8HW\D0'
M!-Z,-/X*/38PT/?-UWU@"V'A?,!V$E2O<U@(EH(PH#""A8PV7E!JG#8.82&K
MBO>9XB@F&?;!XH:)]L'BHXSN-6)'\1'E/J+<1Y3[B/+^"KSHD,$UK*S7/E ;
M$=5A%SZC8/6>).<S"E7783L[P]II_=MK-%94LQ5$S>Z><XN0[]M-?4;Q\CW:
MT\\H9+X'>Z2^Z'EKT>K+E7MVX?5:XJHT!MM;E[^A(UCKG"+P^_!*G%/D?9_1
M&SKC[VW%K>]:S IA][9#TW<DS/!1Y>_>3S*T+/\_11OV5&2R;/C- B=4M\&E
ME7]!TG7E"F@72][GE -&D/=/=J>X\4N2TBDIA9>T+0[?/"%\'"\K;ME#+/"^
M:$6=9D@2 372QCJ#D_O\AJ"0Y/X7S9"^THLBHZ=?EEV2]1.ED!%U$:3+ "?W
M11JN@@Q]I#^SLVV9X+_*MV9/8]>[#6;T04BZ-DF,H\J[P(YM@9M;W-@&XH61
M$;+F)ABHCZW&LT32RB"Y5&E^K#8XC'!>>Q/E).FM&592"_TY1J7@EC0^(7U2
M4E+>U7QD%,M^OZ%B'LM1QDE!3][#)72!Z,&+CMP+UR]Y&E"1E9Y5Z;;<$2P=
MD&4WD[B4XQ(JEJ),'#:J94:30.XK"1SXXP#0T-(*PNO-UBRB %L;()]I$70Y
MD->HBB,TQ9U,?HVZ#!QO[>S^[&,+N[%0+5XQV4UM#(;E[<3$W<:#1!:*^OB(
M3A_1>?81G;VJH3Z.T\=QRA5>HJI;NH(+[%8BH!O8.4SD8:[RN]RYV%_90@%;
M<?6%7-J,#-"B[-RRX>XEB"G2%33@MQ!(I=<7@FOI#@+945TY5U1$%I!UUA5@
MALW)&<O>\3DY\$@(GL5.WSUC+10 P_<9YL:T\1"=84),/U[R,TR%4?-UG&&:
MRX .24@86_T7]I\GNJKI;_Y_4$L! A0#%     @ %8EJ2E#.;'\,40$ Z(<1
M !$              ( !     &IY;G0M,C Q-C$R,S$N>&UL4$L! A0#%
M  @ %8EJ2H[ 5D7&&P  &5,! !$              ( !.U$! &IY;G0M,C Q
M-C$R,S$N>'-D4$L! A0#%     @ %8EJ2A9G. $.$@  KQX! !4
M     ( !,&T! &IY;G0M,C Q-C$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( !6)
M:DK?UX*4O&L   5N"0 5              "  7%_ 0!J>6YT+3(P,38Q,C,Q
M7V1E9BYX;6Q02P$"% ,4    "  5B6I*'(T_8=22  !C20@ %0
M    @ %@ZP$ :GEN="TR,#$V,3(S,5]L86(N>&UL4$L! A0#%     @ %8EJ
M2D6G-^M,;@  Y?,) !4              ( !9WX" &IY;G0M,C Q-C$R,S%?
=<')E+GAM;%!+!08     !@ & (H!  #F[ (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
